Drug	Variant/Haplotypes	Gene_Symbol	Allele	Phenotype_outcome	Effect_direction	Effect_type	Previous_Condition_Term	Metabolizer_status	ATC	Variant_Normalized	Drug_CID
nicotine	rs1801272	CYP2A6	AA	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1801272:AA	936
nicotine	rs1801272	CYP2A6	AT	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1801272:AT	936
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C1458155		No_ATC	*1/*28	91668186
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C1458155		No_ATC	*28/*28	91668186
tacrolimus	rs2740574	CYP3A4	T	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2740574:T	131769926
aripiprazole	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0033975	ultrarapid metabolizer	N05AX12	__UNKNOWN__	10114519
sulfamethoxazole / trimethoprim	rs1799930	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0032285		J01EE01	rs1799930:A	5578
atorvastatin, fluvastatin, hmg coa reductase inhibitors, pitavastatin, pravastatin, rosuvastatin, simvastatin	HLA-DRB1*01:01, HLA-DRB1*04:06	HLA-DRB1	*04:06	Toxicity	increased	Adverse_Event	Healthy		C10AA|C10AA01|C10AA03|C10AA04|C10AA05|C10AA07|C10AA08	*04:06	60823
ethanol	rs615470	CHRNA5	T	Toxicity, Other	decreased	Adverse_Event	Healthy		V03AB16	rs615470:T	444899
liraglutide	rs2254336	GLP1R	AT	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs2254336:AT	16134956
liraglutide	rs2254336	GLP1R	TT	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs2254336:TT	16134956
peginterferon alfa-2a, ribavirin, simeprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB11	rs8099917:TT	37542
drugs for treatment of tuberculosis	rs1041983	NAT2	T	Toxicity	increased	Adverse_Event	Other:C0041296		J04A	rs1041983:T	No_match
drugs for treatment of tuberculosis	rs1799931	NAT2	A	Toxicity	increased	Adverse_Event	Other:C0041296		J04A	rs1799931:A	No_match
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
gefitinib	rs2231142	ABCG2	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs2231142:GG	135496227
liraglutide	rs3765467	GLP1R	AA	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs3765467:AA	16134956
liraglutide	rs3765467	GLP1R	AG	Toxicity	increased	Adverse_Event	Other:C0011849		A10BJ02	rs3765467:AG	16134956
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
tamoxifen	CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
atorvastatin, pravastatin, simvastatin	rs2276307	HTR3B	G	Toxicity	increased	Adverse_Event	Disease:C0020443		C10AA01|C10AA03|C10AA05	rs2276307:G	60823
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	Adverse_Event	Disease:C0009324		L04AD02	*3/*3	131769926
nortriptyline	rs2500535	UST	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AA10	rs2500535:A	9918
tacrolimus	rs1851426	CYP3A4	G	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs1851426:G	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	*3	54688261
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*17	13748464
osimertinib	rs1800796	IL6	CG	Efficacy	decreased	Adverse_Event	Other:C0007131		L01EB04	rs1800796:CG	71496458
osimertinib	rs1800796	IL6	GG	Efficacy	decreased	Adverse_Event	Other:C0007131		L01EB04	rs1800796:GG	71496458
flucloxacillin	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*03:03	21319
risperidone	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6311:CT	849421
risperidone	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6311:TT	849421
tamoxifen	CYP2D6*6	CYP2D6	*6/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*6/*6	2733525
tamoxifen	CYP2D6*5	CYP2D6	*5/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*5	2733525
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
risperidone	rs6313	HTR2A	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6313:AA	849421
risperidone	rs6313	HTR2A	AG	Toxicity	increased	Adverse_Event	Other:C0036341		N05AX08	rs6313:AG	849421
oxazepam	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Healthy		N05BA04	rs1902023:AA	160870
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AG	11329481
oxazepam	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Healthy		N05BA04	rs1902023:AA	160870
sulfamethoxazole / trimethoprim	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*08:01	5578
efavirenz, isoniazid	poor metabolizer	CYP2B6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease	poor metabolizer	J04AC01|J05AG03	__UNKNOWN__	64139
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
tacrolimus	rs4823613	PPARA	GG	Toxicity	decreased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs4823613:GG	131769926
mercaptopurine, methotrexate	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*1/*3A	126941
nitrous oxide	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N01AX13	rs1801133:AA	948
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*3/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3	13748464
risperidone	rs167771	DRD3	G	Toxicity	increased	Adverse_Event	Disease:C0005586|Disease:C0036341		N05AX08	rs167771:G	849421
antipsychotics	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*1/*10	No_match
antipsychotics	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*10/*10	No_match
flucloxacillin	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*02:01	21319
flucloxacillin	HLA-A*01:01	HLA-A	*01:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*01:01	21319
amoxicillin	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*58:01	23663126
cisplatin, paclitaxel	rs5751901	GGT1	CC	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01|L01XA01	rs5751901:CC	5460033
antithyroid preparations	HLA-B*27:05	HLA-B	*27:05	Toxicity	increased	Adverse_Event	Healthy		H03B	*27:05	No_match
flucloxacillin	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*07:01	21319
busulfan	CYP2B6*1, CYP2B6*5, CYP2B6*9	CYP2B6	*1/*1	Efficacy	increased	Efficacy_Response	Disease:hemopoietic_stem_cell_transplant		L01AB01	*1/*1	4684
busulfan	CYP2B6*1, CYP2B6*5, CYP2B6*9	CYP2B6	*1/*5	Efficacy	increased	Efficacy_Response	Disease:hemopoietic_stem_cell_transplant		L01AB01	*1/*5	4684
busulfan	CYP2B6*1, CYP2B6*5, CYP2B6*9	CYP2B6	*1/*9	Efficacy	increased	Efficacy_Response	Disease:hemopoietic_stem_cell_transplant		L01AB01	*1/*9	4684
tamoxifen	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BA01	__UNKNOWN__	2733525
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*3	54688261
capecitabine, fluorouracil	rs17822471	ABCC11	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs17822471:AA	60953
capecitabine, fluorouracil	rs17822471	ABCC11	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs17822471:AG	60953
sulfamethoxazole / trimethoprim	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*15:02	5578
antipsychotics	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*1/*4	No_match
antipsychotics	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*1/*5	No_match
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*1/*10	154032615
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*1/*5	154032615
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*10/*10	154032615
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	Indeterminado	LADME	Healthy		N06AB08	*5/*10	154032615
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQA1*05	HLA-DQA1	*05	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	*05	No_match
peginterferon alfa-2a, peginterferon alfa-2b	rs9657182	IDO1	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		L03AB10|L03AB11	rs9657182:CC	No_match
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs3129763	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	rs3129763:AA	No_match
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs3129763	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	rs3129763:AG	No_match
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQB1*03:01	HLA-DQB1	*03:01	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	*03:01	No_match
nitrous oxide	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Other:C0549433		N01AX13	rs1801131:GG	948
ciprofloxacin, levofloxacin, moxifloxacin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01MA12|S01AE07|S03AA07	*57:01	2764
omeprazole	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Other:C0024198		A02BC01	rs11188072:TT	9579578
methadone	rs3735451	CYP3A4	C	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs3735451:C	10090
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2	13748464
carboplatin, paclitaxel	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs2032582:AA	10339178
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*1	2733525
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*1/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
sulfamethoxazole / trimethoprim	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*13:01	5578
antipsychotics	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Toxicity	Indeterminado	Adverse_Event	Disease:C0036341		N05A	*10	No_match
antidepressants	CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Efficacy	increased	Adverse_Event	Disease:C0011581	ultrarapid metabolizer	N06A	*2/*2xN	No_match
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10	2733525
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
asparaginase	rs59569490	ATL2	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01XX02	rs59569490:T	6267
azathioprine, mercaptopurine	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*02:01	5778
aspirin, cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	Efficacy_Response	Other:C0155626|diabetes_e.g.)		B01AC04|B01AC23	*2/*3	2244
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
escitalopram	rs4986893	CYP2C19	A	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	rs4986893:A	162180
platinum compounds	rs1862513	RETN	GG	Toxicity	increased	Adverse_Event	Other:C0024121		L01XA	rs1862513:GG	23939
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*1/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*6/*6	74990
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*4	2733525
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*6	6395
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*28	6395
primaquine	rs1137070	MAOA	CC	Efficacy	increased	Adverse_Event	Other:C0024530		P01BA03	rs1137070:CC	6135
primaquine	rs1137070	MAOA	CT	Efficacy	increased	Adverse_Event	Other:C0024530		P01BA03	rs1137070:CT	6135
omeprazole	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Other:C0024198		A02BC01	rs12248560:TT	9579578
primaquine	normal metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Adverse_Event	Other:C0024530	normal metabolizer	P01BA03	__UNKNOWN__	6135
azathioprine, mercaptopurine	rs746071566	NUDT15	GGAGTC	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs746071566:GGAGTC	5778
primaquine	CYP2D6*4	CYP2D6	*4	Efficacy	increased	Adverse_Event	Other:C0024530		P01BA03	*4	6135
escitalopram	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB10	rs11188072:TT	162180
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tenofovir	rs2125739	ABCC10	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs2125739:C	9574768
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*3	131769926
clopidogrel	CYP2C19*1, CYP2C19*5	CYP2C19	*5	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*5	13748464
efavirenz, isoniazid	poor metabolizer	CYP2B6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961	poor metabolizer	J04AC01|J05AG03	__UNKNOWN__	64139
rosuvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C0027051|Other:C0242339|Other:C0011849|Other:C0007222		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0027051|Other:C0242339|Other:C0011849|Other:C0007222		C10AA07	rs2231142:TT	5282455
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0235031		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0235031		L04AX01	*1/*3C	5778
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0007222|Other:C0011849|Other:C0027051|Other:C0242339		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C0007222|Other:C0011849|Other:C0027051|Other:C0242339		C10AA05	rs4149056:CT	656846
tacrolimus	rs2687116	CYP3A4	A	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2687116:A	131769926
carboplatin, paclitaxel	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:AG	10339178
carboplatin, paclitaxel	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:GG	10339178
carboplatin, paclitaxel	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:AG	10339178
carboplatin, paclitaxel	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01CD01|L01XA02	rs1128503:GG	10339178
escitalopram	rs4244285	CYP2C19	A	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	rs4244285:A	162180
none	rs11322783	IFNL4	TT/TT	Other	increased	Other	Disease:C0019372		A03DA02	rs11322783:TT/TT	5282367
mercaptopurine	rs72552763	SLC22A1	del	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs72552763:del	1268107
carboplatin, cisplatin	rs6856089	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Other:C0007131		L01XA01|L01XA02	rs6856089:AA	10339178
carboplatin, cisplatin	rs6856089	__INTRONIC__	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01XA01|L01XA02	rs6856089:AG	10339178
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Metabolism/PK	decreased	LADME	Disease:C0023449		L01BB02	*1/*3A	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Metabolism/PK	decreased	LADME	Disease:C0023449		L01BB02	*1/*3C	1268107
none	rs36232792	SOD1	GCCCAGTAAAGCATGGGGCCTGGGGCCAGGGACCCCCTTGTTCAGGTGTG/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs36232792:GCCCAGTAAAGCATGGGGCCTGGGGCCAGGGACCCCCTTGTTCAGGTGTG/del	5282367
none	rs36232792	SOD1	del/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs36232792:del/del	5282367
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3A/*3A	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3C/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3C/*3C	2265
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*5	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*5	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*14	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*14	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7	135483892
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy, Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*2	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy, Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*3	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy, Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*3/*3	156613579
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3A/*3A	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3C/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*3C/*3C	2265
none	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Other	increased	Adverse_Event	Other:C0178298		A03DA02	*1/*3	5282367
none	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Other	increased	Adverse_Event	Other:C0178298		A03DA02	*3/*3	5282367
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*17	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*3/*3	162180
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	Adverse_Event	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*3/*3	18642483
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3B	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3C	5778
antineoplastic agents, tamoxifen	CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*10	2733526
cyclosporine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*3A	86666680
cyclosporine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*3B	86666680
cyclosporine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*3C	86666680
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
cisplatin, pemetrexed	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BA04|L01XA01	rs1801131:GG	5460033
cisplatin, pemetrexed	rs1801131	MTHFR	GT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BA04|L01XA01	rs1801131:GT	5460033
escitalopram	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB10	rs12248560:TT	162180
phenytoin	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*13:01	1775
sufentanil	rs1801253	ADRB1	GG	Efficacy	decreased	Adverse_Event	Other:C0549433		N01AH03	rs1801253:GG	41693
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*5	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*10	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Side_Effect:C1458155		L01|L02BA01	*10/*41	2733526
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
tenofovir	rs9349256	ABCC10	G	Toxicity	increased	Adverse_Event	Healthy		J05AF07	rs9349256:G	9574768
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
imatinib	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Other:C0023480		L01EA01	rs1045642:A	6113
imatinib	rs3814055	NR1I2	TT	Toxicity	increased	Adverse_Event	Other:C0023480		L01EA01	rs3814055:TT	6113
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
selective serotonin reuptake inhibitors	rs6295	HTR1A	C	Efficacy	increased	Adverse_Event	Other:C0003469|Other:C0011581		N06AB	rs6295:C	5202
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*1/*4	5790
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*1/*7	5790
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*1/*9	5790
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*4/*4	5790
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*7/*7	5790
fluorouracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	*9/*9	5790
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:TT/TT	37542
methotrexate	rs1801394	MTRR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801394:G	11329481
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*4	4604
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*7	4604
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*9	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*9	4604
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*10	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	*10	4604
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
clopidogrel, rosuvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Other	increased	Other	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04|C10AA07	*2	446157
clopidogrel, rosuvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Other	increased	Other	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04|C10AA07	*3	446157
methadone	rs4646437	CYP3A4	A	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs4646437:A	10090
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1/*4	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*7	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1/*7	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*9	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1/*9	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*4/*4	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*7	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*7/*7	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9/*9	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*9/*9	5386
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17/*17	13748464
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*3	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*3	No_match
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*4	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*4	No_match
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*5	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*5	No_match
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*6	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*6	No_match
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*7	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*7	No_match
antipsychotics	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*14	CYP2D6	*14	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*14	No_match
azathioprine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5778
lamotrigine	HLA-C*07:18	HLA-C	*07:18	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*07:18	71236569
lamotrigine	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*58:01	71236569
rivaroxaban	rs4148738	ABCB1	CC	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01	rs4148738:CC	10700
lamotrigine	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*06:09	71236569
rivaroxaban	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Other:C0004238		B01AF01	rs1045642:AA	10700
tamoxifen	CYP2D6*10	CYP2D6	*10	Toxicity	increased	Adverse_Event	Other:C1458155		L02BA01	*10	2733525
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*3/*3	13748464
methotrexate	rs2236225	MTHFD1	A	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs2236225:A	11329481
methadone	rs2242480	CYP3A4	T	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs2242480:T	10090
carboplatin, cisplatin	rs2297136	CD274	AG	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2297136:AG	10339178
carboplatin, cisplatin	rs2297136	CD274	GG	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2297136:GG	10339178
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*17/*17	13748464
carboplatin, cisplatin	rs822336	CD274	CC	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs822336:CC	10339178
carboplatin, cisplatin	rs822336	CD274	CG	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs822336:CG	10339178
carboplatin, cisplatin	rs2282055	CD274	GT	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2282055:GT	10339178
carboplatin, cisplatin	rs2282055	CD274	TT	Efficacy	increased	Adverse_Event	Other:C0007134		L01XA01|L01XA02	rs2282055:TT	10339178
hydromorphone, morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01|N02AA03	rs1799971:AA	5359421
antipsychotics	CYP2D6*1, CYP2D6*2	CYP2D6	*2	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	*2	No_match
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02	1775
doxorubicin	rs1883112	NCF4	AA	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1883112:AA	83958
doxorubicin	rs1883112	NCF4	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1883112:AG	83958
azathioprine	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer	L04AX01	*1/*2	5778
azathioprine	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer	L04AX01	*1/*3	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*2	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*3C	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*8	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*8	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*9	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*9	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*12	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*12	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*1/*24	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*1/*24	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*2/*3A	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*2/*3A	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*3A/*3A	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*8, TPMT*9, TPMT*12, TPMT*24	TPMT	*3C/*3C	Toxicity	increased	Adverse_Event	Other:C0021368	intermediate metabolizer and poor metabolizer	L04AX01	*3C/*3C	5778
doxorubicin	rs3787728	CBR1	CT	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs3787728:CT	83958
doxorubicin	rs3787728	CBR1	TT	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs3787728:TT	83958
infliximab	HLA-DRB1*04:04	HLA-DRB1	*04:04	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*04:04	No_match
doxorubicin	rs1005695	CBR1	CG	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs1005695:CG	83958
doxorubicin	rs1005695	CBR1	GG	Efficacy	decreased	Adverse_Event	Other:C2239176		L01DB01	rs1005695:GG	83958
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*1/*5	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*1/*5	656846
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5/*5	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*5/*5	656846
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Other	increased	Other	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	*2	13748464
dabigatran	rs2244613	CES1	GG	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AE07	rs2244613:GG	169501783
dabigatran	rs2244613	CES1	GT	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AE07	rs2244613:GT	169501783
olanzapine, quetiapine, risperidone	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Healthy		N05AH03|N05AH04|N05AX08		5073
rivaroxaban	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs1045642:AA	10700
rivaroxaban	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs1045642:AG	10700
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02	1775
capecitabine, platinum	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C2931822		L01BC06|L01XA	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	23939
capecitabine, platinum	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C2931822		L01BC06|L01XA	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	23939
ondansetron	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Other	Disease:C0085762		A04AA01		4595
chop, rituximab	rs8133052	CBR3	AA	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8133052:AA	No_match
chop, rituximab	rs8133052	CBR3	AG	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8133052:AG	No_match
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*15:02	71236569
chop, rituximab	rs8187710	ABCC2	AA	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8187710:AA	No_match
chop, rituximab	rs8187710	ABCC2	AG	Toxicity	increased	Adverse_Event	Other:C0024299		L01FA01	rs8187710:AG	No_match
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	decreased	Efficacy_Response	Other:C0026640		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5790
cyclophosphamide	CYP2B6*1, CYP2B6*5, CYP2B6*6	CYP2B6	*5/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01	*5/*6	9554282
methotrexate	rs1051266	SLC19A1	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0023449		L04AX03	rs1051266:T	11329481
selective serotonin reuptake inhibitors	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Healthy		N06AB		5202
warfarin	CYP2C9*1, CYP2C9*11	CYP2C9	*1/*11	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*11	54688261
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C	2265
gemcitabine, platinum compounds	rs1042927	RRM1	C	Efficacy	decreased	Efficacy_Response	Disease:C0025500		L01BC05|L01XA	rs1042927:C	23939
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CC	11329481
selective serotonin reuptake inhibitors	rs6311	HTR2A	CC	Toxicity	decreased	Adverse_Event	Other:C0011581		N06AB	rs6311:CC	5202
selective serotonin reuptake inhibitors	rs6311	HTR2A	TT	Toxicity	decreased	Adverse_Event	Other:C0011581		N06AB	rs6311:TT	5202
amoxicillin, clavulanate	HLA-B*15:18	HLA-B	*15:18	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:18	16204478
irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*37	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*37	UGT1A1	*28/*37	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*37	74990
capecitabine, paclitaxel	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD01	rs11280056:TTAAAGTTA/TTAAAGTTA	60953
azathioprine, mercaptopurine	rs11664064	PTPN2	C	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0409974|Other:C0004364		L01BB02|L04AX01	rs11664064:C	5778
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*3/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*5	2733526
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1979277	SHMT1	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1979277:A	135403648
methotrexate	rs2236225	MTHFD1	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs2236225:AA	11329481
tamoxifen	rs3892097	CYP2D6	CT	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs3892097:CT	2733525
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs3892097:TT	2733525
methotrexate	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1045642:GG	11329481
methotrexate	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs1695:AA	11329481
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463|Other:C0024299|Other:C1261473		L04AX03	rs1801133:AG	11329481
mercaptopurine, methotrexate	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1142345:C	126941
methotrexate	rs11045879	SLCO1B1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs11045879:T	11329481
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01	16204478
amoxicillin, clavulanate	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*02:01	16204478
amoxicillin, clavulanate	rs1363907	ERAP1, ERAP2	G	Toxicity	increased	Adverse_Event	Healthy		J01CA04	rs1363907:G	16204478
cyclophosphamide	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01		9554282
amoxicillin, clavulanate	rs2476601	PTPN22	A	Toxicity	increased	Adverse_Event	Healthy		J01CA04	rs2476601:A	16204478
cyclophosphamide	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01		9554282
capecitabine	rs3786362	TYMS	G	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC06	rs3786362:G	11809635
capecitabine	rs699517	TYMS	C	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs699517:C	11809635
capecitabine	rs11280056	ENOSF1, TYMS	TTAAAGTTA	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs11280056:TTAAAGTTA	11809635
capecitabine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	11809635
capecitabine	rs2790	ENOSF1, TYMS	G	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC06	rs2790:G	11809635
none	rs2302254	NME1, NME1-NME2	TT	Efficacy	decreased	Adverse_Event	Other:C0023055		A03DA02	rs2302254:TT	5282367
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*1a/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1a/*3	74990
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*2/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*2/*3	74990
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*3/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*3/*3	74990
rivaroxaban	rs76292544	SUSD3	TT	Toxicity	increased	Adverse_Event	Other:C1861172		B01AF01	rs76292544:TT	10700
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*6/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*6/*6	74990
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*1a/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*1a/*3	74990
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*2/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*2/*3	74990
irinotecan	UGT1A7*1a, UGT1A7*2, UGT1A7*3	UGT1A7	*3/*3	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*3/*3	74990
methotrexate	rs4149081	SLCO1B1	G	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs4149081:G	11329481
sulfamethoxazole / trimethoprim	HLA-A*02:07	HLA-A	*02:07	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*02:07	5578
aspirin	rs11587213	FCER1G	AA	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs11587213:AA	72204814
lapatinib	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*02:01	208908
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*7	131769926
lapatinib	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Other:C1458155		L01EH01	*02:01	208908
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:C	131769926
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Other:C1458155		L01EH01	*07:01	208908
none	rs569108	MS4A2	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs569108:AG	5282367
none	rs569108	MS4A2	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs569108:GG	5282367
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*07:01	208908
paclitaxel	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01CD01	rs2032582:AA	36314
ethambutol, isoniazid / pyrazinamide / rifampin	rs536560	FECH	CC	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs536560:CC	135483892
none	rs11587213	FCER1G	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs11587213:AG	5282367
none	rs11587213	FCER1G	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs11587213:GG	5282367
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*1/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*2/*2	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*2/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3/*3	1775
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Adverse_Event	Healthy		B01AA07	*3	54742534
cisplatin, radiotherapy	rs1051740	EPHX1	CT	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs1051740:CT	5460033
cisplatin, radiotherapy	rs1051740	EPHX1	TT	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs1051740:TT	5460033
cisplatin, radiotherapy	rs13181	ERCC2	GG	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs13181:GG	5460033
cisplatin, radiotherapy	rs13181	ERCC2	GT	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs13181:GT	5460033
cisplatin, radiotherapy	rs1799793	ERCC2	CT	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs1799793:CT	5460033
cisplatin, radiotherapy	rs1799793	ERCC2	TT	Efficacy	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms|Other:C0024121|Other:Neoplasm_of_esophagus		L01XA01	rs1799793:TT	5460033
gemcitabine, platinum compounds	rs2072671	CDA	C	Toxicity	increased	Adverse_Event	Disease:C0025500		L01BC05|L01XA	rs2072671:C	23939
none	CYP2A6*4	CYP2A6	*4/*4	Other	increased	Adverse_Event	Other:C0039338		A03DA02	*4/*4	5282367
anthracyclines and related substances	rs4646450	CYP3A5	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0029463		L01DB	rs4646450:AA	No_match
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*1/*6	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*6	NUDT15	*2/*2	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	*2/*2	1268107
anthracyclines and related substances	rs7853758	SLC28A3	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB	rs7853758:AA	No_match
azathioprine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3C	5778
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Adverse_Event	Disease:C0079487		A02BC01	*1/*1	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Adverse_Event	Disease:C0079487		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Adverse_Event	Disease:C0079487		A02BC01	*1/*3	9579578
ethambutol, isoniazid / pyrazinamide / rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__	135483892
phenprocoumon	rs9923231	VKORC1	TT	Dosage, Other	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT	91987769
methotrexate	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs11280056:TTAAAGTTA/TTAAAGTTA	11329481
carboplatin, gemcitabine	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC05|L01XA02	rs11280056:TTAAAGTTA/TTAAAGTTA	10339178
methotrexate	rs4149056	SLCO1B1	C	Other, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:C	11329481
asparaginase	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	*07:01	6267
enalapril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Adverse_Event	Disease:C0017658|IGA		C09AA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5950
succinylcholine, volatile anesthetics	rs193922752	RYR1	G	Toxicity	increased	Adverse_Event	Healthy		N01	rs193922752:G	5314
egfr inhibitors	rs2227983	EGFR	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB	rs2227983:GG	No_match
gemcitabine, platinum compounds	rs12806698	RRM1	A	Toxicity	decreased	Adverse_Event	Disease:C0025500		L01BC05|L01XA	rs12806698:A	23939
gemcitabine, platinum compounds	rs11030918	RRM1	C	Toxicity	decreased	Adverse_Event	Disease:C0025500		L01BC05|L01XA	rs11030918:C	23939
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
verapamil	rs1801252	ADRB1	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801252:AA	65808
verapamil	rs1801252	ADRB1	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801252:AG	65808
heroin	rs12364283	DRD2	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12364283:G	9844225
repaglinide	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		A10BX02	*3	22132924
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*3/*3	13748464
azathioprine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AX01	*1/*3C	5778
sulfamethoxazole / trimethoprim	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J01EE01	__UNKNOWN__	5578
azathioprine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3/*3	5778
tacrolimus	rs2257401	CYP3A7	C	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2257401:C	131769926
simvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	*3/*3	14373154
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*3/*3	13748464
phenytoin	rs4986893	CYP2C19	A	Toxicity	increased	Adverse_Event	Healthy		N03AB02	rs4986893:A	1775
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*3/*5	63013
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3/*3	13748464
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*4/*4	63013
tacrolimus	rs4646437	CYP3A4	G	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs4646437:G	131769926
isoniazid, rifampin	NAT2*4	NAT2	*4	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0041296		J04AC01	*4	135483892
asparaginase	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs4880:GG	6267
none	rs762551	CYP1A2	AC	Other	increased	Adverse_Event	Other:C0426596		A03DA02	rs762551:AC	5282367
none	rs762551	CYP1A2	CC	Other	increased	Adverse_Event	Other:C0426596		A03DA02	rs762551:CC	5282367
antithyroid preparations	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*39:01	No_match
trastuzumab	rs1136201	ERBB2	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		No_ATC	rs1136201:AG	166596981
trastuzumab	rs1136201	ERBB2	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		No_ATC	rs1136201:GG	166596981
simvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	*3/*3	14373154
phenytoin	rs1799853	CYP2C9	T	Toxicity	increased	Adverse_Event	Healthy		N03AB02	rs1799853:T	1775
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
beta blocking agents	rs61767072	ADRA2C	GGGGCGGGGCCG/GGGGCGGGGCCG	Efficacy	increased	Adverse_Event	Other:C0027051		S01ED	rs61767072:GGGGCGGGGCCG/GGGGCGGGGCCG	No_match
paclitaxel	rs7001034	FZD3	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01	rs7001034:A	36314
capecitabine, fluorouracil	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs11280056:TTA/TTA	60953
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	Indeterminado	Adverse_Event	Healthy		M04AA01	*58:01	168354693
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB06		18642483
clozapine	HLA-DRB1*04:02	HLA-DRB1	*04:02	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	*04:02	131769989
direct acting antivirals	rs12979860	IFNL3, IFNL4	TT	Toxicity	increased	Adverse_Event	Other:C0019372		J05A	rs12979860:TT	No_match
gliclazide, glimepiride, glipizide, gliquidone, glyburide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Other	increased	Adverse_Event	Disease:C0011849		A10BB07|A10BB08|A10BB09|A10BB12	*2	91610
gliclazide, glimepiride, glipizide, gliquidone, glyburide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Other	increased	Adverse_Event	Disease:C0011849		A10BB07|A10BB08|A10BB09|A10BB12	*3	91610
tramadol	CYP2D6*1, CYP2D6*5	CYP2D6	*5/*5	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*5/*5	63013
aspirin, beta blocking agents, clopidogrel, hmg coa reductase inhibitors	rs1799983	NOS3	T	Other	increased	Adverse_Event	Disease:C1956346		B01AC04|C10AA|S01ED	rs1799983:T	2244
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA	5460033
anthracyclines and related substances, tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01DB|L02BA01	*4/*4	2733526
aspirin, clopidogrel	rs1057910	CYP2C9	AC	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs1057910:AC	2244
aspirin, clopidogrel	rs1057910	CYP2C9	CC	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs1057910:CC	2244
tacrolimus	rs6956344	CYP3A4	C	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs6956344:C	131769926
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA	5460033
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*1/*28	74990
carbamazepine	HLA-B*15:21	HLA-B	*15:21	Toxicity	increased	Adverse_Event	Other:C0014544|Other:C0040435|Other:C0522067		N03AF01	*15:21	114709
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
paclitaxel	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0220650		L01CD01	rs1045642:AG	36314
clopidogrel	CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2	13748464
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2	13748464
paclitaxel	rs776746	CYP3A5	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs776746:C	36314
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4	2733525
infliximab	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*02:01	No_match
infliximab	HLA-DPB1*10:01	HLA-DPB1	*10:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*10:01	No_match
infliximab	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*03:01	No_match
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*10x2	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*10x2	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*10x2	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10x2	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*14	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*14	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*21	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*21	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*36	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*36	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*1xN/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1xN/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*21	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*21	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*21	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*21	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*36	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*36	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*41	2733525
none	HLA-DPB1*03:01	HLA-DPB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		A03DA02	*03:01	5282367
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*10	2733526
tramadol	CYP2D6*1, CYP2D6*6	CYP2D6	*6/*6	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*6/*6	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Dosage, Efficacy	increased	Adverse_Event	Healthy		N02AX02	*4/*5	63013
clopidogrel	CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*2	13748464
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0235889|Gouty		M04AA01	*58:01	168354693
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs12283870	CPT1A, IGHMBP2	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs12283870:T	2907
folfirinox	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Other:C0030297		No_ATC	*28	No_match
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*14	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*14	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*21	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*21	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*36	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*36	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*41	CYP2D6	*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*41	2733525
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:lung_transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	rs2242480	CYP3A4	C	Metabolism/PK	Indeterminado	LADME	Healthy		L04AD02	rs2242480:C	131769926
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*10	2733525
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A	1268107
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02	No_match
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT	37542
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other	increased	Other	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		C01BC04	*4	134295
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		C01BC04	*5	134295
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*10	Metabolism/PK	increased	LADME	Healthy		C01BC04	*10	134295
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*21	Metabolism/PK	increased	LADME	Healthy		C01BC04	*21	134295
flecainide	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*36	Metabolism/PK	increased	LADME	Healthy		C01BC04	*36	134295
tranilast	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0151744		No_ATC	*28/*28	5282230
nortriptyline	CYP2D6*1, CYP2D6*3	CYP2D6	*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*3	9918
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*5/*36	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*5/*36	134295
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*10/*10	134295
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*10/*36	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*10/*36	134295
flecainide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36	CYP2D6	*21/*36	Metabolism/PK	decreased	LADME	Healthy		C01BC04	*21/*36	134295
antithyroid preparations	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*08:03	No_match
antithyroid preparations	HLA-DQA1*01:03	HLA-DQA1	*01:03	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*01:03	No_match
antithyroid preparations	HLA-DQB1*06:01	HLA-DQB1	*06:01	Toxicity	increased	Adverse_Event	Other:C0242656		H03B	*06:01	No_match
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*1/*3	54688261
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*41	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*1/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*20, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*2/*5	2733526
capecitabine	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs67376798:AT	11809635
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
cytarabine, idarubicin	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2032582:CC	6253
clopidogrel	rs2069514	CYP1A2	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs2069514:A	13748464
opioids	rs548646	OPRM1	T	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs548646:T	No_match
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:heart_transplantation		L04AD02	*1/*3	131769926
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*10	9918
tacrolimus	rs2242480	CYP3A4	C/T	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs2242480:C/T	131769926
tacrolimus	rs2242480	CYP3A4	T/T	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs2242480:T/T	131769926
rhodamine 123	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:GG	9929799
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs4244285:AA	2244
aspirin, clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	rs4244285:AG	2244
mercaptopurine, thioguanine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	Indeterminado	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3A	2723601
aspirin, clopidogrel, ticagrelor	rs2768759	PEAR1	AC	Toxicity	increased	Adverse_Event	Other:C0018839		B01AC04|B01AC24	rs2768759:AC	2244
lamotrigine	HLA-A*68:01	HLA-A	*68:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*68:01	71236569
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		M01AH01	*1/*3	66824
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*2	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*2	5778
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*3	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*3	5778
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*4	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*4	5778
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*5	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*5	5778
azathioprine, mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6	NUDT15	*6	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*6	5778
carbamazepine	HLA-A*01:01	HLA-A	*01:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*01:01	114709
tetanus antitoxin	HLA-A*02:06	HLA-A	*02:06	Toxicity	increased	Adverse_Event	Healthy		J06AA02	*02:06	No_match
carbamazepine	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*11:01	114709
acetaminophen	HLA-A*24:02	HLA-A	*24:02	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	*24:02	1983
carbamazepine	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*24:02	114709
infliximab	HLA-B*08:01	HLA-B	*08:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*08:01	No_match
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
vancomycin	HLA-A*32:01	HLA-A	*32:01	Toxicity	increased	Adverse_Event	Healthy		J01XA01	*32:01	6420023
phenytoin	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*38:02	1775
nevirapine	HLA-B*14:02	HLA-B	*14:02	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*14:02	15979285
phenytoin	HLA-B*15:01	HLA-B	*15:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:01	1775
antiepileptics	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Other:C0014544		N03A	*15:02	No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
antiepileptics	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03A	*15:02	No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02	1775
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02	1775
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11	114709
phenytoin	HLA-B*15:13	HLA-B	*15:13	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:13	1775
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	*3A	5778
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	*3C	5778
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*4	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*6	1268107
clindamycin	HLA-B*15:27	HLA-B	*15:27	Toxicity	increased	Adverse_Event	Healthy		J01FF01	*15:27	443385
nevirapine	HLA-B*35:01	HLA-B	*35:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*35:01	15979285
clozapine	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02	*38:01	131769989
lamotrigine	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*38:01	71236569
sulfamethoxazole / trimethoprim	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*38:02	5578
infliximab	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*39:01	No_match
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*40:01	114709
oxcarbazepine	HLA-B*40:02	HLA-B	*40:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*40:02	46782646
mirtazapine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX11	*3/*4	6451144
mirtazapine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX11	*4/*6	6451144
phenytoin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*51:01	1775
carbamazepine	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*51:01	114709
nilotinib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023473|BCR-ABL1_positive		L01EA03	*28/*28	6395
clindamycin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		J01FF01	*51:01	443385
phenytoin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*51:01	1775
phenytoin	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*51:01	1775
isoniazid	HLA-B*52:01	HLA-B	*52:01	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*52:01	135483892
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01	No_match
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01	No_match
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0004936		N06AX11	*4	6451144
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0004936		N06AX11	*5	6451144
opioids	rs609148	OPRM1	A	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs609148:A	No_match
atazanavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	*1/*28	118753185
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02	No_match
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*1	86666680
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*18	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*18	86666680
sulfamethoxazole / trimethoprim	HLA-C*07:27	HLA-C	*07:27	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*07:27	5578
nevirapine	HLA-C*08:02	HLA-C	*08:02	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*08:02	15979285
infliximab	HLA-C*12:03	HLA-C	*12:03	Toxicity	increased	Adverse_Event	Healthy		L04AB02	*12:03	No_match
none	HLA-DPB1*03:01	HLA-DPB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		A03DA02	*03:01	5282367
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
phenytoin	HLA-C*15:02	HLA-C	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02	1775
tacrolimus	rs890293	CYP2J2	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs890293:AA	131769926
tacrolimus	rs890293	CYP2J2	AC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs890293:AC	131769926
carbamazepine	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*03:03	114709
abacavir	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*03:03	56927907
nevirapine	HLA-DQB1*05:01	HLA-DQB1	*05:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*05:01	15979285
flupirtine	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Healthy		N02BG07	*05:02	53276
amoxicillin, clavulanate	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Disease:C0699744		J01CA04	*06:02	16204478
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:01	15979285
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*01:01	15979285
nevirapine	HLA-DRB1*01:02	HLA-DRB1	*01:02	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:02	15979285
hydralazine	HLA-DRB1*04:01	HLA-DRB1	*04:01	Toxicity	increased	Adverse_Event	Other:C0020538		C02DB02	*04:01	81764
oxcarbazepine	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*04:03	46782646
abacavir	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*07:01	56927907
asparaginase	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	*07:01	6267
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		L01EH01	*07:01	208908
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4969170	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs4969170:AA	37542
pravastatin	rs2738466	LDLR	G	Efficacy	increased	Adverse_Event	Healthy		C10AA03	rs2738466:G	58746970
lamotrigine	HLA-DRB1*13:01	HLA-DRB1	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*13:01	71236569
flupirtine	HLA-DRB1*16:01	HLA-DRB1	*16:01	Toxicity	increased	Adverse_Event	Healthy		N02BG07	*16:01	53276
thalidomide	rs4630	GSTT1	AA	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX02	rs4630:AA	5743568
minocycline	HLA-B*35:02	HLA-B	*35:02	Toxicity	increased	Adverse_Event	Healthy		J01AA08	*35:02	54675783
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	*1/*2	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	*1/*3	1775
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*3	54688261
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01	168354693
rosiglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Toxicity	decreased	Adverse_Event	Disease:C0011849		A10BG02	*3	9846723
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*3	131769926
calcineurin inhibitors, cyclosporine, tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD|L04AD01|L04AD02	*3	445643
aspirin, cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	Efficacy_Response	Other:C0155626|diabetes_e.g.)		B01AC04|B01AC23	*2/*3	2244
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
paclitaxel, platinum compounds	rs1799931	NAT2	AA	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CD01|L01XA	rs1799931:AA	23939
caffeine	low activity	CYP1A2	__UNKNOWN__	Other	increased	Other	Disease:C0032961	low activity	N06BC01	__UNKNOWN__	936
hmg coa reductase inhibitors	rs5443	GNB3	CT	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA	rs5443:CT	445127
hmg coa reductase inhibitors	rs5443	GNB3	TT	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA	rs5443:TT	445127
none	rs3846662	HMGCR	AA	Other	decreased	Other	Healthy		A03DA02	rs3846662:AA	5282367
atazanavir, ritonavir	UGT1A1*28	UGT1A1	*28	Metabolism/PK	Indeterminado	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*28	25134325
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*2/*2	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*2/*2	135405018
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*2/*3	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*2/*3	135405018
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*3/*3	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*3/*3	135405018
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*5/*5	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	poor metabolizer	No_ATC	*5/*5	135405018
methotrexate	SLCO1B1*15	SLCO1B1	*15	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX03	*15	11329481
caffeine	rs35320474	ADORA2A	T/del	Efficacy	increased	Adverse_Event	Other:Apnea_of_prematurity|Other:C0022876		N06BC01	rs35320474:T/del	936
caffeine	rs35320474	ADORA2A	TT	Efficacy	increased	Adverse_Event	Other:Apnea_of_prematurity|Other:C0022876		N06BC01	rs35320474:TT	936
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*3	54688261
none	rs70991108	DHFR	del/del	Other	increased	Other	Healthy		A03DA02	rs70991108:del/del	5282367
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA	5460033
fluoxetine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*1/*17	1548968
fluoxetine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*17/*17	1548968
fluoxetine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*1/*1	1548968
fluoxetine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	decreased	Adverse_Event	Other:C0003469|Other:C0235876|Other:C0011581		N06AB03	*1/*3	1548968
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*20	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*20	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*26	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*26	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*24	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*24	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*9	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*27	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*27	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*20, CYP2A6*24, CYP2A6*26, CYP2A6*27	CYP2A6	*17	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*17	936
cocaine, ethanol, opioids	rs3823010	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs3823010:A	702
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11	114709
capecitabine, fluorouracil, folfox, xelox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055|Other:C0027651		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	60953
capecitabine, fluorouracil, folfox, xelox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055|Other:C0027651		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	60953
cocaine, ethanol, opioids	rs495491	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs495491:G	702
interferon beta-1a, interferon beta-1b	rs9272105	HLA-DQA1	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs9272105:G	No_match
capecitabine, fluorouracil, folfox, xelox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055|Other:C0027651		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	60953
repaglinide	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*37/*37	Metabolism/PK	decreased	LADME	Healthy		A10BX02	*37/*37	22132924
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01	15979285
egfr inhibitors	rs2227983	EGFR	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		L01EB	rs2227983:A	No_match
atazanavir, ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*28/*28	25134325
atazanavir, ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*1/*28	25134325
nevirapine	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*08:01	15979285
interferon beta-1a, interferon beta-1b	rs4961252	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs4961252:G	No_match
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	11329481
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	11329481
pegaspargase	HLA-DRB1*16:02	HLA-DRB1	*16:02	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX24	*16:02	No_match
asparaginase, cytarabine, daunorubicin, etoposide, mercaptopurine, methotrexate, prednisone, vincristine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Adverse_Event	Disease:C0023449		H02AB07|L01BB02|L01BC01|L01CA02|L01CB01|L01DB02|L01XX02|L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	5865
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	11329481
gemcitabine	rs9937	RRM1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01BC05	rs9937:G	597
none	rs1799752	ACE	del/del	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs1799752:del/del	5282367
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	PD	decreased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	PD	decreased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
ethanol	rs1381376	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1381376:T	444899
nevirapine	HLA-B*35:01	HLA-B	*35:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*35:01	15979285
pegaspargase	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Healthy		L01XX24	*02:01	No_match
pegaspargase	HLA-DQB1*02:02	HLA-DQB1	*02:02	Toxicity	increased	Adverse_Event	Healthy		L01XX24	*02:02	No_match
pegaspargase	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		L01XX24	*07:01	No_match
methotrexate	rs70991108	DHFR, MSH3	TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs70991108:TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT	11329481
methotrexate	rs11280056	ENOSF1, TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs11280056:TTA/TTA	11329481
methotrexate	rs11280056	ENOSF1, TYMS	TTA/TTAAAGTTA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs11280056:TTA/TTAAAGTTA	11329481
none	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Adverse_Event	Healthy		A03DA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5282367
cyclosporine, tacrolimus	rs1128503	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD01|L04AD02	rs1128503:GG	445643
none	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Adverse_Event	Other:COVID-19		A03DA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5282367
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AA04|N06AA09	*2/*2	2160
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*1	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AA04|N06AA09	*2/*1	2160
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AA04|N06AA09	*2/*17	2160
none	rs1799752	ACE	del	Other	increased	Adverse_Event	Healthy		A03DA02	rs1799752:del	5282367
aspirin, beta blocking agents, clopidogrel, hmg coa reductase inhibitors	rs1050450	__INTRONIC__	A	Other	increased	Adverse_Event	Disease:C1956346		B01AC04|C10AA|S01ED	rs1050450:A	2244
none	rs1799752	ACE	del/del	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs1799752:del/del	5282367
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*1	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AB06	*2/*1	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0005586	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17	18642483
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*5	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*5	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*6	1268107
clopidogrel	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	13748464
leflunomide	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Toxicity	decreased	Adverse_Event	Other:C0003873		No_ATC	*1/*17	54684141
leflunomide	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Other:C0003873		No_ATC	*17/*17	54684141
anakinra, canakinumab, rilonacept, tocilizumab	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Other:C0003873|Other:Adult-onset_Still_disease		L04AC03|L04AC04|L04AC07|L04AC08	*15:01	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	GG	Efficacy	increased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs11322783:GG	37542
nortriptyline	CYP2D6*1, CYP2D6*3	CYP2D6	*3	Metabolism/PK	increased	LADME	Healthy		N06AA10	*3	9918
flucloxacillin	HLA-B*57:03	HLA-B	*57:03	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:03	21319
cisplatin	TPMT*1, TPMT*3B, TPMT*3C	TPMT	*3B	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	*3B	441203
cisplatin	TPMT*1, TPMT*3B, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	*3C	441203
prednisone, tacrolimus	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:heart_transplantation		H02AB07|L04AD02	rs1045642:GG	5865
carbamazepine	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*11:01	114709
flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:01	21319
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
atazanavir	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	*1/*3	118753185
atazanavir	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	*1/*1	118753185
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3A	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3B	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3C	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Other:C0023449	intermediate metabolizer	L01BB02	*1/*2	1268107
antiinflammatory agents, non-steroids	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*3	No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
egfr inhibitors	rs712829	EGFR	T	Toxicity	Indeterminado	Efficacy_Response	Healthy		L01EB	rs712829:T	No_match
antineoplastic agents	rs11280056	TYMS	TTA	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs11280056:TTA	No_match
carbamazepine	HLA-A*74:01	HLA-A	*74:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*74:01	114709
carbamazepine	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*08:01	114709
carbamazepine	HLA-A*24:07	HLA-A	*24:07	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*24:07	114709
carbamazepine	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*24:02	114709
azathioprine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0035435		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C0035435		L04AX01	*1/*1	5778
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
clopidogrel	CYP2C19*1, CYP2C19*4	CYP2C19	*4	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*4	13748464
atazanavir	UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	*28	118753185
atorvastatin, pravastatin	rs429358	APOE	CC	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs429358:CC	60823
atorvastatin, pravastatin	rs429358	APOE	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs429358:CT	60823
clozapine	GSTM1 non-null, GSTM1 null	GSTM1	null/null	Toxicity	decreased	Adverse_Event	Healthy		N05AH02		131769989
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*3/*17	2244
opioids	rs1799971	OPRM1	AA	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1799971:AA	No_match
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
tamoxifen	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*4, CYP2D6*7	CYP2D6	*4/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*7	2733525
tramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy	poor metabolizer	N02AX02	__UNKNOWN__	63013
methotrexate	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs4149056:CT	11329481
tamoxifen	CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*6	2733525
carbamazepine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*07:01	114709
carbamazepine	HLA-DRB1*12:02	HLA-DRB1	*12:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*12:02	114709
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*5	2733525
carbamazepine	HLA-DRB1*04:05	HLA-DRB1	*04:05	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*04:05	114709
omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Other	Disease:C0041582		A02BC01	*1/*2	9579578
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-B*46:01	HLA-B	*46:01	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*46:01	114709
nortriptyline	CYP2D6*1, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		N06AA10	*5	9918
carbamazepine	HLA-DRB1*09:01	HLA-DRB1	*09:01	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*09:01	114709
carbamazepine	HLA-DQA1*03:02	HLA-DQA1	*03:02	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*03:02	114709
ticagrelor	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	*1/*22	78358176
efavirenz	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*08:03	64139
efavirenz	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*01:02	64139
nevirapine	HLA-DRB1*04:05	HLA-DRB1	*04:05	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG01	*04:05	15979285
tamoxifen	CYP2D6*4, CYP2D6*11	CYP2D6	*4/*11	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*11	2733525
cyclosporine	rs1128503	ABCB1	AA	Dosage, Metabolism/PK	increased	LADME	Disease:C0026896		L04AD01	rs1128503:AA	86666680
none	rs383510	TMPRSS2	CC	Other	increased	Adverse_Event	Healthy		A03DA02	rs383510:CC	5282367
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*07:01	208908
tamoxifen	CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3/*4	2733525
fluvastatin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	*2	131750727
fluvastatin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	*3	131750727
nortriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		N06AA10	*4	9918
tamoxifen	CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3/*5	2733525
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28, UGT1A1*36	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28	25134325
cyclosporine	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	increased	LADME	Disease:C0026896		L04AD01	rs2032582:AA	86666680
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*1/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*1/*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*2/*17	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB06	*2/*3	18642483
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*3/*3	54688261
methadone	rs2246709	CYP3A4	G	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs2246709:G	10090
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB08	*10/*10	154032615
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB08	*5/*10	154032615
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*4	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*4	162180
pravastatin	rs20455	KIF6	AG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:AG	58746970
pravastatin	rs20455	KIF6	GG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:GG	58746970
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*41	2733525
methazolamide	HLA-B*55:02	HLA-B	*55:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*55:02	No_match
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01	No_match
acetaminophen, codeine, levomepromazine	CYP2D6*1	CYP2D6	*1/*1	Efficacy, Metabolism/PK	Indeterminado	LADME	Disease:C0004604		N02BE01|N05AA02|R05DA04	*1/*1	1983
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*15:02	71236569
methadone	rs2242480	CYP3A4	T	Other	increased	Adverse_Event	Disease:C0028043		N07BC02	rs2242480:T	10090
docetaxel, thalidomide	rs12960	RPL13, SNORD68, SPG7	G	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs12960:G	148124
docetaxel, thalidomide	rs1871450	CHST3	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs1871450:A	148124
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*3/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*3	13748464
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2	162180
peginterferon alfa-2b, ribavirin	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10		37542
methadone	rs4646440	CYP3A4	A	Other	increased	Adverse_Event	Disease:C0028043		N07BC02	rs4646440:A	10090
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*2/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Adverse_Event	Other:C0007222	normal metabolizer	B01AC04	*1/*17	13748464
carbamazepine	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*03:02	114709
ethanol, opioids	rs511435	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		N02A|V03AB16	rs511435:T	702
docetaxel, thalidomide	rs1799931	NAT2	G	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs1799931:G	148124
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*1/*17	162180
docetaxel, thalidomide	rs4646487	CYP4B1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs4646487:T	148124
sulfamethoxazole / trimethoprim	HLA-B*07:02	HLA-B	*07:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*07:02	5578
sulfamethoxazole / trimethoprim	HLA-C*07:02	HLA-C	*07:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*07:02	5578
sulfamethoxazole / trimethoprim	GSTM1 null	GSTM1	null/null	Toxicity	increased	Adverse_Event	Disease:C0001175		J01EE01		5578
carbamazepine	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*58:01	114709
carbamazepine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*07:01	114709
olanzapine	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*28	74603552
olanzapine	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*28/*28	74603552
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*1/*6	No_match
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*1/*28	No_match
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*6/*28	No_match
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*6/*6	No_match
folfirinox	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0030297	intermediate metabolizer and poor metabolizer	No_ATC	*28/*28	No_match
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
methotrexate	rs3045983	DHFR	GGGAGCTGG/del	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs3045983:GGGAGCTGG/del	11329481
methotrexate	rs3045983	DHFR	del/del	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs3045983:del/del	11329481
opioids	rs589046	OPRM1	CC	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs589046:CC	No_match
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02	168354693
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2	64139
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3	64139
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3	131769926
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	decreased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	decreased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3C	5778
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2	64139
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3	64139
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*1/*2	4543
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*2	4543
alprazolam	low activity	CYP3A4	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0085762|Other:C0003469	low activity	N05BA12	__UNKNOWN__	2118
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*1/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*1/*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*2/*2	2244
paclitaxel	CYP3A4*1, CYP3A4*8, CYP3A4*20	CYP3A4	*1/*8	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	*1/*8	36314
paclitaxel	CYP3A4*1, CYP3A4*8, CYP3A4*20	CYP3A4	*1/*20	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	*1/*20	36314
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*41	2733525
carbamazepine	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*33:03	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02	114709
docetaxel	rs144854329	VEGFA	del/del	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02	rs144854329:del/del	154272
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*3/*3	54688261
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*2	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*3/*2	54688261
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*3	54688261
citalopram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AB04		162180
azathioprine, mercaptopurine	NUDT15*1, NUDT15*3, NUDT15*6	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*1/*3	5778
azathioprine, mercaptopurine	NUDT15*1, NUDT15*3, NUDT15*6	NUDT15	*3/*3	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3/*3	5778
azathioprine, mercaptopurine	NUDT15*1, NUDT15*3, NUDT15*6	NUDT15	*1/*6	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*1/*6	5778
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06A		No_match
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C0001418		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5790
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*2/*3	54688261
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*3/*3	54688261
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	*2/*2	54688261
haloperidol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0033936		N05AD01	*1/*4	9828
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC	445127
none	HLA-DPB1*04:01	HLA-DPB1	*04:01	Toxicity	decreased	Adverse_Event	Healthy		A03DA02	*04:01	5282367
carboplatin, cisplatin	DPYD Reference	DPYD	Reference	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA01|L01XA02	Reference	10339178
methamphetamine	rs947267	DAOA	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs947267:T	36604
carbamazepine, oxcarbazepine, phenobarbital	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AA02|N03AF01|N03AF02	*15:02	2554
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*36	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	N02AX02	*10/*10	63013
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*36	CYP2D6	*5/*10	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	N02AX02	*5/*10	63013
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*10x2, CYP2D6*36	CYP2D6	*36	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	N02AX02	*36	63013
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2	64139
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3	64139
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	Indeterminado	Other	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
methamphetamine	rs2075572	OPRM1	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2075572:C	36604
acetaminophen	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*13:01	1983
acetaminophen	HLA-A*02:06	HLA-A	*02:06	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*02:06	1983
acetaminophen	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*44:03	1983
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*2	64139
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01|J05AG03	*1/*3	64139
acetaminophen	HLA-C*14:03	HLA-C	*14:03	Toxicity	increased	Adverse_Event	Healthy		N02BE01	*14:03	1983
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3	13748464
carbamazepine, lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01|N03AX09	*15:02	3878
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*5	2733525
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*2	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3A	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3C	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*9	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*9	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*21	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*21	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*33	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*33	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*34	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*34	2723601
methadone	rs2246709	CYP3A4	A	Other	decreased	Adverse_Event	Disease:C0028043		N07BC02	rs2246709:A	10090
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:A	13748464
atorvastatin, pravastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs7412:CT	60823
atorvastatin, pravastatin	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03|C10AA05	rs7412:TT	60823
atorvastatin, pravastatin, simvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5	Toxicity	increased	Adverse_Event	Disease:C0020443		C10AA01|C10AA03|C10AA05	*5	60823
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
antivirals for treatment of hiv infections, combinations	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AP|S02DA30	*28	No_match
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
atenolol, hydrochlorothiazide, trandolapril, verapamil	rs2230345	GRK5	AT	Other	decreased	Adverse_Event	Other:C1956346		C03AA03|C07AB03|C08DA01|C09AA10	rs2230345:AT	2520
atenolol, hydrochlorothiazide, trandolapril, verapamil	rs2230345	GRK5	TT	Other	decreased	Adverse_Event	Other:C1956346		C03AA03|C07AB03|C08DA01|C09AA10	rs2230345:TT	2520
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:Leprosy		J04BA02	*13:01	2955
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*15:02	1775
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
methamphetamine	rs6265	BDNF	CC	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs6265:CC	36604
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
tacrolimus	rs1045642	ABCB1	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Healthy		L04AD02	rs1045642:GG	131769926
drugs for treatment of tuberculosis	NAT2*4	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	*4	No_match
anticholinergic agents	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N04A	__UNKNOWN__	No_match
antiepileptics	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03A	*15:02	No_match
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:human_liver_microsomes		L04AD02	*1/*3	131769926
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*2	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*2	5778
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*3	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*3	5778
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*5	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*5	5778
azathioprine	NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*6	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*6	5778
none	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Other	increased	Adverse_Event	Healthy		A03DA02		5282367
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*04:01	15979285
none	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Other	increased	Adverse_Event	Healthy		A03DA02		5282367
methamphetamine	rs2391191	DAOA	A	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2391191:A	36604
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*1/*6	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*6/*6	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*4/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*4/*6	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*5/*6	Toxicity	decreased	Adverse_Event	Other:C0206624	intermediate metabolizer and poor metabolizer	L01AA01	*5/*6	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*1	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*1	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*5	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*5	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*4	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*22	CYP2B6	*1/*22	Toxicity	increased	Adverse_Event	Other:C0206624	normal metabolizer and rapid metabolizer	L01AA01	*1/*22	9554282
irinotecan	rs2859101	HLA-DQB3	C	Toxicity	decreased	Adverse_Event	Healthy		L01CE02	rs2859101:C	74990
cyclosporine, methotrexate	rs3737967	MTHFR	GG	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs3737967:GG	126941
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Healthy		J05AG01	*01:01	15979285
antidepressants	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0011581		N06A	*1/*1	No_match
cyclophosphamide, epirubicin, fluorouracil	rs55633228	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs55633228:T	2907
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA	13748464
carboplatin, dexamethasone, etoposide, irinotecan	UGT1A1*6	UGT1A1	*6	Efficacy	increased	Efficacy_Response	Disease:C0024299|Large_B-Cell|Diffuse		L01CB01|L01CE02|L01XA02|S02BA06	*6	10339178
sulfasalazine	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*13:01	5336
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	*1/*3	54676537
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	*3/*3	54676537
azathioprine, mercaptopurine	rs746071566	NUDT15	GGAGTC	Toxicity	increased	Adverse_Event	Other:C0004364|Other:C0021390		L01BB02|L04AX01	rs746071566:GGAGTC	5778
cyclosporine, methotrexate	rs2274976	MTHFR	CC	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs2274976:CC	126941
tamoxifen	CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Healthy		L02BA01	*4/*4	2733525
cyclophosphamide, epirubicin, fluorouracil	rs117101815	PERP	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117101815:T	2907
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3B	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3B	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3C	5778
cisplatin	rs11615	ERCC1	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs11615:GG	441203
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28, UGT1A1*36	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28	25134325
pravastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15/*15	58746970
capecitabine, fluorouracil	low activity	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0027651	low activity	L01BC02|L01BC06	__UNKNOWN__	60953
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3	54742534
cisplatin, radiotherapy	GSTM1 non-null, GSTM1 null	GSTM1	null/null	Efficacy	decreased	Adverse_Event	Disease:C0007869		L01XA01		5460033
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*17	13748464
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	*3/*3	54742534
antidepressants, antiepileptics, beta blocking agents, calcium channel blockers	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Other	Other:C0150055		C08|N03A|N06A|S01ED	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5460341
antidepressants, antiepileptics, beta blocking agents, calcium channel blockers	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	decreased	Other	Disease:C0338480		C08|N03A|N06A|S01ED	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5460341
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1	131769926
irinotecan	rs1042482	DPYD	T	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs1042482:T	74990
pazopanib	UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:C0007134	reduced metabolizers	L01EX03	*28	10113978
pazopanib	UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	*37	Toxicity	increased	Adverse_Event	Disease:C0007134	reduced metabolizers	L01EX03	*37	10113978
pazopanib	UGT1A1*6, UGT1A1*28, UGT1A1*37	UGT1A1	*6	Toxicity	increased	Adverse_Event	Disease:C0007134	reduced metabolizers	L01EX03	*6	10113978
methadone	rs4646440	CYP3A4	A	Toxicity	increased	Adverse_Event	Disease:C0028043		N07BC02	rs4646440:A	10090
warfarin	rs9923231	VKORC1	CC	Other	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CC	54688261
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA04	*3	91987769
cyclophosphamide, epirubicin, fluorouracil	rs3805945	PPP2R5D	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs3805945:C	2907
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0007820		B01AC04	*2	13748464
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*1/*36	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*1/*36	60825
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*28/*36	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*28/*36	60825
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*36/*37	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*36/*37	60825
atazanavir / ritonavir, lamivudine, zidovudine	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease|Other:C0032961		J05AE03|J05AE08|J05AF01|J05AF05	*1/*1	60825
cyclophosphamide, epirubicin, fluorouracil	rs77769901	CCNK	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs77769901:G	2907
carbamazepine	rs3812718	SCN1A	TT	Efficacy	increased	Adverse_Event	Other:C0014544		N03AF01	rs3812718:TT	114709
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10|L03AB11	rs11322783:TT/TT	37542
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	74990
rosiglitazone	rs894160	PLIN1	CT	Toxicity	decreased	Adverse_Event	Other:C0011849		A10BG02	rs894160:CT	9846723
rosiglitazone	rs894160	PLIN1	TT	Toxicity	decreased	Adverse_Event	Other:C0011849		A10BG02	rs894160:TT	9846723
platinum	rs836554	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs836554:T	441203
cyclosporine, methotrexate	rs17264736	ABCC1	GG	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs17264736:GG	126941
cyclosporine, methotrexate	rs17264736	ABCC1	GT	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs17264736:GT	126941
methadone	CYP2B6*6	CYP2B6	*6	Toxicity	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	*6	10090
oxcarbazepine	HLA-B*15:01	HLA-B	*15:01	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AF02	*15:01	46782646
cyclophosphamide, epirubicin, fluorouracil	rs118129530	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs118129530:A	2907
citalopram	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AB04	*1/*4	162180
cyclophosphamide, epirubicin, fluorouracil	rs148013902	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs148013902:T	2907
drugs used in nicotine dependence	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA	rs4680:AA	89594
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	decreased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3	131769926
nicotine	rs1800497	ANKK1	AA	Efficacy	increased	Adverse_Event	Other:female_gender		N07BA01	rs1800497:AA	936
nicotine	rs1800497	ANKK1	AG	Efficacy	increased	Adverse_Event	Other:female_gender		N07BA01	rs1800497:AG	936
valganciclovir	rs11568658	ABCC4	AC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		J05AB14	rs11568658:AC	135413534
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*3	13748464
cyclophosphamide, epirubicin, fluorouracil	rs145623321	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs145623321:T	2907
cyclosporine, methotrexate	rs1017860	NFATC1	CC	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs1017860:CC	126941
cyclophosphamide, epirubicin, fluorouracil	rs117458836	CYP2C8	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117458836:A	2907
prasugrel	rs822442	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs822442:AA	24757771
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*3	131769926
carbamazepine	HLA-B*07:02, HLA-B*15:21	HLA-B	*15:21	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:21	114709
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
nicotine	rs4680	COMT	G	Toxicity, Other	decreased	Adverse_Event	Other:smokers		N07BA01	rs4680:G	936
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Disease:C0023055	deficiency	L01BC02	__UNKNOWN__	5790
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*3	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*41	2733525
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01	16204478
risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy		N05AX08	*4/*4	849421
risperidone	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C0036341	poor metabolizer	N05AX08	*4/*4	849421
risperidone	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C0036341	poor metabolizer	N05AX08	*4/*5	849421
risperidone	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C0036341	poor metabolizer	N05AX08	*4/*6	849421
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	*3	54688261
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3/*3	91987769
phenytoin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*02:01	1775
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Side_Effect:C0014544		N03AX09	*15:02	71236569
bosentan	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		C02KX01	*3	6426756
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3	54742534
clozapine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*2	131769989
bosentan	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		C02KX01	*2	6426756
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT	60953
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
atorvastatin	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA05	rs1800629:GG	656846
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3	54688261
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
lamotrigine	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*44:03	71236569
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11	114709
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	G/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs11322783:G/TT	37542
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	GG	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs11322783:GG	37542
peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs11322783:TT/TT	37542
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28	74990
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
lamotrigine	HLA-A*02:07	HLA-A	*02:07	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*02:07	71236569
flucloxacillin	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*06:02	21319
nicotine	low activity	CYP2A6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:C0039338	low activity	N07BA01	__UNKNOWN__	936
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08		5324346
nicotine	low activity	CYP2A6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Healthy	low activity	N07BA01	__UNKNOWN__	936
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02	No_match
methazolamide	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*59:01	No_match
warfarin	CYP2C9*1, CYP2C9*6	CYP2C9	*6	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*6	54688261
methotrexate	rs11045879	SLCO1B1	T	Other, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs11045879:T	11329481
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*17/*17	13748464
warfarin	CYP2C9*1, CYP2C9*11	CYP2C9	*11	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*11	54688261
warfarin	CYP2C9*1, CYP2C9*5	CYP2C9	*5	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*5	54688261
codeine, tramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C0030193	poor metabolizer	N02AX02|R05DA04	__UNKNOWN__	33741
bosentan	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		C02KX01	*2	6426756
tacrolimus	CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
clopidogrel	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*3/*3	13748464
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3	131769926
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
ace inhibitors, plain	rs71103505	BDKRB2	(GGTGGGGAC)2/(GGTGGGGAC)2	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs71103505:(GGTGGGGAC)2/(GGTGGGGAC)2	No_match
ace inhibitors, plain	rs71103505	BDKRB2	(GGTGGGGAC)2/GGTGGGGACGGTGGGGACGGTGGGGAC	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs71103505:(GGTGGGGAC)2/GGTGGGGACGGTGGGGACGGTGGGGAC	No_match
codeine, tramadol	poor and ultrarapid metabolizers	CYP2D6	__UNKNOWN__	Efficacy, Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193	poor metabolizer and ultrarapid metabolizer	N02AX02|R05DA04	__UNKNOWN__	33741
none	rs727957	KCNE1	T	Other	increased	Other	Healthy		A03DA02	rs727957:T	5282367
amoxicillin, clavulanate	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	decreased	Adverse_Event	Healthy		J01CA04	*07:01	16204478
oxcarbazepine	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		N03AF02	*38:02	46782646
hydrochlorothiazide	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799752:del/del	2904
methotrexate	rs11280056	TYMS	del/del	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AX03	rs11280056:del/del	11329481
perindopril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Toxicity	increased	Adverse_Event	Disease:C0011849		C09AA04	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	441313
methotrexate	rs11280056	TYMS	del/del	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs11280056:del/del	11329481
none	rs34717272	RGS2	TC/del	Other	increased	Adverse_Event	Healthy		A03DA02	rs34717272:TC/del	5282367
none	rs34717272	RGS2	del/del	Other	increased	Adverse_Event	Healthy		A03DA02	rs34717272:del/del	5282367
carbamazepine	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*02:01	114709
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	11329481
carbamazepine	HLA-DRB1*14:05	HLA-DRB1	*14:05	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*14:05	114709
cyclophosphamide, epirubicin, fluorouracil	rs74743371	CBR3	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs74743371:T	2907
carbamazepine	HLA-B*58:01	HLA-B	*58:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*58:01	114709
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	11329481
lamotrigine	HLA-A*30:01	HLA-A	*30:01	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*30:01	71236569
carbamazepine	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*03:01	114709
oxcarbazepine	HLA-B*13:02	HLA-B	*13:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*13:02	46782646
oxcarbazepine	HLA-B*15:27	HLA-B	*15:27	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:27	46782646
oxcarbazepine	HLA-B*15:19	HLA-B	*15:19	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:19	46782646
oxcarbazepine	HLA-B*48:04	HLA-B	*48:04	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*48:04	46782646
raloxifene	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Efficacy	increased	Efficacy_Response	Disease:C0029456		G03XC01	*28/*28	10100752
aspirin	HLA-DQB1*03:02	HLA-DQB1	*03:02	Efficacy, Toxicity	decreased	Adverse_Event	Side_Effect:Aspirin-induced_asthma		No_ATC	*03:02	72204814
oxcarbazepine	HLA-B*27:09	HLA-B	*27:09	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*27:09	46782646
nevirapine	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*58:01	15979285
tamoxifen	rs1045642	ABCB1	AG	Other	increased	Adverse_Event	Disease:C1458155		L02BA01	rs1045642:AG	2733525
nevirapine	HLA-B*58:02	HLA-B	*58:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*58:02	15979285
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
prasugrel	rs3737224	PEAR1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs3737224:TT	24757771
nevirapine	HLA-C*02:10	HLA-C	*02:10	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*02:10	15979285
cyclosporine, methotrexate	rs4781712	ABCC1	AA	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4781712:AA	126941
cyclosporine, methotrexate	rs4781712	ABCC1	AG	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4781712:AG	126941
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
capecitabine, fluorouracil	rs895819	MIR27A	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs895819:CT	60953
olanzapine	rs4728709	ABCB1	GG	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs4728709:GG	74603552
bupropion	rs3211371	CYP2B6	TT	Efficacy	increased	Adverse_Event	Other:female_gender		N06AX12	rs3211371:TT	446
cyclophosphamide, epirubicin, fluorouracil	rs118088833	TP53AIP1	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs118088833:T	2907
aspirin, sulfasalazine	CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3	Dosage, Toxicity	increased	Adverse_Event	Side_Effect:C0006444		A07EC01	*3	2244
aspirin, sulfasalazine	CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Dosage, Toxicity	increased	Adverse_Event	Side_Effect:C0006444		A07EC01	*4	2244
prasugrel	rs41273215	PEAR1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs41273215:TT	24757771
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05		667572
tamoxifen	rs1045642	ABCB1	AG	Other	increased	Adverse_Event	Disease:C1458155		L02BA01	rs1045642:AG	2733525
cyclophosphamide, epirubicin, fluorouracil	rs112242273	GNL3	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs112242273:T	2907
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Dosage	Indeterminado	Other	Healthy		N02AX02	*10/*10	63013
prasugrel	rs822441	PEAR1	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs822441:CC	24757771
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Disease:Lung_transplantation		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Disease:Lung_transplantation		J02AC03	*17/*17	9741
clopidogrel	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
cytarabine, idarubicin	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2032582:CC	6253
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
caffeine	high activity	CYP1A2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0032961	high activity	N06BC01	__UNKNOWN__	936
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3	54688261
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
cyclophosphamide, epirubicin, fluorouracil	rs181501757	TOP2A	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs181501757:A	2907
lamotrigine	HLA-B*13:02	HLA-B	*13:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*13:02	71236569
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A		No_match
lamotrigine	HLA-A*33:03	HLA-A	*33:03	Toxicity	decreased	Adverse_Event	Healthy		N03AX09	*33:03	71236569
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06A		No_match
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*1/*60	Toxicity	increased	Adverse_Event	Disease:C0027651		No_ATC	*1/*60	6918638
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*60/*60	Toxicity	increased	Adverse_Event	Disease:C0027651		No_ATC	*60/*60	6918638
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A		No_match
cyclophosphamide, epirubicin, fluorouracil	rs9402944	PERP	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs9402944:T	2907
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs2660	OAS1	AG	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs2660:AG	37542
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR long form (L allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0040435		N06A		No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
olanzapine	rs3842	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs3842:CC	74603552
irinotecan	rs10929302	UGT1A1	A	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs10929302:A	74990
cyclophosphamide, epirubicin, fluorouracil	rs112783657	CBR3	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs112783657:T	2907
bupropion	rs2717162	GALR1	CC	Efficacy	decreased	Adverse_Event	Healthy		N06AX12	rs2717162:CC	446
bupropion	rs2717162	GALR1	CT	Efficacy	decreased	Adverse_Event	Healthy		N06AX12	rs2717162:CT	446
carbamazepine	HLA-B*46:01	HLA-B	*46:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*46:01	114709
heroin	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:AG	9844225
cyclosporine, methotrexate	rs8090560	NFATC1	GG	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs8090560:GG	126941
vincristine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	*1/*3	24848381
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*33:03	168354693
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02	168354693
azathioprine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX01	*1/*3A	5778
risperidone	rs7799039	LEP	A	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs7799039:A	849421
bupropion	rs2717162	GALR1	CC	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12	rs2717162:CC	446
bupropion	rs2717162	GALR1	CT	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12	rs2717162:CT	446
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs231775	CTLA4	AG	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs231775:AG	37542
cyclophosphamide, epirubicin, fluorouracil	rs149212925	NOS1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs149212925:G	2907
cyclosporine, methotrexate	rs34965641	DHFR	GG	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs34965641:GG	126941
etravirine	rs4244285	CYP2C19	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG04	rs4244285:AA	193962
etravirine	rs4244285	CYP2C19	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG04	rs4244285:AG	193962
cisplatin	rs3212986	ERCC1	A	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs3212986:A	441203
rosuvastatin	rs2231142	ABCG2	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA07	rs2231142:T	5282455
fluorouracil	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0022665		L01BC02	rs1801131:TT	5790
fluoxetine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB05		667572
cyclophosphamide, epirubicin, fluorouracil	rs58695150	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs58695150:T	2907
pemetrexed	rs11545078	GGH	A	Toxicity	decreased	Adverse_Event	Disease:C0007131|Disease:C0025500		L01BA04	rs11545078:A	135565228
metformin	rs72552763	SLC22A1	GAT/del	Other, Metabolism/PK	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs72552763:GAT/del	155906370
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0522067		N03AF01	*15:02	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
phenazepam	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:C0085762|Other:C0003469		No_ATC	*2	40113
capecitabine	rs602950	CDA	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:AG	11809635
capecitabine	rs602950	CDA	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:GG	11809635
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	11329481
fluorouracil, irinotecan, leucovorin	low activity	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0023055	low activity	L01BC02|L01CE02	__UNKNOWN__	135403648
phenytoin	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*08:01	1775
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651	deficiency	L01BC02	__UNKNOWN__	5790
cyclophosphamide, epirubicin, fluorouracil	rs150688309	PIK3R2	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs150688309:G	2907
capecitabine	rs602950	CDA	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:AG	11809635
capecitabine	rs602950	CDA	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:GG	11809635
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
tamoxifen	CYP2D6*2	CYP2D6	*2	Efficacy	decreased	Adverse_Event	Healthy		L02BA01	*2	2733525
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
tamoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BA01	*22	2733525
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-A*74:01	HLA-A	*74:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*74:01	114709
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0085096		B01AC04	*2	13748464
carbamazepine	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*02:01	114709
codeine	low activity	SLC22A1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	low activity	R05DA04		5284371
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:C0178298		J04BA02	*13:01	2955
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*1/*3C	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	*3A/*3A	5778
oxcarbazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:02	46782646
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Other	Disease:C0027051		B01AC04	*3	13748464
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*2	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3C	5778
venlafaxine	CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AX16	*4/*4	9795857
cyclophosphamide, epirubicin, fluorouracil	rs299293	HMMR	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs299293:T	2907
exemestane	rs934635	__INTRONIC__	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs934635:AA	13472
cyclophosphamide, epirubicin, fluorouracil	rs9389568	PERP	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs9389568:C	2907
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Other	Disease:C0010068		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Other	Disease:C0010068		B01AC04	*3	13748464
cyclophosphamide, epirubicin, fluorouracil	rs144991623	FOXO1	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs144991623:T	2907
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*1/*6	74990
prasugrel	rs12407843	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs12407843:AA	24757771
digoxin	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs1045642:AA	15478
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT	37542
prasugrel	rs77235035	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs77235035:AA	24757771
venlafaxine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AX16	*4/*4	9795857
venlafaxine	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AX16	*1/*4	9795857
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2	54742534
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*17/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*17	13748464
digoxin	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs2032582:AA	15478
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3	13748464
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651		L01CE02	*6	74990
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651		L01CE02	*28	74990
digoxin	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs1128503:AA	15478
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AC04	*3/*3	13748464
capecitabine	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs1801131:GG	11809635
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*1/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
cyclophosphamide, epirubicin, fluorouracil	rs8110364	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs8110364:A	2907
olanzapine	rs10248420	ABCB1	G	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs10248420:G	74603552
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02	114709
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*28	74990
fluorouracil	rs56293913	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02	rs56293913:AG	5790
fluorouracil	rs56293913	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02	rs56293913:GG	5790
fluticasone propionate	rs2569190	CD14, TMCO6	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs2569190:AA	5311101
cyclophosphamide, epirubicin, fluorouracil	rs117341846	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117341846:T	2907
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	Indeterminado	Efficacy_Response	Healthy	intermediate metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy	intermediate metabolizer	B01AC04	*1/*3	13748464
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT	37542
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB10		162180
cyclophosphamide, epirubicin, fluorouracil	rs115457081	IRS1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs115457081:A	2907
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AF01	*40:01	114709
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*15:02	71236569
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	Indeterminado	Efficacy_Response	Healthy	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy	poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy	poor metabolizer	B01AC04	*3/*3	13748464
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02	1775
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*1/*17	162180
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*17/*17	162180
cyclophosphamide, epirubicin, fluorouracil	rs142244113	INSR	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs142244113:T	2907
citalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04		162180
aspirin, clopidogrel	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*1/*3	2244
aspirin, clopidogrel	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*3/*3	2244
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3	13748464
methotrexate	rs2372536	ATIC	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:GG	11329481
doxepin	CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*4	59023617
cyclophosphamide, epirubicin, fluorouracil	rs79430272	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs79430272:T	2907
olanzapine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	*1/*3	74603552
olanzapine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	*1/*4	74603552
cyclophosphamide, epirubicin, fluorouracil	rs4968187	TP53	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs4968187:T	2907
citalopram, fluoxetine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB03|N06AB04|N06AB05		667572
cisplatin	rs3212986	ERCC1	AA	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs3212986:AA	441203
palbociclib	rs2231137	ABCG2	CT	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01	rs2231137:CT	5330286
cyclophosphamide, epirubicin, fluorouracil	rs117951771	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs117951771:T	2907
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*2/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*3/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*4/*4	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*4/*4	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2/*4	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*2/*4	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3/*4	Efficacy	increased	Adverse_Event	Healthy		N06AB10	*3/*4	162180
exemestane	rs934635	__INTRONIC__	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs934635:AA	13472
primaquine	deficiency	G6PD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0024530|Vivax	deficiency	P01BA03		6135
cyclophosphamide, epirubicin, fluorouracil	rs148235907	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs148235907:A	2907
methamphetamine	rs3916965	DAOA	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs3916965:C	36604
none	rs34993780	UGT1A1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs34993780:G	5282367
cyclophosphamide	poor metabolizer	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C0042384|Disease:C0043092	poor metabolizer	L01AA01	*2	9554282
cyclophosphamide	poor metabolizer	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C0042384|Disease:C0043092	poor metabolizer	L01AA01	*3	9554282
capecitabine	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	11809635
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*10/*10	65327
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*5/*10	65327
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*1	1775
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*1	1775
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
atazanavir, ritonavir	UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Healthy		J05AE03|J05AE08	*28	25134325
atazanavir	UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Healthy		J05AE08	*28	118753185
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28	74990
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
palbociclib	rs182420	SULT2A1	CC	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01	rs182420:CC	5330286
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28	74990
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*1/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*4/*4	2733526
imipramine	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*1/*17	65327
imipramine	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*17/*17	65327
cyclophosphamide, epirubicin, fluorouracil	rs299313	HMMR	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs299313:A	2907
primaquine	deficiency	G6PD	__UNKNOWN__	Other	increased	Other	Healthy	deficiency	P01BA03		6135
sulfanilamide	deficiency	G6PD	__UNKNOWN__	Other	increased	Other	Healthy	deficiency	J01EB06		5315
chloramphenicol	deficiency	G6PD	__UNKNOWN__	Other	increased	Other	Healthy	deficiency	S03AA08		69745
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3	54688261
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*28/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*6/*6	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*1/*6	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0042065|Other:C0030297		L01CE02	*1/*28	60838
codeine, morphine, tramadol	rs73823859	UGT2B7	A	Efficacy	increased	Efficacy_Response	Other:C0002895		N02AA01|N02AX02|R05DA04	rs73823859:A	33741
cisplatin, docetaxel	rs671	ALDH2	AA	Toxicity	increased	Adverse_Event	Other:C0027651		L01CD02|L01XA01	rs671:AA	5460033
cisplatin, docetaxel	rs671	ALDH2	AG	Toxicity	increased	Adverse_Event	Other:C0027651		L01CD02|L01XA01	rs671:AG	5460033
cyclophosphamide, epirubicin, fluorouracil	rs299314	HMMR	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs299314:C	2907
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*8	54688261
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:C0027651		L01CE02	*28	74990
anthracyclines and related substances	rs1056892	CBR3	G	Toxicity	increased	Adverse_Event	Healthy		L01DB	rs1056892:G	No_match
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	74990
cisplatin	rs13181	ERCC2	G	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs13181:G	441203
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*33:03	168354693
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*03:02	168354693
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	*2/*2	13748464
allopurinol	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*08:01	168354693
anthracyclines and related substances	rs10836235	CAT	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01DB	rs10836235:CC	No_match
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
exemestane	deficiency	UGT2B17	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1458155	deficiency	L02BG06		13472
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0040435		N06AB05		667572
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531C	Toxicity	increased	Adverse_Event	Disease:C0040435		N06AB05		667572
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T	Toxicity	increased	Adverse_Event	Disease:C0040435		N06AB05		667572
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*3	54742534
valproic acid	rs2269577	XBP1	G	Efficacy	increased	Adverse_Event	Disease:C0005586		N03AG01	rs2269577:G	134459
ace inhibitors, plain	rs1799752	ACE	del	Toxicity	increased	Adverse_Event	Disease:C1956346		A03B|C09A	rs1799752:del	No_match
paclitaxel	rs1056836	CYP1B1	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD01	rs1056836:GG	36314
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*10/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*5/*10	2733525
docetaxel	rs1056836	CYP1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L01CD02	rs1056836:CC	154272
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8	Dosage, Metabolism/PK	decreased	LADME	Healthy		B01AA03	*8	54688261
cyclophosphamide, doxorubicin, fluorouracil	rs9561778	ABCC4	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs9561778:T	2907
cyclophosphamide	rs9561778	ABCC4	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01AA01	rs9561778:T	9554282
cyclophosphamide	rs9561778	ABCC4	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01AA01	rs9561778:T	9554282
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*2	13748464
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
hydrochlorothiazide	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Other	increased	Other	Disease:C0020538		C03AA03	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	2904
hormonal contraceptives for systemic use	rs6025	F5	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:T	No_match
enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs1799752:del/del	5950
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4	2733525
clozapine	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*38:01	131769989
paroxetine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB05	*1/*1xN	667572
flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:01	21319
flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CF05	*57:01	21319
drugs for treatment of tuberculosis	NAT2*4	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	*4	No_match
capecitabine	rs143414470	ANK3	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs143414470:T	11809635
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0007131	poor metabolizer	L01EB01	*10/*10	135496227
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*5/*10	Toxicity	increased	Adverse_Event	Disease:C0007131	poor metabolizer	L01EB01	*5/*10	135496227
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*2	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*3	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*3	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*8	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*8	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*9	Other	increased	Adverse_Event	Disease:C0004096	poor metabolizer	A02BC03	*9	11985
nevirapine	rs130072	CCHCR1	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs130072:T	15979285
nevirapine	HLA-B*35:05	HLA-B	*35:05	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*35:05	15979285
ritonavir	rs5128	APOC3	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	rs5128:G	71749331
efavirenz	rs3745274	CYP2B6	T	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
metformin	rs6265	BDNF	C	Efficacy	increased	Adverse_Event	Healthy		A10BA02	rs6265:C	155906370
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*18	64139
lumiracoxib	HLA-DRB1*01:01, HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		M01AH06	*15:01	154585067
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6	10090
mercaptopurine, methotrexate	TPMT*1, TPMT*12	TPMT	*12	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*12	126941
mycophenolate mofetil(mycophenolic acid)	rs2278293	IMPDH1	CT	Toxicity	decreased	Adverse_Event	Disease:C0277631		L04AA06	rs2278293:CT	5281078
mycophenolate mofetil(mycophenolic acid)	rs2278293	IMPDH1	TT	Toxicity	decreased	Adverse_Event	Disease:C0277631		L04AA06	rs2278293:TT	5281078
mitoxantrone	rs2032582	ABCB1	AA	Other	increased	Other	Healthy		L01DB07	rs2032582:AA	51082
lumiracoxib	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Healthy		M01AH06	*06:02	154585067
acenocoumarol	CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	Adverse_Event	Healthy		B01AA07	*3	54742534
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:CT	2244
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:TT	2244
acenocoumarol	CYP2C9*2	CYP2C9	*2	Metabolism/PK	increased	Adverse_Event	Healthy		B01AA07	*2	54742534
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Healthy		N07BC02	*6/*6	10090
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6	10090
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy		N06AA06	*4/*4	3045275
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Toxicity	increased	Adverse_Event	Healthy		N06AA06	*3/*5	3045275
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Toxicity	increased	Adverse_Event	Healthy		N06AA06	*3/*3	3045275
clopidogrel	rs1045642	ABCB1	A	Other	increased	Adverse_Event	Disease:C0010068		B01AC04	rs1045642:A	13748464
nevirapine	rs9461684	HLA-C	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs9461684:T	15979285
aspirin	rs1143627	IL1B	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0007222		No_ATC	rs1143627:A	72204814
paclitaxel	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs35599367:AA	36314
paclitaxel	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs35599367:AG	36314
cyclophosphamide, doxorubicin	rs714368	SLC22A16	CC	Toxicity	decreased	Adverse_Event	Other:C1458155		L01AA01|L01DB01	rs714368:CC	2907
cyclophosphamide, doxorubicin	rs714368	SLC22A16	CT	Toxicity	decreased	Adverse_Event	Other:C1458155		L01AA01|L01DB01	rs714368:CT	2907
phenytoin	rs2234922	EPHX1	G	Toxicity	increased	Adverse_Event	Other:C0240802		N03AB02	rs2234922:G	1775
phenytoin	rs1051740	EPHX1	T	Toxicity	increased	Adverse_Event	Other:C0240802		N03AB02	rs1051740:T	1775
nevirapine	rs2073724	TCF19	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2073724:T	15979285
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	*10	849421
carboplatin, paclitaxel	rs1649942	NRG3	G	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs1649942:G	10339178
phenprocoumon	rs1051740	EPHX1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs1051740:CC	91987769
none	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Disease:C0020443		A03DA02	rs4149056:C	5282367
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2	2244
cyclophosphamide, doxorubicin, fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	2907
caffeine	rs5751876	ADORA2A	TT	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs5751876:TT	936
paclitaxel, platinum compounds	rs1208	NAT2	AG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CD01|L01XA	rs1208:AG	23939
paclitaxel, platinum compounds	rs1208	NAT2	GG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CD01|L01XA	rs1208:GG	23939
drugs for treatment of tuberculosis	HLA-DQB1*05:01, HLA-DQB1*05:02, HLA-DQB1*05:03	HLA-DQB1	*05:01	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*05:01	No_match
drugs for treatment of tuberculosis	HLA-DQB1*05:01, HLA-DQB1*05:02, HLA-DQB1*05:03	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*05:02	No_match
drugs for treatment of tuberculosis	HLA-DQB1*05:01, HLA-DQB1*05:02, HLA-DQB1*05:03	HLA-DQB1	*05:03	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*05:03	No_match
venlafaxine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5/*4	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0011581		N06AX16	*5/*4	9795857
venlafaxine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0011581		N06AX16	*6/*6	9795857
venlafaxine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6/*4	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0011581		N06AX16	*6/*4	9795857
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	*1/*5	154032615
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	*10/*10	154032615
fluvoxamine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	*5/*10	154032615
nemonapride	rs1800497	ANKK1	A	Toxicity	increased	Adverse_Event	Other:C0036341		No_ATC	rs1800497:A	156333
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*3/*3	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*4/*4	2733525
methotrexate	rs1051266	SLC19A1	TT	Other, Metabolism/PK	increased	LADME	Disease:C0003873		L04AX03	rs1051266:TT	11329481
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
fluvoxamine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB08	__UNKNOWN__	154032615
methotrexate	rs3758149	GGH	AA	Metabolism/PK	decreased	LADME	Disease:C0003873		L04AX03	rs3758149:AA	11329481
risperidone	rs1799978	DRD2	C	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs1799978:C	849421
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
risperidone	rs1800497	ANKK1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs1800497:AA	849421
risperidone	rs1800497	ANKK1	AG	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs1800497:AG	849421
mycophenolate mofetil(mycophenolic acid)	rs11706052	IMPDH2	G	Other	increased	Other	Disease:Kidney_Transplantation		L04AA06	rs11706052:G	5281078
mercaptopurine	rs2281547	XDH	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CC	1268107
mercaptopurine	rs2281547	XDH	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CT	1268107
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*2	2244
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	G	Metabolism/PK	decreased	LADME	Other:C1262018		L04AA06	rs4149117:G	5281078
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2	2244
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	*3	13748464
indinavir	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE02	*6/*28	11954281
anastrozole	rs1045642	ABCB1	AA	Other	decreased	Adverse_Event	Disease:C1458155		L02BG03	rs1045642:AA	713
methotrexate	rs1801131	MTHFR	GG	Efficacy	decreased	Other	Disease:C0023449		L04AX03	rs1801131:GG	11329481
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
none	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:AG	5282367
none	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:GG	5282367
mercaptopurine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs1127354:AC	1268107
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:C0009324		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0009324		L04AD02	*1/*3	131769926
flecainide	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		C01BC04	*3/*3	134295
ethanol	rs671	ALDH2	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs671:GG	444899
didanosine	rs1429376	XDH	AA	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs1429376:AA	64975
daunorubicin	rs6603859	SZRD1	T	Other, Metabolism/PK	decreased	LADME	Healthy		L01DB02	rs6603859:T	11570269
didanosine	rs11598702	NT5C2	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11598702:CC	64975
didanosine	rs11598702	NT5C2	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11598702:CT	64975
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Other	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Other	Disease:C1956346		B01AC04	*2/*2	13748464
didanosine	rs1594160	XDH	AA	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs1594160:AA	64975
clopidogrel	CYP2C19*1, CYP2C19*6	CYP2C19	*6	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*6	13748464
daunorubicin	rs7929521	__INTRONIC__	GG	Other, Metabolism/PK	increased	LADME	Healthy		L01DB02	rs7929521:GG	11570269
irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*37	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*28/*28	74990
azacitidine	rs11280056	TYMS	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0026986		L01BC07	rs11280056:del/del	47751
daunorubicin	rs3750518	MAN1B1	T	Other, Metabolism/PK	increased	LADME	Healthy		L01DB02	rs3750518:T	11570269
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*3/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*5	5462350
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*6	5462350
oxycodone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*7	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	*4/*7	5462350
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2	13748464
didanosine	rs11191561	NT5C2	CG	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11191561:CG	64975
didanosine	rs11191561	NT5C2	GG	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF02	rs11191561:GG	64975
drugs for treatment of tuberculosis	HLA-DQA1*01:02	HLA-DQA1	*01:02	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A	*01:02	No_match
iguratimod	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0003873		No_ATC	rs4244285:A	No_match
cyclosporine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD01	*1/*22	86666680
phenytoin	HLA-C*14:02	HLA-C	*14:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*14:02	1775
phenytoin	HLA-B*56:02	HLA-B	*56:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*56:02	1775
nicotine	rs1801272	CYP2A6	AT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1801272:AT	936
nicotine	rs1801272	CYP2A6	TT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1801272:TT	936
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
olanzapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3	74603552
olanzapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*2/*3	74603552
olanzapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6	CYP2C9	*3/*6	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*3/*6	74603552
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*10/*10	65327
desipramine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA01	*5/*10	65327
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16	135496227
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3A	74603552
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3C	74603552
none	NAT1*4, NAT1*11B	NAT1	*11B/*4	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*11B/*4	5282367
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*32, TPMT*33, TPMT*34	TPMT	*1/*3C	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L01BB02|L01BB03	*1/*3C	2723601
olanzapine	rs1799735	GSTM3	CCT/CCT	Metabolism/PK	decreased	LADME	Healthy		N05AH03	rs1799735:CCT/CCT	74603552
olanzapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Healthy		N05AH03	*1/*1	74603552
olanzapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Healthy		N05AH03	*1/*3	74603552
mercaptopurine	rs2281547	XDH	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CC	1268107
mercaptopurine	rs2281547	XDH	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2281547:CT	1268107
anastrozole	rs727479	CYP19A1	AA	Efficacy	increased	Other	Disease:C1458155		L02BG03	rs727479:AA	713
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*4/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*4/*6	5462350
fluvastatin	rs11045819	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA04	rs11045819:CC	131750727
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*4/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		N02AA05	*3/*4	5462350
efavirenz	CYP2B6*18	CYP2B6	*18/*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*18/*18	64139
cyclophosphamide, doxorubicin	rs1143684	NQO2	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs1143684:C	2907
pioglitazone	CYP2C8*1, CYP2C8*2	CYP2C8	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A10BG03	*1/*2	60560
pioglitazone	CYP2C8*1, CYP2C8*2	CYP2C8	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A10BG03	*2/*2	60560
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*3	1775
diclofenac	rs7668258	UGT2B7	T	Toxicity	increased	Adverse_Event	Healthy		S01BC03	rs7668258:T	112230
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Adverse_Event	Disease:C0019158		J05AP01|J05AP02|L03AB10	rs8099917:TT	37542
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*17/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Adverse_Event	Disease:C1956346		B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	decreased	Adverse_Event	Disease:C1956346		B01AC04	*17/*17	13748464
ibuprofen	CYP2C8*1, CYP2C8*2	CYP2C8	*1/*2	Metabolism/PK	increased	LADME	Healthy		M02AA13	*1/*2	53464135
cisplatin, cyclophosphamide	rs36120609	GSTM3	TCCTC/TCCTC	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs36120609:TCCTC/TCCTC	2907
aspirin, clopidogrel	rs4244285	CYP2C19	A	Toxicity	Indeterminado	Adverse_Event	Other:drug-eluting_stents		B01AC04	rs4244285:A	2244
none	rs1801123	IRS1	C	Other	Indeterminado	Other	Disease:C1458155		A03DA02	rs1801123:C	5282367
estradiol	rs1864729	__INTRONIC__	A	Other	increased	Other	Disease:C1458155		G03CA03	rs1864729:A	9046
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16	135496227
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17	135496227
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	*3	54676537
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16	135496227
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17	135496227
carbimazole, methimazole, propylthiouracil	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	increased	Adverse_Event	Disease:C0242656		H03BA02|H03BB01	*08:03	657298
anthracyclines and related substances	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB		No_match
ethambutol, isoniazid, pyrazinamide, rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__	135483892
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB04	*2	162180
diclofenac	rs717620	ABCC2	T	Toxicity	increased	Adverse_Event	Healthy		S01BC03	rs717620:T	112230
antiarrhythmics, class i and iii	rs10033464	__INTRONIC__	GG	Efficacy	increased	Adverse_Event	Disease:C0004238		C01B	rs10033464:GG	No_match
carbimazole, methimazole	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Disease:C0242656		H03BB01	*38:02	31072
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2/*3	54688261
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16	135496227
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17	135496227
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*3	13748464
gefitinib	rs11568315	EGFR	(CA)16/(CA)16	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)16	135496227
gefitinib	rs11568315	EGFR	(CA)16/(CA)17	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs11568315:(CA)16/(CA)17	135496227
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*3	54688261
rifampicin	SLCO1B1*15	SLCO1B1	*15	Toxicity	increased	Adverse_Event	Healthy		J04AB02	*15	135542225
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*2	13748464
fluvoxamine, paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08		5324346
fluvoxamine, paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/L allele-rs25531C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08		5324346
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*4/*5	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*4/*6	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*3/*4	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Other	decreased	Other	Healthy	poor metabolizer	N05AX08	*4/*4	849421
none	rs2854744	IGFBP3	T	Other	Indeterminado	Other	Disease:C1458155		A03DA02	rs2854744:T	5282367
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6	74990
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28	74990
carbamazepine	HLA-A*24:02	HLA-A	*24:02	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*24:02	114709
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11	114709
nevirapine	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01		15979285
cisplatin, cyclophosphamide	rs36120609	GSTM3	TCCTC/TCCTC	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs36120609:TCCTC/TCCTC	2907
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*40:01	114709
cisplatin, cyclophosphamide	rs36120609	GSTM3	TCCTC/TCCTC	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs36120609:TCCTC/TCCTC	2907
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*4/*5	667572
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3	13748464
none	rs36120609	GSTM3	TC/TC	Other	increased	Adverse_Event	Other:C0029463		A03DA02	rs36120609:TC/TC	5282367
none	rs36120609	GSTM3	TC/TCCTC	Other	increased	Adverse_Event	Other:C0029463		A03DA02	rs36120609:TC/TCCTC	5282367
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*5/*4	1548968
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*3	1548968
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*4	1548968
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*5	1548968
fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*6	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*1/*6	1548968
peginterferon alfa-2b, ribavirin, telaprevir	rs1127354	ITPA	CC	Other	Indeterminado	Adverse_Event	Disease:C0019158		J05AP01|J05AP02|L03AB10	rs1127354:CC	37542
carboplatin, cyclophosphamide, thiotepa	rs6151031	ALDH1A1	CTGGTGAGGAGAGAACC/del	Toxicity	increased	Adverse_Event	Disease:C0027651		L01AA01|L01AC01|L01XA02	rs6151031:CTGGTGAGGAGAGAACC/del	2907
antithyroid preparations	HLA-B*27:05	HLA-B	*27:05	Toxicity	increased	Adverse_Event	Healthy		H03B	*27:05	No_match
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	*1/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	*2/*2	2244
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*6/*28	74990
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*1/*4	667572
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Healthy		N06AB05	*1/*5	667572
diclofenac	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	increased	LADME	Healthy		S01BC03	*1/*3	112230
diclofenac	CYP2C8*1, CYP2C8*3	CYP2C8	*3/*3	Metabolism/PK	increased	LADME	Healthy		S01BC03	*3/*3	112230
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*3/*4	667572
heparin	HLA-DRB3*01:01	HLA-DRB3	*01:01	Toxicity	increased	Adverse_Event	Healthy		S01XA14	*01:01	5282448
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*2/*2	54742534
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*6	74990
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28	74990
peginterferon alfa-2b, ribavirin, simeprevir	rs11322783	IFNL4	TT/TT	Toxicity	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs11322783:TT/TT	37542
citalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04		162180
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
ibuprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*1/*3	53464135
tenoxicam	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		M01AC02	*1/*2	54677971
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2	2244
tenoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		M01AC02	*1/*3	54677971
efavirenz, lamivudine, stavudine, zidovudine	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF01|J05AF04|J05AF05|J05AG03	*6	64139
tamoxifen	low activity	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C1458155	low activity	L02BA01	__UNKNOWN__	2733525
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		M02AA07	*1/*3	54697648
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9, CYP2A6*10	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4	936
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9, CYP2A6*10	CYP2A6	*10	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*10	936
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9, CYP2A6*10	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9	936
aspirin, clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*17	2244
lumiracoxib	HLA-DQA1*01:01, HLA-DQA1*01:02	HLA-DQA1	*01:02	Toxicity	increased	Adverse_Event	Healthy		M01AH06	*01:02	154585067
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	2244
paroxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AB05	*4/*4	667572
ibuprofen	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Other	decreased	Other	Healthy		M02AA13	*1/*2	53464135
irinotecan	rs2070959	UGT1A6	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs2070959:A	74990
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	increased	LADME	Healthy		M02AA13	*1/*3	53464135
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Other:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5790
imatinib	rs2072454	EGFR	CC	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs2072454:CC	6113
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	5790
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*3	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*3	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*4	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*5	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*5	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*6	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*1/*6	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*4/*41	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*6/*10	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*6/*10	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*10/*10	33741
ketoprofen, tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*41/*41	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer	M02AA10|N02AX02	*41/*41	33741
piroxicam	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		M02AA07	*1/*2	54697648
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		M02AA07	*1/*3	54697648
piroxicam	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		M02AA07	*1/*2	54697648
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*114	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Disease:C0007131		L01EB01	*10/*10	135496227
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	G	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:G	37542
citalopram, escitalopram	rs1065852	CYP2D6	A	Other	Indeterminado	Other	Disease:C0011581		N06AB04|N06AB10	rs1065852:A	162180
hydrochlorothiazide	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799752:del/del	2904
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0027051|Disease:C0027051		B01AC04	*1/*1	2244
carbamazepine, lamotrigine, phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	Indeterminado	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*15:02	1775
mirtazapine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		N06AX11	*1/*1xN	6451144
tacrolimus	CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0026896		L04AD02	*3/*3	131769926
none	CYP2D6*2xN	CYP2D6	*2xN	Other	increased	Adverse_Event	Other:gene_duplication/multiduplication		A03DA02	*2xN	5282367
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	increased	Adverse_Event	Disease:C0027651		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Adverse_Event	Disease:C0027651		B01AA03	*1/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28	74990
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
mirtazapine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX11	*4/*4	6451144
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
none	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Other	decreased	Adverse_Event	Healthy		A03DA02	*2/*2	5282367
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3	54688261
irinotecan	rs11692021	UGT1A9	C	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs11692021:C	74990
metoprolol	rs1042714	ADRB2	CG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB02	rs1042714:CG	6322
lamotrigine	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX09	*33:03	71236569
tamoxifen	rs2016347	IGF1R	GG	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs2016347:GG	2733525
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*1/*28	135400182
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*28/*28	135400182
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027651		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0027651		B01AA03	*1/*3	54688261
none	CYP2D6*1xN	CYP2D6	*1xN	Other	increased	Adverse_Event	Other:gene_duplication/multiduplication		A03DA02	*1xN	5282367
allopurinol	HLA-B*48:01	HLA-B	*48:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*48:01	168354693
paclitaxel	rs10509681	CYP2C8	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs10509681:C	36314
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*1/*28	135400182
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*28/*28	135400182
pazopanib	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0919267|Disease:C1261473|Disease:C1561230		L01EX03	*57:01	10113978
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*1/*28	135400182
irinotecan, raltitrexed	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BA03|L01CE02	*28/*28	135400182
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	*2	162180
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
quetiapine	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*1/*2	Metabolism/PK	increased	Adverse_Event	Healthy		N05AH04	*1/*2	118753024
quetiapine	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*2	Metabolism/PK	increased	Adverse_Event	Healthy		N05AH04	*2/*2	118753024
quetiapine	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*2/*4	Metabolism/PK	increased	Adverse_Event	Healthy		N05AH04	*2/*4	118753024
caffeine	rs35060421	ADORA2A	TTTTTTT/TTTTTTT	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs35060421:TTTTTTT/TTTTTTT	936
allopurinol	HLA-DRB1*14:01	HLA-DRB1	*14:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*14:01	168354693
allopurinol	HLA-DRB1*09:01	HLA-DRB1	*09:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*09:01	168354693
ethambutol, isoniazid, pyrazinamide, rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__	135483892
zonisamide	HLA-A*02:07	HLA-A	*02:07	Toxicity	Indeterminado	Adverse_Event	Healthy		N03AX15	*02:07	10467478
phenobarbital	HLA-B*51:01	HLA-B	*51:01	Toxicity	Indeterminado	Adverse_Event	Healthy		N03AA02	*51:01	71371485
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28	74990
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*17/*17	162180
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N02AX02	*10/*10	63013
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
lamivudine, nevirapine, stavudine	HLA-B*35:05	HLA-B	*35:05	Toxicity	Indeterminado	Adverse_Event	Disease:HIV_infectious_disease		J05AF04|J05AF05|J05AG01	*35:05	15979285
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
methotrexate	rs3740065	ABCC2	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3740065:AG	11329481
methotrexate	rs3740065	ABCC2	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3740065:GG	11329481
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01	168354693
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
metoprolol	rs1042714	ADRB2	CC	Toxicity	decreased	Adverse_Event	Disease:C0020538		C07AB02	rs1042714:CC	6322
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
methotrexate	rs9516519	ABCC4	GG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs9516519:GG	11329481
methotrexate	rs9516519	ABCC4	GT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs9516519:GT	11329481
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*58:01	168354693
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
azathioprine, mercaptopurine, thioguanine	rs746071566	NUDT15	del	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L01BB03|L04AX01	rs746071566:del	2265
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG	13748464
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*3	162180
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*2/*3	162180
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05		667572
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05		667572
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05		667572
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Dosage, Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB10	*17/*17	162180
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3/*3	13748464
mirtazapine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AX11		6451144
escitalopram	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	*3	162180
lisinopril	rs35068180	MMP3	del/del	Efficacy	decreased	Adverse_Event	Disease:C0020538		C09AA03	rs35068180:del/del	6322
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB05		667572
acenocoumarol, warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	*2	54676537
escitalopram	CYP2D6*1, CYP2D6*4, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	*4/*41	162180
peginterferon alfa-2a, peginterferon alfa-2b	rs11322783	IFNL4	TT/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		L03AB10|L03AB11	rs11322783:TT/TT	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Efficacy_Response	Healthy		B01AC04	*2/*2	13748464
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027651|Disease:C0030193		N02AB03	*3/*3	13653606
direct acting antivirals, sofosbuvir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05A|J05AP08	rs11322783:TT/TT	45375808
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Dosage, Metabolism/PK	increased	LADME	Disease:C0004936		N06AB10	*2	162180
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2	13748464
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*1/*28	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	*28/*28	No_match
citalopram	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB04	__UNKNOWN__	162180
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*03:02	168354693
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*6	64139
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Healthy		J05AG03	*6/*6	64139
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*33:03	168354693
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Disease:C0022661		M04AA01	*03:02	168354693
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0024121		No_ATC	*28/*28	No_match
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*9	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*9	64139
capecitabine, fluorouracil	rs56038477	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs56038477:CT	60953
clopidogrel	CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*2	13748464
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A6*2a	UGT1A6	*2a	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03|L01CE02|L01XA03	*2a	9887054
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*28	74990
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A1*28	UGT1A1	*28	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*28	9887054
folfox	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs11280056:TTA/TTA	135403647
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A1*60	UGT1A1	*60	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*60	9887054
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10/*10	2733525
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
drugs for treatment of tuberculosis	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*04:01	No_match
isoniazid, rifampin	NAT2*4	NAT2	*4	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0041296		J04AC01	*4	135483892
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
methotrexate	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs11280056:TTA/TTA	11329481
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*9/*9	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*9/*9	64139
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*1/*9	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*1/*9	64139
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0007787|Disease:C0018839		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*3	Efficacy	increased	Adverse_Event	Disease:C0007787|Disease:C0018839		B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*8	Efficacy	increased	Adverse_Event	Disease:C0007787|Disease:C0018839		B01AC04	*8	13748464
folfox	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	135403647
mercaptopurine, methotrexate	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*1/*2	126941
mercaptopurine, methotrexate	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*1/*3A	126941
mercaptopurine, methotrexate	TPMT*1, TPMT*2, TPMT*3A, TPMT*3B	TPMT	*3A/*3B	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	*3A/*3B	126941
egfr inhibitors	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	*02:01	No_match
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Toxicity	decreased	Adverse_Event	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*1/*6	2907
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*6/*6	2907
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
antineoplastic agents, tamoxifen	UGT2B15*1, UGT2B15*2	UGT2B15	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*2/*2	2733526
antineoplastic agents, tamoxifen	UGT2B15*1, UGT2B15*2	UGT2B15	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*1/*2	2733526
egfr inhibitors	HLA-A*03:01	HLA-A	*03:01	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	*03:01	No_match
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	*28/*28	74990
docetaxel	rs3834935	SLCO1B3	A	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs3834935:A	154272
carbamazepine, phenytoin, valproic acid	rs2279020	GABRA1	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs2279020:GG	1775
paclitaxel	CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	*2	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD01	*2	36314
paclitaxel	CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD01	*3	36314
paclitaxel	CYP2C8*2, CYP2C8*3, CYP2C8*4	CYP2C8	*4	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD01	*4	36314
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
ethambutol, isoniazid, pyrazinamide, rifampin	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*6	135483892
amoxicillin, clavulanate	HLA-A*30:02	HLA-A	*30:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*30:02	16204478
citalopram, escitalopram	rs1074145	__INTRONIC__	A	Other	Indeterminado	Other	Disease:C0011581		N06AB04|N06AB10	rs1074145:A	162180
nevirapine	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:02	15979285
nevirapine	HLA-DQB1*06:03	HLA-DQB1	*06:03	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:03	15979285
antineoplastic agents, tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*2/*2	2733526
nevirapine	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:02	15979285
nevirapine	HLA-DRB1*15:03	HLA-DRB1	*15:03	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*15:03	15979285
nevirapine	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:09	15979285
nevirapine	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*02:01	15979285
imatinib	rs11636419	CYP1A2	AA	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs11636419:AA	6113
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Healthy		B01AC04	*2	13748464
nevirapine	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*02:01	15979285
nevirapine	HLA-DQB1*03:02	HLA-DQB1	*03:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*03:02	15979285
nevirapine	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*06:02	15979285
nevirapine	HLA-DQB1*03:02	HLA-DQB1	*03:02	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*03:02	15979285
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01	15979285
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01	15979285
ethanol	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Healthy		V03AB16		444899
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*17	13748464
nevirapine	HLA-DQB1*05:01	HLA-DQB1	*05:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*05:01	15979285
carbamazepine, phenytoin, valproic acid	rs2279020	GABRA1	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs2279020:G	1775
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*17	Other	Indeterminado	Other	Healthy		C07AB02	*3/*17	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*4	Other	Indeterminado	Other	Healthy		C07AB02	*3/*4	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Other	Indeterminado	Other	Healthy		C07AB02	*4/*10	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*17	Other	Indeterminado	Other	Healthy		C07AB02	*4/*17	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*4	Other	Indeterminado	Other	Healthy		C07AB02	*4/*4	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Other	Indeterminado	Other	Healthy		C07AB02	*4/*41	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*5	Other	Indeterminado	Other	Healthy		C07AB02	*4/*5	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*6	Other	Indeterminado	Other	Healthy		C07AB02	*4/*6	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*10	Other	Indeterminado	Other	Healthy		C07AB02	*5/*10	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*17	Other	Indeterminado	Other	Healthy		C07AB02	*5/*17	6322
bucillamine	HLA-DRB1*08:02	HLA-DRB1	*08:02	Toxicity	increased	Adverse_Event	Disease:C0003873		No_ATC	*08:02	656604
mercaptopurine	deficiency	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	L01BB02	__UNKNOWN__	1268107
azathioprine, cyclosporine, prednisone	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*1/*2	2265
azathioprine, cyclosporine, prednisone	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*1/*3A	2265
azathioprine, cyclosporine, prednisone	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*1/*3C	2265
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	74990
bucillamine	HLA-DQB1*04:02	HLA-DQB1	*04:02	Toxicity	increased	Adverse_Event	Disease:C0003873		No_ATC	*04:02	656604
cyclophosphamide	rs3211371	CYP2B6	CT	Efficacy	increased	Efficacy_Response	Disease:C0024299		L01AA01	rs3211371:CT	9554282
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3	13748464
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*6	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*11	54688261
sulfamethoxazole / trimethoprim	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*06:02	5578
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*13:01	2955
dapsone	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*15:02	2955
lapatinib	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*02:01	208908
dapsone	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*15:02	2955
lapatinib	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C1458155		L01EH01	*07:01	208908
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*13:01	2955
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2	13748464
mercaptopurine	deficiency	ABCC4	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	L01BB02		1268107
clopidogrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Other	Healthy		B01AC04	rs4244285:A	13748464
amoxicillin, clavulanate	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*06:02	16204478
clozapine	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*05:02	131769989
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*2	2244
aspirin	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*06:09	72204814
aspirin, clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*3	2244
aspirin	HLA-DRB1*13:02	HLA-DRB1	*13:02	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*13:02	72204814
sulfamethoxazole / trimethoprim	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*15:02	5578
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*1/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*28/*28	60838
clozapine	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*05:02	131769989
clozapine	HLA-DPB1*04:01	HLA-DPB1	*04:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*04:01	131769989
clozapine	HLA-DRB5*02:02	HLA-DRB5	*02:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*02:02	131769989
sulfamethoxazole / trimethoprim	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*08:01	5578
aspirin, clopidogrel, prasugrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	decreased	Adverse_Event	Disease:C0039338		B01AC04|B01AC22	*17/*17	2244
aspirin, clopidogrel, prasugrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Adverse_Event	Disease:C0039338		B01AC04|B01AC22	*1/*17	2244
oxcarbazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF02	*15:02	46782646
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01	16204478
paroxetine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Other	Indeterminado	Other	Disease:C0011581		N06AB05		667572
amoxicillin, clavulanate	HLA-DRB5*01:01	HLA-DRB5	*01:01	Toxicity	increased	Adverse_Event	Disease:C0699744		J01CA04	*01:01	16204478
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*1/*28	67424139
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*28/*28	67424139
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*1/*28	67424139
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		L01EX02	*28/*28	67424139
amoxicillin, clavulanate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Disease:C0699744		J01CA04	*15:01	16204478
sunitinib	rs1128503	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1128503:AA	11221549
sunitinib	rs1128503	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1128503:AG	11221549
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
ticlopidine	HLA-DRB1*13:02	HLA-DRB1	*13:02	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*13:02	5472
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*3	13748464
amitriptyline	CYP2D6*1, CYP2D6*41	CYP2D6	*41	Other, Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*41	4543
ticlopidine	HLA-C*14:03	HLA-C	*14:03	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*14:03	5472
cyclophosphamide	rs3211371	CYP2B6	CT	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	rs3211371:CT	9554282
atorvastatin	rs1805094	LEPR	GG	Other	increased	Other	Disease:C0027051		C10AA05	rs1805094:GG	656846
ticlopidine	HLA-DQB1*06:04	HLA-DQB1	*06:04	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*06:04	5472
ticlopidine	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*33:03	5472
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28	74990
busulfan, cytarabine, etoposide	rs4148405	ABCC3	G	Efficacy, Toxicity	decreased	Other	Disease:C0023418|Myeloid|Acute		L01AB01|L01BC01|L01CB01	rs4148405:G	6253
ticlopidine	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Healthy		B01AC05	*44:03	5472
cocaine, ethanol, nicotine	rs1799972	OPRM1	TT	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N07BA01|V03AB16	rs1799972:TT	89594
nevirapine	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*08:01	15979285
antipsychotics	rs4680	COMT	A	Other	increased	Other	Disease:C0036341		N05A	rs4680:A	No_match
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	__UNKNOWN__	135483892
aspirin	HLA-DRB1*09:01	HLA-DRB1	*09:01	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	*09:01	72204814
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*3	54688261
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
aspirin	HLA-DPB1*05:01	HLA-DPB1	*05:01	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	*05:01	72204814
clopidogrel	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	13748464
drugs for treatment of tuberculosis	CYP2E1*1A, CYP2E1*5B	CYP2E1	*1A/*5B	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*1A/*5B	No_match
aspirin	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	*03:03	72204814
drugs for treatment of tuberculosis	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	__UNKNOWN__	No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
aspirin	HLA-DRB1*13:02	HLA-DRB1	*13:02	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*13:02	72204814
mercaptopurine, thioguanine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	Indeterminado	Adverse_Event	Disease:C0023449		L01BB02|L01BB03	*1/*3C	2723601
aspirin	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*06:09	72204814
fluticasone propionate	rs2569190	CD14, TMCO6	AA	Other	decreased	Efficacy_Response	Disease:C0004096		R03BA05	rs2569190:AA	5311101
fluticasone propionate	rs2569190	CD14, TMCO6	AG	Other	decreased	Efficacy_Response	Disease:C0004096		R03BA05	rs2569190:AG	5311101
bleomycin, dacarbazine, doxorubicin, vinblastine	GSTM1 non-null, GSTM1 null	GSTM1	non-null/non-null	Toxicity	decreased	Adverse_Event	Disease:C0019829		L01AX04|L01CA01|L01DB01|L01DC01		135398738
efavirenz, nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01|J05AG03	*01:01	64139
nevirapine	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*15:01	15979285
ethanol	rs1229984	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1229984:T	444899
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01	15979285
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*28/*28	74990
isoniazid, rifampin	GSTT1 null	GSTT1	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0041296		J04AC01		135483892
capecitabine, fluorouracil, tegafur	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs56038477:T	60953
isoniazid, rifampin	GSTM1 null	GSTM1	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0041296		J04AC01		135483892
allopurinol	HLA-DQB1*05:02	HLA-DQB1	*05:02	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*05:02	168354693
ethambutol, isoniazid, pyrazinamide, rifampin	GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02		135483892
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A	1268107
nevirapine	HLA-B*35:01	HLA-B	*35:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*35:01	15979285
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A	1268107
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
methadone	rs3735451	CYP3A4	C	Other	increased	Adverse_Event	Disease:C0028043		N07BC02	rs3735451:C	10090
irinotecan	UGT1A1*1, UGT1A1*27	UGT1A1	*1/*27	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*1/*27	74990
clozapine	CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02	*17/*17	131769989
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:01	15979285
clozapine	HLA-B*59:01	HLA-B	*59:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*59:01	131769989
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	*1/*6	74990
nevirapine	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*04:01	15979285
phenytoin	HLA-B*07:02, HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*13:01	1775
fluoxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	Indeterminado	LADME	Disease:C0004936		N06AB03	*4/*4	1548968
none	rs920829	TRPA1	CT	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs920829:CT	5282367
none	rs920829	TRPA1	TT	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs920829:TT	5282367
ethanol	rs671	ALDH2	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs671:A	444899
none	deficiency	NAT2	__UNKNOWN__	Other	Indeterminado	Adverse_Event	Healthy	deficiency	A03DA02	__UNKNOWN__	5282367
fluoxetine	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*1/*2	1548968
fluoxetine	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*1/*3	1548968
nortriptyline	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA10	*1/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA10	*1/*5	9918
ritodrine	rs10774053	CACNA1C	AA	Other	decreased	Adverse_Event	Disease:C0022876		G02CA01	rs10774053:AA	33572
ritodrine	rs10774053	CACNA1C	AG	Other	decreased	Adverse_Event	Disease:C0022876		G02CA01	rs10774053:AG	33572
spironolactone	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	169502192
spironolactone	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	169502192
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
warfarin	rs429358	APOE	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs429358:TT	54688261
warfarin	rs7412	APOE	CC	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs7412:CC	54688261
amoxicillin, clavulanate, flucloxacillin	HLA-DQB1*06:02	HLA-DQB1	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*06:02	16204478
atorvastatin, quinapril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA06|C10AA05	rs1799752:del/del	54892
timolol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy, Metabolism/PK	increased	LADME	Healthy	poor metabolizer	S01ED01	__UNKNOWN__	33624
lansoprazole	normal metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	normal metabolizer	A02BC03	__UNKNOWN__	11985
amoxicillin, clavulanate, flucloxacillin	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*06:02	16204478
rabeprazole	normal metabolizer	CYP2C19	__UNKNOWN__	Efficacy	decreased	Other	Healthy	normal metabolizer	A02BC04	__UNKNOWN__	11985
none	rs1615111	AREG	A	Other	decreased	Other	Disease:C0001418		A03DA02	rs1615111:A	5282367
cisplatin, epirubicin, fluorouracil	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus|Disease:C0026640		L01BC02|L01DB03|L01XA01	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5460033
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*3	13748464
atorvastatin, quinapril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA06|C10AA05	rs1799752:del/del	54892
atorvastatin, quinapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06|C10AA05	rs1799752:del/del	54892
amoxicillin, clavulanate, flucloxacillin	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*57:01	16204478
clopidogrel	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2/*2	13748464
vincristine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	*1/*3	24848381
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2	2244
ethanol	rs2031920	CYP2E1	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2031920:T	444899
cisplatin, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CE02|L01XA01	*1/*28	5460033
cisplatin, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CE02|L01XA01	*28/*28	5460033
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Other	increased	Adverse_Event	Disease:C0004238|Disease:C0004239|Disease:C0042487		B01AA07	*3	54742534
tolterodine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		G04BD07	*10/*10	443878
tolterodine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Healthy		G04BD07	*5/*10	443878
amoxicillin, clavulanate, flucloxacillin	HLA-DQB1*03:03	HLA-DQB1	*03:03	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*03:03	16204478
phenytoin	CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*3	1775
anastrozole	rs1008805	CYP19A1	GG	Other	decreased	Adverse_Event	Disease:C1458155		L02BG03	rs1008805:GG	713
ace inhibitors, plain	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	No_match
olanzapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*1	74603552
cyclophosphamide, epirubicin, fluorouracil	rs41412545	INSR	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs41412545:A	2907
cyclosporine, methotrexate	rs2177735	ATIC	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs2177735:AA	126941
levetiracetam	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AX14	*11:01	59708
allopurinol	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:01	168354693
cyclophosphamide, epirubicin, fluorouracil	rs56022120	PIK3R2	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs56022120:T	2907
valproic acid	rs6759892	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Dosage, Metabolism/PK	increased	LADME	Healthy		N03AG01	rs6759892:G	134459
valproic acid	rs2070959	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Dosage, Metabolism/PK	increased	LADME	Healthy		N03AG01	rs2070959:G	134459
cyclophosphamide, epirubicin, fluorouracil	rs138602176	PIK3R2	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs138602176:A	2907
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02	168354693
phenytoin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*02:01	1775
nevirapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*01:01	15979285
clopidogrel	rs5853517	MED12L, P2RY12	T/del	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs5853517:T/del	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2/*2	13748464
phenytoin	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*24:02	1775
exemestane	rs16964189	__INTRONIC__	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs16964189:TT	13472
cyclophosphamide, epirubicin, fluorouracil	rs78428806	PERP	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs78428806:A	2907
aspirin, clopidogrel, prasugrel	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Disease:C0039338		B01AC04|B01AC22	*2	2244
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*3	54688261
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	L01BC02	__UNKNOWN__	5790
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
antipsychotics	rs11123469	INSIG2	CC	Efficacy	increased	Adverse_Event	Disease:C0036341		N05A	rs11123469:CC	No_match
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
fenofibrate, sertraline, terbinafine, ticlopidine	HLA-A*33:01	HLA-A	*33:01	Toxicity	increased	Adverse_Event	Healthy		B01AC05|C10AB05|D01BA02|N06AB06	*33:01	5472
carbamazepine, phenytoin, valproic acid	rs2032582	ABCB1	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs2032582:T	1775
fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	135403648
fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3	135403648
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	*3	54688261
aspirin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0007222		No_ATC	*1/*3	72204814
capecitabine, fluorouracil, tegafur	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs67376798:A	60953
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		C07AB02	*1/*4	6322
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		C07AB02	*4/*4	6322
fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0027651	deficiency	L01BC02	__UNKNOWN__	5790
atazanavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	*28	118753185
none	rs2285666	ACE2	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs2285666:C	5282367
"""ace inhibitors, plain"", ""beta blocking agents"", ""calcium channel blockers"", ""digoxin"", ""diuretics"""	rs1799752	ACE	del	Efficacy	increased	Efficacy_Response	Disease:C0085605		C03|C08|C09A|S01ED	rs1799752:del	2724385
ivacaftor, tezacaftor	rs113993960	CFTR	del/del	Other	decreased	Adverse_Event	Disease:C0156318		R07AX02|R07AX31	rs113993960:del/del	72722243
mercaptopurine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3C	1268107
desipramine	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N06AA01	*1/*1	65327
pamaquine	deficiency	G6PD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Other:G6PD_deficient_mice	deficiency	No_ATC		No_match
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Efficacy, Other	increased	Other	Healthy		C07AB02	*1/*4	6322
metoprolol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy, Other	increased	Other	Healthy		C07AB02	*4/*4	6322
primaquine	deficiency	G6PD	__UNKNOWN__	Toxicity	Indeterminado	Adverse_Event	Other:G6PD_deficient_mice	deficiency	P01BA03		6135
itraconazole, ketoconazole	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other, Metabolism/PK	decreased	Adverse_Event	Other:Human_Liver_Microsomes		J02AB02|J02AC02	*1/*1	47576
itraconazole, ketoconazole	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Other, Metabolism/PK	decreased	Adverse_Event	Other:Human_Liver_Microsomes		J02AB02|J02AC02	*1/*3	47576
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	*3	13748464
hmg coa reductase inhibitors	rs3764261	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs3764261:A	445127
capecitabine	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	11809635
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	*3	13748464
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	decreased	Adverse_Event	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	decreased	Adverse_Event	Healthy		B01AA04	*3	91987769
osimertinib	rs28399433	CYP2A6	CC	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB04	rs28399433:CC	71496458
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
amitriptyline, fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*1xN	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09|N06AB03	*1/*1xN	1548970
amitriptyline, fluoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09|N06AB03	*2/*2xN	1548970
pazopanib, pemetrexed	rs833061	VEGFA	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BA04|L01EX03	rs833061:CC	10113978
pazopanib, pemetrexed	rs833061	VEGFA	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BA04|L01EX03	rs833061:CT	10113978
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
penicillin g, penicillin v	HLA-B*55:01	HLA-B	*55:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*55:01	6869
ethanol	rs2948694	GHSR	AG	Other	Indeterminado	Other	Healthy		V03AB16	rs2948694:AG	444899
opioids	rs495491	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs495491:AG	No_match
opioids	rs495491	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs495491:GG	No_match
opioids	rs10457090	OPRM1	AA	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs10457090:AA	No_match
opioids	rs10457090	OPRM1	AG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs10457090:AG	No_match
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02	114709
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*3	1775
allopurinol	HLA-B*58:01	HLA-B	*58:01/*58:01	Toxicity	increased	Adverse_Event	Disease:C0235889|Gouty		M04AA01	*58:01/*58:01	168354693
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02	1775
carbamazepine, phenytoin, valproic acid	rs17183814	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AG01	rs17183814:A	1775
warfarin	CYP2C9*2	CYP2C9	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2	54688261
atorvastatin, pravastatin, simvastatin	rs1935349	HTR7	T	Toxicity	increased	Adverse_Event	Disease:C0020443		C10AA01|C10AA03|C10AA05	rs1935349:T	60823
methotrexate	rs45445694	TYMS	CCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs45445694:CCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTGGCCTGCCTCCGTCCCGCCGCGCCACTTCGCCTGCCTCCGTCCCCC	11329481
nevirapine	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*6/*18	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*6/*18	15979285
docetaxel, tegafur	CYP2A6*1, CYP2A6*4	CYP2A6	*4/*4	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC03|L01CD02	*4/*4	148124
cisplatin	rs1799793	ERCC2	T	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs1799793:T	441203
carbamazepine	HLA-B*40:01	HLA-B	*40:01	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*40:01	114709
cocaine	rs3836790	SLC6A3	CACATACCATGCAACATACACACTCAGACA/CACATACCATGCAACATACACACTCAGACA	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs3836790:CACATACCATGCAACATACACACTCAGACA/CACATACCATGCAACATACACACTCAGACA	2826
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02	114709
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2	54688261
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02	1775
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
phenytoin	HLA-DRB1*16:02	HLA-DRB1	*16:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*16:02	1775
paroxetine	CYP2D6*1, CYP2D6*4, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*1/*4	667572
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Side_Effect:C0235030		N03AB02	*1/*3	1775
ibuprofen	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		M02AA13	*3	53464135
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*1	1775
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*1	1775
acetaminophen	CYP2E1*1, CYP2E1*5B	CYP2E1	*1/*5B	Metabolism/PK	increased	LADME	Disease:C0341439		N02BE01	*1/*5B	1983
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	LADME	Disease:C0023449		L01BB02	*1/*3A	1268107
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Other	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*2	13748464
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*4	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*4	CYP2C9	*1/*4	Dosage	decreased	Other	Healthy		B01AA03	*1/*4	54688261
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
mercaptopurine	rs73032311	CYP2A7	C	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs73032311:C	1268107
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*2	13748464
bupropion	CYP2B6*18	CYP2B6	*18	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*18	446
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*1	1775
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
phenytoin	CYP2C9*1	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*1	1775
antiepileptics, carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03A|N03AF01	*15:02	2554
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*3	4543
phenytoin	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*13:01	1775
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*3	13748464
none	NAT1*10, NAT1*11A	NAT1	*10/*11A	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*11A	5282367
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2	54688261
none	NAT1*4, NAT1*10	NAT1	*10/*4	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*4	5282367
isoniazid, pyrazinamide, rifampin	GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01		135483892
drugs for treatment of tuberculosis	slow acetylator	NAT2	*5	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*5	No_match
paclitaxel	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Disease:C0919267		L01CD01	*3	36314
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6	446
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*2	13748464
irinotecan, raltitrexed	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BA03|L01CE02	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	135400182
clopidogrel	CYP2C19*3	CYP2C19	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*3	13748464
temsirolimus	rs6785049	NR1I2	AG	Toxicity	decreased	Adverse_Event	Disease:C0877645		L01EG01	rs6785049:AG	6918289
temsirolimus	rs6785049	NR1I2	GG	Toxicity	decreased	Adverse_Event	Disease:C0877645		L01EG01	rs6785049:GG	6918289
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/C	131769926
none	NAT1*3, NAT1*11B	NAT1	*11B/*3	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*11B/*3	5282367
none	NAT1*10	NAT1	*10/*10	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*10	5282367
oxcarbazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF02	*15:02	46782646
calcineurin inhibitors, cyclosporine, tacrolimus	CYP2C8*3	CYP2C8	*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD|L04AD01|L04AD02	*3	445643
daunorubicin	rs10932125	NRP2	C	Dosage, Metabolism/PK	increased	LADME	Healthy		L01DB02	rs10932125:C	11570269
cisplatin, cyclophosphamide	rs1799735	GSTM3	CCT/CCT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799735:CCT/CCT	2907
cisplatin, cyclophosphamide	rs1799735	GSTM3	CCT/CCT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799735:CCT/CCT	2907
cisplatin, cyclophosphamide	rs1799735	GSTM3	CCT/CCT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799735:CCT/CCT	2907
metoprolol	rs5030655	CYP2D6	del/del	Other	increased	LADME	Healthy		C07AB02	rs5030655:del/del	6322
antidepressants	rs57098334	SLC6A4	(CCCACCCGA)12/(CCCACCCGA)12	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A	rs57098334:(CCCACCCGA)12/(CCCACCCGA)12	No_match
valproic acid	rs1105879	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	C	Metabolism/PK	increased	LADME	Healthy		N03AG01	rs1105879:C	134459
nevirapine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*6/*6	15979285
isoniazid, pyridoxal phosphate	CYP2E1*1A	CYP2E1	*1A/*1A	Toxicity	increased	Adverse_Event	Disease:C0041296		A11HA06|J04AC01	*1A/*1A	1050
atenolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C07AB03	rs1801253:CC	14211540
amitriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AA09	*4/*4	4543
amitriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AA09	*4/*4	4543
repaglinide	SLCO1B1*1, SLCO1B1*37	SLCO1B1	*37/*37	Metabolism/PK	decreased	LADME	Healthy		A10BX02	*37/*37	22132924
phenytoin	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*08:01	1775
benzene	rs1800566	NQO1	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1800566:AA	637796
atazanavir, efavirenz	rs4570625	TPH2	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE08|J05AG03	rs4570625:TT	64139
methotrexate	rs70991108	DHFR	TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs70991108:TGGCGCGTCCCGCCCAGGT/TGGCGCGTCCCGCCCAGGT	11329481
allopurinol	HLA-C*03:02	HLA-C	*03:02	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*03:02	168354693
efavirenz	CYP2B6*1	CYP2B6	*1	Efficacy, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1	64139
antithyroid preparations	HLA-B*08:01	HLA-B	*08:01	Toxicity	increased	Adverse_Event	Healthy		H03B	*08:01	No_match
tegafur	CYP2A6*1	CYP2A6	*1	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC03	*1	5386
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*1/*2	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*1/*3	1775
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	*6/*6	74990
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	*1/*1	86666680
antiepileptics	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Adverse_Event	Disease:C0014544		N03A	*1/*3	No_match
atorvastatin	UGT1A3*1, UGT1A3*2	UGT1A3	*2/*2	Efficacy, Metabolism/PK	increased	LADME	Healthy		C10AA05	*2/*2	656846
atorvastatin	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy		C10AA05	*2	656846
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
doxepin	CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*3/*3	59023617
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*2	64139
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*3	64139
tacrolimus	CYP2C19*2	CYP2C19	*2/*2	Other	increased	Other	Disease:Kidney_Transplantation		L04AD02	*2/*2	131769926
mercaptopurine	rs4680	COMT	A	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs4680:A	1268107
rosiglitazone	CYP2C8*3	CYP2C8	*3	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG02	*3	9846723
nortriptyline	CYP2D6*1, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Healthy		N06AA10	*1/*2xN	9918
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15	58746970
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*2	4543
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2	13748464
none	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Other	Indeterminado	Adverse_Event	Healthy		A03DA02	*17	5282367
caffeine	rs5751876	ADORA2A	TT	Other	increased	Adverse_Event	Healthy		N06BC01	rs5751876:TT	936
methotrexate	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)3	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)3	11329481
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*3	13748464
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:patients_that_had_undergone_coronary_angiography_or_had_an_uneventful_PCI		B01AC04	*2	13748464
atorvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*3/*3	656846
nevirapine	rs2125739	ABCC10	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2125739:CC	15979285
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
metformin	rs36056065	SLC22A1	GTAAGTTG	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0011849		A10BA02	rs36056065:GTAAGTTG	155906370
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
drugs for treatment of tuberculosis	CYP2E1*1A	CYP2E1	*1A/*1A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*1A/*1A	No_match
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
clopidogrel	CYP2C19*17	CYP2C19	*17	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	*17	13748464
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*1/*3	1775
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*2	13748464
none	NAT1*10, NAT1*11B	NAT1	*10/*11B	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*10/*11B	5282367
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*2	64139
efavirenz, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC01|J05AG03	*1/*3	64139
drugs for treatment of tuberculosis	HLA-DQB1*02:01	HLA-DQB1	*02:01	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*02:01	No_match
none	NAT1*4, NAT1*11A	NAT1	*11A/*4	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption_and_rs2066853_genotype_AA_or_GA		A03DA02	*11A/*4	5282367
warfarin	CYP2C9*3	CYP2C9	*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*3	54688261
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Toxicity	increased	LADME	Disease:C0023449		L01BB02	*1/*3A	1268107
pravastatin	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*1/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*1/*15	58746970
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*1/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*1/*15	58746970
warfarin	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Dosage	decreased	Other	Healthy		B01AA03	*1/*13	54688261
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage, Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage, Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3	91987769
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
metoprolol	CYP2D6*4	CYP2D6	*4	Dosage, Toxicity	increased	Adverse_Event	Healthy		C07AB02	*4	6322
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15/*15	58746970
drugs for treatment of tuberculosis	GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A		No_match
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
aspirin, clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*2	2244
aspirin, clopidogrel	CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:patients_undergoing_PCI		B01AC04	*3	2244
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Other	Healthy		B01AA03	*1/*3	54688261
doxepin	CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*3/*5	59023617
haloperidol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AD01	rs4680:AG	9828
atorvastatin	CYP2D6*4	CYP2D6	*4	Toxicity	increased	Adverse_Event	Healthy		C10AA05	*4	656846
doxepin	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*5	59023617
warfarin	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*1/*13	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*14	CYP2C9	*1/*14	Dosage	decreased	Other	Healthy		B01AA03	*1/*14	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*3	54688261
clopidogrel	CYP2B6*5	CYP2B6	*5	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	*5	13748464
venlafaxine	CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N06AX16	*10/*10	9795857
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Other	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Other	Healthy		B01AA03	*3	54688261
venlafaxine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Healthy		N06AX16	*1/*10	9795857
warfarin	CYP2C9*1, CYP2C9*14	CYP2C9	*1/*14	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*1/*14	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	*1/*3	54688261
phenprocoumon	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3	91987769
phenprocoumon	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Adverse_Event	Healthy		B01AA04	*3	91987769
phenprocoumon	CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Healthy		B01AA04	*2	91987769
escitalopram	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*10	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	*4/*10	162180
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Other	Healthy		A02BC03	*1/*1	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Other	Healthy		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Other	Healthy		A02BC03	*1/*3	11985
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*2	13748464
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*10/*10	63013
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy		N02AX02	*4/*4	63013
omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Other	Disease:C0041582		A02BC01	*1/*2	9579578
paroxetine	CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*4/*4	667572
paroxetine	CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Healthy		N06AB05	*3/*4	667572
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	decreased	Efficacy_Response	Healthy		N02AX02	*4/*4	63013
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3/*3	13748464
tamoxifen	CYP2D6*6, CYP2D6*7	CYP2D6	*6/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*6/*7	2733525
escitalopram	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	*5/*10	162180
tamoxifen	CYP2D6*3, CYP2D6*6	CYP2D6	*3/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3/*6	2733525
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Dosage, Efficacy	decreased	Efficacy_Response	Healthy		N02AX02	*3/*4	63013
clomipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AA04	*2	68539
nortriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4	9918
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	Indeterminado	LADME	Healthy		N02AA05	*4/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	Indeterminado	LADME	Healthy		N02AA05	*3/*4	5462350
paroxetine	CYP2D6*1, CYP2D6*41	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N06AB05	*1/*1	667572
paroxetine	CYP2D6*1, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Healthy		N06AB05	*1/*41	667572
nortriptyline	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*5/*10	9918
desipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N06AA01	*1/*1	65327
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*2/*10	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*5	CYP2D6	*3/*5	Dosage, Efficacy	decreased	Efficacy_Response	Healthy		N02AX02	*3/*5	63013
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*5	9918
paroxetine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*1/*10	667572
paroxetine	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*1/*5	667572
cotinine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17, CYP2A6*20	CYP2A6	*1/*1	Metabolism/PK	Indeterminado	LADME	Healthy		No_ATC	*1/*1	108114
mirtazapine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX11	*4/*4	6451144
paroxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0028768		N06AB05	*1/*4	667572
clomipramine	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AA04	*3	68539
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*2/*2	162180
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*2/*3	162180
paroxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*10/*10	667572
paroxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB05	*1/*10	667572
mirtazapine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		N06AX11	*1/*1xN	6451144
codeine	CYP2D6*1, CYP2D6*36	CYP2D6	*36	Metabolism/PK	decreased	LADME	Healthy		R05DA04	*36	5284371
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*1	Metabolism/PK	increased	LADME	Healthy		R05DA04	*1/*1	5284371
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		R05DA04	*1/*4	5284371
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2	13748464
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
none	rs34946978	UGT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs34946978:T	5282367
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
flurbiprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		S01BC04	*1/*3	23684814
diclofenac	CYP2C8*1, CYP2C8*4	CYP2C8	*1/*4	Metabolism/PK	increased	LADME	Healthy		S01BC03	*1/*4	112230
diclofenac	CYP2C8*1, CYP2C8*4	CYP2C8	*4/*4	Metabolism/PK	increased	LADME	Healthy		S01BC03	*4/*4	112230
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3/*3	13748464
pyrimidine analogues	rs895819	MIR27A	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC	rs895819:CC	No_match
pyrimidine analogues	rs895819	MIR27A	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC	rs895819:CT	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3/*3	13748464
citalopram	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AB04	__UNKNOWN__	162180
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Metabolism/PK	increased	LADME	Healthy		S01ED01	*3/*3	33624
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Healthy		S01ED01	*3/*4	33624
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		S01ED01	*4/*4	33624
timolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*5/*4	Metabolism/PK	increased	LADME	Healthy		S01ED01	*5/*4	33624
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AF01	*15:02	114709
clopidogrel	rs662	PON1	C	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:C	13748464
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
tenoxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Healthy		M01AC02	*3	54677971
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Toxicity	decreased	Adverse_Event	Healthy		M02AA13	*1/*3	53464135
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
clopidogrel	rs2046934	P2RY12	A	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs2046934:A	13748464
antiepileptics	HLA-B*58:01	HLA-B	*58:01	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03A	*58:01	No_match
aspirin	HLA-DPB1*03:01	HLA-DPB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*03:01	72204814
sulfonamides, urea derivatives	rs7903146	TCF7L2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs7903146:CC	1176
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3/*3	54688261
lumacaftor	rs113993960	CFTR	del/del	Toxicity	increased	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del	16678941
caffeine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:AA	936
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Disease:Leprosy		J04BA02	*13:01	2955
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	*2/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	*3/*3	54742534
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	*3	13748464
codeine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA04	*1/*10	5284371
codeine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA04	*10/*10	5284371
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*2	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation		L04AX01	*1/*3C	5778
bosentan	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		C02KX01	*2	6426756
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*1	Other	increased	Other	Healthy		R05DA04	*1/*1	5284371
codeine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Other	increased	Other	Healthy		R05DA04	*1/*4	5284371
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2	13748464
tetrabenazine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Efficacy	Indeterminado	Efficacy_Response	Healthy	intermediate metabolizer	N07XX06	__UNKNOWN__	6018
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3	Toxicity	decreased	Adverse_Event	Healthy		B01AA03	*3	54688261
citalopram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/L allele-rs25531C	Toxicity	increased	Adverse_Event	Disease:C0497327		N06AB04		162180
citalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*1/*17	162180
clopidogrel	rs1330344	PTGS1	T	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1330344:T	13748464
clomipramine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Toxicity	increased	Adverse_Event	Healthy		N06AA04		68539
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*1/*2	162180
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2	162180
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05		667572
phenobarbital	CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		N03AA02	*2	71371485
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3A	74603552
olanzapine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Healthy		N05AH03	*1/*3C	74603552
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*1/*2	13748464
carbamazepine	HLA-B*07:02, HLA-B*08:01	HLA-B	*07:02	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	*07:02	114709
trichloroethylene	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*13:01	6575
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
azathioprine, cyclosporine, prednisone	TPMT*3A, TPMT*3C	TPMT	*3A/*3C	Toxicity	Indeterminado	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AD01|L04AX01	*3A/*3C	2265
allopurinol	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Healthy		M04AA01	*02:01	168354693
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3	13748464
allopurinol	HLA-C*08:01	HLA-C	*08:01	Toxicity	increased	Adverse_Event	Disease:C0745761		M04AA01	*08:01	168354693
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A7*3	UGT1A7	*3	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03|L01CE02|L01XA03	*3	9887054
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*1/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_interventions		B01AC04	*2/*2	2244
osimertinib	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs1057910:CC	71496458
citalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04		162180
mycophenolate mofetil(mycophenolic acid)	rs11572076	CYP2C8	CC	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs11572076:CC	5281078
allopurinol	HLA-A*33:03	HLA-A	*33:03	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*33:03	168354693
clozapine	HLA-DRB3*02:02	HLA-DRB3	*02:02	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*02:02	131769989
mercaptopurine	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs1142345:C	1268107
mycophenolate mofetil(mycophenolic acid)	rs7438135	UGT2B7	G	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs7438135:G	5281078
clozapine	HLA-C*07:01	HLA-C	*07:01	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	*07:01	131769989
clozapine	HLA-DRB1*01:01	HLA-DRB1	*01:01	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH02	*01:01	131769989
azathioprine, mercaptopurine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	*07:01	5778
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Other	Disease:C0027051		B01AC04	*2	13748464
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
sulfasalazine	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*39:01	5336
methazolamide	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		S01EC05	*01:02	No_match
carbimazole, methimazole, propylthiouracil	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Disease:C0242656		H03BA02|H03BB01	*38:02	657298
platinum compounds, pyrimidine analogues	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Other:C0026640		L01BC|L01XA	rs1801265:AG	23939
platinum compounds, pyrimidine analogues	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Other:C0026640		L01BC|L01XA	rs1801265:GG	23939
cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04|B01AC23	*2	2754
cilostazol, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04|B01AC23	*3	2754
phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	*15:02	1775
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3	54742534
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*3	54688261
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Disease:C0005586|Disease:C0014544		N03AF01	*15:02	114709
capecitabine, fluorouracil	deficiency	DPYD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0027651	deficiency	L01BC02|L01BC06	__UNKNOWN__	60953
dolasetron	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Efficacy	increased	Adverse_Event	Disease:C0520904		A04AA04	*1/*1xN	3033818
cyclosporine, methotrexate	rs6123048	NFATC2	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs6123048:AA	126941
cyclophosphamide, epirubicin, paclitaxel	CYP2C8*1, CYP2C8*4	CYP2C8	*4	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	*4	2907
tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	*1/*2	2733525
abacavir	HLA-B*57:01	HLA-B	*57:01	Toxicity	Indeterminado	Adverse_Event	Disease:HIV_infectious_disease		J05AF06	*57:01	56927907
ifosfamide	rs3764435	ALDH1A1	AA	Efficacy	decreased	Efficacy_Response	Other:C1561230|Other:C1261473		L01AA06	rs3764435:AA	700
aspirin, clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17	2244
dapsone	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J04BA02	*13:01	2955
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT	37542
clozapine	GSTT1 non-null, GSTT1 null	GSTT1	null/null	Toxicity	increased	Adverse_Event	Healthy		N05AH02		131769989
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	*3	13748464
peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs11322783:TT/TT	37542
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:TT/TT	37542
azathioprine, mercaptopurine	rs746071566	NUDT15	del	Toxicity	increased	Adverse_Event	Other:C0004364|Other:C0021390		L01BB02|L04AX01	rs746071566:del	5778
hmg coa reductase inhibitors	rs402007	ADAMTS1	CC	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs402007:CC	445127
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
nicotine	CYP2B6*1, CYP2B6*4	CYP2B6	*1/*4	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*1/*4	936
nicotine	CYP2B6*1, CYP2B6*4	CYP2B6	*4/*4	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*4/*4	936
nicotine	CYP2A6*1, CYP2A6*12	CYP2A6	*1/*1	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	*1/*1	936
antithyroid preparations	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		H03B	*38:02	No_match
antithyroid preparations	HLA-DRB1*08:03	HLA-DRB1	*08:03	Toxicity	increased	Adverse_Event	Healthy		H03B	*08:03	No_match
amoxicillin, clavulanate, flucloxacillin	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	*15:01	16204478
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
gefitinib	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0007131	poor metabolizer	L01EB01	*3/*3	135496227
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
carboplatin, paclitaxel	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01XA02	*1/*3	10339178
lamotrigine	rs3812718	SCN1A	C	Efficacy	increased	Efficacy_Response	Healthy		N03AX09	rs3812718:C	71236569
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:human_kidney_microsomes		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
pemetrexed	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	decreased	Efficacy_Response	Disease:C0025500		L01BA04	rs11280056:TTAAAGTTA/TTAAAGTTA	135565228
methotrexate	rs11280056	TYMS	del	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs11280056:del	11329481
none	rs4149056	SLCO1B1	C	Other	decreased	Other	Healthy		A03DA02	rs4149056:C	5282367
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Other:C0014544		N03AF01	*15:02	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
levofloxacin	HLA-B*13:01, HLA-B*13:02	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01MA12	*13:01	71749775
levofloxacin	HLA-B*13:01, HLA-B*13:02	HLA-B	*13:02	Toxicity	increased	Adverse_Event	Healthy		J01MA12	*13:02	71749775
phenytoin	HLA-A*03:01	HLA-A	*03:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02	*03:01	1775
aspirin, clopidogrel	intermediate metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	2244
beta-lactam antibacterials, penicillins	HLA-DRB1*10:01	HLA-DRB1	*10:01	Toxicity	increased	Adverse_Event	Healthy		J01C|J01D	*10:01	2349
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:C1956346	intermediate metabolizer and poor metabolizer	B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*3	Toxicity	increased	Adverse_Event	Other:C1956346	intermediate metabolizer and poor metabolizer	B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*8	Toxicity	increased	Adverse_Event	Other:C1956346	intermediate metabolizer and poor metabolizer	B01AC04	*8	13748464
clopidogrel, proton pump inhibitors	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*1	Toxicity	increased	Adverse_Event	Other:C1956346	normal metabolizer and ultrarapid metabolizer and rapid metabolizer	A02BC|B01AC04	*1/*1	5460653
clopidogrel, proton pump inhibitors	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Other:C1956346	normal metabolizer and ultrarapid metabolizer and rapid metabolizer	A02BC|B01AC04	*1/*17	5460653
clopidogrel, proton pump inhibitors	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Other:C1956346	normal metabolizer and ultrarapid metabolizer and rapid metabolizer	A02BC|B01AC04	*17/*17	5460653
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BA01	*10/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BA01	*1/*10	2733525
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*1	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*1/*1	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17/*17	13748464
aspirin, clopidogrel	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:high_on-treatment_platelet_reactivity	poor metabolizer	B01AC04	__UNKNOWN__	2244
cyclosporine, methotrexate	rs4818789	SLC19A1	TT	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4818789:TT	126941
atenolol, metoprolol	rs1042714	ADRB2	GG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB02|C07AB03	rs1042714:GG	4171
zoledronic acid	rs1152003	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		M05BA08	rs1152003:CC	68740
carbamazepine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:02	114709
antidepressants, antipsychotics	intermediate metabolizer	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1868980	intermediate metabolizer and poor metabolizer	N05A|N06A	__UNKNOWN__	No_match
atorvastatin	rs17671591	HMGCR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs17671591:T	656846
antidepressants, antipsychotics	intermediate metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1868980	intermediate metabolizer and poor metabolizer	N05A|N06A	__UNKNOWN__	No_match
tacrolimus, voriconazole	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	Adverse_Event	Other:Kidney_Transplantation		J02AC03|L04AD02	*3/*3	71616
carboplatin, paclitaxel	rs1052536	LIG3	T	Toxicity	increased	Adverse_Event	Other:C0919267		L01CD01|L01XA02	rs1052536:T	10339178
clopidogrel	rs2069514	CYP1A2	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs2069514:A	13748464
cyclosporine, methotrexate	rs4819128	SLC19A1	TT	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs4819128:TT	126941
ethambutol, isoniazid / pyrazinamide / rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__	135483892
atorvastatin	rs10474433	HMGCR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs10474433:T	656846
vancomycin	HLA-A*32:01	HLA-A	*32:01	Toxicity	increased	Adverse_Event	Healthy		J01XA01	*32:01	6420023
mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:T	1268107
atorvastatin	rs11591147	PCSK9	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs11591147:T	656846
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-A*02:07	HLA-A	*02:07	Toxicity	decreased	Adverse_Event	Healthy		J01D	*02:07	2349
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-A*01:01	HLA-A	*01:01	Toxicity	increased	Adverse_Event	Healthy		J01D	*01:01	2349
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-C*06:02	HLA-C	*06:02	Toxicity	increased	Adverse_Event	Healthy		J01D	*06:02	2349
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-DRB1*15:01	HLA-DRB1	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01D	*15:01	2349
"""beta-lactam antibacterials, penicillins"", ""other beta-lactam antibacterials"""	HLA-DQB1*03:02	HLA-DQB1	*03:02	Toxicity	increased	Adverse_Event	Healthy		J01D	*03:02	2349
clopidogrel	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	13748464
valproic acid	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	*1/*3	134459
valproic acid	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	*3/*3	134459
atorvastatin	rs429358	APOE	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs429358:T	656846
enalapril	rs495828	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Disease:C0020538		C09AA02	rs495828:TT	5950
ribavirin, sofosbuvir	rs1127354	ITPA	AC	Efficacy	increased	Adverse_Event	Other:C0019372		J05AP01|J05AP08	rs1127354:AC	37542
enalapril	rs495828	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Disease:C0020538		C09AA02	rs495828:TT	5950
atorvastatin	rs7412	APOE	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0010068		C10AA05	rs7412:T	656846
none	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Efficacy, Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		A03DA02		5282367
simvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs2231142:TT	14373154
cisplatin, docetaxel, fluorouracil	rs11280056	TYMS	TTA/TTA	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs11280056:TTA/TTA	5460033
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11	114709
none	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	A03DA02	*2	5282367
none	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	A03DA02	*3	5282367
efavirenz	poor metabolizer	CYP2B6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0233407|Other:HIV_infectious_disease	poor metabolizer	J05AG03	__UNKNOWN__	64139
capecitabine, fluorouracil	rs143004875	DPYS	(T)7/(T)8	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs143004875:(T)7/(T)8	60953
fluvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs2231142:TT	131750727
capecitabine, fluorouracil	DPYD c.1129-5923C>G, c.1236G>A (HapB3)	DPYD	c.1129-5923C>G, c.1236G>A (HapB3)	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	c.1129-5923C>G, c.1236G>A (HapB3)	60953
osimertinib	CYP2A6*4	CYP2A6	*4	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	*4	71496458
osimertinib	rs2622604	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs2622604:TT	71496458
l-asparagine, prednisone, vincristine	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	*3/*3	5865
l-asparagine, prednisone, vincristine	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*6	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	*3/*6	5865
l-asparagine, prednisone, vincristine	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*7	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	*3/*7	5865
l-asparagine, prednisone, vincristine	rs3832526	ASNS	(GCGGGGCGCAGGGC)3/(GCGGGGCGCAGGGC)3	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	rs3832526:(GCGGGGCGCAGGGC)3/(GCGGGGCGCAGGGC)3	5865
pravastatin	rs17655652	NPC1L1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs17655652:CC	58746970
pravastatin	rs17655652	NPC1L1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs17655652:CC	58746970
ethambutol, isoniazid / pyrazinamide / rifampin	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	__UNKNOWN__	135483892
clopidogrel	CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Other:C0007222		B01AC04	*2	13748464
clopidogrel	CYP2C19*2	CYP2C19	*2	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*17	CYP2C19	*17	Toxicity	decreased	Adverse_Event	Healthy		B01AC04	*17	13748464
tramadol	poor metabolizer	CYP2B6	__UNKNOWN__	Efficacy	decreased	Adverse_Event	Other:C0030193|Postoperative	poor metabolizer	N02AX02	__UNKNOWN__	63013
tramadol	poor metabolizer	CYP3A4	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__	63013
citalopram, escitalopram	poor metabolizer	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0011581	poor metabolizer	N06AB04|N06AB10	__UNKNOWN__	162180
irinotecan	rs9266271	HLA-B	C	Toxicity	decreased	Adverse_Event	Healthy		L01CE02	rs9266271:C	74990
antiinflammatory agents, non-steroids	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*02:01	No_match
antiinflammatory agents, non-steroids	HLA-A*34:01	HLA-A	*34:01	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*34:01	No_match
antiinflammatory agents, non-steroids	HLA-DRB1*16:02	HLA-DRB1	*16:02	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*16:02	No_match
atorvastatin	rs3846662	HMGCR	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs3846662:GG	656846
clopidogrel	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Other:C0018839		B01AC04	rs1128503:GG	13748464
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
drugs for treatment of tuberculosis	NAT2*4, NAT2*6	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*6	No_match
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:CT	5778
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:TT	5778
beta blocking agents, metoprolol	rs1801252	ADRB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02|S01ED	rs1801252:AG	4171
beta blocking agents, metoprolol	rs1801252	ADRB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02|S01ED	rs1801252:GG	4171
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC03	*2/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC03	*2/*3	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC03	*3/*3	11985
folfiri, folfox, xelox	rs11280056	TYMS	del/del	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs11280056:del/del	No_match
irinotecan	rs1051713	ALOX5	T	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs1051713:T	74990
etoposide	rs6539870	__INTRONIC__	GG	Other	increased	Other	Healthy		L01CB01	rs6539870:GG	46173784
"""interferon alfa-2b, recombinant"", ""ribavirin"""	rs1127354	ITPA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB05	rs1127354:CC	71306834
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	increased	Adverse_Event	Healthy		B01AC04	*3	13748464
"""interferon alfa-2b, recombinant"", ""ribavirin"""	rs1127354	ITPA	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB05	rs1127354:CC	71306834
asparaginase	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	rs6025:CT	6267
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Disease:C0004238		B01AE07	rs2244613:GG	169501783
dabigatran	rs2244613	CES1	GT	Metabolism/PK	decreased	LADME	Disease:C0004238		B01AE07	rs2244613:GT	169501783
desipramine	rs2228478	MC1R	G	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AA01	rs2228478:G	65327
acenocoumarol	rs9934438	VKORC1	AA	Dosage, Efficacy, Toxicity	decreased	Efficacy_Response	Healthy		B01AA07	rs9934438:AA	54742534
desipramine	rs2228479	MC1R	A	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AA01	rs2228479:A	65327
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*16/*7	135483892
carbamazepine	rs1800629	LTA, TNF	A	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs1800629:A	114709
asparaginase	rs11556218	IL16	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	rs11556218:GG	6267
asparaginase	rs11556218	IL16	GT	Toxicity	increased	Adverse_Event	Other:C0023449		L01XX02	rs11556218:GT	6267
mercaptopurine	rs2413739	PACSIN2	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs2413739:TT	1268107
gemcitabine	rs9394992	SLC29A1	CT	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs9394992:CT	597
gemcitabine	rs9394992	SLC29A1	TT	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs9394992:TT	597
docetaxel, thalidomide	rs2292954	SPG7	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2292954:A	148124
antineoplastic agents	rs648743	CTH	CC	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs648743:CC	No_match
docetaxel, thalidomide	rs2238472	ABCC6	C	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2238472:C	148124
docetaxel, thalidomide	rs2227291	ATP7A	G	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2227291:G	148124
mercaptopurine	rs10948059	GNMT	CT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:CT	1268107
mercaptopurine	rs10948059	GNMT	TT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:TT	1268107
acenocoumarol	rs2108622	CYP4F2	CC	Other, Metabolism/PK	decreased	Other	Disease:C0004238		B01AA07	rs2108622:CC	54742534
acenocoumarol	rs2108622	CYP4F2	CT	Other, Metabolism/PK	decreased	Other	Disease:C0004238		B01AA07	rs2108622:CT	54742534
dabigatran	rs2244613	CES1	GG	Toxicity	decreased	Adverse_Event	Disease:C0004238		B01AE07	rs2244613:GG	169501783
dabigatran	rs2244613	CES1	GT	Toxicity	decreased	Adverse_Event	Disease:C0004238		B01AE07	rs2244613:GT	169501783
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
acenocoumarol	rs2108622	CYP4F2	CC	Dosage, Efficacy, Toxicity	decreased	Efficacy_Response	Disease:C0004238		B01AA07	rs2108622:CC	54742534
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1045642:AA	13748464
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*41	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	*1/*3	2733525
irinotecan	rs4149015	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149015:AA	74990
irinotecan	rs4149015	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149015:AG	74990
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*16	135483892
salbutamol, salmeterol	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		R03AC12|R03CC02	rs1042713:AA	2083
irinotecan	rs3832043	UGT1A9	del/del	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs3832043:del/del	74990
antipsychotics, aripiprazole, clozapine, olanzapine, quetiapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A|N05AH02|N05AH03|N05AH04|N05AX08|N05AX12	rs1414334:C	60795
cisplatin	rs4788863	SLC16A5	T	Toxicity	decreased	Adverse_Event	Disease:C0039591		L01XA01	rs4788863:T	441203
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*5	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*5	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*5G	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*5G	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*6	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*6	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*17	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*17	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*16	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*16	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*7	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*7	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*34	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*34	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*14	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*14	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*5J	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*5J	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*5G, NAT2*5J, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*17, NAT2*30, NAT2*34	NAT2	*30	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*30	135483892
irinotecan	rs3740066	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs3740066:CC	74990
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7	135483892
enalapril, imidapril, lisinopril	rs1799722	BDKRB2	CT	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02|C09AA03|C09AA16	rs1799722:CT	5388962
enalapril, imidapril, lisinopril	rs1799722	BDKRB2	TT	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02|C09AA03|C09AA16	rs1799722:TT	5388962
irinotecan	rs2231137	ABCG2	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs2231137:CT	74990
irinotecan	rs2231137	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs2231137:TT	74990
clozapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AX08	rs1414334:C	135398737
hmg coa reductase inhibitors	rs11868035	SREBF1	AA	Other	increased	Other	Disease:C0036341		C10AA	rs11868035:AA	445127
hmg coa reductase inhibitors	rs11868035	SREBF1	AG	Other	increased	Other	Disease:C0036341		C10AA	rs11868035:AG	445127
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*4	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*3/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*4	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*4	5462350
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*5	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*5	5462350
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*6	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*6	5462350
oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*7	Dosage	increased	LADME	Healthy	poor metabolizer	N02AA05	*4/*7	5462350
cisplatin	rs1695	GSTP1	G	Toxicity	increased	Adverse_Event	Disease:C0039591		L01XA01	rs1695:G	441203
ace inhibitors, plain	rs1799722	BDKRB2	T	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C09A	rs1799722:T	No_match
atorvastatin	rs2231142	ABCG2	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		C10AA05	rs2231142:TT	656846
lansoprazole	intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	intermediate metabolizer	A02BC03	__UNKNOWN__	11985
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*5/*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*5, NAT2*6, NAT2*7	NAT2	*7/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*7/*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*7	135483892
irbesartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs5186:AC	2901
irbesartan	rs5186	AGTR1	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs5186:CC	2901
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*6	135483892
opioids	rs12305038	PDE3A	A	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs12305038:A	No_match
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*5/*7	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*6/*6	135483892
isoniazid, rifampin	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*6/*7	135483892
dexmedetomidine	rs1800544	ADRA2A	G	Efficacy	increased	Efficacy_Response	Healthy		N05CM18	rs1800544:G	6918081
paclitaxel	rs1113129	CYP2C8	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs1113129:G	36314
opioids	rs11882256	MUC16	T	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs11882256:T	No_match
isoniazid, rifampin	NAT2*6	NAT2	*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	*6	135483892
rosuvastatin	rs2231142	ABCG2	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		C10AA07	rs2231142:TT	5282455
isoniazid, pyrazinamide, rifampin	NAT2*6	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*6/*6	135483892
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*16	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*5	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*5	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*6	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*6	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*7	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*7	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*14	5578
sulfamethoxazole / trimethoprim	NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Disease:C0001175	slow acetylator	J01EE01	*14	5578
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4148323:AA	74990
rosuvastatin	rs2231142	ABCG2	GG	Dosage, Metabolism/PK	decreased	LADME	Other:C0024198		C10AA07	rs2231142:GG	5282455
drugs for treatment of tuberculosis	NAT2*6	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	*6	No_match
isoniazid, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	*6/*7	135483892
sorafenib	rs1800629	TNF	GG	Toxicity	increased	Adverse_Event	Disease:C2239176		L01EX02	rs1800629:GG	67424139
opioids	rs12305038	PDE3A	A	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs12305038:A	No_match
irinotecan	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149056:CC	74990
irinotecan	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs4149056:CT	74990
alfentanil	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Other:Extracorporeal_shock_wave_lithotripsy_(ESWL)		N01AH02	rs1799971:AG	51263
alfentanil	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Other:Extracorporeal_shock_wave_lithotripsy_(ESWL)		N01AH02	rs1799971:GG	51263
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*16/*16	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*16/*6	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*16/*7	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*6/*6	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*6/*7	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04AC01	*7/*7	135483892
"""interferon alfa-2b, recombinant"", ""ribavirin"""	rs1127354	ITPA	CC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB05	rs1127354:CC	71306834
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6	135483892
alfentanil	rs1799971	OPRM1	AG	Metabolism/PK	increased	LADME	Disease:C0030193		N01AH02	rs1799971:AG	51263
alfentanil	rs1799971	OPRM1	GG	Metabolism/PK	increased	LADME	Disease:C0030193		N01AH02	rs1799971:GG	51263
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7	135483892
salmeterol	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		R03AC12	rs1042713:AA	5152
peginterferon alfa-2b, ribavirin	rs6051702	DNAAF9, ITPA	C	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs6051702:C	37542
clopidogrel	rs1463411	MIR6076	GG	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC04	rs1463411:GG	13748464
clopidogrel	rs1463411	MIR6076	GT	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC04	rs1463411:GT	13748464
lansoprazole	intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	intermediate metabolizer	A02BC03	__UNKNOWN__	11985
tamoxifen	rs10509373	LRMDA	C	Efficacy	decreased	Other	Disease:C1458155		L02BA01	rs10509373:C	2733525
opioids	rs36024412	CRYBG2	T	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs36024412:T	No_match
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799930	NAT2	G	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:G	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6/*7	135483892
opioids	rs168107	CLCC1	T	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs168107:T	No_match
capecitabine	rs1048977	CDA	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1048977:CT	11809635
capecitabine	rs1048977	CDA	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1048977:TT	11809635
boceprevir, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10	rs12979860:CC	37542
platinum compounds	rs10759637	SLC31A1	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10759637:AC	23939
opioids	rs41269255	POM121L2	T	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs41269255:T	No_match
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*16/*16	No_match
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*16/*6	No_match
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*16/*7	No_match
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*6/*6	No_match
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	NAT2*1, NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection	slow acetylator	J04A|J05AP|S02DA30	*6/*7	No_match
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*16	121882
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*6	121882
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*7	121882
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	No_ATC	*14	121882
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*14	135483892
methotrexate	rs3740065	ABCC2	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs3740065:AG	11329481
methotrexate	rs3740065	ABCC2	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs3740065:GG	11329481
irinotecan	rs61754806	NR3C1	A	Toxicity	decreased	Adverse_Event	Healthy		L01CE02	rs61754806:A	74990
irinotecan	rs7294	VKORC1	T	Toxicity	increased	Adverse_Event	Healthy		L01CE02	rs7294:T	74990
platinum compounds	rs2233914	SLC31A1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs2233914:AA	23939
opioids	rs9393888	ZNF165	C	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs9393888:C	No_match
cisplatin, cyclophosphamide	rs1142345	TPMT	CT	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs1142345:CT	2907
hmg coa reductase inhibitors	SLCO1B1*5	SLCO1B1	*5	Toxicity	decreased	Adverse_Event	Other:cardio-metabolic_conditions		C10AA	*5	445127
gemcitabine	rs9937	RRM1	AA	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs9937:AA	597
olanzapine, risperidone	rs1799978	DRD2	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH03|N05AX08	rs1799978:C	5073
platinum compounds	rs2233914	SLC31A1	AA	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs2233914:AA	23939
clopidogrel	rs12248560	CYP2C19	CT	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:CT	13748464
clopidogrel	rs12248560	CYP2C19	TT	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:TT	13748464
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*5/*5	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*5	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*5/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6/*6J	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6J	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*6J/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6J/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7	135483892
methotrexate	rs9516519	ABCC4	GG	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs9516519:GG	11329481
methotrexate	rs9516519	ABCC4	GT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs9516519:GT	11329481
escitalopram	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0235876|Other:C0003469	poor metabolizer	N06AB10	__UNKNOWN__	162180
risperidone	normal metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	N05AX08	__UNKNOWN__	849421
paliperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX13	__UNKNOWN__	9823781
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	*6/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	*7/*7	135483892
tramadol	CYP2D6*10	CYP2D6	*10/*10	Toxicity	increased	Adverse_Event	Other:C0030193		N02AX02	*10/*10	63013
clopidogrel	rs12248560	CYP2C19	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:CT	13748464
clopidogrel	rs12248560	CYP2C19	TT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:TT	13748464
isoniazid	NAT2*6, NAT2*7	NAT2	*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6	135483892
isoniazid	NAT2*6, NAT2*7	NAT2	*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7	135483892
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*16/*16	135483892
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*16/*6	135483892
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*16/*7	135483892
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*6/*6	135483892
isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01	*6/*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7	135483892
antiinflammatory agents, non-steroids	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*04:03	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AG	13748464
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*16	NAT2	*16/*4	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*16/*4	135483892
platinum compounds	rs10759637	SLC31A1	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA	rs10759637:AC	23939
capecitabine	rs2072671	CDA	AC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2072671:AC	11809635
capecitabine	rs2072671	CDA	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2072671:CC	11809635
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7	135483892
isoniazid	NAT2*16	NAT2	*16	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01	*16	135483892
drugs for treatment of tuberculosis	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*16	No_match
drugs for treatment of tuberculosis	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*6	No_match
drugs for treatment of tuberculosis	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*7	No_match
olanzapine, risperidone	rs1799732	DRD2	del	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03|N05AX08	rs1799732:del	5073
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*5/*6	No_match
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*5/*7	No_match
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*6/*6	No_match
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*6/*7	No_match
drugs for treatment of tuberculosis	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	*7/*7	No_match
opioids	rs3745274	CYP2A7P1, CYP2B6	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs3745274:GG	No_match
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*16	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*6	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6/*7	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7/*7	135483892
antiinflammatory agents, non-steroids	HLA-B*35:03	HLA-B	*35:03	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*35:03	No_match
platinum compounds	rs4979223	SLC31A1	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA	rs4979223:AC	23939
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Other:C0007131		A03DA02	rs1051730:A	5282367
ribavirin, sofosbuvir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Other:C0019372		J05AP01|J05AP08	rs1127354:CC	37542
proton pump inhibitors	rapid and ultrarapid metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Healthy	ultrarapid metabolizer and rapid metabolizer	A02BC	__UNKNOWN__	5460653
antineoplastic agents	rs2853539	TYMS	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs2853539:AG	No_match
antineoplastic agents	rs2853539	TYMS	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs2853539:GG	No_match
cyclophosphamide, dactinomycin, vincristine	rs2279343	CYP2B6	AG	Efficacy	increased	Efficacy_Response	Disease:Rhabdomyosarcoma		L01AA01|L01CA02|L01DA01	rs2279343:AG	2907
cyclophosphamide, dactinomycin, vincristine	rs2279343	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Disease:Rhabdomyosarcoma		L01AA01|L01CA02|L01DA01	rs2279343:GG	2907
antipsychotics	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0036337|Other:C0036341	poor metabolizer	N05A	__UNKNOWN__	No_match
omeprazole	normal metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Other	Healthy	normal metabolizer	A02BC01	__UNKNOWN__	9579578
tamoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1458155	intermediate metabolizer and poor metabolizer	L02BA01	__UNKNOWN__	2733525
antineoplastic agents	rs1937840	AKR1C3	G	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs1937840:G	No_match
antihypertensives	rs266729	ADIPOQ	CG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs266729:CG	No_match
antihypertensives	rs266729	ADIPOQ	GG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs266729:GG	No_match
mycophenolic acid, tacrolimus	rs2278293	IMPDH1	T	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06|L04AD02	rs2278293:T	446541
gemcitabine	rs2072671	CDA	AA	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AA	597
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*3	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*3	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*4	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*4	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*5	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*3/*6	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*3/*6	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*4	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*4xN	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*4xN	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*5	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*6	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4/*6	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*5/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*5/*5	6093336
atomoxetine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*17	CYP2D6	*4xN/*5	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	*4xN/*5	6093336
codeine	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative	poor metabolizer	R05DA04	__UNKNOWN__	5284371
nicotine	CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*2xN	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*2xN	936
gemcitabine	rs4694362	DCK	TT	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs4694362:TT	597
cyclophosphamide, epirubicin, fluorouracil	rs141084494	RBX1	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs141084494:A	2907
ethambutol, isoniazid / pyrazinamide / rifampin	rs1801280	NAT2	T	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1801280:T	135483892
platinum compounds	rs4978536	SLC31A1	AG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4978536:AG	23939
platinum compounds	rs4978536	SLC31A1	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4978536:GG	23939
opioids	rs11030096	BDNF-AS	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs11030096:CC	No_match
opioids	rs11030096	BDNF-AS	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs11030096:CT	No_match
irinotecan, platinum compounds	rs1799930	NAT2	AA	Efficacy	increased	Efficacy_Response	Other:C0024121		L01CE02|L01XA	rs1799930:AA	23939
platinum compounds	rs10817464	SLC31A1	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10817464:CC	23939
platinum compounds	rs10817464	SLC31A1	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10817464:CT	23939
voriconazole	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	J02AC03	__UNKNOWN__	9741
platinum compounds	rs4979223	SLC31A1	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4979223:AC	23939
cocaine	rs2251214	SYT1	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs2251214:G	2826
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0241910		L04AX01	rs116855232:CT	5778
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0241910		L04AX01	rs116855232:TT	5778
valganciclovir	rs2229109	ABCB1	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		J05AB14	rs2229109:CT	135413534
fluoxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB03	*4/*4	1548968
tetrabenazine	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	Indeterminado	Other	Healthy	ultrarapid metabolizer	N07XX06	__UNKNOWN__	6018
mycophenolate mofetil(mycophenolic acid)	rs3832043	UGT1A9	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs3832043:T	5281078
olanzapine	poor metabolizers	CYP2C9	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	N05AH03	__UNKNOWN__	74603552
"""folic acid"", ""vitamin b-complex, plain"""	rs1801394	MTRR	AA	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801394:AA	135398658
"""folic acid"", ""vitamin b-complex, plain"""	rs1801394	MTRR	AG	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801394:AG	135398658
nicotine	rs3758987	HTR3B	TT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs3758987:TT	936
capecitabine	rs11280056	TYMS	TTAAAGTTA	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs11280056:TTAAAGTTA	11809635
capecitabine	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs67376798:AT	11809635
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*3/*4	No_match
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*4/*4	No_match
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*4/*5	No_match
antidepressants	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06A	*4/*6	No_match
enalapril	rs1044147	PCGF3	A	Toxicity	increased	Adverse_Event	Other:C0020538		C09AA02	rs1044147:A	5950
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*4	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*3/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*5	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*3/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*6	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*11	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*11	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*6	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*4/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*7	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*5/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*5/*5	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*6/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*6/*6	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11	CYP2D6	*6/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*6/*7	2733525
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*3/*4	667572
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*4/*4	667572
paroxetine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB05	*4/*5	667572
tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AA	63013
tramadol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AG	63013
anticholinergic agents	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N04A	__UNKNOWN__	No_match
venlafaxine	normal metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0028768	normal metabolizer	N06AX16	__UNKNOWN__	9795857
antineoplastic agents	rs2231164	ABCG2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01	rs2231164:CC	No_match
antineoplastic agents	rs2231164	ABCG2	CT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01	rs2231164:CT	No_match
citalopram, clomipramine, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, paroxetine, sertraline, venlafaxine	normal metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C0028768	normal metabolizer	N06AA04|N06AB03|N06AB04|N06AB05|N06AB06|N06AB08|N06AB10|N06AX11|N06AX16|N06AX21	__UNKNOWN__	5324346
mycophenolate mofetil(mycophenolic acid)	rs3832043	UGT1A9	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs3832043:T	5281078
mycophenolate mofetil(mycophenolic acid)	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs2273697:AG	5281078
capecitabine	rs2297595	DPYD	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC06	rs2297595:CT	11809635
opioids	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Other:C0030193		N02A	rs1799971:GG	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0018839	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Toxicity	increased	Adverse_Event	Healthy	ultrarapid metabolizer	B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Toxicity	increased	Adverse_Event	Healthy	ultrarapid metabolizer	B01AC04	*17/*17	13748464
atenolol	rs2245360	PAH	AA	Toxicity	increased	Adverse_Event	Other:C0020538		C07AB03	rs2245360:AA	14211540
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*3/*4	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*3/*5	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7	CYP2D6	*4/*7	Efficacy	increased	Adverse_Event	Healthy	poor metabolizer	L02BA01	*4/*7	2733525
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:CT	2244
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:TT	2244
opioids	rs1125394	DRD2	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1125394:CC	No_match
opioids	rs1125394	DRD2	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1125394:CT	No_match
opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Other:C0030193		N02A	rs1799971:G	No_match
sorafenib	rs3025040	VEGFA	CC	Toxicity	increased	Adverse_Event	Disease:C2239176		L01EX02	rs3025040:CC	67424139
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10	2733526
opioids	rs1079596	DRD2	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1079596:CT	No_match
opioids	rs1079596	DRD2	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1079596:TT	No_match
tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AA	63013
tramadol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:AG	63013
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10	2733526
efavirenz	poor metabolizer and intermediate metabolizer genotypes	CYP2B6	__UNKNOWN__	Other	increased	Adverse_Event	Disease:HIV_infectious_disease	intermediate metabolizer and poor metabolizer	J05AG03	__UNKNOWN__	64139
anthracyclines and related substances	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C1561230|Other:C1261473		L01DB	rs3740066:TT	No_match
azathioprine, mercaptopurine, purine analogues	intermediate metabolizers	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0021390	intermediate metabolizer	L01BB|L01BB02|L04AX01	__UNKNOWN__	2265
fluorouracil	rs2847153	TYMS	AG	Efficacy	decreased	Adverse_Event	Disease:C0030297		L01BC02	rs2847153:AG	5790
fluorouracil	rs2847153	TYMS	GG	Efficacy	decreased	Adverse_Event	Disease:C0030297		L01BC02	rs2847153:GG	5790
morphine	rs4148412	ABCC3	T	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs4148412:T	5284371
sorafenib	rs7574296	UGT1A9	AA	Toxicity	increased	Adverse_Event	Disease:C2239176		L01EX02	rs7574296:AA	67424139
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*1	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*28	74990
sorafenib	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2071559:AA	67424139
tacrolimus	intermediate metabolizer and normal metabolizer	CYP3A5	__UNKNOWN__	Dosage	increased	Adverse_Event	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	__UNKNOWN__	131769926
tramadol	rs4680	COMT	GG	Efficacy	increased	Adverse_Event	Other:C0549433		N02AX02	rs4680:GG	63013
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0338480		B03BB01	rs1801133:AG	135398658
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0338480		B03BB01	rs1801133:GG	135398658
amitriptyline, clomipramine, doxepin, imipramine, trimipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0004936	poor metabolizer	N06AA02|N06AA04|N06AA06|N06AA09|N06AA12	__UNKNOWN__	5584
sorafenib	rs2257212	SLC15A2	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2257212:CC	67424139
fluorouracil	rs9344	CCND1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01BC02	rs9344:AA	5790
azathioprine	intermediate metabolizer genotype	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0021390	intermediate metabolizer	L04AX01	__UNKNOWN__	5778
capecitabine	rs2279199	UMPS	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2279199:CC	11809635
capecitabine	rs2279199	UMPS	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2279199:CT	11809635
metformin	rs578427	__INTRONIC__	TT	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs578427:TT	155906370
capecitabine	rs2853741	TYMS	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2853741:CT	11809635
capecitabine	rs2853741	TYMS	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs2853741:TT	11809635
clopidogrel	rapid and ultrarapid metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0007222	ultrarapid metabolizer and rapid metabolizer	B01AC04	__UNKNOWN__	13748464
capecitabine	rs4149178	SLC22A7	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs4149178:AG	11809635
capecitabine	rs4149178	SLC22A7	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs4149178:GG	11809635
cisplatin	rs1051640	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1051640:G	441203
galantamine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*3/*4	443722
galantamine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*4	443722
galantamine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*5	443722
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*3/*6	2733525
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*4/*6	2733525
tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*6/*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L02BA01	*6/*7	2733525
clopidogrel	normal metabolizers	CYP2C19	__UNKNOWN__	Other	decreased	Adverse_Event	Disease:C1956346	normal metabolizer	B01AC04	__UNKNOWN__	13748464
methotrexate	rs1051266	SLC19A1	T	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs1051266:T	11329481
clopidogrel	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	13748464
abt-751	rs6755571	UGT1A4	AC	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	rs6755571:AC	No_match
capecitabine	rs4678145	UMPS	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs4678145:CC	11809635
capecitabine	rs4678145	UMPS	CG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs4678145:CG	11809635
abt-751	rs6431558	UGT1A8	CC	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs6431558:CC	No_match
abt-751	rs6431558	UGT1A8	CT	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs6431558:CT	No_match
imipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__	65327
antineoplastic agents	rs1760217	DPYD	AA	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs1760217:AA	No_match
antineoplastic agents	rs1760217	DPYD	AG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs1760217:AG	No_match
azathioprine	rs1142345	TPMT	CC	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	L04AX01	rs1142345:CC	5778
azathioprine	rs1142345	TPMT	CT	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	L04AX01	rs1142345:CT	5778
antineoplastic agents	rs17091162	SERPINA3	AC	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs17091162:AC	No_match
antineoplastic agents	rs17091162	SERPINA3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01	rs17091162:CC	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0007222	intermediate metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Disease:C0007222	intermediate metabolizer	B01AC04	*2/*17	13748464
valproic acid	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0014544	intermediate metabolizer and poor metabolizer	N03AG01	__UNKNOWN__	134459
aspirin, clopidogrel	rs10306114	PTGS1	AG	Toxicity	increased	Adverse_Event	Other:C1536220		B01AC04	rs10306114:AG	2244
aspirin, clopidogrel	rs10306114	PTGS1	GG	Toxicity	increased	Adverse_Event	Other:C1536220		B01AC04	rs10306114:GG	2244
metformin	rs12943590	SLC47A2	AA	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12943590:AA	155906370
tamoxifen	rs1804645	NCOA1	CT	Other	increased	Adverse_Event	Healthy		L02BA01	rs1804645:CT	2733525
clopidogrel	intermediate metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	intermediate metabolizer	B01AC04	__UNKNOWN__	13748464
citalopram, escitalopram	rs352428	__INTRONIC__	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB04|N06AB10	rs352428:A	162180
clopidogrel	intermediate metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	intermediate metabolizer	B01AC04	__UNKNOWN__	13748464
citalopram	rs352428	__INTRONIC__	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB04	rs352428:A	162180
clopidogrel	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	poor metabolizer	B01AC04	__UNKNOWN__	13748464
midazolam	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Healthy		N05CD08	rs1057868:CT	5384200
clopidogrel	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:percutaneous_coronary_intervention_(most_of_the_patients)	poor metabolizer	B01AC04	__UNKNOWN__	13748464
lenvatinib	rs2231142	ABCG2	GG	Toxicity	increased	Adverse_Event	Other:C0030521		L01EX08	rs2231142:GG	11237762
nicotine	rs578776	CHRNA3	G	Metabolism/PK	increased	LADME	Other:tobacco_users		N07BA01	rs578776:G	936
galantamine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*3/*4	443722
galantamine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*4	443722
galantamine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0497327	poor metabolizer	N06DA04	*4/*5	443722
trazodone	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	normal metabolizer	N06AX05	__UNKNOWN__	62935
capecitabine	rs17376848	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs17376848:AG	11809635
risperidone	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Disease:C0004352	ultrarapid metabolizer	N05AX08	__UNKNOWN__	849421
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1536220		B01AC04	rs4244285:AA	2244
lenvatinib	rs2242480	CYP3A4	C	Toxicity	increased	Adverse_Event	Other:C0030521		L01EX08	rs2242480:C	11237762
lenvatinib	rs776746	CYP3A5	C	Toxicity	increased	Adverse_Event	Other:C0030521		L01EX08	rs776746:C	11237762
capecitabine	rs699517	ENOSF1, TYMS	TT	Toxicity	increased	Adverse_Event	Healthy		L01BC06	rs699517:TT	11809635
heroin	rs6473797	OPRK1	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs6473797:C	9844225
heroin	rs1534891	CSNK1E	T	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1534891:T	9844225
capecitabine	rs12119882	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12119882:AG	11809635
ethanol	rs16969968	CHRNA5	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs16969968:G	444899
heroin	rs694066	GAL	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs694066:A	9844225
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Other	Healthy	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Other	Healthy	poor metabolizer	B01AC04	*3/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Other	Healthy	poor metabolizer	B01AC04	*2/*3	13748464
heroin	rs2236861	OPRD1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236861:A	9844225
capecitabine	rs2270860	SLC22A7	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2270860:TT	11809635
heroin	rs3766951	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3766951:C	9844225
methadone	rs1500	CRHBP	G	Other	decreased	Other	Disease:C0028043		N07BC02	rs1500:G	10090
methamphetamine	rs324420	FAAH	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs324420:A	36604
ethanol	rs1051730	CHRNA3	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1051730:G	444899
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*3/*6	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*3/*6	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*4/*6	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*4/*6	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*35	CYP2D6	*6/*7	Efficacy	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L02BA01	*6/*7	2733525
heroin	rs2236857	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236857:C	9844225
naloxone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:AG	11274356
naloxone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:GG	11274356
tamoxifen	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C1458155	ultrarapid metabolizer	L02BA01	__UNKNOWN__	2733525
capecitabine	rs699517	ENOSF1, TYMS	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs699517:CT	11809635
capecitabine	rs699517	ENOSF1, TYMS	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs699517:TT	11809635
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*1	Toxicity	increased	Adverse_Event	Other:C1458155	normal metabolizer	L02BA01	*1/*1	2733525
tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Toxicity	increased	Adverse_Event	Other:C1458155	normal metabolizer	L02BA01	*1/*10	2733525
heroin	rs3758987	HTR3B	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3758987:C	9844225
metoprolol	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	C07AB02	__UNKNOWN__	6322
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC04	*1/*3	13748464
osimertinib	rs2231142	ABCG2	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs2231142:GG	71496458
tamoxifen	normal metabolizers	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C1458155	normal metabolizer	L02BA01	__UNKNOWN__	2733525
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
escitalopram	rs6318	HTR2C	C	Efficacy	decreased	Adverse_Event	Disease:C0522067		N06AB10	rs6318:C	162180
oxycodone	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA05	__UNKNOWN__	5462350
oxycodone	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Healthy	poor metabolizer	N02AA05	__UNKNOWN__	5462350
mercaptopurine	rs10948059	GNMT	CT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:CT	1268107
mercaptopurine	rs10948059	GNMT	TT	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02	rs10948059:TT	1268107
nicotine	rs16969968	CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A	936
oxycodone	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	LADME	Healthy	poor metabolizer	N02AA05	__UNKNOWN__	5462350
nicotine	rs1051730	CHRNA3	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1051730:A	936
paroxetine	normal metabolizers	CYP2D6	__UNKNOWN__	Other	increased	Other	Disease:C0003469	normal metabolizer	N06AB05	__UNKNOWN__	667572
irinotecan, platinum compounds	rs1799931	NAT2	AA	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01CE02|L01XA	rs1799931:AA	23939
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0004936	poor metabolizer	N06AB05	__UNKNOWN__	667572
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Other	Healthy	intermediate metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Other	Healthy	intermediate metabolizer	B01AC04	*1/*3	13748464
heroin	rs3778151	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3778151:C	9844225
escitalopram	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	intermediate metabolizer	N06AB10	__UNKNOWN__	162180
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB05	__UNKNOWN__	667572
capecitabine	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801265:AG	11809635
capecitabine	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801265:GG	11809635
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0011581	poor metabolizer	N06AB05	__UNKNOWN__	667572
fluoxetine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1	Metabolism/PK	increased	LADME	Disease:C0011581	normal metabolizer	N06AB03	*1/*1	1548968
capecitabine	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs1801265:AG	11809635
capecitabine	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C2931822		L01BC06	rs1801265:GG	11809635
alkylating agents, cisplatin	rs2207396	ESR1	A	Toxicity	increased	Adverse_Event	Other:C0699790		L01A|L01XA01	rs2207396:A	5460033
heroin	rs510769	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs510769:T	9844225
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	B01AC04	*3/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	B01AC04	*2/*3	13748464
antidepressants	poor metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0011581	poor metabolizer	N06A	__UNKNOWN__	No_match
citalopram	poor metabolizers	CYP2C19	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C0011581	poor metabolizer	N06AB04	__UNKNOWN__	162180
tamoxifen	normal metabolizers	CYP2D6	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C1458155	normal metabolizer	L02BA01	*1/*1	2733525
tamoxifen	normal metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	normal metabolizer	L02BA01	__UNKNOWN__	2733525
antipsychotics	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0036341	intermediate metabolizer and poor metabolizer	N05A	__UNKNOWN__	No_match
osimertinib	rs4796793	STAT3	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB04	rs4796793:GG	71496458
escitalopram	rs1065852	CYP2D6	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB10	rs1065852:AA	162180
3,4-methylenedioxymethamphetamine	poor metabolizer genotype	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	V04CX05	__UNKNOWN__	1615
drugs for treatment of tuberculosis	rs4149014	SLCO1B1	GG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs4149014:GG	No_match
drugs for treatment of tuberculosis	rs4149014	SLCO1B1	GT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs4149014:GT	No_match
docetaxel, epirubicin	poor metabolizer genotype	__INTRONIC__	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C1458155	poor metabolizer	L01CD02|L01DB03		148124
none	rs6968865	__INTRONIC__	T	Dosage	increased	Other	Healthy		A03DA02	rs6968865:T	5282367
sulfamethoxazole	rs761142	GCLC	AA	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J01EC01	rs761142:AA	114821
azathioprine, mercaptopurine	intermediate metabolizer genotype	TPMT	__UNKNOWN__	Efficacy, Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390	intermediate metabolizer	L01BB02|L04AX01	__UNKNOWN__	5778
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C1956346	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C1956346	poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C1956346	poor metabolizer	B01AC04	*3/*3	13748464
none	rs2472297	CYP1A1	T	Dosage	increased	Other	Healthy		A03DA02	rs2472297:T	5282367
sulfamethoxazole	rs761142	GCLC	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J01EC01	rs761142:A	114821
apixaban, dabigatran, edoxaban, rivaroxaban	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs2244613:GT	216210
apixaban, dabigatran, edoxaban, rivaroxaban	rs2244613	CES1	TT	Toxicity	increased	Adverse_Event	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs2244613:TT	216210
tramadol	normal metabolizer and ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0024031|Disease:C0022408	normal metabolizer and ultrarapid metabolizer	N02AX02	__UNKNOWN__	63013
anthracyclines and related substances	rs2273697	ABCC2	AG	Efficacy	increased	Efficacy_Response	Other:C1561230|Other:C1261473		L01DB	rs2273697:AG	No_match
anthracyclines and related substances	rs2273697	ABCC2	GG	Efficacy	increased	Efficacy_Response	Other:C1561230|Other:C1261473		L01DB	rs2273697:GG	No_match
sorafenib	rs1870377	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs1870377:TT	67424139
tacrolimus	rs35599367	CYP3A4	AG	Other	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG	131769926
anthracyclines and related substances	rs3740066	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Other:C1561230|Other:C1261473		L01DB	rs3740066:TT	No_match
clopidogrel	rs662	PON1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0151744		B01AC04	rs662:CC	13748464
antipsychotics	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0036337|Other:C0036341	ultrarapid metabolizer	N05A	__UNKNOWN__	No_match
isoniazid	rs117491755	ASTN2	C	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	rs117491755:C	135483892
alectinib	rs4253728	PPARA	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01ED03	rs4253728:AA	49806720
alectinib	rs4253728	PPARA	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01ED03	rs4253728:AG	49806720
valproic acid	rs2298771	SCN1A	TT	Efficacy	decreased	Adverse_Event	Other:C0014544		N03AG01	rs2298771:TT	134459
sulfamethoxazole / trimethoprim	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*13:01	5578
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	*6	74990
atomoxetine	CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Adverse_Event	Other:C1263846	intermediate metabolizer	N06BA09	*10/*10	6093336
cisplatin	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01		441203
cisplatin	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01		441203
aripiprazole, olanzapine, risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Other:C0036341	intermediate metabolizer and poor metabolizer	N05AH03|N05AX08|N05AX12	*1/*4	60795
aripiprazole, olanzapine, risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Other:C0036341	intermediate metabolizer and poor metabolizer	N05AH03|N05AX08|N05AX12	*4/*4	60795
codeine	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs2032582:AA	5284371
ethanol	rs10055255	CRHBP	TT	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs10055255:TT	444899
sunitinib	rs2276707	NR1I2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2276707:TT	11221549
antipsychotics	rs1799732	DRD2	del	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05A	rs1799732:del	No_match
lamotrigine	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AX09	*15:02	71236569
oxaliplatin	HLA-DRB1*12:01	HLA-DRB1	*12:01	Toxicity	increased	Adverse_Event	Healthy		L01XA03	*12:01	9887054
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*4	4604
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*7	4604
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*9	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*9	4604
tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*10	Efficacy	decreased	Adverse_Event	Other:C0026640		L01BC03	*10	4604
cefaclor	HLA-DRB1*14:54	HLA-DRB1	*14:54	Toxicity	increased	Adverse_Event	Healthy		J01DC04	*14:54	8663
ethanol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:GG	444899
sulfasalazine	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*11:01	5336
sulfasalazine	HLA-B*39:01	HLA-B	*39:01	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*39:01	5336
sulfasalazine	HLA-B*56:03	HLA-B	*56:03	Toxicity	increased	Adverse_Event	Healthy		A07EC01	*56:03	5336
metoprolol	CYP2D6*1, CYP2D6*2	CYP2D6	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		C07AB02	*1/*2	6322
methamphetamine	rs778293	DAOA	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs778293:C	36604
cefaclor	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Healthy		J01DC04	*04:03	8663
cefaclor	HLA-DRB1*04:03	HLA-DRB1	*04:03	Toxicity	increased	Adverse_Event	Healthy		J01DC04	*04:03	8663
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Healthy		M04AA01	*58:01	168354693
atorvastatin, simvastatin	SLCO1B1*15	SLCO1B1	*15	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*15	60823
atorvastatin, simvastatin	SLCO1B1*20	SLCO1B1	*20	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*20	60823
atorvastatin, simvastatin	SLCO1B1*37	SLCO1B1	*37	Efficacy	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	*37	60823
atorvastatin, simvastatin	SLCO1B1*5	SLCO1B1	*5	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*5	60823
atorvastatin, simvastatin	SLCO1B1*15	SLCO1B1	*15	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*15	60823
atorvastatin, simvastatin	SLCO1B1*5	SLCO1B1	*5	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*5	60823
sorafenib	rs2071559	KDR	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2071559:GG	67424139
atorvastatin, simvastatin	SLCO1B1*15	SLCO1B1	*15	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	*15	60823
atorvastatin, simvastatin	SLCO1B1*14	SLCO1B1	*14	Efficacy	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	*14	60823
tacrolimus	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG	131769926
risperidone	rs1042713	ADRB2	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1042713:G	849421
beclomethasone, budesonide, fluticasone, fluticasone propionate, mometasone	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA01|R03BA02|R03BA05|R03BA07	*1/*1	5311101
beclomethasone, budesonide, fluticasone, fluticasone propionate, mometasone	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA01|R03BA02|R03BA05|R03BA07	*1/*3	5311101
nicotine	CYP2A6*1, CYP2A6*1x2	CYP2A6	*1/*1x2	Toxicity	increased	Adverse_Event	Healthy		N07BA01	*1/*1x2	936
cytarabine	rs2228224	GLI1	AA	Efficacy	decreased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01	rs2228224:AA	6918130
cytarabine	rs2229300	ARHGAP9, GLI1	GT	Efficacy	decreased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01	rs2229300:GT	6918130
cytarabine	rs2229300	ARHGAP9, GLI1	TT	Efficacy	decreased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01	rs2229300:TT	6918130
codeine	rs1128503	ABCB1	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs1128503:A	5284371
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	135403648
sorafenib	rs1870377	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs1870377:TT	67424139
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0013182		M04AA01	*58:01	168354693
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01	168354693
codeine	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs2032582:AA	5284371
codeine	rs1045642	ABCB1	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0030193		R05DA04	rs1045642:A	5284371
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*1/*2	60606
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*1/*3	60606
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*2/*2	60606
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*2/*3	60606
clopidogrel, respiratory system	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:Elderly_Adult|Other:C0007222	intermediate metabolizer and poor metabolizer	B01AC04|V09E	*3/*3	60606
none	rs602633	CELSR2, PSRC1	T	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs602633:T	5282367
cocaine, ethanol, opioids	rs524731	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs524731:A	702
atazanavir, indinavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE02|J05AE08	*28/*28	5362440
atazanavir, ritonavir	UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	*28/*28	25134325
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*1/*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*3/*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA04	*2/*3	91987769
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*1/*28	25134325
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28	25134325
methotrexate	rs4149081	SLCO1B1	G	Other, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs4149081:G	11329481
beta blocking agents	rs2230345	GRK5	AA	Efficacy	decreased	Adverse_Event	Other:C0085605		S01ED	rs2230345:AA	No_match
valproic acid	rs10167228	SCN1A	AA	Efficacy	decreased	Adverse_Event	Other:C0014544		N03AG01	rs10167228:AA	134459
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*3	131769926
tacrolimus	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG	131769926
clopidogrel	CYP2C19*1, CYP2C19*5	CYP2C19	*5	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*5	13748464
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AX11	*4/*4	6451144
mirtazapine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Healthy		N06AX11	*4/*6	6451144
troglitazone	rs10811661	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Other:high_risk_for_type_2_diabetes		A10BG01	rs10811661:C	5591
platinum compounds	rs1799793	ERCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:CC	23939
platinum compounds	rs1799793	ERCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:CT	23939
nevirapine	rs3745274	CYP2B6	T	Metabolism/PK	increased	Other	Disease:HIV_infectious_disease		J05AG01	rs3745274:T	15979285
citalopram	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB04	*3	162180
methamphetamine	rs713729	PICK1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs713729:T	36604
imatinib	rs2231142	ABCG2	T	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs2231142:T	6113
caffeine	rs1110976	DRD2	GG	Other	decreased	Adverse_Event	Other:C0024198		N06BC01	rs1110976:GG	936
opioids	rs4530637	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4530637:AG	No_match
opioids	rs4530637	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4530637:GG	No_match
nevirapine	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs1045642:A	15979285
cocaine, ethanol, opioids	rs3778156	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01|N02A|V03AB16	rs3778156:G	702
none	rs1111875	__INTRONIC__	C	Metabolism/PK	decreased	LADME	Other:high_risk_of_type_2_diabetes		A03DA02	rs1111875:C	5282367
cisplatin	rs9332377	COMT	T	Toxicity	increased	Adverse_Event	Healthy		L01XA01	rs9332377:T	441203
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*4	1548968
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*6	Metabolism/PK	increased	LADME	Disease:C0004936		N06AB03	*6	1548968
opioids	rs1384401	TACR3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1384401:AG	No_match
opioids	rs1384401	TACR3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1384401:GG	No_match
cisplatin	rs4646316	COMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs4646316:C	441203
folfiri	rs2273697	ABCC2	GG	Toxicity	decreased	Adverse_Event	Other:C0030297		No_ATC	rs2273697:GG	No_match
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2	162180
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*3	162180
platinum compounds	rs316003	SLC22A2	CT	Efficacy	increased	Efficacy_Response	Other:C0024121|Other:C0039338		L01XA	rs316003:CT	23939
platinum compounds	rs316003	SLC22A2	TT	Efficacy	increased	Efficacy_Response	Other:C0024121|Other:C0039338		L01XA	rs316003:TT	23939
methotrexate	rs717620	ABCC2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs717620:T	11329481
tamoxifen	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	*4/*4	2733525
methamphetamine	rs713729	PICK1	T	Other	increased	Adverse_Event	Disease:C0036502		No_ATC	rs713729:T	36604
opioids	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1065852:AA	No_match
folfiri	rs1885301	ABCC2	AA	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1885301:AA	No_match
citalopram, escitalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB04|N06AB10	*1/*2	162180
opioids	rs6280	DRD3	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6280:CC	No_match
opioids	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6280:CT	No_match
hydrochlorothiazide	rs17137967	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs17137967:CC	2904
hydrochlorothiazide	rs17137967	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs17137967:CT	2904
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Other	decreased	Adverse_Event	Healthy		A03DA02	*4/*4	5282367
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*7	Other	decreased	Adverse_Event	Healthy		A03DA02	*4/*7	5282367
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*9	Other	decreased	Adverse_Event	Healthy		A03DA02	*4/*9	5282367
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*7	Other	decreased	Adverse_Event	Healthy		A03DA02	*7/*7	5282367
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7/*9	Other	decreased	Adverse_Event	Healthy		A03DA02	*7/*9	5282367
none	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9/*9	Other	decreased	Adverse_Event	Healthy		A03DA02	*9/*9	5282367
opioids	rs324029	DRD3	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:AA	No_match
opioids	rs324029	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:AG	No_match
tamoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Disease:C1458155	intermediate metabolizer and poor metabolizer	L02BA01	__UNKNOWN__	2733525
opioids	rs718656	EXOC4	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs718656:TT	No_match
ethambutol, isoniazid, pyrazinamide, rifampin	rs4646244	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs4646244:A	135483892
amisulpride, clozapine, haloperidol, olanzapine, quetiapine, risperidone, ziprasidone, zuclopenthixol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0005586|Other:C0031212|Other:C0033975|Other:C0028768	poor metabolizer	N05AD01|N05AE04|N05AF05|N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	*4/*4	5311507
nicotine	rs2072660	CHRNB2	T	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs2072660:T	936
direct acting antivirals	rs11322783	IFNL4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05A	rs11322783:GG	No_match
platinum compounds	rs3213239	APLF	CCGG/CCGG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs3213239:CCGG/CCGG	23939
platinum compounds	rs3213239	APLF	CCGG/del	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs3213239:CCGG/del	23939
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:GG	37542
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*1/*28	25134325
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28	25134325
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
platinum compounds	rs50872	ERCC2	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs50872:GG	23939
platinum compounds	rs1448784	ABCG2	GG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01XA	rs1448784:GG	23939
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799930	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:A	135483892
nicotine	rs2072661	CHRNB2	A	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs2072661:A	936
codeine, hydrocodone, oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|R05DA03|R05DA04	*3/*3	5284569
codeine, hydrocodone, oxycodone	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|R05DA03|R05DA04	*4/*4	5284569
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*1	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	decreased	Adverse_Event	Other:C0024121		L01CE02	*1/*28	74990
boceprevir, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP03|L03AB10	rs12979860:CC	37542
platinum compounds	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:AA	23939
platinum compounds	rs11615	ERCC1	AG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:AG	23939
carbamazepine	HLA-B*15:11	HLA-B	*15:11	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:11	114709
hydroxychloroquine	rs10882526	CYP2C8	GG	Toxicity	increased	Adverse_Event	Other:C0003873|Other:C0024141		P01BA02	rs10882526:GG	71826
opium alkaloids and derivatives	rs660652	CHRNA5	GG	Toxicity	increased	Adverse_Event	Disease:C0030193		R05DA	rs660652:GG	No_match
methamphetamine	rs1421292	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1421292:T	36604
ace inhibitors, plain	rs495828	ABO	GT	Toxicity	Indeterminado	Adverse_Event	Healthy		A03B|C09A	rs495828:GT	No_match
ace inhibitors, plain	rs495828	ABO	TT	Toxicity	Indeterminado	Adverse_Event	Healthy		A03B|C09A	rs495828:TT	No_match
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	*4/*4	9417
gliclazide	rs5219	KCNJ11	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs5219:CT	169502072
gliclazide	rs5219	KCNJ11	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs5219:TT	169502072
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1	Efficacy	decreased	Other	Disease:C1956346		B01AC04	*1	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Other	Disease:C1956346		B01AC04	*17	13748464
platinum compounds	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1128503:AA	23939
drugs for treatment of tuberculosis	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04A	__UNKNOWN__	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*3/*3	13748464
opioids	rs7597593	ZNF804A	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs7597593:CC	No_match
nortriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*4/*4	9918
opium alkaloids and derivatives	rs1051730	CHRNA3	AA	Toxicity	increased	Adverse_Event	Disease:C0030193		R05DA	rs1051730:AA	No_match
hydroxychloroquine	rs776746	CYP3A5	TT	Toxicity	increased	Adverse_Event	Other:C0003873|Other:C0024141		P01BA02	rs776746:TT	71826
platinum compounds	rs7170924	IL16	GT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs7170924:GT	23939
platinum compounds	rs7170924	IL16	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs7170924:TT	23939
indomethacin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Other:C0013274		S01BC01	*2	4292
none	rs1051730	CHRNA3	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1051730:AA	5282367
none	rs1051730	CHRNA3	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs1051730:AG	5282367
nevirapine	HLA-B*15:10	HLA-B	*15:10	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	*15:10	15979285
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Toxicity	increased	Adverse_Event	Healthy		B01AA07	*3/*3	54742534
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2	Efficacy	increased	Adverse_Event	Other:C0007787|Other:C0018839		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*3	Efficacy	increased	Adverse_Event	Other:C0007787|Other:C0018839		B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*8	Efficacy	increased	Adverse_Event	Other:C0007787|Other:C0018839		B01AC04	*8	13748464
aspirin	rs1131882	TBXA2R	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0011849		No_ATC	rs1131882:A	72204814
opioids	rs2023239	CNR1	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2023239:TT	No_match
none	rs1800566	NQO1	AA	Other	Indeterminado	Other	Disease:C0007131		A03DA02	rs1800566:AA	5282367
busulfan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	*2	4684
busulfan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	*3	4684
platinum compounds	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1128503:AA	23939
metformin	rs3889348	SLC29A4	G	Toxicity	increased	Adverse_Event	Other:C0011849		A10BA02	rs3889348:G	155906370
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0027651		L01CE02	*28/*28	74990
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	60838
none	rs1800566	NQO1	A	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1800566:A	5282367
hydrochlorothiazide	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	2904
drugs for treatment of tuberculosis	GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A		No_match
drugs for treatment of tuberculosis	GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A		No_match
opioids	rs6928499	CNR1	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6928499:CC	No_match
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10	2733526
nevirapine	rs58425034	CYP2B6	CC	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs58425034:CC	15979285
nevirapine	rs58425034	CYP2B6	CG	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs58425034:CG	15979285
fluorouracil	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	decreased	Adverse_Event	Disease:C0022665		L01BC02	rs11280056:TTAAAGTTA/TTAAAGTTA	5790
clopidogrel	CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Disease:C0002962		B01AC04	*2/*2	13748464
docetaxel, thalidomide	rs4148945	CHST3	C	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs4148945:C	148124
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	AG	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801133:AG	135398658
"""folic acid"", ""vitamin b-complex, plain"""	rs1801133	MTHFR	GG	Efficacy	decreased	Adverse_Event	Disease:C0338480		B03BB01	rs1801133:GG	135398658
carbamazepine	HLA-B*51:01	HLA-B	*51:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*51:01	114709
docetaxel, thalidomide	rs2301159	SLC10A2	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs2301159:A	148124
axitinib, sorafenib	rs11549465	HIF1A	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EK01|L01EX02	rs11549465:CT	216239
fluorouracil, irinotecan, leucovorin	rs11280056	TYMS	TTAAAGTTA/TTAAAGTTA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs11280056:TTAAAGTTA/TTAAAGTTA	135403648
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
methotrexate	rs1051266	SLC19A1	CC	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CC	11329481
methotrexate	rs1051266	SLC19A1	CT	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CT	11329481
sorafenib	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2071559:AA	67424139
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	*2	54688261
nicotine	rs77905	DBH	AA	Efficacy	increased	Adverse_Event	Disease:C0039338		N07BA01	rs77905:AA	936
nicotine	rs77905	DBH	AG	Efficacy	increased	Adverse_Event	Disease:C0039338		N07BA01	rs77905:AG	936
methotrexate	rs2298383	ADORA2A	GG	Toxicity	increased	Adverse_Event	Disease:C0745761		L04AX03	rs2298383:GG	11329481
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	L01|L02BA01	*5/*10	2733526
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Other	increased	Other	Disease:C0027051		B01AC04	*1/*2	13748464
risperidone	rs3892097	CYP2D6	CT	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AX08	rs3892097:CT	849421
risperidone	rs3892097	CYP2D6	TT	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AX08	rs3892097:TT	849421
none	rs3211371	CYP2B6	TT	Other	increased	Adverse_Event	Other:rs1800497_GG_genotypes		A03DA02	rs3211371:TT	5282367
none	rs3211371	CYP2B6	CT	Other	increased	Adverse_Event	Other:rs1800497_GG_genotypes		A03DA02	rs3211371:CT	5282367
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*41	2733525
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB03		1548968
irinotecan	rs4124874	UGT1A1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs4124874:G	74990
none	rs2762939	CYP24A1	C	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2762939:C	5282367
opium alkaloids and derivatives	rs16969968	CHRNA5	A	Toxicity	increased	Adverse_Event	Disease:C0030193		R05DA	rs16969968:A	No_match
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Toxicity	increased	Adverse_Event	Other:orthopedic_patients		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	Adverse_Event	Other:orthopedic_patients		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Toxicity	increased	Adverse_Event	Other:orthopedic_patients		B01AA03	*2/*3	54688261
morphine	rs739923	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs739923:G	5284371
citalopram	rs11628713	PAPLN	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs11628713:T	162180
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Toxicity	increased	Adverse_Event	Healthy		B01AA03	*2	54688261
sulfonamides, urea derivatives	rs5219	KCNJ11	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs5219:CT	1176
sulfonamides, urea derivatives	rs5219	KCNJ11	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs5219:TT	1176
fluoxetine	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AB03	*1/*1xN	1548968
imatinib	rs1867351	SLC22A1	TT	Toxicity	increased	Adverse_Event	Other:C0238198		L01EA01	rs1867351:TT	6113
fluorouracil, leucovorin	rs13181	ERCC2	GG	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC02	rs13181:GG	135403648
fluorouracil, leucovorin	rs13181	ERCC2	GT	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC02	rs13181:GT	135403648
verapamil	rs11739136	KCNIP1, KCNMB1	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C08DA01	rs11739136:CT	65808
verapamil	rs11739136	KCNIP1, KCNMB1	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C08DA01	rs11739136:TT	65808
opioids	rs9288993	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs9288993:AG	No_match
opioids	rs9288993	DRD3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs9288993:GG	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
osimertinib	rs1057910	CYP2C9	AC	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB04	rs1057910:AC	71496458
opioids	rs2654754	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:AG	No_match
opioids	rs2654754	DRD3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:GG	No_match
opioids	rs10405238	ZNF568	G	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02A	rs10405238:G	No_match
antiepileptics	HLA-B*53:01	HLA-B	*53:01	Toxicity	increased	Adverse_Event	Healthy		N03A	*53:01	No_match
sulfamethoxazole, sulfamethoxazole / trimethoprim	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		J01EA01|J01EC01	*15:02	5578
penicillin g	HLA-DPB1*05:01	HLA-DPB1	*05:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*05:01	656811
sulfamethoxazole, sulfamethoxazole / trimethoprim	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		J01EA01|J01EC01	*13:01	5578
sulfamethoxazole, sulfamethoxazole / trimethoprim	HLA-B*38:02	HLA-B	*38:02	Toxicity	increased	Adverse_Event	Healthy		J01EA01|J01EC01	*38:02	5578
apixaban, dabigatran, edoxaban, rivaroxaban	rs3842	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AE07|B01AF01|B01AF02|B01AF03	rs3842:CC	216210
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0007820|Other:C0007282	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3	13748464
metformin	rs784892	AMHR2	G	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs784892:G	155906370
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs4149117:GG	5281078
clopidogrel	intermediate metabolizer	CYP2C19	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:percutaneous_coronary_intervention	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*1/*9	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*1/*9	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*2/*13	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*13	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*9/*17	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*9/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*9, CYP2C19*13, CYP2C19*17	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:CT	2244
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs662:TT	2244
opioids	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1799971:AA	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*2	Other	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*4	Other	increased	Adverse_Event	Healthy		B01AC04	*4	13748464
clopidogrel	CYP2C19*1, CYP2C19*8	CYP2C19	*8	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*8	13748464
clopidogrel	CYP2C19*1, CYP2C19*5	CYP2C19	*5	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	*5	13748464
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Efficacy	increased	Adverse_Event	Other:C0018839		B01AA07	*2	54742534
atezolizumab, durvalumab, ipilimumab, nivolumab, pembrolizumab	HLA-A*26:01	HLA-A	*26:01	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0030793|Other:C0859290|Other:C1458155|Other:Head_and_Neck_Neoplasms		No_ATC	*26:01	No_match
carboplatin, gemcitabine	rs9937	RRM1	GG	Toxicity	Indeterminado	Adverse_Event	Disease:C0007131		L01BC05|L01XA02	rs9937:GG	10339178
ethanol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AA	444899
metformin	rs628031	SLC22A1	A	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0011849		A10BA02	rs628031:A	155906370
opioids	rs4906902	GABRB3	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4906902:AA	No_match
amitriptyline	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Other, Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*4	4543
amitriptyline	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Other, Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*10	4543
beclomethasone dipropionate, fluticasone propionate	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA05	*1/*1	5311101
beclomethasone dipropionate, fluticasone propionate	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:C0004096		R03BA05	*1/*3	5311101
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*1/*3	4543
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*3	4543
mycophenolate mofetil(mycophenolic acid)	rs7311358	SLCO1B3	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs7311358:AA	5281078
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, sofosbuvir	rs12979860	IFNL3, IFNL4	TT	Efficacy	decreased	Adverse_Event	Other:C0019372		J05AP01|J05AP08|L03AB10|L03AB11	rs12979860:TT	37542
isoniazid, rifampin	HLA-DPB1*05:01	HLA-DPB1	*05:01	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*05:01	135483892
isoniazid, rifampin	HLA-A*11:01	HLA-A	*11:01	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01	*11:01	135483892
ethanol	rs1799732	DRD2	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799732:GG	444899
salbutamol	rs892940	THRB	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs892940:A	2083
opioids	rs735668	TACR1	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs735668:AA	No_match
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*3	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*3	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*4	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*5	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*5	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*6	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*6	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*7	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*7	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*9	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*9	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*10	2733525
tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*41	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*41	2733525
aspirin, clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AA	2244
aspirin, clopidogrel	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AG	2244
aspirin, clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AA	2244
aspirin, clopidogrel	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1045642:AG	2244
apixaban, dabigatran, edoxaban, rivaroxaban	rs13306198	APOB	AA	Toxicity	increased	Adverse_Event	Healthy		B01AE07|B01AF01|B01AF02|B01AF03	rs13306198:AA	216210
apixaban, dabigatran, edoxaban, rivaroxaban	rs13306198	APOB	AG	Toxicity	increased	Adverse_Event	Healthy		B01AE07|B01AF01|B01AF02|B01AF03	rs13306198:AG	216210
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*1/*3	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*1/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*1/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*41/*41	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*4	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*3/*4	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*3	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*3/*3	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*3/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*10	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*4/*41	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*41	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*5/*41	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*5	Efficacy	increased	Adverse_Event	Disease:C1458155		L01|L02BA01	*5/*5	2733526
antineoplastic agents, tamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01|L02BA01	*10/*10	2733526
opioids	rs510769	OPRM1	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs510769:CC	No_match
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G	444899
first-generation cephalosporins, fourth-generation cephalosporins, other cephalosporins, third-generation cephalosporins	HLA-B*55:02	HLA-B	*55:02	Toxicity	increased	Adverse_Event	Healthy		J01DB|J01DD|J01DE|J01DI	*55:02	No_match
amoxicillin	HLA-B*15:01	HLA-B	*15:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04	*15:01	23663126
"""metformin"", ""sulfonamides, urea derivatives"""	rs72552763	SLC22A1	GAT/del	Efficacy	increased	Adverse_Event	Other:C0011849		A10BA02|S01AB	rs72552763:GAT/del	4091
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0041296	rapid acetylator	J04AC01|J04AK01|J04AK02	*4	135483892
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*16	135483892
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*6	135483892
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*16/*7	135483892
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*6/*6	135483892
isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	*7/*7	135483892
first-generation cephalosporins, fourth-generation cephalosporins, other cephalosporins, third-generation cephalosporins	HLA-C*01:02	HLA-C	*01:02	Toxicity	increased	Adverse_Event	Healthy		J01DB|J01DD|J01DE|J01DI	*01:02	No_match
first-generation cephalosporins, fourth-generation cephalosporins, other cephalosporins, third-generation cephalosporins	HLA-DQB1*06:09	HLA-DQB1	*06:09	Toxicity	increased	Adverse_Event	Healthy		J01DB|J01DD|J01DE|J01DI	*06:09	No_match
infliximab	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	increased	Adverse_Event	Other:C0010346		L04AB02	*05	No_match
nicotine	rs72552266	CYP2A13	CT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs72552266:CT	936
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*1	13748464
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*1/*3	9554282
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*1/*6	9554282
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*3	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*3/*3	9554282
cyclophosphamide	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*6	Toxicity	increased	Adverse_Event	Other:Rhabdomyosarcoma	intermediate metabolizer and poor metabolizer	L01AA01	*3/*6	9554282
none	UGT1A1*28	UGT1A1	*28	Other	increased	Adverse_Event	Healthy		A03DA02	*28	5282367
doxorubicin	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01		83958
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQB1*03:01	HLA-DQB1	*03:01	Toxicity	increased	Adverse_Event	Other:C0011849		No_ATC	*03:01	No_match
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:AA	74990
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:AG	74990
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1	131769926
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*6	74990
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*6	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*28	60838
folfiri	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0023055		No_ATC	*1/*6	No_match
folfiri	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0023055		No_ATC	*6/*6	No_match
folfiri	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*28/*28	No_match
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C1458155		No_ATC	*28/*28	91668186
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*28/*28	No_match
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*6/*6	No_match
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*6/*28	No_match
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	60838
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	74990
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*28/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*1/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*28/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		L01CE02	*1/*28	60838
sunitinib	rs1870377	KDR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1870377:TT	11221549
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*28	74990
irinotecan	UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*6	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*28	74990
irinotecan	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Healthy		L01CE02	*6/*6	74990
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*6	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*6	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*28	60838
mirabegron	intermediate metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	G04BD12	__UNKNOWN__	91810674
mirabegron	deficiency	SLCO1B1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	deficiency	G04BD12	__UNKNOWN__	91810674
tramadol	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Adverse_Event	Other:C0030193|Postoperative	ultrarapid metabolizer	N02AX02	__UNKNOWN__	63013
methotrexate	rs3768142	MTR	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs3768142:GG	11329481
carbamazepine	HLA-B*13:01	HLA-B	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*13:01	114709
carbamazepine	HLA-B*15:01	HLA-B	*15:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*15:01	114709
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3C	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390		L01BB|L01BB02|L04AX01	*3A/*3C	2265
cisplatin	GSTT1 non-null, GSTT1 null	GSTT1	non-null	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01		441203
sulfamethoxazole / trimethoprim	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*4	Toxicity	decreased	Adverse_Event	Disease:C0032285		J01EE01	*4	5578
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A	1268107
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3C	1268107
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Dosage	increased	Adverse_Event	Disease:C0023449		L01BB02	*3A/*3A	1268107
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8	CYP2C19	*2	Efficacy	decreased	Adverse_Event	Healthy		B01AC04	*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8	CYP2C19	*3	Efficacy	decreased	Adverse_Event	Healthy		B01AC04	*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8	CYP2C19	*8	Efficacy	decreased	Adverse_Event	Healthy		B01AC04	*8	2244
tacrolimus	rs4646437	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:AG	131769926
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:GG	131769926
dihydropyridine derivatives	rs877087	RYR3	TT	Efficacy	increased	Adverse_Event	Other:C0010068		C08CA	rs877087:TT	No_match
none	rs1126742	CYP4A11	AG	Metabolism/PK	decreased	LADME	Healthy		A03DA02	rs1126742:AG	5282367
none	rs1126742	CYP4A11	GG	Metabolism/PK	decreased	LADME	Healthy		A03DA02	rs1126742:GG	5282367
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*1x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*1x2	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*2x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*2x2	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1x2/*41	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1x2/*41	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*2x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*2x2	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2xN/*4	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2xN/*4	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*1	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*1	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*10	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*10	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*2	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*41	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*41	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*41x2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*41x2	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*1/*9	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*1/*9	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*2	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*2	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*41	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*41	5284371
codeine	CYP2D6*1, CYP2D6*1x2, CYP2D6*2, CYP2D6*2x2, CYP2D6*2xN, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41, CYP2D6*41x2	CYP2D6	*2/*9	Other	increased	Adverse_Event	Healthy	normal metabolizer and ultrarapid metabolizer	R05DA04	*2/*9	5284371
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*1/*2	78358176
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*1/*3	78358176
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*2/*17	78358176
ticagrelor	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer	B01AC24	*3/*17	78358176
pemetrexed	rs914232	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs914232:TT	135565228
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C0024121		L01CE02	*6	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C0024121		L01CE02	*28	74990
fluorouracil, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	*1/*28	60838
fluorouracil, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	*28/*28	60838
fluorouracil, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	*6/*6	60838
fluorouracil, irinotecan	DPYD c.1627A>G (*5)	DPYD	c.1627A>G (*5)	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02|L01CE02	c.1627A>G (*5)	60838
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*2	162180
citalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AB04	*2/*3	162180
pemetrexed	rs1051298	SLC19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1051298:AA	135565228
pemetrexed	rs1051298	SLC19A1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1051298:AG	135565228
risperidone	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*1/*1	Toxicity	increased	Adverse_Event	Healthy		N05AX08	*1/*1	849421
risperidone	CYP2C19*1, CYP2C19*2, CYP2C19*4	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Healthy		N05AX08	*1/*2	849421
cetuximab	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1801274:GG	No_match
amoxicillin, ampicillin, bacampicillin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CA06|S01AA19	*02:01	6249
methamphetamine	rs6280	DRD3	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		No_ATC	rs6280:CC	36604
methamphetamine	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		No_ATC	rs6280:CT	36604
nicotine	low activity	CYP2A6	__UNKNOWN__	Other	decreased	Adverse_Event	Disease:C0039338	low activity	N07BA01	__UNKNOWN__	936
vincristine	rs2268979	ACTN1	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs2268979:T	24848381
capecitabine, fluorouracil	rs2070474	UPB1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2070474:GG	60953
pemetrexed	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1801133:AA	135565228
pemetrexed	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs1801133:AG	135565228
capecitabine, fluorouracil, folfiri, folfirinox, folfox	DPYD c.2194G>A (*6)	DPYD	c.2194G>A (*6)	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0026640		L01BC02|L01BC06	c.2194G>A (*6)	60953
vincristine	rs12235805	PAPPA	A	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12235805:A	24848381
capecitabine, fluorouracil	rs2070474	UPB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2070474:GG	60953
capecitabine, fluorouracil	rs1801265	DPYD	AA	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC02|L01BC06	rs1801265:AA	60953
capecitabine, fluorouracil	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC02|L01BC06	rs1801265:AG	60953
pemetrexed	rs3788189	SLC19A1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs3788189:GG	135565228
pemetrexed	rs3788189	SLC19A1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs3788189:GT	135565228
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0236036	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0236036	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0236036	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
nicotine	rs1800497	ANKK1, DRD2	AA	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1800497:AA	936
nicotine	rs1800497	ANKK1, DRD2	AG	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1800497:AG	936
capecitabine, fluorouracil, folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.1679T>G (*13), DPYD c.2846A>T	DPYD	c.2846A>T	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0027651	deficiency	L01BC02|L01BC06	c.2846A>T	60953
capecitabine, fluorouracil, folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.1679T>G (*13), DPYD c.2846A>T	DPYD	c.1129-5923C>G, c.1236G>A (HapB3)	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0027651	deficiency	L01BC02|L01BC06	c.1129-5923C>G, c.1236G>A (HapB3)	60953
capecitabine, fluorouracil, folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.1679T>G (*13), DPYD c.2846A>T	DPYD	c.1679T>G (*13)	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0027651	deficiency	L01BC02|L01BC06	c.1679T>G (*13)	60953
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*3	667572
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*4	667572
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*5	667572
amitriptyline, antidepressants, clomipramine, desipramine, fluoxetine, imipramine, nortriptyline, paroxetine, venlafaxine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Toxicity	increased	Adverse_Event	Disease:C0235876		N06A|N06AA01|N06AA02|N06AA04|N06AA09|N06AA10|N06AB03|N06AB05|N06AX16	*6	667572
sirolimus	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AA	5284616
sirolimus	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AG	5284616
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*28/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*6	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*1/*6	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Toxicity	increased	Adverse_Event	Other:C0023055		L01CE02	*6/*28	60838
folfiri	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*1/*1	Toxicity	decreased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	*1/*1	No_match
atomoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C1263846	poor metabolizer	N06BA09	__UNKNOWN__	6093336
vincristine	rs12253008	NRG3	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12253008:T	24848381
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Efficacy	decreased	Efficacy_Response	Other:C0023055|Other:C2939419		L01CE02	*28/*28	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Efficacy	decreased	Efficacy_Response	Other:C0023055|Other:C2939419		L01CE02	*6/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Efficacy	decreased	Efficacy_Response	Other:C0023055|Other:C2939419		L01CE02	*6/*28	74990
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3B	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*1/*3B	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*1/*3C	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A/*3B	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*3A/*3B	5778
mercaptopurine, methotrexate	intermediate metabolizer	TPMT	__UNKNOWN__	Toxicity	increased	Adverse_Event	Disease:C0023449	intermediate metabolizer	L01BB02|L04AX03	__UNKNOWN__	126941
vincristine	rs10997459	LRRTM3	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs10997459:G	24848381
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Toxicity	increased	Adverse_Event	Other:C0021390	intermediate metabolizer	L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Toxicity	increased	Adverse_Event	Other:C0021390	intermediate metabolizer	L04AX01	*1/*3C	5778
vincristine	rs8006511	ARHGAP5	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs8006511:G	24848381
mercaptopurine, methotrexate	normal metabolizer	TPMT	__UNKNOWN__	Efficacy	increased	Adverse_Event	Disease:C0023449	normal metabolizer	L01BB02|L04AX03	__UNKNOWN__	126941
nicotine	rs28399433	CYP2A6	CC	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs28399433:CC	936
vincristine	rs79802223	METTL8	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs79802223:G	24848381
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	*2/*3	13748464
none	rs4148325	UGT1A1	CT	Metabolism/PK	decreased	Adverse_Event	Healthy		A03DA02	rs4148325:CT	5282367
none	rs11888492	UGT1A1	G	Metabolism/PK	decreased	Adverse_Event	Healthy		A03DA02	rs11888492:G	5282367
naloxone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:AG	11274356
naloxone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:GG	11274356
cisplatin	rs13022792	CERS6	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	rs13022792:T	441203
cisplatin	rs10759932	TLR4	C	Toxicity	decreased	Adverse_Event	Other:C0027651		L01XA01	rs10759932:C	441203
vincristine	rs10961381	NFIB	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs10961381:G	24848381
antiarrhythmics, class i and iii	rs10033464	__INTRONIC__	GT	Efficacy	increased	Efficacy_Response	Disease:C0004238		C01B	rs10033464:GT	No_match
antiarrhythmics, class i and iii	rs10033464	__INTRONIC__	TT	Efficacy	increased	Efficacy_Response	Disease:C0004238		C01B	rs10033464:TT	No_match
vincristine	rs1815857	MCM3AP	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01CA02	rs1815857:T	24848381
vincristine	rs12474420	SPDYA	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12474420:T	24848381
vincristine	rs12658429	PDE4D	C	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12658429:C	24848381
vincristine	rs12656510	FBN2	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs12656510:T	24848381
vincristine	rs17129858	VTI1A	T	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs17129858:T	24848381
vincristine	rs200858088	ZFAND3	C	Toxicity	decreased	Adverse_Event	Other:C0027651		L01CA02	rs200858088:C	24848381
antiinflammatory agents, non-steroids	HLA-DRB1*11:01	HLA-DRB1	*11:01	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	*11:01	No_match
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Toxicity	increased	Adverse_Event	Healthy		B01AC04	*2	13748464
mycophenolate mofetil, prednisone, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other	increased	Adverse_Event	Other:Kidney_Transplantation		D08AE03|H02AB07|L04AD02	*1/*1	5865
mycophenolate mofetil, prednisone, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Other	increased	Adverse_Event	Other:Kidney_Transplantation		D08AE03|H02AB07|L04AD02	*1/*3	5865
sirolimus	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AA	5284616
sirolimus	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1045642:AG	5284616
acetaminophen / codeine	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative	poor metabolizer	N02AJ06	__UNKNOWN__	1983
rasburicase	deficiency	G6PD	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0740394	deficiency	V03AF07		No_match
nevirapine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AG01	*1/*6	15979285
nevirapine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AG01	*6/*6	15979285
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*1/*6	64139
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AG03	*6/*6	64139
sirolimus	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		No_ATC	rs1128503:AA	5284616
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Other:C0010068|Other:C0549433	intermediate metabolizer and poor metabolizer	B01AC04	*3/*3	13748464
risperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	N05AX08	__UNKNOWN__	849421
isoniazid	NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*7	135483892
isoniazid	NAT2*5, NAT2*6, NAT2*7	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*6	135483892
isoniazid	NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*6	135483892
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
adalimumab, amiodarone, bevacizumab, bicalutamide, carboplatin, cyclophosphamide, docetaxel, erlotinib, everolimus, fluorouracil, gefitinib, gemcitabine, irinotecan, leucovorin, methotrexate, oxaliplatin, paclitaxel, pembrolizumab, sitagliptin, tegafur / gimeracil / oteracil, trastuzumab	HLA-DRB1*04:05	HLA-DRB1	*04:05	Toxicity	increased	Adverse_Event	Healthy		A10BH01|C01BD01|L01AA01|L01BC02|L01BC03|L01BC05|L01CD01|L01CD02|L01CE02|L01EB01|L01EB02|L01EG02|L01FG01|L01XA02|L01XA03|L02BB03|L04AB04|L04AX03	*04:05	176870
tamsulosin	intermediate metabolizer	CYP2D6	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	G04CA02	__UNKNOWN__	5362376
anastrozole, exemestane, letrozole	rs79048288	CCDC148	CT	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BG03|L02BG04|L02BG06	rs79048288:CT	3902
anastrozole, exemestane, letrozole	rs79048288	CCDC148	TT	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BG03|L02BG04|L02BG06	rs79048288:TT	3902
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	increased	Adverse_Event	Disease:C0740394		M04AA01	*58:01	168354693
pemetrexed	rs1650697	DHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0007131|Disease:C0025500		L01BA04	rs1650697:AA	135565228
pemetrexed	rs1650697	DHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0007131|Disease:C0025500		L01BA04	rs1650697:AG	135565228
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*3	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*6	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*3/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*7	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*3/*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*6	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*6/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*7	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*6/*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7/*7	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*7/*7	131769926
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*1	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
fluorouracil, folfiri, folfox	DPYD c.85T>C (*9A)	DPYD	c.85T>C (*9A)/c.85T>C (*9A)	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	c.85T>C (*9A)/c.85T>C (*9A)	3385
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*2	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*2/*3	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Other:C0014544	poor metabolizer	N03AX18	*3/*3	156613579
fluorouracil, folfiri, folfox	DPYD c.1627A>G (*5)	DPYD	c.1627A>G (*5)/c.1627A>G (*5)	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC02	c.1627A>G (*5)/c.1627A>G (*5)	3385
carbamazepine	HLA-A*31:01	HLA-A	*31:01	Toxicity	increased	Adverse_Event	Healthy		N03AF01	*31:01	114709
aspirin	rs12042763	PTGS2	GG	Efficacy	decreased	Adverse_Event	Healthy		No_ATC	rs12042763:GG	72204814
methotrexate	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*37/*37	Toxicity	decreased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	*37/*37	11329481
methotrexate	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*37/*15	Toxicity	decreased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	*37/*15	11329481
none	rs56267346	CYP2A6	G	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs56267346:G	5282367
none	rs6479643	DBH	C	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs6479643:C	5282367
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*16	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	*7	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*16	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*6	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01|J04AK01|J04AK02	*7	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*16	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*5	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*5	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*6	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*7	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Toxicity	increased	Adverse_Event	Disease:C0041296	slow acetylator	J04AC01	*14	135483892
flurbiprofen, irinotecan	UGT1A1*1, UGT1A1*36	UGT1A1	*1/*36	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01CE02|S01BC04	*1/*36	60838
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*5	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*5	135483892
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*6	135483892
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*5/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*5/*7	135483892
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*6	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*6	135483892
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*7	135483892
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*6/*14	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*6/*14	135483892
isoniazid, rifampin	NAT2*1, NAT2*5, NAT2*6, NAT2*7, NAT2*14	NAT2	*7/*7	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator	J04AC01	*7/*7	135483892
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3	131769926
irinotecan	rs4148323	UGT1A1	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:A	74990
none	rs1052576	CASP9	T	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs1052576:T	5282367
capecitabine, fluorouracil	rs1801265	DPYD	AA	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801265:AA	60953
capecitabine, fluorouracil	rs1801265	DPYD	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801265:AG	60953
irinotecan	rs4148323	UGT1A1	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs4148323:A	74990
cyclosporine, methotrexate	rs1051266	SLC19A1	CC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs1051266:CC	126941
cyclosporine, methotrexate	rs17514110	ATIC	CC	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs17514110:CC	126941
cyclosporine, methotrexate	rs3787186	NFATC2	TT	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs3787186:TT	126941
cyclosporine, methotrexate	rs3740065	ABCC2	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs3740065:AA	126941
cetuximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs396991:CC	No_match
cyclosporine, methotrexate	rs8058040	ABCC1	AA	Efficacy	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs8058040:AA	126941
carbamazepine, lamotrigine, phenytoin	HLA-A*24:02	HLA-A	*24:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*24:02	1775
carbamazepine, lamotrigine, phenytoin	HLA-B*15:02	HLA-B	*15:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*15:02	1775
atazanavir, efavirenz	rs7305115	TPH2	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE08|J05AG03	rs7305115:GG	64139
carbamazepine, lamotrigine, phenytoin	HLA-A*01:02	HLA-A	*01:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*01:02	1775
carbamazepine, lamotrigine, phenytoin	HLA-B*52:01	HLA-B	*52:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*52:01	1775
carbamazepine, lamotrigine, phenytoin	HLA-DRB1*03:01	HLA-DRB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*03:01	1775
atazanavir, efavirenz	rs1386493	TPH2	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE08|J05AG03	rs1386493:GG	64139
carbamazepine, lamotrigine, phenytoin	HLA-DRB1*13:01	HLA-DRB1	*13:01	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*13:01	1775
capecitabine	rs2612091	ENOSF1	TT	Efficacy	increased	Efficacy_Response	Other:C0023055		L01BC06	rs2612091:TT	11809635
carbamazepine, lamotrigine, phenytoin	HLA-A*02:01	HLA-A	*02:01	Toxicity	decreased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*02:01	1775
carbamazepine, lamotrigine, phenytoin	HLA-B*40:02	HLA-B	*40:02	Toxicity	increased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*40:02	1775
carbamazepine, lamotrigine, phenytoin	HLA-A*31:03	HLA-A	*31:03	Toxicity	decreased	Adverse_Event	Healthy		N03AB02|N03AF01|N03AX09	*31:03	1775
carboplatin, paclitaxel	rs544093	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs544093:GG	10339178
carboplatin, paclitaxel	rs544093	OPRM1	GT	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs544093:GT	10339178
mycophenolate mofetil(mycophenolic acid)	rs2228075	IMPDH1	T	Efficacy, Toxicity	increased	Adverse_Event	Disease:Organ_Transplantation		L04AA06	rs2228075:T	5281078
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801160:CT	60953
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801160:TT	60953
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Other:C0041296	slow acetylator and intermediate acetylator	J04AC01	__UNKNOWN__	135483892
erlotinib, gefitinib	rs3744797	USP36	CC	Efficacy	increased	Adverse_Event	Other:C0007131		L01EB01|L01EB02	rs3744797:CC	176870
osimertinib	HLA-B*51:02	HLA-B	*51:02	Toxicity	increased	Adverse_Event	Other:C0024121		L01EB04	*51:02	71496458
dexmedetomidine	rs10764319	CACNB2	CT	Toxicity	decreased	Adverse_Event	Other:C0549433		N05CM18	rs10764319:CT	6918081
dexmedetomidine	rs2236957	CACNA2D2	AA	Toxicity	decreased	Adverse_Event	Other:C0549433		N05CM18	rs2236957:AA	6918081
drugs for treatment of tuberculosis	slow acetylator	NAT2	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy	slow acetylator	J04A	__UNKNOWN__	No_match
dexmedetomidine	rs1841042	UGT2B10	AA	Toxicity	decreased	Adverse_Event	Other:C0549433		N05CM18	rs1841042:AA	6918081
dexmedetomidine	rs3813662	ADRA2B	AA	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs3813662:AA	6918081
dexmedetomidine	rs3813662	ADRA2B	CC	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs3813662:CC	6918081
methylphenidate	rs2307227	CES1	T	Toxicity	increased	Adverse_Event	Other:C1263846		N06BA04	rs2307227:T	154100
purine analogues	NUDT15*1, NUDT15*3	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB	*1/*3	1044
clopidogrel	rs7807369	THSD7A	G	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs7807369:G	13748464
clopidogrel	rs1149515	__INTRONIC__	C	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs1149515:C	13748464
ondansetron	normal metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Healthy	normal metabolizer	A04AA01	__UNKNOWN__	4595
none	rs17524572	ERAP2	TT	Toxicity	increased	Adverse_Event	Other:C0041296		A03DA02	rs17524572:TT	5282367
mycophenolate mofetil(mycophenolic acid)	rs1042597	UGT1A8	CC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs1042597:CC	5281078
pembrolizumab	HLA-DRB1*13:01	HLA-DRB1	*13:01	Efficacy	decreased	Adverse_Event	"""Other:C0001418|""Other:C0007131|""Other:C0007097|Squamous_Cell""|""Other:Neuroendocrine_Carcinoma"""		No_ATC	*13:01	No_match
pembrolizumab	HLA-DPB1*02:02	HLA-DPB1	*02:02	Toxicity	increased	Adverse_Event	"""Other:C0001418|""Other:C0007131|""Other:C0007097|Squamous_Cell""|""Other:Neuroendocrine_Carcinoma"""		No_ATC	*02:02	No_match
capecitabine, fluorouracil	rs1801158	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs1801158:CT	60953
morphine	rs72552763	SLC22A1	del/del	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs72552763:del/del	5284371
drugs for treatment of tuberculosis	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Toxicity	increased	Adverse_Event	Healthy		J04A		No_match
none	rs4661636	CASP9	C	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs4661636:C	5282367
none	rs6736233	CASP8	G	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs6736233:G	5282367
clozapine	rs6657868	LEPR	AG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs6657868:AG	131769989
clozapine	rs6657868	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs6657868:GG	131769989
clozapine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs762551:AA	131769989
cisplatin, paclitaxel	rs2017869	GGT1	CC	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01|L01XA01	rs2017869:CC	5460033
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs12201199:T	441203
none	rs4148323	UGT1A1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs4148323:A	5282367
clozapine	rs1137101	LEPR, LEPROT	AA	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs1137101:AA	131769989
dolutegravir	rs2472677	NR1I2	CT	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AJ03	rs2472677:CT	118753073
dolutegravir	rs2472677	NR1I2	TT	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AJ03	rs2472677:TT	118753073
cisplatin	rs1800460	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1800460:T	441203
clozapine	rs1805096	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs1805096:GG	131769989
clozapine	rs9436746	LEPR	AC	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs9436746:AC	131769989
clozapine	rs9436746	LEPR	CC	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH02	rs9436746:CC	131769989
risperidone	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Other:C0033975		N05AX08	rs1800497:AA	849421
risperidone	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Other:C0033975		N05AX08	rs1800497:AG	849421
none	rs35350960	UGT1A1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs35350960:A	5282367
cisplatin	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1142345:C	441203
warfarin	rs4379440	ASPH	T	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs4379440:T	54688261
carboplatin, paclitaxel	rs7311358	SLCO1B3	AA	Toxicity	decreased	Adverse_Event	Other:C0919267		L01CD01|L01XA02	rs7311358:AA	10339178
aspirin, clopidogrel, ticagrelor	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Other:C0018839		B01AC04|B01AC24	rs12041331:AA	2244
aspirin, clopidogrel, ticagrelor	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Other:C0018839		B01AC04|B01AC24	rs12041331:AG	2244
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs67376798:AT	60953
methotrexate	rs1801131	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G	11329481
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs1127354:AC	37542
hmg coa reductase inhibitors	rs3764261	CETP	A	Efficacy, Metabolism/PK	increased	Other	Healthy		C10AA	rs3764261:A	445127
methotrexate	rs1127354	ITPA	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0003873		L04AX03	rs1127354:A	11329481
gefitinib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs1128503:AA	135496227
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs231775	CTLA4	A	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs231775:A	37542
caffeine	rs4410790	__INTRONIC__	T	Other	Indeterminado	Other	Healthy		N06BC01	rs4410790:T	936
liraglutide	rs6923761	GLP1R	AA	Efficacy	increased	Adverse_Event	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs6923761:AA	16134956
liraglutide	rs6923761	GLP1R	AG	Efficacy	increased	Adverse_Event	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs6923761:AG	16134956
methamphetamine	rs2234693	ESR1	CC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2234693:CC	36604
none	rs11887534	ABCG8	CG	Other	increased	Adverse_Event	Healthy		A03DA02	rs11887534:CG	5282367
platinum	rs17655	ERCC5	GG	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01XA	rs17655:GG	441203
platinum	rs17655	ERCC5	GG	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs17655:GG	441203
risperidone	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C1510586		N05AX08	rs3813929:T	849421
paclitaxel	rs10771973	FGD4	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs10771973:A	36314
caffeine	rs2470893	CYP1A1	T	Other	Indeterminado	Other	Healthy		N06BC01	rs2470893:T	936
citalopram	rs25531	SLC6A4	C	Toxicity	increased	Adverse_Event	Disease:C0497327		N06AB04	rs25531:C	162180
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4969170	SOCS3	AG	Toxicity	decreased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs4969170:AG	37542
midazolam	rs1057868	POR	TT	Other, Metabolism/PK	increased	LADME	Healthy		N05CD08	rs1057868:TT	5384200
enalapril	rs13009649	PNPT1	G	Toxicity	decreased	Adverse_Event	Other:C0020538		C09AA02	rs13009649:G	5950
methotrexate	rs1127354	ITPA	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0003873		L04AX03	rs1127354:A	11329481
nicotine	rs11606194	HTR3B	CT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs11606194:CT	936
nicotine	rs11606194	HTR3B	TT	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs11606194:TT	936
aspirin	rs499368	SLC6A12	A	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs499368:A	72204814
gefitinib	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs1045642:AA	135496227
warfarin	rs2189784	CYP4F2	GG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2189784:GG	54688261
aspirin	rs557881	SLC6A12	G	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs557881:G	72204814
platinum compounds	rs10878232	WIF1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs10878232:GG	23939
platinum compounds	rs10878232	WIF1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs10878232:GT	23939
antiepileptics	rs1045642	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:G	No_match
anthracyclines and related substances	rs1056892	CBR3	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB	rs1056892:AG	No_match
platinum compounds	rs12819505	WNT5B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs12819505:AG	23939
platinum compounds	rs12819505	WNT5B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs12819505:GG	23939
platinum compounds	rs4541111	AXIN2	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs4541111:AA	23939
platinum compounds	rs4541111	AXIN2	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs4541111:AC	23939
mercaptopurine, methotrexate	rs2413739	PACSIN2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2413739:T	126941
mercaptopurine	rs11045879	SLCO1B1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs11045879:T	1268107
mercaptopurine, methotrexate	rs1127354	ITPA	CC	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BB02|L04AX03	rs1127354:CC	126941
platinum compounds	rs4413407	CXXC4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs4413407:AA	23939
platinum compounds	rs4413407	CXXC4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs4413407:AG	23939
enalapril	rs13015243	PNPT1	C	Toxicity	decreased	Adverse_Event	Other:C0020538		C09AA02	rs13015243:C	5950
azathioprine, mercaptopurine, thioguanine	rs11969064	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L01BB03|L04AX01	rs11969064:T	2265
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	T	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs8099917:T	37542
platinum compounds	rs13181	ERCC2	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs13181:GG	23939
platinum compounds	rs1799793	ERCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:CT	23939
platinum compounds	rs1799793	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1799793:TT	23939
doxorubicin	rs1883112	NCF4	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB01	rs1883112:AA	83958
doxorubicin	rs1883112	NCF4	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L01DB01	rs1883112:AG	83958
amphetamine	rs12364283	DRD2	AA	Efficacy	decreased	Other	Healthy		No_ATC	rs12364283:AA	11597698
antiepileptics	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:AA	No_match
antiepileptics	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:GG	No_match
paroxetine	rs6313	HTR2A	GG	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05	rs6313:GG	667572
clopidogrel	rs34394661	CD80	AA	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs34394661:AA	13748464
mycophenolate mofetil(mycophenolic acid)	rs6714486	UGT1A9	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation		L04AA06	rs6714486:A	5281078
carbamazepine	rs1633021	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs1633021:TT	114709
platinum compounds	rs11868547	AXIN2	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11868547:CC	23939
platinum compounds	rs11868547	AXIN2	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11868547:CG	23939
mycophenolate mofetil(mycophenolic acid)	rs17868320	UGT1A9	T	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation		L04AA06	rs17868320:T	5281078
morphine	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N02AA01	rs1045642:GG	5284371
cyclosporine, mycophenolate mofetil	rs1042597	UGT1A8	CC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1042597:CC	6918995
tacrolimus	rs1800871	IL10	AA	Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1800871:AA	131769926
methotrexate	rs4948496	ARID5B	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4948496:CC	11329481
methotrexate	rs4948496	ARID5B	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4948496:CT	11329481
none	rs3760657	CYP2B6	AA	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs3760657:AA	5282367
follitropin beta, thyrotropin alfa, urofollitropin	rs6166	FSHR	T	Efficacy, Metabolism/PK	Indeterminado	Efficacy_Response	Healthy		G03GA04|G03GA06|V04CJ01	rs6166:T	73759969
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Other	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AA	2244
aspirin, clopidogrel	rs4244285	CYP2C19	AG	Efficacy, Other	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AG	2244
none	rs11726322	UGT2B10	CC	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs11726322:CC	5282367
hormonal contraceptives for systemic use	rs6025	F5	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:T	No_match
aspirin, clopidogrel	rs12248560	CYP2C19	CT	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs12248560:CT	2244
aspirin, clopidogrel	rs12248560	CYP2C19	TT	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs12248560:TT	2244
hormonal contraceptives for systemic use	rs1799963	F2	A	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799963:A	No_match
clopidogrel	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs1045642:AG	13748464
capecitabine, fluorouracil	rs11479	TYMP	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs11479:AA	60953
capecitabine, fluorouracil	rs11479	TYMP	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs11479:AG	60953
warfarin	rs2108622	CYP4F2	CT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:TT	54688261
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs67376798:AT	60953
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT	60953
capecitabine, fluorouracil	rs75017182	DPYD	CG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs75017182:CG	60953
alendronate	rs1544410	VDR	CC	Efficacy	increased	Efficacy_Response	Disease:C0029456		No_ATC	rs1544410:CC	2088
fenofibrate	rs135543	PPARA	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AB05	rs135543:TT	11350701
fenofibrate	rs9626730	PPARA	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AB05	rs9626730:CC	11350701
fenofibrate	rs9626730	PPARA	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AB05	rs9626730:CT	11350701
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Other	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	decreased	Other	Healthy		B01AA03	rs2108622:TT	54688261
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG	13748464
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG	13748464
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG	13748464
fenofibrate	rs135550	PPARA	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AB05	rs135550:TT	11350701
alendronate	rs1544410	VDR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0029456		No_ATC	rs1544410:CC	2088
exemestane	rs7176005	CYP19A1	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C1458155		L02BG06	rs7176005:TT	13472
tacrolimus	rs4253728	PPARA	GG	Toxicity	decreased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs4253728:GG	131769926
vincristine	rs1013940	SLC5A7	AG	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs1013940:AG	24848381
vincristine	rs1013940	SLC5A7	GG	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs1013940:GG	24848381
ethanol	rs1229984	ADH1B	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1229984:T	444899
vincristine	rs10504361	NKAIN3	A	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs10504361:A	24848381
simvastatin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	rs4149056:C	14373154
atenolol	rs340874	PROX1	C	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB03	rs340874:C	14211540
tacrolimus	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs35599367:AA	131769926
tacrolimus	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs35599367:AG	131769926
abemaciclib, palbociclib, ribociclib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01|L01EF02|L01EF03	rs1128503:AA	5330286
simvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA01	rs2231142:GT	14373154
vincristine	rs3784867	ABCC1	T	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs3784867:T	24848381
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs4244285:AG	13748464
opioids	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AA	No_match
opioids	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AG	No_match
opioids	rs1800795	IL6	CG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs1800795:CG	No_match
opioids	rs1800795	IL6	GG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs1800795:GG	No_match
fluorouracil	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Healthy		L01BC02	rs67376798:A	5790
sunitinib	rs776746	CYP3A5	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs776746:CT	11221549
sunitinib	rs776746	CYP3A5	TT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs776746:TT	11221549
abemaciclib, palbociclib, ribociclib	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01EF01|L01EF02|L01EF03	rs35599367:AG	5330286
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Healthy		L01CA02	rs924607:TT	24848381
metoprolol	rs1065852	CYP2D6	GG	Efficacy	decreased	Efficacy_Response	Healthy		C07AB02	rs1065852:GG	6322
conjugated estrogens, medroxyprogesterone	rs1544410	VDR	TT	Efficacy	increased	Other	Healthy		G03CA57|L02AB02	rs1544410:TT	10631
verapamil	rs2357928	CACNB2	GG	Efficacy, Toxicity	increased	Adverse_Event	Other:C1956346		C08DA01	rs2357928:GG	65808
metformin	rs2252281	SLC47A1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2252281:CC	155906370
tacrolimus	rs4646450	CYP3A5	A	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs4646450:A	131769926
metformin	rs2252281	SLC47A1	CC	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs2252281:CC	155906370
trazodone	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		N06AX05	rs1045642:AA	62935
interferons, ribavirin	rs1800477	BCL2	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB	rs1800477:T	37542
cetuximab, fluorouracil, irinotecan, oxaliplatin	rs112445441	KRAS	T	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01XA03	rs112445441:T	9887054
fluorouracil, leucovorin, oxaliplatin	rs3136228	MSH6	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs3136228:GG	135403648
fluorouracil, leucovorin, oxaliplatin	rs1799794	XRCC3	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs1799794:CC	135403648
none	rs7643645	NR1I2	GG	Other	increased	Adverse_Event	Other:C0860195		A03DA02	rs7643645:GG	5282367
platinum compounds	rs9344	CCND1	AA	Toxicity	increased	Adverse_Event	Other:C0024121		L01XA	rs9344:AA	23939
verapamil	rs11014166	CACNB2	AT	Efficacy, Toxicity	increased	Adverse_Event	Other:C1956346		C08DA01	rs11014166:AT	65808
verapamil	rs11014166	CACNB2	TT	Efficacy, Toxicity	increased	Adverse_Event	Other:C1956346		C08DA01	rs11014166:TT	65808
fluorouracil, leucovorin, oxaliplatin	rs2074087	ABCC1	C	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs2074087:C	135403648
fluorouracil	rs2960436	__INTRONIC__	AA	Efficacy	Indeterminado	Other	Disease:C0026640		L01BC02	rs2960436:AA	5790
fluorouracil, leucovorin, oxaliplatin	rs1885301	ABCC2	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs1885301:AA	135403648
fluorouracil	rs2854744	IGFBP3	TT	Efficacy	Indeterminado	Other	Disease:C0026640		L01BC02	rs2854744:TT	5790
fluorouracil, leucovorin, oxaliplatin	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs717620:TT	135403648
fluorouracil, leucovorin, oxaliplatin	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs3740066:TT	135403648
cocaine	rs1125394	DRD2	C	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs1125394:C	2826
cocaine	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs1076560:A	2826
cocaine	rs2283265	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs2283265:A	2826
mycophenolate mofetil(mycophenolic acid)	rs4149015	SLCO1B1	A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149015:A	5281078
tacrolimus	rs4646453	CYP3A5	CC	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs4646453:CC	131769926
tacrolimus	rs776746	CYP3A5	CC	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
mycophenolate mofetil(mycophenolic acid)	rs4149056	SLCO1B1	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149056:TT	5281078
opioids	rs4633	COMT	CC	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs4633:CC	No_match
mycophenolate mofetil(mycophenolic acid)	rs4149056	SLCO1B1	C	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149056:C	5281078
acetaminophen / tramadol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1799971:AG	1983
acetaminophen / tramadol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1799971:GG	1983
opioids	rs4633	COMT	CT	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs4633:CT	No_match
capecitabine	rs1128503	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs1128503:AA	11809635
opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1799971:G	No_match
capecitabine	rs2032582	ABCB1	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2032582:CC	11809635
opioids	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs1799971:GG	No_match
fluorouracil	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02	rs1045642:GG	5790
capecitabine	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1045642:GG	11809635
warfarin	rs7900194	CYP2C9	A	Dosage, Metabolism/PK	Indeterminado	Other	Healthy		B01AA03	rs7900194:A	54688261
sunitinib	rs3814055	NR1I2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs3814055:TT	11221549
amphetamine	rs510769	OPRM1	TT	Other	decreased	Other	Healthy		No_ATC	rs510769:TT	11597698
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA01	rs4149056:CT	14373154
sunitinib	rs2231137	ABCG2	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2231137:CT	11221549
cisplatin	rs11265375	NHLH1	CT	Efficacy	increased	Efficacy_Response	Other:C0007134|Other:C0024121		L01XA01	rs11265375:CT	441203
cisplatin	rs11265375	NHLH1	TT	Efficacy	increased	Efficacy_Response	Other:C0007134|Other:C0024121		L01XA01	rs11265375:TT	441203
bortezomib	rs915854	CBS	TT	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma		L01XG01	rs915854:TT	11552
none	rs3100	UGT2B15	AA	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs3100:AA	5282367
amphetamine	rs2281617	OPRM1	CC	Other	increased	Other	Healthy		No_ATC	rs2281617:CC	11597698
warfarin	rs6130615	HNF4A	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs6130615:CC	54688261
cisplatin	rs3806915	SEMA6A	A	Efficacy	increased	Efficacy_Response	Other:C0007134|Other:C0024121		L01XA01	rs3806915:A	441203
aspirin, clopidogrel	rs1045642	ABCB1	AA	Efficacy, Other	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs1045642:AA	2244
warfarin	rs1884613	HNF4A	GG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1884613:GG	54688261
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
aspirin, clopidogrel	rs5918	ITGB3	CC	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs5918:CC	2244
aspirin, clopidogrel	rs5918	ITGB3	CT	Efficacy, Other	decreased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs5918:CT	2244
warfarin	rs3212191	HNF4A	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs3212191:TT	54688261
ondansetron	rs1042173	SLC6A4	AA	Efficacy	increased	Efficacy_Response	Disease:C0085762		A04AA01	rs1042173:AA	4595
warfarin	rs61162043	__INTRONIC__	G	Other	increased	Adverse_Event	Healthy		B01AA03	rs61162043:G	54688261
risperidone	rs6313	HTR2A	GG	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs6313:GG	849421
heroin	rs2075572	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2075572:G	9844225
risperidone	rs1805054	__INTRONIC__	TT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs1805054:TT	849421
antihypertensives	rs4149601	NEDD4L	AA	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs4149601:AA	No_match
antihypertensives	rs1801252	ADRB1	GG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs1801252:GG	No_match
fluorouracil	rs1801133	MTHFR	AA	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801133:AA	5790
fluorouracil	rs1801133	MTHFR	AG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801133:AG	5790
risperidone	rs3813929	HTR2C	CT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs3813929:CT	849421
risperidone	rs3813929	HTR2C	TT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs3813929:TT	849421
heroin	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:G	9844225
bleomycin, cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine, vindesine	rs2229109	ABCB1	CT	Toxicity	increased	Adverse_Event	Disease:C0024299		H02AB07|L01AA01|L01CA02|L01CA03|L01DB01|L01DC01|L01FA01	rs2229109:CT	2907
cyclophosphamide	rs4802101	CYP2B6	C	Toxicity	decreased	Adverse_Event	Disease:C0409974		L01AA01	rs4802101:C	9554282
antihypertensives	rs776746	CYP3A5, ZSCAN25	CC	Efficacy	decreased	Adverse_Event	Other:C0020538		C02	rs776746:CC	No_match
cisplatin	rs2228001	XPC	GG	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GG	441203
cisplatin	rs2228001	XPC	GT	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GT	441203
methadone	rs1799971	OPRM1	G	Other	decreased	Adverse_Event	Disease:C0028043		N07BC02	rs1799971:G	10090
sufentanil	rs2242480	CYP3A4	TT	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs2242480:TT	41693
none	rs3750625	ADRA2A	A	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs3750625:A	5282367
none	rs11195418	ADRA2A	G	Other	decreased	Adverse_Event	Other:C0032961		A03DA02	rs11195418:G	5282367
muraglitazar	rs2368564	REN	TT	Toxicity	decreased	Adverse_Event	Disease:C0011849		No_ATC	rs2368564:TT	44448594
chloroquine, primaquine	rs12422149	SLCO2B1	GG	Efficacy	increased	Adverse_Event	Disease:C0024530		P01BA01|P01BA03	rs12422149:GG	444810
aspirin	rs2243250	IL4	TT	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2243250:TT	72204814
antipsychotics	rs806374	CNR1	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs806374:CC	No_match
warfarin	rs1057910	CYP2C9	AC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs1057910:AC	54688261
warfarin	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs1057910:CC	54688261
methotrexate	rs3763980	SLC16A7	A	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3763980:A	11329481
metformin	rs784892	AMHR2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs784892:G	155906370
acetaminophen, aspirin, diclofenac, propionic acid derivatives, pyrazolones	rs12746200	PLA2G4A	G	Toxicity	increased	Adverse_Event	Healthy		M01AE|N02BB|N02BE01|S01BC03	rs12746200:G	1983
antipsychotics	rs806374	CNR1	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs806374:CC	No_match
warfarin	rs9923231	VKORC1	TT	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
fluorouracil	rs75017182	DPYD	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs75017182:C	5790
ethanol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AA	444899
nevirapine	rs3099844	CYCSP5	A	Toxicity, Other	increased	Adverse_Event	Disease:C0001175		J05AG01	rs3099844:A	15979285
acetaminophen, aspirin, diclofenac, propionic acid derivatives, pyrazolones	rs2228246	PLCG1	G	Toxicity	increased	Adverse_Event	Healthy		M01AE|N02BB|N02BE01|S01BC03	rs2228246:G	1983
acetaminophen, aspirin, diclofenac, propionic acid derivatives, pyrazolones	rs1805034	TNFRSF11A	C	Toxicity	increased	Adverse_Event	Healthy		M01AE|N02BB|N02BE01|S01BC03	rs1805034:C	1983
antihypertensives	rs1799983	NOS3	G	Efficacy	increased	Adverse_Event	Disease:C0032914		C02	rs1799983:G	No_match
antihypertensives	rs2070744	NOS3	C	Efficacy	increased	Adverse_Event	Disease:C0032914		C02	rs2070744:C	No_match
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1045642:AG	11329481
none	rs1800038	ADRA2A	A	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs1800038:A	5282367
tacrolimus	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs776746:T	131769926
cisplatin	rs683369	SLC22A1	CG	Efficacy	increased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs683369:CG	441203
cisplatin	rs683369	SLC22A1	GG	Efficacy	increased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs683369:GG	441203
nicotine	rs4887074	__INTRONIC__	G	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs4887074:G	936
fluorouracil, irinotecan, leucovorin	rs10937158	ABCC5	T	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs10937158:T	135403648
fluorouracil, irinotecan, leucovorin	rs3749438	ABCC5	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs3749438:A	135403648
fluorouracil, irinotecan, leucovorin	rs225440	ABCG1	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs225440:T	135403648
clopidogrel	rs854552	PON1	CC	Efficacy	increased	Efficacy_Response	Other:C1956346		B01AC04	rs854552:CC	13748464
fluorouracil, irinotecan, leucovorin	rs2292997	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs2292997:A	135403648
cisplatin	rs2038067	PPARD	AG	Efficacy	decreased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs2038067:AG	441203
cisplatin	rs2038067	PPARD	GG	Efficacy	decreased	Efficacy_Response	Other:Neoplasm_of_esophagus		L01XA01	rs2038067:GG	441203
tacrolimus	rs6977165	CYP3A5	C	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs6977165:C	131769926
cyclophosphamide	rs4244285	CYP2C19	A	Toxicity	decreased	Adverse_Event	Disease:C0409974		L01AA01	rs4244285:A	9554282
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	T	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:T	54688261
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:TT	5790
none	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:AA	5282367
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:TT	5790
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:TT	5790
fluorouracil	rs17376848	DPYD	G	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs17376848:G	5790
opioids	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CC	No_match
opioids	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CT	No_match
acetaminophen / tramadol	rs2296616	MIR107	AA	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs2296616:AA	1983
acetaminophen / tramadol	rs2296616	MIR107	AG	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs2296616:AG	1983
lithium	rs334558	GSK3B	AA	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs334558:AA	11125
cyclophosphamide, doxorubicin, epirubicin, fluorouracil, methotrexate	rs1800566	NQO1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01|L01DB03|L04AX03	rs1800566:AA	2907
acetaminophen / tramadol	rs1011784	MIR23B	GG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1011784:GG	1983
acetaminophen / tramadol	rs1011784	MIR23B	CG	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1011784:CG	1983
acetaminophen / tramadol	rs1011784	MIR23B	GG	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs1011784:GG	1983
opioids	rs2069514	CYP1A2	AA	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2069514:AA	No_match
opioids	rs2069514	CYP1A2	AG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2069514:AG	No_match
opioids	rs2654754	DRD3	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:AA	No_match
opioids	rs2654754	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2654754:AG	No_match
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
opioids	rs324029	DRD3	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:AG	No_match
opioids	rs324029	DRD3	GG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs324029:GG	No_match
methamphetamine	rs324420	FAAH	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs324420:A	36604
opioids	rs2740574	CYP3A4	CC	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2740574:CC	No_match
opioids	rs2740574	CYP3A4	CT	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs2740574:CT	No_match
risperidone	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs2231142:GT	849421
risperidone	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Healthy		N05AX08	rs2231142:TT	849421
aspirin	rs1105879	UGT1A6	AC	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs1105879:AC	72204814
aspirin	rs1105879	UGT1A6	CC	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs1105879:CC	72204814
acetaminophen / tramadol	rs677830	OPRM1	CT	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs677830:CT	1983
acetaminophen / tramadol	rs677830	OPRM1	TT	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AJ13	rs677830:TT	1983
opioids	rs15524	CYP3A5	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs15524:AA	No_match
opioids	rs15524	CYP3A5	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs15524:AG	No_match
regorafenib	rs4864950	KDR	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01EX05	rs4864950:A	11167602
efavirenz, ethambutol, isoniazid, rifampin	rs2472677	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01|J04AK02|J05AG03	rs2472677:TT	135483892
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	rs9923231:TT	54688261
efavirenz, ethambutol, isoniazid, rifampin	rs2472677	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01|J04AK02|J05AG03	rs2472677:TT	135483892
cyclophosphamide, doxorubicin	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:AA	2907
cyclophosphamide, doxorubicin	rs2032582	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:TT	2907
taxanes	rs11584174	NR1I3	CC	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs11584174:CC	9548828
atazanavir, ritonavir	rs8330	UGT1A1	G	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs8330:G	25134325
cyclophosphamide, doxorubicin	rs2032582	ABCB1	AC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:AC	2907
cyclophosphamide, doxorubicin	rs2032582	ABCB1	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs2032582:CT	2907
efavirenz	rs28399499	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:TT	64139
nevirapine	rs10276036	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs10276036:TT	15979285
taxanes	rs7438284	UGT2B7	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7438284:AA	9548828
atazanavir, ritonavir	rs10929303	UGT1A1	T	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs10929303:T	25134325
taxanes	rs7439366	UGT2B7	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7439366:TT	9548828
atazanavir, ritonavir	rs1042640	UGT1A1	G	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs1042640:G	25134325
taxanes	rs7662029	UGT2B7	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7662029:AA	9548828
taxanes	rs7668258	UGT2B7	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD	rs7668258:TT	9548828
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
antipsychotics	rs1468412	GRM3	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1468412:TT	No_match
aspirin, clopidogrel	rs662	PON1	CT	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:CT	2244
aspirin, clopidogrel	rs662	PON1	TT	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	rs662:TT	2244
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03	rs9923231:TT	54688261
risperidone	rs6265	BDNF	TT	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AX08	rs6265:TT	849421
corticosteroids	rs28364072	FCER2	G	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs28364072:G	No_match
fluorouracil, radiotherapy	rs4073	CXCL8	AA	Efficacy	decreased	Adverse_Event	Disease:C0022665		L01BC02	rs4073:AA	3385
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:AA	11329481
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:AG	11329481
fluorouracil, radiotherapy	rs1870377	KDR	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C0022665		L01BC02	rs1870377:AA	3385
peginterferon alfa-2b, ribavirin	rs1800795	IL6	CC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1800795:CC	37542
atorvastatin	rs3808607	CYP7A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05	rs3808607:TT	656846
cangrelor	rs6787801	P2RY12	G	Other	Indeterminado	Other	Healthy		B01AC25	rs6787801:G	9854012
none	rs445925	APOC1, APOE	A	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs445925:A	5282367
sunitinib	rs2981582	FGFR2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2981582:AA	11221549
sulfamethoxazole / trimethoprim	rs1799931	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0032285		J01EE01	rs1799931:A	5578
sunitinib	rs307826	FLT4	CC	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs307826:CC	11221549
sunitinib	rs307826	FLT4	CT	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs307826:CT	11221549
heroin	rs1799971	OPRM1	AG	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:AG	9844225
heroin	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:GG	9844225
sunitinib	rs2307424	NR1I3	AA	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2307424:AA	11221549
sunitinib	rs2307424	NR1I3	AG	Efficacy	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2307424:AG	11221549
none	rs174541	FADS1, FEN1, MIR611, TMEM258	T	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs174541:T	5282367
none	rs258494	__INTRONIC__	C	Metabolism/PK	Indeterminado	LADME	Disease:C0679403		A03DA02	rs258494:C	5282367
none	rs6511720	LDLR	T	Other	Indeterminado	LADME	Disease:C0679403		A03DA02	rs6511720:T	5282367
none	rs2934965	PNMT	T	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs2934965:T	5282367
fluorouracil, leucovorin, levamisole, radiotherapy	rs1695	GSTP1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC02	rs1695:GG	135403648
dexamethasone, lenalidomide	rs2229109	ABCB1	CT	Efficacy	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX04|S02BA06	rs2229109:CT	216326
azathioprine	rs1127354	DDRGK1, ITPA	AC	Efficacy	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:AC	5778
none	rs2941523	PNMT	GG	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs2941523:GG	5282367
mycophenolic acid	rs4149117	SLCO1B3	GT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:GT	5281078
mycophenolic acid	rs4149117	SLCO1B3	TT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:TT	5281078
none	rs876493	PNMT	AA	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs876493:AA	5282367
none	rs876493	PNMT	AG	Other	decreased	Adverse_Event	Other:C0002895		A03DA02	rs876493:AG	5282367
atenolol, bisoprolol	rs2514036	ACY3	C	Efficacy	decreased	Adverse_Event	Disease:C0020538		C07AB03|C07AB07	rs2514036:C	2249
losartan	rs3814995	KIRREL2, NPHS1	T	Efficacy	decreased	Adverse_Event	Disease:C0020538		C09CA01	rs3814995:T	11751549
aspirin	rs16851030	ADORA1	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs16851030:TT	72204814
antineoplastic agents	rs1544105	FPGS	TT	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs1544105:TT	No_match
sunitinib	rs4073054	NR1I3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs4073054:AA	11221549
sunitinib	rs307821	FLT4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs307821:AA	11221549
sunitinib	rs307821	FLT4	AC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs307821:AC	11221549
alprazolam	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0085762|Other:C0003469		N05BA12	rs35599367:AG	2118
mycophenolic acid	rs7311358	SLCO1B3	AG	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:AG	5281078
mycophenolic acid	rs7311358	SLCO1B3	GG	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:GG	5281078
mycophenolic acid	rs7311358	SLCO1B3	AG	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:AG	5281078
mycophenolic acid	rs7311358	SLCO1B3	GG	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs7311358:GG	5281078
sunitinib	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:AG	11221549
sunitinib	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:GG	11221549
olanzapine	rs2472297	CYP1A1	T	Metabolism/PK	Indeterminado	LADME	Disease:C0033975		N05AH03	rs2472297:T	74603552
mycophenolic acid	rs4149117	SLCO1B3	GT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:GT	5281078
mycophenolic acid	rs4149117	SLCO1B3	TT	Efficacy	increased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:TT	5281078
bevacizumab, capecitabine, cetuximab, oxaliplatin	rs885036	MGAT4A	G	Efficacy	increased	Adverse_Event	Disease:C0023055		L01BC06|L01FG01|L01XA03	rs885036:G	9887054
opioids	rs2366929	ADGRV1	C	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2366929:C	No_match
bevacizumab, capecitabine, oxaliplatin	rs885036	MGAT4A	G	Efficacy	decreased	Adverse_Event	Disease:C0023055		L01BC06|L01FG01|L01XA03	rs885036:G	9887054
clopidogrel	rs1736557	FMO3	AA	Efficacy	decreased	Adverse_Event	Efficacy:C1956346		B01AC04	rs1736557:AA	13748464
mycophenolic acid	rs4149117	SLCO1B3	GT	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:GT	5281078
mycophenolic acid	rs4149117	SLCO1B3	TT	Efficacy	decreased	Adverse_Event	Other:Lung_transplantation		L04AA06	rs4149117:TT	5281078
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AA	74990
aspirin, clopidogrel	rs2644592	PEAR1	G	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs2644592:G	2244
aspirin, clopidogrel	rs11264580	PEAR1	C	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs11264580:C	2244
bupropion, nicotine	rs429358	APOE	CC	Other	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs429358:CC	89594
bupropion, nicotine	rs429358	APOE	CT	Other	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs429358:CT	89594
aspirin, clopidogrel	rs57731889	PEAR1	TT	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs57731889:TT	2244
alendronate, ibandronate, risedronate, zoledronate	rs932658	SIRT1	A	Toxicity	decreased	Adverse_Event	Other:C0027651		No_ATC	rs932658:A	60852
valproic acid	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:AG	134459
valproic acid	rs1137101	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:GG	134459
antineoplastic agents	rs3754446	GSTM5	C	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs3754446:C	No_match
atorvastatin, bezafibrate	rs449647	APOE	AT	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05|C10AB02	rs449647:AT	60823
atorvastatin, bezafibrate	rs449647	APOE	TT	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05|C10AB02	rs449647:TT	60823
haloperidol	rs2298826	SLC6A5	AA	Toxicity	Indeterminado	Adverse_Event	Disease:C0036341		N05AD01	rs2298826:AA	9828
olanzapine	rs4410790	AHR	T	Metabolism/PK	Indeterminado	LADME	Disease:C0033975		N05AH03	rs4410790:T	74603552
clopidogrel	rs6785930	P2RY12	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6785930:AA	13748464
clopidogrel	rs6785930	P2RY12	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6785930:AG	13748464
aspirin, clopidogrel	rs3737224	PEAR1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs3737224:T	2244
aspirin, clopidogrel	rs3093135	CYP4F2	T	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs3093135:T	2244
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G	444899
venlafaxine	rs5030655	CYP2D6	del	Metabolism/PK	Indeterminado	LADME	Disease:C0011581		N06AX16	rs5030655:del	9795857
aspirin, ticagrelor	rs3093135	CYP4F2	T	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC24	rs3093135:T	2244
clopidogrel	rs6809699	P2RY12	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6809699:AA	13748464
clopidogrel	rs6809699	P2RY12	AC	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs6809699:AC	13748464
cisplatin, doxorubicin	rs2720376	CASP3	C	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs2720376:C	5460033
ace inhibitors, plain	rs3788853	XPNPEP2	A	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs3788853:A	No_match
hmg coa reductase inhibitors	rs59502379	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs59502379:C	445127
capecitabine	rs2244613	CES1	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GG	11809635
capecitabine	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GT	11809635
nevirapine	rs1265112	CCHCR1	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs1265112:C	15979285
cisplatin, doxorubicin	rs4646437	CYP3A4	A	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs4646437:A	5460033
none	rs2228226	GLI1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024121		A03DA02	rs2228226:CC	5282367
nicotine	rs1800497	ANKK1, DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AA	936
nicotine	rs1800497	ANKK1, DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AG	936
valproic acid	rs2070959	UGT1A6	AG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs2070959:AG	134459
valproic acid	rs2070959	UGT1A6	GG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs2070959:GG	134459
escitalopram	rs4646425	CYP1A2	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646425:T	162180
clozapine	rs2814778	ACKR1	CC	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs2814778:CC	131769989
escitalopram	rs2069521	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs2069521:A	162180
aspirin, clopidogrel	rs41273215	PEAR1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AC04	rs41273215:T	2244
escitalopram	rs4646427	CYP1A2	C	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646427:C	162180
escitalopram	rs2069521	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs2069521:A	162180
escitalopram	rs4646425	CYP1A2	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646425:T	162180
escitalopram	rs4646427	CYP1A2	C	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB10	rs4646427:C	162180
allopurinol	rs3099844	CYCSP5	AA	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AA	168354693
allopurinol	rs3099844	CYCSP5	AC	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AC	168354693
clopidogrel	rs762551	CYP1A2	AA	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Other:cigarette_smokers		B01AC04	rs762551:AA	13748464
clopidogrel	rs762551	CYP1A2	AC	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Other:cigarette_smokers		B01AC04	rs762551:AC	13748464
ethanol	rs6473797	OPRK1	CC	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6473797:CC	444899
ethanol	rs6473797	OPRK1	CT	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6473797:CT	444899
cyclophosphamide, doxorubicin	rs1800566	NQO1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs1800566:A	2907
heroin	rs274618	GRM3	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs274618:T	9844225
thiazolidinediones	rs296766	AQP2	T	Toxicity	increased	Adverse_Event	Disease:C0011849		A10BG	rs296766:T	5437
ethanol	rs578776	CHRNA3	G	Toxicity, Other	decreased	Adverse_Event	Healthy		V03AB16	rs578776:G	444899
cisplatin, doxorubicin	rs939338	ABCC5	G	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs939338:G	5460033
cisplatin, doxorubicin	rs763110	FASLG	T	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs763110:T	5460033
cisplatin, doxorubicin	rs4638843	MSH2	C	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01DB01|L01XA01	rs4638843:C	5460033
selective serotonin reuptake inhibitors	rs3087879	SLC1A1	C	Efficacy	increased	Adverse_Event	Disease:C0028768		N06AB	rs3087879:C	5202
cocaine	rs684513	CHRNA5	G	Other	increased	Adverse_Event	Healthy		N01BC01	rs684513:G	2826
ace inhibitors, plain	rs3788853	XPNPEP2	A	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs3788853:A	No_match
allopurinol	rs2734583	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs2734583:AG	168354693
allopurinol	rs2734583	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs2734583:GG	168354693
methotrexate	rs717620	ABCC2	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:CT	11329481
methotrexate	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:TT	11329481
allopurinol	rs9263726	PSORS1C1	AA	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:AA	168354693
allopurinol	rs9263726	PSORS1C1	AG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:AG	168354693
fexofenadine	rs2306168	SLCO2B1	T	Metabolism/PK	decreased	LADME	Healthy		R06AX26	rs2306168:T	63002
antineoplastic agents	rs17343066	SLC28A3	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs17343066:AA	No_match
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
clozapine	rs116982346	TRAT1	C	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs116982346:C	131769989
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT	1268107
efavirenz	rs8192726	CYP2A6	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192726:AC	64139
efavirenz	rs8192726	CYP2A6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192726:CC	64139
cyclophosphamide, doxorubicin, fluorouracil	rs2740574	CYP3A4	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2740574:CC	2907
cyclophosphamide, doxorubicin, fluorouracil	rs2740574	CYP3A4	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2740574:CT	2907
none	rs1789891	ADH1B	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs1789891:A	5282367
antineoplastic agents	rs12067645	DCTD	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs12067645:AA	No_match
efavirenz	rs7439366	UGT2B7	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs7439366:CC	64139
efavirenz	rs7439366	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs7439366:CT	64139
mercaptopurine	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs1051266:TT	1268107
fluorouracil, leucovorin, oxaliplatin	rs13181	ERCC2	G	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01XA03	rs13181:G	135403648
clozapine	rs377360	TRAC	A	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs377360:A	131769989
nevirapine	rs746647	CCHCR1	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs746647:G	15979285
none	rs2245964	FGFBP1	CC	Other	increased	Other	Healthy		A03DA02	rs2245964:CC	5282367
acenocoumarol	rs9923231	VKORC1	CT	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AA07	rs9923231:TT	54742534
none	rs16892645	FGFBP1	TT	Other	increased	Other	Healthy		A03DA02	rs16892645:TT	5282367
atorvastatin	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:GG	656846
none	rs2824292	__INTRONIC__	G	Other	increased	Adverse_Event	Disease:C0027051		A03DA02	rs2824292:G	5282367
nevirapine	rs6545803	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs6545803:G	15979285
nicotine	rs10912675	FMO1	C	Other	increased	Adverse_Event	Healthy		N07BA01	rs10912675:C	936
nevirapine	rs2562519	POLR3G	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2562519:T	15979285
nicotine	rs7877	FMO1	T	Other	increased	Adverse_Event	Healthy		N07BA01	rs7877:T	936
asparaginase	rs4958381	GRIA1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs4958381:T	6267
paclitaxel	rs743572	CYP17A1	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs743572:AG	36314
paclitaxel	rs743572	CYP17A1	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs743572:GG	36314
acenocoumarol	rs1057910	CYP2C9	C	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AA07	rs1057910:C	54742534
cisplatin, fluorouracil	rs3212986	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs3212986:AA	5460033
cisplatin, fluorouracil	rs3212986	ERCC1	AC	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs3212986:AC	5460033
doxorubicin	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AA	83958
doxorubicin	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AG	83958
anastrozole, letrozole	rs2073618	TNFRSF11B	CC	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG03|L02BG04	rs2073618:CC	3902
carboplatin, docetaxel, paclitaxel	rs139887	SOX10	CG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs139887:CG	10339178
anastrozole, letrozole	rs2073618	TNFRSF11B	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG03|L02BG04	rs2073618:CC	3902
anastrozole, letrozole	rs7984870	TNFSF11	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG03|L02BG04	rs7984870:CC	3902
antineoplastic agents	rs12067645	CTPS1	A	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs12067645:A	No_match
doxorubicin	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AA	83958
doxorubicin	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AG	83958
antineoplastic agents	rs12067645	CTPS1	A	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs12067645:A	No_match
capecitabine	rs11075646	CES2	CG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs11075646:CG	11809635
capecitabine	rs11075646	CES2	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs11075646:GG	11809635
warfarin	rs9923231	VKORC1	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004238		B01AA03	rs9923231:T	54688261
anastrozole, letrozole	rs7984870	TNFSF11	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG03|L02BG04	rs7984870:CC	3902
drugs for treatment of tuberculosis	rs4880	SOD2	AG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs4880:AG	No_match
drugs for treatment of tuberculosis	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs4880:GG	No_match
"""analgesics and anesthetics"", ""antibiotics"", ""antiepileptics"", ""antifungals for systemic use"", ""antiinflammatory and antirheumatic products, non-steroids"", ""antimycobacterials"", ""antithyroid preparations"""	rs4880	SOD2	AG	Toxicity	increased	Adverse_Event	Healthy		D01BA|H03B|J04|M01|N03A|S01AA|S02DA	rs4880:AG	No_match
"""analgesics and anesthetics"", ""antibiotics"", ""antiepileptics"", ""antifungals for systemic use"", ""antiinflammatory and antirheumatic products, non-steroids"", ""antimycobacterials"", ""antithyroid preparations"""	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Healthy		D01BA|H03B|J04|M01|N03A|S01AA|S02DA	rs4880:GG	No_match
doxorubicin	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AA	83958
doxorubicin	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs4244285:AG	83958
metformin	rs1801282	PPARG	G	Other	increased	Adverse_Event	Healthy		A10BA02	rs1801282:G	155906370
mitotane	rs3745274	CYP2B6	GT	Metabolism/PK	Indeterminado	LADME	Disease:C1370740		L01XX23	rs3745274:GT	4211
mitotane	rs3745274	CYP2B6	TT	Metabolism/PK	Indeterminado	LADME	Disease:C1370740		L01XX23	rs3745274:TT	4211
bortezomib, melphalan, prednisone	rs4553808	CTLA4	GG	Toxicity	Indeterminado	Adverse_Event	Disease:Multiple_Myeloma		H02AB07|L01AA03|L01XG01	rs4553808:GG	5865
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
none	rs1876828	CRHR1	TT	Metabolism/PK	decreased	LADME	Disease:C0004096		A03DA02	rs1876828:TT	5282367
efavirenz	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
valproic acid	rs4880	SOD2	AG	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs4880:AG	134459
valproic acid	rs4880	SOD2	GG	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs4880:GG	134459
none	rs1045642	ABCB1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1045642:AA	5282367
valproic acid	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:AG	134459
valproic acid	rs1137101	LEPR	GG	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs1137101:GG	134459
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Other	Healthy		B01AC04	rs4244285:A	13748464
capecitabine	rs10916825	CDA	AG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs10916825:AG	11809635
capecitabine	rs10916825	CDA	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs10916825:GG	11809635
antineoplastic agents	rs4148737	ABCB1	CC	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs4148737:CC	No_match
antineoplastic agents	rs4148737	ABCB1	CT	Toxicity	decreased	Adverse_Event	Other:C0023449		L01	rs4148737:CT	No_match
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:C	445127
clopidogrel, ticagrelor	rs3093135	CYP4F2	TT	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04|B01AC24	rs3093135:TT	9871419
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
deferasirox	rs3806596	UGT1A3	CC	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs3806596:CC	214348
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs13181	ERCC2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs13181:GG	5460033
deferasirox	rs887829	UGT1A1	TT	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs887829:TT	214348
metformin	rs12943590	SLC47A2	AA	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12943590:AA	155906370
metformin	rs12943590	SLC47A2	AG	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12943590:AG	155906370
metformin	rs12943590	SLC47A2	AA	Efficacy	decreased	Efficacy_Response	Healthy		A10BA02	rs12943590:AA	155906370
capecitabine	rs2244613	CES1	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GG	11809635
capecitabine	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GT	11809635
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	decreased	LADME	Disease:C0028754		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	decreased	LADME	Disease:C0028754		C10AA05	rs4149056:CT	656846
capecitabine	rs2244613	CES1	GG	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GG	11809635
capecitabine	rs2244613	CES1	GT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC06	rs2244613:GT	11809635
deferasirox	rs762551	CYP1A2	AA	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs762551:AA	214348
antineoplastic agents	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs776746:T	No_match
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs13181	ERCC2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs13181:GG	5460033
deferasirox	rs2606345	CYP1A1	CC	Efficacy	decreased	Adverse_Event	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:CC	214348
heroin	rs274622	GRM3	C	Other	increased	Adverse_Event	Healthy		No_ATC	rs274622:C	9844225
efavirenz	rs3842	ABCB1	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:CC	64139
efavirenz	rs3842	ABCB1	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:CT	64139
ethanol	rs1044394	CHRNA4	G	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1044394:G	444899
hormonal contraceptives for systemic use	rs1799963	F2	AG	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799963:AG	No_match
opioids	rs2249015	ENPP2	AA	Efficacy	increased	Adverse_Event	Other:C0027651		N02A	rs2249015:AA	No_match
hormonal contraceptives for systemic use	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:CT	No_match
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs25487	XRCC1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs25487:CT	5460033
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs25487:TT	5460033
aspirin	rs2228079	ADORA1	GG	Toxicity	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2228079:GG	72204814
aspirin	rs2228079	ADORA1	GT	Toxicity	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2228079:GT	72204814
lovastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA02	rs4149056:CC	40474546
methotrexate	rs1801131	MTHFR	GG	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GG	11329481
methotrexate	rs1801131	MTHFR	GT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GT	11329481
methotrexate	rs1801394	FASTKD3, MTRR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801394:AG	11329481
methotrexate	rs1801394	FASTKD3, MTRR	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801394:GG	11329481
fluorouracil	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs56038477:T	5790
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG	11329481
propranolol	rs1065852	CYP2D6	AA	Metabolism/PK	increased	LADME	Healthy		C07AA05	rs1065852:AA	135862
capecitabine, fluorouracil	rs6668296	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs6668296:T	60953
clozapine	rs113332494	HLA-DQB1	G	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs113332494:G	131769989
capecitabine, cisplatin, docetaxel, epirubicin, gemcitabine	rs1799793	ERCC2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05|L01BC06|L01CD02|L01DB03|L01XA01	rs1799793:CC	5460033
none	rs7412	APOE	CT	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs7412:CT	5282367
none	rs7412	APOE	TT	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs7412:TT	5282367
capecitabine, fluorouracil	rs115349832	DPYD	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs115349832:C	60953
metformin	rs1801282	PPARG	G	Other	increased	Adverse_Event	Healthy		A10BA02	rs1801282:G	155906370
none	rs429358	APOE	CC	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs429358:CC	5282367
none	rs429358	APOE	CT	Other	increased	Other	Other:C0010068|Other:C0020538		A03DA02	rs429358:CT	5282367
clozapine	rs113332494	HLA-DQB1	G	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs113332494:G	131769989
simvastatin	rs429358	APOE	C	Efficacy	increased	Adverse_Event	Healthy		C10AA01	rs429358:C	14373154
clozapine, haloperidol, olanzapine, risperidone	rs518147	HTR2C	G	Other	increased	Adverse_Event	Disease:C0036341		N05AD01|N05AH02|N05AH03|N05AX08	rs518147:G	135398737
amisulpride, clozapine, haloperidol, iloperidone, olanzapine, quetiapine, risperidone, ziprasidone	rs3813929	HTR2C	C	Other	increased	Adverse_Event	Healthy		N05AD01|N05AE04|N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs3813929:C	60854
heroin	rs5746136	SOD2	TT	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs5746136:TT	9844225
opioids	rs7832704	ENPP2	A	Efficacy	increased	Adverse_Event	Other:C0027651		N02A	rs7832704:A	No_match
carboplatin, docetaxel, paclitaxel	rs2849380	BCL2	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs2849380:TT	10339178
carboplatin, docetaxel, paclitaxel	rs544093	OPRM1	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs544093:TT	10339178
carboplatin, docetaxel, paclitaxel	rs879207	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD01|L01CD02|L01XA02	rs879207:AG	10339178
tolcapone	rs4680	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Other:abstinent_smokers		N04BX01	rs4680:GG	4659569
dolasetron, granisetron	rs10494366	NOS1AP	GT	Toxicity	increased	Adverse_Event	Other:surgery_as_part_of_anesthetic_management		A04AA02|A04AA04	rs10494366:GT	3033818
dolasetron, granisetron	rs10494366	NOS1AP	TT	Toxicity	increased	Adverse_Event	Other:surgery_as_part_of_anesthetic_management		A04AA02|A04AA04	rs10494366:TT	3033818
sunitinib	rs2032582	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2032582:A	11221549
capecitabine, fluorouracil	rs56276561	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs56276561:T	60953
clozapine	rs73482673	ELAVL2	A	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs73482673:A	131769989
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
fluorouracil	rs2297595	DPYD	CC	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs2297595:CC	5790
fluorouracil	rs2297595	DPYD	CT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs2297595:CT	5790
docetaxel	rs4149118	SLCO1B3	G	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs4149118:G	154272
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
tolcapone	rs4680	COMT	AG	Efficacy	decreased	Efficacy_Response	Other:abstinent_smokers		N04BX01	rs4680:AG	4659569
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
heroin	rs2758339	SOD2	AC	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2758339:AC	9844225
heroin	rs2758339	SOD2	CC	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs2758339:CC	9844225
docetaxel	rs11045585	SLCO1B3	G	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs11045585:G	154272
docetaxel	rs7311358	SLCO1B3	A	Other, Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs7311358:A	154272
irinotecan	rs6072262	TOP1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs6072262:GG	74990
warfarin	rs679899	APOB	G	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs679899:G	54688261
erlotinib	rs712829	EGFR	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB02	rs712829:GG	176870
erlotinib	rs2622604	ABCG2	CC	Other, Metabolism/PK	decreased	LADME	Healthy		L01EB02	rs2622604:CC	176870
warfarin	rs1367117	APOB	G	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs1367117:G	54688261
capecitabine, fluorouracil	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs56038477:T	60953
morphine	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027651		N02AA01	rs1799971:AA	5284371
morphine	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027651		N02AA01	rs1045642:AA	5284371
phenytoin	rs1045642	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03AB02	rs1045642:G	1775
atorvastatin, fluvastatin, hmg coa reductase inhibitors, pravastatin, rosuvastatin, simvastatin	rs4149056	SLCO1B1	C	Toxicity	Indeterminado	Adverse_Event	Healthy		C10AA|C10AA01|C10AA03|C10AA04|C10AA05|C10AA07	rs4149056:C	60823
aspirin, clopidogrel	rs1061781	B4GALT2	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs1061781:CT	2244
aspirin, clopidogrel	rs1061781	B4GALT2	TT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs1061781:TT	2244
leflunomide	rs1790834	CYB5A	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		No_ATC	rs1790834:AA	54684141
leflunomide	rs1790834	CYB5A	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		No_ATC	rs1790834:AG	54684141
hormonal contraceptives for systemic use	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:CT	No_match
nevirapine	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs28399499:CT	15979285
nevirapine	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:T	15979285
cetuximab, panitumumab	rs61764370	KRAS	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0001418		No_ATC	rs61764370:C	No_match
edoxaban	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149056:CC	118753694
edoxaban	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149056:CT	118753694
cyclosporine	rs1045642	ABCB1	GG	Efficacy, Metabolism/PK	decreased	LADME	Disease:C0277631		L04AD01	rs1045642:GG	86666680
bleomycin	rs1050565	BLMH	CC	Efficacy	decreased	Efficacy_Response	Disease:C0039591		L01DC01	rs1050565:CC	5360373
cisplatin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C0039591		L01XA01	rs1695:AA	441203
cisplatin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01XA01	rs1695:AG	441203
citalopram	rs4713916	FKBP5	A	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB04	rs4713916:A	162180
opioids	rs10770141	TH	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770141:AA	No_match
opioids	rs10770141	TH	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770141:AG	No_match
disulfiram	rs1611115	DBH	CC	Efficacy	decreased	Adverse_Event	Other:C0278080|Other:C0036502		N07BB01	rs1611115:CC	101405
opioids	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02A	rs4680:AA	No_match
none	rs2010963	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0027651		A03DA02	rs2010963:CC	5282367
none	rs2010963	VEGFA	CG	Efficacy	increased	Efficacy_Response	Disease:C0027651		A03DA02	rs2010963:CG	5282367
sofosbuvir, velpatasvir, voxilaprevir	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP08|J05AP55|J05AP56	rs12979860:CT	91885554
sofosbuvir, velpatasvir, voxilaprevir	rs12979860	IFNL3, IFNL4	TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP08|J05AP55|J05AP56	rs12979860:TT	91885554
opioids	rs10770140	TH	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770140:CT	No_match
opioids	rs10770140	TH	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs10770140:TT	No_match
phenytoin	rs1128503	ABCB1	A	Other, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs1128503:A	1775
phenytoin	rs1045642	ABCB1	A	Other, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs1045642:A	1775
anthracyclines and related substances	rs1056892	CBR3	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs1056892:GG	No_match
dexmedetomidine	rs9922316	PRKCB	T	Other	increased	Other	Healthy		N05CM18	rs9922316:T	6918081
prasugrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC22	rs12248560:T	24757771
cyclosporine	rs2229109	ABCB1	CC	Efficacy, Metabolism/PK	increased	LADME	Disease:C0277631		L04AD01	rs2229109:CC	86666680
prasugrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC22	rs12248560:T	24757771
hmg coa reductase inhibitors	rs10455872	LPA	G	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:G	445127
efavirenz	rs28399499	CYP2B6	C	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C	64139
prasugrel	rs12248560	CYP2C19	T	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC22	rs12248560:T	24757771
nicotine	rs686	DRD1	A	Efficacy, Toxicity, Other	increased	Adverse_Event	Other:smokers		N07BA01	rs686:A	936
prasugrel	rs12248560	CYP2C19	T	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC22	rs12248560:T	24757771
antipsychotics	rs1799732	DRD2	del	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1799732:del	No_match
mitotane	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:C1370740		L01XX23	rs3745274:GT	4211
mitotane	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:C1370740		L01XX23	rs3745274:TT	4211
nicotine	rs4532	DRD1	T	Efficacy, Toxicity, Other	increased	Adverse_Event	Other:smokers		N07BA01	rs4532:T	936
repaglinide	rs16889462	SLC30A8	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs16889462:AG	22132924
atazanavir, ritonavir	rs17863778	UGT1A7	AA	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs17863778:AA	25134325
bevacizumab	rs5370	EDN1	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01FG01	rs5370:TT	No_match
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	T	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs2278294:T	5281078
atazanavir, ritonavir	rs3806596	UGT1A3	CC	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs3806596:CC	25134325
gefitinib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01EB01	rs1128503:AA	135496227
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	T	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs2278294:T	5281078
atazanavir, ritonavir	rs7586110	UGT1A7	GG	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs7586110:GG	25134325
oxaliplatin	rs13181	ERCC2, KLC3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs13181:GG	9887054
oxaliplatin	rs13181	ERCC2, KLC3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs13181:GT	9887054
aprepitant, olanzapine	rs6766410	HTR3C	CC	Efficacy	increased	Adverse_Event	Other:C0027651		A04AD12|N05AH03	rs6766410:CC	135413536
atazanavir, ritonavir	rs17868323	UGT1A7	GG	Toxicity, Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AE08	rs17868323:GG	25134325
bevacizumab	rs3025039	VEGFA	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01FG01	rs3025039:TT	No_match
aprepitant, olanzapine	rs1801131	MTHFR	TT	Efficacy	decreased	Adverse_Event	Other:C0027651		A04AD12|N05AH03	rs1801131:TT	135413536
aprepitant, olanzapine	rs7943062	HTR3B	GG	Efficacy	decreased	Adverse_Event	Other:C0027651		A04AD12|N05AH03	rs7943062:GG	135413536
tafenoquine	rs62103056	__INTRONIC__	A	Efficacy	increased	Adverse_Event	Other:C0024530|Vivax		No_ATC	rs62103056:A	163761
methotrexate	rs719235	GGH	CC	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs719235:CC	11329481
timolol	rs1801252	ADRB1	AA	Other	increased	Other	Healthy		S01ED01	rs1801252:AA	33624
cisplatin	rs2228171	LRP2	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs2228171:G	441203
disulfiram	rs1611115	DBH	CT	Toxicity	increased	Adverse_Event	Other:C0085762		N07BB01	rs1611115:CT	101405
disulfiram	rs1611115	DBH	TT	Toxicity	increased	Adverse_Event	Other:C0085762		N07BB01	rs1611115:TT	101405
fentanyl, propofol, remifentanil, sevoflurane	rs1042718	ADRB2	AA	Toxicity	increased	Adverse_Event	Healthy		N01AB08|N01AH06|N01AX10|N02AB03	rs1042718:AA	5206
rosuvastatin	rs2231142	ABCG2	T	Efficacy	Indeterminado	Adverse_Event	Healthy		C10AA07	rs2231142:T	5282455
none	rs13266634	SLC30A8	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs13266634:C	5282367
thiazides, plain	rs34550074	SLCO2A1	T	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C03A	rs34550074:T	No_match
rosuvastatin	rs1736557	FMO3	A	Efficacy	Indeterminado	Adverse_Event	Healthy		C10AA07	rs1736557:A	5282455
warfarin	rs699664	GGCX	C	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs699664:C	54688261
cisplatin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Disease:C0017636		L01XA01	rs1695:AG	441203
cisplatin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0017636		L01XA01	rs1695:GG	441203
warfarin	rs11676382	GGCX	G	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs11676382:G	54688261
methylphenidate	rs4680	COMT	A	Toxicity	increased	Adverse_Event	Other:C1263846|Other:C0015923		N06BA04	rs4680:A	154100
antiepileptics	rs2304016	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2304016:A	No_match
warfarin	rs11676382	GGCX	G	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs11676382:G	54688261
warfarin	rs1800566	NQO1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1800566:AA	54688261
warfarin	rs1800566	NQO1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1800566:AG	54688261
antithyroid preparations, methimazole, propylthiouracil	rs2734565	KLRC4	C	Toxicity	increased	Adverse_Event	Other:C0242656		H03B|H03BA02	rs2734565:C	657298
oxaliplatin	rs11615	ERCC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs11615:AA	9887054
fluorouracil	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs1801133:AA	5790
fluorouracil	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs1801133:AG	5790
ace inhibitors, plain	rs4267385	__INTRONIC__	CC	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4267385:CC	No_match
ace inhibitors, plain	rs4267385	__INTRONIC__	CT	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4267385:CT	No_match
ace inhibitors, plain	rs4459610	__INTRONIC__	AA	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4459610:AA	No_match
ace inhibitors, plain	rs4459610	__INTRONIC__	AT	Other	Indeterminado	Other	Other:homozygous_GG_genotype_for_rs4343		A03B|C09A	rs4459610:AT	No_match
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AG	11329481
ace inhibitors, plain	rs8016905	BDKRB2	AG	Toxicity	Indeterminado	Adverse_Event	Healthy		A03B|C09A	rs8016905:AG	No_match
none	rs6025	F5	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs6025:C	5282367
carboplatin, paclitaxel	rs7950311	TRIM5	C	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01CD01|L01XA02	rs7950311:C	10339178
none	rs1801131	MTHFR	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801131:G	5282367
antineoplastic agents	rs6674079	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01	rs6674079:G	No_match
none	rs1801133	MTHFR	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801133:G	5282367
carboplatin, paclitaxel	rs2549714	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01CD01|L01XA02	rs2549714:C	10339178
none	rs2227631	SERPINE1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs2227631:A	5282367
antineoplastic agents	rs4910232	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01	rs4910232:G	No_match
warfarin	rs2108622	CYP4F2	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2108622:TT	54688261
aspirin	rs3856806	PPARG	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3856806:TT	72204814
cyclosporine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AA	86666680
antineoplastic agents	rs3795247	ZNF100	C	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01	rs3795247:C	No_match
warfarin	rs9923231	VKORC1	T	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:T	54688261
aspirin	rs1126510	PTGIR	AG	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1126510:AG	72204814
aspirin	rs1126510	PTGIR	GG	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1126510:GG	72204814
warfarin	rs9923231	VKORC1	CT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
aspirin	rs1131882	TBXA2R	GG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1131882:GG	72204814
aspirin	rs7551789	PTGER3	A	Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7551789:A	72204814
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
aspirin	rs1353411	PTGER2	GG	Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1353411:GG	72204814
aspirin	rs2075797	PTGER2	G	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs2075797:G	72204814
docetaxel, paclitaxel	rs2740574	CYP3A4	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01CD02	rs2740574:CC	36314
doxorubicin	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1045642:AA	83958
doxorubicin	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L01DB01	rs1045642:AG	83958
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:TT	54688261
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG	13748464
clopidogrel	rs4244285	CYP2C19	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:GG	13748464
aspirin	rs3856806	PPARG	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3856806:TT	72204814
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4986893:AG	13748464
clopidogrel	rs4986893	CYP2C19	GG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4986893:GG	13748464
aspirin, clopidogrel	rs74569896	NECAB1	G	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs74569896:G	2244
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4244285:AG	13748464
clopidogrel	rs4244285	CYP2C19	GG	Efficacy	Indeterminado	Efficacy_Response	Other:undergoing_scheduled_percutaneous_coronary_intervention		B01AC04	rs4244285:GG	13748464
warfarin	rs9923231	VKORC1	T	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T	54688261
warfarin	rs1799853	CYP2C9	T	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1799853:T	54688261
aspirin, clopidogrel	rs4736529	EFR3A	G	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs4736529:G	2244
docetaxel, paclitaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01CD02	rs1045642:AA	36314
gemcitabine	rs2242046	SLC28A1	GG	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05	rs2242046:GG	597
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T	54688261
warfarin	rs1057910	CYP2C9	C	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1057910:C	54688261
gemcitabine	rs1048977	CDA	CC	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs1048977:CC	597
gemcitabine	rs1048977	CDA	CT	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs1048977:CT	597
paclitaxel	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01	rs1045642:AA	36314
paclitaxel	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L01CD01	rs1045642:AG	36314
hmg coa reductase inhibitors	rs10455872	LPA	AG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:AG	445127
hmg coa reductase inhibitors	rs10455872	LPA	GG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:GG	445127
hmg coa reductase inhibitors	rs10455872	LPA	AG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:AG	445127
hmg coa reductase inhibitors	rs10455872	LPA	GG	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs10455872:GG	445127
cytarabine	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1128503:GG	6918130
hmg coa reductase inhibitors	rs10455872	LPA	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:AG	445127
hmg coa reductase inhibitors	rs10455872	LPA	GG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:GG	445127
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799930	NAT2	AA	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:AA	135483892
hmg coa reductase inhibitors	rs10455872	LPA	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:AG	445127
hmg coa reductase inhibitors	rs10455872	LPA	GG	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA	rs10455872:GG	445127
pravastatin	rs2032582	ABCB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs2032582:CC	58746970
gemcitabine	rs1044457	CMPK1	CC	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC05	rs1044457:CC	597
aspirin, clopidogrel	rs11640115	WDR24	G	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs11640115:G	2244
gemcitabine	rs4655226	CDA	CC	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs4655226:CC	597
carboplatin, paclitaxel	rs1801368	MAD1L1	CT	Other	decreased	Other	Disease:C0919267		L01CD01|L01XA02	rs1801368:CT	10339178
carboplatin, paclitaxel	rs1801368	MAD1L1	TT	Other	decreased	Other	Disease:C0919267		L01CD01|L01XA02	rs1801368:TT	10339178
varenicline	rs901886	ICAM5	T	Toxicity	increased	Adverse_Event	Other:C0039338|Other:C0558401		N07BA03	rs901886:T	6918678
methotrexate	rs2238476	ABCC1	AG	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs2238476:AG	11329481
mitoxantrone	rs1128503	ABCB1	AA	Other	increased	Other	Healthy		L01DB07	rs1128503:AA	51082
mercaptopurine, methotrexate	rs61886492	FOLH1	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs61886492:A	126941
cytarabine	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs2032582:CC	6918130
ethambutol, isoniazid / pyrazinamide / rifampin	rs1041983	NAT2	TT	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1041983:TT	135483892
nevirapine	rs28399499	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:C	15979285
none	rs135561	PPARA	AA	Other	decreased	Adverse_Event	Disease:C0027051		A03DA02	rs135561:AA	5282367
none	rs135561	PPARA	AG	Other	decreased	Adverse_Event	Disease:C0027051		A03DA02	rs135561:AG	5282367
clozapine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs1045642:AA	131769989
drugs for treatment of tuberculosis, isoniazid	rs1495741	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A|J04AC01	rs1495741:AA	3767
methotrexate	rs4673993	ATIC	C	Efficacy	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs4673993:C	11329481
drugs for treatment of tuberculosis, isoniazid	rs1495741	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04A|J04AC01	rs1495741:AA	3767
antivirals for treatment of hiv infections, combinations	rs5128	APOC3	CG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs5128:CG	No_match
antivirals for treatment of hiv infections, combinations	rs5128	APOC3	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs5128:GG	No_match
fluticasone propionate	rs35599367	CYP3A4	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03BA05	rs35599367:AA	5311101
fluticasone propionate	rs35599367	CYP3A4	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03BA05	rs35599367:AG	5311101
allopurinol	rs9263745	CCHCR1	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263745:A	168354693
letrozole	rs74418677	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG04	rs74418677:C	10466550
ace inhibitors, plain	rs5186	AGTR1	C	Toxicity	increased	Adverse_Event	Disease:C1956346		A03B|C09A	rs5186:C	No_match
cytarabine, daunorubicin, etoposide, mitoxantrone	rs2291075	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01CB01|L01DB02|L01DB07	rs2291075:CT	6253
cytarabine, daunorubicin, etoposide, mitoxantrone	rs2291075	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01CB01|L01DB02|L01DB07	rs2291075:TT	6253
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CC	131769926
cyclosporine	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AA	86666680
cyclosporine	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AG	86666680
allopurinol	rs3099844	CYCSP5	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:A	168354693
methotrexate	rs3761548	FOXP3	GT	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs3761548:GT	11329481
none	rs1880676	CHAT	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs1880676:G	5282367
antivirals for treatment of hiv infections, combinations	rs139961185	SIK3	AA	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs139961185:AA	No_match
antivirals for treatment of hiv infections, combinations	rs139961185	SIK3	AG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs139961185:AG	No_match
oxaliplatin	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs25487:TT	9887054
cyclosporine	rs35599367	CYP3A4	AA	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AA	86666680
cyclosporine	rs35599367	CYP3A4	AG	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs35599367:AG	86666680
metformin	rs622342	SLC22A1	AA	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs622342:AA	155906370
allopurinol	rs9263733	PSORS1C2	T	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263733:T	168354693
cyclosporine	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AA	86666680
cyclosporine	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AG	86666680
methotrexate	rs13120400	ABCG2	CT	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs13120400:CT	11329481
methotrexate	rs13120400	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0235763		L04AX03	rs13120400:TT	11329481
allopurinol	rs9263726	PSORS1C1, PSORS1C2	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:A	168354693
drugs for treatment of tuberculosis	rs1495741	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs1495741:AA	No_match
exemestane, letrozole	rs912571	__INTRONIC__	G	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BG04|L02BG06	rs912571:G	3902
antivirals for treatment of hiv infections, combinations	rs964184	APOA5	CG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs964184:CG	No_match
antivirals for treatment of hiv infections, combinations	rs964184	APOA5	GG	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AP|S02DA30	rs964184:GG	No_match
valproic acid	rs2307441	POLG	C	Toxicity	increased	Adverse_Event	Healthy		N03AG01	rs2307441:C	134459
cisplatin, cyclophosphamide	rs698	ADH1C	CT	Efficacy	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs698:CT	2907
exemestane, letrozole	rs79048288	CCDC148	T	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG04|L02BG06	rs79048288:T	3902
oxaliplatin	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1695:GG	9887054
atorvastatin, lovastatin, simvastatin	rs35599367	CYP3A4	AA	Dosage, Metabolism/PK	decreased	Other	Healthy		C10AA01|C10AA02|C10AA05	rs35599367:AA	60823
atorvastatin, lovastatin, simvastatin	rs35599367	CYP3A4	AG	Dosage, Metabolism/PK	decreased	Other	Healthy		C10AA01|C10AA02|C10AA05	rs35599367:AG	60823
valproic acid	rs3087374	POLG	A	Toxicity	increased	Adverse_Event	Healthy		N03AG01	rs3087374:A	134459
edoxaban	rs2306283	SLCO1B1	GG	Toxicity	decreased	Adverse_Event	Healthy		B01AF03	rs2306283:GG	118753694
edoxaban	rs3842	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs3842:CC	118753694
hydrochlorothiazide	rs4961	ADD1	TT	Other	increased	Other	Disease:C0020538		C03AA03	rs4961:TT	2904
edoxaban	rs999278	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs999278:AA	118753694
edoxaban	rs999278	SLCO1B1	AC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs999278:AC	118753694
levodopa	rs6280	DRD3	TT	Toxicity	increased	Adverse_Event	Disease:C0030567		N04BA02	rs6280:TT	9307
levodopa	rs1799732	DRD2	GG	Toxicity	increased	Adverse_Event	Side_Effect:C0030567		N04BA02	rs1799732:GG	9307
busulfan, cyclophosphamide	rs1021737	CTH	TT	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01|L01AB01	rs1021737:TT	2907
furosemide, spironolactone	rs1799998	CYP11B2	AA	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs1799998:AA	5833
furosemide, spironolactone	rs1799998	CYP11B2	AG	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs1799998:AG	5833
edoxaban	rs4149057	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149057:CC	118753694
edoxaban	rs4149057	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AF03	rs4149057:CT	118753694
simvastatin	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2032582:AA	14373154
simvastatin	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2032582:AC	14373154
furosemide, spironolactone	rs4341	ACE	CG	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4341:CG	5833
furosemide, spironolactone	rs4341	ACE	GG	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4341:GG	5833
simvastatin	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs1045642:AA	14373154
atorvastatin	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs2070744:CC	656846
atorvastatin	rs2070744	NOS3	CC	Other	increased	Other	Healthy		C10AA05	rs2070744:CC	656846
paroxetine	rs2472304	CYP1A2	A	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB05	rs2472304:A	667572
furosemide, spironolactone	rs4961	ADD1	GT	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4961:GT	5833
furosemide, spironolactone	rs4961	ADD1	TT	Efficacy	increased	Adverse_Event	Disease:Liver_Cirrhosis		C03CA01|C03DA01	rs4961:TT	5833
paroxetine	rs4646425	CYP1A2	T	Efficacy	decreased	Adverse_Event	Disease:C0011581		N06AB05	rs4646425:T	667572
atorvastatin	rs2032582	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA05	rs2032582:AA	656846
cisplatin, doxorubicin	rs11615	ERCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01|L01XA01	rs11615:AA	5460033
methamphetamine	rs4790694	ARRB2	C	Other	increased	Adverse_Event	Healthy		No_ATC	rs4790694:C	36604
methotrexate	rs2231142	ABCG2	GT	Toxicity	decreased	Adverse_Event	Other:C0029463		L04AX03	rs2231142:GT	11329481
paroxetine	rs2470890	CYP1A2	T	Efficacy	increased	Adverse_Event	Disease:C0011581		N06AB05	rs2470890:T	667572
peginterferon alfa-2a, ribavirin	rs10846744	SCARB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs10846744:GG	37542
platinum compounds, radiotherapy	rs1829346	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs1829346:AA	23939
cisplatin, doxorubicin	rs4673	CYBA	AA	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01|L01XA01	rs4673:AA	5460033
cisplatin, doxorubicin	rs4673	CYBA	AG	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01|L01XA01	rs4673:AG	5460033
atorvastatin	rs1128503	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1128503:AA	656846
clozapine	rs4244285	CYP2C19	AA	Other, Metabolism/PK	increased	LADME	Healthy		N05AH02	rs4244285:AA	131769989
atorvastatin	rs1045642	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1045642:AA	656846
prasugrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC22	rs4244285:A	24757771
irinotecan	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs2306283:GG	74990
platinum compounds, radiotherapy	rs2027701	__INTRONIC__	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01XA	rs2027701:AG	23939
platinum compounds, radiotherapy	rs2027701	__INTRONIC__	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01XA	rs2027701:GG	23939
simvastatin	rs1128503	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA01	rs1128503:AA	14373154
prasugrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC22	rs4244285:A	24757771
antipsychotics	rs363341	SLC18A2	TT	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs363341:TT	No_match
platinum compounds, radiotherapy	rs1059698	__INTRONIC__	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01XA	rs1059698:CC	23939
antipsychotics	rs1334802	GRIK3	CT	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs1334802:CT	No_match
platinum compounds, radiotherapy	rs73594404	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs73594404:AA	23939
platinum compounds, radiotherapy	rs73594404	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs73594404:AG	23939
paroxetine	rs4646427	CYP1A2	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB05	rs4646427:TT	667572
methotrexate	rs1979277	SHMT1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1979277:AG	11329481
methotrexate	rs1979277	SHMT1	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1979277:GG	11329481
paroxetine	rs762551	CYP1A2	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05	rs762551:A	667572
antipsychotics	rs9567733	HTR2A	AG	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs9567733:AG	No_match
antipsychotics	rs9567733	HTR2A	GG	Toxicity	increased	Adverse_Event	Disease:C0033975		N05A	rs9567733:GG	No_match
platinum compounds, radiotherapy	rs36080650	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs36080650:CC	23939
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1045642:AG	11329481
methotrexate	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1045642:GG	11329481
antipsychotics	rs1124491	DRD2	AA	Toxicity	decreased	Adverse_Event	Disease:C0033975		N05A	rs1124491:AA	No_match
antipsychotics	rs1124491	DRD2	AG	Toxicity	decreased	Adverse_Event	Disease:C0033975		N05A	rs1124491:AG	No_match
platinum compounds, radiotherapy	rs10132552	MEG3	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA	rs10132552:CC	23939
warfarin	rs2108622	CYP4F2	CT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Metabolism/PK	increased	LADME	Healthy		B01AA03	rs2108622:TT	54688261
mycophenolate mofetil(mycophenolic acid)	rs72551330	UGT1A9	C	Toxicity	Indeterminado	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs72551330:C	5281078
methotrexate	rs17222723	ABCC2	AT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs17222723:AT	11329481
methotrexate	rs17222723	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs17222723:TT	11329481
methamphetamine	rs2486001	SLC6A9	T	Toxicity, Other	increased	Adverse_Event	Healthy		No_ATC	rs2486001:T	36604
mycophenolate mofetil(mycophenolic acid)	rs72551330	UGT1A9	C	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs72551330:C	5281078
antipsychotics, clozapine, olanzapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03|N05AX08	rs1414334:C	135398737
none	rs1805123	KCNH2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1805123:T	5282367
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT	37542
methamphetamine	rs2036657	ARRB2	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs2036657:A	36604
methotrexate	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L04AX03	rs1801133:AG	11329481
aspirin	rs1065776	P2RY1	CT	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs1065776:CT	72204814
rosuvastatin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Disease:C1956346		C10AA07	rs4149056:C	5282455
none	rs110402	CRHR1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs110402:AA	5282367
nicotine	rs4790694	ARRB2	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs4790694:A	936
warfarin	rs7900194	CYP2C9	A	Dosage	decreased	Efficacy_Response	Healthy		B01AA03	rs7900194:A	54688261
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AG	11329481
atorvastatin	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C1956346		C10AA05	rs1045642:A	656846
capecitabine	rs1801133	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801133:GG	11809635
carvedilol	rs1042714	ADRB2	C	Efficacy	increased	Efficacy_Response	Healthy		C07AG02	rs1042714:C	6322
clopidogrel	rs662	PON1	CC	Efficacy	increased	Adverse_Event	Other:C0236036		B01AC04	rs662:CC	13748464
clopidogrel	rs662	PON1	CT	Efficacy	increased	Adverse_Event	Other:C0236036		B01AC04	rs662:CT	13748464
antidepressants	rs1439050	NTRK2	G	Toxicity	increased	Adverse_Event	Disease:C0011581		N06A	rs1439050:G	No_match
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs10929302:AA	74990
bevacizumab	rs1478947	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Other:C0033578		L01FG01	rs1478947:CT	No_match
bevacizumab	rs1478947	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Other:C0033578		L01FG01	rs1478947:TT	No_match
aspirin	rs4523	TBXA2R	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs4523:AA	72204814
methamphetamine	rs1045280	ARRB2	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs1045280:T	36604
aspirin	rs6065	GP1BA	CC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs6065:CC	72204814
olanzapine	rs7973796	PMCH	G	Other	increased	Adverse_Event	Disease:C0036341		N05AH03	rs7973796:G	74603552
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01CE02	rs10929302:AA	74990
warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AA	54688261
aspirin	rs1800469	TGFB1	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1800469:AA	72204814
aspirin	rs1800469	TGFB1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1800469:AG	72204814
warfarin	rs6046	F7	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs6046:AA	54688261
warfarin	rs6046	F7	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs6046:AA	54688261
carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel, vinorelbine	rs1801133	MTHFR	AA	Efficacy	increased	Adverse_Event	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA01|L01XA02	rs1801133:AA	10339178
aspirin, clopidogrel	rs201441480	KRTAP10-4, TSPEAR	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs201441480:A	2244
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs3918290:CT	60953
methotrexate	rs2236225	MTHFD1	AA	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs2236225:AA	11329481
methotrexate	rs2236225	MTHFD1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs2236225:AG	11329481
paclitaxel	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs1128503:AA	36314
methotrexate	rs1801131	MTHFR	GT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1801131:GT	11329481
methotrexate	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Other:C0029463		L04AX03	rs1801131:TT	11329481
atorvastatin	rs2070744	NOS3	CC	Other	decreased	Other	Healthy		C10AA05	rs2070744:CC	656846
warfarin	rs7900194	CYP2C9	A	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs7900194:A	54688261
aspirin, clopidogrel	rs140410716	ECHS1	T	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs140410716:T	2244
cyclophosphamide, epirubicin, fluorouracil	rs12050587	PIGB	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs12050587:G	2907
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs4149035	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs4149035:CT	60823
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs4149035	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs4149035:TT	60823
aspirin, clopidogrel	rs75750968	AGAP3	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs75750968:A	2244
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs11045818	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs11045818:AA	60823
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs11045818	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs11045818:AG	60823
gemcitabine	rs11854484	SLC28A2	CC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05	rs11854484:CC	597
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
acetaminophen	rs1927911	TLR4	AA	Toxicity	increased	Adverse_Event	Healthy		N02BE01	rs1927911:AA	1983
acetaminophen	rs1927911	TLR4	AG	Toxicity	increased	Adverse_Event	Healthy		N02BE01	rs1927911:AG	1983
timolol	rs16947	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Disease:Open-angle_glaucoma		S01ED01	rs16947:AA	33624
timolol	rs16947	__INTRONIC__	AG	Toxicity	increased	Adverse_Event	Disease:Open-angle_glaucoma		S01ED01	rs16947:AG	33624
cyclophosphamide, epirubicin, fluorouracil	rs11636687	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs11636687:C	2907
gemcitabine	rs1060896	SLC28A2	CC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05	rs1060896:CC	597
atorvastatin, fluvastatin, lovastatin, pitavastatin, simvastatin	rs2622629	ABCG2	TT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA02|C10AA04|C10AA05|C10AA08	rs2622629:TT	60823
pravastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA03	rs4149056:CC	58746970
pravastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA03	rs4149056:CT	58746970
aspirin, clopidogrel	rs3749187	ZDHHC3	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs3749187:A	2244
venlafaxine	rs3892097	CYP2D6	CT	Metabolism/PK	increased	LADME	Disease:C0011581		N06AX16	rs3892097:CT	9795857
venlafaxine	rs3892097	CYP2D6	TT	Metabolism/PK	increased	LADME	Disease:C0011581		N06AX16	rs3892097:TT	9795857
none	rs5996696	ADORA2A	AC	Other	decreased	Adverse_Event	Healthy		A03DA02	rs5996696:AC	5282367
none	rs5996696	ADORA2A	CC	Other	decreased	Adverse_Event	Healthy		A03DA02	rs5996696:CC	5282367
none	rs71651683	ADORA2A	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs71651683:CT	5282367
none	rs12252	IFITM3	GG	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs12252:GG	5282367
methotrexate	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	rs1128503:AG	11329481
methotrexate	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:Precursor_T-Cell_Lymphoblastic_Leukemia-Lymphoma|Other:C0029463|Other:C0024299		L04AX03	rs1128503:GG	11329481
caffeine	rs762551	CYP1A2	CC	Other	decreased	Adverse_Event	Other:coffee_consumption		N06BC01	rs762551:CC	936
caffeine	rs2470890	CYP1A2	CC	Other	decreased	Adverse_Event	Other:coffee_consumption		N06BC01	rs2470890:CC	936
clozapine	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N05AH02	rs1045642:AA	131769989
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC	445127
warfarin	rs9934438	VKORC1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9934438:AA	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs1127354	ITPA	CC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs1127354:CC	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
atorvastatin, simvastatin	rs374113543	SLCO1B1	A	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs374113543:A	60823
atorvastatin, simvastatin	rs373327528	SLCO1B1	A	Efficacy	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs373327528:A	60823
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs6051702	DNAAF9	AA	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs6051702:AA	37542
dexamethasone	rs6092	SERPINE1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA06	rs6092:AA	9400
dexamethasone	rs6092	SERPINE1	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA06	rs6092:AG	9400
gemcitabine	rs2072671	CDA	AA	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AA	597
gemcitabine	rs2072671	CDA	AC	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AC	597
nicotine	rs2072661	CHRNB2	GG	Efficacy, Toxicity, Other	increased	Other	Other:smokers		N07BA01	rs2072661:GG	936
peginterferon alfa-2a, peginterferon alfa-2b	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10|L03AB11	rs12979860:CC	No_match
anthracyclines and related substances	rs7853758	SLC28A3	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB	rs7853758:A	No_match
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10|L03AB11	rs8099917:TT	37542
clozapine	rs2069514	CYP1A2	A	Other	increased	Adverse_Event	Disease:C0036341		N05AH02	rs2069514:A	131769989
cisplatin, doxorubicin, methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1801133:AA	5460033
cisplatin, doxorubicin, methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1801133:AG	5460033
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:AG	5460033
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:GG	5460033
everolimus	rs2024627	MTOR	C	Efficacy	decreased	Adverse_Event	Other:C1458155|Other:C0005967|Other:Neuroendocrine_Tumors		L01EG02	rs2024627:C	6442177
capecitabine	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs3918290:CT	11809635
cisplatin, doxorubicin, methotrexate	rs13181	ERCC2	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs13181:GG	5460033
cisplatin, doxorubicin, methotrexate	rs13181	ERCC2	GT	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01|L01XA01|L04AX03	rs13181:GT	5460033
nicotine	rs324650	CHRM2	T	Toxicity, Other	increased	Adverse_Event	Healthy		N07BA01	rs324650:T	936
cetuximab, panitumumab	rs712829	EGFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs712829:GT	No_match
cetuximab, panitumumab	rs712829	EGFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs712829:TT	No_match
clozapine	rs35694136	CYP1A2	del	Other	increased	Adverse_Event	Disease:C0036341		N05AH02	rs35694136:del	131769989
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
cetuximab, panitumumab	rs9996584	AREG	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs9996584:AA	No_match
cetuximab, panitumumab	rs9996584	AREG	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs9996584:AG	No_match
bevacizumab, irinotecan	rs1570360	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01CE02|L01FG01	rs1570360:GG	60838
clopidogrel	rs662	PON1	CT	Other	increased	Other	Healthy		B01AC04	rs662:CT	13748464
clopidogrel	rs662	PON1	TT	Other	increased	Other	Healthy		B01AC04	rs662:TT	13748464
proton pump inhibitors	rs3750425	TRPM6	T	Toxicity	increased	Adverse_Event	Healthy		A02BC	rs3750425:T	5460653
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02	rs3918290:CT	5790
none	rs1360780	FKBP5	CC	Efficacy	increased	Adverse_Event	Disease:C0011581		A03DA02	rs1360780:CC	5282367
none	rs1360780	FKBP5	CT	Efficacy	increased	Adverse_Event	Disease:C0011581		A03DA02	rs1360780:CT	5282367
clozapine, olanzapine, quetiapine, risperidone	rs12836771	HTR2C, MIR1264, MIR1912	GG	Toxicity	increased	Adverse_Event	Disease:C0033975|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AX08	rs12836771:GG	135398737
methotrexate	rs3758149	GGH	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3758149:AA	11329481
halothane, succinylcholine	rs193922803	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01	rs193922803:T	5314
cetuximab, panitumumab	rs11942466	AREG	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs11942466:AA	No_match
simvastatin	rs1045642	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA01	rs1045642:AA	14373154
proton pump inhibitors	rs2274924	TRPM6	C	Toxicity	increased	Adverse_Event	Healthy		A02BC	rs2274924:C	5460653
doxorubicin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01	rs1695:AG	83958
doxorubicin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0029463		L01DB01	rs1695:GG	83958
doxorubicin	rs3212986	ERCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs3212986:AA	83958
doxorubicin	rs3212986	ERCC1	AC	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs3212986:AC	83958
clozapine, olanzapine, quetiapine, risperidone	rs518147	HTR2C	CC	Toxicity	increased	Adverse_Event	Disease:C0033975|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AX08	rs518147:CC	135398737
simvastatin	rs2032582	ABCB1	AA	Other, Metabolism/PK	increased	LADME	Healthy		C10AA01	rs2032582:AA	14373154
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192172	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192172:T	3763
nevirapine	rs2054675	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs2054675:C	15979285
asunaprevir, daclatasvir, direct acting antivirals, ledipasvir / sofosbuvir, ombitasvir / paritaprevir / ritonavir	rs8099917	IFNL3, IFNL4	GG	Toxicity	increased	Adverse_Event	Disease:C0019372		J05A|J05AE03|J05AP07|J05AP08|J05AP51|J05AP53	rs8099917:GG	25154714
asunaprevir, daclatasvir, direct acting antivirals, ledipasvir / sofosbuvir, ombitasvir / paritaprevir / ritonavir	rs8099917	IFNL3, IFNL4	GT	Toxicity	increased	Adverse_Event	Disease:C0019372		J05A|J05AE03|J05AP07|J05AP08|J05AP51|J05AP53	rs8099917:GT	25154714
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192176	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192176:A	3763
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192177	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192177:T	3763
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs121918593	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs121918593:A	3763
nevirapine	rs3786547	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs3786547:C	15979285
capecitabine	rs1801160	DPYD	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801160:CC	11809635
capecitabine	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs1801160:CT	11809635
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs121918592	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs121918592:A	3763
capecitabine	rs1801159	DPYD	C	Toxicity	increased	Adverse_Event	Other:C1458155		L01BC06	rs1801159:C	11809635
methylphenidate	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Disease:C1510586		N06BA04	rs6280:CT	154100
methylphenidate	rs6280	DRD3	TT	Toxicity	increased	Adverse_Event	Disease:C1510586		N06BA04	rs6280:TT	154100
cisplatin	rs1872328	ACYP2	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1872328:AA	441203
cisplatin	rs1872328	ACYP2	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1872328:AG	441203
clopidogrel	rs662	PON1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs662:CT	13748464
clopidogrel	rs662	PON1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs662:TT	13748464
doxorubicin	rs2228001	XPC	GG	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs2228001:GG	83958
doxorubicin	rs2228001	XPC	GT	Toxicity	decreased	Adverse_Event	Other:C0029463		L01DB01	rs2228001:GT	83958
peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs12979860:CC	37542
heroin	rs9479757	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs9479757:GG	9844225
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		N07BB04	rs1799971:AG	5360515
naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		N07BB04	rs1799971:GG	5360515
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT	37542
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs1125338	FTO	CC	Efficacy	increased	Adverse_Event	Other:C0027651		No_ATC	rs1125338:CC	No_match
beta-lactam antibacterials, penicillins	rs71542416	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		J01C|J01D	rs71542416:T	2349
irinotecan	rs425215	ABCG1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs425215:GG	74990
xelox	rs2271862	ABCA2	AA	Toxicity	decreased	Adverse_Event	Other:C0023055|Other:C2939419		No_ATC	rs2271862:AA	60953
irinotecan	rs562	ABCC5	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs562:CC	74990
opioids	rs6715729	TACR1	AG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs6715729:AG	No_match
opioids	rs6715729	TACR1	GG	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs6715729:GG	No_match
opioids	rs4436578	DRD2	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4436578:CT	No_match
opioids	rs4436578	DRD2	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs4436578:TT	No_match
opioids	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CC	No_match
opioids	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs776746:CT	No_match
irinotecan	rs2306283	SLCO1B1	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs2306283:AG	74990
tramadol	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Healthy		N02AX02	rs1045642:AA	63013
none	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Healthy		A03DA02	rs2032582:CC	5282367
none	rs2032582	ABCB1	TT	Efficacy	decreased	Efficacy_Response	Healthy		A03DA02	rs2032582:TT	5282367
carboplatin, paclitaxel	rs7311358	SLCO1B3	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CD01|L01XA02	rs7311358:AA	10339178
methotrexate	rs10106	FPGS	CC	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:CC	11329481
methotrexate	rs10106	FPGS	CT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:CT	11329481
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T	5778
none	rs11549467	HIF1A	AG	Efficacy	decreased	Efficacy_Response	Healthy		A03DA02	rs11549467:AG	5282367
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12596638	FTO	GG	Efficacy	increased	Adverse_Event	Other:C0027651		No_ATC	rs12596638:GG	No_match
coumarin, nicotine	rs28399433	CYP2A6	C	Other, Metabolism/PK	decreased	Other	Healthy		N07BA01	rs28399433:C	89594
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT	11221549
antibiotics	rs11125	LGALS3	AT	Toxicity	increased	Adverse_Event	Disease:C0699744		S01AA	rs11125:AT	2764
antibiotics	rs11125	LGALS3	TT	Toxicity	increased	Adverse_Event	Disease:C0699744		S01AA	rs11125:TT	2764
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT	11221549
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12600192	__INTRONIC__	CG	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs12600192:CG	No_match
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12600192	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs12600192:GG	No_match
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT	11221549
none	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs9934438:AA	5282367
none	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs9934438:AG	5282367
sunitinib	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT	11221549
methotrexate	rs1650723	DHFR	T	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1650723:T	11329481
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12600192	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Other:C0027651		No_ATC	rs12600192:CC	No_match
methotrexate	rs2231135	ABCG2	AG	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs2231135:AG	11329481
nicotine	rs3852209	HINT1	CC	Other	increased	Adverse_Event	Other:C0039338		N07BA01	rs3852209:CC	936
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1051266:TT	11329481
none	rs1544410	VDR	CC	Other	decreased	Adverse_Event	Other:C0032961		A03DA02	rs1544410:CC	5282367
ethambutol, isoniazid / pyrazinamide / rifampin	rs352139	ALAS1	AA	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs352139:AA	135483892
ethambutol, isoniazid / pyrazinamide / rifampin	rs352139	ALAS1	AG	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs352139:AG	135483892
risperidone	rs3813034	SLC6A4	AA	Other	increased	Adverse_Event	Disease:C0036341		N05AX08	rs3813034:AA	849421
isoniazid, rifampin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1695:AA	135483892
cyclophosphamide, doxorubicin	rs3764435	ALDH1A1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs3764435:A	2907
cyclophosphamide, doxorubicin	rs168351	ALDH1A1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs168351:A	2907
methotrexate	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:A	11329481
carboplatin, paclitaxel	rs4149117	SLCO1B3	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CD01|L01XA02	rs4149117:GG	10339178
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs117648444	IFNL3, IFNL4	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs117648444:AA	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs117648444	IFNL3, IFNL4	AG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs117648444:AG	37542
ethanol, naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Healthy		N07BB04|V03AB16	rs1799971:AG	5360515
ethanol, naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Healthy		N07BB04|V03AB16	rs1799971:GG	5360515
isoniazid, rifampin	rs1799929	NAT2	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1799929:TT	135483892
opioids	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs4680:AG	No_match
isoniazid, rifampin	rs1799930	NAT2	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1799930:AA	135483892
methotrexate	rs1051266	SLC19A1	CC	Efficacy	increased	Efficacy_Response	Disease:C0029463		L04AX03	rs1051266:CC	11329481
methotrexate	rs1053129	DHFR	CC	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1053129:CC	11329481
methotrexate	rs1801133	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1801133:GG	11329481
tamoxifen	rs118042719	HS6ST3	A	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs118042719:A	2733525
phenytoin	rs2229107	ABCB1	A	Other, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs2229107:A	1775
"""3,4-methylenedioxymethamphetamine"", ""cocaine"", ""ethanol"", ""opioids"""	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:AG	1615
trastuzumab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs396991:CC	166596981
mycophenolic acid, tacrolimus	rs717620	ABCC2	C	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AA06|L04AD02	rs717620:C	446541
methadone	rs1038376	CYP2B6	TT	Toxicity	increased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0036439"		N07BC02	rs1038376:TT	10090
trastuzumab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs1801274:AA	166596981
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:CC	11329481
methotrexate	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:CT	11329481
succinylcholine	rs1799807	BCHE	C	Metabolism/PK	Indeterminado	Adverse_Event	Healthy		No_ATC	rs1799807:C	66129
succinylcholine	rs1803274	BCHE	T	Metabolism/PK	Indeterminado	Adverse_Event	Healthy		No_ATC	rs1803274:T	66129
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT	5790
clopidogrel	rs1042192	CYP2C18	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs1042192:A	13748464
clozapine	rs2737385	HNMT	GG	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02	rs2737385:GG	131769989
fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs1801160:CT	5790
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs4244285:A	13748464
methadone	rs2279343	CYP2B6	AG	Toxicity	increased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0036439"		N07BC02	rs2279343:AG	10090
methadone	rs2279343	CYP2B6	GG	Toxicity	increased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0036439"		N07BC02	rs2279343:GG	10090
clopidogrel	rs12572897	NOC3L	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs12572897:A	13748464
tamoxifen	rs6790761	LPP	A	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs6790761:A	2733525
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799929	NAT2	T	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:T	135483892
sunitinib	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1128503:AA	11221549
sunitinib	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1128503:AG	11221549
nicotine	rs16969968	CHRNA5	A	Toxicity, Other	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A	936
clopidogrel	rs1058932	CYP2C8	A	Efficacy	increased	Efficacy_Response	Other:C0007222		B01AC04	rs1058932:A	13748464
sunitinib	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs2032582:AA	11221549
sunitinib	rs2032582	ABCB1	AC	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs2032582:AC	11221549
nicotine	rs578776	CHRNA3	A	Toxicity, Other	decreased	Adverse_Event	Healthy		N07BA01	rs578776:A	936
tamoxifen	rs77693286	LPP	A	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs77693286:A	2733525
anthracyclines and related substances	rs17863783	UGT1A6	T	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C1261473|Other:C0206624|Other:C0029463|Other:C0024299		L01DB	rs17863783:T	No_match
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
rifampicin	rs10946739	RIPOR2	C	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs10946739:C	135542225
anthracyclines and related substances	rs2229774	RARG	A	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C1261473|Other:C0206624|Other:C0029463|Other:C0024299		L01DB	rs2229774:A	No_match
none	rs763317	EGFR	AA	Efficacy	increased	Adverse_Event	Other:C0024121		A03DA02	rs763317:AA	5282367
none	rs948854	GAL	C	Other	increased	Adverse_Event	Disease:C0003469		A03DA02	rs948854:C	5282367
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC	445127
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CT	445127
carbamazepine	rs3869066	ZNRD1-AS1	AG	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs3869066:AG	114709
carbamazepine	rs3869066	ZNRD1-AS1	GG	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs3869066:GG	114709
atazanavir	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs2032582:AA	118753185
hmg coa reductase inhibitors	rs1337512	EYS	G	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs1337512:G	445127
rifampicin	rs393994	AGBL4	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs393994:A	135542225
atazanavir	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs1045642:AA	118753185
phenytoin	rs1799853	CYP2C9	T	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	rs1799853:T	1775
hmg coa reductase inhibitors, other combinations	rs9342288	EYS	A	Toxicity	increased	Adverse_Event	Disease:C0007222		B03AE|C10AA	rs9342288:A	445127
aspirin	rs1047626	SLC30A9	A	Toxicity, Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1047626:A	72204814
escitalopram, nortriptyline	rs962369	BDNF	C	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA10|N06AB10	rs962369:C	146570
ace inhibitors, plain	rs2253201	KCNMA1	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2253201:G	No_match
hmg coa reductase inhibitors, other combinations	rs3857532	EYS	A	Toxicity	increased	Adverse_Event	Disease:C0007222		B03AE|C10AA	rs3857532:A	445127
aspirin	rs7862221	TSC1	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7862221:C	72204814
rifampicin	rs320003	AGBL4	G	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs320003:G	135542225
aspirin	rs11819745	THRA	G	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs11819745:G	72204814
rifampicin	rs7958375	CUX2	G	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs7958375:G	135542225
anthracyclines and related substances	rs7853758	SLC28A3	A	Toxicity	decreased	Adverse_Event	Other:C0023449|Other:C1261473|Other:C0206624|Other:C0029463|Other:C0024299		L01DB	rs7853758:A	No_match
hmg coa reductase inhibitors	rs9806699	GATM	A	Toxicity	decreased	Adverse_Event	Disease:C0007222		C10AA	rs9806699:A	445127
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4363657:CC	445127
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4363657:CT	445127
aspirin	rs3818822	CHIA	A	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3818822:A	72204814
atazanavir	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs1128503:AA	118753185
aspirin	rs1074373	__INTRONIC__	C	Toxicity, Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs1074373:C	72204814
phenytoin	rs1799853	CYP2C9	T	Toxicity, Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1799853:T	1775
phenytoin	rs1057910	CYP2C9	C	Toxicity, Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1057910:C	1775
heroin	rs1990040	GRM3	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs1990040:A	9844225
aspirin	rs3130100	ZBTB22	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3130100:C	72204814
cyclosporine, sirolimus, tacrolimus	rs7903146	TCF7L2	T	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01|L04AD02	rs7903146:T	5284616
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4149056:CC	445127
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA	rs4149056:CT	445127
phenytoin	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AB02	rs1057910:C	1775
clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Toxicity	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy, Toxicity	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs4244285:AG	13748464
aspirin	rs3097671	HLA-DPB1	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3097671:C	72204814
aspirin	rs3129294	HLA-DPB2	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3129294:C	72204814
aspirin	rs1042151	HLA-DPB1	G	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1042151:G	72204814
aspirin	rs1042136	HLA-DPB1	C	Toxicity, Other	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1042136:C	72204814
atorvastatin, simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs4149056:CC	60823
atorvastatin, simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01|C10AA05	rs4149056:CT	60823
rifampicin	rs10946737	RIPOR2	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs10946737:A	135542225
prednisolone	rs3824662	GATA3	AA	PD	increased	Adverse_Event	Other:C0023449		S02BA03	rs3824662:AA	54605501
rifampicin	rs319952	AGBL4	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AB02	rs319952:A	135542225
nicotine	rs10485057	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs10485057:AA	936
ethanol	rs2533200	DPP6	C	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs2533200:C	444899
cisplatin, cyclophosphamide	rs1051740	EPHX1	CT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1051740:CT	2907
carbamazepine	rs192543598	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs192543598:G	114709
ethanol	rs7900002	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs7900002:T	444899
ethanol	rs2582405	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2582405:T	444899
cisplatin, cyclophosphamide	rs1801280	NAT2	CT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1801280:CT	2907
ethanol	rs56722963	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs56722963:T	444899
cisplatin, cyclophosphamide	rs3219484	MUTYH	CT	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3219484:CT	2907
carbamazepine	rs187926838	ALK	G	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs187926838:G	114709
ethanol	rs576859	MED19, TMX2	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs576859:A	444899
methotrexate	rs7563206	ATIC	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs7563206:CC	11329481
enzymes	rs669	A2M	TT	Toxicity	increased	Adverse_Event	Disease:C0018839		M09AB	rs669:TT	No_match
methotrexate	rs3821353	ATIC	GT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3821353:GT	11329481
methotrexate	rs3821353	ATIC	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3821353:TT	11329481
chop, rituximab	rs1883112	NCF4	AA	Efficacy	decreased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:AA	No_match
enzymes	rs1801020	F12	GG	Toxicity	increased	Adverse_Event	Disease:C0018839		M09AB	rs1801020:GG	No_match
sunitinib	rs1128503	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:A	11221549
methotrexate	rs2372536	ATIC	CG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2372536:CG	11329481
methotrexate	rs2372536	ATIC	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2372536:GG	11329481
ethanol	rs6589386	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs6589386:T	444899
ethanol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:GG	444899
ethanol	rs13125415	ADH1C	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs13125415:A	444899
methotrexate	rs12995526	ATIC	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs12995526:CC	11329481
cisplatin, cyclophosphamide	rs11226	RAD52	AG	Toxicity	decreased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs11226:AG	2907
ethanol	rs13135092	SLC39A8	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs13135092:A	444899
cisplatin, cyclophosphamide	rs1052536	LIG3	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1052536:CC	2907
abiraterone, prednisolone	rs3828743	TSPYL1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L02BX03|S02BA03	rs3828743:AA	132971
opioids	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AA	No_match
opioids	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs4680:AG	No_match
cisplatin, fluorouracil, radiotherapy	rs1799782	XRCC1	AA	Efficacy	increased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs1799782:AA	5460033
cisplatin, fluorouracil, radiotherapy	rs1799782	XRCC1	AG	Efficacy	increased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs1799782:AG	5460033
indinavir	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Other:HIV		J05AE02	rs4148323:AG	11954281
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
ethanol	rs1229984	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1229984:T	444899
methotrexate	rs10760502	FPGS	AA	Efficacy, Toxicity, Other	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10760502:AA	11329481
methotrexate	rs10106	FPGS	TT	Efficacy, Toxicity, Other	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:TT	11329481
capecitabine, fluorouracil, tegafur	rs55886062	DPYD	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs55886062:AC	60953
capecitabine, fluorouracil, tegafur	rs55886062	DPYD	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs55886062:CC	60953
methotrexate	rs10106	FPGS	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs10106:TT	11329481
ethanol	rs9679319	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs9679319:T	444899
ethanol	rs1402398	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1402398:A	444899
ethanol	rs13382553	THSD7B	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs13382553:A	444899
peginterferon alfa-2a, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4273729:GG	37542
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA	37542
methotrexate	rs868755	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs868755:TT	11329481
ethanol	rs2673136	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs2673136:A	444899
ethanol	rs13129401	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs13129401:A	444899
methotrexate	rs10280623	ABCB1	TT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs10280623:TT	11329481
ethanol	rs62250713	CADM2	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs62250713:A	444899
ethanol	rs75967634	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs75967634:T	444899
carboplatin, cyclophosphamide, etoposide, lomustine, methotrexate, vincristine	rs1139130	METTL3	AA	Toxicity	increased	Adverse_Event	Other:C0017636|Other:C0017636|Other:C0004114|Other:C0006118		L01AA01|L01AD02|L01CA02|L01CB01|L01XA02|L04AX03	rs1139130:AA	2907
carboplatin, cyclophosphamide, etoposide, lomustine, methotrexate, vincristine	rs1139130	METTL3	AG	Toxicity	increased	Adverse_Event	Other:C0017636|Other:C0017636|Other:C0004114|Other:C0006118		L01AA01|L01AD02|L01CA02|L01CB01|L01XA02|L04AX03	rs1139130:AG	2907
heroin	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:AG	9844225
heroin	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:GG	9844225
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4273729:GG	37542
none	rs56113850	CYP2A6	T	Other	decreased	Adverse_Event	Other:C0039338		A03DA02	rs56113850:T	5282367
ethanol	rs6421482	PDE4B	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs6421482:A	444899
ethanol	rs61767420	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs61767420:A	444899
ethanol	rs1260326	GCKR	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1260326:T	444899
ethanol	rs494904	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs494904:T	444899
none	rs503464	CHRNA5	AA	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs503464:AA	5282367
none	rs503464	CHRNA5	AT	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs503464:AT	5282367
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
methotrexate	rs72783407	SPATA9	A	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs72783407:A	11329481
methotrexate	rs9904341	BIRC5	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs9904341:GG	11329481
protein kinase inhibitors	rs324011	STAT6	TT	Toxicity	increased	Adverse_Event	Other:C0007131		L01E	rs324011:TT	45139106
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Healthy		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT	5790
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:TT	5790
capecitabine, fluorouracil, tegafur	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs3918290:CT	60953
capecitabine, fluorouracil, tegafur	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs3918290:TT	60953
opioids	rs1800497	ANKK1, DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1800497:AA	No_match
opioids	rs1800497	ANKK1, DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1800497:AG	No_match
tamoxifen	rs114557570	C1QTNF6	C	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BA01	rs114557570:C	2733525
none	rs637137	CHRNA5	AA	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs637137:AA	5282367
none	rs637137	CHRNA5	AT	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs637137:AT	5282367
docetaxel	rs833061	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02	rs833061:CC	154272
docetaxel	rs13207351	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02	rs13207351:GG	154272
docetaxel	rs35864111	VEGFA	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02	rs35864111:GG	154272
asparaginase, cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, leucovorin, mercaptopurine, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs3824662	GATA3	A	Efficacy	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX02|L01XX24|L04AX03|S02BA06	rs3824662:A	2907
asparaginase, cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, leucovorin, mercaptopurine, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs3824662	GATA3	A	Efficacy	increased	Efficacy_Response	Disease:C0023449		H02AB07|L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX02|L01XX24|L04AX03|S02BA06	rs3824662:A	2907
docetaxel	rs699947	VEGFA	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02	rs699947:AA	154272
exemestane	rs62293499	__INTRONIC__	C	Efficacy	decreased	Adverse_Event	Other:C1458155		L02BG06	rs62293499:C	13472
aspirin, clopidogrel	rs2108622	CYP4F2	CT	Other	increased	Other	Disease:C0027051		B01AC04	rs2108622:CT	2244
fluorouracil	rs4294451	DPYD	AT	Efficacy	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:AT	5790
fluorouracil	rs4294451	DPYD	TT	Efficacy	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:TT	5790
citalopram	rs17135437	COL26A1	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs17135437:T	162180
citalopram	rs16965962	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs16965962:A	162180
allopurinol	rs9263726	PSORS1C1, PSORS1C2	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9263726:A	168354693
aspirin	rs4292	ACE	CC	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4292:CC	72204814
aspirin	rs4292	ACE	CT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4292:CT	72204814
clopidogrel	rs6809699	P2RY12	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs6809699:AA	13748464
anthracyclines and related substances	rs4982753	SLC22A17	T	Toxicity	decreased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs4982753:T	No_match
tacrolimus	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs776746:T	131769926
fluorouracil	rs4294451	DPYD	AT	Toxicity	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:AT	5790
fluorouracil	rs4294451	DPYD	TT	Toxicity	decreased	Adverse_Event	Healthy		L01BC02	rs4294451:TT	5790
none	rs2074192	ACE2	T	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs2074192:T	5282367
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs6809699:AA	13748464
aspirin, clopidogrel	rs168753	F2R	T	Efficacy	decreased	Efficacy_Response	Other:C0007787|Other:C0018839		B01AC04	rs168753:T	2244
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs6809699:AA	13748464
aspirin	rs1065776	P2RY1	CT	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1065776:CT	72204814
mercaptopurine	rs1127354	ITPA	AC	Metabolism/PK	increased	LADME	Disease:C0023449		L01BB02	rs1127354:AC	1268107
none	rs1219648	FGFR2	G	Toxicity, Other	increased	Adverse_Event	Disease:C0019829		A03DA02	rs1219648:G	5282367
anastrozole	rs6735923	__INTRONIC__	T	Efficacy	increased	Adverse_Event	Other:C1458155		L02BG03	rs6735923:T	713
acenocoumarol	rs1799853	CYP2C9	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1799853:CT	54742534
acenocoumarol	rs1799853	CYP2C9	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1799853:TT	54742534
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Other:C0007787|Other:C0018839		B01AC04	rs4244285:A	2244
anthracyclines and related substances	rs7319981	SLC10A2	A	Toxicity	increased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs7319981:A	No_match
none	rs699	AGT	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs699:AG	5282367
anastrozole	rs1877193	__INTRONIC__	C	Efficacy	increased	Adverse_Event	Other:C1458155		L02BG03	rs1877193:C	713
capecitabine	rs2786783	DPYD	A	Toxicity	increased	Adverse_Event	Healthy		L01BC06	rs2786783:A	11809635
none	rs4818	COMT	CC	Other	increased	Adverse_Event	Other:C0011334|Other:C0040435|Other:C0040460		A03DA02	rs4818:CC	5282367
none	rs4818	COMT	CG	Other	increased	Adverse_Event	Other:C0011334|Other:C0040435|Other:C0040460		A03DA02	rs4818:CG	5282367
drugs for treatment of tuberculosis	rs7662029	UGT2B7	G	Toxicity	increased	Adverse_Event	Healthy		J04A	rs7662029:G	No_match
drugs for treatment of tuberculosis	rs7439366	UGT2B7	C	Toxicity	increased	Adverse_Event	Healthy		J04A	rs7439366:C	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AG	13748464
cefaclor	rs62242178	LIMD1	C	Toxicity	increased	Adverse_Event	Healthy		J01DC04	rs62242178:C	8663
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:TT	54688261
cefaclor	rs62242177	LIMD1	G	Toxicity	increased	Adverse_Event	Healthy		J01DC04	rs62242177:G	8663
repaglinide	rs4149056	SLCO1B1	CC	Other, Metabolism/PK	increased	LADME	Healthy		A10BX02	rs4149056:CC	22132924
dihydropyridine derivatives	rs1048101	ADRA1A	AG	Efficacy	decreased	Adverse_Event	Healthy		C08CA	rs1048101:AG	No_match
dihydropyridine derivatives	rs1048101	ADRA1A	GG	Efficacy	decreased	Adverse_Event	Healthy		C08CA	rs1048101:GG	No_match
thalidomide	rs1051685	XRCC5	AG	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs1051685:AG	5743568
thalidomide	rs735482	ERCC1	AC	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs735482:AC	5743568
thalidomide	rs735482	ERCC1	CC	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs735482:CC	5743568
clozapine, olanzapine	rs13429709	GCG	C	Other	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs13429709:C	135398737
clozapine, olanzapine	rs2268639	GLP1R	T	Other	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs2268639:T	135398737
nicotine	rs1799971	OPRM1	AA	Dosage	increased	Other	Healthy		N07BA01	rs1799971:AA	936
nicotine	rs1799971	OPRM1	AG	Dosage	increased	Other	Healthy		N07BA01	rs1799971:AG	936
nicotine	rs1799971	OPRM1	AG	Dosage	increased	Other	Healthy		N07BA01	rs1799971:AG	936
nicotine	rs1799971	OPRM1	GG	Dosage	increased	Other	Healthy		N07BA01	rs1799971:GG	936
tolcapone	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Other:C0221016		N04BX01	rs4680:AA	4659569
nicotine	rs112561475	UGT2B10	AG	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs112561475:AG	936
nicotine	rs112561475	UGT2B10	GG	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs112561475:GG	936
nicotine	rs61750900	UGT2B10	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs61750900:T	936
clozapine, olanzapine	rs13429709	GCG	CC	Other	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs13429709:CC	135398737
dihydropyridine derivatives	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Healthy		C08CA	rs776746:TT	No_match
methamphetamine	rs878567	HTR1A	A	Toxicity, Other	Indeterminado	Adverse_Event	Disease:C0036502		No_ATC	rs878567:A	36604
methotrexate	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0029463|Other:C0023449		L04AX03	rs1801133:A	11329481
cisplatin, fluorouracil, mitoxantrone	rs9679162	GALNT14	TT	Efficacy	increased	Adverse_Event	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs9679162:TT	5460033
captopril	rs4291	ACE	AA	Efficacy	decreased	Adverse_Event	Disease:C0002395		C09AA01	rs4291:AA	44146831
antiepileptics	rs4471527	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N03A	rs4471527:T	No_match
antipsychotics	rs1137101	LEPR	G	Other	increased	Adverse_Event	Healthy		N05A	rs1137101:G	No_match
anthracyclines and related substances	rs2232228	HAS3	A	Toxicity	decreased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs2232228:A	No_match
ethanol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:GG	444899
antiepileptics	rs77542827	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N03A	rs77542827:T	No_match
stavudine	rs8124728	SAMHD1	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AF04	rs8124728:A	15979285
carvedilol	rs1801253	ADRB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085605		C07AG02	rs1801253:CC	6322
irinotecan	rs1800469	TGFB1	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs1800469:AG	74990
irinotecan	rs1800469	TGFB1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs1800469:GG	74990
anthracyclines and related substances	rs2229774	RARG	A	Toxicity	increased	Adverse_Event	Other:C0019829|Other:C1261473		L01DB	rs2229774:A	No_match
cytarabine, daunorubicin, mitoxantrone	rs4643786	DCK	CT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB02|L01DB07	rs4643786:CT	6253
antiepileptics	rs199755581	NIPAL2	A	Toxicity	increased	Adverse_Event	Healthy		N03A	rs199755581:A	No_match
oxaliplatin, paclitaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01|L01XA03	rs1045642:AA	9887054
oxaliplatin, paclitaxel	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01|L01XA03	rs1045642:AG	9887054
amlodipine, chlorthalidone, lisinopril	rs4291	ACE	AA	Other	decreased	Adverse_Event	Disease:C0020538		C03BA04|C08CA01|C09AA03	rs4291:AA	5362119
amlodipine, chlorthalidone, lisinopril	rs4291	ACE	AT	Other	decreased	Adverse_Event	Disease:C0020538		C03BA04|C08CA01|C09AA03	rs4291:AT	5362119
sorafenib	rs1870377	KDR	T	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs1870377:T	67424139
irinotecan	rs3087465	TGFBR2	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs3087465:GG	74990
sorafenib	rs1870377	KDR	T	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs1870377:T	67424139
sunitinib	rs307826	FLT4	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007134		L01EX01	rs307826:CT	11221549
sunitinib	rs776746	CYP3A5	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs776746:TT	11221549
ritodrine	rs17128809	PDE4B	AA	Toxicity	increased	Adverse_Event	Healthy		G02CA01	rs17128809:AA	33572
cyclophosphamide, docetaxel, epirubicin	rs246221	ABCC1	CC	Toxicity	increased	Adverse_Event	Other:C1458155		L01AA01|L01CD02|L01DB03	rs246221:CC	2907
sunitinib	rs307821	FLT4	AC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs307821:AC	11221549
beta blocking agents	rs1042713	ADRB2	AG	Efficacy	increased	Adverse_Event	Other:C0085605		S01ED	rs1042713:AG	No_match
beta blocking agents	rs1042713	ADRB2	GG	Efficacy	increased	Adverse_Event	Other:C0085605		S01ED	rs1042713:GG	No_match
salbutamol	rs9552679	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs9552679:C	2083
salbutamol	rs6988229	COL22A1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs6988229:T	2083
salbutamol	rs17495520	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs17495520:T	2083
aspirin, clopidogrel	rs72819363	CDH15	C	Efficacy	increased	Adverse_Event	Other:C0010068		B01AC04	rs72819363:C	2244
antiepileptics	rs77491650	DDX12P	C	Toxicity	decreased	Adverse_Event	Healthy		N03A	rs77491650:C	No_match
salbutamol	rs1663332	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1663332:T	2083
salbutamol	rs1663330	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1663330:G	2083
salbutamol	rs17701271	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs17701271:A	2083
salbutamol	rs518350	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs518350:T	2083
salbutamol	rs10511905	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs10511905:G	2083
sorafenib	rs717620	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs717620:CC	67424139
salbutamol	rs1522113	CLOCK	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1522113:A	2083
salbutamol	rs1423515	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1423515:A	2083
salbutamol	rs1419555	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs1419555:T	2083
salbutamol	rs6002674	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs6002674:C	2083
none	rs2106809	ACE2	A	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs2106809:A	5282367
doxorubicin	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs1695:AG	83958
doxorubicin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB01	rs1695:GG	83958
methotrexate	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0029463|Other:C0023449		L04AX03	rs1045642:A	11329481
aspirin, clopidogrel	rs11859453	CDH13	AA	Efficacy	decreased	Adverse_Event	Other:C0010068		B01AC04	rs11859453:AA	2244
aspirin, clopidogrel	rs11859453	CDH13	AG	Efficacy	decreased	Adverse_Event	Other:C0010068		B01AC04	rs11859453:AG	2244
allopurinol	rs3099844	CYCSP5	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:A	168354693
allopurinol	rs1634776	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs1634776:T	168354693
paclitaxel	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01	rs1128503:AA	36314
paclitaxel	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C1458155|Other:C0023055		L01CD01	rs1128503:AG	36314
salbutamol	rs11252394	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs11252394:A	2083
sorafenib	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs4149056:CT	67424139
sorafenib	rs4149056	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs4149056:TT	67424139
cocaine	rs11503014	GABRA2	G	Toxicity	increased	Adverse_Event	Healthy		N01BC01	rs11503014:G	2826
cocaine	rs2236256	OPRM1	C	Toxicity	decreased	Adverse_Event	Healthy		N01BC01	rs2236256:C	2826
sorafenib	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs2306283:AG	67424139
sorafenib	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Healthy		L01EX02	rs2306283:GG	67424139
sorafenib	rs2306283	SLCO1B1	AG	Toxicity	decreased	Adverse_Event	Healthy		L01EX02	rs2306283:AG	67424139
sorafenib	rs2306283	SLCO1B1	GG	Toxicity	decreased	Adverse_Event	Healthy		L01EX02	rs2306283:GG	67424139
methotrexate	rs1128503	ABCB1	A	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0029463|Other:C0023449		L04AX03	rs1128503:A	11329481
none	rs699	AGT	A	Other	decreased	Adverse_Event	Other:COVID-19		A03DA02	rs699:A	5282367
cangrelor	rs9859552	P2RY12	TT	Other	Indeterminado	Other	Healthy		B01AC25	rs9859552:TT	9854012
sorafenib	rs2070744	NOS3	TT	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2070744:TT	67424139
radiotherapy	rs10497203	TANC1	C	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs10497203:C	No_match
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T	5778
sorafenib	rs1799983	NOS3	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs1799983:GG	67424139
sorafenib	rs1799983	NOS3	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs1799983:GG	67424139
glucocorticoids	rs37973	GLCCI1	GG	Efficacy	increased	Adverse_Event	Disease:C0004096		R03BA	rs37973:GG	No_match
fluorouracil, irinotecan, leucovorin	rs7699188	ABCG2	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02	rs7699188:A	135403648
sorafenib	rs2070744	NOS3	TT	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2070744:TT	67424139
azathioprine	rs116855232	NUDT15	T	Toxicity	decreased	Adverse_Event	Disease:C0023530		L04AX01	rs116855232:T	5778
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3087243	CTLA4	AG	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs3087243:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3087243	CTLA4	GG	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs3087243:GG	No_match
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G	54688261
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0010346		L01BB02|L04AX01	rs116855232:T	5778
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10782001	FBXL19	GG	Toxicity	increased	Adverse_Event	Disease:C0235763		No_ATC	rs10782001:GG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11209026	IL23R	AG	Toxicity	increased	Adverse_Event	Disease:C0235763		No_ATC	rs11209026:AG	No_match
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0010346		L04AX01	rs116855232:TT	5778
methotrexate	rs1801133	MTHFR	A	Metabolism/PK	increased	Adverse_Event	Disease:C0023418		L04AX03	rs1801133:A	11329481
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G	54688261
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G	444899
morphine	rs2032582	ABCB1	CC	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N02AA01	rs2032582:CC	5284371
colistimethate	rs2257212	SLC15A2	T	Toxicity	increased	Adverse_Event	Other:C0004623		No_ATC	rs2257212:T	216258
heroin	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1799971:G	9844225
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801133:AA	5755
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801133:AG	5755
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801131	MTHFR	GT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801131:GT	5755
asparaginase, daunorubicin, methotrexate, prednisolone, vincristine	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB02|L01XX02|L04AX03|S02BA03	rs1801131:TT	5755
warfarin	rs699664	GGCX	CT	Dosage	decreased	Other	Healthy		B01AA03	rs699664:CT	54688261
warfarin	rs699664	GGCX	TT	Dosage	decreased	Other	Healthy		B01AA03	rs699664:TT	54688261
cetuximab	rs396991	FCGR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs396991:A	No_match
warfarin	rs28371685	CYP2C9	CT	Dosage	decreased	Other	Healthy		B01AA03	rs28371685:CT	54688261
cetuximab	rs9344	CCND1	G	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs9344:G	No_match
warfarin	rs510335	F7	GT	Dosage	decreased	Other	Healthy		B01AA03	rs510335:GT	54688261
warfarin	rs510335	F7	TT	Dosage	decreased	Other	Healthy		B01AA03	rs510335:TT	54688261
tacrolimus	rs1800871	IL10	AA	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs1800871:AA	131769926
escitalopram	rs11568817	HTR1B	AC	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs11568817:AC	162180
escitalopram	rs11568817	HTR1B	CC	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs11568817:CC	162180
cetuximab	rs9344	CCND1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs9344:AA	No_match
methotrexate	rs1051266	SLC19A1	TT	Toxicity	decreased	Adverse_Event	Other:C0003873		L04AX03	rs1051266:TT	11329481
fluvoxamine, milnacipran, paroxetine	rs1160351	MDGA2	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs1160351:A	5324346
"""antivirals for treatment of hiv infections, combinations"", ""ritonavir"""	rs429358	APOC1, APOE, TOMM40	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AP|S02DA30	rs429358:CC	392622
"""antivirals for treatment of hiv infections, combinations"", ""ritonavir"""	rs429358	APOC1, APOE, TOMM40	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AP|S02DA30	rs429358:CT	392622
escitalopram	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs6311:CT	162180
escitalopram	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Disease:C0003469		N06AB10	rs6311:TT	162180
tacrolimus	rs1800872	IL10	TT	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs1800872:TT	131769926
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:GG	54688261
levodopa	rs4704559	HOMER1	AG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:AG	9307
levodopa	rs4704559	HOMER1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:GG	9307
cyclophosphamide, docetaxel, epirubicin	rs4880	SOD2	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L01AA01|L01CD02|L01DB03	rs4880:AG	2907
cyclophosphamide, docetaxel, epirubicin	rs4880	SOD2	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L01AA01|L01CD02|L01DB03	rs4880:GG	2907
levodopa	rs4704559	HOMER1	AG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:AG	9307
levodopa	rs4704559	HOMER1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030567		N04BA02	rs4704559:GG	9307
estradiol	rs6721961	NFE2L2	T	Toxicity	increased	Adverse_Event	Healthy		G03CA03	rs6721961:T	9046
hydrochlorothiazide	rs7297610	YEATS4	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs7297610:CC	2904
capecitabine	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs3918290:CT	11809635
warfarin	rs5896	F2	CT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:CT	54688261
warfarin	rs5896	F2	TT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:TT	54688261
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Other:C0024299		L01CA02	rs924607:TT	24848381
cisplatin, paclitaxel	rs1042522	TP53	CG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:CG	5460033
cisplatin, paclitaxel	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:GG	5460033
azathioprine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:AC	5778
clopidogrel	rs71647871	CES1	CT	PD	increased	Adverse_Event	Healthy		B01AC04	rs71647871:CT	13748464
none	rs1800797	IL6	AG	Other	increased	Adverse_Event	Other:C0027651		A03DA02	rs1800797:AG	5282367
none	rs1800797	IL6	GG	Other	increased	Adverse_Event	Other:C0027651		A03DA02	rs1800797:GG	5282367
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A	54688261
ethanol	rs1229984	ADH1B	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1229984:T	444899
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG	54688261
none	rs10965219	CDKN2B-AS1	G	Other	increased	Other	Healthy		A03DA02	rs10965219:G	5282367
morphine	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02AA01	rs4680:AA	5284371
ethanol	rs61826952	RABGAP1L	G	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs61826952:G	444899
morphine	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02AA01	rs4680:AA	5284371
none	rs10965219	CDKN2B-AS1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs10965219:G	5282367
tramadol	rs1058172	CYP2D6	CC	Toxicity	increased	Adverse_Event	Other:C0277589		N02AX02	rs1058172:CC	63013
clozapine	rs16947	CYP2D6	GG	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs16947:GG	131769989
tramadol	rs4803419	CYP2B6	CC	Toxicity	increased	Adverse_Event	Other:C0277589		N02AX02	rs4803419:CC	63013
none	rs4240157	ACE2	CC	Other	increased	Adverse_Event	Other:COVID-19		A03DA02	rs4240157:CC	5282367
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
none	rs4240157	ACE2	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs4240157:C	5282367
clozapine	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs1065852:AA	131769989
clozapine	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs1065852:AA	131769989
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:TT	11329481
clozapine	rs16947	CYP2D6	GG	Toxicity	increased	Adverse_Event	Other:C0036341		N05AH02	rs16947:GG	131769989
hmg coa reductase inhibitors	rs10849757	COQ5	AA	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs10849757:AA	445127
hmg coa reductase inhibitors	rs10849757	COQ5	AG	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs10849757:AG	445127
azathioprine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs1127354:AC	5778
zoledronic acid	rs2297480	FDPS	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		M05BA08	rs2297480:TT	68740
hmg coa reductase inhibitors	rs11548336	COQ3	TT	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs11548336:TT	445127
imatinib	rs3745274	CYP2B6	GG	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GG	6113
hmg coa reductase inhibitors	rs4693075	COQ2	CG	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs4693075:CG	445127
hmg coa reductase inhibitors	rs4693075	COQ2	GG	Efficacy	increased	Adverse_Event	Other:C0018839		C10AA	rs4693075:GG	445127
cyclophosphamide, doxorubicin	rs2032582	ABCB1	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs2032582:CT	2907
cyclophosphamide, doxorubicin	rs2032582	ABCB1	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs2032582:TT	2907
cyclophosphamide, doxorubicin	rs3211371	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs3211371:T	2907
atorvastatin, pravastatin, simvastatin	rs8014194	CLMN	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		C10AA01|C10AA03|C10AA05	rs8014194:A	60823
cyclophosphamide, doxorubicin	rs12721655	CYP2B6	AG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs12721655:AG	2907
nintedanib	rs2076295	DSP	TT	Efficacy	decreased	Efficacy_Response	Other:C0034069		L01EX09	rs2076295:TT	135461425
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:TT	54688261
cyclophosphamide, doxorubicin	rs8192709	CYP2B6	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs8192709:CT	2907
fluorouracil, leucovorin	rs1801133	MTHFR	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC02	rs1801133:GG	135403648
warfarin	rs5896	F2	CT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:CT	54688261
warfarin	rs5896	F2	TT	Dosage	decreased	Other	Healthy		B01AA03	rs5896:TT	54688261
busulfan	rs12248560	CYP2C19	CC	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	rs12248560:CC	4684
capecitabine	rs1801131	MTHFR	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01BC06	rs1801131:TT	11809635
warfarin	rs510317	F7	GG	Dosage	decreased	Other	Healthy		B01AA03	rs510317:GG	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1135216	TAP1	CT	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs1135216:CT	No_match
olanzapine, quetiapine, risperidone	rs1800497	ANKK1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AH03|N05AH04|N05AX08	rs1800497:AA	5073
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs651630	SLC12A8	AA	Toxicity	decreased	Adverse_Event	Disease:C0235763		No_ATC	rs651630:AA	No_match
radiotherapy	rs264588	TANC1	A	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264588:A	No_match
efavirenz	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
radiotherapy	rs264631	TANC1	G	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264631:G	No_match
busulfan	rs1799853	CYP2C9	CT	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	rs1799853:CT	4684
busulfan	rs1799853	CYP2C9	TT	Metabolism/PK	increased	LADME	Disease:hemopoietic_stem_cell_transplant		L01AB01	rs1799853:TT	4684
cyclophosphamide, doxorubicin	rs714368	SLC22A16	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs714368:C	2907
radiotherapy	rs7582141	TANC1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs7582141:T	No_match
fluorouracil, irinotecan, leucovorin	rs7699188	ABCG2	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02	rs7699188:A	135403648
radiotherapy	rs6432512	TANC1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs6432512:T	No_match
radiotherapy	rs264663	TANC1	T	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264663:T	No_match
fluorouracil, irinotecan, leucovorin	rs2032582	ABCB1	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02	rs2032582:CC	135403648
radiotherapy	rs264651	TANC1	G	Toxicity	increased	Adverse_Event	Disease:C0033578		No_ATC	rs264651:G	No_match
cyclophosphamide, doxorubicin	rs3745274	CYP2B6	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs3745274:T	2907
cyclophosphamide, doxorubicin	rs8192709	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs8192709:T	2907
platinum compounds	rs2228000	XPC	AA	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs2228000:AA	23939
platinum compounds	rs2228000	XPC	AG	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs2228000:AG	23939
secukinumab	rs2248374	ERAP2	GG	Efficacy	increased	Adverse_Event	Other:C0235763		L04AC10	rs2248374:GG	No_match
cyclophosphamide, doxorubicin	rs12210538	SLC22A16	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs12210538:G	2907
cyclophosphamide, doxorubicin	rs723685	SLC22A16	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs723685:G	2907
cyclophosphamide, doxorubicin	rs6907567	SLC22A16	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB01	rs6907567:G	2907
aspirin	rs730012	LTC4S	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs730012:C	72204814
atorvastatin, rosuvastatin	rs4693075	COQ2	G	Toxicity	increased	Adverse_Event	Disease:C0342882		C10AA05|C10AA07	rs4693075:G	60823
atezolizumab, avelumab, durvalumab, ipilimumab, nivolumab, pembrolizumab	rs35719165	SEMA5A	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs35719165:A	No_match
methotrexate	rs2236225	MTHFD1	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs2236225:AA	11329481
methotrexate	rs2236225	MTHFD1	AG	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs2236225:AG	11329481
warfarin	rs2884737	VKORC1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs2884737:CC	54688261
efavirenz, nelfinavir	rs1045642	ABCB1	AA	Efficacy, Other	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AE04|J05AG03	rs1045642:AA	64139
efavirenz	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:AA	64139
atezolizumab, avelumab, durvalumab, ipilimumab, nivolumab, pembrolizumab	rs1862167	EDIL3	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1862167:T	No_match
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
doxorubicin	rs17222723	ABCC2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0024299		L01DB01	rs17222723:A	83958
amitriptyline, citalopram, paroxetine, venlafaxine	rs2032583	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2032583:AG	667572
amitriptyline, citalopram, paroxetine, venlafaxine	rs2032583	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2032583:GG	667572
azathioprine	rs2295475	XDH	AA	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs2295475:AA	5778
azathioprine	rs2295475	XDH	AG	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs2295475:AG	5778
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs116855232:CT	5778
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0021390|Other:C0024141|Other:C0030353		L04AX01	rs116855232:TT	5778
none	rs10421558	ATP8B3	G	Toxicity	decreased	Adverse_Event	Other:C0004096		A03DA02	rs10421558:G	5282367
none	rs1045642	ABCB1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1045642:AA	5282367
isoniazid, pyrazinamide, rifampin	rs1799929	NAT2	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1799929:T	135483892
isoniazid, pyrazinamide, rifampin	rs1799930	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1799930:A	135483892
anthracyclines and related substances, doxorubicin, epirubicin	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01DB|L01DB01|L01DB03	rs1045642:GG	31703
ritonavir	rs2854117	APOC3	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	rs2854117:T	71749331
none	rs5186	AGTR1	CC	Other	increased	Adverse_Event	Disease:C1956346		A03DA02	rs5186:CC	5282367
imatinib	rs10821936	ARID5B	TT	Efficacy	increased	Adverse_Event	Other:C0023473|BCR-ABL1_positive		L01EA01	rs10821936:TT	6113
isoniazid, pyrazinamide, rifampin	rs1041983	NAT2	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1041983:T	135483892
isoniazid, pyrazinamide, rifampin	rs1801280	NAT2	C	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs1801280:C	135483892
fexofenadine	rs1045642	ABCB1	AA	Dosage, Metabolism/PK	decreased	LADME	Healthy		R06AX26	rs1045642:AA	63002
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C	64139
efavirenz	rs4803419	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs4803419:T	64139
imatinib	rs2372536	ATIC	G	Efficacy	increased	Adverse_Event	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2372536:G	6113
atorvastatin, simvastatin	rs2740574	CYP3A4	CC	Other	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	rs2740574:CC	60823
atorvastatin, simvastatin	rs2740574	CYP3A4	CT	Other	decreased	Adverse_Event	Healthy		C10AA01|C10AA05	rs2740574:CT	60823
fexofenadine	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	decreased	LADME	Healthy		R06AX26	rs2032582:AA	63002
ritodrine	rs7625907	KCNMB2	GG	Toxicity	decreased	Adverse_Event	Healthy		G02CA01	rs7625907:GG	33572
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
doxorubicin	rs45511401	ABCC1	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0024299		L01DB01	rs45511401:T	83958
doxorubicin	rs8187710	ABCC2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0024299		L01DB01	rs8187710:A	83958
capecitabine, folfox, tegafur	rs4939827	SMAD7	CC	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01BC03|L01BC06	rs4939827:CC	60953
doxorubicin	rs1883112	NCF4	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L01DB01	rs1883112:AA	83958
none	rs10403288	ATP8B3	A	Toxicity	decreased	Adverse_Event	Other:C0004096		A03DA02	rs10403288:A	5282367
simvastatin	rs1128503	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA01	rs1128503:A	14373154
none	rs2074192	ACE2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs2074192:T	5282367
doxorubicin	rs4673	CYBA	A	Toxicity	increased	Adverse_Event	Disease:C0024299		L01DB01	rs4673:A	83958
simvastatin	rs1045642	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:C0020443		C10AA01	rs1045642:A	14373154
doxorubicin	rs13058338	RAC2	T	Toxicity	increased	Adverse_Event	Disease:C0024299		L01DB01	rs13058338:T	83958
simvastatin	rs2032582	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0020443		C10AA01	rs2032582:C	14373154
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
atorvastatin, simvastatin	rs705379	PON1	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs705379:AA	60823
atorvastatin, simvastatin	rs705379	PON1	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs705379:AG	60823
atorvastatin, simvastatin	rs662	PON1	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs662:CC	60823
atorvastatin, simvastatin	rs662	PON1	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs662:CT	60823
atorvastatin	rs705379	PON1	GG	Other	decreased	Other	Disease:C0020443		C10AA05	rs705379:GG	656846
clozapine	rs58933792	TACR1	C	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs58933792:C	131769989
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
fluconazole, tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	LADME	Disease:C0277631		J02AC01|L04AD02	rs776746:CC	445643
fluconazole, tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	LADME	Disease:C0277631		J02AC01|L04AD02	rs776746:CC	445643
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	LADME	Disease:C0277631		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	LADME	Disease:C0277631		L04AD02	rs776746:TT	131769926
tamoxifen	rs10841795	SLCO1A2	AG	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BA01	rs10841795:AG	2733525
tamoxifen	rs10841795	SLCO1A2	GG	Toxicity	decreased	Adverse_Event	Other:C1458155		L02BA01	rs10841795:GG	2733525
clozapine	rs3942465	ERBB4	C	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs3942465:C	131769989
diazepam	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:C0085762		N05BA01	rs4244285:AA	3016
diazepam	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C0085762		N05BA01	rs4244285:AG	3016
"""ace inhibitors, plain"", ""angiotensin ii antagonists"", ""beta blocking agents"", ""digoxin"", ""diuretics"", ""spironolactone"""	rs1042713	ADRB2	GG	Other	increased	Adverse_Event	Disease:C0085605		C03|C03DA01|C09A|S01ED	rs1042713:GG	2724385
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AA	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10	rs1127354:AA	37542
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AC	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10	rs1127354:AC	37542
l-asparagine, prednisone, vincristine	rs1049674	ASNS	AT	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	rs1049674:AT	5865
"""ace inhibitors, plain"", ""angiotensin ii antagonists"", ""beta blocking agents"", ""digoxin"", ""diuretics"", ""spironolactone"""	rs1799983	NOS3	TT	Other	increased	Adverse_Event	Disease:C0085605		C03|C03DA01|C09A|S01ED	rs1799983:TT	2724385
efavirenz, lopinavir, nucleoside and nucleotide reverse transcriptase inhibitors, ritonavir	rs2853826	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AF|J05AG03|J05AR10	rs2853826:G	64139
diazepam	rs12248560	CYP2C19	CT	Toxicity	decreased	Adverse_Event	Other:C0085762		N05BA01	rs12248560:CT	3016
diazepam	rs12248560	CYP2C19	TT	Toxicity	decreased	Adverse_Event	Other:C0085762		N05BA01	rs12248560:TT	3016
"""ace inhibitors, plain"", ""angiotensin ii antagonists"", ""beta blocking agents"", ""digoxin"", ""diuretics"", ""spironolactone"""	rs1801253	ADRB1	GG	Other	decreased	Adverse_Event	Disease:C0085605		C03|C03DA01|C09A|S01ED	rs1801253:GG	2724385
l-asparagine, prednisone, vincristine	rs9282564	ABCB1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01CA02	rs9282564:CT	5865
olanzapine	rs2011425	UGT1A4	GG	Toxicity	decreased	Adverse_Event	Other:C0036341		N05AH03	rs2011425:GG	74603552
olanzapine	rs2011425	UGT1A4	GT	Toxicity	decreased	Adverse_Event	Other:C0036341		N05AH03	rs2011425:GT	74603552
olanzapine	rs2740574	CYP3A4	CC	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs2740574:CC	74603552
olanzapine	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs2740574:CT	74603552
cabazitaxel	rs17327624	ABCB1	T	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0033578		L01CD04	rs17327624:T	148124
simvastatin	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs1128503:AA	14373154
olanzapine	rs2011425	UGT1A4	GG	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs2011425:GG	74603552
olanzapine	rs2011425	UGT1A4	GT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs2011425:GT	74603552
cyclosporine	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs1045642:AG	86666680
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
clopidogrel	rs6785930	P2RY12	AA	Efficacy	increased	Adverse_Event	Other:C0010068		B01AC04	rs6785930:AA	13748464
clopidogrel	rs6785930	P2RY12	AG	Efficacy	increased	Adverse_Event	Other:C0010068		B01AC04	rs6785930:AG	13748464
cabazitaxel	rs2235040	ABCB1	T	Toxicity	decreased	Adverse_Event	Other:C2939419|Other:C0033578		L01CD04	rs2235040:T	148124
tacrolimus	rs2066844	NOD2	CC	Other	increased	Other	Disease:Kidney_Transplantation		L04AD02	rs2066844:CC	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
cyclosporine, tacrolimus	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Healthy		L04AD01|L04AD02	rs2740574:CT	445643
warfarin	rs2359612	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2359612:AA	54688261
warfarin	rs2359612	VKORC1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2359612:AG	54688261
azathioprine, mercaptopurine	rs16952570	FTO	CC	Toxicity	decreased	Adverse_Event	Other:C0009324|Other:C0010346		L01BB02|L04AX01	rs16952570:CC	5778
oseltamivir	rs121912777	CES1	CT	Metabolism/PK	Indeterminado	LADME	Healthy		J05AH02	rs121912777:CT	78000
oseltamivir	rs121912777	CES1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		J05AH02	rs121912777:TT	78000
azathioprine, mercaptopurine	rs16952570	FTO	CT	Toxicity	increased	Adverse_Event	Other:C0009324|Other:C0010346		L01BB02|L04AX01	rs16952570:CT	5778
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
cabazitaxel	rs11572093	CYP2C8	T	Toxicity	increased	Adverse_Event	Other:C2939419|Other:C0033578		L01CD04	rs11572093:T	148124
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
citalopram	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs4244285:A	162180
warfarin	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:AG	54688261
nortriptyline	rs5443	GNB3	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C0011581		N06AA10	rs5443:TT	9918
warfarin	rs8050894	VKORC1	CG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs8050894:CG	54688261
warfarin	rs8050894	VKORC1	GG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs8050894:GG	54688261
nortriptyline	rs5443	GNB3	TT	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AA10	rs5443:TT	9918
warfarin	rs2884737	VKORC1	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2884737:AC	54688261
warfarin	rs2884737	VKORC1	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs2884737:CC	54688261
nortriptyline	rs5443	GNB3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AA10	rs5443:TT	9918
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
warfarin	rs9934438	VKORC1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:A	54688261
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
none	rs1051266	SLC19A1	C	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs1051266:C	5282367
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1045642:AA	15478
olanzapine	rs7997012	HTR2A	AA	Toxicity	increased	Adverse_Event	Other:C0033975		N05AH03	rs7997012:AA	74603552
capecitabine, fluorouracil, tegafur	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs3918290:T	60953
capecitabine, fluorouracil, tegafur	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs67376798:A	60953
olanzapine	rs1045642	ABCB1	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		N05AH03	rs1045642:A	74603552
olanzapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0033975		N05AH03	rs762551:AA	74603552
nicotine	rs1799971	OPRM1	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1799971:AA	936
olanzapine	rs6275	DRD2	A	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs6275:A	74603552
anthracyclines and related substances	rs9024	CBR1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs9024:GG	No_match
olanzapine	rs6279	DRD2	G	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs6279:G	74603552
cephalexin	rs34545984	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs34545984:T	27447
olanzapine	rs1124493	DRD2	T	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs1124493:T	74603552
olanzapine	rs2734841	DRD2	A	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs2734841:A	74603552
aspirin	rs115346678	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs115346678:A	72204814
methotrexate	rs2236225	MTHFD1	A	Efficacy	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs2236225:A	11329481
simvastatin	rs4253728	PPARA	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs4253728:AA	14373154
methotrexate	rs1801133	MTHFR	A	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:A	11329481
codeine	rs9620007	WBP2NL	G	Toxicity	decreased	Adverse_Event	Healthy		R05DA04	rs9620007:G	5284371
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A	54688261
codeine, hydrocodone, oxycodone, tramadol	rs62436463	OPRM1	T	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|N02AX02|R05DA03|R05DA04	rs62436463:T	5284569
metformin	rs316009	SLC22A2	CC	Toxicity	increased	Adverse_Event	Other:C0011849		A10BA02	rs316009:CC	155906370
metformin	rs316019	SLC22A2	CC	Toxicity	increased	Adverse_Event	Other:C0011849		A10BA02	rs316019:CC	155906370
simvastatin	rs4823613	PPARA	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs4823613:GG	14373154
none	rs1800497	ANKK1	GG	Efficacy	increased	Adverse_Event	Healthy		A03DA02	rs1800497:GG	5282367
nicotine	rs4680	COMT	GG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs4680:GG	936
escitalopram	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Other:C0235876|Other:C0003469	intermediate metabolizer	N06AB10	rs6311:CT	162180
escitalopram	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0235876|Other:C0003469	intermediate metabolizer	N06AB10	rs6311:TT	162180
nicotine	rs1800497	ANKK1	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AA	936
nicotine	rs1800497	ANKK1	AG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AG	936
amiodarone, antibiotics, antipsychotics, diuretics, quinidine, sotalol	rs1805128	KCNE1	T	Toxicity	increased	Adverse_Event	Healthy		C01BA01|C01BD01|C03|C07AA07|N05A|S01AA	rs1805128:T	441074
nicotine	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1799971:GG	936
nicotine	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs1799971:AG	936
bupropion	rs1800497	ANKK1	GG	Efficacy	increased	Adverse_Event	Healthy		N06AX12	rs1800497:GG	446
olanzapine	rs2734842	DRD2	G	Other, Metabolism/PK	increased	Other	Healthy		N05AH03	rs2734842:G	74603552
methotrexate	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:A	11329481
pyrimidine analogues	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Healthy		L01BC	rs1801160:CT	No_match
pyrimidine analogues	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Healthy		L01BC	rs1801160:TT	No_match
rosuvastatin	rs2231142	ABCG2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA07	rs2231142:GG	5282455
amitriptyline	rs4244285	CYP2C19	AA	Other, Metabolism/PK	increased	LADME	Healthy		N06AA09	rs4244285:AA	4543
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
rosuvastatin	rs4149056	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0020443		C10AA07	rs4149056:TT	5282455
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A	13748464
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0020443		C10AA07	rs2231142:TT	5282455
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0085096		B01AC04	rs1045642:AA	13748464
cisplatin, docetaxel, fluorouracil	rs1024611	CCL2	GG	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1024611:GG	5460033
none	rs7242	SERPINE1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs7242:T	5282367
none	rs2227684	SERPINE1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs2227684:G	5282367
methotrexate	rs1801131	MTHFR	G	Efficacy	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G	11329481
gemcitabine	rs60369023	CDA	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0027651		L01BC05	rs60369023:A	597
methotrexate	rs3758149	GGH	AA	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0023449		L04AX03	rs3758149:AA	11329481
bisphosphonates	rs16944	IL1B	GG	Efficacy	increased	Adverse_Event	Disease:C0015230		M05BA	rs16944:GG	No_match
clodronate	rs1544410	VDR	C	Efficacy	increased	Adverse_Event	Disease:C0015230		No_ATC	rs1544410:C	31195
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
clodronate	rs731236	VDR	A	Efficacy	increased	Adverse_Event	Disease:C0015230		No_ATC	rs731236:A	31195
cytarabine, idarubicin	rs3750117	NT5C3A	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs3750117:GG	6253
atorvastatin, lovastatin, simvastatin	rs662799	APOA5	AG	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA02|C10AA05	rs662799:AG	60823
atorvastatin, lovastatin, simvastatin	rs662799	APOA5	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA02|C10AA05	rs662799:GG	60823
citalopram, sertraline	rs6311	HTR2A	T	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB04|N06AB06	rs6311:T	2771
cisplatin, docetaxel, fluorouracil	rs1800796	IL6	CC	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1800796:CC	5460033
citalopram	rs6313	HTR2A	AA	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB04	rs6313:AA	162180
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0024299|Other:C0023449		L04AX03	rs1801133:AA	11329481
buprenorphine / naloxone	rs648893	OPRM1	AG	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs648893:AG	11274356
buprenorphine / naloxone	rs648893	OPRM1	GG	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs648893:GG	11274356
methotrexate	rs2267076	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2267076:T	11329481
methotrexate	rs2236624	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2236624:T	11329481
methotrexate	rs2298383	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2298383:T	11329481
tacrolimus	rs776746	CYP3A5	CT	Other	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Other	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
methotrexate	rs3761422	ADORA2A	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs3761422:T	11329481
cisplatin, docetaxel, fluorouracil	rs1799964	TNF	CC	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1799964:CC	5460033
cisplatin, docetaxel, fluorouracil	rs1799964	TNF	CT	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs1799964:CT	5460033
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Other:C0018839		B01AC04	rs1045642:AA	13748464
aspirin, clopidogrel	rs12041331	PEAR1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs12041331:AA	2244
aspirin, clopidogrel	rs12041331	PEAR1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs12041331:AG	2244
cisplatin, docetaxel, fluorouracil	rs717620	ABCC2	CT	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs717620:CT	5460033
cisplatin, docetaxel, fluorouracil	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0001418|""Other:C0001418|""Other:Neoplasm_of_esophagus"""		L01BC02|L01CD02|L01XA01	rs717620:TT	5460033
hydrochlorothiazide	rs12279250	NELL1	C	Metabolism/PK	increased	Adverse_Event	Disease:C0020538		C03AA03	rs12279250:C	2904
buprenorphine / naloxone	rs678849	OPRD1	TT	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs678849:TT	11274356
aripiprazole	rs2391191	DAOA	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX12	rs2391191:A	10114519
buprenorphine / naloxone	rs569356	OPRD1	A	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs569356:A	11274356
olanzapine	rs6318	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs6318:C	74603552
tacrolimus	rs776746	CYP3A5	T	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:T	131769926
tacrolimus	rs776746	CYP3A5	CC	Efficacy, Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
simvastatin	rs4673	CYBA	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA01	rs4673:AA	14373154
simvastatin	rs4673	CYBA	AG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA01	rs4673:AG	14373154
bupropion	rs3211371	CYP2B6	CT	Efficacy	increased	Adverse_Event	Other:female_gender		N06AX12	rs3211371:CT	446
aspirin	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Other:C0018839		No_ATC	rs1045642:AG	72204814
aspirin	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:C0018839		No_ATC	rs1045642:GG	72204814
olanzapine	rs6280	DRD3	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs6280:CC	74603552
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0010346		L01BB02|L04AX01	rs116855232:CT	5778
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0010346		L01BB02|L04AX01	rs116855232:TT	5778
olanzapine	rs951439	RGS4	CT	Efficacy	increased	Adverse_Event	Disease:C0036341		N05AH03	rs951439:CT	74603552
cabazitaxel	rs151352	TUBB1	G	Efficacy	increased	Efficacy_Response	Other:C2939419|Other:C0033578		L01CD04	rs151352:G	148124
risperidone	rs951439	RGS4	TT	Efficacy	increased	Adverse_Event	Disease:C0036341		N05AX08	rs951439:TT	849421
olanzapine, perphenazine	rs951439	RGS4	CC	Efficacy	increased	Adverse_Event	Disease:C0036341		N05AB03|N05AH03	rs951439:CC	135398745
cabazitaxel	rs1341164	CYP2C8	C	Efficacy	increased	Efficacy_Response	Other:C2939419|Other:C0033578		L01CD04	rs1341164:C	148124
olanzapine	rs4731426	LEP	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs4731426:GG	74603552
heroin	rs13242038	GRM3	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs13242038:T	9844225
amitriptyline, citalopram, paroxetine, venlafaxine	rs2235015	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2235015:A	667572
none	rs4343	ACE	G	Metabolism/PK	increased	Other	Disease:C0020538		A03DA02	rs4343:G	5282367
antidepressants	rs6295	HTR1A	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs6295:GG	No_match
opioids	rs9282564	ABCB1	CC	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02A	rs9282564:CC	No_match
opioids	rs9282564	ABCB1	CT	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02A	rs9282564:CT	No_match
anthracyclines and related substances, taxanes	rs1045642	ABCB1	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L01CD|L01DB	rs1045642:AA	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
paroxetine, sertraline	rs6295	HTR1A	CC	Efficacy	increased	Adverse_Event	Disease:C0030319		N06AB05|N06AB06	rs6295:CC	667572
opioids	rs2070995	KCNJ6	TT	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02A	rs2070995:TT	No_match
warfarin	rs8050894	VKORC1	G	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs8050894:G	54688261
warfarin	rs9923231	VKORC1	T	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:T	54688261
nevirapine	rs28399499	CYP2B6	CT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:CT	15979285
nevirapine	rs776746	CYP3A5	CC	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs776746:CC	15979285
nevirapine	rs776746	CYP3A5	CT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs776746:CT	15979285
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3849942	C9orf72	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs3849942:T	No_match
methamphetamine	rs3213207	DTNBP1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3213207:C	36604
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2814707	MOB3B	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs2814707:T	No_match
methamphetamine	rs2076369	PICK1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2076369:T	36604
nevirapine	rs12721646	CYP2B6	CT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs12721646:CT	15979285
nevirapine	rs12721646	CYP2B6	TT	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs12721646:TT	15979285
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs928655	GBP6	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs928655:A	No_match
fluorouracil	rs1801265	DPYD	AG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801265:AG	5790
fluorouracil	rs1801265	DPYD	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs1801265:GG	5790
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs774359	C9orf72	C	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs774359:C	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs983332	CSRP3	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs983332:T	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs868856	MOB3B	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs868856:A	No_match
methotrexate	rs1801131	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G	11329481
methotrexate	rs1801131	MTHFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:TT	11329481
methotrexate	rs1051266	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:TT	11329481
gefitinib	rs712829	EGFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:GT	135496227
gefitinib	rs712829	EGFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:TT	135496227
antiandrogens	rs12529	AKR1C3	CC	Efficacy	increased	Adverse_Event	Disease:C0033578		G03H	rs12529:CC	No_match
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:AG	54688261
cisplatin, cyclophosphamide	rs11615	ERCC1	AG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs11615:AG	2907
cisplatin, cyclophosphamide	rs1042522	TP53	GG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1042522:GG	2907
paclitaxel	rs11572080	CYP2C8	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs11572080:TT	36314
methotrexate	rs2238476	ABCC1	GG	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs2238476:GG	11329481
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6028945	MAFB	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs6028945:T	No_match
olanzapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0011581|Disease:C0036341		N05AH03	rs3813929:T	74603552
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6071980	MAFB	C	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs6071980:C	No_match
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT	5790
olanzapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH03	rs3813929:T	74603552
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6138150	CST5	T	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs6138150:T	No_match
olanzapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH03	rs3813929:T	74603552
cisplatin, cyclophosphamide	rs1695	GSTP1	AA	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs1695:AA	2907
antipsychotics	rs1801133	CLCN6, MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1801133:A	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs854548	PON1	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs854548:A	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs854555	PON1	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs854555:A	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs7046653	MOB3B	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs7046653:A	No_match
buprenorphine	rs2740574	CYP3A4	CC	Efficacy	increased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs2740574:CC	11274356
buprenorphine	rs2740574	CYP3A4	CT	Efficacy	increased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01	rs2740574:CT	11274356
warfarin	rs9934438	VKORC1	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:AG	54688261
docetaxel	rs11185648	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs11185648:CT	154272
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T	54688261
docetaxel	rs11185647	RXRA	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs11185647:AG	154272
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs12201199:T	441203
docetaxel	rs2234753	RXRA	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs2234753:AG	154272
docetaxel	rs6413517	RXRA	GT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs6413517:GT	154272
docetaxel	rs62576288	RXRA	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs62576288:GG	154272
none	rs2298771	SCN1A	CT	Other	increased	Adverse_Event	Healthy		A03DA02	rs2298771:CT	5282367
methotrexate	rs9345389	__INTRONIC__	G	Toxicity	Indeterminado	Adverse_Event	Healthy		L04AX03	rs9345389:G	11329481
docetaxel	rs6130615	HNF4A	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs6130615:TT	154272
antipsychotics	rs7997012	HTR2A	GG	Efficacy	increased	Adverse_Event	Other:C0036341		N05A	rs7997012:GG	No_match
simvastatin	rs76103438	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs76103438:A	14373154
diazepam	rs35599367	CYP3A4	GG	Toxicity	increased	Adverse_Event	Other:C0085762		N05BA01	rs35599367:GG	3016
antipsychotics	rs6314	HTR2A	AG	Efficacy	increased	Adverse_Event	Other:C0036341		N05A	rs6314:AG	No_match
docetaxel	rs2273618	HNF4A	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs2273618:CT	154272
docetaxel	rs3746574	HNF4A	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3746574:CT	154272
warfarin	rs9934438	VKORC1	A	Dosage, Efficacy	Indeterminado	Other	Healthy		B01AA03	rs9934438:A	54688261
docetaxel	rs3732360	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3732360:TT	154272
none	rs985919	NRXN1	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs985919:C	5282367
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	AG	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03|S01ED	rs4149601:AG	No_match
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03|S01ED	rs4149601:GG	No_match
meperidine	rs185462714	SERINC5	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs185462714:C	4058
cisplatin, cyclophosphamide	rs3957357	GSTA1	AA	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs3957357:AA	2907
docetaxel	rs3732359	NR1I2	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3732359:AA	154272
none	rs17408276	CHRNA5	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs17408276:C	5282367
beta blocking agents	rs139945292	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Other:C0020538		S01ED	rs139945292:T	No_match
nicotine	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs4680:AA	936
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT	14373154
penicillin g, penicillin v	rs115200108	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs115200108:A	6869
nicotine	rs4680	COMT	AG	Efficacy	increased	Adverse_Event	Healthy		N07BA01	rs4680:AG	936
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A	54688261
docetaxel	rs3814058	NR1I2	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3814058:CC	154272
docetaxel	rs3814058	NR1I2	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3814058:TT	154272
none	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs16969968:A	5282367
none	rs1882296	NRXN1	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs1882296:C	5282367
docetaxel	rs10538494	NR1I3	TT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs10538494:TT	154272
codeine, hydrocodone, oxycodone, tramadol	rs739296	SEPTIN3, WBP2NL	A	Toxicity	decreased	Adverse_Event	Healthy		N02AA05|N02AX02|R05DA03|R05DA04	rs739296:A	5284569
meperidine	rs113100019	FIP1L1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs113100019:G	4058
docetaxel	rs75114882	NR1I3	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs75114882:AG	154272
none	rs10865246	NRXN1	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs10865246:C	5282367
cisplatin	rs9332377	COMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs9332377:T	441203
docetaxel	rs2501873	NR1I3	CC	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CD02	rs2501873:CC	154272
cisplatin, cyclophosphamide	rs1799793	ERCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799793:CT	2907
cisplatin, cyclophosphamide	rs3212986	ERCC1	AC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3212986:AC	2907
cisplatin, cyclophosphamide	rs25487	XRCC1	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs25487:CC	2907
meperidine	rs11049274	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs11049274:A	4058
docetaxel	rs1536475	RXRA	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs1536475:AG	154272
cisplatin	rs2228001	XPC	G	Toxicity	increased	Adverse_Event	Disease:C0029463		L01XA01	rs2228001:G	441203
docetaxel	rs2502815	NR1I3	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs2502815:GG	154272
docetaxel	rs9725457	NR1I3	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs9725457:AA	154272
cisplatin	rs13181	ERCC2, KLC3	G	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs13181:G	441203
ethanol	rs6088638	ACSS2	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6088638:T	444899
capecitabine, fluorouracil	rs17376848	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs17376848:AG	60953
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:G	444899
angiotensin ii antagonists	rs1058164	CYP2D6	C	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs1058164:C	172198
cisplatin	rs11615	ERCC1	G	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01XA01	rs11615:G	441203
none	rs429358	APOE	CC	Other	increased	Adverse_Event	Healthy		A03DA02	rs429358:CC	5282367
clopidogrel	rs4986893	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A	13748464
angiotensin ii antagonists	rs1985842	CYP2D6	T	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs1985842:T	172198
none	rs1801280	NAT2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801280:T	5282367
angiotensin ii antagonists	rs1135840	CYP2D6	G	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs1135840:G	172198
clopidogrel	rs28399504	CYP2C19	G	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs28399504:G	13748464
angiotensin ii antagonists	rs28371713	CYP2D6	G	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs28371713:G	172198
none	rs1208	NAT2	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs1208:A	5282367
amoxicillin, clavulanate, flucloxacillin	rs72631546	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	rs72631546:C	16204478
gefitinib	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01EB01	rs2231142:GT	135496227
angiotensin ii antagonists	rs112568578	CYP2D6	G	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs112568578:G	172198
capecitabine, fluorouracil	rs895819	MIR23A, MIR24-2, MIR27A	C	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs895819:C	60953
fluorouracil	rs3918290	DPYD	CT	Toxicity	Indeterminado	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
amoxicillin, clavulanate	rs2476601	PTPN22	A	Toxicity	increased	Adverse_Event	Healthy		J01CA04	rs2476601:A	16204478
morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs1799971:AA	5284371
cocaine	rs6454674	CNR1	GT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:GT	2826
cocaine	rs6454674	CNR1	TT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:TT	2826
atenolol, beta blocking agents, carvedilol, metoprolol	rs4253778	PPARA	GG	Efficacy	decreased	Other	Disease:C0027051		C07AB02|C07AB03|C07AG02|S01ED	rs4253778:GG	185394
doxorubicin	rs2229774	RARG	AG	Toxicity	increased	Adverse_Event	Healthy		L01DB01	rs2229774:AG	83958
fluvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	rs2231142:GT	131750727
fluvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		C10AA04	rs2231142:TT	131750727
aspirin	rs9886152	TMEM196	T	Toxicity	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs9886152:T	72204814
pazopanib	rs11549467	HIF1A	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs11549467:AG	10113978
none	rs1801260	CLOCK	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801260:AA	5282367
none	rs1801260	CLOCK	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs1801260:AG	5282367
mercaptopurine, methotrexate	rs7270101	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs7270101:CC	126941
cocaine	rs6454674	CNR1	GT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:GT	2826
cocaine	rs6454674	CNR1	TT	Other	increased	Adverse_Event	Healthy		N01BC01	rs6454674:TT	2826
rituximab	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	Disease:C0024299|Large_B-Cell|Diffuse		L01FA01	rs396991:C	No_match
mercaptopurine, methotrexate	rs2278293	IMPDH1	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2278293:CT	126941
cocaine	rs806368	CNR1	C	Other	decreased	Adverse_Event	Healthy		N01BC01	rs806368:C	2826
mercaptopurine, methotrexate	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1127354:CC	126941
alendronate, raloxifene	rs1544410	VDR	CC	Efficacy	increased	Efficacy_Response	Disease:C0029456|Postmenopausal		G03XC01	rs1544410:CC	5035
asparaginase, dexamethasone, methotrexate	rs7142143	PYGL	CC	Dosage	increased	Adverse_Event	Disease:C0023449		L01XX02|L04AX03|S02BA06	rs7142143:CC	5743
asparaginase, dexamethasone, methotrexate	rs7142143	PYGL	CT	Dosage	increased	Adverse_Event	Disease:C0023449		L01XX02|L04AX03|S02BA06	rs7142143:CT	5743
interferons	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB	rs12979860:CC	No_match
pazopanib	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs4073:AA	10113978
erlotinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB02	rs121434569:T	176870
erlotinib, gefitinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01|L01EB02	rs121434569:T	176870
interferons	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB	rs8099917:TT	No_match
capecitabine, irinotecan, oxaliplatin	rs17376848	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06|L01CE02|L01XA03	rs17376848:AG	9887054
methotrexate	rs4888024	__INTRONIC__	G	Toxicity	Indeterminado	Adverse_Event	Healthy		L04AX03	rs4888024:G	11329481
tacrolimus	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1128503:AG	131769926
tacrolimus	rs2032582	ABCB1	AC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:AC	131769926
tacrolimus	rs2032582	ABCB1	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:CT	131769926
methotrexate	rs3784862	ABCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0235763		L04AX03	rs3784862:AA	11329481
ethanol	rs1799971	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1799971:A	444899
capecitabine	rs2297595	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2297595:CT	11809635
clopidogrel	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs1045642:A	13748464
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs945665113	CTBP2	A	Efficacy	increased	Efficacy_Response	Other:C0024121		No_ATC	rs945665113:A	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Other:PCI-scheduled_patients		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Other:PCI-scheduled_patients		B01AC04	rs4244285:AG	13748464
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs1801133:AG	135403648
antidepressants	rs6313	HTR2A	AA	Toxicity	decreased	Adverse_Event	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AA	No_match
antidepressants	rs6313	HTR2A	AG	Toxicity	decreased	Adverse_Event	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AG	No_match
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
sunitinib	rs2631367	SLC22A5	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs2631367:C	11221549
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:G	176870
clopidogrel	rs4244285	CYP2C19	AA	Efficacy, Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA	13748464
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB02	rs121434568:G	176870
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB02	rs121434568:G	176870
sunitinib	rs2631370	SLC22A5	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs2631370:C	11221549
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs376695472	CTBP2	G	Efficacy	increased	Efficacy_Response	Other:C0024121		No_ATC	rs376695472:G	No_match
antidepressants	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6311:CC	No_match
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs4244285:A	13748464
beta blocking agents	rs1042713	ADRB2	GG	Efficacy	decreased	Adverse_Event	Other:C0027051		S01ED	rs1042713:GG	No_match
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0027051|Other:C0027051		C10AA	rs4149056:CC	445127
fluorouracil	rs2959023	DPYS	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs2959023:G	5790
sunitinib	rs1805015	IL4R	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs1805015:C	11221549
omega-3 polyunsaturated fatty acids	rs20417	PTGS2	CG	Other	increased	Adverse_Event	Healthy		No_ATC	rs20417:CG	56842239
omega-3 polyunsaturated fatty acids	rs20417	PTGS2	GG	Other	increased	Adverse_Event	Healthy		No_ATC	rs20417:GG	56842239
none	rs20417	PTGS2	CG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs20417:CG	5282367
none	rs20417	PTGS2	GG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs20417:GG	5282367
fluorouracil	rs2669429	DPYS	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC02	rs2669429:G	5790
methotrexate	rs1801133	CLCN6, MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0085136		L04AX03	rs1801133:AG	11329481
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT	60953
sunitinib	rs2631372	SLC22A5	C	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs2631372:C	11221549
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs1801131:GG	135403648
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:G	176870
sunitinib	rs1801275	IL4R	G	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EX01	rs1801275:G	11221549
aminoglycoside antibacterials	rs267606619	MT-RNR1	T	Toxicity	increased	Adverse_Event	Healthy		J01G	rs267606619:T	No_match
tenofovir	rs1751034	ABCC4	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs1751034:CC	9574768
tenofovir	rs1751034	ABCC4	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs1751034:CT	9574768
azithromycin, erythromycin	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17|S01AA26	rs1045642:AA	9810601
azithromycin, erythromycin	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17|S01AA26	rs1045642:AG	9810601
corticosteroids	rs35514893	DTNBP1	T	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs35514893:T	No_match
none	rs1056836	CYP1B1	CC	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1056836:CC	5282367
none	rs1056836	CYP1B1	CG	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1056836:CG	5282367
thiotepa	rs1138272	GSTP1	T	Other	increased	LADME	Healthy		L01AC01	rs1138272:T	5453
tenofovir	rs1751034	ABCC4	TT	Other	increased	LADME	Healthy		J05AF07	rs1751034:TT	9574768
fluorouracil	rs2786783	DPYD	A	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs2786783:A	5790
none	rs72554664	G6PD	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs72554664:T	5282367
opioids	rs12442183	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N02A	rs12442183:T	No_match
corticosteroids	rs450789	KL	G	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs450789:G	No_match
interferon beta-1a, interferon beta-1b	rs2205986	IRF6	G	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AB07|L03AB08	rs2205986:G	No_match
methotrexate	rs3814058	NR1I2	C	Toxicity	decreased	Adverse_Event	Disease:C0029463		L04AX03	rs3814058:C	11329481
methotrexate	rs2273697	ABCC2	A	Toxicity	increased	Adverse_Event	Disease:C0029463		L04AX03	rs2273697:A	11329481
fluorouracil	rs2010851	WNT5B	CC	Efficacy	decreased	Other	Disease:C0024121		L01BC02	rs2010851:CC	5790
corticosteroids	rs2125362	ME3	A	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs2125362:A	No_match
methotrexate	rs6785049	NR1I2	G	Toxicity	decreased	Adverse_Event	Disease:C0029463		L04AX03	rs6785049:G	11329481
corticosteroids	rs7851998	LHX2	A	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs7851998:A	No_match
fluorouracil	rs2811178	DPYD	C	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs2811178:C	5790
corticosteroids	rs61585310	LHFPL3	G	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs61585310:G	No_match
asparaginase, corticosteroids, cyclophosphamide, cytarabine, mercaptopurine, methotrexate, vincristine	rs1800896	IL10	CC	Efficacy	increased	Efficacy_Response	Other:C0023449		L01AA01|L01BB02|L01BC01|L01CA02|L01XX02|L04AX03|S02BA	rs1800896:CC	2907
methotrexate	rs3732361	GSK3B	A	Metabolism/PK	decreased	Adverse_Event	Disease:C0029463		L04AX03	rs3732361:A	11329481
morphine	rs12208357	SLC22A1	T	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs12208357:T	5284371
corticosteroids	rs4897302	TRDN	T	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs4897302:T	No_match
nicotine	rs55781567	CHRNA5	G	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs55781567:G	936
heroin	rs4654327	OPRD1	AA	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs4654327:AA	9844225
olanzapine	rs10423928	GIPR	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs10423928:AA	74603552
olanzapine	rs10423928	GIPR	AT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs10423928:AT	74603552
nicotine	rs16969968	CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A	936
nicotine	rs503464	CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs503464:A	936
allopurinol	rs9469003	CYCSP5	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs9469003:C	168354693
fluorouracil	rs1801265	DPYD	G	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs1801265:G	5790
daunorubicin, doxorubicin	rs4982753	SLC22A17	T	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs4982753:T	31703
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
allopurinol, carbamazepine, phenytoin	rs9469003	CYCSP5	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs9469003:C	1775
nicotine	rs55853698	CHRNA5	G	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs55853698:G	936
amantadine, anticholinergics, dopamine agonists, levodopa, selegiline	rs622342	SLC22A1	C	Dosage, Efficacy, Toxicity	increased	Adverse_Event	Disease:C0030567		N04BA02|N04BC|N04BD01|S01FA	rs622342:C	5195
melphalan	rs967591	POLR1G	A	Efficacy, Toxicity	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01AA03	rs967591:A	20189
corticosteroids	rs11121611	ACOT7	G	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs11121611:G	No_match
peginterferon alfa-2b, ribavirin, telaprevir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs1127354:CC	37542
morphine	rs3804100	TLR2	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs3804100:CC	5284371
morphine	rs3804100	TLR2	CT	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs3804100:CT	5284371
daunorubicin, doxorubicin	rs4149178	SLC22A7	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs4149178:G	31703
rosuvastatin	rs12487736	SCAP	CC	Efficacy	decreased	Adverse_Event	Disease:C0524620		C10AA07	rs12487736:CC	5282455
rosuvastatin	rs12487736	SCAP	CT	Efficacy	decreased	Adverse_Event	Disease:C0524620		C10AA07	rs12487736:CT	5282455
allopurinol	rs3094188	PSORS1C3	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3094188:A	168354693
corticosteroids	rs5995653	APOBEC3B	A	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs5995653:A	No_match
allopurinol, carbamazepine, phenytoin	rs3094188	PSORS1C3	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3094188:A	1775
morphine	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs4680:AA	5284371
morphine	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs4680:AG	5284371
gemcitabine, paclitaxel	rs2072671	CDA	CC	Toxicity	increased	Adverse_Event	Other:C0030297		L01BC05|L01CD01	rs2072671:CC	36314
montelukast	rs119774	ABCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03DC03	rs119774:CT	122021
triamcinolone	rs2523864	HCG22	T	Toxicity	increased	Adverse_Event	Disease:C0231303		S01BA05	rs2523864:T	6216
antidepressants	rs7569963	CREB1, METTL21A	GG	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs7569963:GG	No_match
morphine	rs10499563	IL6	CC	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs10499563:CC	5284371
allopurinol	rs3130501	POU5F1	G	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3130501:G	168354693
allopurinol, carbamazepine, phenytoin	rs3130501	POU5F1	G	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3130501:G	1775
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs184278615	HLA-DRB5	A	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs184278615:A	No_match
citalopram	rs4675690	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04	rs4675690:T	162180
citalopram	rs7569963	CREB1, METTL21A	A	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AB04	rs7569963:A	162180
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs201469165	HLA-DRB5	T	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs201469165:T	No_match
"""antivirals for treatment of hiv infections, combinations"", ""ritonavir"""	rs7412	APOE	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03|J05AP|S02DA30	rs7412:T	392622
allopurinol	rs3130931	POU5F1	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3130931:C	168354693
triamcinolone	rs3873352	HCG22	G	Toxicity	increased	Adverse_Event	Disease:C0231303		S01BA05	rs3873352:G	6216
allopurinol, carbamazepine, phenytoin	rs3815087	PSORS1C1	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3815087:A	1775
morphine	rs2228145	IL6R	AC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2228145:AC	5284371
morphine	rs2228145	IL6R	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2228145:CC	5284371
allopurinol, carbamazepine, phenytoin	rs3130931	POU5F1	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs3130931:C	1775
morphine	rs6265	BDNF	TT	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs6265:TT	5284371
allopurinol	rs3815087	PSORS1C1	A	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3815087:A	168354693
morphine	rs2069762	IL2	AC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2069762:AC	5284371
morphine	rs2069762	IL2	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA01	rs2069762:CC	5284371
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs1071748	HLA-DRB5	C	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs1071748:C	No_match
aspirin, clopidogrel	rs1061781	B4GALT2	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1061781:CT	2244
aspirin, clopidogrel	rs1061781	B4GALT2	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1061781:TT	2244
methotrexate	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1128503:AA	11329481
methotrexate	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1128503:AG	11329481
allopurinol	rs2844665	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs2844665:C	168354693
mercaptopurine, methotrexate	rs2413775	SLC28A2	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2413775:AA	126941
chlorthalidone	rs5065	NPPA	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03BA04	rs5065:G	2732
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1045642:AA	11329481
methotrexate	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1045642:AG	11329481
mercaptopurine, methotrexate	rs2413775	SLC28A2	AT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2413775:AT	126941
cyclophosphamide	rs4880	SOD2	G	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01	rs4880:G	9554282
cyclophosphamide	rs2740574	CYP3A4	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01	rs2740574:C	9554282
doxorubicin	rs714368	SLC22A16	CC	Toxicity, Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs714368:CC	83958
mercaptopurine, methotrexate	rs747199	SLC29A1	CC	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs747199:CC	126941
allopurinol, carbamazepine, phenytoin	rs2844665	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		M04AA01|N03AB02|N03AF01	rs2844665:C	1775
cyclophosphamide	rs2279343	CYP2B6	AG	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs2279343:AG	9554282
cyclophosphamide	rs2279343	CYP2B6	GG	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs2279343:GG	9554282
cyclophosphamide	rs8192709	CYP2B6	CT	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs8192709:CT	9554282
cyclophosphamide	rs8192709	CYP2B6	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs8192709:TT	9554282
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors	rs973541788	KIR3DL2	G	Efficacy	decreased	Efficacy_Response	Other:C0024121		No_ATC	rs973541788:G	No_match
amoxicillin, clavulanate, flucloxacillin	rs3129880	HLA-DRA	T	Toxicity	increased	Adverse_Event	Healthy		J01CA04|J01CF05	rs3129880:T	16204478
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG	11329481
cyclophosphamide	rs3745274	CYP2B6	GT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Other:HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs3745274:GT	9554282
cyclophosphamide	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	decreased	Adverse_Event	Other:HLA-identical_hematopoietic_stem_cell_transplantation		L01AA01	rs3745274:TT	9554282
angiotensin ii antagonists	rs28371725	CYP2D6	C	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs28371725:C	172198
opioids	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:C0030193		N02A	rs1799971:GG	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG	13748464
cyclosporine, methotrexate	rs1801133	MTHFR	A	Other	Indeterminado	Adverse_Event	Other:recipients_of_HLA-identical_hematopoietic_stem_cell_transplantation		L04AD01|L04AX03	rs1801133:A	126941
carboplatin, cisplatin, gemcitabine	rs1695	GSTP1	AG	Efficacy	increased	Adverse_Event	Other:C0005695		L01BC05|L01XA01|L01XA02	rs1695:AG	10339178
carboplatin, cisplatin, gemcitabine	rs1695	GSTP1	GG	Efficacy	increased	Adverse_Event	Other:C0005695		L01BC05|L01XA01|L01XA02	rs1695:GG	10339178
angiotensin ii antagonists	rs2004511	CYP2D6	T	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs2004511:T	172198
mercaptopurine, methotrexate	rs2274407	ABCC4	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs2274407:CC	126941
doxorubicin	rs8133052	CBR3	G	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01DB01	rs8133052:G	83958
doxorubicin	rs8133052	CBR3	G	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C1458155		L01DB01	rs8133052:G	83958
doxorubicin	rs1056892	CBR3	A	Dosage, Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs1056892:A	83958
antihypertensives	rs1401982	ATP2B1	AA	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs1401982:AA	No_match
antihypertensives	rs1401982	ATP2B1	AG	Efficacy	increased	Adverse_Event	Other:C0020538		C02	rs1401982:AG	No_match
angiotensin ii antagonists	rs28371702	CYP2D6	A	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs28371702:A	172198
morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N02AA01	rs1799971:AA	5284371
mercaptopurine, methotrexate	rs10868138	SLC28A3	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs10868138:CC	126941
mercaptopurine, methotrexate	rs10868138	SLC28A3	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs10868138:CT	126941
heroin	rs724226	GRM3	A	Other	increased	Adverse_Event	Healthy		No_ATC	rs724226:A	9844225
acenocoumarol	rs7294	VKORC1	T	Other	decreased	Adverse_Event	Disease:C0004238|Disease:C0004239|Disease:C0042487		B01AA07	rs7294:T	54742534
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG	13748464
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T	54688261
corticosteroids	rs242941	CRHR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs242941:AA	No_match
methotrexate	rs1801133	CLCN6, MTHFR	AA	Efficacy	increased	Adverse_Event	Disease:C0029463		L04AX03	rs1801133:AA	11329481
corticosteroids	rs4713916	FKBP5	AA	Efficacy	increased	Adverse_Event	Disease:C0010346		S02BA	rs4713916:AA	No_match
corticosteroids	rs4713916	FKBP5	AG	Efficacy	increased	Adverse_Event	Disease:C0010346		S02BA	rs4713916:AG	No_match
budesonide, fluticasone propionate	rs242941	CRHR1	AA	Efficacy	Indeterminado	LADME	Disease:C0004096		R03BA02|R03BA05	rs242941:AA	5311101
opioids	rs1045642	ABCB1	G	Toxicity	increased	Adverse_Event	Other:C0024031		N02A	rs1045642:G	No_match
corticosteroids	rs1876828	CRHR1	TT	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs1876828:TT	No_match
gemcitabine	rs1155463	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		L01BC05	rs1155463:C	597
efavirenz	rs3745274	CYP2B6	GT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
antineoplastic and immunomodulating agents	rs212090	ABCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212090:AA	No_match
antineoplastic and immunomodulating agents	rs212090	ABCC1	AT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212090:AT	No_match
budesonide, fluticasone propionate	rs1876828	CRHR1	TT	Efficacy	Indeterminado	LADME	Disease:C0004096		R03BA02|R03BA05	rs1876828:TT	5311101
antineoplastic and immunomodulating agents	rs4149171	SLC22A6	CC	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149171:CC	No_match
antineoplastic and immunomodulating agents	rs4149171	SLC22A6	CT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149171:CT	No_match
antineoplastic and immunomodulating agents	rs955434	__INTRONIC__	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs955434:AA	No_match
antineoplastic and immunomodulating agents	rs955434	__INTRONIC__	AG	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs955434:AG	No_match
chlorothiazide, hydrochlorothiazide	rs61824877	__INTRONIC__	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03|C03EA01	rs61824877:A	2720
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
antineoplastic and immunomodulating agents	rs4149170	SLC22A6	CT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149170:CT	No_match
antineoplastic and immunomodulating agents	rs4149170	SLC22A6	TT	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs4149170:TT	No_match
tramadol	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Healthy		N02AX02	rs1799971:GG	63013
chlorothiazide, hydrochlorothiazide	rs9943291	HMGCS2	G	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03|C03EA01	rs9943291:G	2720
methotrexate	rs1801133	CLCN6, MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG	11329481
methadone	rs55944529	DAO	TT	Efficacy	increased	Adverse_Event	Other:C0028043		N07BC02	rs55944529:TT	10090
antineoplastic and immunomodulating agents	rs4148579	ABCC5	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs4148579:CC	No_match
none	rs11739136	KCNIP1, KCNMB1	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11739136:CT	5282367
none	rs11739136	KCNIP1, KCNMB1	TT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11739136:TT	5282367
infliximab	rs1143634	IL1B	GG	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs1143634:GG	No_match
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AA	74990
atazanavir	rs2032582	ABCB1	AT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	rs2032582:AT	118753185
dabigatran	rs4148738	ABCB1	CC	Toxicity	increased	Adverse_Event	Other:C0018839		B01AE07	rs4148738:CC	169501783
dabigatran	rs4148738	ABCB1	CT	Toxicity	increased	Adverse_Event	Other:C0018839		B01AE07	rs4148738:CT	169501783
nicotine	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A	936
antineoplastic and immunomodulating agents	rs212087	ABCC1	AA	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212087:AA	No_match
antineoplastic and immunomodulating agents	rs212087	ABCC1	AG	Toxicity	decreased	Adverse_Event	Other:C0023449		L	rs212087:AG	No_match
infliximab	rs10489629	IL23R	TT	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs10489629:TT	No_match
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs10929302:AA	74990
antineoplastic and immunomodulating agents	rs4148580	ABCC5	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs4148580:CC	No_match
infliximab	rs3794271	SLCO1C1	GG	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs3794271:GG	No_match
nicotine	rs578776	CHRNA3	A	Other	decreased	Adverse_Event	Healthy		N07BA01	rs578776:A	936
carvedilol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AG02	rs1801253:CC	6322
peginterferon alfa-2a	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs1045642:AA	No_match
peginterferon alfa-2a	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs1045642:AG	No_match
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs16906115	IL7	A	Toxicity	increased	Adverse_Event	Other:C0027651		No_ATC	rs16906115:A	No_match
irinotecan	rs3743527	ABCC1	CT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs3743527:CT	74990
irinotecan	rs3743527	ABCC1	TT	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs3743527:TT	74990
nicotine	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs1051730:A	936
irinotecan	rs12720066	ABCB1	AC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs12720066:AC	74990
irinotecan	rs12720066	ABCB1	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs12720066:CC	74990
nicotine	rs3743078	CHRNA3	C	Other	decreased	Adverse_Event	Healthy		N07BA01	rs3743078:C	936
antineoplastic and immunomodulating agents	rs4148575	ABCC5	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs4148575:GG	No_match
nicotine	rs3813567	CHRNB4	G	Other	decreased	Adverse_Event	Healthy		N07BA01	rs3813567:G	936
irinotecan	rs17501331	ABCC1	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs17501331:AG	74990
irinotecan	rs17501331	ABCC1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs17501331:GG	74990
carvedilol	rs1801253	ADRB1	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0085605		C07AG02	rs1801253:CC	6322
peginterferon alfa-2a	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs12979860:CC	No_match
peginterferon alfa-2a	rs8099917	IFNL4	TT	Efficacy	increased	Adverse_Event	Healthy		L03AB11	rs8099917:TT	No_match
none	rs4148323	UGT1A1	AA	Efficacy	increased	Adverse_Event	Other:C0020433		A03DA02	rs4148323:AA	5282367
peginterferon alfa-2a	rs10883841	NT5C2	CT	Efficacy	decreased	Adverse_Event	Healthy		L03AB11	rs10883841:CT	No_match
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
infliximab	rs10929587	ADAM17	TT	Efficacy	decreased	Adverse_Event	Other:C0010346		L04AB02	rs10929587:TT	No_match
clopidogrel	rs10935838	MED12L, P2RY12	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs10935838:AG	13748464
none	rs4961280	AGO2	AA	Other	decreased	Other	Other:C0007134		A03DA02	rs4961280:AA	5282367
none	rs4961280	AGO2	AC	Other	decreased	Other	Other:C0007134		A03DA02	rs4961280:AC	5282367
stavudine	rs1799964	TNF	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF04	rs1799964:C	15979285
clopidogrel	rs2046934	MED12L, P2RY12	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs2046934:AG	13748464
clopidogrel	rs6809699	MED12L, P2RY12	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs6809699:AC	13748464
antineoplastic and immunomodulating agents	rs3749442	ABCC5	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs3749442:AA	No_match
nicotine	rs684513	CHRNA5	G	Other	decreased	Adverse_Event	Healthy		N07BA01	rs684513:G	936
aminoglycoside antibacterials	rs267606618	MT-RNR1	C	Toxicity	increased	Adverse_Event	Healthy		J01G	rs267606618:C	No_match
antineoplastic and immunomodulating agents	rs1132776	ABCC5	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs1132776:GG	No_match
nicotine	rs637137	CHRNA5	A	Other	decreased	Adverse_Event	Healthy		N07BA01	rs637137:A	936
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
none	rs1800587	IL1A	A	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs1800587:A	5282367
fluticasone / salmeterol	rs242941	CRHR1	CC	Efficacy	increased	Efficacy_Response	Disease:C0024117		R03AK06	rs242941:CC	5311101
propranolol	rs4680	COMT	G	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs4680:G	135862
antineoplastic and immunomodulating agents	rs939338	ABCC5	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs939338:AA	No_match
peginterferon alfa-2a	rs10877012	CYP27B1, METTL1	GT	Efficacy	decreased	Adverse_Event	Disease:C0019372		L03AB11	rs10877012:GT	No_match
peginterferon alfa-2a	rs10877012	CYP27B1, METTL1	TT	Efficacy	decreased	Adverse_Event	Disease:C0019372		L03AB11	rs10877012:TT	No_match
propranolol	rs4818	COMT	G	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs4818:G	135862
corticosteroids	rs6001366	APOBEC3B	T	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs6001366:T	No_match
peginterferon alfa-2a	rs12979860	IFNL3	TT	Efficacy	increased	Adverse_Event	Disease:C0019372		L03AB11	rs12979860:TT	No_match
corticosteroids	rs2278992	KCNN1	C	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs2278992:C	No_match
peginterferon alfa-2a	rs7975232	VDR	AA	Efficacy	decreased	Adverse_Event	Disease:C0019372		L03AB11	rs7975232:AA	No_match
corticosteroids	rs12959468	ANKRD30B	A	Efficacy	decreased	Adverse_Event	Disease:C0004096		S02BA	rs12959468:A	No_match
rosuvastatin	rs1205	CRP	CT	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1205:CT	5282455
rosuvastatin	rs1205	CRP	TT	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1205:TT	5282455
propranolol	rs6269	COMT	G	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs6269:G	135862
antineoplastic and immunomodulating agents	rs129081	ABCC1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs129081:CC	No_match
antineoplastic and immunomodulating agents	rs129081	ABCC1	CG	Toxicity	increased	Adverse_Event	Other:C0023449		L	rs129081:CG	No_match
risperidone	rs6311	HTR2A	TT	Toxicity	decreased	Adverse_Event	Healthy		N05AX08	rs6311:TT	849421
heroin	rs2189814	GRM3	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs2189814:T	9844225
rosuvastatin	rs2808630	__INTRONIC__	CC	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs2808630:CC	5282455
rosuvastatin	rs2808630	__INTRONIC__	CT	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs2808630:CT	5282455
methadone	rs204076	OPRD1	AT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs204076:AT	10090
methadone	rs204076	OPRD1	TT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs204076:TT	10090
rosuvastatin	rs1169288	HNF1A	AC	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1169288:AC	5282455
rosuvastatin	rs1169288	HNF1A	CC	Efficacy, Other, Metabolism/PK	decreased	Other	Disease:C0010068		C10AA07	rs1169288:CC	5282455
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02	rs1801253:CC	6322
propranolol	rs4633	COMT	C	Efficacy	increased	Adverse_Event	Efficacy:C0030193|Disease:C0155943		C07AA05	rs4633:C	135862
bucindolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		No_ATC	rs1801253:CC	51045
erythromycin	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17	rs35599367:AA	9831800
erythromycin	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0004623|Other:C0948873		S01AA17	rs35599367:AG	9831800
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:A	13748464
aspirin	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12041331:AA	72204814
aspirin	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12041331:AG	72204814
none	rs11739136	KCNIP1, KCNMB1	CT	Other	decreased	Other	Healthy		A03DA02	rs11739136:CT	5282367
none	rs11739136	KCNIP1, KCNMB1	TT	Other	decreased	Other	Healthy		A03DA02	rs11739136:TT	5282367
tacrolimus	rs2032582	ABCB1	A	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2032582:A	131769926
caffeine, isoflurane	rs118192162	RYR1	AC	Toxicity	Indeterminado	Adverse_Event	Healthy		N01AB06|N06BC01	rs118192162:AC	3763
risperidone	rs7643645	NR1I2	GG	Metabolism/PK	decreased	LADME	Disease:C0033975		N05AX08	rs7643645:GG	849421
repaglinide	rs2306283	SLCO1B1	GG	Other, Metabolism/PK	decreased	LADME	Healthy		A10BX02	rs2306283:GG	22132924
halothane	rs118192161	RYR1	CT	Toxicity	Indeterminado	Adverse_Event	Healthy		N01AB01	rs118192161:CT	445258
risperidone	rs7643645	NR1I2	GG	Metabolism/PK	decreased	LADME	Disease:C0033975		N05AX08	rs7643645:GG	849421
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
tacrolimus	rs1045642	ABCB1	G	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs1045642:G	131769926
gefitinib	rs1065852	CYP2D6	AA	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB01	rs1065852:AA	135496227
gefitinib	rs1065852	CYP2D6	AG	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB01	rs1065852:AG	135496227
dalcetrapib	rs1967309	ADCY9	AA	Efficacy	decreased	Adverse_Event	Disease:C0027051		No_ATC	rs1967309:AA	6918540
egfr inhibitors	rs6443624	PIK3CA	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	rs6443624:C	No_match
egfr inhibitors	rs2677760	PIK3CA	T	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	rs2677760:T	No_match
misoprostol	rs4149087	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Disease:C0032797		G02AD06	rs4149087:GG	9886273
misoprostol	rs11568658	ABCC4	AA	Toxicity	increased	Adverse_Event	Disease:C0032797|Disease:Therapeutic_abortion		G02AD06	rs11568658:AA	9886273
aspirin, clopidogrel	rs12041331	PEAR1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs12041331:A	2244
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:TT	135483892
carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel	rs11710163	RAF1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CD01|L01CD02|L01XA01|L01XA02	rs11710163:AG	10339178
clopidogrel	rs12248560	CYP2C19	T	Toxicity	decreased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:T	13748464
aspirin, clopidogrel	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AA	2244
aspirin, clopidogrel	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AG	2244
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:TT	1268107
olanzapine	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH03	rs1695:AG	74603552
olanzapine	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0036337		N05AH03	rs1695:GG	74603552
aspirin, clopidogrel	rs12041331	PEAR1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AA	2244
aspirin, clopidogrel	rs12041331	PEAR1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs12041331:AG	2244
antiinflammatory agents, non-steroids	rs3892408	ALOX15	C	Toxicity	increased	Adverse_Event	Disease:C0004096		M01A|V10A	rs3892408:C	No_match
methadone	rs1129844	CCL11	A	Toxicity	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs1129844:A	10090
egfr inhibitors	rs2699905	PIK3CA	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01EB	rs2699905:C	No_match
fluoxetine	rs2433320	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB03	rs2433320:GG	1548968
antipsychotics	rs1801133	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs1801133:G	No_match
asparaginase, cyclophosphamide, cytarabine, daunorubicin, mercaptopurine, prednisolone, vincristine	rs738409	PNPLA3	CG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01BB02|L01BC01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:CG	2907
asparaginase, cyclophosphamide, cytarabine, daunorubicin, mercaptopurine, prednisolone, vincristine	rs738409	PNPLA3	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01BB02|L01BC01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:GG	2907
antiinflammatory agents, non-steroids	rs5789	PTGS1	C	Toxicity	decreased	Adverse_Event	Disease:C0004096		M01A|V10A	rs5789:C	No_match
clozapine, olanzapine	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03	rs1801131:GG	135398737
drugs for treatment of tuberculosis	rs1799929	NAT2	CT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs1799929:CT	No_match
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs738409	PNPLA3	G	Toxicity	increased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs738409:G	2907
leucovorin, tegafur	rs1801019	UMPS	CC	Toxicity	increased	Adverse_Event	Other:C0022665		L01BC03	rs1801019:CC	135403648
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	T	Efficacy	decreased	Efficacy_Response	Other:EGFR_mutation_negative_non-small-cell_lung_cancer		L01EB01	rs121434568:T	135496227
carboplatin, cisplatin, docetaxel, paclitaxel	rs726501	MAP3K1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs726501:AA	10339178
carboplatin, cisplatin, docetaxel, paclitaxel	rs726501	MAP3K1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs726501:AG	10339178
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	CT	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:CT	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	TT	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:TT	135483892
anthracyclines and related substances, cyclophosphamide, fluorouracil, taxanes	rs17102977	CYP4X1	AA	Efficacy	increased	Efficacy_Response	Other:C1458155		L01AA01|L01BC02|L01CD|L01DB	rs17102977:AA	2907
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs1142345	TPMT	C	Toxicity	decreased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs1142345:C	2907
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AA	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AA	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AG	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AG	135483892
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
antiinflammatory agents, non-steroids	rs10306135	PTGS1	A	Toxicity	increased	Adverse_Event	Disease:C0004096		M01A|V10A	rs10306135:A	No_match
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
imatinib	rs683369	SLC22A1	CG	Efficacy	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CG	6113
imatinib	rs683369	SLC22A1	GG	Efficacy	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:GG	6113
antipsychotics	rs2061051	GABRG3	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs2061051:A	No_match
gemcitabine	rs642990	__INTRONIC__	CT	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs642990:CT	597
gemcitabine	rs642990	__INTRONIC__	TT	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs642990:TT	597
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
carboplatin, cisplatin, docetaxel, paclitaxel	rs16886403	MAP3K1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs16886403:CC	10339178
carboplatin, cisplatin, docetaxel, paclitaxel	rs16886403	MAP3K1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs16886403:CT	10339178
gemcitabine	rs1042858	RRM1	A	Dosage	decreased	Adverse_Event	Disease:C1458155		L01BC05	rs1042858:A	597
carboplatin, cisplatin, docetaxel, paclitaxel	rs17661089	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs17661089:AG	10339178
carboplatin, cisplatin, docetaxel, paclitaxel	rs17661089	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01CD02|L01XA01|L01XA02	rs17661089:GG	10339178
carboplatin, cisplatin, docetaxel, gemcitabine, paclitaxel	rs17309872	ACSS2	AT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01CD01|L01CD02|L01XA01|L01XA02	rs17309872:AT	10339178
methotrexate	rs246240	ABCC1	AG	Toxicity	decreased	Adverse_Event	Disease:C0235763		L04AX03	rs246240:AG	11329481
methotrexate	rs246240	ABCC1	GG	Toxicity	decreased	Adverse_Event	Disease:C0235763		L04AX03	rs246240:GG	11329481
bupropion, nicotine	rs6702335	EPB41	AA	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12|N07BA01	rs6702335:AA	89594
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
drugs for treatment of tuberculosis	rs62328061	METTL14	G	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs62328061:G	No_match
none	rs763780	IL17F	CC	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs763780:CC	5282367
daunorubicin	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB02	rs1799983:GG	11570269
none	rs2275913	IL17A	AA	Other	increased	Adverse_Event	Other:C0032961		A03DA02	rs2275913:AA	5282367
ace inhibitors, plain	rs145489027	KCNIP4	A	Other	increased	Adverse_Event	Healthy		A03B|C09A	rs145489027:A	No_match
pemetrexed	rs12995526	ATIC	C	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04	rs12995526:C	135565228
opioids	rs910080	PDYN	A	Toxicity	increased	Adverse_Event	Healthy		N02A	rs910080:A	No_match
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0042065|Disease:C0030297		L01CE02	rs4148323:AA	74990
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0042065|Disease:C0030297		L01CE02	rs4148323:AG	74990
ace inhibitors, plain	rs1495509	KCNIP4	C	Other	increased	Adverse_Event	Healthy		A03B|C09A	rs1495509:C	No_match
folfiri, folfox, xelox	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1801131:GG	No_match
gemcitabine	rs1705772	ALG10	AA	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs1705772:AA	597
gemcitabine	rs1705772	ALG10	AG	Toxicity	decreased	Adverse_Event	Healthy		L01BC05	rs1705772:AG	597
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:TT	1268107
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
cyclophosphamide, cytarabine, daunorubicin, doxorubicin, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine	rs887829	UGT1A1	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01AA01|L01BB02|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03	rs887829:T	2907
ritonavir	rs2854116	APOC3	C	Other	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	rs2854116:C	71749331
pemetrexed	rs16930092	GGH	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04	rs16930092:CT	135565228
pemetrexed	rs16930092	GGH	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04	rs16930092:TT	135565228
anastrozole	rs3732218	UGT1A4	GG	Metabolism/PK	increased	LADME	Other:human_liver_microsomes		L02BG03	rs3732218:GG	713
haloperidol	rs3892097	CYP2D6	CT	Toxicity	increased	Adverse_Event	Other:C0236663		N05AD01	rs3892097:CT	9828
folfiri, folfox, xelox	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1045642:GG	No_match
ace inhibitors, plain	rs7675300	KCNIP4	A	Other	increased	Adverse_Event	Healthy		A03B|C09A	rs7675300:A	No_match
cyclophosphamide	rs2010963	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L01AA01	rs2010963:CC	9554282
nicotine	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Other:smokers_who_are_pregnant		N07BA01	rs1051730:A	936
nevirapine	rs76228616	TRAF3IP2	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs76228616:C	15979285
gemcitabine	rs4769060	ALOX5AP	AG	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs4769060:AG	597
gemcitabine	rs4769060	ALOX5AP	GG	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs4769060:GG	597
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB02	rs121434568:G	176870
sufentanil	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs1799971:AG	41693
ipilimumab, nivolumab, pembrolizumab	rs16906115	IL7	AA	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs16906115:AA	No_match
ipilimumab, nivolumab, pembrolizumab	rs16906115	IL7	AG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs16906115:AG	No_match
gemtuzumab ozogamicin	rs1803254	CD33	CC	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		No_ATC	rs1803254:CC	No_match
gemtuzumab ozogamicin	rs1803254	CD33	CG	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		No_ATC	rs1803254:CG	No_match
folfiri, folfox, xelox	rs113488022	BRAF	T	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs113488022:T	No_match
methotrexate	rs1801133	CLCN6, MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG	11329481
methotrexate	rs1801133	CLCN6, MTHFR	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:GG	11329481
opioids	rs2070762	TH	G	Toxicity	increased	Adverse_Event	Healthy		N02A	rs2070762:G	No_match
gemtuzumab ozogamicin	rs35112940	CD33	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		No_ATC	rs35112940:GG	No_match
isoniazid, rifampin	rs6413432	CYP2E1, DUX1	AT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs6413432:AT	135483892
cisplatin	rs316019	SLC22A2	A	Toxicity	decreased	Adverse_Event	Healthy		L01XA01	rs316019:A	441203
antineoplastic agents, fluorouracil, leucovorin	rs1059829	SPARC	AG	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01|L01BC02	rs1059829:AG	135403648
antineoplastic agents, fluorouracil, leucovorin	rs1059829	SPARC	GG	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01|L01BC02	rs1059829:GG	135403648
opioids	rs1611131	DBH	G	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1611131:G	No_match
antipsychotics	rs2445142	HSPG2	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs2445142:C	No_match
folfiri, folfox, xelox	rs1801265	DPYD	AG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1801265:AG	No_match
folfiri, folfox, xelox	rs1801265	DPYD	GG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1801265:GG	No_match
antipsychotics	rs878949	HSPG2	T	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs878949:T	No_match
quetiapine	rs502046	RIMS1	CC	Efficacy, Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH04	rs502046:CC	118753024
quetiapine	rs502046	RIMS1	CT	Efficacy, Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH04	rs502046:CT	118753024
ethanol	rs846664	TAS2R16	C	Other	increased	Adverse_Event	Healthy		V03AB16	rs846664:C	444899
drugs for treatment of tuberculosis	rs1139130	METTL3	G	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs1139130:G	No_match
methotrexate	rs1801131	C1orf167, CLCN6, MTHFR	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GG	11329481
methotrexate	rs1801131	C1orf167, CLCN6, MTHFR	GT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GT	11329481
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB02	rs121434568:G	176870
hormonal contraceptives for systemic use	rs6025	F5	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs6025:T	No_match
sorafenib	rs2239702	KDR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:CT	67424139
sorafenib	rs2239702	KDR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:TT	67424139
fluorouracil	rs3812718	SCN1A	CC	Other	decreased	Other	Disease:C0023055		L01BC02	rs3812718:CC	5790
efavirenz	rs3745274	CYP2B6	GT	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs510769	OPRM1	CT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs510769:CT	1983
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs510769	OPRM1	TT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs510769:TT	1983
warfarin	rs9934438	VKORC1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:A	54688261
opioids	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1076560:A	No_match
efavirenz	rs2472677	NR1I2	TT	Efficacy	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs2472677:TT	64139
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
cetuximab	rs112445441	KRAS	T	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs112445441:T	No_match
cisplatin, cyclophosphamide, dactinomycin, doxorubicin, methotrexate, vincristine	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DA01|L01DB01|L01XA01|L04AX03	rs1801133:AA	2907
sorafenib	rs2010963	VEGFA	CG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs2010963:CG	67424139
sorafenib	rs2010963	VEGFA	GG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs2010963:GG	67424139
cisplatin, cyclophosphamide, dactinomycin, doxorubicin, methotrexate, vincristine	rs1805087	MTR	GG	Toxicity	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DA01|L01DB01|L01XA01|L04AX03	rs1805087:GG	2907
sorafenib	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs1045642:AA	67424139
sorafenib	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX02	rs1045642:AG	67424139
sorafenib	rs1570360	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs1570360:AA	67424139
sorafenib	rs1570360	VEGFA	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs1570360:AG	67424139
atorvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2231142:GT	656846
atorvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2231142:TT	656846
cocaine, heroin	rs62638690	OPRM1	T	Toxicity	decreased	Adverse_Event	Healthy		N01BC01	rs62638690:T	446220
sorafenib	rs2239702	KDR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:CT	67424139
sorafenib	rs2239702	KDR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX02	rs2239702:TT	67424139
efavirenz	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:AA	64139
cetuximab, panitumumab	rs112445441	KRAS	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs112445441:A	No_match
hormonal contraceptives for systemic use	rs1799853	CYP2C9	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799853:T	No_match
none	rs1805087	MTR	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs1805087:GG	5282367
methotrexate	rs1805087	MTR	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1805087:GG	11329481
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs2236861	OPRD1	AG	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs2236861:AG	1983
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs2236861	OPRD1	GG	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs2236861:GG	1983
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:CT	58746970
hormonal contraceptives for systemic use	rs1799963	F2	A	Toxicity	increased	Adverse_Event	Healthy		G03A	rs1799963:A	No_match
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
fluorouracil	rs3812718	SCN1A	TT	Other	decreased	Other	Disease:C0023055		L01BC02	rs3812718:TT	5790
atazanavir	rs887829	UGT1A1	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	rs887829:T	118753185
simvastatin	rs4363657	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0027051		C10AA01	rs4363657:CC	14373154
efavirenz	rs28399499	CYP2B6	CC	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC	64139
efavirenz	rs28399499	CYP2B6	CT	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
tacrolimus	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0027051		C10AA01	rs4149056:CC	14373154
efavirenz	rs4803419	CYP2B6	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs4803419:CT	64139
efavirenz	rs4803419	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs4803419:TT	64139
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
fluorouracil	rs1801160	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs1801160:CT	5790
allopurinol	rs3131003	PSORS1C1	AG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3131003:AG	168354693
allopurinol	rs3131003	PSORS1C1	GG	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3131003:GG	168354693
fluorouracil	rs1801133	MTHFR	GG	Efficacy	increased	Adverse_Event	Disease:C0022665		L01BC02	rs1801133:GG	5790
opioids	rs1997794	PDYN	CT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1997794:CT	No_match
opioids	rs1997794	PDYN	TT	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1997794:TT	No_match
ondansetron	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		A04AA01	rs1045642:GG	4595
dexmedetomidine	rs8192733	CYP2A6	GG	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs8192733:GG	6918081
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
"""acetaminophen"", ""antiepileptics"", ""antiinflammatory agents, non-steroids"", ""opioids"""	rs1799971	OPRM1	AA	Efficacy	increased	Adverse_Event	Other:C0023055|Other:C2939419		N02BE01|N03A|V10A	rs1799971:AA	1983
opioids	rs1022563	PDYN	CC	Toxicity	increased	Adverse_Event	Healthy		N02A	rs1022563:CC	No_match
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
risperidone	rs7799039	LEP	GG	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs7799039:GG	849421
perindopril	rs5182	AGTR1	TT	Efficacy	decreased	Adverse_Event	Disease:C1956346		C09AA04	rs5182:TT	441313
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
gemcitabine	rs2072671	CDA	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC05	rs2072671:AC	597
gemcitabine	rs2072671	CDA	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC05	rs2072671:CC	597
cytarabine	rs602950	CDA	GG	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0023418|Myeloid		L01BC01	rs602950:GG	6918130
haloperidol	rs3892097	CYP2D6	CC	Toxicity	decreased	Adverse_Event	Disease:C0033936|Disease:C0085762|Disease:C0221016		N05AD01	rs3892097:CC	9828
cytarabine	rs532545	CDA	TT	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0023418|Myeloid		L01BC01	rs532545:TT	6918130
allopurinol	rs3099844	CYCSP5	AA	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AA	168354693
allopurinol	rs3099844	CYCSP5	AC	Toxicity	increased	Adverse_Event	Healthy		M04AA01	rs3099844:AC	168354693
bisphosphonates	rs17024608	RBMS3	A	Toxicity	increased	Adverse_Event	Healthy		M05BA	rs17024608:A	No_match
none	rs4149601	NEDD4L	AG	Other	increased	Adverse_Event	Disease:C0020538		A03DA02	rs4149601:AG	5282367
fluorouracil	rs55886062	DPYD	AC	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs55886062:AC	5790
antipsychotics	rs17587100	INSIG2	C	Other	increased	Adverse_Event	Disease:C0036341		N05A	rs17587100:C	No_match
ondansetron	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		A04AA01	rs2032582:CC	4595
none	rs3087243	CTLA4	A	Other	decreased	Adverse_Event	Healthy		A03DA02	rs3087243:A	5282367
epirubicin, fluorouracil, oxaliplatin	rs780094	GCKR	CC	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780094:CC	9887054
epirubicin, fluorouracil, oxaliplatin	rs780094	GCKR	CT	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780094:CT	9887054
fluorouracil	rs115232898	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs115232898:CT	5790
ribavirin, sofosbuvir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:Liver_Cirrhosis		J05AP01|J05AP08	rs12979860:CC	37542
tenofovir	rs1059751	ABCC4	G	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs1059751:G	9574768
epirubicin, fluorouracil, oxaliplatin	rs6769511	IGF2BP2	C	Efficacy	increased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs6769511:C	9887054
warfarin	rs9934438	VKORC1	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9934438:A	54688261
cytarabine	rs2072671	CDA	CC	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C0023418|Myeloid		L01BC01	rs2072671:CC	6918130
warfarin	rs9934438	VKORC1	A	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:A	54688261
allopurinol	rs367398	NOTCH4	AA	Toxicity	decreased	Adverse_Event	Healthy		M04AA01	rs367398:AA	168354693
allopurinol	rs367398	NOTCH4	AG	Toxicity	decreased	Adverse_Event	Healthy		M04AA01	rs367398:AG	168354693
epirubicin, fluorouracil, oxaliplatin	rs163182	KCNQ1	CC	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs163182:CC	9887054
epirubicin, fluorouracil, oxaliplatin	rs163182	KCNQ1	GG	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs163182:GG	9887054
none	rs1800566	NQO1	AA	Other	decreased	Adverse_Event	Disease:C1458155		A03DA02	rs1800566:AA	5282367
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
epirubicin, fluorouracil, oxaliplatin	rs4402960	IGF2BP2	G	Efficacy	decreased	Adverse_Event	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs4402960:G	9887054
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:chemorefractory_advanced_non-small-cell_lung_cancer_patients		L01EB01	rs121434568:G	135496227
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01|L01EB02	rs121434568:G	176870
efavirenz	rs3745274	CYP2B6	GG	Efficacy	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GG	64139
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:CT	5778
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:TT	5778
cyclophosphamide, epirubicin, fluorouracil	rs1800566	NQO1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs1800566:AA	2907
methotrexate	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:AG	11329481
methotrexate	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:GG	11329481
efavirenz	rs3745274	CYP2B6	GT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
sunitinib	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:AA	11221549
verapamil	rs1051375	CACNA1C	AA	Efficacy	decreased	Adverse_Event	Disease:C1956346		C08DA01	rs1051375:AA	65808
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AA	5460033
cisplatin, irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AG	5460033
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
sunitinib	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:AA	11221549
sunitinib	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:AG	11221549
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AA	5460033
cisplatin, irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AG	5460033
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
efavirenz	rs28399433	CYP2A6	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:AC	64139
efavirenz	rs28399433	CYP2A6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:CC	64139
none	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Disease:C0085762		A03DA02	rs1800497:AA	5282367
none	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Disease:C0085762		A03DA02	rs1800497:AG	5282367
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC	64139
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
verapamil	rs1051375	CACNA1C	GG	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1051375:GG	65808
epirubicin, fluorouracil, oxaliplatin	rs780093	GCKR	CC	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780093:CC	9887054
epirubicin, fluorouracil, oxaliplatin	rs780093	GCKR	CT	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01DB03|L01XA03	rs780093:CT	9887054
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G	135496227
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT	656846
carboplatin, cisplatin, gemcitabine	rs12118636	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs12118636:AG	10339178
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T	5778
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AA	5460033
cisplatin, irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0017416		L01CE02|L01XA01	rs4148323:AG	5460033
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Toxicity	Indeterminado	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:TT	5778
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
antineoplastic agents	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01	rs1045642:AG	No_match
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
carboplatin, cisplatin, gemcitabine	rs1065634	NRAS	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs1065634:CT	10339178
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
carboplatin, cisplatin, gemcitabine	rs451774	GPX5	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs451774:AG	10339178
carboplatin, cisplatin, gemcitabine	rs451774	GPX5	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01|L01XA02	rs451774:GG	10339178
vincristine	rs1135989	ACTG1	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs1135989:A	24848381
acenocoumarol, warfarin	rs9923231	VKORC1	T	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03|B01AA07	rs9923231:T	54676537
methadone	rs3745274	CYP2B6	GG	Toxicity	increased	Adverse_Event	Healthy		N07BC02	rs3745274:GG	10090
carboplatin, taxanes	rs1801249	ATP7B	AA	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs1801249:AA	10339178
vincristine	rs3770102	CAPG	T	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs3770102:T	24848381
valproic acid	rs1800012	COL1A1	AA	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs1800012:AA	134459
valproic acid	rs1800012	COL1A1	AC	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs1800012:AC	134459
vincristine	rs4728709	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs4728709:A	24848381
doxorubicin	rs1937840	AKR1C3	GG	Other	decreased	Other	Disease:C1458155		L01DB01	rs1937840:GG	83958
methadone	rs2279343	CYP2B6	AA	Toxicity	increased	Adverse_Event	Healthy		N07BC02	rs2279343:AA	10090
ketoprofen	rs1799853	CYP2C9	CC	Toxicity	decreased	Adverse_Event	Other:C0030193|Postoperative		M02AA10	rs1799853:CC	667550
acenocoumarol, warfarin	rs9923231	VKORC1	T	Efficacy	increased	Other	Disease:C1861172		B01AA03|B01AA07	rs9923231:T	54676537
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	GG	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AA06	rs4149117:GG	5281078
remifentanil	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N01AH06	rs1799971:GG	60815
warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AG	54688261
mercaptopurine	rs1127354	ITPA	AA	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0023418		L01BB02	rs1127354:AA	1268107
mercaptopurine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0023418		L01BB02	rs1127354:AC	1268107
carboplatin, taxanes	rs3594	GSR	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs3594:CC	10339178
acenocoumarol, warfarin	rs429358	APOE	C	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03|B01AA07	rs429358:C	54676537
ethanol	rs4251417	SLC6A4	T	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs4251417:T	444899
carboplatin, taxanes	rs6900017	VEGFA	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs6900017:TT	10339178
acenocoumarol, warfarin	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Disease:C1861172		B01AA03|B01AA07	rs1057910:C	54676537
methylphenidate	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Other:C1263846		N06BA04	rs4680:AA	154100
methylphenidate	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:C1263846		N06BA04	rs4680:AG	154100
naloxone	rs1799971	OPRM1	G	Efficacy	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:G	11274356
ethanol	rs25531	SLC6A4	C	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs25531:C	444899
interferons, ribavirin	rs2228570	VDR	AG	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB	rs2228570:AG	37542
interferons, ribavirin	rs2228570	VDR	GG	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB	rs2228570:GG	37542
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T	54688261
egfr inhibitors	rs2677760	PIK3CA	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB	rs2677760:C	No_match
cetuximab	rs2227983	EGFR	AA	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs2227983:AA	No_match
cetuximab	rs2227983	EGFR	AG	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs2227983:AG	No_match
egfr inhibitors	rs2459693	PIK3CA	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EB	rs2459693:T	No_match
irinotecan	rs7187684	CES1	CC	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs7187684:CC	74990
methotrexate	rs2372536	ATIC	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2372536:GG	11329481
ethanol	rs2066713	SLC6A4	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2066713:A	444899
corticosteroids, salmeterol	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		R03AC12|S02BA	rs1042713:AA	5152
antipsychotics	rs4849127	IL1B	AA	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs4849127:AA	No_match
antipsychotics	rs4849127	IL1B	AG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs4849127:AG	No_match
beta blocking agents	rs1065852	CYP2D6	GG	Toxicity	increased	Adverse_Event	Other:C0027051		S01ED	rs1065852:GG	No_match
fluorouracil	rs1801265	DPYD	GG	Metabolism/PK	increased	LADME	Other:without_the_rs115232898_A>G_variant_(DPYD_Y186C)		L01BC02	rs1801265:GG	5790
egfr inhibitors	rs6443624	PIK3CA	C	Efficacy	decreased	Efficacy_Response	Disease:C0027651		L01EB	rs6443624:C	No_match
antipsychotics	rs16944	IL1B	AG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs16944:AG	No_match
daunorubicin, doxorubicin	rs885004	SLC28A3	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs885004:A	31703
cyclosporine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation|Disease:Kidney_Transplantation|Disease:Liver_transplantation|Disease:C0277631		L04AD01	rs1045642:AA	86666680
egfr inhibitors	rs2677760	PIK3CA	T	Efficacy	decreased	Efficacy_Response	Disease:C0027651		L01EB	rs2677760:T	No_match
corticosteroids	rs1042713	ADRB2	AA	Efficacy	increased	Adverse_Event	Disease:C0004096		S02BA	rs1042713:AA	No_match
irinotecan	rs2244614	CES1	AA	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2244614:AA	74990
irinotecan	rs2244614	CES1	AG	Toxicity	decreased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2244614:AG	74990
exemestane, letrozole	rs6493497	CYP19A1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs6493497:AA	3902
antipsychotics	rs1143634	IL1B	AA	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs1143634:AA	No_match
antipsychotics	rs6265	BDNF	CT	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs6265:CT	No_match
antipsychotics	rs6265	BDNF	TT	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A	rs6265:TT	No_match
methylphenidate	rs2345039	ADGRL3	CG	Toxicity	increased	Adverse_Event	Other:C1263846		N06BA04	rs2345039:CG	154100
methylphenidate	rs2345039	ADGRL3	GG	Toxicity	increased	Adverse_Event	Other:C1263846		N06BA04	rs2345039:GG	154100
daunorubicin, doxorubicin	rs7853758	SLC28A3	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01DB01|L01DB02	rs7853758:A	31703
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0023418		L01BB02	rs116855232:CT	1268107
warfarin	rs1799853	CYP2C9	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs1799853:T	54688261
carboplatin, taxanes	rs1061472	ATP7B	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs1061472:TT	10339178
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs4148323:AG	74990
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:C	445127
hormonal contraceptives for systemic use	rs4379368	SUGCT	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs4379368:T	No_match
none	rs2266780	FMO3	AG	Other	decreased	Adverse_Event	Disease:C0039338		A03DA02	rs2266780:AG	5282367
none	rs2266780	FMO3	GG	Other	decreased	Adverse_Event	Disease:C0039338		A03DA02	rs2266780:GG	5282367
hormonal contraceptives for systemic use	rs710446	KNG1	C	Toxicity	increased	Adverse_Event	Healthy		G03A	rs710446:C	No_match
fluorouracil	rs1801265	DPYD	AA	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BC02	rs1801265:AA	5790
irinotecan	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2231142:GT	74990
irinotecan	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030297|Other:C0023055|Other:C0919267|Other:C0026640		L01CE02	rs2231142:TT	74990
aspirin	rs3798220	LPA	CT	Efficacy	decreased	Adverse_Event	Healthy		No_ATC	rs3798220:CT	72204814
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:TT	11329481
boceprevir, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10	rs12979860:CC	37542
warfarin	rs3814637	CYP2C19	T	Toxicity	Indeterminado	Adverse_Event	Healthy		B01AA03	rs3814637:T	54688261
fluorouracil	rs72728438	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs72728438:CT	5790
fluorouracil	rs7194667	ABCC11	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs7194667:GG	5790
fluorouracil	rs7194667	ABCC11	GT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs7194667:GT	5790
egfr inhibitors	rs2699905	PIK3CA	C	Efficacy	decreased	Efficacy_Response	Disease:C0027651		L01EB	rs2699905:C	No_match
fluorouracil	rs115632870	DPYD	CT	Metabolism/PK	decreased	LADME	Healthy		L01BC02	rs115632870:CT	5790
hormonal contraceptives for systemic use	rs56392308	ABO	del	Toxicity	decreased	Adverse_Event	Healthy		G03A	rs56392308:del	No_match
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT	5790
ethanol	rs6350	SLC6A3	AG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs6350:AG	444899
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AT	60953
hormonal contraceptives for systemic use	rs8176719	ABO	C	Toxicity	increased	Adverse_Event	Healthy		G03A	rs8176719:C	No_match
methotrexate	rs4149056	SLCO1B1	TT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L04AX03	rs4149056:TT	11329481
hormonal contraceptives for systemic use	rs9574	PROCR	G	Toxicity	increased	Adverse_Event	Healthy		G03A	rs9574:G	No_match
hormonal contraceptives for systemic use	rs2289252	F11	T	Toxicity	increased	Adverse_Event	Healthy		G03A	rs2289252:T	No_match
methotrexate	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs2306283:AG	11329481
methotrexate	rs2306283	SLCO1B1	GG	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs2306283:GG	11329481
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BC02	rs3918290:CT	5790
dexmedetomidine	rs3814057	NR1I2	CC	Toxicity	increased	Adverse_Event	Other:C0549433		N05CM18	rs3814057:CC	6918081
none	rs1137070	MAOA	TT	Toxicity	decreased	Adverse_Event	Healthy		A03DA02	rs1137070:TT	5282367
none	rs1799836	MAOB	CC	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799836:CC	5282367
capecitabine	rs9936750	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs9936750:C	11809635
fluorouracil	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BC02	rs1801265:AG	5790
fluorouracil	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BC02	rs1801265:GG	5790
doxorubicin	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01DB01	rs1045642:A	83958
doxorubicin	rs1056892	CBR3	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01DB01	rs1056892:A	83958
capecitabine	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs3918290:T	11809635
folfiri	rs4124874	UGT1A1	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs4124874:GG	No_match
capecitabine	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs67376798:A	11809635
cetuximab	rs4444903	EGF	GG	Efficacy	increased	Adverse_Event	Disease:C0022665		No_ATC	rs4444903:GG	No_match
afatinib, erlotinib, gefitinib	rs2261988	UHRF1	TT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs2261988:TT	176870
none	rs10515746	HAVCR2	AA	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs10515746:AA	5282367
none	rs10515746	HAVCR2	AC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs10515746:AC	5282367
none	rs1036199	HAVCR2	AC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs1036199:AC	5282367
none	rs1036199	HAVCR2	CC	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		A03DA02	rs1036199:CC	5282367
afatinib, erlotinib, gefitinib	rs2074216	DVL2	AA	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs2074216:AA	176870
glatiramer acetate	rs12459996	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AX13	rs12459996:T	3081884
warfarin	rs9923231	VKORC1	T	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:T	54688261
warfarin	rs9923231	VKORC1	T	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T	54688261
fluorouracil	rs10876844	OR10AE3P, PSMB3P	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs10876844:A	5790
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Healthy		L04AX03	rs1801133:AA	11329481
heroin	rs6265	BDNF	TT	Other	increased	Adverse_Event	Healthy		No_ATC	rs6265:TT	9844225
methamphetamine	rs6265	BDNF	T	Other	increased	Adverse_Event	Healthy		No_ATC	rs6265:T	36604
doxorubicin, paclitaxel, trastuzumab	rs2235047	ABCB1	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01DB01	rs2235047:C	36314
doxorubicin, paclitaxel, trastuzumab	rs1056892	CBR3	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01|L01DB01	rs1056892:A	36314
fentanyl	rs540825	OPRM1	T	Toxicity	increased	Adverse_Event	Disease:C0030193|Postoperative		N02AB03	rs540825:T	13653606
aspirin, ticagrelor	rs3093135	CYP4F2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051|Disease:C0027051		B01AC24	rs3093135:AA	2244
clopidogrel	rs2032582	ABCB1	T	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs2032582:T	13748464
afatinib, erlotinib, gefitinib	rs9523	NUP62	CC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs9523:CC	176870
none	rs2207418	__INTRONIC__	GG	Other	increased	Adverse_Event	Disease:C0085605		A03DA02	rs2207418:GG	5282367
alfentanil	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Healthy		N01AH02	rs1799971:GG	51263
warfarin	rs9332197	CYP2C9	C	Efficacy	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9332197:C	54688261
warfarin	rs1057910	CYP2C9	C	Toxicity	Indeterminado	Adverse_Event	Healthy		B01AA03	rs1057910:C	54688261
warfarin	rs2901783	CYP2C18	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs2901783:AG	54688261
warfarin	rs2901783	CYP2C18	GG	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs2901783:GG	54688261
warfarin	rs6018	F5	G	Toxicity	Indeterminado	Adverse_Event	Healthy		B01AA03	rs6018:G	54688261
warfarin	rs8178607	PROS1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs8178607:AA	54688261
none	rs2165870	CHRM3	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs2165870:GG	5282367
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
cisplatin, gemcitabine	rs2072671	CDA	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05|L01XA01	rs2072671:AA	5460033
capecitabine	rs1801265	DPYD	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01BC06	rs1801265:G	11809635
doxorubicin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Healthy		L01DB01	rs1695:GG	83958
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
methotrexate	rs1801131	MTHFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801131:TT	11329481
methotrexate	rs1801133	MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801133:GG	11329481
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1801274:AG	No_match
none	rs7626962	SCN5A	GT	Other	increased	Adverse_Event	Healthy		A03DA02	rs7626962:GT	5282367
none	rs7626962	SCN5A	TT	Other	increased	Adverse_Event	Healthy		A03DA02	rs7626962:TT	5282367
carboplatin, taxanes	rs879825	VEGFA	GG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs879825:GG	10339178
exemestane, letrozole	rs4870061	ESR1	CT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs4870061:CT	3902
exemestane, letrozole	rs4870061	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs4870061:TT	3902
methotrexate	rs1801394	MTRR	AG	Metabolism/PK	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801394:AG	11329481
methotrexate	rs1801394	MTRR	GG	Metabolism/PK	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801394:GG	11329481
carboplatin, taxanes	rs9825762	SCN10A	TT	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs9825762:TT	10339178
carboplatin, taxanes	rs9369421	VEGFA	CC	Toxicity	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA02	rs9369421:CC	10339178
letrozole	rs4870061	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04	rs4870061:TT	10466550
warfarin	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1057910:CC	54688261
methotrexate	rs2273697	ABCC2	AA	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs2273697:AA	11329481
methotrexate	rs2273697	ABCC2	AG	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs2273697:AG	11329481
exemestane, letrozole	rs9322335	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04|L02BG06	rs9322335:TT	3902
letrozole	rs9322335	ESR1	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04	rs9322335:TT	10466550
cisplatin, etoposide	rs1800566	NQO1	AA	Other	decreased	Other	Disease:C0007131		L01CB01|L01XA01	rs1800566:AA	5460033
cisplatin	rs316019	SLC22A2	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs316019:AC	441203
letrozole	rs10140457	ESR2	CC	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG04	rs10140457:CC	10466550
exemestane	rs2813543	ESR1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG06	rs2813543:AA	13472
exemestane	rs6493497	CYP19A1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L02BG06	rs6493497:AA	13472
methotrexate	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT	11329481
methotrexate	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT	11329481
bisphosphonates	rs2736308	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C0027651		M05BA	rs2736308:C	No_match
methotrexate	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT	11329481
bisphosphonates	rs2736308	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C0029456		M05BA	rs2736308:C	No_match
antiinflammatory agents, non-steroids	rs10306135	PTGS1	TT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs10306135:TT	No_match
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs67376798:AT	9887054
carboplatin, gemcitabine	rs1800629	TNF	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs1800629:A	10339178
sorafenib	rs2305948	KDR	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs2305948:CC	67424139
none	rs4680	COMT	AG	Other	decreased	Other	Disease:C0270276		A03DA02	rs4680:AG	5282367
none	rs4680	COMT	GG	Other	decreased	Other	Disease:C0270276		A03DA02	rs4680:GG	5282367
carboplatin, gemcitabine	rs11229	PRRC2A	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs11229:G	10339178
carboplatin, gemcitabine	rs10885	PRRC2A	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs10885:T	10339178
methadone, morphine	rs4680	COMT	AG	Other	decreased	Adverse_Event	Other:C0270276		N02AA01|N07BC02	rs4680:AG	4095
methadone, morphine	rs4680	COMT	GG	Other	decreased	Adverse_Event	Other:C0270276		N02AA01|N07BC02	rs4680:GG	4095
sorafenib	rs664393	FLT1	TT	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs664393:TT	67424139
sorafenib	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2071559:AA	67424139
carboplatin, gemcitabine	rs3115672	MSH5	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3115672:T	10339178
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	AA	Efficacy	increased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:AA	2907
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	AG	Efficacy	increased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:AG	2907
hmg coa reductase inhibitors	rs17381194	ATP2B1	T	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA	rs17381194:T	445127
carboplatin, gemcitabine	rs10491684	DOCK8	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs10491684:A	10339178
hmg coa reductase inhibitors	rs4693570	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA	rs4693570:C	445127
none	rs1617640	EPO	A	Other	increased	Other	Healthy		A03DA02	rs1617640:A	5282367
hmg coa reductase inhibitors	rs672348	DMPK	G	Toxicity	increased	Adverse_Event	Disease:C0020473		C10AA	rs672348:G	445127
aspirin	rs12678747	EYA1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs12678747:T	72204814
carboplatin, gemcitabine	rs1058932	CYP2C8	A	Toxicity	decreased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs1058932:A	10339178
carboplatin, gemcitabine	rs11572078	CYP2C8	A	Toxicity	decreased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs11572078:A	10339178
azithromycin, chlorpromazine, cilostazol, ciprofloxacin, citalopram, clarithromycin, dofetilide, donepezil, dronedarone, erythromycin, escitalopram, flecainide, fluconazole, haloperidol, hydroxychloroquine, levofloxacin, methadone, moxifloxacin, ondansetron, oxaliplatin, papaverine, pentamidine, procainamide, propofol, quinidine, sotalol	rs1805128	KCNE1	T	Toxicity	increased	Adverse_Event	Healthy		A04AA01|B01AC23|C01BA01|C01BA02|C01BC04|C01BD04|C01BD07|C07AA07|G04BE02|J01FA09|J01MA12|J02AC01|L01XA03|N01AX10|N05AA01|N05AD01|N06AB04|N06AB10|N06DA02|N07BC02|P01BA02|P01CX01|S01AA17|S01AA26|S01AE07|S03AA07	rs1805128:T	4595
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
carboplatin, gemcitabine	rs2233980	C6orf15	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs2233980:A	10339178
carboplatin, gemcitabine	rs3130985	CDSN	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3130985:T	10339178
etoposide, platinum compounds	rs716274	DYNC2H1	AG	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs716274:AG	23939
etoposide, platinum compounds	rs716274	DYNC2H1	GG	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs716274:GG	23939
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:bronchioloalveolar_carcinoma_and_adenocarcinoma_patients		L01EB02	rs121434568:G	176870
methadone, morphine	rs1799971	OPRM1	AG	Other	decreased	Adverse_Event	Disease:C0270276		N02AA01|N07BC02	rs1799971:AG	4095
methadone, morphine	rs1799971	OPRM1	GG	Other	decreased	Adverse_Event	Disease:C0270276		N02AA01|N07BC02	rs1799971:GG	4095
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs1800566	NQO1	AA	Efficacy	decreased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs1800566:AA	2907
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs1800566	NQO1	AG	Efficacy	decreased	Adverse_Event	Other:C1458155		L01AA01|L01BC02|L01DB01	rs1800566:AG	2907
etoposide, platinum compounds	rs10895256	YAP1	GT	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs10895256:GT	23939
etoposide, platinum compounds	rs10895256	YAP1	TT	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CB01|L01XA	rs10895256:TT	23939
hmg coa reductase inhibitors	rs6535454	COQ2	A	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs6535454:A	445127
hmg coa reductase inhibitors	rs4693075	COQ2	G	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4693075:G	445127
carboplatin, gemcitabine	rs1049709	HLA-C	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs1049709:C	10339178
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:bronchioloalveolar_carcinoma_and_adenocarcinoma_patients		L01EB02	rs121434568:G	176870
carboplatin, gemcitabine	rs3130907	HCP5	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3130907:G	10339178
lenalidomide	rs4135385	CTNNB1	AA	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX04	rs4135385:AA	165412089
carboplatin, erlotinib, paclitaxel	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01EB02|L01XA02	rs121434568:G	176870
carboplatin, gemcitabine	rs5877	SERPINC1	C	Toxicity	decreased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs5877:C	10339178
ibrutinib	rs2237895	KCNQ1	AA	Toxicity	increased	Adverse_Event	"""Other:C0023418|Lymphocytic|Chronic|B-Cell""|""Other:Waldenstrom_Macroglobulinemia""|""Other:C0334634"		L01EL01	rs2237895:AA	24821094
tamoxifen	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs4149056:CC	2733525
tamoxifen	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs4149056:CT	2733525
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1051266:CC	11329481
none	rs7626962	SCN5A	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs7626962:GG	5282367
lenalidomide	rs4533622	CTNNB1	AA	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		L04AX04	rs4533622:AA	165412089
carboplatin, gemcitabine	rs886423	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs886423:C	10339178
carboplatin, gemcitabine	rs886424	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs886424:T	10339178
beta blocking agents	rs1801252	ADRB1	AG	Efficacy	increased	Adverse_Event	Healthy		S01ED	rs1801252:AG	No_match
beta blocking agents	rs1801252	ADRB1	GG	Efficacy	increased	Adverse_Event	Healthy		S01ED	rs1801252:GG	No_match
carboplatin, gemcitabine	rs9262132	ATAT1	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs9262132:C	10339178
sorafenib	rs2010963	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2010963:GG	67424139
sorafenib	rs2010963	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs2010963:GG	67424139
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G	135496227
none	rs495828	ABO	GG	Metabolism/PK	increased	Other	Disease:C0020538		A03DA02	rs495828:GG	5282367
carboplatin, gemcitabine	rs9262143	PPP1R18	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs9262143:T	10339178
none	rs1799971	OPRM1	AG	Other	decreased	Other	Disease:C0270276		A03DA02	rs1799971:AG	5282367
none	rs1799971	OPRM1	GG	Other	decreased	Other	Disease:C0270276		A03DA02	rs1799971:GG	5282367
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G	135496227
sorafenib	rs4604006	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs4604006:CC	67424139
ibrutinib	rs163182	KCNQ1	GG	Toxicity	increased	Adverse_Event	"""Other:C0023418|Lymphocytic|Chronic|B-Cell""|""Other:Waldenstrom_Macroglobulinemia""|""Other:C0334634"		L01EL01	rs163182:GG	24821094
carboplatin, gemcitabine	rs3094086	MUCL3	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs3094086:A	10339178
olanzapine	rs10423928	GIPR	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH03	rs10423928:AA	74603552
sorafenib	rs4604006	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs4604006:CC	67424139
sorafenib	rs25648	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs25648:CC	67424139
anthracyclines and related substances	rs28714259	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01DB	rs28714259:A	No_match
cyclosporine	rs231775	CTLA4	A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01	rs231775:A	86666680
sorafenib	rs833061	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs833061:CC	67424139
sorafenib	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs699947:CC	67424139
sorafenib	rs25648	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01EX02	rs25648:CC	67424139
fentanyl	rs9397685	OPRM1	AG	Toxicity	decreased	Adverse_Event	Disease:C0030193|Postoperative		N02AB03	rs9397685:AG	13653606
sorafenib	rs833061	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C2239176		L01EX02	rs833061:CC	67424139
tacrolimus	rs776746	CYP3A5	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
none	rs2274407	ABCC4	AA	Efficacy	decreased	Adverse_Event	Disease:C0023449		A03DA02	rs2274407:AA	5282367
none	rs2274407	ABCC4	AC	Efficacy	decreased	Adverse_Event	Disease:C0023449		A03DA02	rs2274407:AC	5282367
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:people_with_EGFR_mutation_positive_advanced_non-small-cell_lung_cancer		L01EB01	rs121434568:G	135496227
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer_patients		L01EB01|L01EB02	rs121434568:G	176870
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Other:EGFR_mutation_positive_non-small-cell_lung_cancer_patients		L01EB01|L01EB02	rs121434568:G	176870
warfarin	rs9923231	VKORC1	TT	Dosage, Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
pazopanib	rs2858996	HFE	TT	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX03	rs2858996:TT	10113978
paclitaxel	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1128503:AA	36314
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG	11329481
none	rs2207418	__INTRONIC__	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs2207418:GG	5282367
tacrolimus	rs776746	CYP3A5	CT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
glatiramer acetate	rs75041078	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AX13	rs75041078:A	3081884
glatiramer acetate	rs1056854	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0026769		L03AX13	rs1056854:A	3081884
methamphetamine	rs2236418	GAD2	AG	Other	increased	Adverse_Event	Healthy		No_ATC	rs2236418:AG	36604
methamphetamine	rs2236418	GAD2	GG	Other	increased	Adverse_Event	Healthy		No_ATC	rs2236418:GG	36604
gliclazide, glyburide	rs757110	ABCC8, KCNJ11	CC	Efficacy	increased	Adverse_Event	Other:C0011849		A10BB09	rs757110:CC	3475
erlotinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB02	rs121434568:G	176870
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	AA	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4803217:AA	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	AC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4803217:AC	37542
tacrolimus	rs2229109	ABCB1	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2229109:CT	131769926
tacrolimus	rs2229109	ABCB1	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2229109:TT	131769926
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs4803217:CC	37542
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
fentanyl	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0030193|Postoperative		N02AB03	rs1045642:AA	13653606
tacrolimus	rs776746	CYP3A5	CT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
afatinib, erlotinib, gefitinib	rs11541557	ARF1	GT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs11541557:GT	176870
afatinib, erlotinib, gefitinib	rs11541557	ARF1	TT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01EB01|L01EB02|L01EB03	rs11541557:TT	176870
drugs for treatment of tuberculosis	rs2031920	CYP2E1	CT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs2031920:CT	No_match
drugs for treatment of tuberculosis	rs2031920	CYP2E1	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs2031920:TT	No_match
oseltamivir	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0035222|Other:suspected_influenza_A/H1N1_infection		J05AH02	rs1045642:AG	78000
oseltamivir	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0035222|Other:suspected_influenza_A/H1N1_infection		J05AH02	rs1045642:GG	78000
methotrexate	rs9895420	ABCC3	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AA	11329481
methotrexate	rs9895420	ABCC3	AT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AT	11329481
methotrexate	rs9895420	ABCC3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs9895420:AA	11329481
methotrexate	rs9895420	ABCC3	AT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs9895420:AT	11329481
cocaine	rs678849	OPRD1	T	Toxicity	decreased	Adverse_Event	Healthy		N01BC01	rs678849:T	2826
cerivastatin	rs2819742	RYR2	AA	Toxicity	decreased	Adverse_Event	Healthy		C10AA06	rs2819742:AA	23663992
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs1891059	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs1891059:A	2907
antiepileptics	rs2273697	ABCC2	A	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs2273697:A	No_match
methotrexate	rs9895420	ABCC3	AA	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AA	11329481
methotrexate	rs9895420	ABCC3	AT	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs9895420:AT	11329481
none	rs35694136	CYP1A2	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs35694136:T	5282367
antithymocyte globulin	rs396991	FCGR3A	AC	Other	increased	Other	Disease:Kidney_Transplantation		No_ATC	rs396991:AC	No_match
antithymocyte globulin	rs396991	FCGR3A	CC	Other	increased	Other	Disease:Kidney_Transplantation		No_ATC	rs396991:CC	No_match
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs141059755	LINC00251	G	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs141059755:G	2907
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs17021408	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs17021408:C	2907
pegaspargase	rs9958628	ARHGAP28	T	Toxicity	increased	Adverse_Event	Healthy		L01XX24	rs9958628:T	No_match
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs117532069	DOK5	A	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs117532069:A	2907
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs80223967	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs80223967:G	2907
carboplatin, etoposide, ifosfamide	rs3114020	ABCG2	CT	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs3114020:CT	9588020
carboplatin, etoposide, ifosfamide	rs3114020	ABCG2	TT	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs3114020:TT	9588020
theophylline	rs35694136	CYP1A2	T/del	Efficacy	increased	Adverse_Event	Disease:C0024117		R03DA04	rs35694136:T/del	5489638
theophylline	rs35694136	CYP1A2	TT	Efficacy	increased	Adverse_Event	Disease:C0024117		R03DA04	rs35694136:TT	5489638
theophylline	rs35694136	CYP1A2	T	Efficacy, Metabolism/PK	decreased	LADME	Disease:C0024117		R03DA04	rs35694136:T	5489638
none	rs762551	CYP1A2	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs762551:C	5282367
ethambutol, isoniazid / pyrazinamide / rifampin	rs1061472	ATP7B	CC	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1061472:CC	135483892
verapamil	rs2279238	NR1H3	T	Efficacy	increased	Adverse_Event	Disease:C1956346|Disease:C0020538		C08DA01	rs2279238:T	65808
verapamil	rs12221497	NR1H3	A	Efficacy	decreased	Adverse_Event	Disease:C1956346|Disease:C0020538		C08DA01	rs12221497:A	65808
atenolol, verapamil	rs11039149	NR1H3	G	Efficacy	decreased	Adverse_Event	Disease:C1956346|Disease:C0020538		C07AB03|C08DA01	rs11039149:G	2520
sevoflurane	rs6686529	KCNK2	CC	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs6686529:CC	13529
sevoflurane	rs6686529	KCNK2	CG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs6686529:CG	13529
chop, rituximab	rs74832512	SLC35F4	CC	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs74832512:CC	No_match
protease inhibitors	rs2854116	APOC3	CC	Efficacy	decreased	Adverse_Event	Healthy		J05AE	rs2854116:CC	No_match
protease inhibitors	rs2854116	APOC3	CT	Efficacy	decreased	Adverse_Event	Healthy		J05AE	rs2854116:CT	No_match
varenicline	rs2302764	CHRNB1, ZBTB4	C	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs2302764:C	6918678
protease inhibitors	rs2854117	APOC3	CT	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs2854117:CT	No_match
protease inhibitors	rs2854117	APOC3	TT	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs2854117:TT	No_match
varenicline	rs2072661	CHRNB2	A	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs2072661:A	6918678
cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, methotrexate, pegaspargase, prednisone, thioguanine, vincristine	rs79085477	BMP7	T	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB03|L01BC01|L01CA02|L01DB01|L01DB02|L01XX24|L04AX03|S02BA06	rs79085477:T	2907
varenicline	rs4292956	CHRNB2	T	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs4292956:T	6918678
varenicline	rs2072660	CHRNB2	C	Toxicity	increased	Adverse_Event	Disease:C0039338		N07BA03	rs2072660:C	6918678
carboplatin, etoposide, ifosfamide	rs1045642	ABCB1	AA	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs1045642:AA	9588020
carboplatin, etoposide, ifosfamide	rs1045642	ABCB1	AG	Efficacy	increased	Adverse_Event	Other:C0266453		L01AA06|L01CB01|L01XA02	rs1045642:AG	9588020
azathioprine	rs1127354	DDRGK1, ITPA	A	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:A	5778
morphine	rs324420	FAAH	AA	Toxicity	increased	Adverse_Event	Disease:C0022821|Disease:C0036439		N02AA01	rs324420:AA	5284371
chop, rituximab	rs11721010	OXNAD1	TT	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs11721010:TT	No_match
morphine	rs11576941	FAAH	TT	Toxicity	increased	Adverse_Event	Disease:C0022821|Disease:C0036439		N02AA01	rs11576941:TT	5284371
protease inhibitors	rs5128	APOC3	CG	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs5128:CG	No_match
protease inhibitors	rs5128	APOC3	GG	Toxicity	decreased	Adverse_Event	Healthy		J05AE	rs5128:GG	No_match
sunitinib	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AC	11221549
docetaxel	rs11045585	SLCO1B3	G	Toxicity	increased	Adverse_Event	Healthy		L01CD02	rs11045585:G	154272
apixaban	rs4148738	ABCB1	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AF02	rs4148738:CT	91667715
apixaban	rs4148738	ABCB1	TT	Toxicity	decreased	Adverse_Event	Healthy		B01AF02	rs4148738:TT	91667715
docetaxel	rs12762549	ABCC2	G	Toxicity	increased	Adverse_Event	Healthy		L01CD02	rs12762549:G	154272
aspirin	rs5918	ITGB3	CT	Other	increased	Other	Healthy		No_ATC	rs5918:CT	72204814
chop, rituximab	rs75614943	CIDEA	TT	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs75614943:TT	No_match
cytarabine	rs3215400	CDA	C/del	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs3215400:C/del	6918130
cytarabine	rs3215400	CDA	del/del	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs3215400:del/del	6918130
methamphetamine	rs6265	BDNF	CC	Other	increased	Adverse_Event	Healthy		No_ATC	rs6265:CC	36604
chop, rituximab	rs77241831	NOS1	GG	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs77241831:GG	No_match
methamphetamine	rs6265	BDNF	CC	Other	decreased	Adverse_Event	Disease:C0036502		No_ATC	rs6265:CC	36604
cytarabine	rs2072671	CDA	AC	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs2072671:AC	6918130
cytarabine	rs2072671	CDA	CC	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs2072671:CC	6918130
antipsychotics	rs9346455	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs9346455:GG	No_match
antipsychotics	rs9346455	__INTRONIC__	GT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs9346455:GT	No_match
sufentanil	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs1045642:GG	41693
cytarabine	rs602950	CDA	AG	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs602950:AG	6918130
cytarabine	rs602950	CDA	GG	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs602950:GG	6918130
heroin	rs2236857	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236857:C	9844225
cytarabine	rs532545	CDA	CT	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs532545:CT	6918130
cytarabine	rs532545	CDA	TT	Toxicity	increased	Adverse_Event	Healthy		L01BC01	rs532545:TT	6918130
heroin	rs2236855	OPRD1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2236855:A	9844225
sunitinib	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:AG	11221549
rivaroxaban	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Healthy		B01AF01	rs1045642:AA	10700
rivaroxaban	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Healthy		B01AF01	rs1045642:AG	10700
heroin	rs3766951	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3766951:C	9844225
nicotine	rs2193225	NRXN1	C	Other	Indeterminado	Other	Other:smokers		N07BA01	rs2193225:C	936
heroin	rs2298897	OPRD1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs2298897:C	9844225
nicotine	rs2193225	NRXN1	C	Other	Indeterminado	Other	Other:smokers		N07BA01	rs2193225:C	936
nicotine	rs6721498	NRXN1	A	Other	Indeterminado	Other	Other:smokers		N07BA01	rs6721498:A	936
sunitinib	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs1045642:AG	11221549
chop, rituximab	rs1607795	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1607795:CC	No_match
sufentanil	rs4680	COMT	AA	Efficacy	increased	Adverse_Event	Other:C0030193|Postoperative		N01AH03	rs4680:AA	41693
ethanol	rs492602	FUT2	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs492602:A	444899
ethanol	rs9937709	FTO	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs9937709:A	444899
platinum	rs6878291	RICTOR	GG	Toxicity	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs6878291:GG	441203
antidepressants	rs852977	NR3C1	G	Efficacy	increased	LADME	Healthy		N06A	rs852977:G	No_match
cerivastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA06	rs4149056:CC	23663992
paroxetine	rs1176744	HTR3B	AA	Toxicity	increased	Adverse_Event	Disease:C0004936		N06AB05	rs1176744:AA	667572
ethanol	rs1783835	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs1783835:A	444899
chop, rituximab	rs116665727	TNIP3	CC	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs116665727:CC	No_match
cisplatin, fluorouracil, radiotherapy	rs1760944	APEX1	GG	Efficacy	decreased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs1760944:GG	5460033
chop, rituximab	rs1800871	IL10	AG	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1800871:AG	No_match
chop, rituximab	rs1800871	IL10	GG	Efficacy	increased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1800871:GG	No_match
sunitinib	rs2032582	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:A	11221549
cisplatin, fluorouracil, radiotherapy	rs3219489	MUTYH	CG	Efficacy	decreased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs3219489:CG	5460033
cisplatin, fluorouracil, radiotherapy	rs3219489	MUTYH	GG	Efficacy	decreased	Adverse_Event	Other:C0007097|Squamous_Cell		L01BC02|L01XA01	rs3219489:GG	5460033
ethanol	rs12296477	SLC4A8	C	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs12296477:C	444899
aspirin	rs5918	ITGB3	CC	Other	Indeterminado	Other	Healthy		No_ATC	rs5918:CC	72204814
aspirin	rs5918	ITGB3	CT	Other	Indeterminado	Other	Healthy		No_ATC	rs5918:CT	72204814
escitalopram	rs9316233	HTR2A	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10	rs9316233:C	162180
ethanol	rs61974485	ARID4A	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs61974485:T	444899
ethanol	rs8008020	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs8008020:T	444899
nicotine	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1799971:AG	936
ethanol	rs72768626	TNRC6A	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs72768626:A	444899
glimepiride, glipizide, glyburide	rs10494366	NOS1AP	T	Toxicity	increased	Adverse_Event	Other:C0011849		A10BB07|A10BB12	rs10494366:T	3478
ketorolac	rs2562456	__INTRONIC__	CC	Efficacy	Indeterminado	Efficacy_Response	Healthy		S01BC05	rs2562456:CC	3082630
opioids	rs1799971	OPRM1	AG	Dosage	decreased	Adverse_Event	Healthy		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Dosage	decreased	Adverse_Event	Healthy		N02A	rs1799971:GG	No_match
azathioprine	rs2074087	ABCC1	CC	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs2074087:CC	5778
azathioprine	rs2074087	ABCC1	CG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs2074087:CG	5778
fluvastatin	rs60282872	SREBF1	CC	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA04	rs60282872:CC	131750727
bevacizumab, pemetrexed	rs1051298	SLC19A1	G	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BA04|L01FG01	rs1051298:G	135410875
cisplatin, radiotherapy	rs1042522	TP53	CG	Efficacy	increased	Efficacy_Response	Other:C0007869		L01XA01	rs1042522:CG	5460033
none	rs13266634	SLC30A8	C	Other, Metabolism/PK	increased	Other	Other:suspected_increased_risk_of_diabetes		A03DA02	rs13266634:C	5282367
opioids	rs1799971	OPRM1	AG	Dosage	decreased	Adverse_Event	Other:C0030193|Postoperative		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Dosage	decreased	Adverse_Event	Other:C0030193|Postoperative		N02A	rs1799971:GG	No_match
antiinflammatory agents, non-steroids	rs943580	AGT	GG	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs943580:GG	No_match
antiinflammatory agents, non-steroids	rs2071230	MMP1, MMP10	AG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs2071230:AG	No_match
antiinflammatory agents, non-steroids	rs2071230	MMP1, MMP10	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs2071230:GG	No_match
levonorgestrel	rs7255721	ADAMTS10	CG	Toxicity	decreased	Adverse_Event	Healthy		G03AD01	rs7255721:CG	5991
antiinflammatory agents, non-steroids	rs7945189	MMP1, MMP10	CT	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs7945189:CT	No_match
antiinflammatory agents, non-steroids	rs7945189	MMP1, MMP10	TT	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs7945189:TT	No_match
citalopram	rs6313	HTR2A	AA	Toxicity	decreased	Adverse_Event	Disease:C0235876		N06AB04	rs6313:AA	162180
antiinflammatory agents, non-steroids	rs12353214	PTGS1	TT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs12353214:TT	No_match
antiinflammatory agents, non-steroids	rs211247	KL	CG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs211247:CG	No_match
antiinflammatory agents, non-steroids	rs211247	KL	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs211247:GG	No_match
antiinflammatory agents, non-steroids	rs1205	CRP	CT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs1205:CT	No_match
antiinflammatory agents, non-steroids	rs1205	CRP	TT	Toxicity	increased	Adverse_Event	Disease:C0027051		M01A|V10A	rs1205:TT	No_match
nicotine	rs1044396	CHRNA4	AG	Other	increased	Adverse_Event	Healthy		N07BA01	rs1044396:AG	936
antiinflammatory agents, non-steroids	rs10757274	CDKN2B-AS1	AA	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs10757274:AA	No_match
antiinflammatory agents, non-steroids	rs10757274	CDKN2B-AS1	AG	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs10757274:AG	No_match
nicotine	rs1044396	CHRNA4	GG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1044396:GG	936
antiinflammatory agents, non-steroids	rs699	AGT	GG	Toxicity	decreased	Adverse_Event	Disease:C0027051		M01A|V10A	rs699:GG	No_match
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
nicotine	rs1044397	CHRNA4	CC	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1044397:CC	936
coxibs	rs20417	PTGS2	CG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs20417:CG	No_match
coxibs	rs20417	PTGS2	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs20417:GG	No_match
coxibs	rs4648276	PTGS2	AG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs4648276:AG	No_match
coxibs	rs4648276	PTGS2	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		M01AH	rs4648276:GG	No_match
sevoflurane	rs3733784	FASTKD3, MTRR	CC	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs3733784:CC	13529
sevoflurane	rs3733784	FASTKD3, MTRR	CT	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs3733784:CT	13529
heroin	rs524731	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs524731:A	9844225
heroin	rs511435	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs511435:T	9844225
heroin	rs495491	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs495491:G	9844225
azathioprine	rs10824095	ADK	TT	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs10824095:TT	5778
heroin	rs510769	OPRM1	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs510769:T	9844225
cisplatin	rs1872328	ACYP2	A	Toxicity	increased	Adverse_Event	Disease:C0006118		L01XA01	rs1872328:A	441203
azathioprine	rs747199	SLC29A1	CG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs747199:CG	5778
azathioprine	rs747199	SLC29A1	GG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs747199:GG	5778
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG	13748464
azathioprine	rs11706052	IMPDH2	AG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs11706052:AG	5778
azathioprine	rs11706052	IMPDH2	GG	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs11706052:GG	5778
heroin	rs3778151	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3778151:C	9844225
azathioprine	rs2278294	IMPDH1	CT	Toxicity	decreased	Adverse_Event	Disease:C0021390		L04AX01	rs2278294:CT	5778
azathioprine	rs2278294	IMPDH1	TT	Toxicity	decreased	Adverse_Event	Disease:C0021390		L04AX01	rs2278294:TT	5778
clozapine, olanzapine, risperidone	rs2228622	SLC1A1	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs2228622:A	135398737
heroin	rs3823010	OPRM1	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3823010:A	9844225
clozapine, olanzapine, risperidone	rs3780413	SLC1A1	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs3780413:G	135398737
clozapine, olanzapine, risperidone	rs3780412	SLC1A1	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs3780412:C	135398737
heroin	rs9478495	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs9478495:A	9844225
aspirin, clopidogrel	rs1062535	ITGA2	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1062535:AA	2244
aspirin, clopidogrel	rs1062535	ITGA2	AG	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1062535:AG	2244
none	rs1187075	ITGB1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		A03DA02	rs1187075:AA	5282367
heroin	rs562859	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs562859:C	9844225
fluorouracil	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Healthy		L01BC02	rs3918290:T	5790
letrozole	rs1324052	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Other:C1458155		L02BG04	rs1324052:A	10466550
platinum, vinorelbine	rs182455	STMN1	AA	Efficacy	decreased	Efficacy_Response	Healthy		L01CA04|L01XA	rs182455:AA	23939
tegafur	rs1801159	DPYD	TT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC03	rs1801159:TT	5386
none	rs2230395	ITGB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023055		A03DA02	rs2230395:GG	5282367
heroin	rs3778150	OPRM1	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs3778150:C	9844225
bevacizumab, pemetrexed	rs3780126	GGH	G	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BA04|L01FG01	rs3780126:G	135410875
none	rs1843809	TPH2	TT	Other	decreased	Adverse_Event	Disease:C0085762		A03DA02	rs1843809:TT	5282367
aspirin, clopidogrel	rs1126643	ITGA2	CT	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1126643:CT	2244
aspirin, clopidogrel	rs1126643	ITGA2	TT	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1126643:TT	2244
heroin	rs9384169	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs9384169:C	9844225
antipsychotics	rs762551	CYP1A2	AC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:AC	No_match
antipsychotics	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:CC	No_match
platinum compounds	rs316019	SLC22A2	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AA	23939
platinum compounds	rs316019	SLC22A2	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AC	23939
platinum compounds	rs316019	SLC22A2	AA	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AA	23939
platinum compounds	rs316019	SLC22A2	AC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs316019:AC	23939
antidepressants, antipsychotics, benzodiazepine derivatives, opioids, sympathomimetics	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Other:C1963951		N02A|N05A|N05CD|N06A|R01BA	rs1799971:G	No_match
bevacizumab, pemetrexed	rs11545077	GGH	CT	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BA04|L01FG01	rs11545077:CT	135410875
digoxin	rs10494366	NOS1AP	GG	Toxicity	increased	Adverse_Event	Healthy		C01AA05	rs10494366:GG	15478
sunitinib	rs2032582	ABCB1	CC	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2032582:CC	11221549
aspirin, clopidogrel	rs1126643	ITGA2	CT	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs1126643:CT	2244
aspirin, clopidogrel	rs1126643	ITGA2	TT	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs1126643:TT	2244
fentanyl	rs1799971	OPRM1	GG	Dosage	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:GG	13653606
cannabinoids, cocaine, ethanol, nicotine, opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Healthy		N01BC01|N02A|N02BG10|N07BA01|V03AB16	rs1799971:G	89594
capecitabine, fluorouracil	rs895819	MIR27A	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs895819:CT	60953
sunitinib	rs7993418	FLT1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs7993418:GG	11221549
cisplatin	rs6721961	NFE2L2	GG	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs6721961:GG	441203
cisplatin	rs6721961	NFE2L2	GT	Toxicity	increased	Adverse_Event	Other:Head_and_Neck_Neoplasms		L01XA01	rs6721961:GT	441203
sunitinib	rs9582036	FLT1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9582036:CC	11221549
fentanyl	rs1799971	OPRM1	AG	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:AG	13653606
fentanyl	rs1799971	OPRM1	GG	Dosage, Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:GG	13653606
fluvoxamine	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	rs6311:CC	154032615
fluvoxamine	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB08	rs6311:CT	154032615
fentanyl	rs1799971	OPRM1	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:AG	13653606
fentanyl	rs1799971	OPRM1	GG	Efficacy	Indeterminado	Efficacy_Response	Healthy		N02AB03	rs1799971:GG	13653606
olanzapine	rs2266780	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		N05AH03	rs2266780:GG	74603552
metoprolol	rs3892097	CYP2D6	T	Efficacy, Metabolism/PK	increased	LADME	Healthy		C07AB02	rs3892097:T	6322
sunitinib	rs9554320	FLT1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9554320:AA	11221549
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs4244285:A	13748464
platinum compounds	rs10956697	CCN4	AA	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs10956697:AA	23939
platinum compounds	rs10956697	CCN4	AC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs10956697:AC	23939
aspirin	rs5918	ITGB3	CC	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs5918:CC	72204814
aspirin	rs5918	ITGB3	CT	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs5918:CT	72204814
sunitinib	rs9554320	FLT1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9554320:AA	11221549
olanzapine	rs12720462	FMO1	AA	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs12720462:AA	74603552
olanzapine	rs12720462	FMO1	AC	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs12720462:AC	74603552
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	rs4244285:A	13748464
platinum compounds	rs3212986	ERCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01XA	rs3212986:CC	23939
aripiprazole	rs2514218	DRD2	CC	Toxicity	increased	Adverse_Event	Other:C0033975|Other:C0036337|Other:C0036341		N05AX12	rs2514218:CC	10114519
platinum compounds, taxanes	rs1695	GSTP1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0919267		L01CD|L01XA	rs1695:AA	23939
platinum, taxanes	rs2032582	ABCB1	CC	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0919267		L01CD|L01XA	rs2032582:CC	23939
clopidogrel	rs4986893	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	rs4986893:A	13748464
sunitinib	rs9582036	FLT1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9582036:CC	11221549
olanzapine	rs7877	FMO1	CT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs7877:CT	74603552
olanzapine	rs7877	FMO1	TT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs7877:TT	74603552
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs4986893:A	13748464
bumetanide, furosemide, torasemide	rs1529927	SLC12A3	C	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs1529927:C	41781
amphetamine, cannabinoids, cocaine, opioids	rs9829896	KAT2B	C	Toxicity	decreased	Adverse_Event	Healthy		N01BC01|N02A|N02BG10	rs9829896:C	3007
paclitaxel	rs7349683	EPHA5	TT	Toxicity	increased	Adverse_Event	Other:C1458155		L01CD01	rs7349683:TT	36314
imatinib	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2231142:TT	6113
aspirin	rs4271002	NAT2	C	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4271002:C	72204814
opioids	rs1799971	OPRM1	AG	Toxicity	decreased	Adverse_Event	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:GG	No_match
methadone	rs3786047	ARRB2	AA	Efficacy	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs3786047:AA	10090
bumetanide, furosemide, torasemide	rs5723	SCNN1G	G	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5723:G	41781
platinum compounds	rs2929973	CCN4	GG	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2929973:GG	23939
platinum compounds	rs2929973	CCN4	GT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2929973:GT	23939
enalapril	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02	rs4149056:CC	5950
enalapril	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Disease:C0085580		C09AA02	rs4149056:CT	5950
antipsychotics	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs6311:TT	No_match
methadone	rs1045280	ARRB2	CC	Efficacy	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs1045280:CC	10090
methadone	rs1714984	MYOCD	AA	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BC02	rs1714984:AA	10090
methadone	rs1714984	MYOCD	AG	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BC02	rs1714984:AG	10090
methadone	rs2036657	ARRB2	GG	Efficacy	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs2036657:GG	10090
bumetanide, furosemide, torasemide	rs5729	SCNN1G	A	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5729:A	41781
antipsychotics	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:CC	No_match
antipsychotics	rs1065852	CYP2D6	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1065852:A	No_match
olanzapine	rs518147	HTR2C	C	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH03	rs518147:C	74603552
pravastatin	rs708272	CETP	AG	Efficacy	decreased	Adverse_Event	Other:C1956346		C10AA03	rs708272:AG	58746970
atorvastatin	rs20455	KIF6	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA05	rs20455:AG	656846
atorvastatin	rs20455	KIF6	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA05	rs20455:GG	656846
aspirin	rs5918	ITGB3	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		No_ATC	rs5918:TT	72204814
aspirin	rs5985	F13A1	AA	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs5985:AA	72204814
aspirin	rs5985	F13A1	AC	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs5985:AC	72204814
verapamil	rs1801253	ADRB1	CC	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801253:CC	65808
verapamil	rs1801253	ADRB1	CG	Efficacy	increased	Adverse_Event	Disease:C1956346		C08DA01	rs1801253:CG	65808
azathioprine	rs1127354	ITPA	C	Efficacy	decreased	Adverse_Event	Other:Liver_transplantation		L04AX01	rs1127354:C	5778
chop, rituximab	rs1883112	NCF4	GG	Efficacy	decreased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:GG	No_match
ivacaftor	rs75527207	CFTR	AA	Efficacy	decreased	Adverse_Event	Disease:C0156318		R07AX02	rs75527207:AA	72722243
ivacaftor	rs75527207	CFTR	AG	Efficacy	decreased	Adverse_Event	Disease:C0156318		R07AX02	rs75527207:AG	72722243
chop, rituximab	rs2231137	ABCG2	CC	Efficacy	decreased	Efficacy_Response	Other:C0024299|Large_B-Cell|Diffuse		L01FA01	rs2231137:CC	No_match
pravastatin	rs708272	CETP	GG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C10AA03	rs708272:GG	58746970
amiodarone, diuretics, sotalol	rs10800397	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01|C03|C07AA07	rs10800397:T	5253
antipsychotics	rs6977820	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs6977820:CT	No_match
antipsychotics	rs6977820	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs6977820:TT	No_match
amiodarone	rs10800397	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01	rs10800397:T	74769
warfarin	rs17880887	VKORC1	T	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs17880887:T	54688261
amiodarone	rs10919035	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01	rs10919035:T	74769
aspirin	rs1050891	HNMT	G	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs1050891:G	72204814
amiodarone	rs10919035	NOS1AP	T	Toxicity	Indeterminado	Adverse_Event	Healthy		C01BD01	rs10919035:T	74769
aspirin	rs730012	LTC4S	AC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs730012:AC	72204814
aspirin	rs730012	LTC4S	CC	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs730012:CC	72204814
antipsychotics	rs2485914	SMYD3	T	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs2485914:T	No_match
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799929	NAT2	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:TT	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799929	NAT2	CC	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:CC	135483892
cytarabine, idarubicin	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1045642:GG	6253
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Other	Healthy		B01AA03	rs1057910:AC	54688261
levonorgestrel	rs1042522	TP53	CG	Toxicity	increased	Adverse_Event	Healthy		G03AD01	rs1042522:CG	5991
aspirin	rs1613662	GP6	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		No_ATC	rs1613662:AG	72204814
cisplatin, doxorubicin, ifosfamide, methotrexate	rs1799793	ERCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01AA06|L01DB01|L01XA01|L04AX03	rs1799793:CT	9588020
cisplatin, doxorubicin, ifosfamide, methotrexate	rs1799793	ERCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01AA06|L01DB01|L01XA01|L04AX03	rs1799793:TT	9588020
cytarabine, idarubicin	rs1045642	ABCB1	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1045642:GG	6253
cisplatin, doxorubicin, ifosfamide, methotrexate	rs13181	ERCC2, KLC3	GG	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01AA06|L01DB01|L01XA01|L04AX03	rs13181:GG	9588020
acenocoumarol, phenprocoumon, warfarin	rs2108622	CYP4F2	CT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03|B01AA04|B01AA07	rs2108622:CT	54680692
acenocoumarol, phenprocoumon, warfarin	rs2108622	CYP4F2	TT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03|B01AA04|B01AA07	rs2108622:TT	54680692
aspirin	rs5918	ITGB3	CT	Toxicity	increased	Adverse_Event	Disease:C1956346		No_ATC	rs5918:CT	72204814
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0024299		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0024299		L04AX03	rs1801133:AG	11329481
sunitinib	rs2305948	KDR	C	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs2305948:C	11221549
capecitabine, epirubicin, platinum	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC06|L01DB03|L01XA	rs1695:GG	23939
clopidogrel	rs662	PON1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:CT	13748464
clopidogrel	rs662	PON1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:TT	13748464
none	rs5918	ITGB3	CC	Other	Indeterminado	Other	Healthy		A03DA02	rs5918:CC	5282367
none	rs5918	ITGB3	CT	Other	Indeterminado	Other	Healthy		A03DA02	rs5918:CT	5282367
beta blocking agents	rs2230345	GRK5	AA	Other	increased	Adverse_Event	Other:C0085605		S01ED	rs2230345:AA	No_match
fentanyl, hydromorphone, oxycodone	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Other:C0027651		N02AA03|N02AA05|N02AB03	rs1799971:AG	5284603
fentanyl, hydromorphone, oxycodone	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Other:C0027651		N02AA03|N02AA05|N02AB03	rs1799971:GG	5284603
clopidogrel	rs662	PON1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:CT	13748464
clopidogrel	rs662	PON1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs662:TT	13748464
bevacizumab	rs2228014	CXCR4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01FG01	rs2228014:AA	No_match
bevacizumab	rs2228014	CXCR4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01FG01	rs2228014:AG	No_match
beta blocking agents	rs1801253	ADRB1	CC	Other	decreased	Adverse_Event	Other:C0085605		S01ED	rs1801253:CC	No_match
docetaxel, fec100, gemcitabine, trastuzumab, zoledronate	rs147451859	PPCDC	G	Toxicity	decreased	Adverse_Event	Other:C1458155		L01BC05|L01CD02	rs147451859:G	148124
sunitinib	rs6877011	FLT4	GG	Efficacy	decreased	Adverse_Event	Disease:C0238198		L01EX01	rs6877011:GG	11221549
haloperidol	rs17143212	ABCB5	CT	Toxicity	increased	Adverse_Event	Disease:C0033975		N05AD01	rs17143212:CT	9828
docetaxel, fec100, gemcitabine, trastuzumab, zoledronate	rs17587029	__INTRONIC__	G	Toxicity	decreased	Adverse_Event	Other:C1458155		L01BC05|L01CD02	rs17587029:G	148124
sunitinib	rs2231142	ABCG2	T	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:T	11221549
opioids	rs10799590	CNIH3	A	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs10799590:A	No_match
azathioprine, mercaptopurine	rs7270101	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	rs7270101:AC	5778
azathioprine, mercaptopurine	rs7270101	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX01	rs7270101:CC	5778
sunitinib	rs3025039	VEGFA	CT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EX01	rs3025039:CT	11221549
sunitinib	rs3025039	VEGFA	TT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EX01	rs3025039:TT	11221549
antipsychotics	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs762551:CC	No_match
methotrexate	rs1801133	MTHFR	A	Efficacy	decreased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:A	11329481
cisplatin	rs316019	SLC22A2	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs316019:A	441203
sunitinib	rs4646437	CYP3A4	AA	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs4646437:AA	11221549
sunitinib	rs4646437	CYP3A4	AG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs4646437:AG	11221549
atorvastatin	rs2032582	ABCB1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2032582:C	656846
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs6025	F5	CT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs6025:CT	172198
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs6025	F5	TT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs6025:TT	172198
cisplatin	rs6721961	NFE2L2	T	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs6721961:T	441203
carvedilol	rs1042714	ADRB2	CC	Efficacy	decreased	Adverse_Event	Disease:C0085605		C07AG02	rs1042714:CC	6322
tacrolimus	rs3761548	FOXP3	GT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs3761548:GT	131769926
tacrolimus	rs3761548	FOXP3	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs3761548:TT	131769926
tacrolimus	rs2740574	CYP3A4	CC	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CC	131769926
tacrolimus	rs2740574	CYP3A4	CT	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
methotrexate	rs72675408	RAVER2	A	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs72675408:A	11329481
phenytoin	rs1057910	CYP2C9	C	Efficacy	increased	Adverse_Event	Other:C0014544		N03AB02	rs1057910:C	1775
phenytoin	rs1799853	CYP2C9	T	Efficacy	increased	Adverse_Event	Other:C0014544		N03AB02	rs1799853:T	1775
capecitabine, fluorouracil	rs2016520	PPARD	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs2016520:T	60953
efavirenz	rs8192719	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192719:CT	64139
efavirenz	rs8192719	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192719:TT	64139
none	rs1801030	SULT1A1, SULT1A2	CC	Other	increased	Adverse_Event	Other:C0025320		A03DA02	rs1801030:CC	5282367
none	rs1801030	SULT1A1, SULT1A2	CT	Other	increased	Adverse_Event	Other:C0025320		A03DA02	rs1801030:CT	5282367
opioids	rs116181528	MCOLN1	A	Toxicity	increased	Adverse_Event	Healthy		N02A	rs116181528:A	No_match
cerivastatin, hmg coa reductase inhibitors, rosuvastatin, simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA|C10AA01|C10AA06|C10AA07	rs4149056:CC	446157
cerivastatin, hmg coa reductase inhibitors, rosuvastatin, simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA|C10AA01|C10AA06|C10AA07	rs4149056:CT	446157
none	rs2494732	AKT1	CC	Other	increased	Adverse_Event	Disease:Marijuana_Abuse		A03DA02	rs2494732:CC	5282367
capecitabine	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0017185		L01BC06	rs1801131:GG	11809635
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G	54688261
bevacizumab	rs6770663	KCNAB1	G	Toxicity	increased	Adverse_Event	Other:C0027651		L01FG01	rs6770663:G	No_match
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs9934438:A	54688261
cyclophosphamide, epirubicin	rs1695	GSTP1	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB03	rs1695:AA	2907
cyclophosphamide, epirubicin	rs1695	GSTP1	AG	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01DB03	rs1695:AG	2907
aspirin	rs7572857	CEP68	AA	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7572857:AA	72204814
opioids	rs114077267	MCOLN1	T	Toxicity	increased	Adverse_Event	Healthy		N02A	rs114077267:T	No_match
acenocoumarol	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	rs9923231:TT	54742534
platinum compounds	rs2279744	MDM2	GT	Toxicity	increased	Adverse_Event	Other:C0007131		L01XA	rs2279744:GT	23939
platinum compounds	rs2279744	MDM2	TT	Toxicity	increased	Adverse_Event	Other:C0007131		L01XA	rs2279744:TT	23939
sunitinib	rs1933437	FLT3	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:AG	11221549
sunitinib	rs1933437	FLT3	GG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:GG	11221549
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
aspirin	rs5918	ITGB3	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		No_ATC	rs5918:CT	72204814
none	rs62293298	SLC2A9	AG	Other	decreased	Adverse_Event	Other:C1956346		A03DA02	rs62293298:AG	5282367
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG	64139
aspirin	rs3775291	TLR3	CT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3775291:CT	72204814
aspirin	rs3775291	TLR3	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs3775291:TT	72204814
efavirenz	rs2279345	CYP2B6	CC	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CC	64139
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT	64139
opioids	rs115208233	MCOLN1	G	Toxicity	increased	Adverse_Event	Healthy		N02A	rs115208233:G	No_match
tacrolimus	rs2740574	CYP3A4	CC	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CC	131769926
tacrolimus	rs2740574	CYP3A4	CT	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
nicotine	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AA	936
nicotine	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:AG	936
nicotine	rs1800497	DRD2	GG	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs1800497:GG	936
warfarin	rs2884737	VKORC1	CC	Dosage	decreased	Other	Healthy		B01AA03	rs2884737:CC	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs1800795	IL6	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs1800795:CC	37542
none	rs2231142	ABCG2	GT	Other	increased	Adverse_Event	Other:C1956346		A03DA02	rs2231142:GT	5282367
none	rs2231142	ABCG2	TT	Other	increased	Adverse_Event	Other:C1956346		A03DA02	rs2231142:TT	5282367
acenocoumarol, warfarin	rs72558189	CYP2C9	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AA03|B01AA07	rs72558189:AG	54676537
telbivudine	rs3826160	TK2	CC	Toxicity	increased	Adverse_Event	Other:C0019163|Chronic		J05AF11	rs3826160:CC	159269
telbivudine	rs3826160	TK2	CT	Toxicity	increased	Adverse_Event	Other:C0019163|Chronic		J05AF11	rs3826160:CT	159269
sunitinib	rs9582036	FLT1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs9582036:CC	11221549
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T	54688261
none	rs3825017	SLC22A12	CT	Other	increased	Adverse_Event	Other:C1956346		A03DA02	rs3825017:CT	5282367
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03|B01AA07	rs2108622:CT	54676537
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03|B01AA07	rs2108622:TT	54676537
sunitinib	rs1048943	CYP1A1	C	Toxicity	increased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1048943:C	11221549
olanzapine	rs2440390	DRD2	T	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs2440390:T	74603552
pravastatin	rs428785	ADAMTS1	GG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs428785:GG	58746970
olanzapine	rs6318	HTR2C	G	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs6318:G	74603552
caffeine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Other:who_are_pregnant		N06BC01	rs762551:AA	936
olanzapine	rs2497538	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs2497538:C	74603552
olanzapine	rs1414334	HTR2C	G	Toxicity	increased	Adverse_Event	Disease:C0004936		N05AH03	rs1414334:G	74603552
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs924607:TT	24848381
pioglitazone	rs328	LPL	CG	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG03	rs328:CG	60560
pioglitazone	rs328	LPL	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG03	rs328:GG	60560
paclitaxel	rs7349683	EPHA5	CT	Toxicity	increased	Adverse_Event	Healthy		L01CD01	rs7349683:CT	36314
paclitaxel	rs7349683	EPHA5	TT	Toxicity	increased	Adverse_Event	Healthy		L01CD01	rs7349683:TT	36314
none	rs3812718	SCN1A	T	Other	increased	Adverse_Event	Disease:C0014544		A03DA02	rs3812718:T	5282367
none	rs4148323	UGT1A1	AA	Other	increased	Adverse_Event	Healthy		A03DA02	rs4148323:AA	5282367
none	rs4148323	UGT1A1	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs4148323:AG	5282367
none	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs16969968:A	5282367
paclitaxel	rs3213619	ABCB1	AG	Toxicity	decreased	Adverse_Event	Healthy		L01CD01	rs3213619:AG	36314
paclitaxel	rs3213619	ABCB1	GG	Toxicity	decreased	Adverse_Event	Healthy		L01CD01	rs3213619:GG	36314
verapamil	rs10494366	NOS1AP	GG	Toxicity	increased	Adverse_Event	Healthy		C08DA01	rs10494366:GG	65808
mercaptopurine	rs2413739	PACSIN2	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs2413739:TT	1268107
none	rs1051730	__INTRONIC__	A	Other	increased	Adverse_Event	Other:C0039338		A03DA02	rs1051730:A	5282367
none	rs12794714	CYP2R1	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs12794714:A	5282367
olanzapine	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0033975		N05AH03	rs1045642:AA	74603552
peginterferon alfa-2b, ribavirin, simeprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs12979860:CC	37542
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799930	NAT2	A	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:A	135483892
none	rs10741657	CYP2R1	A	Other	decreased	Adverse_Event	Healthy		A03DA02	rs10741657:A	5282367
ethambutol, isoniazid / pyrazinamide / rifampin	rs1799929	NAT2	T	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs1799929:T	135483892
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT	656846
paroxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB05	rs6295:GG	667572
tamoxifen	rs310786	E2F7	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BA01	rs310786:CC	2733525
alendronate	rs2241529	DKK1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0005944|Disease:C0029456		No_ATC	rs2241529:AA	2088
clopidogrel	rs8192950	CES1	G	Efficacy	decreased	Adverse_Event	Other:C0007820		B01AC04	rs8192950:G	13748464
antipsychotics	rs1799732	DRD2	GG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1799732:GG	No_match
sunitinib	rs2305948	KDR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2305948:CC	11221549
warfarin	rs4918758	CYP2C9	C	Dosage	decreased	Other	Healthy		B01AA03	rs4918758:C	54688261
sunitinib	rs3025039	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs3025039:CC	11221549
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT	14373154
olanzapine	rs1800497	ANKK1	GG	Other	decreased	LADME	Healthy		N05AH03	rs1800497:GG	74603552
exemestane	rs9322336	ESR1	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L02BG06	rs9322336:CC	13472
warfarin	rs9332096	CYP2C9	T	Dosage	decreased	Other	Healthy		B01AA03	rs9332096:T	54688261
olanzapine	rs1800497	ANKK1	GG	Other	decreased	Other	Healthy		N05AH03	rs1800497:GG	74603552
sunitinib	rs2010963	VEGFA	G	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs2010963:G	11221549
sunitinib	rs6877011	FLT4	C	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs6877011:C	11221549
olanzapine	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Healthy		N05AH03	rs1695:AA	74603552
sunitinib	rs2276707	NR1I2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2276707:TT	11221549
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:GG	54688261
anthracyclines and related substances	rs2232228	HAS3	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs2232228:AA	No_match
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Other	Healthy		B01AA03	rs9923231:T	54688261
sunitinib	rs1933437	FLT3	AG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:AG	11221549
sunitinib	rs1933437	FLT3	GG	Toxicity	decreased	Adverse_Event	Disease:C0007134|Disease:C0238198		L01EX01	rs1933437:GG	11221549
nortriptyline	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA10	rs1045642:AA	9918
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Other	Healthy		B01AA03	rs2359612:A	54688261
morphine, oxycodone	rs1799971	OPRM1	GG	Toxicity	decreased	Adverse_Event	Other:C0024121		N02AA01|N02AA05	rs1799971:GG	5288826
morphine, oxycodone	rs4680	COMT	GG	Toxicity	increased	Adverse_Event	Other:C0024121		N02AA01|N02AA05	rs4680:GG	5288826
carbamazepine	rs2071197	HNF4A	GG	Efficacy	increased	LADME	Disease:C0014544		N03AF01	rs2071197:GG	114709
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Other	Healthy		B01AA03	rs8050894:G	54688261
pravastatin	rs1801133	MTHFR	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		C10AA03	rs1801133:GG	58746970
sunitinib	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1128503:AA	11221549
sunitinib	rs833061	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CC	11221549
sunitinib	rs833061	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CT	11221549
cyclosporine, mycophenolate mofetil	rs11706052	IMPDH2	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs11706052:AG	6918995
cyclosporine, mycophenolate mofetil	rs11706052	IMPDH2	GG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs11706052:GG	6918995
cyclosporine, mycophenolate mofetil	rs1800629	TNF	AA	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1800629:AA	6918995
cyclosporine, mycophenolate mofetil	rs1800629	TNF	AG	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1800629:AG	6918995
methotrexate	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801131:GG	11329481
cyclosporine, mycophenolate mofetil	rs1800872	IL10	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs1800872:TT	6918995
sunitinib	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AA	11221549
sunitinib	rs2032582	ABCB1	AT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AT	11221549
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:C0007820		B01AC04	rs4986893:A	13748464
sunitinib	rs2010963	VEGFA	G	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2010963:G	11221549
nicotine	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Other:Schizophrenia_who_are_smokers		N07BA01	rs16969968:A	936
nicotine	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Other:C0008301		N07BA01	rs16969968:A	936
none	rs16969968	CHRNA5	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs16969968:A	5282367
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AA	11329481
clopidogrel	rs2254638	N6AMT1	GG	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs2254638:GG	13748464
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024299		L04AX03	rs1801133:AA	11329481
nicotine	rs2717162	GALR1	CT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:CT	936
nicotine	rs2717162	GALR1	TT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:TT	936
capecitabine, fluorouracil	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:A	60953
capecitabine, fluorouracil	rs3918290	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs3918290:T	60953
erythromycin	rs4149056	SLCO1B1	C	Metabolism/PK	decreased	LADME	Disease:C0027651		S01AA17	rs4149056:C	9831800
pazopanib, simvastatin	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C0027651		C10AA01|L01EX03	rs2231142:GT	10113978
pazopanib, simvastatin	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		C10AA01|L01EX03	rs2231142:TT	10113978
gentamicin	rs267606617	MT-RNR1	G	Toxicity	increased	Adverse_Event	Healthy		S02AA14	rs267606617:G	9855350
cyclosporine, tacrolimus	rs2167270	LEP	A	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01|L04AD02	rs2167270:A	445643
erlotinib	rs1045642	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0007131		L01EB02	rs1045642:AA	176870
mercaptopurine	rs73189762	NUDT15	GT	Dosage	increased	Adverse_Event	Other:C0023449		L01BB02	rs73189762:GT	1268107
ethanol	rs1176744	HTR3B	C	Other	increased	Adverse_Event	Healthy		V03AB16	rs1176744:C	444899
clopidogrel	rs12248560	CYP2C19	T	Toxicity	decreased	Adverse_Event	Disease:C0027051		B01AC04	rs12248560:T	13748464
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:Hematopoietic_stem_cell_transplantation		L04AX03	rs1801133:AA	11329481
methotrexate	rs5760410	ADORA2A, SPECC1L	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs5760410:G	11329481
calcium channel blockers, nitrendipine	rs1137617	KCNH2	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C08|C08CA08	rs1137617:AA	4507
calcium channel blockers, nitrendipine	rs1137617	KCNH2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C08|C08CA08	rs1137617:AG	4507
clopidogrel	rs7667298	KDR	CC	Toxicity	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs7667298:CC	13748464
methotrexate	rs1801131	MTHFR	G	Efficacy	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L04AX03	rs1801131:G	11329481
methotrexate	rs1801133	MTHFR	AA	Efficacy	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L04AX03	rs1801133:AA	11329481
nicotine	rs2717162	GALR1	CT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:CT	936
nicotine	rs2717162	GALR1	TT	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs2717162:TT	936
antineoplastic agents	rs1801133	CLCN6, MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01	rs1801133:GG	No_match
irinotecan	rs4148323	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs4148323:AG	74990
none	rs1801131	MTHFR	G	Efficacy	increased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		A03DA02	rs1801131:G	5282367
busulfan, cyclophosphamide, methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Healthy		L01AA01|L01AB01|L04AX03	rs1801133:AA	2907
erlotinib	rs1128503	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0007131		L01EB02	rs1128503:AA	176870
methotrexate	rs1801131	MTHFR	GG	Efficacy	decreased	Adverse_Event	Other:allogeneic_hematopoietic_cell_transplantation_for_chronic_myelogenous_leukemia.		L04AX03	rs1801131:GG	11329481
clopidogrel	rs2305948	KDR	TT	Toxicity	increased	Adverse_Event	Disease:C0010068		B01AC04	rs2305948:TT	13748464
methotrexate	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1128503:GG	11329481
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801131	MTHFR	GG	Toxicity	decreased	Adverse_Event	Other:hematopoietic-cell-transplantation		L04AX03	rs1801131:GG	11329481
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023418		L04AX03	rs1801133:AA	11329481
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	rs9923231:TT	54688261
erlotinib	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0007131		L01EB02	rs2032582:AA	176870
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C0004238		B01AA03	rs9923231:TT	54688261
paclitaxel	rs9657362	ARHGEF10	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs9657362:C	36314
none	rs3800373	FKBP5	AA	Other	increased	Adverse_Event	Other:history_of_Child_Abuse		A03DA02	rs3800373:AA	5282367
none	rs3800373	FKBP5	AC	Other	increased	Adverse_Event	Other:history_of_Child_Abuse		A03DA02	rs3800373:AC	5282367
paclitaxel	rs9657362	ARHGEF10	C	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CD01	rs9657362:C	36314
none	rs2296840	PSMB4	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs2296840:T	5282367
metformin	rs34059508	SLC22A1	A	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BA02	rs34059508:A	155906370
metformin	rs12208357	SLC22A1	C	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12208357:C	155906370
clopidogrel	rs12248560	CYP2C19	T	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs12248560:T	13748464
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
none	rs680244	CHRNA5	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs680244:C	5282367
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:A	13748464
methotrexate	rs2476601	PTPN22	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2476601:AA	11329481
methotrexate	rs6920220	TNFAIP3	A	Toxicity	increased	Adverse_Event	Disease:C0235889		L04AX03	rs6920220:A	11329481
sunitinib	rs2231142	ABCG2	TT	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs2231142:TT	11221549
risperidone	rs1045642	ABCB1	AA	Metabolism/PK	increased	Adverse_Event	Disease:C0005586|Disease:C0036337|Disease:C0036341		N05AX08	rs1045642:AA	849421
carbamazepine, phenobarbital, phenytoin, valproic acid	rs2606345	CYP1A1	A	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:C0014544		N03AA02|N03AB02|N03AF01|N03AG01	rs2606345:A	1775
none	rs2417940	SLCO1B3	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs2417940:C	5282367
sertraline	rs13432159	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB06	rs13432159:G	18642483
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC	445127
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CT	445127
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:TT	2733525
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT	14373154
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:TT	2733525
tamoxifen	rs3892097	CYP2D6	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:TT	2733525
none	rs20455	KIF6	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:AG	5282367
none	rs20455	KIF6	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:GG	5282367
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:A	37542
rosuvastatin	rs9806699	GATM	AA	Toxicity	decreased	Adverse_Event	Healthy		C10AA07	rs9806699:AA	5282455
rosuvastatin	rs9806699	GATM	AG	Toxicity	decreased	Adverse_Event	Healthy		C10AA07	rs9806699:AG	5282455
tamoxifen	rs3892097	CYP2D6	T	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs3892097:T	2733525
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CC	Toxicity	decreased	Adverse_Event	Healthy		C10AA	rs4363657:CC	445127
hmg coa reductase inhibitors	rs4363657	SLCO1B1	CT	Toxicity	decreased	Adverse_Event	Healthy		C10AA	rs4363657:CT	445127
peginterferon alfa-2b, ribavirin	rs7270101	ITPA	C	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs7270101:C	37542
irinotecan	rs4148323	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs4148323:AA	74990
fluorouracil, irinotecan, oxaliplatin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02|L01CE02|L01XA03	rs1695:AA	9887054
pravastatin	rs16944	IL1B	GG	Other	increased	Other	Healthy		C10AA03	rs16944:GG	58746970
hmg coa reductase inhibitors	rs116561224	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs116561224:G	445127
none	rs3815459	KCNH2	T	Other	increased	Other	Healthy		A03DA02	rs3815459:T	5282367
fenofibrate, sertraline, terbinafine, ticlopidine	rs114577328	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		B01AC05|C10AB05|D01BA02|N06AB06	rs114577328:C	5472
antidepressants	rs17288723	HTR2A	CC	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs17288723:CC	No_match
none	rs3807375	KCNH2	CT	Other	increased	Other	Healthy		A03DA02	rs3807375:CT	5282367
none	rs3807375	KCNH2	TT	Other	increased	Other	Healthy		A03DA02	rs3807375:TT	5282367
citalopram	rs1954787	GRIK4	C	Efficacy	decreased	Adverse_Event	Disease:C0235876		N06AB04	rs1954787:C	162180
none	rs1805123	KCNH2	GT	Other	increased	Other	Healthy		A03DA02	rs1805123:GT	5282367
none	rs1805123	KCNH2	TT	Other	increased	Other	Healthy		A03DA02	rs1805123:TT	5282367
cyclosporine	rs2276707	NR1I2	C	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2276707:C	86666680
drugs for treatment of tuberculosis	rs1799929	NAT2	CT	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799929:CT	No_match
drugs for treatment of tuberculosis	rs1799929	NAT2	TT	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799929:TT	No_match
drugs for treatment of tuberculosis	rs1799930	NAT2	AA	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799930:AA	No_match
drugs for treatment of tuberculosis	rs1799930	NAT2	AG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799930:AG	No_match
platinum compounds	rs1695	GSTP1	G	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0007131		L01XA	rs1695:G	23939
clozapine	rs149104283	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs149104283:T	131769989
drugs for treatment of tuberculosis	rs1799931	NAT2	AA	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799931:AA	No_match
drugs for treatment of tuberculosis	rs1799931	NAT2	AG	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1799931:AG	No_match
none	rs1805123	KCNH2	G	Other	decreased	Other	Healthy		A03DA02	rs1805123:G	5282367
asparaginase, cyclophosphamide, daunorubicin, prednisolone, vincristine	rs738409	PNPLA3	CG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:CG	2907
asparaginase, cyclophosphamide, daunorubicin, prednisolone, vincristine	rs738409	PNPLA3	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01AA01|L01CA02|L01DB02|L01XX02|S02BA03	rs738409:GG	2907
none	rs3807375	KCNH2	T	Other	increased	Other	Healthy		A03DA02	rs3807375:T	5282367
oxaliplatin	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01XA03	rs1695:GG	9887054
none	rs757092	KCNQ1	G	Other	increased	Other	Healthy		A03DA02	rs757092:G	5282367
none	rs3815459	KCNH2	T	Other	increased	Other	Healthy		A03DA02	rs3815459:T	5282367
pravastatin	rs16944	IL1B	GG	Other	increased	Other	Healthy		C10AA03	rs16944:GG	58746970
none	rs2010963	VEGFA	CG	Other	increased	Adverse_Event	Healthy		A03DA02	rs2010963:CG	5282367
none	rs2010963	VEGFA	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs2010963:GG	5282367
none	rs1805123	KCNH2	GG	Other	decreased	Other	Healthy		A03DA02	rs1805123:GG	5282367
none	rs757092	KCNQ1	G	Other	increased	Other	Healthy		A03DA02	rs757092:G	5282367
oxaliplatin	rs1695	GSTP1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0017185		L01XA03	rs1695:AA	9887054
methotrexate	rs4149056	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:TT	11329481
cyclosporine	rs2276707	NR1I2	T	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2276707:T	86666680
rifampicin	rs3814055	NR1I2	TT	Other	increased	LADME	Healthy		J04AB02	rs3814055:TT	135542225
platinum compounds	rs2977549	CCN4	CC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977549:CC	23939
platinum compounds	rs2977549	CCN4	CT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977549:CT	23939
citalopram	rs7997012	HTR2A	AA	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB04	rs7997012:AA	162180
tacrolimus	rs2740574	CYP3A4	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2740574:CC	131769926
tacrolimus	rs2740574	CYP3A4	TT	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs2740574:TT	131769926
citalopram	rs7997012	HTR2A	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB04	rs7997012:A	162180
tacrolimus	rs776746	CYP3A5	T	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:T	131769926
cyclosporine	rs3814055	NR1I2	C	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs3814055:C	86666680
aspirin, clopidogrel	rs17064642	MYOM2	CC	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs17064642:CC	2244
aspirin, clopidogrel	rs17064642	MYOM2	CT	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs17064642:CT	2244
antidepressants	rs7997012	HTR2A	G	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs7997012:G	No_match
citalopram	rs7997012	HTR2A	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB04	rs7997012:A	162180
sufentanil	rs4680	COMT	AA	Dosage	increased	Adverse_Event	Other:C0032961		N01AH03	rs4680:AA	41693
sufentanil	rs4680	COMT	AG	Dosage	increased	Adverse_Event	Other:C0032961		N01AH03	rs4680:AG	41693
antidepressants	rs1954787	GRIK4	CC	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs1954787:CC	No_match
sufentanil	rs1799971	OPRM1	AG	Dosage	decreased	Adverse_Event	Other:C0032961		N01AH03	rs1799971:AG	41693
sufentanil	rs1799971	OPRM1	GG	Dosage	decreased	Adverse_Event	Other:C0032961		N01AH03	rs1799971:GG	41693
antidepressants	rs12800734	GRIK4	GG	Efficacy	increased	Adverse_Event	Disease:C0011581		N06A	rs12800734:GG	No_match
pravastatin	rs20455	KIF6	AG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:AG	58746970
pravastatin	rs20455	KIF6	GG	Efficacy	decreased	Adverse_Event	Healthy		C10AA03	rs20455:GG	58746970
none	rs20455	KIF6	AG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:AG	5282367
none	rs20455	KIF6	GG	Other	increased	Adverse_Event	Healthy		A03DA02	rs20455:GG	5282367
pravastatin	rs2306283	SLCO1B1	G	Metabolism/PK	decreased	LADME	Healthy		C10AA03	rs2306283:G	58746970
pravastatin	rs4149015	SLCO1B1	AG	Other, Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149015:AG	58746970
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:TT	1268107
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:TT	1268107
platinum compounds	rs2977551	CCN4	CC	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977551:CC	23939
platinum compounds	rs2977551	CCN4	CT	Efficacy	decreased	Adverse_Event	Other:C0024121		L01XA	rs2977551:CT	23939
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs1045642:AA	13748464
fluorouracil	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02	rs1042522:GG	5790
peginterferon alfa-2a, ribavirin	rs6051702	ITPA	AC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs6051702:AC	37542
peginterferon alfa-2a, ribavirin	rs6051702	ITPA	CC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs6051702:CC	37542
nicotine	rs578776	CHRNA3, CHRNA5	GG	Toxicity	increased	Adverse_Event	Other:C0024121		N07BA01	rs578776:GG	936
nicotine	rs1044396	CHRNA4	AA	Toxicity	increased	Adverse_Event	Other:C0024121		N07BA01	rs1044396:AA	936
nicotine	rs2229959	CHRNA4	CC	Toxicity	increased	Adverse_Event	Other:C0024121		N07BA01	rs2229959:CC	936
selective serotonin reuptake inhibitors	rs13306278	COMT, TXNRD2	T	Efficacy	decreased	Adverse_Event	Disease:C0011581		N06AB	rs13306278:T	5202
pravastatin	rs4986790	TLR4	AG	Efficacy	decreased	Adverse_Event	Disease:C1956346		C10AA03	rs4986790:AG	58746970
pravastatin	rs4986790	TLR4	GG	Efficacy	decreased	Adverse_Event	Disease:C1956346		C10AA03	rs4986790:GG	58746970
phenprocoumon	rs9923231	VKORC1	TT	Efficacy	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT	91987769
aminoglycoside antibacterials	rs267606617	MT-RNR1	G	Toxicity	increased	Adverse_Event	Healthy		J01G	rs267606617:G	No_match
peginterferon alfa-2a, ribavirin	rs1544410	VDR	TT	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB11	rs1544410:TT	37542
phenprocoumon	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT	91987769
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT	54742534
fluorouracil	rs2854746	IGFBP3	CC	Efficacy	Indeterminado	Other	Disease:C0026640		L01BC02	rs2854746:CC	5790
phenprocoumon	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA04	rs9923231:TT	91987769
platinum compounds	rs1695	GSTP1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs1695:AA	23939
platinum compounds	rs13181	ERCC2, KLC3	GG	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs13181:GG	23939
phenprocoumon	rs1051740	EPHX1	CC	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs1051740:CC	91987769
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs11615:AA	23939
clopidogrel	rs2032582	ABCB1	AA	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs2032582:AA	13748464
platinum compounds	rs1695	GSTP1	AA	Efficacy	increased	Adverse_Event	Disease:C0023055		L01XA	rs1695:AA	23939
carboplatin, paclitaxel	rs1523130	NR1I2	TT	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs1523130:TT	10339178
azathioprine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390|Disease:C0023449		L04AX01	rs116855232:T	5778
cetuximab	rs4444903	EGF	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs4444903:AA	No_match
carboplatin, paclitaxel	rs1523127	NR1I2	CC	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs1523127:CC	10339178
irinotecan	rs10929302	UGT1A1	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AA	74990
irinotecan	rs10929302	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CE02	rs10929302:AG	74990
carboplatin, paclitaxel	rs4149117	SLCO1B3	GT	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs4149117:GT	10339178
carboplatin, paclitaxel	rs4149117	SLCO1B3	TT	Toxicity	decreased	Adverse_Event	Disease:C0024121|Disease:C1153706|Disease:C0027651|Disease:C0919267|Disease:C0042138		L01CD01|L01XA02	rs4149117:TT	10339178
nicotine	rs1044396	CHRNA4	G	Other	increased	Adverse_Event	Healthy		N07BA01	rs1044396:G	936
cisplatin	rs2075252	LRP2	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs2075252:T	441203
cetuximab	rs4444903	EGF	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs4444903:AA	No_match
capecitabine	rs3215400	CDA	C/del	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC06	rs3215400:C/del	11809635
capecitabine	rs3215400	CDA	CC	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01BC06	rs3215400:CC	11809635
clopidogrel	rs2286823	POR	GG	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs2286823:GG	13748464
sunitinib	rs1057868	POR	TT	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EX01	rs1057868:TT	11221549
sunitinib	rs4149117	SLCO1B3	GG	Efficacy	decreased	Efficacy_Response	Efficacy:C0238198		L01EX01	rs4149117:GG	11221549
methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CC	11329481
methotrexate	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CT	11329481
phenprocoumon	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT	91987769
capecitabine	rs532545	CDA	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs532545:T	11809635
clopidogrel	rs3785161	CES1P1	AC	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs3785161:AC	13748464
clopidogrel	rs3785161	CES1P1	CC	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs3785161:CC	13748464
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
leucovorin, tegafur	rs1801394	FASTKD3, MTRR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03	rs1801394:GG	135403648
capecitabine	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs67376798:A	11809635
leucovorin, tegafur	rs1801019	UMPS	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03	rs1801019:CC	135403648
leucovorin, tegafur	rs1801019	UMPS	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03	rs1801019:CC	135403648
aspirin, clopidogrel	rs5985	F13A1	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AA	2244
aspirin, clopidogrel	rs5985	F13A1	AC	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AC	2244
pazopanib	rs1126647	CXCL8	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs1126647:TT	10113978
warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:TT	54688261
nicotine	rs2236196	CHRNA4	G	Other	increased	Adverse_Event	Healthy		N07BA01	rs2236196:G	936
angiotensin ii antagonists	rs111564371	CYP2D6	CT	Efficacy	decreased	Adverse_Event	Other:C0020538		No_ATC	rs111564371:CT	172198
methotrexate	rs1051266	SLC19A1	CT	Toxicity	decreased	Adverse_Event	Other:C0029463		L04AX03	rs1051266:CT	11329481
methotrexate	rs1051266	SLC19A1	TT	Toxicity	decreased	Adverse_Event	Other:C0029463		L04AX03	rs1051266:TT	11329481
nicotine	rs1051730	CHRNA3	AA	Toxicity	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs1051730:AA	936
nicotine	rs1051730	CHRNA3	AG	Toxicity	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs1051730:AG	936
cyclophosphamide, fluorouracil	rs1801133	MTHFR	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02	rs1801133:A	2907
ledipasvir, sofosbuvir	rs12979860	IFNL3, IFNL4	TT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP08|J05AP51	rs12979860:TT	67505836
carbamazepine	rs1043620	HSPA1A	T	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	rs1043620:T	114709
aspirin, clopidogrel	rs5985	F13A1	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AA	2244
aspirin, clopidogrel	rs5985	F13A1	AC	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs5985:AC	2244
ledipasvir, sofosbuvir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP08|J05AP51	rs8099917:TT	67505836
carbamazepine	rs506770	HSPA1A	G	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	rs506770:G	114709
aspirin, clopidogrel	rs5985	F13A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs5985:AA	2244
cyclophosphamide, fluorouracil	rs1042522	TP53	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02	rs1042522:G	2907
carbamazepine	rs2227956	HSPA1L	G	Toxicity	decreased	Adverse_Event	Healthy		N03AF01	rs2227956:G	114709
clopidogrel	rs6787801	P2RY12	AG	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs6787801:AG	13748464
clopidogrel	rs6787801	P2RY12	GG	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs6787801:GG	13748464
clozapine	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:AG	131769989
clozapine	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:GG	131769989
ribavirin	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01	rs1127354:CC	451448
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
clozapine	rs212090	ABCC1	AT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs212090:AT	131769989
clozapine	rs212090	ABCC1	TT	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs212090:TT	131769989
carbamazepine	rs2894342	MLN	A	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs2894342:A	114709
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC	64139
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
clozapine	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:AG	131769989
clozapine	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1045642:GG	131769989
clozapine	rs212090	ABCC1	AT	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs212090:AT	131769989
clozapine	rs212090	ABCC1	TT	Toxicity	increased	Adverse_Event	Healthy		N05AH02	rs212090:TT	131769989
caffeine	rs5751876	ADORA2A	TT	Toxicity	increased	Adverse_Event	Other:C0024198		N06BC01	rs5751876:TT	936
caffeine	rs2298383	ADORA2A	CC	Toxicity	increased	Adverse_Event	Other:C0024198		N06BC01	rs2298383:CC	936
caffeine	rs4822492	__INTRONIC__	CC	Toxicity	increased	Adverse_Event	Other:C0024198		N06BC01	rs4822492:CC	936
none	rs267606617	MT-RNR1	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs267606617:G	5282367
carbamazepine	rs3130690	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs3130690:T	114709
caffeine	rs5751876	ADORA2A	CC	Efficacy	increased	Adverse_Event	Healthy		N06BC01	rs5751876:CC	936
caffeine	rs5751876	ADORA2A	CC	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs5751876:CC	936
ethanol, heroin, methamphetamine	rs2133896	ANKS1B	T	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs2133896:T	702
carbamazepine	rs2848716	MICA	C	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs2848716:C	114709
"""antiinflammatory agents, non-steroids"", ""aspirin"""	rs2965667	__INTRONIC__	TT	Other	decreased	Adverse_Event	Healthy		V10A	rs2965667:TT	2244
caffeine	rs5751876	ADORA2A	TT	Dosage	decreased	Other	Healthy		N06BC01	rs5751876:TT	936
carbamazepine	rs750332	BAG6, PRRC2A	C	Toxicity	increased	Adverse_Event	Healthy		N03AF01	rs750332:C	114709
"""antiinflammatory agents, non-steroids"", ""aspirin"""	rs16973225	__INTRONIC__	AA	Other	decreased	Adverse_Event	Healthy		V10A	rs16973225:AA	2244
none	rs588765	CHRNA5	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		A03DA02	rs588765:T	5282367
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Other	Healthy		B01AA03	rs9934438:GG	54688261
ribavirin	rs7270101	ITPA	AA	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01	rs7270101:AA	451448
simvastatin	rs1137101	LEPR	GG	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs1137101:GG	14373154
alendronate	rs1234612	SOST	CC	Efficacy	increased	Efficacy_Response	Disease:C0005944|Disease:C0029456		No_ATC	rs1234612:CC	2088
cytarabine, daunorubicin	rs1128503	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs1128503:GG	6253
cytarabine, daunorubicin	rs532545	CDA	CC	Toxicity	decreased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs532545:CC	6253
cytarabine, daunorubicin	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs1045642:GG	6253
clopidogrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Other:patients_undergoing_percutaneous_coronary_intervention		B01AC04	rs4244285:A	13748464
alendronate	rs865429	SOST	GG	Efficacy	decreased	Efficacy_Response	Disease:C0005944|Disease:C0029456		No_ATC	rs865429:GG	2088
ribavirin	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01	rs1127354:CC	451448
cytarabine	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1128503:AA	6918130
cytarabine	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1128503:AG	6918130
clopidogrel	rs6801273	MED12L, P2RY12	T	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs6801273:T	13748464
cytarabine	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs2032582:AA	6918130
cytarabine	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs2032582:AC	6918130
clopidogrel	rs6798347	MED12L	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs6798347:G	13748464
erlotinib, gefitinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB01|L01EB02	rs121434569:T	176870
cytarabine	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1045642:AA	6918130
cytarabine	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs1045642:AG	6918130
sevoflurane	rs1128503	ABCB1	GG	Other	decreased	Adverse_Event	Other:tonsillectomy		N01AB08	rs1128503:GG	13529
tacrolimus	rs5219	KCNJ11	CT	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation|Disease:Kidney_Transplantation		L04AD02	rs5219:CT	131769926
tacrolimus	rs5219	KCNJ11	TT	Toxicity	increased	Adverse_Event	Disease:Heart_transplantation|Disease:Kidney_Transplantation		L04AD02	rs5219:TT	131769926
ace inhibitors, plain	rs2724635	ETV6	GG	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2724635:GG	No_match
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01|L01EB02	rs121434568:G	176870
sunitinib	rs1128503	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01EX01	rs1128503:AA	11221549
aspirin	rs2071888	TAPBP	CC	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs2071888:CC	72204814
aspirin	rs2071888	TAPBP	CG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs2071888:CG	72204814
drugs for treatment of tuberculosis	rs3740065	ABCC2	AG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs3740065:AG	No_match
drugs for treatment of tuberculosis	rs3740065	ABCC2	GG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04A	rs3740065:GG	No_match
escitalopram	rs6311	HTR2A	CT	Toxicity	increased	Adverse_Event	Other:C0003469		N06AB10	rs6311:CT	162180
escitalopram	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0003469		N06AB10	rs6311:TT	162180
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA	13748464
hydrochlorothiazide	rs12795437	KCNJ1	C	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs12795437:C	2904
phenprocoumon	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9934438:AA	91987769
phenprocoumon	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9934438:AG	91987769
valproic acid	rs1137101	LEPR	AA	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1137101:AA	134459
valproic acid	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1137101:AG	134459
phenytoin	rs78239784	CFHR4	G	Toxicity	increased	Adverse_Event	Healthy		N03AB02	rs78239784:G	1775
hydrochlorothiazide	rs11600347	KCNJ1	A	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs11600347:A	2904
cabazitaxel	rs2032582	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs2032582:A	148124
valproic acid	rs1800497	ANKK1	AG	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1800497:AG	134459
valproic acid	rs1800497	ANKK1	GG	Toxicity	increased	Adverse_Event	Disease:C0014544		N03AG01	rs1800497:GG	134459
hydrochlorothiazide	rs658903	KCNJ1	A	Toxicity	decreased	Adverse_Event	Disease:C0020538		C03AA03	rs658903:A	2904
cabazitaxel	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs1045642:A	148124
clopidogrel	rs6787801	P2RY12	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs6787801:G	13748464
cabazitaxel	rs776746	CYP3A5	T	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs776746:T	148124
ace inhibitors, plain	rs500766	PRKCQ	CT	Toxicity	decreased	Adverse_Event	Healthy		A03B|C09A	rs500766:CT	No_match
ace inhibitors, plain	rs500766	PRKCQ	TT	Toxicity	decreased	Adverse_Event	Healthy		A03B|C09A	rs500766:TT	No_match
hydrochlorothiazide	rs675388	KCNJ1	A	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs675388:A	2904
doxorubicin	rs1695	GSTP1	GG	Efficacy	decreased	Adverse_Event	Disease:C1458155		L01DB01	rs1695:GG	83958
cabazitaxel	rs1128503	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C0007134		L01CD04	rs1128503:A	148124
propofol	rs2283265	DRD2	AA	Other	decreased	Other	Healthy		N01AX10	rs2283265:AA	3014064
propofol	rs2283265	DRD2	AC	Other	decreased	Other	Healthy		N01AX10	rs2283265:AC	3014064
nicotine	rs2236196	CHRNA4	A	Other	increased	Adverse_Event	Healthy		N07BA01	rs2236196:A	936
acetaminophen	rs1042640	UGT1A	CG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs1042640:CG	1983
acetaminophen	rs1042640	UGT1A	GG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs1042640:GG	1983
clopidogrel	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA	13748464
acetaminophen	rs8330	UGT1A	CG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs8330:CG	1983
acetaminophen	rs8330	UGT1A	GG	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs8330:GG	1983
gefitinib	rs121434569	EGFR	T	Efficacy	decreased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434569:T	135496227
hydrochlorothiazide	rs59172778	KCNJ1	AG	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs59172778:AG	2904
ethanol	rs1034936	CACNA1C	TT	Toxicity	increased	Adverse_Event	Other:C0005586		V03AB16	rs1034936:TT	444899
doxorubicin, methotrexate, prednisolone, vincristine	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02|L01DB01|L04AX03|S02BA03	rs1045642:AA	5755
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:AA	13748464
warfarin	rs114504854	EPHA7	A	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs114504854:A	54688261
acetaminophen	rs10929303	UGT1A	CT	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs10929303:CT	1983
acetaminophen	rs10929303	UGT1A	TT	Toxicity	decreased	Adverse_Event	Healthy		N02BE01	rs10929303:TT	1983
ace inhibitors, plain	rs2050011	XPNPEP2	T	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2050011:T	No_match
ethambutol, isoniazid, pyrazinamide, rifampin	rs1800629	TNF	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1800629:AA	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs1800629	TNF	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1800629:AG	135483892
nicotine	rs2271339	ADGRL3	AG	Toxicity	increased	Adverse_Event	Other:C1263846		N07BA01	rs2271339:AG	936
nicotine	rs1456862	ADGRL3	AT	Toxicity	increased	Adverse_Event	Other:C1263846		N07BA01	rs1456862:AT	936
gefitinib	rs2293347	EGFR	CC	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs2293347:CC	135496227
gefitinib	rs2293347	EGFR	CC	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs2293347:CC	135496227
ethanol	rs2159140	MAP2K4	CT	Toxicity	increased	Adverse_Event	Other:C1263846		V03AB16	rs2159140:CT	444899
sunitinib	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1045642:GG	11221549
sorafenib	rs17868320	UGT1A9	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EX02	rs17868320:T	67424139
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Efficacy:C0007131		L01EB01	rs121434568:G	135496227
gefitinib	rs712829	EGFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:GT	135496227
gefitinib	rs712829	EGFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01EB01	rs712829:TT	135496227
acenocoumarol	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AA	54742534
acenocoumarol	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AG	54742534
morphine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs1799971:AA	5284371
ace inhibitors, plain	rs3788853	XPNPEP2	A	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs3788853:A	No_match
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01CA02	rs924607:TT	24848381
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AG	13748464
docetaxel	rs2125739	ABCC10	CT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01CD02	rs2125739:CT	154272
none	rs2228099	ARNT	CG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2228099:CG	5282367
none	rs2228099	ARNT	GG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2228099:GG	5282367
ethambutol, isoniazid, pyrazinamide, rifampin	rs3813867	CYP2E1	GG	Toxicity	increased	Adverse_Event	Disease:C0745744		J04AC01|J04AK01|J04AK02	rs3813867:GG	135483892
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AG	13748464
none	rs4871827	DEPTOR	AA	Other	increased	Other	Other:C0011849		A03DA02	rs4871827:AA	5282367
none	rs4871827	DEPTOR	AG	Other	increased	Other	Other:C0011849		A03DA02	rs4871827:AG	5282367
cisplatin, irinotecan	rs8020368	SYNE3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs8020368:CC	5460033
none	rs4871827	DEPTOR	AG	Other	decreased	Adverse_Event	Other:C0011849		A03DA02	rs4871827:AG	5282367
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection		J04A|J05AP|S02DA30	rs3745274:TT	No_match
none	rs4871827	DEPTOR	AG	Other	decreased	Adverse_Event	Other:C0011849		A03DA02	rs4871827:AG	5282367
losartan	rs6749447	STK39	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09CA01	rs6749447:GG	11751549
losartan	rs6749447	STK39	GT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09CA01	rs6749447:GT	11751549
clopidogrel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs1045642:AA	13748464
none	rs2066853	AHR	AA	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption		A03DA02	rs2066853:AA	5282367
none	rs2066853	AHR	AG	Other	increased	Adverse_Event	Other:a_NAT1_rapid_acetylator_genotype_and_high_meat_consumption		A03DA02	rs2066853:AG	5282367
risperidone	rs9659997	HTR6	CC	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs9659997:CC	849421
risperidone	rs9659997	HTR6	CT	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs9659997:CT	849421
cisplatin, irinotecan	rs17574269	DCBLD1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs17574269:AG	5460033
cisplatin, irinotecan	rs7186128	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs7186128:AG	5460033
cisplatin, irinotecan	rs7186128	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs7186128:GG	5460033
risperidone	rs3786362	TYMS	A	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs3786362:A	849421
none	rs1800630	TNF	C	Efficacy	increased	Adverse_Event	Other:C0023449		A03DA02	rs1800630:C	5282367
cisplatin, irinotecan	rs2166219	__INTRONIC__	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs2166219:TT	5460033
risperidone	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6311:CC	849421
cisplatin, irinotecan	rs4655567	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs4655567:CC	5460033
antineoplastic agents, corticosteroids	rs1127354	ITPA	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs1127354:AA	No_match
antineoplastic agents, corticosteroids	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs1127354:AC	No_match
cisplatin, irinotecan	rs2018683	__INTRONIC__	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs2018683:TT	5460033
risperidone	rs6265	BDNF	CT	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6265:CT	849421
risperidone	rs6265	BDNF	TT	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6265:TT	849421
antineoplastic agents, corticosteroids	rs2236624	ADORA2A	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs2236624:CC	No_match
leucovorin, methotrexate	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:CT	135403648
leucovorin, methotrexate	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:TT	135403648
cisplatin, irinotecan	rs2018683	__INTRONIC__	TT	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CE02|L01XA01	rs2018683:TT	5460033
none	rs1799971	OPRM1	G	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1799971:G	5282367
cisplatin, irinotecan	rs8020368	SYNE3	CC	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CE02|L01XA01	rs8020368:CC	5460033
cisplatin, irinotecan	rs4655567	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Disease:C0007134		L01CE02|L01XA01	rs4655567:CC	5460033
methotrexate	rs7317112	ABCC4	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs7317112:AA	11329481
risperidone	rs1976391	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs1976391:AG	849421
risperidone	rs6318	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6318:C	849421
cyclosporine	rs2275913	__INTRONIC__	GG	Efficacy	increased	Adverse_Event	Disease:Liver_transplantation		L04AD01	rs2275913:GG	86666680
lenalidomide	rs2032582	ABCB1	AA	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs2032582:AA	165412089
heroin	rs1611114	DBH	TT	Toxicity	decreased	Adverse_Event	Other:C0028043		No_ATC	rs1611114:TT	9844225
diltiazem	rs12946454	PLCD3	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08DB01	rs12946454:T	71315210
capecitabine, fluorouracil, oxaliplatin	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01XA03	rs1801131:GG	9887054
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	AC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:AC	37542
docetaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		L01CD02	rs1045642:AA	154272
"""beta blocking agents"", ""thiazides, plain"""	rs11191548	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		S01ED	rs11191548:C	No_match
nicotine	rs4680	COMT	GG	Other	increased	Adverse_Event	Disease:C0039338		N07BA01	rs4680:GG	936
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
morphine	rs9282564	ABCB1	CC	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs9282564:CC	5284371
morphine	rs9282564	ABCB1	CT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs9282564:CT	5284371
antineoplastic agents, corticosteroids	rs246240	ABCC1	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|S02BA	rs246240:GG	No_match
lenalidomide	rs1883112	NCF4	AA	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs1883112:AA	165412089
lenalidomide	rs1883112	NCF4	AG	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs1883112:AG	165412089
nicotine	rs4680	COMT	GG	Other	increased	Other	Disease:C0039338		N07BA01	rs4680:GG	936
lenalidomide	rs1695	GSTP1	GG	Toxicity	decreased	Adverse_Event	Other:C0334634		L04AX04	rs1695:GG	165412089
cisplatin, irinotecan	rs16950650	ABCC4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CE02|L01XA01	rs16950650:CT	5460033
aspirin, clopidogrel	rs1126643	ITGA2	CT	Other	increased	Other	Other:patients_undergoing_coronary_stenting		B01AC04	rs1126643:CT	2244
aspirin, clopidogrel	rs1126643	ITGA2	TT	Other	increased	Other	Other:patients_undergoing_coronary_stenting		B01AC04	rs1126643:TT	2244
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149117:TT	5281078
efavirenz, lamivudine, tenofovir	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AF05|J05AF07|J05AG03	rs1045642:GG	64139
gemcitabine	rs780668	SLC29A3	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs780668:CT	597
gemcitabine	rs780668	SLC29A3	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs780668:TT	597
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:A	37542
mycophenolate mofetil(mycophenolic acid)	rs4149117	SLCO1B3	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs4149117:TT	5281078
atorvastatin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:C	656846
peginterferon alfa-2b, ribavirin	rs7270101	ITPA	C	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs7270101:C	37542
caffeine	rs762551	CYP1A2	AC	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:AC	936
caffeine	rs762551	CYP1A2	CC	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:CC	936
gemcitabine	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05	rs2231142:GT	597
gemcitabine	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05	rs2231142:TT	597
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Adverse_Event	Disease:C0919267		L01XA	rs11615:AA	23939
capecitabine	rs1048977	CDA	CT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs1048977:CT	11809635
capecitabine	rs1048977	CDA	TT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs1048977:TT	11809635
clopidogrel	rs1799853	CYP2C9	CT	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1799853:CT	13748464
clopidogrel	rs1799853	CYP2C9	TT	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1799853:TT	13748464
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT	656846
allopurinol	rs1594	CFLAR	A	Toxicity	Indeterminado	Adverse_Event	Healthy		M04AA01	rs1594:A	168354693
oxycodone	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA05	rs1045642:AA	5462350
oxycodone	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02AA05	rs1045642:AG	5462350
capecitabine	rs11075646	CES2	CG	Efficacy	increased	Efficacy_Response	Disease:C0027651		L01BC06	rs11075646:CG	11809635
capecitabine	rs11075646	CES2	GG	Efficacy	increased	Efficacy_Response	Disease:C0027651		L01BC06	rs11075646:GG	11809635
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Adverse_Event	Disease:C0919267		L01XA	rs11615:AA	23939
clopidogrel	rs1799853	CYP2C9	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1799853:CT	13748464
clopidogrel	rs1799853	CYP2C9	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1799853:TT	13748464
platinum compounds	rs430397	HSPA5	TT	Efficacy	decreased	Other	Disease:C0007131		L01XA	rs430397:TT	23939
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:A	13748464
aspirin	rs5050	AGT	GG	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs5050:GG	72204814
sunitinib	rs6785049	NR1I2	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01EX01	rs6785049:A	11221549
bupropion	rs2251954	SACM1L	C	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2251954:C	446
rosuvastatin	rs9806699	GATM	AA	Toxicity	decreased	Adverse_Event	Other:C1956346		C10AA07	rs9806699:AA	5282455
clopidogrel	rs4244285	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs4244285:A	13748464
bupropion	rs2742421	SACM1L	G	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742421:G	446
ethambutol, isoniazid / pyrazinamide / rifampin	rs28371759	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs28371759:AG	135483892
rosuvastatin	rs4149081	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA07	rs4149081:AG	5282455
bupropion	rs2742423	SACM1L	G	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742423:G	446
efavirenz	rs3745274	CYP2B6	TT	Toxicity	Indeterminado	Adverse_Event	Healthy		J05AG03	rs3745274:TT	64139
clopidogrel	rs1057910	CYP2C9	AC	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1057910:AC	13748464
clopidogrel	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1057910:CC	13748464
bupropion	rs1969624	SACM1L	T	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs1969624:T	446
efavirenz	rs2307424	NR1I3	GG	Toxicity	Indeterminado	Adverse_Event	Healthy		J05AG03	rs2307424:GG	64139
bupropion	rs2245705	SACM1L	C	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2245705:C	446
bupropion	rs2742435	SACM1L	G	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742435:G	446
clopidogrel	rs1057910	CYP2C9	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1057910:AC	13748464
clopidogrel	rs1057910	CYP2C9	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1057910:CC	13748464
bupropion	rs2742390	SACM1L	A	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742390:A	446
simvastatin	rs4149081	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs4149081:AG	14373154
platinum compounds	rs430397	HSPA5	TT	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs430397:TT	23939
simvastatin	rs4149081	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs4149081:AA	14373154
pemetrexed	rs442767	DHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BA04	rs442767:GG	135565228
fluorouracil	rs1801131	MTHFR	GG	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs1801131:GG	5790
bupropion	rs2742417	SACM1L	T	Toxicity	decreased	Adverse_Event	Disease:C0011581		N06AX12	rs2742417:T	446
temsirolimus	rs3814055	NR1I2	T	Toxicity	decreased	Adverse_Event	Disease:C0877645		L01EG01	rs3814055:T	6918289
phenprocoumon	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:CT	91987769
phenprocoumon	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA04	rs9923231:TT	91987769
sunitinib	rs1933437	FLT3	AA	Toxicity	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1933437:AA	11221549
capecitabine	rs71647871	CES1	CT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs71647871:CT	11809635
capecitabine	rs71647871	CES1	TT	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC06	rs71647871:TT	11809635
rosuvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA07	rs4149056:CC	5282455
rosuvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Other:C1956346		C10AA07	rs4149056:CT	5282455
gemcitabine	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs2231142:GT	597
gemcitabine	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs2231142:TT	597
platinum compounds	rs430397	HSPA5	TT	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs430397:TT	23939
rosuvastatin	rs4149081	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA07	rs4149081:AA	5282455
naltrexone	rs4654327	OPRD1	A	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs4654327:A	5360515
irinotecan	rs11563250	UGT1A	AG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs11563250:AG	74990
irinotecan	rs11563250	UGT1A	GG	Toxicity	decreased	Adverse_Event	Disease:C0023055		L01CE02	rs11563250:GG	74990
atorvastatin, simvastatin	rs2819742	RYR2	A	Toxicity	increased	Adverse_Event	Disease:C0007222		C10AA01|C10AA05	rs2819742:A	60823
capecitabine, fluorouracil, gemcitabine	rs2347128	SPARC	GG	Efficacy	increased	Other	Disease:C0030297		L01BC02|L01BC05|L01BC06	rs2347128:GG	60953
none	rs40239	MET	AG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:AG	5282367
none	rs40239	MET	GG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:GG	5282367
azathioprine	rs7270101	ITPA	AC	Toxicity	increased	Adverse_Event	Other:C0010346		L04AX01	rs7270101:AC	5778
azathioprine	rs7270101	ITPA	CC	Toxicity	increased	Adverse_Event	Other:C0010346		L04AX01	rs7270101:CC	5778
capecitabine, fluorouracil, gemcitabine	rs17718347	SPARC	TT	Efficacy	increased	Other	Disease:C0030297		L01BC02|L01BC05|L01BC06	rs17718347:TT	60953
none	rs40239	MET	AG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:AG	5282367
none	rs40239	MET	GG	Other	increased	Other	Disease:C0026640		A03DA02	rs40239:GG	5282367
"""antivirals for treatment of hiv infections, combinations"", ""drugs for treatment of tuberculosis"""	rs1045642	ABCB1	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Other:HIV_and_tuberculosis_co-infection		J04A|J05AP|S02DA30	rs1045642:AA	No_match
efavirenz	rs3745274	CYP2B6	T	Other, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
efavirenz	rs3745274	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs112563513	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs112563513:A	3763
efavirenz	rs2740574	CYP3A4	C	Other, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2740574:C	64139
fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs67376798:AT	5790
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AG	11329481
efavirenz	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	PK:HIV		J05AG03	rs776746:C	64139
clopidogrel	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs1045642:GG	13748464
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4986893	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A	13748464
ace inhibitors, plain	rs989692	MME	CT	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs989692:CT	No_match
ace inhibitors, plain	rs989692	MME	TT	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs989692:TT	No_match
hmg coa reductase inhibitors	rs12975366	LILRB5	TT	Dosage, Toxicity	increased	Adverse_Event	Healthy		C10AA	rs12975366:TT	445127
escitalopram, fluoxetine, paroxetine, sertraline, venlafaxine	rs6311	HTR2A	TT	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB03|N06AB05|N06AB06|N06AB10|N06AX16	rs6311:TT	667572
cabazitaxel	rs776746	CYP3A5	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CD04	rs776746:CT	148124
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:AA	13748464
citalopram, escitalopram, fluoxetine, paroxetine, sertraline	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0235876		N06AB03|N06AB04|N06AB05|N06AB06|N06AB10	rs6311:CC	667572
cabazitaxel	rs463312	TUBB1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01CD04	rs463312:AC	148124
clopidogrel	rs28399504	CYP2C19	G	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs28399504:G	13748464
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA	11329481
clopidogrel	rs4986893	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:AA	13748464
nevirapine	rs28399499	CYP2B6	C	Metabolism/PK	increased	Other	Disease:HIV_infectious_disease		J05AG01	rs28399499:C	15979285
none	rs16890979	SLC2A9	T	Metabolism/PK	decreased	LADME	Healthy		A03DA02	rs16890979:T	5282367
cyclophosphamide	rs9908694	IKZF3	CC	Efficacy	increased	Adverse_Event	Disease:C0206624		L01AA01	rs9908694:CC	9554282
methotrexate	rs1045642	ABCB1	AG	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs1045642:AG	11329481
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs118192122	RYR1	A	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs118192122:A	3763
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs193922816	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs193922816:T	3763
methamphetamine	rs1800955	DRD4	CC	Toxicity	decreased	Adverse_Event	Other:Methamphetamine_dependence		No_ATC	rs1800955:CC	36604
methamphetamine	rs1800955	DRD4	CT	Toxicity	decreased	Adverse_Event	Other:Methamphetamine_dependence		No_ATC	rs1800955:CT	36604
bevacizumab	rs4588	GC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C2939419		L01FG01	rs4588:TT	No_match
cetuximab	rs4588	GC	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055|Disease:C2939419		No_ATC	rs4588:TT	No_match
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs28933397	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs28933397:T	3763
aspirin	rs1059288	TAPBP	AG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1059288:AG	72204814
aspirin	rs1059288	TAPBP	GG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs1059288:GG	72204814
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs140530655	F5	CT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs140530655:CT	172198
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AG	13748464
gefitinib	rs2272733	IKBKB	CC	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2272733:CC	135496227
"""metformin"", ""sulfonamides, urea derivatives"""	rs628031	SLC22A1	AA	Efficacy	increased	Adverse_Event	Other:C0011849		A10BA02|S01AB	rs628031:AA	4091
"""metformin"", ""sulfonamides, urea derivatives"""	rs628031	SLC22A1	AG	Efficacy	increased	Adverse_Event	Other:C0011849		A10BA02|S01AB	rs628031:AG	4091
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:AA	13748464
desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine	rs193922772	RYR1	T	Other	increased	Adverse_Event	Healthy		N01AB01|N01AB04|N01AB06|N01AB07|N01AB08	rs193922772:T	3763
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:AG	13748464
fenoterol	rs12208357	SLC22A1	T	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs12208357:T	3343
fenoterol	rs34130495	SLC22A1	A	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs34130495:A	3343
ace inhibitors, plain	rs699	AGT	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		A03B|C09A	rs699:GG	No_match
none	rs2046934	P2RY12	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs2046934:G	5282367
gefitinib	rs11227247	RELA	CC	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs11227247:CC	135496227
fenoterol	rs55918055	SLC22A1	C	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs55918055:C	3343
irinotecan	rs9351963	KCNQ5	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs9351963:C	74990
fenoterol	rs34059508	SLC22A1	A	Toxicity	increased	Adverse_Event	Healthy		R03CC04	rs34059508:A	3343
none	rs2046934	P2RY12	G	Other	increased	Efficacy_Response	Healthy		A03DA02	rs2046934:G	5282367
gefitinib	rs2151222	IKBKE	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2151222:AG	135496227
gefitinib	rs2151222	IKBKE	GG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2151222:GG	135496227
isoniazid, phenytoin	rs1801280	NAT2	C	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1801280:C	1775
isoniazid, phenytoin	rs1799931	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1799931:A	1775
tamoxifen	rs28371725	CYP2D6	T	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs28371725:T	2733525
tamoxifen	rs3892097	CYP2D6	C	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs3892097:C	2733525
tamoxifen	rs1065852	CYP2D6	A	Efficacy	increased	Adverse_Event	Disease:C1458155		L02BA01	rs1065852:A	2733525
paroxetine	rs6314	HTR2A	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0235876		N06AB05	rs6314:AG	667572
gabapentin, pregabalin	rs4240803	SLC7A5	AG	Toxicity	increased	Adverse_Event	Other:C0522067		N02BF02	rs4240803:AG	5486971
bevacizumab, cyclophosphamide	rs2230054	CXCR2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01FG01	rs2230054:TT	2907
paroxetine	rs6314	HTR2A	AG	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AB05	rs6314:AG	667572
tamoxifen	rs12248560	CYP2C19	T	Efficacy	decreased	Adverse_Event	Disease:C1458155		L02BA01	rs12248560:T	2733525
gemcitabine	rs4149086	SLCO1B1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs4149086:AG	597
gemcitabine	rs4149086	SLCO1B1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs4149086:GG	597
paroxetine	rs6313	HTR2A	GG	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AB05	rs6313:GG	667572
hydrochlorothiazide	rs5443	CDCA3, GNB3, USP5	TT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs5443:TT	2904
beta blocking agents	rs2230345	GRK5	AT	Other	decreased	Adverse_Event	Disease:C0085605		S01ED	rs2230345:AT	No_match
beta blocking agents	rs2230345	GRK5	TT	Other	decreased	Adverse_Event	Disease:C0085605		S01ED	rs2230345:TT	No_match
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9923231:CT	54676537
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9923231:TT	54676537
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Other:who_have_ever_been_smokers		A03DA02	rs1051730:A	5282367
citalopram	rs2518224	GRIK2	CC	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AB04	rs2518224:CC	162180
acenocoumarol, warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9934438:AA	54676537
acenocoumarol, warfarin	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03|B01AA07	rs9934438:AG	54676537
irinotecan	rs7586110	UGT1A9	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs7586110:G	74990
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AA03|B01AA07	rs2108622:CT	54676537
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Toxicity	decreased	Adverse_Event	Healthy		B01AA03|B01AA07	rs2108622:TT	54676537
none	rs8034191	HYKK	C	Other	increased	Adverse_Event	Other:who_have_ever_been_smokers		A03DA02	rs8034191:C	5282367
isoniazid, phenytoin	rs1041983	NAT2	T	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1041983:T	1775
tacrolimus	rs290487	TCF7L2	CC	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs290487:CC	131769926
tacrolimus	rs290487	TCF7L2	CT	Toxicity	increased	Adverse_Event	Disease:Liver_transplantation		L04AD02	rs290487:CT	131769926
ace inhibitors, plain	rs699	AGT	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		A03B|C09A	rs699:GG	No_match
gemcitabine	rs2228130	POLR2A	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05	rs2228130:CC	597
valproic acid	rs1057910	CYP2C9	AC	Other, Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs1057910:AC	134459
citalopram	rs4825476	GRIA3	G	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AB04	rs4825476:G	162180
imatinib	rs274558	SLC22A5	AA	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs274558:AA	6113
imatinib	rs274558	SLC22A5	AG	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs274558:AG	6113
isoniazid, phenytoin	rs1208	NAT2	G	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1208:G	1775
antipsychotics	rs4818	COMT	CC	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs4818:CC	No_match
antipsychotics	rs4818	COMT	CG	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs4818:CG	No_match
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1051730:A	5282367
none	rs1051730	CHRNA3	A	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1051730:A	5282367
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AA	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AA	135398738
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AG	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AG	135398738
isoniazid, phenytoin	rs1799930	NAT2	A	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1799930:A	1775
none	rs1051730	CHRNA3	A	Other	increased	Other	Disease:C0039338		A03DA02	rs1051730:A	5282367
isoniazid, phenytoin	rs1799929	NAT2	T	Toxicity	increased	Adverse_Event	Disease:C0220650|Disease:C0860040		J04AC01|N03AB02	rs1799929:T	1775
imatinib	rs2235040	ABCB1	CT	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs2235040:CT	6113
dexamethasone, doxorubicin, vincristine	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01CA02|L01DB01|S02BA06	rs2032582:AA	5743
dexamethasone, doxorubicin, vincristine	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01CA02|L01DB01|S02BA06	rs2032582:AC	5743
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AA	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AA	135398738
dacarbazine, procarbazine	rs1800734	EPM2AIP1	AG	Toxicity	increased	Adverse_Event	Disease:C0019829		L01AX04|L01XB01	rs1800734:AG	135398738
imatinib	rs10258429	EGFR	CT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs10258429:CT	6113
imatinib	rs10258429	EGFR	TT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs10258429:TT	6113
antipsychotics	rs165599	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs165599:AG	No_match
imatinib	rs683369	SLC22A1	CG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs683369:CG	6113
imatinib	rs683369	SLC22A1	GG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs683369:GG	6113
risperidone	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs1065852:AA	849421
daclatasvir, sofosbuvir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP07|J05AP08	rs8099917:TT	25154714
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs6305	HTR2A	A	Other	increased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs6305:A	5358
aspirin	rs4523	TBXA2R	AA	Efficacy	increased	Adverse_Event	Other:off-pump_coronary_artery_bypass_grafting		No_ATC	rs4523:AA	72204814
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs1611115	DBH	T	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs1611115:T	5358
risperidone	rs1799978	DRD2	CT	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs1799978:CT	849421
paclitaxel	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs2032582:AA	36314
paclitaxel	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CD01	rs1045642:AA	36314
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs1799971	OPRM1	G	Other	increased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs1799971:G	5358
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs6265	BDNF	T	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs6265:T	5358
antipsychotics	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0036341		N05A	rs4680:AA	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs4680	COMT	AA	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs4680:AA	5358
risperidone	rs1065852	CYP2D6	AA	Toxicity	increased	Adverse_Event	Disease:C0233523|Disease:C0004936		N05AX08	rs1065852:AA	849421
tacrolimus	rs5030952	CAPN10	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs5030952:CT	131769926
warfarin	rs2901783	CYP2C18	G	Dosage	Indeterminado	Other	Healthy		B01AA03	rs2901783:G	54688261
idarubicin	rs13058338	RAC2	AA	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs13058338:AA	124720
"""analgesics"", ""antiinflammatory agents, non-steroids"", ""ergot alkaloids"", ""opioids"", ""sumatriptan"""	rs6275	DRD2	AA	Other	decreased	Adverse_Event	Healthy		N02|N02CA|N02CC01|V10A	rs6275:AA	5358
idarubicin	rs1883112	NCF4	AA	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs1883112:AA	124720
opioids	rs9479757	OPRM1	AG	Other	decreased	Adverse_Event	Healthy		N02A	rs9479757:AG	No_match
tacrolimus	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Other:Liver_transplantation		L04AD02	rs776746:CC	131769926
peginterferon alfa-2b, protease inhibitors, ribavirin	rs1127354	ITPA	AA	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AE|J05AP01|L03AB10	rs1127354:AA	37542
peginterferon alfa-2b, protease inhibitors, ribavirin	rs1127354	ITPA	AC	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AE|J05AP01|L03AB10	rs1127354:AC	37542
opioids	rs948854	GAL	CC	Other	increased	Adverse_Event	Healthy		N02A	rs948854:CC	No_match
opioids	rs1045642	ABCB1	GG	Other	decreased	Adverse_Event	Healthy		N02A	rs1045642:GG	No_match
opioids	rs2236861	OPRD1	A	Other	decreased	Adverse_Event	Healthy		N02A	rs2236861:A	No_match
idarubicin	rs4673	CYBA	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:AG	124720
idarubicin	rs4673	CYBA	GG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:GG	124720
hydrochlorothiazide	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1799983:GG	2904
idarubicin	rs4673	CYBA	AA	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:AA	124720
idarubicin	rs4673	CYBA	AG	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01DB06	rs4673:AG	124720
pravastatin	rs708272	CETP	A	Efficacy	increased	Adverse_Event	Disease:C1956346		C10AA03	rs708272:A	58746970
peginterferon alfa-2b, protease inhibitors, ribavirin	rs11854484	SLC28A2	TT	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AE|J05AP01|L03AB10	rs11854484:TT	37542
daclatasvir, sofosbuvir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP07|J05AP08	rs12979860:CC	25154714
diuretics	rs702553	PDE4D	TT	Efficacy	decreased	Efficacy_Response	Disease:C0027719		C03	rs702553:TT	No_match
citalopram, fluvoxamine, paroxetine, sertraline, venlafaxine	rs2235040	ABCB1	T	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04|N06AB05|N06AB06|N06AB08|N06AX16	rs2235040:T	5324346
escitalopram	rs1805127	KCNE1	C	Toxicity	increased	Adverse_Event	Healthy		N06AB10	rs1805127:C	162180
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	13748464
escitalopram	rs4817668	KCNE1	TT	Toxicity	increased	Adverse_Event	Healthy		N06AB10	rs4817668:TT	162180
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:coronary_artery_disease_undergoing_stent_implantation		B01AC04	rs4244285:A	13748464
drugs used in nicotine dependence	rs588765	CHRNA5	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BA	rs588765:T	89594
none	rs1051730	CHRNA3	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		A03DA02	rs1051730:A	5282367
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Other:C0004364|Other:C0021390		L01BB02|L04AX01	rs116855232:T	5778
drugs used in nicotine dependence	rs1051730	CHRNA3	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		N07BA	rs1051730:A	89594
citalopram, fluvoxamine, paroxetine, sertraline, venlafaxine	rs2032583	ABCB1	G	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AB04|N06AB05|N06AB06|N06AB08|N06AX16	rs2032583:G	5324346
fluorouracil	rs1801159	DPYD	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0027651		L01BC02	rs1801159:CC	5790
fluorouracil	rs1801159	DPYD	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0027651		L01BC02	rs1801159:CC	5790
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs4148737	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs4148737:C	2907
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs4148416	ABCC3	T	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs4148416:T	2907
none	rs4946936	FOXO3	TT	Efficacy	decreased	Efficacy_Response	Other:Rhabdomyosarcoma		A03DA02	rs4946936:TT	5282367
nevirapine	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs1045642:A	15979285
none	rs17069665	FOXO3	GG	Efficacy	decreased	Efficacy_Response	Other:Rhabdomyosarcoma		A03DA02	rs17069665:GG	5282367
none	rs3215133	ARNT	T/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs3215133:T/del	5282367
none	rs3215133	ARNT	del/del	Other	decreased	Adverse_Event	Healthy		A03DA02	rs3215133:del/del	5282367
methadone	rs2036657	ARRB2	GG	Efficacy	increased	Adverse_Event	Other:C0027651		N07BC02	rs2036657:GG	10090
cyclophosphamide, epirubicin, paclitaxel	rs2032582	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs2032582:A	2907
ethanol	rs2232165	GHSR	AG	Other	Indeterminado	Other	Healthy		V03AB16	rs2232165:AG	444899
cyclophosphamide, epirubicin, paclitaxel	rs1045642	ABCB1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs1045642:G	2907
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs10276036	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs10276036:C	2907
antipsychotics	rs1379357	NEFM	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05A	rs1379357:G	No_match
cisplatin, cyclophosphamide, doxorubicin, methotrexate, vincristine	rs1128503	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0029463		L01AA01|L01CA02|L01DB01|L01XA01|L04AX03	rs1128503:G	2907
antipsychotics	rs1457266	NEFM	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05A	rs1457266:G	No_match
none	rs12410394	ARNT	AA	Other	decreased	Adverse_Event	Healthy		A03DA02	rs12410394:AA	5282367
none	rs12410394	ARNT	AG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs12410394:AG	5282367
celecoxib	rs7518660	IL23R	A	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs7518660:A	66824
celecoxib	rs11078659	ALOX12	A	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs11078659:A	66824
none	rs2470890	CYP1A2	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2470890:CT	5282367
none	rs2470890	CYP1A2	TT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs2470890:TT	5282367
none	rs11072508	__INTRONIC__	CT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11072508:CT	5282367
none	rs11072508	__INTRONIC__	TT	Other	decreased	Adverse_Event	Healthy		A03DA02	rs11072508:TT	5282367
celecoxib	rs2302821	PTGES	C	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs2302821:C	66824
none	rs4886410	CSK	CG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs4886410:CG	5282367
none	rs4886410	CSK	GG	Other	decreased	Adverse_Event	Healthy		A03DA02	rs4886410:GG	5282367
celecoxib	rs4133101	PTGER4	T	Toxicity	increased	Adverse_Event	Disease:C0023055		M01AH01	rs4133101:T	66824
carboplatin, cyclophosphamide, thiotepa	rs2228100	ALDH3A1	CC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01AA01|L01AC01|L01XA02	rs2228100:CC	2907
carboplatin, cyclophosphamide, thiotepa	rs2228100	ALDH3A1	CG	Toxicity	increased	Adverse_Event	Disease:C0027651		L01AA01|L01AC01|L01XA02	rs2228100:CG	2907
tamoxifen	rs3740065	ABCC2	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:C1458155		L02BA01	rs3740065:AA	2733525
caffeine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Healthy		N06BC01	rs762551:AA	936
dexamethasone, doxorubicin, vincristine	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:Multiple_Myeloma		L01CA02|L01DB01|S02BA06	rs1045642:GG	5743
farglitazar, insulins and analogues	rs34241435	SCNN1B	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0011849		A10A	rs34241435:A	No_match
hydrochlorothiazide	rs5723	SCNN1G	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C03AA03	rs5723:CC	2904
farglitazar, glyburide	rs889299	SCNN1B	A	Toxicity	Indeterminado	Adverse_Event	Disease:C0011849		No_ATC	rs889299:A	No_match
hydrochlorothiazide	rs5729	SCNN1G	TT	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C03AA03	rs5729:TT	2904
gefitinib	rs12142086	IKBKE	CC	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs12142086:CC	135496227
nicotine	rs680244	CHRNA5	C	Other	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs680244:C	936
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG	11329481
methadone	rs1045280	ARRB2	CC	Efficacy	increased	Adverse_Event	Other:C0027651		N07BC02	rs1045280:CC	10090
tacrolimus	rs776746	CYP3A5	CT	Efficacy	decreased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
lorazepam	rs1902023	UGT2B15	AA	Metabolism/PK	increased	LADME	Healthy		N05BA06	rs1902023:AA	13314
cyclophosphamide, epirubicin, paclitaxel	rs3213619	ABCB1	G	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs3213619:G	2907
cyclophosphamide, epirubicin, paclitaxel	rs9501929	TUBB2A	C	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs9501929:C	2907
naloxone, oxycodone	rs4680	COMT	GG	Toxicity	increased	Adverse_Event	Other:C0030193		N02AA05|V03AB15	rs4680:GG	5284603
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
nicotine	rs16969968	CHRNA5	A	Other	decreased	Adverse_Event	Disease:C0039338		N07BA01	rs16969968:A	936
methadone	rs3786047	ARRB2	AA	Efficacy	increased	Adverse_Event	Other:C0027651		N07BC02	rs3786047:AA	10090
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AG	11329481
bisoprolol	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Other:C0027051		C07AB07	rs776746:TT	91810599
naloxone, oxycodone	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0030193		N02AA05|V03AB15	rs1799971:AA	5284603
pazopanib	rs2010963	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs2010963:CC	10113978
hydrochlorothiazide	rs1159744	WNK1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs1159744:GG	2904
tamoxifen	rs12248560	CYP2C19	T	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs12248560:T	2733525
cyclophosphamide	rs3745274	CYP2B6	TT	Toxicity	decreased	Adverse_Event	Other:C0027697		L01AA01	rs3745274:TT	9554282
none	rs2504938	SLC22A3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030297		A03DA02	rs2504938:TT	5282367
naloxone, oxycodone	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030193		N02AA05|V03AB15	rs4680:AA	5284603
cyclophosphamide	rs3745274	CYP2B6	GT	Toxicity	increased	Adverse_Event	Other:C0027697		L01AA01	rs3745274:GT	9554282
fluorouracil, leucovorin	rs1801019	UMPS	CC	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0001418		L01BC02	rs1801019:CC	135403648
fluorouracil, leucovorin	rs1801019	UMPS	CG	Toxicity, Metabolism/PK	Indeterminado	Adverse_Event	Disease:C0001418		L01BC02	rs1801019:CG	135403648
fluorouracil, leucovorin	rs1801019	UMPS	CC	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0001418		L01BC02	rs1801019:CC	135403648
buprenorphine, methadone	rs4680	COMT	AG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs4680:AG	4095
buprenorphine, methadone	rs4680	COMT	GG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs4680:GG	4095
capecitabine, fluorouracil	rs56038477	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs56038477:T	60953
none	rs512077	SLC22A3	AA	Efficacy	increased	Efficacy_Response	Disease:C0030297		A03DA02	rs512077:AA	5282367
buprenorphine, methadone	rs1799971	OPRM1	AG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs1799971:AG	4095
buprenorphine, methadone	rs1799971	OPRM1	GG	Efficacy	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC01|N07BC02	rs1799971:GG	4095
capecitabine, fluorouracil	rs2297595	DPYD	CC	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02|L01BC06	rs2297595:CC	60953
capecitabine, fluorouracil	rs2297595	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C2931822		L01BC02|L01BC06	rs2297595:CT	60953
glucarpidase	rs7317112	ABCC4	AG	Toxicity	increased	Adverse_Event	Other:C0023449		V03AF09	rs7317112:AG	21195079
glucarpidase	rs7317112	ABCC4	GG	Toxicity	increased	Adverse_Event	Other:C0023449		V03AF09	rs7317112:GG	21195079
hydrochlorothiazide	rs2400707	ADRB2	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2400707:AA	2904
hydrochlorothiazide	rs2400707	ADRB2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2400707:AG	2904
cyclophosphamide	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Other:C0027697		L01AA01	rs3745274:TT	9554282
nicotine	rs16969968	CHRNA5	GG	Other	increased	Other	Other:C0028043		N07BA01	rs16969968:GG	936
hydrochlorothiazide	rs1159744	WNK1	CC	Other	increased	Adverse_Event	Disease:C0085580		C03AA03	rs1159744:CC	2904
heroin	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1076560:A	9844225
sufentanil	rs1128503	ABCB1	GG	Efficacy	decreased	Adverse_Event	"""Other:C0549433|""Other:C0016658|Bone"""		N01AH03	rs1128503:GG	41693
hydrochlorothiazide	rs2107614	WNK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2107614:CC	2904
hydrochlorothiazide	rs2107614	WNK1	CT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2107614:CT	2904
hydrochlorothiazide	rs2277869	RAD52, WNK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs2277869:CC	2904
asparaginase, cyclophosphamide, cytarabine, doxorubicin, mercaptopurine, prednisone, vincristine	rs1799782	XRCC1	AA	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01AA01|L01BB02|L01BC01|L01CA02|L01DB01|L01XX02	rs1799782:AA	2907
asparaginase, cyclophosphamide, cytarabine, doxorubicin, mercaptopurine, prednisone, vincristine	rs1799782	XRCC1	AG	Toxicity	increased	Adverse_Event	Other:C0023449		H02AB07|L01AA01|L01BB02|L01BC01|L01CA02|L01DB01|L01XX02	rs1799782:AG	2907
metformin	rs34399035	SLC47A2	T	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs34399035:T	155906370
oxaliplatin	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1128503:AA	9887054
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs1870377	KDR	A	Toxicity	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs1870377:A	216239
cytarabine, idarubicin	rs8133052	CBR3	GG	Toxicity	decreased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs8133052:GG	6253
warfarin	rs16871327	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs16871327:T	54688261
warfarin	rs78132896	EPHA7	C	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs78132896:C	54688261
fenofibrate	rs2241883	FABP1	CC	Toxicity	increased	Adverse_Event	Disease:C0020557		C10AB05	rs2241883:CC	11350701
fenofibrate	rs2241883	FABP1	CT	Toxicity	increased	Adverse_Event	Disease:C0020557		C10AB05	rs2241883:CT	11350701
antipsychotics	rs1051312	SNAP25	TT	Toxicity	decreased	Adverse_Event	Healthy		N05A	rs1051312:TT	No_match
gefitinib	rs577001	TAB2	CT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs577001:CT	135496227
gefitinib	rs577001	TAB2	TT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs577001:TT	135496227
peginterferon alfa-2b, ribavirin	rs304478	IFIT1	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs304478:TT	37542
peginterferon alfa-2b, ribavirin	rs12819210	OASL	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12819210:T	37542
oxaliplatin	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1045642:AG	9887054
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
pazopanib	rs833061	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs833061:TT	10113978
cocaine	rs6347	SLC6A3	TT	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs6347:TT	2826
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB01	rs121434568:G	135496227
atorvastatin	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs1045642:AA	656846
cyclophosphamide, epirubicin, paclitaxel	rs8187710	ABCC2	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs8187710:A	2907
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB01	rs121434568:G	135496227
cocaine	rs1076560	DRD2	A	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs1076560:A	2826
antiinflammatory agents, non-steroids	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	rs9923231:CT	No_match
antiinflammatory agents, non-steroids	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	rs9923231:TT	No_match
cyclophosphamide, epirubicin, paclitaxel	rs17222723	ABCC2	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs17222723:A	2907
cyclophosphamide, epirubicin, paclitaxel	rs1056836	CYP1B1	C	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs1056836:C	2907
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs1870377	KDR	A	Efficacy	increased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs1870377:A	216239
gefitinib	rs121434568	EGFR	G	Efficacy	increased	Efficacy_Response	Disease:C0001418		L01EB01	rs121434568:G	135496227
gefitinib	rs2233407	NFKBIA	AA	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233407:AA	135496227
gefitinib	rs2233407	NFKBIA	AT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233407:AT	135496227
cyclophosphamide, epirubicin, paclitaxel	rs6473187	SPIDR	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs6473187:G	2907
gefitinib	rs2695121	NR1H2	CT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2695121:CT	135496227
gefitinib	rs2695121	NR1H2	TT	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2695121:TT	135496227
cyclophosphamide, epirubicin, paclitaxel	rs3829306	SLCO1B1	T	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs3829306:T	2907
sunitinib	rs2010963	VEGFA	CG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2010963:CG	11221549
sunitinib	rs2010963	VEGFA	GG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs2010963:GG	11221549
cyclophosphamide, epirubicin, paclitaxel	rs301927	EPHA6	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs301927:G	2907
warfarin	rs115112393	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs115112393:G	54688261
antipsychotics	rs6318	HTR2C	GG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs6318:GG	No_match
antipsychotics	rs3813929	HTR2C	CC	Toxicity	increased	Adverse_Event	Healthy		N05A	rs3813929:CC	No_match
antipsychotics	rs518147	HTR2C	GG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs518147:GG	No_match
atorvastatin	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs2032582:AA	656846
cocaine	rs2283265	DRD2	A	Toxicity	increased	Adverse_Event	Disease:C0278080		N01BC01	rs2283265:A	2826
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs2305948	KDR	CT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs2305948:CT	216239
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs2305948	KDR	TT	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs2305948:TT	216239
antipsychotics	rs6275	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N05A	rs6275:A	No_match
antipsychotics	rs7131056	DRD2	CC	Toxicity	decreased	Adverse_Event	Healthy		N05A	rs7131056:CC	No_match
antipsychotics	rs17047764	INSIG2	C	Toxicity	increased	Adverse_Event	Healthy		N05A	rs17047764:C	No_match
antipsychotics	rs5443	GNB3	TT	Toxicity	increased	Adverse_Event	Healthy		N05A	rs5443:TT	No_match
antipsychotics	rs489693	MC4R	AA	Toxicity	increased	Adverse_Event	Healthy		N05A	rs489693:AA	No_match
tianeptine	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0011581		N06AX14	rs1799971:AA	68870
atorvastatin	rs1128503	ABCB1	A	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs1128503:A	656846
antipsychotics	rs6265	BDNF, BDNF-AS	CC	Toxicity	increased	Adverse_Event	Healthy		N05A	rs6265:CC	No_match
antipsychotics	rs1800544	ADRA2A	G	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1800544:G	No_match
anlotinib, apatinib, axitinib, bevacizumab, sorafenib, sunitinib	rs2071559	KDR	G	Efficacy	decreased	Adverse_Event	Other:C0023055|Other:C1458155|Other:C0919267|Other:C2239176|Other:C0007131|Other:C0029463|Other:C0027651		L01EH01|L01EK01|L01EX01|L01EX02|L01FG01	rs2071559:G	216239
theophylline	rs2069514	CYP1A2	GG	Metabolism/PK	increased	LADME	Disease:C0004096		R03DA04	rs2069514:GG	5489638
antipsychotics	rs1799732	DRD2	del	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1799732:del	No_match
gefitinib	rs2233409	NFKBIA	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233409:AG	135496227
gefitinib	rs2233409	NFKBIA	GG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233409:GG	135496227
gefitinib	rs8904	NFKBIA	AG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs8904:AG	135496227
gefitinib	rs8904	NFKBIA	GG	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs8904:GG	135496227
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:patients_who_underwent_successful_percutaneous_coronary_intervention		B01AC04	rs4986893:A	13748464
gefitinib	rs2053071	NFKBIB	CC	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2053071:CC	135496227
levodopa	rs6280	DRD3	CT	Toxicity	increased	Adverse_Event	Other:C0030567		N04BA02	rs6280:CT	9307
levodopa	rs6280	DRD3	TT	Toxicity	increased	Adverse_Event	Other:C0030567		N04BA02	rs6280:TT	9307
gefitinib	rs2233406	NFKBIA	AG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233406:AG	135496227
gefitinib	rs2233406	NFKBIA	GG	Toxicity	decreased	Adverse_Event	Other:C0007131		L01EB01	rs2233406:GG	135496227
clopidogrel	rs5918	ITGB3	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs5918:C	13748464
clopidogrel	rs5918	ITGB3	CT	Efficacy	decreased	Efficacy_Response	Other:patients_undergoing_coronary_stent_implantation		B01AC04	rs5918:CT	13748464
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs2070673	CYP2E1	A	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs2070673:A	657237
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs2515641	CYP2E1	T	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs2515641:T	657237
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs4149056:C	657237
perindopril	rs275651	AGTR1	TT	Efficacy	decreased	Adverse_Event	Disease:C1956346		C09AA04	rs275651:TT	441313
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs2302948	SULT2B1	T	Toxicity	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs2302948:T	657237
escitalopram	rs3807372	KCNH2	AA	Toxicity	increased	Adverse_Event	Healthy		N06AB10	rs3807372:AA	162180
heroin	rs1799971	OPRM1	AA	Other	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:AA	9844225
heroin	rs1799971	OPRM1	AG	Other	decreased	Adverse_Event	Healthy		No_ATC	rs1799971:AG	9844225
gefitinib	rs9694958	IKBKB	AA	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs9694958:AA	135496227
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs11231825	SLC22A12	TT	Toxicity	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs11231825:TT	657237
gefitinib	rs3748022	IKBKE	CC	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs3748022:CC	135496227
gefitinib	rs3748022	IKBKE	CT	Toxicity	increased	Adverse_Event	Other:C0007131		L01EB01	rs3748022:CT	135496227
aspirin	rs7179742	FSIP1	G	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7179742:G	72204814
aspirin	rs10306114	PTGS1	G	Efficacy	increased	Adverse_Event	Disease:C1956346		No_ATC	rs10306114:G	72204814
drugs for treatment of tuberculosis	rs4430924	XPO1	AA	Toxicity	increased	Adverse_Event	Other:C0041296		J04A	rs4430924:AA	No_match
aspirin	rs7572857	CEP68	AA	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7572857:AA	72204814
aspirin	rs7572857	CEP68	AG	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs7572857:AG	72204814
cyclosporine, mycophenolate mofetil	rs2032582	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		D08AE03|L04AD01	rs2032582:A	6918995
paroxetine	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB05	rs6311:CC	667572
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10945919	__INTRONIC__	G	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs10945919:G	No_match
amisulpride, clozapine, haloperidol, olanzapine, quetiapine, risperidone, ziprasidone, zuclopenthixol	rs5030655	CYP2D6	A/DELA	Toxicity	increased	Adverse_Event	Other:C0036341|Other:C0005586|Other:C0031212|Other:C0033975|Other:C0028768		N05AD01|N05AE04|N05AF05|N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs5030655:A/DELA	5311507
daunorubicin, doxorubicin, epirubicin	rs7853758	SLC28A3	AA	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02|L01DB03	rs7853758:AA	31703
daunorubicin, doxorubicin, epirubicin	rs7853758	SLC28A3	AG	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02|L01DB03	rs7853758:AG	31703
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799930	NAT2	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799930:AA	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799931	NAT2	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799931:AG	135483892
cetuximab, panitumumab	rs61764370	KRAS	AC	Efficacy	increased	Adverse_Event	Disease:C0023055		No_ATC	rs61764370:AC	No_match
cetuximab, panitumumab	rs61764370	KRAS	CC	Efficacy	increased	Adverse_Event	Disease:C0023055		No_ATC	rs61764370:CC	No_match
ethambutol, isoniazid, pyrazinamide, rifampin	rs1041983	NAT2	TT	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1041983:TT	135483892
cyclophosphamide, fluorouracil, methotrexate	rs351855	FGFR4	GG	Efficacy	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L04AX03	rs351855:GG	2907
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs13393173	CERS6	A	Efficacy	increased	Adverse_Event	Disease:C0003873		No_ATC	rs13393173:A	No_match
clopidogrel	rs71647871	CES1	CT	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs71647871:CT	13748464
clopidogrel	rs71647871	CES1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs71647871:CT	13748464
clopidogrel	rs71647871	CES1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0010068		B01AC04	rs71647871:CT	13748464
clopidogrel	rs4986893	CYP2C19	A	Efficacy	decreased	LADME	Healthy		B01AC04	rs4986893:A	13748464
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	LADME	Healthy		B01AC04	rs4244285:A	13748464
carboplatin, pemetrexed	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BA04|L01XA02	rs1801133:AA	10339178
vemurafenib	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0859290		L01EC01	rs1045642:AA	42611257
vemurafenib	rs35599367	CYP3A4	AA	Toxicity	increased	Adverse_Event	Other:C0859290		L01EC01	rs35599367:AA	42611257
vemurafenib	rs35599367	CYP3A4	AG	Toxicity	increased	Adverse_Event	Other:C0859290		L01EC01	rs35599367:AG	42611257
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs4244285:A	13748464
citalopram, escitalopram, fluoxetine, paroxetine, sertraline	rs7997012	HTR2A	AA	Toxicity	increased	Adverse_Event	Healthy		N06AB03|N06AB04|N06AB05|N06AB06|N06AB10	rs7997012:AA	667572
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs4986893:A	13748464
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
fluorouracil, irinotecan, leucovorin	rs861539	KLC1, XRCC3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02	rs861539:GG	135403648
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
opioids	rs363332	SLC18A2	A	Other	increased	Adverse_Event	Healthy		N02A	rs363332:A	No_match
opioids	rs363334	SLC18A2	G	Other	increased	Adverse_Event	Healthy		N02A	rs363334:G	No_match
opioids	rs363338	SLC18A2	C	Other	increased	Adverse_Event	Healthy		N02A	rs363338:C	No_match
cyclophosphamide, epirubicin, paclitaxel	rs8110536	MISP	G	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01CD01|L01DB03	rs8110536:G	2907
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4986893:AA	13748464
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4986893:AG	13748464
paclitaxel	rs7349683	EPHA5	TT	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	rs7349683:TT	36314
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
sunitinib	rs699947	VEGFA	AA	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs699947:AA	11221549
sunitinib	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs699947:AC	11221549
pazopanib	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs699947:CC	10113978
cytarabine, idarubicin	rs1143684	NQO2	CC	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1143684:CC	6253
paclitaxel	rs301927	EPHA6	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	rs301927:G	36314
tacrolimus	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
clopidogrel	rs4986893	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A	13748464
warfarin	rs35410204	VEGFA	CC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs35410204:CC	54688261
paclitaxel	rs209709	EPHA8	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0919267		L01CD01	rs209709:G	36314
ursodeoxycholic acid	rs661899	MGAT5	TT	Toxicity	increased	Adverse_Event	Other:C0008311		A05AA02	rs661899:TT	222528
glucocorticoids, methotrexate, radiotherapy	rs1944294	CDH2	AT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03|R03BA	rs1944294:AT	126941
glucocorticoids, methotrexate, radiotherapy	rs1944294	CDH2	TT	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03|R03BA	rs1944294:TT	126941
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	13748464
mycophenolate mofetil(mycophenolic acid)	rs11706052	IMPDH2	AG	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		L04AA06	rs11706052:AG	5281078
paclitaxel	rs7349683	EPHA5	TT	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01	rs7349683:TT	36314
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007820		B01AC04	rs4244285:AG	13748464
cytarabine, idarubicin	rs1800566	NQO1	AA	Toxicity	increased	Adverse_Event	Other:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs1800566:AA	6253
warfarin	rs866236	VEGFA	AA	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03	rs866236:AA	54688261
paclitaxel	rs492338	ABCG1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs492338:AA	36314
cisplatin	rs1049305	AQP1	CC	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC	441203
cisplatin	rs1049305	AQP1	CG	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CG	441203
oxaliplatin	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1128503:AG	9887054
paclitaxel	rs301927	EPHA6	AA	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01	rs301927:AA	36314
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1042028:T	5282367
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1042028:T	5282367
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Disease:C1458155		A03DA02	rs1042028:T	5282367
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AG	13748464
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	rs3892097	CYP2D6	TT	Toxicity	increased	Adverse_Event	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	rs3892097:TT	9417
calcium	rs731236	VDR	G	Efficacy	increased	Adverse_Event	Healthy		A12AA	rs731236:G	5282455
none	rs1042028	SULT1A1	T	Other	decreased	Adverse_Event	Healthy		A03DA02	rs1042028:T	5282367
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AG	13748464
none	rs1042028	SULT1A1	T	Other	increased	Adverse_Event	Healthy		A03DA02	rs1042028:T	5282367
amitriptyline, citalopram, paroxetine, venlafaxine	rs2235040	ABCB1	T	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2235040:T	667572
amitriptyline, citalopram, paroxetine, venlafaxine	rs12720067	ABCB1	T	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs12720067:T	667572
aspirin, clopidogrel	rs13431554	IRS1	AG	Efficacy	increased	Efficacy_Response	"""Disease:C1956346|""Disease:C0011849"""		B01AC04	rs13431554:AG	2244
aspirin, clopidogrel	rs13431554	IRS1	GG	Efficacy	increased	Efficacy_Response	"""Disease:C1956346|""Disease:C0011849"""		B01AC04	rs13431554:GG	2244
docetaxel	rs875858	VAC14	T	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02	rs875858:T	154272
clopidogrel	rs2242480	CYP3A4	CT	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs2242480:CT	13748464
clopidogrel	rs2242480	CYP3A4	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs2242480:TT	13748464
amitriptyline, citalopram, paroxetine, venlafaxine	rs10280101	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs10280101:C	667572
direct factor xa inhibitors, direct thrombin inhibitors	rs1800792	FGG	CC	Toxicity	increased	Adverse_Event	Healthy		B01AE|B01AF	rs1800792:CC	No_match
amitriptyline, citalopram, paroxetine, venlafaxine	rs7787082	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs7787082:A	667572
opioids	rs6269	COMT	AG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs6269:AG	No_match
opioids	rs6269	COMT	GG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs6269:GG	No_match
fluindione	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA	68942
fluindione	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA	68942
osimertinib	rs121434569	EGFR	T	Efficacy	increased	Adverse_Event	Other:C0007131		L01EB04	rs121434569:T	71496458
amitriptyline, citalopram, paroxetine, venlafaxine	rs4148739	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs4148739:C	667572
fluindione	rs9934438	VKORC1	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA	68942
opioids	rs4680	COMT	AG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4680:AG	No_match
opioids	rs4680	COMT	GG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4680:GG	No_match
ethanol	rs1229984	ADH1B	TT	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs1229984:TT	444899
amitriptyline, citalopram, paroxetine, venlafaxine	rs11983225	ABCB1	C	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs11983225:C	667572
fluindione	rs9934438	VKORC1	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA	68942
opioids	rs4818	COMT	CG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4818:CG	No_match
opioids	rs4818	COMT	GG	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4818:GG	No_match
fluindione	rs9934438	VKORC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1861172		No_ATC	rs9934438:AA	68942
opioids	rs4633	COMT	CC	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4633:CC	No_match
opioids	rs4633	COMT	CT	Other	increased	Adverse_Event	Other:adenotonsillectomy		N02A	rs4633:CT	No_match
amitriptyline, citalopram, paroxetine, venlafaxine	rs10248420	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs10248420:G	667572
ethambutol, isoniazid, pyrazinamide, rifampin	rs1799931	NAT2	A	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs1799931:A	135483892
antineoplastic agents	rs6744284	UGT1A	TT	Efficacy	increased	Efficacy_Response	Other:C0023449|Side_Effect:C0020433		L01	rs6744284:TT	No_match
direct factor xa inhibitors, direct thrombin inhibitors	rs5896	F2	TT	Toxicity	increased	Adverse_Event	Healthy		B01AE|B01AF	rs5896:TT	No_match
bortezomib	rs2839629	PKNOX1	A	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma		L01XG01	rs2839629:A	11552
antineoplastic agents	rs6744284	UGT1A	T	Toxicity	increased	Adverse_Event	Other:C0023449		L01	rs6744284:T	No_match
sunitinib	rs699947	VEGFA	A	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs699947:A	11221549
amitriptyline, citalopram, paroxetine, venlafaxine	rs2235067	ABCB1	T	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs2235067:T	667572
atenolol	rs9940629	FTO	G	Other	Indeterminado	Adverse_Event	Disease:C0020538		C07AB03	rs9940629:G	14211540
sunitinib	rs833061	VEGFA	C	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs833061:C	11221549
alfentanil, fentanyl	rs1799971	OPRM1	AG	Efficacy	increased	Adverse_Event	Other:tonsillectomy		N01AH02|N02AB03	rs1799971:AG	3345
alfentanil, fentanyl	rs1799971	OPRM1	GG	Efficacy	increased	Adverse_Event	Other:tonsillectomy		N01AH02|N02AB03	rs1799971:GG	3345
sunitinib	rs2010963	VEGFA	G	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs2010963:G	11221549
amitriptyline, citalopram, paroxetine, venlafaxine	rs4148740	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0235876		N06AA09|N06AB04|N06AB05|N06AX16	rs4148740:G	667572
atenolol	rs10267099	ABCB1	G	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs10267099:G	14211540
clopidogrel	rs4244285	CYP2C19	AA	Other	decreased	Other	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Other	decreased	Other	Disease:C0027051		B01AC04	rs4244285:AG	13748464
atenolol	rs3213619	ABCB1	G	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs3213619:G	14211540
corticosteroids	rs7160796	DCAF4	CC	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs7160796:CC	No_match
sunitinib	rs2070744	NOS3	CC	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs2070744:CC	11221549
sunitinib	rs2070744	NOS3	CT	Toxicity	increased	Adverse_Event	Healthy		L01EX01	rs2070744:CT	11221549
atenolol	rs11649514	PRKCB	GT	Toxicity, Other	increased	Adverse_Event	Disease:C0085580		C07AB03	rs11649514:GT	14211540
atenolol	rs11649514	PRKCB	TT	Toxicity, Other	increased	Adverse_Event	Disease:C0085580		C07AB03	rs11649514:TT	14211540
atenolol	rs12595985	FTO	AA	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs12595985:AA	14211540
cyclophosphamide	rs8187996	ALDH1A1	CT	Toxicity	decreased	Adverse_Event	Other:C1458155|Other:C0027651		L01AA01	rs8187996:CT	9554282
cyclophosphamide	rs8187996	ALDH1A1	TT	Toxicity	decreased	Adverse_Event	Other:C1458155|Other:C0027651		L01AA01	rs8187996:TT	9554282
clopidogrel	rs2046934	P2RY12	AG	Other	decreased	Other	Disease:C0027051		B01AC04	rs2046934:AG	13748464
clopidogrel	rs2046934	P2RY12	GG	Other	decreased	Other	Disease:C0027051		B01AC04	rs2046934:GG	13748464
atenolol	rs2144297	GALNT2	T	Other	Indeterminado	Adverse_Event	Disease:C0020538		C07AB03	rs2144297:T	14211540
atenolol	rs2144300	GALNT2	C	Other	Indeterminado	Adverse_Event	Disease:C0020538		C07AB03	rs2144300:C	14211540
ethanol	rs1800497	ANKK1, DRD2	A	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs1800497:A	444899
warfarin	rs1057910	CYP2C9	AC	Dosage, Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs1057910:AC	54688261
atenolol	rs10157410	PLA2G4A	C	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs10157410:C	14211540
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG	13748464
atenolol	rs4648287	PTGS2	G	Other	increased	Adverse_Event	Disease:C0020538		C07AB03	rs4648287:G	14211540
isoniazid, rifampin	rs11080344	NOS2	CC	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs11080344:CC	135483892
enalapril	rs2306283	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Other:C0020538		C09AA02	rs2306283:AA	5950
isoniazid, rifampin	rs2070401	BACH1	GG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs2070401:GG	135483892
clopidogrel	rs12248560	CYP2C19	CT	Efficacy	decreased	Efficacy_Response	Efficacy:C1956346		B01AC04	rs12248560:CT	13748464
clopidogrel	rs12248560	CYP2C19	TT	Efficacy	decreased	Efficacy_Response	Efficacy:C1956346		B01AC04	rs12248560:TT	13748464
isoniazid, rifampin	rs4720833	MAFK	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs4720833:AA	135483892
isoniazid, rifampin	rs4720833	MAFK	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs4720833:AG	135483892
isoniazid, rifampin	rs11125883	XPO1	AC	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01	rs11125883:AC	135483892
isoniazid, rifampin	rs11125883	XPO1	CC	Toxicity	decreased	Adverse_Event	Disease:C0041296		J04AC01	rs11125883:CC	135483892
clopidogrel	rs12248560	CYP2C19	CC	Efficacy	Indeterminado	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:CC	13748464
isoniazid	rs1041983	NAT2	T	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1041983:T	135483892
isoniazid	rs1495741	NAT2	G	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01	rs1495741:G	135483892
clopidogrel	rs1057910	CYP2C9	C	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs1057910:C	13748464
capecitabine, fluorouracil	rs1801158	DPYD	CT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs1801158:CT	60953
capecitabine, fluorouracil	rs1801158	DPYD	TT	Toxicity	increased	Adverse_Event	Other:C0027651		L01BC02|L01BC06	rs1801158:TT	60953
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs4244285:AG	13748464
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs7270101	ITPA	AA	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs7270101:AA	37542
anastrozole, letrozole	rs9340799	ESR1	A	Other	increased	Adverse_Event	Other:C0235653		L02BG03|L02BG04	rs9340799:A	3902
clopidogrel	rs776746	CYP3A5	CT	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs776746:CT	13748464
clopidogrel	rs776746	CYP3A5	TT	Efficacy	decreased	Adverse_Event	Disease:C0010068		B01AC04	rs776746:TT	13748464
anastrozole, letrozole	rs2234693	ESR1	C	Other	increased	Adverse_Event	Other:C0235653		L02BG03|L02BG04	rs2234693:C	3902
clopidogrel	rs2046934	P2RY12	AG	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	rs2046934:AG	13748464
clopidogrel	rs2046934	P2RY12	GG	Efficacy	increased	Adverse_Event	Disease:C0010068		B01AC04	rs2046934:GG	13748464
none	rs2740574	CYP3A4	CC	Other	increased	Adverse_Event	Other:C0007222|Other:C0020473		A03DA02	rs2740574:CC	5282367
opioids	rs1799971	OPRM1	AA	Other	decreased	Adverse_Event	Healthy		N02A	rs1799971:AA	No_match
opioids	rs1799971	OPRM1	AG	Other	decreased	Adverse_Event	Healthy		N02A	rs1799971:AG	No_match
capecitabine, fluorouracil	rs75017182	DPYD	C	Dosage, Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs75017182:C	60953
repaglinide	rs1801262	NEUROD1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:CT	22132924
repaglinide	rs1801262	NEUROD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:TT	22132924
repaglinide	rs114202595	PAX4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs114202595:AA	22132924
repaglinide	rs114202595	PAX4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs114202595:AG	22132924
none	rs2740574	CYP3A4	CT	Other	increased	Adverse_Event	Healthy		A03DA02	rs2740574:CT	5282367
vincristine	rs1045644	COCH	CG	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs1045644:CG	24848381
vincristine	rs1045644	COCH	GG	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs1045644:GG	24848381
cetuximab, irinotecan, leucovorin, tegafur	rs712830	EGFR	CC	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC03|L01CE02	rs712830:CC	135403648
tamoxifen	rs2740574	CYP3A4	CT	Other	increased	Adverse_Event	Disease:C1458155		L02BA01	rs2740574:CT	2733525
vincristine	rs7963521	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs7963521:C	24848381
repaglinide	rs1801262	NEUROD1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:CT	22132924
repaglinide	rs1801262	NEUROD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1801262:TT	22132924
none	rs3782905	VDR	G	Other	increased	Adverse_Event	Healthy		A03DA02	rs3782905:G	5282367
opioids	rs6090043	OPRL1	C	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6090043:C	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_placement		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_placement		B01AC04	rs4244285:AG	13748464
clopidogrel	rs6785930	P2RY12	A	Efficacy	increased	Adverse_Event	Disease:C0085096		B01AC04	rs6785930:A	13748464
opioids	rs165599	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs165599:AA	No_match
opioids	rs165599	COMT	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs165599:AG	No_match
docetaxel, paclitaxel	rs2032582	ABCB1	A	Toxicity	decreased	Adverse_Event	Disease:C1458155		L01CD01|L01CD02	rs2032582:A	36314
cisplatin	rs1049305	AQP1	CC	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC	441203
cisplatin	rs1049305	AQP1	CG	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CG	441203
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:AA	13748464
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:AG	13748464
calcitriol	rs2228570	VDR	A	Efficacy	increased	Adverse_Event	Healthy		D05AX03	rs2228570:A	6437079
cisplatin	rs1049305	AQP1	CC	Toxicity	decreased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC	441203
cisplatin	rs1049305	AQP1	CG	Toxicity	decreased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CG	441203
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
perindopril	rs12050217	BDKRB1	AA	Efficacy	decreased	Adverse_Event	Disease:C1956346		C09AA04	rs12050217:AA	441313
cisplatin	rs1049305	AQP1	CC	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs1049305:CC	441203
atenolol, verapamil	rs1801058	GRK4	TT	Efficacy, Toxicity, Other	increased	Adverse_Event	Other:hypertension_and_coronory_artery_disease		C07AB03|C08DA01	rs1801058:TT	2520
clozapine	rs762551	CYP1A2	AA	Toxicity	increased	Adverse_Event	Disease:C0036341|Disease:C0039338		N05AH02	rs762551:AA	131769989
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	CT	Toxicity	decreased	Adverse_Event	Other:C1262018		L04AA06	rs2278294:CT	5281078
mycophenolate mofetil(mycophenolic acid)	rs2278294	IMPDH1	TT	Toxicity	decreased	Adverse_Event	Other:C1262018		L04AA06	rs2278294:TT	5281078
platinum compounds	rs2071554	HLA-DOB	CT	Efficacy	increased	Adverse_Event	Disease:C0024121		L01XA	rs2071554:CT	23939
platinum compounds	rs2071554	HLA-DOB	TT	Efficacy	increased	Adverse_Event	Disease:C0024121		L01XA	rs2071554:TT	23939
platinum compounds	rs2900420	__INTRONIC__	AA	Efficacy	decreased	Adverse_Event	Disease:C0024121		L01XA	rs2900420:AA	23939
platinum compounds	rs2900420	__INTRONIC__	AG	Efficacy	decreased	Adverse_Event	Disease:C0024121		L01XA	rs2900420:AG	23939
clozapine	rs762551	CYP1A2	AA	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH02	rs762551:AA	131769989
cyclophosphamide, cytarabine, daunorubicin, mercaptopurine, methotrexate, prednisone, vincristine	rs639174	DROSHA	T	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BB02|L01BC01|L01CA02|L01DB02|L04AX03	rs639174:T	2907
opioids	rs6275	DRD2	AG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs6275:AG	No_match
opioids	rs6275	DRD2	GG	Toxicity	increased	Adverse_Event	Other:C0030193|Other:C0027651		N02A	rs6275:GG	No_match
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs12201199:T	441203
isoniazid, pyrazinamide, rifampin	rs6413432	CYP2E1	A	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01	rs6413432:A	135483892
cisplatin	rs3746444	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA01	rs3746444:AG	441203
cisplatin	rs3746444	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA01	rs3746444:GG	441203
acenocoumarol, warfarin	rs1057910	CYP2C9	CC	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03|B01AA07	rs1057910:CC	54676537
aspirin	rs20417	PTGS2	G	Other	decreased	Adverse_Event	Healthy		No_ATC	rs20417:G	72204814
cisplatin	rs28362731	AQP1	AG	Toxicity	increased	Adverse_Event	Other:C0025500		L01XA01	rs28362731:AG	441203
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	CC	Toxicity	increased	Adverse_Event	Disease:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:CC	135483892
aspirin	rs20417	PTGS2	G	Other	increased	Adverse_Event	Healthy		No_ATC	rs20417:G	72204814
clopidogrel	rs4986893	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:A	13748464
folfiri	rs17501011	ABCC1	AA	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs17501011:AA	No_match
folfiri	rs17501011	ABCC1	AG	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs17501011:AG	No_match
opioids	rs6090041	OPRL1	G	Toxicity	increased	Adverse_Event	Healthy		N02A	rs6090041:G	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AG	13748464
antidepressants	rs365836	CUX1	G	Efficacy	Indeterminado	Adverse_Event	Disease:C0011581		N06A	rs365836:G	No_match
none	rs1042028	SULT1A1	CT	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1042028:CT	5282367
none	rs1042028	SULT1A1	TT	Other	increased	Adverse_Event	Disease:C0039338		A03DA02	rs1042028:TT	5282367
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:A	13748464
none	rs1042028	SULT1A1	CT	Other	decreased	Adverse_Event	Other:at_least_three_pregnancies_and_premenopausal		A03DA02	rs1042028:CT	5282367
none	rs1042028	SULT1A1	TT	Other	decreased	Adverse_Event	Other:at_least_three_pregnancies_and_premenopausal		A03DA02	rs1042028:TT	5282367
clozapine	rs1137101	LEPR	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1137101:AG	131769989
clozapine	rs1137101	LEPR	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02	rs1137101:GG	131769989
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Other:Heart_valve_replacement		B01AA03|B01AA07	rs9923231:TT	54676537
antidepressants	rs201522	CUX1	A	Efficacy	Indeterminado	Adverse_Event	Disease:C0011581		N06A	rs201522:A	No_match
bortezomib	rs2839629	PKNOX1	AA	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma		L01XG01	rs2839629:AA	11552
cisplatin	rs9332377	COMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs9332377:T	441203
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
cisplatin	rs4646316	COMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs4646316:C	441203
capecitabine	rs2741171	ENOSF1	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2741171:T	11809635
capecitabine	rs2612091	ENOSF1	C	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2612091:C	11809635
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Healthy		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Healthy		L04AX03	rs1801133:AG	11329481
cisplatin	rs1051640	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1051640:G	441203
capecitabine	rs12022243	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12022243:T	11809635
folfiri	rs9921399	CES1	CC	Efficacy	increased	Efficacy_Response	Other:C0023055		No_ATC	rs9921399:CC	No_match
dextroamphetamine, methylphenidate	rs4532	DRD1	CC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs4532:CC	5826
cisplatin	rs1142345	TPMT	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1142345:C	441203
methamphetamine	rs1126442	GRIN1	GG	Toxicity	increased	Adverse_Event	Disease:Methamphetamine_dependence		No_ATC	rs1126442:GG	36604
folfiri	rs1113193	UGT1A10, UGT1A8	AA	Efficacy	decreased	Efficacy_Response	Other:C0023055		No_ATC	rs1113193:AA	No_match
cisplatin	rs1800460	TPMT	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01XA01	rs1800460:T	441203
capecitabine	rs2741171	ENOSF1	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2741171:T	11809635
capecitabine	rs2612091	ENOSF1	C	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs2612091:C	11809635
capecitabine	rs12022243	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12022243:T	11809635
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
iodine (131i) compounds, radiotherapy	rs1800469	TGFB1	AA	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs1800469:AA	807
nicotine	rs588765	CHRNA5	CT	Efficacy	increased	Adverse_Event	Other:smokers		N07BA01	rs588765:CT	936
nicotine	rs588765	CHRNA5	TT	Efficacy	increased	Adverse_Event	Other:smokers		N07BA01	rs588765:TT	936
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG	37542
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT	37542
capecitabine	rs76387818	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs76387818:A	11809635
capecitabine	rs12132152	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12132152:A	11809635
capecitabine	rs76387818	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs76387818:A	11809635
atenolol	rs2669429	DPYS	AG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB03	rs2669429:AG	14211540
atenolol	rs2669429	DPYS	GG	Toxicity	increased	Adverse_Event	Disease:C0020538		C07AB03	rs2669429:GG	14211540
lenalidomide	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma|Other:C0024299|Other:C0026986		L04AX04	rs1045642:AA	165412089
lenalidomide	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:Multiple_Myeloma|Other:C0024299|Other:C0026986		L04AX04	rs1045642:AG	165412089
capecitabine	rs12132152	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC06	rs12132152:A	11809635
none	rs12979860	IFNL3, IFNL4	CC	Other	increased	Other	Disease:C0019372		A03DA02	rs12979860:CC	5282367
risperidone	rs7799039	LEP	G	Other	increased	Adverse_Event	Disease:C1510586		N05AX08	rs7799039:G	849421
warfarin	rs9923231	VKORC1	T	Efficacy, Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T	54688261
iodine (131i) compounds, radiotherapy	rs10514231	ATG10	CC	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs10514231:CC	807
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs924607:TT	24848381
carboplatin, paclitaxel	rs1656402	EIF4E2, TIGD1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs1656402:CC	10339178
iodine (131i) compounds, radiotherapy	rs11212570	ATM	AG	Toxicity	decreased	Adverse_Event	Other:C0030521		V10XA01	rs11212570:AG	807
nicotine	rs2056527	__INTRONIC__	CT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:CT	936
nicotine	rs2056527	__INTRONIC__	TT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:TT	936
nicotine	rs2056527	__INTRONIC__	CT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:CT	936
nicotine	rs2056527	__INTRONIC__	TT	Efficacy	decreased	Adverse_Event	Other:smokers		N07BA01	rs2056527:TT	936
capecitabine, fluorouracil	rs67376798	DPYD	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AA	60953
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AT	60953
pirfenidone	rs5743890	TOLLIP	CC	Efficacy	increased	Efficacy_Response	Other:C0034069		L04AX05	rs5743890:CC	40632
pirfenidone	rs5743890	TOLLIP	CT	Efficacy	increased	Efficacy_Response	Other:C0034069		L04AX05	rs5743890:CT	40632
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:CT	60953
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:TT	60953
warfarin	rs9923231	VKORC1	T	Efficacy	decreased	Efficacy_Response	Healthy		B01AA03	rs9923231:T	54688261
imatinib	rs1045642	ABCB1	GG	Toxicity	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:GG	6113
platinum compounds	rs2269577	XBP1	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs2269577:GG	23939
imatinib	rs683369	SLC22A1	CC	Toxicity	decreased	Adverse_Event	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC	6113
carboplatin, paclitaxel	rs9981861	DSCAM	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs9981861:TT	10339178
carboplatin, paclitaxel	rs1209950	ETS2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs1209950:CT	10339178
carboplatin, paclitaxel	rs1209950	ETS2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA02	rs1209950:TT	10339178
iodine (131i) compounds, radiotherapy	rs10514231	ATG10	CC	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs10514231:CC	807
iodine (131i) compounds, radiotherapy	rs1800469	TGFB1	AA	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs1800469:AA	807
warfarin	rs9923231	VKORC1	T	Efficacy	increased	Adverse_Event	Healthy		B01AA03	rs9923231:T	54688261
iodine (131i) compounds, radiotherapy	rs1864183	ATG10	TT	Toxicity	increased	Adverse_Event	Other:C0030521		V10XA01	rs1864183:TT	807
mercaptopurine	rs186364861	NUDT15	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs186364861:A	1268107
amisulpride, clozapine, olanzapine, paliperidone, quetiapine, risperidone	rs17782313	MC4R	CC	Other	increased	Adverse_Event	Healthy		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08|N05AX13	rs17782313:CC	2159
amisulpride, aripiprazole, clozapine, haloperidol, quetiapine, risperidone, ziprasidone	rs489693	MC4R	A	Other	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AD01|N05AE04|N05AH02|N05AH04|N05AL05|N05AX08|N05AX12	rs489693:A	60854
mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:T	1268107
amisulpride, aripiprazole, clozapine, haloperidol, quetiapine, risperidone, ziprasidone	rs489693	MC4R	AA	Other	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AD01|N05AE04|N05AH02|N05AH04|N05AL05|N05AX08|N05AX12	rs489693:AA	60854
atenolol, verapamil	rs11124945	PLEKHH2	G	Toxicity	decreased	Adverse_Event	Disease:C0020538		C07AB03|C08DA01	rs11124945:G	2520
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0002962|Disease:C0027051		B01AC04	rs4244285:AG	13748464
regadenoson	rs17602729	AMPD1	AA	Efficacy	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AA	219024
regadenoson	rs17602729	AMPD1	AG	Efficacy	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AG	219024
efavirenz	rs3745274	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Other	Disease:C1956346		B01AC04	rs4244285:AA	13748464
capecitabine, fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs3918290:CT	60953
capecitabine, fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs3918290:TT	60953
none	rs2952768	__INTRONIC__	CC	Efficacy	decreased	Adverse_Event	Other:Methamphetamine_dependence|Other:C0085762|Other:C0013473		A03DA02	rs2952768:CC	5282367
cisplatin, cyclophosphamide	rs1799793	ERCC2	CT	Efficacy	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs1799793:CT	2907
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	rs9923231:CT	54676537
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Disease:C0004238|Disease:C1861172		B01AA03|B01AA07	rs9923231:TT	54676537
nicotine	rs1541333	DBH	CC	Efficacy	decreased	Adverse_Event	Other:smokers_with_low_dependency		N07BA01	rs1541333:CC	936
regadenoson	rs17602729	AMPD1	AA	Toxicity	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AA	219024
regadenoson	rs17602729	AMPD1	AG	Toxicity	increased	Adverse_Event	Healthy		C01EB21	rs17602729:AG	219024
risperidone	rs806378	CNR1	T	Other	increased	Adverse_Event	Disease:C1510586		N05AX08	rs806378:T	849421
risperidone	rs1049353	CNR1	C	Other	increased	Adverse_Event	Disease:C1510586		N05AX08	rs1049353:C	849421
mercaptopurine	rs3765534	ABCC4	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs3765534:T	1268107
asparaginase	rs6021191	NFATC2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs6021191:T	6267
asparaginase	rs17885382	HLA-DRB1	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs17885382:T	6267
cyclophosphamide, epirubicin	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01DB03	rs1695:AA	2907
ivacaftor	rs75527207	CFTR	A	Efficacy	decreased	Adverse_Event	Disease:C0156318		R07AX02	rs75527207:A	72722243
vancomycin	rs2789047	__INTRONIC__	A	Toxicity	increased	Adverse_Event	Healthy		J01XA01	rs2789047:A	6420023
lisinopril	rs35068180	MMP3	AA	Efficacy	increased	Adverse_Event	Disease:C0020538		C09AA03	rs35068180:AA	6322
carboplatin, gemcitabine	rs6113	SERPINA5	C	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6113:C	10339178
clopidogrel	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:A	13748464
carboplatin, gemcitabine	rs6118	SERPINA5	T	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6118:T	10339178
carboplatin, gemcitabine	rs6504649	XYLT2	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6504649:G	10339178
carboplatin, gemcitabine	rs6119	SERPINA5	G	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs6119:G	10339178
ethanol	rs1001179	CAT	T	Other	increased	Adverse_Event	Healthy		V03AB16	rs1001179:T	444899
carboplatin, gemcitabine	rs73450548	ETS2	A	Toxicity	increased	Adverse_Event	Other:C0007131		L01BC05|L01XA02	rs73450548:A	10339178
bevacizumab, pegaptanib, ranibizumab	rs2010963	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:Choroidal_Neovascularization		L01FG01|S01LA03|S01LA04	rs2010963:CC	No_match
clopidogrel	rs1045642	ABCB1	AA	Efficacy	increased	Other	Disease:C0027051		B01AC04	rs1045642:AA	13748464
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
doxorubicin	rs3957357	GSTA1	AA	Efficacy	increased	Efficacy_Response	Disease:C1261473		L01DB01	rs3957357:AA	83958
amisulpride, clozapine, olanzapine, paliperidone, quetiapine, risperidone	rs489693	MC4R	AA	Other	increased	Adverse_Event	Healthy		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08|N05AX13	rs489693:AA	2159
ethanol	rs1001179	CAT	T	Other	increased	Adverse_Event	Disease:C0085762		V03AB16	rs1001179:T	444899
none	rs3212986	ERCC1	AC	Other	decreased	Other	Disease:C0007131		A03DA02	rs3212986:AC	5282367
dexmedetomidine	rs279847	GABRA2	GG	Toxicity	decreased	Adverse_Event	Healthy		N05CM18	rs279847:GG	6918081
tamoxifen	rs9340799	ESR1	AG	Toxicity	increased	Adverse_Event	Other:C1458155		L02BA01	rs9340799:AG	2733525
tamoxifen	rs9340799	ESR1	GG	Toxicity	increased	Adverse_Event	Other:C1458155		L02BA01	rs9340799:GG	2733525
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs149389480	F5	AG	Toxicity	increased	Adverse_Event	Healthy		C09A	rs149389480:AG	172198
morphine	rs3766246	FAAH	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs3766246:AA	5284371
morphine	rs3766246	FAAH	AG	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs3766246:AG	5284371
clozapine, olanzapine	rs9852	TBC1D1	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03	rs9852:CC	135398737
fluorouracil	rs67376798	DPYD	AT	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01BC02	rs67376798:AT	5790
morphine	rs4141964	FAAH	CT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs4141964:CT	5284371
morphine	rs4141964	FAAH	TT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs4141964:TT	5284371
none	rs2287622	ABCB11	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs2287622:GG	5282367
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG	5284371
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG	5284371
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG	5284371
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG	5284371
none	rs1800497	DRD2	AA	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1800497:AA	5282367
none	rs1800497	DRD2	AG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs1800497:AG	5282367
opioids	rs5443	GNB3	CT	Toxicity, Other	increased	Adverse_Event	Side_Effect:withdrawal_from_opioid_addiction		N02A	rs5443:CT	No_match
opioids	rs5443	GNB3	TT	Toxicity, Other	increased	Adverse_Event	Side_Effect:withdrawal_from_opioid_addiction		N02A	rs5443:TT	No_match
aripiprazole, clozapine, haloperidol, olanzapine, quetiapine, risperidone	rs324420	FAAH	A	Toxicity	increased	Adverse_Event	Disease:C0033975		N05AD01|N05AH02|N05AH03|N05AH04|N05AX08|N05AX12	rs324420:A	60795
morphine	rs2295632	FAAH	GT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs2295632:GT	5284371
morphine	rs2295632	FAAH	TT	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs2295632:TT	5284371
caffeine	rs762551	CYP1A2	AC	Other	decreased	Adverse_Event	Other:BRCA1_mutations		N06BC01	rs762551:AC	936
caffeine	rs762551	CYP1A2	CC	Other	decreased	Adverse_Event	Other:BRCA1_mutations		N06BC01	rs762551:CC	936
morphine	rs324420	FAAH	AA	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs324420:AA	5284371
morphine	rs324420	FAAH	AC	Toxicity	increased	Adverse_Event	Healthy		N02AA01	rs324420:AC	5284371
peginterferon alfa-2b, ribavirin	rs2228570	VDR	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2228570:AA	37542
peginterferon alfa-2b, ribavirin	rs2228570	VDR	AG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2228570:AG	37542
none	rs2287622	ABCB11	GG	Toxicity	increased	Adverse_Event	Healthy		A03DA02	rs2287622:GG	5282367
peginterferon alfa-2b, ribavirin, simeprevir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs1127354:CC	37542
docetaxel	rs3003593	NR1I3	AA	Toxicity	increased	Adverse_Event	Disease:C0023055		L01CD02	rs3003593:AA	154272
antithyroid preparations	rs652888	EHMT2	G	Toxicity	increased	Adverse_Event	Healthy		H03B	rs652888:G	No_match
iodine (131i) compounds, radiotherapy	rs1800629	TNF	AG	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs1800629:AG	807
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG	5284371
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG	5284371
hmg coa reductase inhibitors	rs1063320	HLA-G	G	Other	decreased	Adverse_Event	Disease:C0004096		C10AA	rs1063320:G	445127
hydrocodone	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:AG	5284371
hydrocodone	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Disease:C0032961		R05DA03	rs1799971:GG	5284371
dexmedetomidine	rs28399433	CYP2A6	C	Efficacy	increased	Efficacy_Response	Healthy		N05CM18	rs28399433:C	6918081
deferiprone	rs6759892	UGT1A6	GG	Toxicity	increased	Adverse_Event	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs6759892:GG	8369
deferiprone	rs6759892	UGT1A6	GG	Toxicity	increased	Adverse_Event	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs6759892:GG	8369
antithyroid preparations	rs111618861	__INTRONIC__	del	Toxicity	increased	Adverse_Event	Healthy		H03B	rs111618861:del	No_match
antithyroid preparations	rs1071816	HLA-B	C	Toxicity	increased	Adverse_Event	Healthy		H03B	rs1071816:C	No_match
iodine (131i) compounds, radiotherapy	rs11212570	ATM	AA	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs11212570:AA	807
iodine (131i) compounds, radiotherapy	rs11212570	ATM	AG	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs11212570:AG	807
efavirenz	rs1800896	IL10	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1800896:TT	64139
ethanol	rs1800497	ANKK1, DRD2	A	Other	increased	Adverse_Event	Healthy		V03AB16	rs1800497:A	444899
iodine (131i) compounds, radiotherapy	rs230493	NFKB1	AT	Toxicity	decreased	Adverse_Event	Disease:C0030521		V10XA01	rs230493:AT	807
opioids	rs1799971	OPRM1	G	Toxicity	decreased	Adverse_Event	Healthy		N02A	rs1799971:G	No_match
ethanol	rs1800497	DRD2	A	Other	increased	Adverse_Event	Healthy		V03AB16	rs1800497:A	444899
iodine (131i) compounds, radiotherapy	rs2241716	TGFB1	TT	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs2241716:TT	807
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L01BB02	rs116855232:TT	1268107
iodine (131i) compounds, radiotherapy	rs1800469	TGFB1	GG	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs1800469:GG	807
antithyroid preparations	rs199564443	FOXF2	del	Toxicity	increased	Adverse_Event	Healthy		H03B	rs199564443:del	No_match
capecitabine	rs7187684	CES1P1	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs7187684:T	11809635
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs6977967	__INTRONIC__	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs6977967:GG	2907
capecitabine	rs11861118	CES1P1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs11861118:G	11809635
platinum	rs25487	XRCC1	TT	Efficacy	Indeterminado	Other	Disease:C0007131		L01XA	rs25487:TT	441203
platinum	rs11615	ERCC1	AG	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:AG	441203
platinum	rs11615	ERCC1	GG	Efficacy	increased	Adverse_Event	Disease:C0007131		L01XA	rs11615:GG	441203
capecitabine	rs2244613	CES1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs2244613:G	11809635
platinum	rs3212986	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3212986:AA	441203
platinum	rs3212986	ERCC1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3212986:AC	441203
clozapine, ethanol	rs2069514	CYP1A2	GG	Toxicity	increased	Adverse_Event	Other:C0033975		N05AH02|V03AB16	rs2069514:GG	702
mercaptopurine, methotrexate	rs2413739	PACSIN2	CT	Efficacy	increased	Adverse_Event	Other:C0023449		L01BB02|L04AX03	rs2413739:CT	126941
mercaptopurine, methotrexate	rs2413739	PACSIN2	TT	Efficacy	increased	Adverse_Event	Other:C0023449		L01BB02|L04AX03	rs2413739:TT	126941
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs4674470	MIR4268	CC	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs4674470:CC	2907
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs4674470	MIR4268	CT	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs4674470:CT	2907
capecitabine	rs2244614	CES1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs2244614:G	11809635
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT	37542
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:TT	37542
citalopram	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Other:C0085762|Other:C0011581		N06AB04	rs4244285:AG	162180
iodine (131i) compounds, radiotherapy	rs620815	ATM	TT	Toxicity	increased	Adverse_Event	Disease:C0030521		V10XA01	rs620815:TT	807
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	TT	Efficacy	increased	Adverse_Event	Healthy		J05AP01|L03AB10|L03AB11	rs12979860:TT	37542
tenofovir	rs17222723	ABCC2	A	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs17222723:A	9574768
tenofovir	rs2273697	ABCC2	A	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs2273697:A	9574768
fluorouracil	rs1801160	DPYD	CT	Efficacy	decreased	Efficacy_Response	Other:C0023055		L01BC02	rs1801160:CT	5790
cytarabine, idarubicin	rs12036333	__INTRONIC__	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs12036333:AA	6253
cytarabine, idarubicin	rs12036333	__INTRONIC__	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs12036333:AG	6253
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs8667	ATF5	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs8667:AA	2907
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs8667	ATF5	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs8667:AG	2907
nevirapine	rs28399499	CYP2B6	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:CC	15979285
nevirapine	rs28399499	CYP2B6	CT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:CT	15979285
peginterferon alfa-2b, ribavirin	rs10741657	CYP2R1	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10741657:AA	37542
peginterferon alfa-2b, ribavirin	rs10741657	CYP2R1	AG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10741657:AG	37542
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs12402181	MIR3117	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs12402181:AA	2907
asparaginase, cyclophosphamide, cytarabine, daunorubicin, hydrocortisone, methotrexate, prednisone, vincristine	rs12402181	MIR3117	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01AA01|L01BC01|L01CA02|L01DB02|L01XX02|L04AX03|S02BA01	rs12402181:AG	2907
nevirapine	rs3745274	CYP2B6	T	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs3745274:T	15979285
tenofovir disoproxil fumarate	rs2248359	CYP24A1	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs2248359:TT	44128157
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0027651		L04AX03	rs1801133:AG	11329481
cyclophosphamide	rs4244285	CYP2C19	GG	Toxicity	increased	Adverse_Event	Disease:C0024141		L01AA01	rs4244285:GG	9554282
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT	37542
tenofovir disoproxil fumarate	rs4646536	CYP27B1	GG	Toxicity	decreased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs4646536:GG	44128157
nicotine	rs2060761	DDC	C	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs2060761:C	936
drugs for treatment of tuberculosis	rs10946737	RIPOR2	AA	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs10946737:AA	No_match
drugs for treatment of tuberculosis	rs10946737	RIPOR2	AG	Toxicity	increased	Adverse_Event	Disease:C0041296		J04A	rs10946737:AG	No_match
nicotine	rs12718541	DDC	A	Other	increased	Adverse_Event	Other:smokers		N07BA01	rs12718541:A	936
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
imipramine	rs12248560	CYP2C19	CT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs12248560:CT	65327
imipramine	rs12248560	CYP2C19	TT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs12248560:TT	65327
imipramine	rs11188072	CYP2C19	CT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs11188072:CT	65327
imipramine	rs11188072	CYP2C19	TT	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	rs11188072:TT	65327
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:AA	37542
none	rs352046	CXCL5	GG	Other	increased	Adverse_Event	Disease:C0027051		A03DA02	rs352046:GG	5282367
nevirapine	rs28399499	CYP2B6	C	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG01	rs28399499:C	15979285
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
warfarin	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs9934438:AG	54688261
capecitabine	rs602950	CDA	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs602950:G	11809635
capecitabine	rs532545	CDA	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs532545:T	11809635
tenofovir disoproxil fumarate	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs717620:TT	44128157
capecitabine	rs6690069	CDA	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs6690069:A	11809635
tenofovir	rs717620	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AF07	rs717620:CC	9574768
methylphenidate	rs4532	DRD1	CC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs4532:CC	154100
capecitabine, fluorouracil	rs67376798	DPYD	AA	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AA	60953
capecitabine, fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs67376798:AT	60953
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_drug-eluting_stent_(DES)_implantation		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_drug-eluting_stent_(DES)_implantation		B01AC04	rs4244285:AG	13748464
capecitabine	rs3217164	CES1	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs3217164:G	11809635
capecitabine	rs10916825	CDA	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC06	rs10916825:A	11809635
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:CT	60953
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs1801160:TT	60953
tenofovir disoproxil fumarate	rs11854484	SLC28A2	CT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs11854484:CT	44128157
tenofovir disoproxil fumarate	rs11854484	SLC28A2	TT	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AF07	rs11854484:TT	44128157
selective serotonin reuptake inhibitors	rs6311	HTR2A	CC	Toxicity	decreased	Adverse_Event	Other:C0011581		N06AB	rs6311:CC	5202
capecitabine	rs144470777	NSUN3	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs144470777:C	11809635
capecitabine	rs187805828	PHC1	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs187805828:C	11809635
alendronate	rs1544410	VDR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0029456		No_ATC	rs1544410:CC	2088
aspirin	rs5918	ITGB3	TT	Efficacy	increased	Adverse_Event	Healthy		No_ATC	rs5918:TT	72204814
capecitabine	rs116134453	FAT1	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs116134453:T	11809635
cisplatin	rs2228001	XPC	GG	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GG	441203
cisplatin	rs2228001	XPC	GT	Toxicity	increased	Adverse_Event	Disease:C0877645		L01XA01	rs2228001:GT	441203
capecitabine	rs141531882	TENM4	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs141531882:C	11809635
ticagrelor	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC24	rs1045642:AA	78358176
ticagrelor	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Other:C0027051		B01AC24	rs1045642:AG	78358176
warfarin	rs2108622	CYP4F2	T	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs2108622:T	54688261
amoxicillin, clavulanate	rs9274407	HLA-DQB1	A	Toxicity	increased	Adverse_Event	Disease:C0013221		J01CA04	rs9274407:A	16204478
capecitabine	rs77475703	CD96	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs77475703:C	11809635
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1045642:AA	11329481
cyclophosphamide, docetaxel, doxorubicin, epirubicin, fluorouracil, goserelin	rs4149056	SLCO1B1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01CD02|L01DB01|L01DB03|L02AE03	rs4149056:TT	2907
warfarin	rs1800566	NQO1	A	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs1800566:A	54688261
capecitabine	rs117484357	ZMIZ1	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117484357:C	11809635
capecitabine	rs138385713	VPS13D	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs138385713:G	11809635
cetuximab	rs2236947	RASSF1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs2236947:CC	No_match
paroxetine	rs4646425	CYP1A2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs4646425:CC	667572
capecitabine	rs141213385	CCDC77	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs141213385:G	11809635
antipsychotics	rs4606	RGS2	C	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs4606:C	No_match
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:C	58746970
dexmedetomidine	rs5758550	WBP2NL	AA	Efficacy	increased	Adverse_Event	Other:C0549433		N05CM18	rs5758550:AA	6918081
capecitabine	rs117308378	ADGRG7	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117308378:T	11809635
carboplatin, cisplatin	rs1130214	AKT1	AA	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs1130214:AA	10339178
carboplatin, cisplatin	rs1130214	AKT1	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs1130214:AC	10339178
cyclosporine, mycophenolic acid, prednisone	rs2280055	NFATC1	CC	Efficacy	Indeterminado	Efficacy_Response	Other:Kidney_Transplantation		H02AB07|L04AA06|L04AD01	rs2280055:CC	5865
aspirin, clopidogrel	rs41273215	PEAR1	T	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs41273215:T	2244
carboplatin, cisplatin	rs2498804	__INTRONIC__	AA	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2498804:AA	10339178
carboplatin, cisplatin	rs2498804	__INTRONIC__	AC	Efficacy	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2498804:AC	10339178
clozapine, olanzapine, risperidone	rs4436578	DRD2	CC	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs4436578:CC	135398737
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT	37542
vincristine	rs12826	ABCC2	T	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs12826:T	24848381
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
nicotine	rs10121600	GRIN3A	C	Other	increased	Adverse_Event	Healthy		N07BA01	rs10121600:C	936
aspirin, clopidogrel	rs762551	CYP1A2	C	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs762551:C	2244
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs4244285:A	2244
citalopram	rs6296	HTR1B	CC	Toxicity	increased	Adverse_Event	Disease:C0003469|Disease:C0011581		N06AB04	rs6296:CC	162180
pravastatin	rs2230806	ABCA1	TT	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA03	rs2230806:TT	58746970
aspirin, clopidogrel	rs662	PON1	T	Efficacy	increased	Adverse_Event	Other:C0027051		B01AC04	rs662:T	2244
dexmedetomidine	rs2231142	ABCG2	GG	Efficacy	increased	Adverse_Event	Other:C0549433		N05CM18	rs2231142:GG	6918081
peginterferon alfa-2b, ribavirin, simeprevir	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10	rs8099917:TT	37542
"""antiinflammatory agents, non-steroids"", ""celecoxib"", ""diclofenac"", ""ibuprofen"", ""naproxen"", ""piroxicam"""	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Healthy		M01AH01|M02AA07|M02AA13|S01BC03|V10A	rs1057910:C	2662
capecitabine	rs75267292	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs75267292:A	11809635
nicotine	rs11788456	GRIN3A	G	Other	Indeterminado	Adverse_Event	Healthy		N07BA01	rs11788456:G	936
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
"""antiinflammatory agents, non-steroids"", ""celecoxib"", ""diclofenac"""	rs1057910	CYP2C9	C	Toxicity	increased	Adverse_Event	Healthy		M01AH01|S01BC03|V10A	rs1057910:C	2662
efavirenz	rs3745274	CYP2B6	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
pravastatin	rs20455	KIF6	AG	Efficacy	decreased	Adverse_Event	Other:C0085096		C10AA03	rs20455:AG	58746970
pravastatin	rs20455	KIF6	GG	Efficacy	decreased	Adverse_Event	Other:C0085096		C10AA03	rs20455:GG	58746970
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1801133:AA	11329481
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs368967198	F5	AG	Toxicity	increased	Adverse_Event	Healthy		C09A	rs368967198:AG	172198
capecitabine	rs146898897	SSU72	C	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs146898897:C	11809635
aspirin, clopidogrel	rs168753	F2R	T	Efficacy	decreased	Adverse_Event	Other:C0027051		B01AC04	rs168753:T	2244
beta blocking agents	rs5443	GNB3	CT	Other	decreased	Other	Healthy		S01ED	rs5443:CT	No_match
beta blocking agents	rs5443	GNB3	TT	Other	decreased	Other	Healthy		S01ED	rs5443:TT	No_match
carboplatin, cisplatin	rs2699887	PIK3CA	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2699887:CC	10339178
beta blocking agents	rs5443	GNB3	CT	Other	decreased	Other	Healthy		S01ED	rs5443:CT	No_match
beta blocking agents	rs5443	GNB3	TT	Other	decreased	Other	Healthy		S01ED	rs5443:TT	No_match
carboplatin, cisplatin	rs2299939	PTEN	AC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2299939:AC	10339178
carboplatin, cisplatin	rs2299939	PTEN	CC	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs2299939:CC	10339178
capecitabine	rs185346775	MAN1A1	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs185346775:A	11809635
carboplatin, cisplatin	rs3803304	AKT1	C	Efficacy	Indeterminado	Adverse_Event	Disease:C0007131		L01XA01|L01XA02	rs3803304:C	10339178
cocaine	rs1803274	BCHE	TT	Other	Indeterminado	Adverse_Event	Healthy		N01BC01	rs1803274:TT	2826
pravastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:CC	58746970
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11506105	EGFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11506105:AA	37542
cisplatin, fluorouracil	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs1045642:GG	5460033
aspirin, clopidogrel	rs2046934	P2RY12	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs2046934:AG	2244
aspirin, clopidogrel	rs2046934	P2RY12	GG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs2046934:GG	2244
hmg coa reductase inhibitors	rs7574865	STAT4	T	Toxicity	increased	Adverse_Event	Disease:C0860207		C10AA	rs7574865:T	445127
cisplatin, fluorouracil	rs1045642	ABCB1	AA	Efficacy	decreased	Adverse_Event	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs1045642:AA	5460033
cisplatin, fluorouracil	rs1045642	ABCB1	AG	Efficacy	decreased	Adverse_Event	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs1045642:AG	5460033
mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs116855232:TT	1268107
heroin	rs671	ALDH2	AA	Other	increased	Adverse_Event	Healthy		No_ATC	rs671:AA	9844225
heroin	rs671	ALDH2	AG	Other	increased	Adverse_Event	Healthy		No_ATC	rs671:AG	9844225
fentanyl	rs145837941	CALCA	GG	Dosage	decreased	Adverse_Event	"""Other:C0030193|Postoperative""|""Other:C0699744"		N02AB03	rs145837941:GG	13653606
"""metformin"", ""sulfonamides, urea derivatives"""	rs5219	KCNJ11	T	Efficacy	increased	Adverse_Event	Disease:C0011849		A10BA02|S01AB	rs5219:T	4091
antihypertensives, beta blocking agents, diuretics	rs1801253	ADRB1	CC	Efficacy	increased	Adverse_Event	Other:C0020538		C02|C03|S01ED	rs1801253:CC	No_match
nicotine	rs17189632	GRIN3A	T	Other	Indeterminado	Adverse_Event	Healthy		N07BA01	rs17189632:T	936
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT	5790
fluorouracil	rs3918290	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:TT	5790
hmg coa reductase inhibitors	rs4149000	SLCO1A2	T	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149000:T	445127
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AG	13748464
tramadol	rs35167514	SLC22A1	del	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs35167514:del	63013
efavirenz	rs3745274	CYP2B6	TT	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
sevoflurane	rs2307116	FASTKD3, MTRR	AA	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AA	13529
sevoflurane	rs2307116	FASTKD3, MTRR	AG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AG	13529
aspirin, clopidogrel	rs2046934	P2RY12	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs2046934:AG	2244
aspirin, clopidogrel	rs2046934	P2RY12	GG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs2046934:GG	2244
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
methotrexate	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:AA	11329481
tramadol	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs34130495:A	63013
tramadol	rs12208357	SLC22A1	T	Metabolism/PK	Indeterminado	LADME	Healthy		N02AX02	rs12208357:T	63013
methadone	rs2070995	KCNJ6	TT	Toxicity	decreased	Adverse_Event	Disease:C0028043		N07BC02	rs2070995:TT	10090
imatinib	rs3764043	SLCO1A2	CC	Metabolism/PK	decreased	LADME	Healthy		L01EA01	rs3764043:CC	6113
imatinib	rs4148978	SLCO1A2	CC	Metabolism/PK	increased	LADME	Healthy		L01EA01	rs4148978:CC	6113
vincristine	rs3740066	ABCC2	T	Toxicity	decreased	Adverse_Event	Other:C0023449		L01CA02	rs3740066:T	24848381
imatinib	rs4148977	SLCO1A2	CC	Metabolism/PK	increased	LADME	Healthy		L01EA01	rs4148977:CC	6113
fluorouracil	rs55886062	DPYD	AC	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs55886062:AC	5790
flucloxacillin	rs3814055	NR1I2	CC	Toxicity	increased	Adverse_Event	Healthy		J01CF05	rs3814055:CC	21319
cyclosporine, mycophenolic acid, prednisone	rs3894049	NFATC1	CC	Efficacy	decreased	Adverse_Event	Disease:Kidney_Transplantation		H02AB07|L04AA06|L04AD01	rs3894049:CC	5865
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
sevoflurane	rs1801394	FASTKD3, MTRR	AG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:AG	13529
sevoflurane	rs1801394	FASTKD3, MTRR	GG	Efficacy	increased	Efficacy_Response	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:GG	13529
fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs67376798:AT	5790
efavirenz	rs28399499	CYP2B6	CC	Toxicity	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC	64139
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs143509841	F5	GT	Toxicity	increased	Adverse_Event	Healthy		C09A	rs143509841:GT	172198
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3, IFNL4	G	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:G	37542
"""ace inhibitors, plain"", ""angiotensin ii antagonists"""	rs200157005	F5	AG	Toxicity	increased	Adverse_Event	Healthy		C09A	rs200157005:AG	172198
paroxetine	rs4646427	CYP1A2	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0011581		N06AB05	rs4646427:TT	667572
carbamazepine	rs3812718	SCN1A	CC	Other	increased	Other	Healthy		N03AF01	rs3812718:CC	114709
methotrexate	rs2114358	MIR1206	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs2114358:GG	11329481
paroxetine	rs4646425	CYP1A2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs4646425:CC	667572
atorvastatin	rs2306283	SLCO1B1	G	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs2306283:G	656846
atorvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:C	656846
folic acid, methotrexate	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C0003873		B03BB01|L04AX03	rs1045642:A	135398658
cytarabine, idarubicin	rs10758713	BRD10	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs10758713:AA	6253
cytarabine, idarubicin	rs10758713	BRD10	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs10758713:AG	6253
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:C	445127
sorafenib	rs4864950	KDR	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01EX02	rs4864950:A	67424139
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	T	Efficacy	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:T	37542
sorafenib	rs444904	PIK3R5	T	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs444904:T	67424139
irinotecan	rs17868323	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs17868323:G	74990
cytarabine, idarubicin	rs2897047	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2897047:AG	6253
methotrexate	rs2273697	ABCC2	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs2273697:AA	11329481
cytarabine, idarubicin	rs6550826	__INTRONIC__	GG	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs6550826:GG	6253
methotrexate	rs1128503	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1128503:AG	11329481
azathioprine, mercaptopurine	rs3765534	ABCC4	CT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs3765534:CT	5778
azathioprine, mercaptopurine	rs3765534	ABCC4	TT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs3765534:TT	5778
methotrexate	rs4148396	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs4148396:CC	11329481
methotrexate	rs4148396	ABCC2	CT	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs4148396:CT	11329481
methotrexate	rs4148396	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs4148396:CC	11329481
cytarabine, idarubicin	rs9883101	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs9883101:CC	6253
folic acid, methotrexate	rs4986790	TLR4	G	Toxicity	increased	Adverse_Event	Disease:C0003873		B03BB01|L04AX03	rs4986790:G	135398658
rosuvastatin	rs2231142	ABCG2	T	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:T	5282455
rosuvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:C	5282455
fluorouracil, leucovorin	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs67376798:AT	135403648
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:C	58746970
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:AA	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0023055		L01BC02	rs3918290:CT	5790
hydrochlorothiazide	rs10792367	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs10792367:G	2904
irinotecan	rs17868323	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Dosage	increased	Adverse_Event	Disease:C0027651		L01CE02	rs17868323:G	74990
none	rs12654264	HMGCR	AT	Other	increased	Other	Healthy		A03DA02	rs12654264:AT	5282367
none	rs12654264	HMGCR	TT	Other	increased	Other	Healthy		A03DA02	rs12654264:TT	5282367
doxorubicin	rs7853758	SLC28A3	AA	Toxicity	decreased	Adverse_Event	"""Other:C0027651|""Other:Wilms_Tumor""|""Other:C1261473|Ewing's""|""Other:C0019829|""Other:C0024299|""Other:C0029463|""Other:C0206624"		L01DB01	rs7853758:AA	83958
doxorubicin	rs7853758	SLC28A3	AG	Toxicity	decreased	Adverse_Event	"""Other:C0027651|""Other:Wilms_Tumor""|""Other:C1261473|Ewing's""|""Other:C0019829|""Other:C0024299|""Other:C0029463|""Other:C0206624"		L01DB01	rs7853758:AG	83958
hmg coa reductase inhibitors	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs1045642:AA	445127
nicotine	rs3743075	CHRNA3	T	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs3743075:T	936
nicotine	rs7178270	CHRNB4	G	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs7178270:G	936
vincristine	rs2272653	NDRG1	G	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs2272653:G	24848381
nicotine	rs1948	CHRNB4	A	Toxicity	decreased	Adverse_Event	Healthy		N07BA01	rs1948:A	936
platinum compounds	rs1052555	ERCC2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AA	23939
platinum compounds	rs1052555	ERCC2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AG	23939
hmg coa reductase inhibitors, simvastatin	rs1719247	__INTRONIC__	T	Toxicity	decreased	Adverse_Event	Healthy		C10AA|C10AA01	rs1719247:T	54454
hmg coa reductase inhibitors	rs2306283	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs2306283:AA	445127
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC	445127
hmg coa reductase inhibitors, simvastatin	rs1346268	__INTRONIC__	C	Toxicity	decreased	Adverse_Event	Healthy		C10AA|C10AA01	rs1346268:C	54454
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:CT	58746970
cyclophosphamide, doxorubicin, fluorouracil	rs3740066	ABCC2	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3740066:CT	2907
cyclophosphamide, doxorubicin, fluorouracil	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3740066:TT	2907
imatinib	rs11249454	UGT2A1	CC	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs11249454:CC	6113
anthracyclines and related substances	rs11155012	ECT2L	A	Efficacy	increased	Adverse_Event	Disease:C1458155		L01DB	rs11155012:A	No_match
hmg coa reductase inhibitors	rs1128503	ABCB1	AA	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs1128503:AA	445127
cyclophosphamide, doxorubicin, fluorouracil	rs1801516	ATM	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1801516:AA	2907
gemcitabine	rs3825876	SLC28A1	AA	Toxicity	increased	Adverse_Event	Disease:C0030297		L01BC05	rs3825876:AA	597
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC	656846
gemcitabine	rs2072671	CDA	AC	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:AC	597
gemcitabine	rs2072671	CDA	CC	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs2072671:CC	597
risperidone	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1045642:AA	849421
risperidone	rs1045642	ABCB1	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1045642:AG	849421
pitavastatin	rs2306283	SLCO1B1	AG	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs2306283:AG	5282451
pitavastatin	rs2306283	SLCO1B1	GG	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs2306283:GG	5282451
sorafenib	rs2330951	EGFR	C	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs2330951:C	67424139
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CC	5282455
hmg coa reductase inhibitors	rs9806699	GATM	A	Toxicity	decreased	Adverse_Event	Healthy		C10AA	rs9806699:A	445127
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:A	13748464
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs4244285:A	13748464
everolimus	rs2032582	ABCB1	A	Toxicity, Other	increased	Adverse_Event	Disease:C1458155		L01EG02	rs2032582:A	6442177
cyclophosphamide, doxorubicin, fluorouracil	rs1056836	CYP1B1	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1056836:CC	2907
azathioprine, mercaptopurine	rs2647087	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs2647087:C	5778
everolimus	rs9906827	RPTOR	T	Toxicity, Other	decreased	Adverse_Event	Disease:C1458155		L01EG02	rs9906827:T	6442177
radiotherapy	rs2228001	XPC	G	Toxicity	decreased	Adverse_Event	Other:Head_and_Neck_Neoplasms		No_ATC	rs2228001:G	No_match
everolimus	rs1045642	ABCB1	A	Toxicity, Other	increased	Adverse_Event	Disease:C1458155		L01EG02	rs1045642:A	6442177
cyclophosphamide, doxorubicin, fluorouracil	rs1801516	ATM	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1801516:AA	2907
cyclophosphamide, doxorubicin, fluorouracil	rs1801516	ATM	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1801516:AG	2907
azathioprine, mercaptopurine	rs116855232	NUDT15	C	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs116855232:C	5778
platelet aggregation inhibitors excl. heparin	rs12041331	PEAR1	AA	Efficacy	increased	Adverse_Event	Other:C1956346		B01AC	rs12041331:AA	No_match
platelet aggregation inhibitors excl. heparin	rs12041331	PEAR1	AG	Efficacy	increased	Adverse_Event	Other:C1956346		B01AC	rs12041331:AG	No_match
sunitinib	rs833061	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CC	11221549
sunitinib	rs833061	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX01	rs833061:CT	11221549
azacitidine	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0026986		L01BC07	rs1801133:AA	47751
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4986893:AA	13748464
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4986893:AG	13748464
platelet aggregation inhibitors excl. heparin	rs2768759	PEAR1	AA	Efficacy	increased	Adverse_Event	Other:C1956346		B01AC	rs2768759:AA	No_match
cyclophosphamide, doxorubicin, fluorouracil	rs3212986	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3212986:AA	2907
imatinib	rs628031	SLC22A1	GG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs628031:GG	6113
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs6500265	__INTRONIC__	CT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs6500265:CT	1983
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs6500265	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs6500265:TT	1983
imatinib	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs1051266:TT	6113
selective serotonin reuptake inhibitors	rs1994862	GRIA1	CC	Other	decreased	Adverse_Event	Disease:C0235876		N06AB	rs1994862:CC	5202
everolimus	rs9906827	RPTOR	CT	Efficacy	increased	Adverse_Event	Disease:C1458155		L01EG02	rs9906827:CT	6442177
everolimus	rs9906827	RPTOR	TT	Efficacy	increased	Adverse_Event	Disease:C1458155		L01EG02	rs9906827:TT	6442177
imatinib	rs9787901	CHST1	AA	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs9787901:AA	6113
imatinib	rs9787901	CHST1	AG	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs9787901:AG	6113
imatinib	rs305968	CYP2F1	AA	Toxicity	increased	Adverse_Event	Disease:C0238198		L01EA01	rs305968:AA	6113
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs9933632	__INTRONIC__	GT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs9933632:GT	1983
acetaminophen, ibuprofen, loxoprofen, salicylamide	rs9933632	__INTRONIC__	TT	Toxicity	increased	Adverse_Event	Healthy		M02AA13|N02BA05|N02BE01	rs9933632:TT	1983
cyclophosphamide, doxorubicin, fluorouracil	rs20572	CBR1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs20572:TT	2907
cyclophosphamide, doxorubicin, fluorouracil	rs1042522	TP53	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1042522:GG	2907
sorafenib	rs11125039	PRKCE	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs11125039:G	67424139
cyclophosphamide, doxorubicin, fluorouracil	rs714368	SLC22A16	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs714368:CC	2907
cyclophosphamide, doxorubicin, fluorouracil	rs714368	SLC22A16	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs714368:CT	2907
antiinflammatory agents, non-steroids	rs1800896	IL10	C	Toxicity	increased	Adverse_Event	Healthy		M01A|V10A	rs1800896:C	No_match
cyclophosphamide, doxorubicin, fluorouracil	rs25487	XRCC1	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs25487:CT	2907
cyclophosphamide, doxorubicin, fluorouracil	rs25487	XRCC1	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs25487:TT	2907
antiinflammatory agents, non-steroids	rs231775	CTLA4	G	Toxicity	decreased	Adverse_Event	Healthy		M01A|V10A	rs231775:G	No_match
none	rs971074	ADH7	CT	Other	increased	Adverse_Event	Other:C0002895		A03DA02	rs971074:CT	5282367
none	rs971074	ADH7	TT	Other	increased	Adverse_Event	Other:C0002895		A03DA02	rs971074:TT	5282367
sorafenib	rs1346563	ADAMTS18	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs1346563:A	67424139
platinum compounds	rs25487	XRCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CT	23939
platinum compounds	rs25487	XRCC1	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:TT	23939
cyclophosphamide, doxorubicin, fluorouracil	rs1695	GSTP1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1695:AA	2907
cyclophosphamide, doxorubicin, fluorouracil	rs1695	GSTP1	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1695:AG	2907
cisplatin	rs10981694	SLC31A1	GG	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA01	rs10981694:GG	441203
cisplatin	rs10981694	SLC31A1	GT	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA01	rs10981694:GT	441203
cyclophosphamide, doxorubicin, fluorouracil	rs12248560	CYP2C19	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs12248560:CC	2907
cyclophosphamide, doxorubicin, fluorouracil	rs3740066	ABCC2	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs3740066:TT	2907
dexmedetomidine	rs11046209	ABCC9	AA	Efficacy	increased	Adverse_Event	Other:C0549433		N05CM18	rs11046209:AA	6918081
cyclophosphamide, doxorubicin, fluorouracil	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs1045642:GG	2907
vincristine	rs12522955	CEP72	A	Toxicity	increased	Adverse_Event	Other:C0017636|Other:C0017638|Other:C0006118		L01CA02	rs12522955:A	24848381
capecitabine	rs72765700	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs72765700:T	11809635
cyclophosphamide, doxorubicin, fluorouracil	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2231142:GT	2907
antineoplastic agents, mercaptopurine, methotrexate	rs2274407	ABCC4	AC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01|L01BB02|L04AX03	rs2274407:AC	126941
azathioprine, mercaptopurine	rs79206939	FTO	A	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs79206939:A	5778
cyclophosphamide, doxorubicin, fluorouracil	rs2228100	ALDH3A1	CG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2228100:CG	2907
cyclophosphamide, doxorubicin, fluorouracil	rs2228100	ALDH3A1	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2228100:GG	2907
antineoplastic agents, mercaptopurine, methotrexate	rs2274407	ABCC4	AC	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L01|L01BB02|L04AX03	rs2274407:AC	126941
pravastatin	rs17238540	HMGCR	GT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs17238540:GT	58746970
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_treated_with_percutaneous_coronary_intervention_(PCI)		B01AC04	rs4244285:AG	13748464
cyclophosphamide, doxorubicin, fluorouracil	rs2273697	ABCC2	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs2273697:GG	2907
cyclophosphamide, doxorubicin, fluorouracil	rs6907567	SLC22A16	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs6907567:AA	2907
everolimus	rs351855	FGFR4	A	Toxicity, Other	decreased	Adverse_Event	Disease:C1458155		L01EG02	rs351855:A	6442177
vincristine	rs924607	CEP72	TT	Toxicity	increased	Adverse_Event	"""Other:C0017636|""Other:C0017638|""Other:C0006118|""Other:C0023449|""Other:C0024299|B-Cell""|""Other:C0023418|""Other:C1261473|Ewing's""|""Other:C0024299"		L01CA02	rs924607:TT	24848381
azathioprine, mercaptopurine	rs2834826	__INTRONIC__	T	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs2834826:T	5778
cyclophosphamide, doxorubicin, fluorouracil	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs4244285:AA	2907
cyclophosphamide, doxorubicin, fluorouracil	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs4244285:AG	2907
imatinib	rs12659	SLC19A1	AG	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs12659:AG	6113
imatinib	rs12659	SLC19A1	GG	Toxicity	decreased	Adverse_Event	Disease:C0238198		L01EA01	rs12659:GG	6113
azathioprine, mercaptopurine	rs16952570	FTO	C	Toxicity	increased	Adverse_Event	Disease:C0022104		L01BB02|L04AX01	rs16952570:C	5778
azacitidine	rs25487	XRCC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026986		L01BC07	rs25487:CC	47751
imatinib	rs10517	NQO1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EA01	rs10517:GG	6113
everolimus	rs10515074	PIK3R1	G	Toxicity, Other	decreased	Adverse_Event	Disease:C1458155		L01EG02	rs10515074:G	6442177
desloratadine	rs901865	HRH1	CC	Toxicity	increased	Adverse_Event	Other:C0042109		R06AX27	rs901865:CC	124087
imatinib	rs2273697	ABCC2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EA01	rs2273697:GG	6113
cytarabine, doxorubicin, leucovorin, methotrexate, prednisone, vincristine	rs1799983	NOS3	TT	Toxicity	decreased	Adverse_Event	Disease:C0023449		H02AB07|L01BC01|L01CA02|L01DB01|L04AX03	rs1799983:TT	5865
imatinib	rs1202283	ABCB4	AA	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs1202283:AA	6113
imatinib	rs1202283	ABCB4	AG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs1202283:AG	6113
everolimus	rs10515074	PIK3R1	G	Toxicity, Other	increased	Adverse_Event	Disease:C1458155		L01EG02	rs10515074:G	6442177
capecitabine	rs10024471	MIR2054	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs10024471:A	11809635
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0004364|Disease:C0024141|Disease:C1527336		L04AX01	rs116855232:CT	5778
azathioprine	rs116855232	NUDT15	TT	Toxicity	increased	Adverse_Event	Disease:C0004364|Disease:C0024141|Disease:C1527336		L04AX01	rs116855232:TT	5778
methotrexate	rs1105525	DHFR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1105525:CT	11329481
methotrexate	rs1105525	DHFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1105525:TT	11329481
antipsychotics, clozapine, olanzapine	rs3766522	PRKAB2	TT	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03	rs3766522:TT	135398737
methadone	rs11265549	NECTIN4	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N07BC02	rs11265549:AA	10090
capecitabine	rs117876855	SPRY2	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117876855:A	11809635
azathioprine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0004364|Disease:C0024141|Disease:C1527336		L04AX01	rs116855232:T	5778
capecitabine	rs139544515	SPRY2	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs139544515:A	11809635
hmg coa reductase inhibitors	rs12654264	HMGCR	AA	Efficacy	decreased	Adverse_Event	Healthy		C10AA	rs12654264:AA	445127
rivaroxaban	rs2246709	CYP3A4	AA	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs2246709:AA	10700
methotrexate	rs11545078	GGH	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs11545078:A	11329481
capecitabine	rs185217050	NCOA7	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs185217050:T	11809635
capecitabine	rs139368788	CCDC70	A	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs139368788:A	11809635
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs1801133:AG	11329481
none	rs12654264	HMGCR	AT	Other	increased	Other	Healthy		A03DA02	rs12654264:AT	5282367
none	rs12654264	HMGCR	TT	Other	increased	Other	Healthy		A03DA02	rs12654264:TT	5282367
cyclophosphamide, doxorubicin, fluorouracil	rs11615	ERCC1	AG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs11615:AG	2907
cyclophosphamide, doxorubicin, fluorouracil	rs11615	ERCC1	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01AA01|L01BC02|L01DB01	rs11615:GG	2907
capecitabine	rs117412990	TMEM131L	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs117412990:G	11809635
pravastatin	rs17244841	HMGCR	AT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs17244841:AT	58746970
hmg coa reductase inhibitors	rs12654264	HMGCR	TT	Efficacy	decreased	Adverse_Event	Healthy		C10AA	rs12654264:TT	445127
capecitabine	rs191934521	SIRPA	G	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs191934521:G	11809635
antipsychotics, clozapine, olanzapine	rs10789038	PRKAA2	AA	Toxicity	decreased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03	rs10789038:AA	135398737
rivaroxaban	rs3735451	CYP3A4	TT	Toxicity	decreased	Adverse_Event	Other:C0004238		B01AF01	rs3735451:TT	10700
capecitabine	rs146644707	LMNTD1	T	Toxicity	increased	Adverse_Event	Disease:C1458155|Disease:C0023055|Disease:C0027651		L01BC06	rs146644707:T	11809635
methotrexate	rs1801133	MTHFR	GG	Toxicity	decreased	Adverse_Event	Disease:C0027651		L04AX03	rs1801133:GG	11329481
antineoplastic agents	rs6500843	RBFOX1	G	Efficacy	increased	Adverse_Event	Disease:C1458155		L01	rs6500843:G	No_match
hmg coa reductase inhibitors	rs12654264	HMGCR	AA	Efficacy	decreased	Adverse_Event	Healthy		C10AA	rs12654264:AA	445127
platinum	rs1051685	XRCC5	G	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01XA	rs1051685:G	441203
clozapine, olanzapine, risperidone	rs7799039	LEP	AG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs7799039:AG	135398737
clozapine, olanzapine, risperidone	rs7799039	LEP	GG	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AH02|N05AH03|N05AX08	rs7799039:GG	135398737
irinotecan	rs17287570	ABCC1	A	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CE02	rs17287570:A	74990
sorafenib	rs1868089	EPAS1	C	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs1868089:C	67424139
platinum	rs6941	XRCC5	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs6941:A	441203
cyclophosphamide	rs143731390	CYP2A6	A	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs143731390:A	9554282
irinotecan	rs2622604	ABCG2	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs2622604:T	74990
folic acid	rs2236225	MTHFD1	AA	Other	decreased	Adverse_Event	Other:C0032961		B03BB01	rs2236225:AA	135804810
methotrexate	rs442767	DHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs442767:GG	11329481
irinotecan	rs11692021	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	CT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CE02	rs11692021:CT	74990
irinotecan	rs11692021	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	TT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01CE02	rs11692021:TT	74990
platinum	rs10875989	AQP2	T	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs10875989:T	441203
apixaban, rivaroxaban	rs3114018	ABCG2	AA	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs3114018:AA	9875401
apixaban, rivaroxaban	rs3114018	ABCG2	AC	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs3114018:AC	9875401
irinotecan	rs7977213	SLCO1B3	G	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs7977213:G	74990
methotrexate	rs408626	DHFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs408626:TT	11329481
cyclophosphamide	rs3745274	CYP2B6	T	Toxicity	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs3745274:T	9554282
platinum	rs3759125	AQP2	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs3759125:AA	441203
platinum	rs3759125	AQP2	AC	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs3759125:AC	441203
irinotecan	rs10841661	SLCO1B3	T	Toxicity	increased	Adverse_Event	Disease:C0027651		L01CE02	rs10841661:T	74990
methotrexate	rs1650697	DHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1650697:AA	11329481
apixaban, rivaroxaban	rs2622604	ABCG2	CT	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs2622604:CT	9875401
apixaban, rivaroxaban	rs2622604	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs2622604:TT	9875401
platinum	rs461872	AQP2	A	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01XA	rs461872:A	441203
platinum	rs7305534	AQP2	CC	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs7305534:CC	441203
platinum	rs7305534	AQP2	CT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01XA	rs7305534:CT	441203
mephenytoin, tolbutamide	rs41291556	CYP2C19	C	Metabolism/PK	Indeterminado	LADME	Healthy		A10BB03|N03AB02	rs41291556:C	5505
platinum	rs2748249	CD74	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs2748249:A	441203
aspirin	rs6962291	TBXAS1	AA	Other	decreased	Adverse_Event	Disease:C0004096		No_ATC	rs6962291:AA	72204814
platinum	rs1560661	CD74	C	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01XA	rs1560661:C	441203
cytarabine	rs2072671	CDA	AA	Toxicity, Metabolism/PK	decreased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01	rs2072671:AA	6918130
warfarin	rs12777823	__INTRONIC__	A	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs12777823:A	54688261
warfarin	rs12777823	__INTRONIC__	A	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs12777823:A	54688261
none	rs12915901	ALDH1A2	A	Other	increased	Adverse_Event	Healthy		A03DA02	rs12915901:A	5282367
raloxifene, tamoxifen	rs10030044	__INTRONIC__	G	Efficacy	increased	Adverse_Event	Disease:C1458155		G03XC01|L02BA01	rs10030044:G	5035
capecitabine, fluorouracil	rs2297595	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2297595:CT	60953
capecitabine, fluorouracil	rs2297595	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2297595:TT	60953
none	rs841844	SLC2A1	CG	Toxicity	increased	Adverse_Event	Disease:C0024121		A03DA02	rs841844:CG	5282367
none	rs841844	SLC2A1	GG	Toxicity	increased	Adverse_Event	Disease:C0024121		A03DA02	rs841844:GG	5282367
capecitabine, fluorouracil	rs2297595	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs2297595:TT	60953
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_implantation		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:patients_undergoing_elective_coronary_stent_implantation		B01AC04	rs4244285:AG	13748464
dasatinib	rs121913459	ABL1	CT	Other, Metabolism/PK	decreased	LADME	Disease:C0023418		L01EA02	rs121913459:CT	3062316
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	decreased	Adverse_Event	Healthy		J05AP01|L03AB10	rs8099917:TT	37542
hydrochlorothiazide	rs5051	AGT	T	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs5051:T	2904
hydrochlorothiazide	rs5186	AGTR1	A	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs5186:A	2904
tamoxifen	rs4986938	ESR2	CC	Other	increased	Adverse_Event	Healthy		L02BA01	rs4986938:CC	2733525
azathioprine, mercaptopurine	rs116855232	NUDT15	T	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:T	5778
ondansetron	rs1045642	ABCB1	AA	Efficacy	decreased	Adverse_Event	Healthy		A04AA01	rs1045642:AA	4595
tamoxifen	rs9340799	ESR1	GG	Other	decreased	Adverse_Event	Healthy		L02BA01	rs9340799:GG	2733525
talinolol	rs2273697	ABCC2	A	Other	increased	LADME	Healthy		No_ATC	rs2273697:A	68770
clozapine, olanzapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AX08	rs1414334:C	135398737
doxorubicin	rs8133052	CBR3	G	Toxicity, Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs8133052:G	83958
ondansetron	rs2032582	ABCB1	AA	Efficacy	decreased	Adverse_Event	Healthy		A04AA01	rs2032582:AA	4595
clozapine, olanzapine, risperidone	rs518147	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AX08	rs518147:C	135398737
bevacizumab, cyanocobalamin, folic acid, pemetrexed	rs1801131	MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		B03BA01|B03BB01|L01BA04|L01FG01	rs1801131:GG	135398658
bevacizumab, cyanocobalamin, folic acid, pemetrexed	rs1801131	MTHFR	GT	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		B03BA01|B03BB01|L01BA04|L01FG01	rs1801131:GT	135398658
artesunate, primaquine, pyrimethamine, sulfadoxine	rs1050828	G6PD, IKBKG	CT	Toxicity	increased	Adverse_Event	Healthy		P01BA03|P01BD01|P01BE03	rs1050828:CT	65404
raloxifene, tamoxifen	rs8060157	ZNF423	A	Efficacy	decreased	Adverse_Event	Disease:C1458155		G03XC01|L02BA01	rs8060157:A	5035
tacrolimus	rs1045642	ABCB1	AA	Efficacy	Indeterminado	Efficacy_Response	Other:Kidney_Transplantation		L04AD02	rs1045642:AA	131769926
tacrolimus	rs1045642	ABCB1	AG	Efficacy	Indeterminado	Efficacy_Response	Other:Kidney_Transplantation		L04AD02	rs1045642:AG	131769926
carbamazepine	rs2273697	ABCC2	AA	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0014544		N03AF01	rs2273697:AA	114709
carbamazepine	rs2273697	ABCC2	AG	Toxicity, Metabolism/PK	increased	Adverse_Event	Disease:C0014544		N03AF01	rs2273697:AG	114709
artesunate, primaquine, pyrimethamine, sulfadoxine	rs1050828	G6PD, IKBKG	TT	Other	increased	Adverse_Event	Healthy		P01BA03|P01BD01|P01BE03	rs1050828:TT	65404
sorafenib	rs12366035	VEGFB	T	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs12366035:T	67424139
cytarabine	rs532545	CDA	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs532545:TT	6918130
cytarabine	rs532545	CDA	TT	Efficacy	increased	Adverse_Event	Disease:C0023418|Myeloid|Acute		L01BC01	rs532545:TT	6918130
vincristine	rs71585289	CEP72	C	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs71585289:C	24848381
cyclosporine, tacrolimus	rs1128503	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:Heart_transplantation		L04AD01|L04AD02	rs1128503:AA	445643
cyclosporine, tacrolimus	rs1128503	ABCB1	AG	Efficacy	increased	Adverse_Event	Disease:Heart_transplantation		L04AD01|L04AD02	rs1128503:AG	445643
clopidogrel	rs2046934	P2RY12	GG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs2046934:GG	13748464
vincristine	rs35650931	MIR6076	CC	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs35650931:CC	24848381
vincristine	rs35650931	MIR6076	CG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs35650931:CG	24848381
sorafenib	rs9927200	WWOX	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs9927200:A	67424139
doxepin	rs4244285	CYP2C19	AA	Metabolism/PK	decreased	LADME	Healthy		N06AA12	rs4244285:AA	59023617
anthracyclines and related substances	rs2229774	RARG	A	Toxicity	increased	Adverse_Event	Disease:C0027651		L01DB	rs2229774:A	No_match
vincristine	rs7896283	MIR4481	G	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs7896283:G	24848381
clomipramine	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA04	rs4244285:AG	68539
capecitabine, fluorouracil	rs2297595	DPYD	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs2297595:CC	60953
methotrexate	rs1051266	SLC19A1	CT	Efficacy	increased	Adverse_Event	Other:C0023449		L04AX03	rs1051266:CT	11329481
corticosteroids	rs11553746	ACP1	TT	Toxicity	increased	Adverse_Event	Other:C0023449		S02BA	rs11553746:TT	No_match
sorafenib	rs11651488	MAP2K6	C	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs11651488:C	67424139
methotrexate	rs1801131	MTHFR	GT	Efficacy	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1801131:GT	11329481
sorafenib	rs17682789	CDH13	C	Toxicity	decreased	Adverse_Event	Other:C0007134		L01EX02	rs17682789:C	67424139
tacrolimus	rs776746	CYP3A5	CC	Efficacy	decreased	Adverse_Event	Other:C0027726		L04AD02	rs776746:CC	131769926
clomipramine	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA04	rs4244285:AA	68539
paroxetine	rs1360780	FKBP5	T	Other	increased	Adverse_Event	Disease:C0235876		N06AB05	rs1360780:T	667572
clomipramine, liothyronine, lithium, nefazodone, paroxetine, venlafaxine	rs1360780	FKBP5	T	Other	increased	Adverse_Event	Disease:C0235876		H03AA02|N05AN01|N06AA04|N06AB05|N06AX06|N06AX16	rs1360780:T	667572
iloperidone	rs1065852	CYP2D6	GG	Other	increased	Adverse_Event	Disease:C0036341		No_ATC	rs1065852:GG	18467218
gemcitabine	rs12148896	SLC28A1	A	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs12148896:A	597
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Adverse_Event	Other:C0023449		L04AX03	rs1801133:AA	11329481
clomipramine, liothyronine, lithium, nefazodone, venlafaxine	rs130058	HTR1B	A	Efficacy	decreased	Adverse_Event	Disease:C0235876		H03AA02|N05AN01|N06AA04|N06AX06|N06AX16	rs130058:A	5656
paroxetine	rs130058	HTR1B	A	Other	increased	Adverse_Event	Disease:C0235876		N06AB05	rs130058:A	667572
gemcitabine	rs471760	CDA	A	Toxicity	decreased	Adverse_Event	Disease:C0030297		L01BC05	rs471760:A	597
cannabidiol	rs3749442	ABCC5	AA	Toxicity	increased	Adverse_Event	Other:C0014544		No_ATC	rs3749442:AA	644019
cannabidiol	rs3749442	ABCC5	AG	Toxicity	increased	Adverse_Event	Other:C0014544		No_ATC	rs3749442:AG	644019
cisplatin	rs1872328	ACYP2	AG	Toxicity	increased	Adverse_Event	Disease:C0029463		L01XA01	rs1872328:AG	441203
clomipramine, liothyronine, lithium, nefazodone, paroxetine, venlafaxine	rs2032582	ABCB1	A	Other	increased	Adverse_Event	Disease:C0235876		H03AA02|N05AN01|N06AA04|N06AB05|N06AX06|N06AX16	rs2032582:A	667572
melphalan	rs4240803	SLC7A5	AA	Toxicity	decreased	Adverse_Event	Disease:Multiple_Myeloma		L01AA03	rs4240803:AA	20189
melphalan	rs4240803	SLC7A5	AG	Toxicity	decreased	Adverse_Event	Disease:Multiple_Myeloma		L01AA03	rs4240803:AG	20189
antipsychotics	rs17782313	MC4R	CC	Other	increased	Adverse_Event	Healthy		N05A	rs17782313:CC	No_match
antipsychotics	rs17782313	MC4R	CT	Other	increased	Adverse_Event	Healthy		N05A	rs17782313:CT	No_match
platinum	rs3738514	SLC2A1	T	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01XA	rs3738514:T	441203
doxorubicin	rs2229774	RARG	AA	Toxicity	increased	Adverse_Event	"""Other:C0027651|""Other:Wilms_Tumor""|""Other:C1261473|Ewing's""|""Other:C0019829|""Other:C0024299|""Other:C0029463|""Other:C0206624"		L01DB01	rs2229774:AA	83958
vincristine	rs1049402	GARS1	G	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs1049402:G	24848381
sorafenib	rs917881	EGFR	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs917881:A	67424139
vincristine	rs12823621	FGD4	A	Toxicity	increased	Adverse_Event	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs12823621:A	24848381
carboplatin, cisplatin	rs7851395	SLC31A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs7851395:AA	10339178
vincristine	rs12402181	MIR3117	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs12402181:AA	24848381
vincristine	rs12402181	MIR3117	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs12402181:AG	24848381
fluorouracil, oxaliplatin	rs13181	ERCC2, KLC3	GT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs13181:GT	9887054
platinum	rs4658	SLC2A1	CC	Toxicity	decreased	Adverse_Event	Healthy		L01XA	rs4658:CC	441203
peginterferon alfa-2b, ribavirin, telaprevir	rs1127354	ITPA	CC	Toxicity	increased	Adverse_Event	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs1127354:CC	37542
fluorouracil, oxaliplatin	rs1695	GSTP1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:AG	9887054
fluorouracil, oxaliplatin	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:GG	9887054
none	rs4961	ADD1	GT	Other	increased	Other	Disease:C0020538		A03DA02	rs4961:GT	5282367
none	rs4961	ADD1	TT	Other	increased	Other	Disease:C0020538		A03DA02	rs4961:TT	5282367
bleomycin, cisplatin, etoposide	rs238406	ERCC2	GT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs238406:GT	5360373
bleomycin, cisplatin, etoposide	rs238406	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs238406:TT	5360373
atorvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA05	rs4149056:CT	656846
clopidogrel	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	rs776746:CC	13748464
clopidogrel	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Disease:C0018839		B01AC04	rs776746:CT	13748464
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CC	445127
hmg coa reductase inhibitors	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs4149056:CT	445127
none	rs2277869	RAD52, WNK1	CC	Other	increased	Other	Disease:C0020538		A03DA02	rs2277869:CC	5282367
fentanyl, morphine, opioids, oxycodone	rs13422094	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs13422094:C	5288826
sunitinib	rs1800925	IL13	TT	Other	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1800925:TT	11221549
fentanyl, morphine, opioids, oxycodone	rs12211463	__INTRONIC__	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs12211463:G	5288826
fentanyl, morphine, opioids, oxycodone	rs7757130	__INTRONIC__	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs7757130:A	5288826
fentanyl	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Healthy		N02AB03	rs1799971:AG	13653606
fentanyl	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Healthy		N02AB03	rs1799971:GG	13653606
fentanyl, morphine, opioids, oxycodone	rs2473967	__INTRONIC__	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs2473967:G	5288826
thiazides, plain	rs4961	ADD1	GG	Efficacy	decreased	Adverse_Event	Disease:C0020538		A03B|C03A	rs4961:GG	No_match
bleomycin, cisplatin, etoposide	rs1799793	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1799793:TT	5360373
sunitinib	rs1800925	IL13	TT	Other	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1800925:TT	11221549
fentanyl	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Healthy		N02AB03	rs4680:AG	13653606
simvastatin	rs4149056	SLCO1B1	CC	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Toxicity	increased	Adverse_Event	Healthy		C10AA01	rs4149056:CT	14373154
fentanyl, morphine, opioids, oxycodone	rs12948783	RHBDF2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs12948783:AA	5288826
fentanyl, morphine, opioids, oxycodone	rs12948783	RHBDF2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs12948783:AG	5288826
ace inhibitors, plain	rs192613545	SH2B1	T	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs192613545:T	No_match
radiotherapy	rs1239344	OSMR	T	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs1239344:T	No_match
bleomycin, cisplatin, etoposide	rs1050565	BLMH	CC	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1050565:CC	5360373
radiotherapy	rs10711	CDK1	G	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs10711:G	No_match
bleomycin, cisplatin, etoposide	rs1050565	BLMH	CC	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1050565:CC	5360373
celecoxib	rs1799853	CYP2C9	CT	Metabolism/PK	Indeterminado	LADME	Healthy		M01AH01	rs1799853:CT	66824
hydrochlorothiazide	rs11240688	REN	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs11240688:GG	2904
hydrochlorothiazide	rs7297610	YEATS4	C	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs7297610:C	2904
ace inhibitors, plain	rs62063838	RBFOX3	C	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs62063838:C	No_match
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:GT	2904
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:TT	2904
radiotherapy	rs940052	PRKCE	G	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs940052:G	No_match
ace inhibitors, plain	rs10946364	MBOAT1	T	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs10946364:T	No_match
radiotherapy	rs11125035	PRKCE	T	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs11125035:T	No_match
rofecoxib	rs3842787	PTGS1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		M01AH02	rs3842787:T	5090
bleomycin, cisplatin, etoposide	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs11615:AA	5360373
radiotherapy	rs11795343	RIGI	C	Toxicity	increased	Adverse_Event	Healthy		No_ATC	rs11795343:C	No_match
cisplatin	rs12201199	TPMT	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01XA01	rs12201199:T	441203
drugs for treatment of tuberculosis	rs1495741	__INTRONIC__	AA	Toxicity	increased	Adverse_Event	Healthy		J04A	rs1495741:AA	No_match
ace inhibitors, plain	rs56044629	RBFOX3	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs56044629:G	No_match
hydrochlorothiazide	rs880054	WNK1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs880054:TT	2904
radiotherapy	rs7259857	__INTRONIC__	C	Toxicity	decreased	Adverse_Event	Healthy		No_ATC	rs7259857:C	No_match
celecoxib	rs3842787	PTGS1	T	Efficacy	Indeterminado	Efficacy_Response	Healthy		M01AH01	rs3842787:T	66824
hydrochlorothiazide	rs4961	ADD1	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:T	2904
ace inhibitors, plain	rs77370934	GABRG2	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs77370934:G	No_match
vincristine	rs3803357	BAHD1	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs3803357:AA	24848381
vincristine	rs3803357	BAHD1	AC	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01CA02	rs3803357:AC	24848381
ace inhibitors, plain	rs56209714	RBFOX3	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs56209714:G	No_match
capecitabine, fluorouracil	rs1801160	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01BC06	rs1801160:CT	60953
capecitabine, fluorouracil	rs1801160	DPYD	TT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01BC06	rs1801160:TT	60953
methylprednisolone, prednisolone	rs1045642	ABCB1	AA	Toxicity	decreased	Adverse_Event	Disease:Kidney_Transplantation		H02AB04|S02BA03	rs1045642:AA	54605501
bleomycin, cisplatin, etoposide	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1695:GG	5360373
anastrozole, letrozole, tamoxifen	rs8113308	ZNF613	C	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01|L02BG03|L02BG04	rs8113308:C	3902
pirfenidone	rs762551	CYP1A2	AA	Toxicity	decreased	Adverse_Event	Other:C0034069		L04AX05	rs762551:AA	40632
bleomycin, cisplatin, etoposide	rs13181	ERCC2	GG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs13181:GG	5360373
bleomycin, cisplatin, etoposide	rs13181	ERCC2	GT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs13181:GT	5360373
cisplatin	rs2291767	OTOS	CC	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs2291767:CC	441203
cisplatin	rs2291767	OTOS	CT	Toxicity	decreased	Adverse_Event	Disease:C0027651		L01XA01	rs2291767:CT	441203
ace inhibitors, plain	rs2061538	RBFOX3	G	Toxicity	increased	Adverse_Event	Healthy		A03B|C09A	rs2061538:G	No_match
selective serotonin reuptake inhibitors	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB	rs6311:CC	5202
citalopram	rs6311	HTR2A	CC	Toxicity	increased	Adverse_Event	Other:C0011581		N06AB04	rs6311:CC	162180
tacrolimus	rs776746	CYP3A5	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
mercaptopurine, methotrexate	rs1801131	MTHFR	GG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1801131:GG	126941
sunitinib	rs1126647	CXCL8	TT	Other	increased	Adverse_Event	Disease:C0007134		L01EX01	rs1126647:TT	11221549
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2302273	PDGFRB	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2302273:AA	135403648
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2302273	PDGFRB	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2302273:AG	135403648
ethanol	rs738409	PNPLA3	GG	Toxicity	increased	Adverse_Event	Healthy		V03AB16	rs738409:GG	444899
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2661280	RGS5	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2661280:CC	135403648
bevacizumab, fluorouracil, irinotecan, leucovorin	rs2661280	RGS5	CG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs2661280:CG	135403648
sorafenib	rs9973653	EPAS1	T	Toxicity	decreased	Adverse_Event	Other:C0007134		L01EX02	rs9973653:T	67424139
none	rs16754	WT1	CC	Other	increased	Adverse_Event	Healthy		A03DA02	rs16754:CC	5282367
none	rs16754	WT1	CT	Other	increased	Adverse_Event	Healthy		A03DA02	rs16754:CT	5282367
tacrolimus	rs776746	CYP3A5	CT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
mercaptopurine	rs1127354	ITPA	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1127354:A	1268107
cannabinoids	rs324420	FAAH	AA	Toxicity	decreased	Adverse_Event	Healthy		N02BG10	rs324420:AA	2543
sorafenib	rs315498	__INTRONIC__	C	Toxicity	decreased	Adverse_Event	Other:C0007134		L01EX02	rs315498:C	67424139
cyclophosphamide	rs3957357	GSTA1	A	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs3957357:A	9554282
vincristine	rs10513762	MRPL47	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs10513762:CT	24848381
vincristine	rs10513762	MRPL47	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs10513762:TT	24848381
fluorouracil	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02	rs67376798:AT	5790
vincristine	rs2781377	SYNE2	A	Toxicity	increased	Adverse_Event	Disease:C0023449		L01CA02	rs2781377:A	24848381
sorafenib	rs4035887	EPAS1	A	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs4035887:A	67424139
antipsychotics	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Healthy		N05A	rs4680:AA	No_match
antipsychotics	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Healthy		N05A	rs4680:AG	No_match
clopidogrel	rs4244285	CYP2C19	A	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	13748464
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801133:AA	11329481
methotrexate	rs408626	DHFR	CC	Efficacy	decreased	Other	Disease:C0023449		L04AX03	rs408626:CC	11329481
methotrexate	rs1801131	MTHFR	G	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:G	11329481
cyclophosphamide	rs1051775	GSTA1	C	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs1051775:C	9554282
efavirenz	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:A	64139
doxorubicin	rs9679162	GALNT14	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01DB01	rs9679162:TT	83958
aspirin	rs28360521	CYP2D6	CC	Toxicity, Other	increased	Adverse_Event	Healthy		No_ATC	rs28360521:CC	72204814
desflurane, propofol	rs45574836	ATP8B3	CT	Toxicity	increased	Adverse_Event	Other:C0549433		N01AB07|N01AX10	rs45574836:CT	42113
desflurane, propofol	rs45574836	ATP8B3	TT	Toxicity	increased	Adverse_Event	Other:C0549433		N01AB07|N01AX10	rs45574836:TT	42113
losartan	rs10752271	CAMK1D	AG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10752271:AG	11751549
losartan	rs10752271	CAMK1D	GG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10752271:GG	11751549
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0235889|Psoriatic		L04AX03	rs1801133:AA	11329481
methotrexate	rs408626	DHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs408626:TT	11329481
losartan	rs10737062	CAMK1D	AG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10737062:AG	11751549
losartan	rs10737062	CAMK1D	GG	Efficacy	decreased	Adverse_Event	Disease:C0085580		C09CA01	rs10737062:GG	11751549
cyclophosphamide	rs1051775	GSTA1	C	Toxicity	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs1051775:C	9554282
methotrexate	rs1801131	MTHFR	T	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs1801131:T	11329481
methotrexate	rs442767	DHFR	GT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs442767:GT	11329481
celecoxib	rs1057910	CYP2C9	C	Efficacy	decreased	Adverse_Event	Disease:C0003126		M01AH01	rs1057910:C	66824
mercaptopurine	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1051266:CT	1268107
mercaptopurine	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1051266:TT	1268107
bleomycin, cisplatin, etoposide	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs2740574:CT	5360373
mercaptopurine	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1801133:AA	1268107
mercaptopurine	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02	rs1801133:AG	1268107
methotrexate	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG	11329481
efavirenz	rs1045642	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs1045642:A	64139
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1127648	CSPG4	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1127648:AG	135403648
sorafenib	rs10958704	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs10958704:G	67424139
methotrexate	rs1979277	SHMT1	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs1979277:AG	11329481
methotrexate	rs1801394	FASTKD3, MTRR	AG	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801394:AG	11329481
sorafenib	rs7557402	EPAS1	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs7557402:G	67424139
methotrexate	rs1801131	MTHFR	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1801131:TT	11329481
cyclophosphamide	rs3211371	CYP2B6	T	Toxicity	increased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation		L01AA01	rs3211371:T	9554282
apixaban, rivaroxaban	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF01|B01AF02	rs1045642:AA	9875401
efavirenz	rs2032582	ABCB1	A	Efficacy	decreased	Adverse_Event	Disease:HIV_infectious_disease		J05AG03	rs2032582:A	64139
cyclophosphamide, docetaxel	rs1570360	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L01AA01|L01CD02	rs1570360:AA	2907
carboplatin, gemcitabine	rs1453542	OR4D6	CC	Toxicity	increased	Adverse_Event	Disease:C0007131		L01BC05|L01XA02	rs1453542:CC	10339178
sorafenib	rs12948059	MAP2K6	G	Toxicity	increased	Adverse_Event	Other:C0007134		L01EX02	rs12948059:G	67424139
carboplatin, gemcitabine	rs5925720	DDX53	T	Toxicity	decreased	Adverse_Event	Disease:C0007131		L01BC05|L01XA02	rs5925720:T	10339178
methotrexate	rs2236225	MTHFD1	AA	Other	increased	LADME	Disease:C0003873		L04AX03	rs2236225:AA	11329481
methotrexate	rs1801394	FASTKD3, MTRR	AA	Other	increased	LADME	Disease:C0003873		L04AX03	rs1801394:AA	11329481
irinotecan	rs11979430	SEMA3C	T	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs11979430:T	74990
antipsychotics	rs1800497	DRD2	A	Toxicity	increased	Adverse_Event	Healthy		N05A	rs1800497:A	No_match
clopidogrel	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Toxicity	increased	Adverse_Event	Healthy		B01AC04	rs4244285:AG	13748464
antipsychotics	rs4680	COMT	AA	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05A	rs4680:AA	No_match
antipsychotics	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05A	rs4680:AG	No_match
irinotecan	rs7779029	SEMA3C	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs7779029:C	74990
antiepileptics	rs2032582	ABCB1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2032582:C	No_match
antipsychotics	rs1800497	DRD2	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1800497:G	No_match
antiepileptics	rs2032582	ABCB1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2032582:C	No_match
antipsychotics	rs1800497	DRD2	G	Toxicity	increased	Adverse_Event	Disease:C0036341		N05A	rs1800497:G	No_match
irinotecan	rs1661167	__INTRONIC__	G	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs1661167:G	74990
antiepileptics	rs2032582	ABCB1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03A	rs2032582:C	No_match
amisulpride, clozapine, olanzapine, quetiapine, risperidone	rs498207	HTR2C	AA	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs498207:AA	2159
cisplatin, cyclophosphamide	rs6413432	CYP2E1	TT	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01AA01|L01XA01	rs6413432:TT	2907
budesonide	rs28364072	FCER2	G	Other	Indeterminado	Other	Disease:C0004096		R03BA02	rs28364072:G	5281004
cyclophosphamide	rs1799983	NOS3	TT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01	rs1799983:TT	9554282
amisulpride, clozapine, olanzapine, quetiapine, risperidone	rs3813928	HTR2C	GG	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs3813928:GG	2159
mycophenolate mofetil(mycophenolic acid)	rs568408	IL12A	A	Toxicity	increased	Adverse_Event	Healthy		L04AA06	rs568408:A	5281078
irinotecan	rs2745761	PLCB1	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs2745761:C	74990
cyclophosphamide	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01	rs2070744:CC	9554282
amisulpride, clozapine, olanzapine, quetiapine, risperidone	rs3813929	HTR2C	CC	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05AH02|N05AH03|N05AH04|N05AL05|N05AX08	rs3813929:CC	2159
cyclophosphamide, doxorubicin, fluorouracil, methotrexate	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01|L04AX03	rs1799983:GG	2907
cyclophosphamide, doxorubicin, fluorouracil, methotrexate	rs1799983	NOS3	GT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB01|L04AX03	rs1799983:GT	2907
irinotecan	rs11128347	PDZRN3	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs11128347:C	74990
methadone	rs4554144	UGT2B7	TT	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs4554144:TT	10090
dapsone	rs201929247	HLA-DRB1	A	Toxicity	increased	Adverse_Event	Healthy		J04BA02	rs201929247:A	2955
olanzapine	rs1801282	PPARG	CG	Other	increased	Adverse_Event	Disease:C0036341		N05AH03	rs1801282:CG	74603552
methadone	rs11940316	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs11940316:CC	10090
corticosteroids	rs2241843	BCL2L11	AA	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA	rs2241843:AA	No_match
methadone	rs7438135	UGT2B7	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7438135:AA	10090
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
methadone	rs7662029	UGT2B7	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7662029:GG	10090
cisplatin, cyclophosphamide	rs3957357	GSTA1	AA	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3957357:AA	2907
cisplatin, cyclophosphamide	rs3957357	GSTA1	AG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs3957357:AG	2907
oxaliplatin	rs2233678	PIN1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs2233678:CC	9887054
oxaliplatin	rs2233678	PIN1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs2233678:CG	9887054
methadone	rs7668258	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7668258:CC	10090
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	CT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:CT	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs9332096	CYP2C9	TT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs9332096:TT	135483892
methotrexate	rs2231142	ABCG2	TT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs2231142:TT	11329481
methotrexate	rs17602729	AMPD1	AG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs17602729:AG	11329481
antiepileptics	rs1045642	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1045642:A	No_match
methadone	rs7439366	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs7439366:CC	10090
antiepileptics	rs1128503	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs1128503:A	No_match
antiepileptics	rs3789243	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs3789243:G	No_match
methadone	rs4292394	UGT2B7	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs4292394:GG	10090
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AA	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AA	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs4986893	CYP2C19	AG	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs4986893:AG	135483892
cisplatin, cyclophosphamide	rs2070676	CYP2E1	CG	Toxicity	increased	Adverse_Event	Disease:C0919267		L01AA01|L01XA01	rs2070676:CG	2907
antiepileptics	rs3789243	ABCB1	G	Efficacy	increased	Adverse_Event	Disease:C0014544		N03A	rs3789243:G	No_match
fluorouracil	rs3918290	DPYD	CT	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02	rs3918290:CT	5790
thiazides, plain	rs5443	GNB3	CC	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs5443:CC	No_match
amlodipine	rs877087	RYR3	TT	Efficacy	increased	Adverse_Event	Disease:C0020538		C08CA01	rs877087:TT	72734364
fluorouracil	rs1695	GSTP1	GG	Toxicity	decreased	Adverse_Event	Disease:C0022665		L01BC02	rs1695:GG	5790
methadone	rs6600879	UGT2B7	GG	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs6600879:GG	10090
methadone	rs6600880	UGT2B7	AA	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs6600880:AA	10090
platinum compounds	rs10510050	EIF3A	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs10510050:A	23939
capecitabine	rs67376798	DPYD	AT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01BC06	rs67376798:AT	11809635
thiazides, plain	rs5186	AGTR1	AA	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs5186:AA	No_match
thiazides, plain	rs5186	AGTR1	AC	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs5186:AC	No_match
thiazides, plain	rs4341	ACE	GG	Toxicity	increased	Adverse_Event	Healthy		A03B|C03A	rs4341:GG	No_match
atorvastatin, rifampin	rs4149056	SLCO1B1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA05	rs4149056:TT	60823
capecitabine, fluorouracil	rs895819	MIR27A	C	Toxicity	Indeterminado	Adverse_Event	Disease:C0027651		L01BC02|L01BC06	rs895819:C	60953
atorvastatin	rs2297480	FDPS	TT	Toxicity	increased	Adverse_Event	Disease:C0010068		C10AA05	rs2297480:TT	656846
none	rs3740066	ABCC2	C	Metabolism/PK	Indeterminado	Other	Healthy		A03DA02	rs3740066:C	5282367
cisplatin	rs560018	GSTM4	CC	Efficacy, Toxicity	increased	Efficacy_Response	Healthy		L01XA01	rs560018:CC	441203
atorvastatin	rs11264359	FDPS	AA	Toxicity	increased	Adverse_Event	Disease:C0010068		C10AA05	rs11264359:AA	656846
irinotecan	rs1517114	C8orf34	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01CE02	rs1517114:C	74990
dicloxacillin, probenecid	rs1045642	ABCB1	GG	Other, Metabolism/PK	increased	LADME	Healthy		J01CF01|M04AB01	rs1045642:GG	18381
antipsychotics, clozapine, olanzapine, risperidone	rs1414334	HTR2C	C	Toxicity	increased	Adverse_Event	Disease:C0036337|Disease:C0036341		N05A|N05AH02|N05AH03|N05AX08	rs1414334:C	135398737
ethanol	rs1799971	OPRM1	G	Other	Indeterminado	Adverse_Event	Healthy		V03AB16	rs1799971:G	444899
cyclosporine, dicloxacillin	rs2032582	ABCB1	CC	Other, Metabolism/PK	increased	LADME	Healthy		J01CF01|L04AD01	rs2032582:CC	18381
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	CT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:CT	135483892
ethambutol, isoniazid, pyrazinamide, rifampin	rs2031920	CYP2E1	TT	Toxicity	decreased	Adverse_Event	Other:C0041296		J04AC01|J04AK01|J04AK02	rs2031920:TT	135483892
platinum compounds	rs1690924	MDM2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1690924:CC	23939
methotrexate	rs1051266	SLC19A1	TT	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1051266:TT	11329481
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	13748464
sevoflurane	rs1806201	GRIN2B	AA	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1806201:AA	13529
sevoflurane	rs1806201	GRIN2B	AG	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1806201:AG	13529
clopidogrel	rs28399504	CYP2C19	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs28399504:G	13748464
drugs for obstructive airway diseases	rs1042714	ADRB2	GG	Efficacy	increased	Other	Disease:C0004096		R03	rs1042714:GG	No_match
methotrexate	rs9344	CCND1	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs9344:AA	11329481
risperidone	rs1045642	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs1045642:A	849421
methotrexate	rs1801133	MTHFR	AA	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity	decreased	Adverse_Event	Disease:C0023449		L04AX03	rs1801133:AG	11329481
paclitaxel	rs4880	SOD2	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs4880:AA	36314
mercaptopurine, methotrexate	rs1051266	SLC19A1	CT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:CT	126941
mercaptopurine, methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:TT	126941
methylphenidate	rs2032582	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs2032582:AA	154100
docetaxel	rs13181	ERCC2	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs13181:TT	154272
cyclosporine, tacrolimus	rs8450	CRTC2	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD01|L04AD02	rs8450:AA	445643
docetaxel	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs11615:AA	154272
clopidogrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:T	13748464
metformin	rs2683511	SP1	C	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs2683511:C	155906370
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT	54742534
nicotine	rs16969968	CHRNA3, CHRNA5	A	Toxicity	increased	Adverse_Event	Healthy		N07BA01	rs16969968:A	936
metformin	rs10747673	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs10747673:G	155906370
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs4244285:AG	13748464
metformin	rs10747673	__INTRONIC__	G	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs10747673:G	155906370
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT	54742534
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L04AX03	rs1051266:TT	11329481
clopidogrel	rs12913988	ATP10A	AA	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12913988:AA	13748464
clopidogrel	rs12913988	ATP10A	AG	Efficacy	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12913988:AG	13748464
platinum compounds	rs4752220	EIF3A	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4752220:A	23939
chop, rituximab	rs1883112	NCF4	AG	Toxicity	decreased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:AG	No_match
chop, rituximab	rs1883112	NCF4	GG	Toxicity	decreased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		L01FA01	rs1883112:GG	No_match
clopidogrel	rs1057910	CYP2C9	AC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:AC	13748464
clopidogrel	rs1057910	CYP2C9	CC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:CC	13748464
platinum compounds	rs1409314	EIF3A	A	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs1409314:A	23939
platinum compounds	rs4752219	EIF3A	C	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs4752219:C	23939
clopidogrel	rs1057910	CYP2C9	AC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:AC	13748464
clopidogrel	rs1057910	CYP2C9	CC	Efficacy	increased	Adverse_Event	Disease:C0007222		B01AC04	rs1057910:CC	13748464
mercaptopurine, methotrexate	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1695:GG	126941
clozapine	rs3813929	HTR2C	T	Toxicity	decreased	Adverse_Event	Disease:C0036341		N05AH02	rs3813929:T	131769989
acenocoumarol	rs1045642	ABCB1	GG	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1045642:GG	54742534
acenocoumarol	rs1045642	ABCB1	GT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs1045642:GT	54742534
risperidone	rs2032582	ABCB1	A	Toxicity	increased	Adverse_Event	Disease:C0036341		N05AX08	rs2032582:A	849421
methotrexate	rs1051266	SLC19A1	TT	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1051266:TT	11329481
sevoflurane	rs1275988	KCNK3	CT	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1275988:CT	13529
sevoflurane	rs1275988	KCNK3	TT	Other	increased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1275988:TT	13529
leucovorin, mercaptopurine, methotrexate	rs1051266	SLC19A1	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:CC	135403648
leucovorin, mercaptopurine, methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:TT	135403648
docetaxel	rs2740574	CYP3A4	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs2740574:CC	154272
docetaxel	rs2740574	CYP3A4	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs2740574:CT	154272
metformin	rs784888	SP1	G	Efficacy	decreased	Adverse_Event	Disease:C0011849		A10BA02	rs784888:G	155906370
platinum compounds	rs1805087	MTR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1805087:AA	23939
platinum compounds	rs1805087	MTR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1805087:AG	23939
sevoflurane	rs279858	GABRA2	CC	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs279858:CC	13529
sevoflurane	rs279858	GABRA2	CT	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs279858:CT	13529
leucovorin, mercaptopurine, methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Adverse_Event	Disease:C0023449		L01BB02|L04AX03	rs1051266:TT	135403648
acenocoumarol	rs9923231	VKORC1	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9923231:TT	54742534
platinum compounds	rs7091672	EIF3A	T	Toxicity	increased	Adverse_Event	Disease:C0007131		L01XA	rs7091672:T	23939
paclitaxel	rs1113129	CYP2C8	CG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1113129:CG	36314
paclitaxel	rs1113129	CYP2C8	GG	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1113129:GG	36314
metformin	rs149711321	PPARA	T	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs149711321:T	155906370
acenocoumarol	rs2108622	CYP4F2	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AA07	rs2108622:CT	54742534
acenocoumarol	rs2108622	CYP4F2	TT	Toxicity	decreased	Adverse_Event	Healthy		B01AA07	rs2108622:TT	54742534
platinum compounds	rs1051266	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1051266:TT	23939
paclitaxel	rs1934951	CYP2C8	CT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1934951:CT	36314
paclitaxel	rs1934951	CYP2C8	TT	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs1934951:TT	36314
lenalidomide	rs699947	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Other:C0334634		L04AX04	rs699947:AA	165412089
metformin	rs2683511	SP1	C	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2683511:C	155906370
sevoflurane	rs1801394	FASTKD3, MTRR	AG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:AG	13529
sevoflurane	rs1801394	FASTKD3, MTRR	GG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs1801394:GG	13529
clopidogrel	rs28399504	CYP2C19	G	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs28399504:G	13748464
bupropion, nicotine	rs2168631	DRD1	A	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs2168631:A	89594
simvastatin	rs17238540	HMGCR	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs17238540:TT	14373154
none	rs9324918	NR3C1	C	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs9324918:C	5282367
clopidogrel	rs4986893	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4986893:A	13748464
sevoflurane	rs2307116	FASTKD3, MTRR	AA	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AA	13529
sevoflurane	rs2307116	FASTKD3, MTRR	AG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2307116:AG	13529
paclitaxel	rs3212986	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs3212986:AA	36314
paclitaxel	rs3212986	ERCC1	AC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD01	rs3212986:AC	36314
morphine	rs1978153	ABCC3	C	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs1978153:C	5284371
clopidogrel	rs12248560	CYP2C19	T	Toxicity	increased	Adverse_Event	Disease:C1956346		B01AC04	rs12248560:T	13748464
bupropion, nicotine	rs11749035	DRD1	T	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs11749035:T	89594
clopidogrel	rs12248560	CYP2C19	T	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:T	13748464
pazopanib, sunitinib	rs1126647	CXCL8	T	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01|L01EX03	rs1126647:T	10113978
none	rs2963155	NR3C1	G	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs2963155:G	5282367
morphine	rs733392	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs733392:G	5284371
methadone	rs6600893	UGT2B7	CC	Efficacy, Metabolism/PK	increased	Adverse_Event	Disease:Opioid-Related_Disorders		N07BC02	rs6600893:CC	10090
fentanyl	rs6853	MYD88	G	Toxicity	decreased	Adverse_Event	Disease:C0027651		N02AB03	rs6853:G	13653606
methotrexate, prednisone	rs1051266	SLC19A1	TT	Efficacy	increased	Adverse_Event	Disease:C0003873		H02AB07|L04AX03	rs1051266:TT	5865
bupropion, nicotine	rs11746641	DRD1	G	Efficacy	increased	Adverse_Event	Disease:C0039338		N06AX12|N07BA01	rs11746641:G	89594
none	rs33389	NR3C1	T	Other	increased	Adverse_Event	Disease:C0002895		A03DA02	rs33389:T	5282367
spironolactone	rs4343	ACE	AA	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs4343:AA	169502192
spironolactone	rs4343	ACE	AG	Efficacy	Indeterminado	Efficacy_Response	Other:C0745744		C03DA01	rs4343:AG	169502192
simvastatin	rs17244841	HMGCR	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs17244841:AA	14373154
docetaxel	rs3212986	ERCC1	CC	Toxicity	increased	Adverse_Event	Disease:C1458155		L01CD02	rs3212986:CC	154272
sevoflurane	rs3813867	CYP2E1	CC	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs3813867:CC	13529
sevoflurane	rs3813867	CYP2E1	CG	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs3813867:CG	13529
cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine	rs3957357	GSTA1	AA	Efficacy	increased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		H02AB07|L01AA01|L01CA02|L01DB01|L01FA01	rs3957357:AA	2907
cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine	rs3957357	GSTA1	AG	Efficacy	increased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		H02AB07|L01AA01|L01CA02|L01DB01|L01FA01	rs3957357:AG	2907
sevoflurane	rs2031920	CYP2E1, DUX1	CT	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2031920:CT	13529
sevoflurane	rs2031920	CYP2E1, DUX1	TT	Other	decreased	Other	Other:otorhinolaryngology_surgery		N01AB08	rs2031920:TT	13529
antihypertensives, diuretics	rs2070744	NOS3	CC	Efficacy	increased	Adverse_Event	Disease:C0020538		C02|C03	rs2070744:CC	No_match
cyclophosphamide, doxorubicin, prednisone, rituximab, vincristine	rs4673	CYBA	AA	Efficacy	decreased	Adverse_Event	Disease:C0024299|Large_B-Cell|Diffuse		H02AB07|L01AA01|L01CA02|L01DB01|L01FA01	rs4673:AA	2907
ibuprofen	rs20417	PTGS2	CG	Efficacy	increased	Efficacy_Response	Healthy		M02AA13	rs20417:CG	53464135
ibuprofen	rs20417	PTGS2	GG	Efficacy	increased	Efficacy_Response	Healthy		M02AA13	rs20417:GG	53464135
diflomotecan	rs2231142	ABCG2	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs2231142:T	No_match
cyclosporine	rs2032582	ABCB1	AA	Efficacy	increased	Adverse_Event	Disease:C0009324		L04AD01	rs2032582:AA	86666680
cyclosporine, tacrolimus	rs8450	CRTC2	AA	Toxicity	increased	Adverse_Event	Disease:C0277631		L04AD01|L04AD02	rs8450:AA	445643
rofecoxib	rs20417	PTGS2	CC	Efficacy	increased	Efficacy_Response	Healthy		M01AH02	rs20417:CC	5090
fentanyl, morphine, opioids, oxycodone	rs2884129	__INTRONIC__	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs2884129:G	5288826
hmg coa reductase inhibitors	rs13210472	__INTRONIC__	C	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs13210472:C	445127
fentanyl, morphine, opioids, oxycodone	rs7104613	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs7104613:T	5288826
pazopanib, sunitinib	rs4073	CXCL8	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01|L01EX03	rs4073:A	10113978
bleomycin, cisplatin, etoposide	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1695:GG	5360373
fentanyl, morphine, opioids, oxycodone	rs10413396	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027651		N02A|N02AA01|N02AA05|N02AB03	rs10413396:T	5288826
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:A	13748464
methotrexate	rs9344	CCND1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs9344:AA	11329481
bleomycin, cisplatin, etoposide	rs3212986	ERCC1	AC	Toxicity	decreased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs3212986:AC	5360373
bleomycin, cisplatin, etoposide	rs3212986	ERCC1	CC	Toxicity	decreased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs3212986:CC	5360373
aspirin	rs10306114	PTGS1	AA	Efficacy	increased	Adverse_Event	Other:C0007785		No_ATC	rs10306114:AA	72204814
aspirin	rs10306114	PTGS1	AG	Efficacy	increased	Adverse_Event	Other:C0007785		No_ATC	rs10306114:AG	72204814
fluorouracil	rs67376798	DPYD	A	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02	rs67376798:A	5790
anthracyclines and related substances	rs2032582	ABCB1	CC	Efficacy	increased	Adverse_Event	Disease:C1458155		L01DB	rs2032582:CC	No_match
cyclosporine, tacrolimus	rs8450	CRTC2	AA	Toxicity	increased	Adverse_Event	Disease:C0277631		L04AD01|L04AD02	rs8450:AA	445643
cyclosporine, tacrolimus	rs8450	CRTC2	AG	Toxicity	increased	Adverse_Event	Disease:C0277631		L04AD01|L04AD02	rs8450:AG	445643
clopidogrel	rs4244285	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs4244285:A	13748464
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Efficacy_Response	Disease:C0004238		B01AA07	rs9923231:TT	54742534
fluorouracil	rs1801160	DPYD	T	Toxicity	increased	Adverse_Event	Disease:C0024121|Disease:C0023055		L01BC02	rs1801160:T	5790
clopidogrel	rs4244285	CYP2C19	A	Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
morphine	rs886493	ABCC3	G	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs886493:G	5284371
bleomycin, cisplatin, etoposide	rs1045642	ABCB1	AA	Toxicity	increased	Adverse_Event	Disease:C0039591		L01CB01|L01DC01|L01XA01	rs1045642:AA	5360373
morphine	rs7216383	ABCC3	T	Toxicity	increased	Adverse_Event	Disease:C0037315|Disease:tonsillectomy		N02AA01	rs7216383:T	5284371
methotrexate	rs1045642	ABCB1	A	Toxicity	decreased	Adverse_Event	Other:C0023449		L04AX03	rs1045642:A	11329481
ethanol	rs10516440	__INTRONIC__	A	Toxicity	decreased	Adverse_Event	Healthy		V03AB16	rs10516440:A	444899
tramadol	rs1045642	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0016658|Bone		N02AX02	rs1045642:A	63013
citalopram	rs12248560	CYP2C19	TT	Metabolism/PK	decreased	LADME	Healthy		N06AB04	rs12248560:TT	162180
tramadol	rs2032582	ABCB1	A	Efficacy	increased	Adverse_Event	Disease:C0016658|Bone		N02AX02	rs2032582:A	63013
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Toxicity	decreased	Adverse_Event	Disease:C0019372		J05AP01|L03AB10	rs1127354:A	37542
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Toxicity	increased	Adverse_Event	Disease:C0027051		B01AC04	rs4244285:A	13748464
methotrexate	rs17222723	ABCC2	A	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs17222723:A	11329481
risperidone	rs887829	UGT1A1	CT	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs887829:CT	849421
fluoxetine	rs242941	CRHR1	CC	Efficacy	increased	Efficacy_Response	Other:C0338908		N06AB03	rs242941:CC	1548968
risperidone	rs10929302	UGT1A1	AG	Toxicity	increased	Adverse_Event	Disease:C1510586		N05AX08	rs10929302:AG	849421
sarilumab	rs11265618	IL6R	CC	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs11265618:CC	No_match
cisplatin	rs1799793	ERCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs1799793:CT	441203
cisplatin	rs1799793	ERCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs1799793:TT	441203
cisplatin	rs1138272	GSTP1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs1138272:CT	441203
cisplatin	rs1138272	GSTP1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs1138272:TT	441203
sarilumab	rs4845625	IL6R	TT	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs4845625:TT	No_match
vitamin k antagonists	rs2108622	CYP4F2	TT	Efficacy	increased	Adverse_Event	Disease:C0004238		B01AA	rs2108622:TT	5280483
risperidone	rs6318	HTR2C	GG	Toxicity	increased	Adverse_Event	Disease:C0004352		N05AX08	rs6318:GG	849421
warfarin	rs1205	CRP	CT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1205:CT	54688261
warfarin	rs1205	CRP	TT	Toxicity	increased	Adverse_Event	Healthy		B01AA03	rs1205:TT	54688261
hydrochlorothiazide	rs4132670	TCF7L2	A	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs4132670:A	2904
hydrochlorothiazide	rs7917983	TCF7L2	T	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs7917983:T	2904
atorvastatin, cerivastatin, fluvastatin, pravastatin, rosuvastatin, simvastatin	rs17238540	HMGCR	GT	Efficacy	decreased	Adverse_Event	Disease:C0011849		C10AA01|C10AA03|C10AA04|C10AA05|C10AA06|C10AA07	rs17238540:GT	60823
hydrochlorothiazide	rs4506565	TCF7L2	T	Toxicity	increased	Adverse_Event	Disease:C0020538		C03AA03	rs4506565:T	2904
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	increased	Adverse_Event	Other:C0018839		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	increased	Adverse_Event	Other:C0018839		B01AC04	rs4244285:AG	13748464
citalopram	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Healthy		N06AB04	rs4244285:AA	162180
lenalidomide	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Other:C0334634		L04AX04	rs2032582:CC	165412089
fluorouracil, leucovorin, oxaliplatin	rs25487	XRCC1	CC	Other	Indeterminado	Other	Disease:C0024121		L01BC02|L01XA03	rs25487:CC	135403648
docetaxel, thalidomide	rs4148950	CHST3	A	Toxicity	increased	Adverse_Event	Disease:C0033578		L01CD02|L04AX02	rs4148950:A	148124
irinotecan	rs3832043	UGT1A9	T/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:T/del	74990
irinotecan	rs3832043	UGT1A9	del/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:del/del	74990
buprenorphine, fentanyl, tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AA	644073
sarilumab	rs4537545	IL6R	CC	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs4537545:CC	No_match
calcium, etidronic acid	rs1544410	VDR	TT	Efficacy	increased	Efficacy_Response	Disease:C0029456|Postmenopausal		A12AA|M05BA01	rs1544410:TT	5460341
sarilumab	rs2228145	IL6R	AA	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs2228145:AA	No_match
buprenorphine, fentanyl, tramadol	rs2234918	OPRD1	CT	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs2234918:CT	644073
valproic acid	rs4880	SOD2	AA	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs4880:AA	134459
valproic acid	rs4880	SOD2	AG	Toxicity	decreased	Adverse_Event	Disease:C0014544		N03AG01	rs4880:AG	134459
sarilumab	rs4329505	IL6R	TT	Efficacy	increased	Adverse_Event	Other:C0003873		L04AC14	rs4329505:TT	No_match
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
buprenorphine, fentanyl, tramadol	rs1045280	ARRB2	TT	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1045280:TT	644073
peginterferon alfa-2a, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4273729:GG	37542
bisphosphonates	rs1934951	CYP2C8	TT	Toxicity	increased	Adverse_Event	Disease:Multiple_Myeloma		M05BA	rs1934951:TT	No_match
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AG	644073
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	GG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:GG	644073
buprenorphine, fentanyl, tramadol	rs4680	COMT	AG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AG	644073
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA	37542
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AA	644073
buprenorphine, fentanyl, tramadol	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AA	644073
buprenorphine, fentanyl, tramadol	rs4680	COMT	GG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:GG	644073
none	rs12979860	IFNL3, IFNL4	CC	Other	increased	Adverse_Event	Disease:C0019372		A03DA02	rs12979860:CC	5282367
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AA	644073
fluorouracil, leucovorin, oxaliplatin	rs717620	ABCC2	CC	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs717620:CC	135403648
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AA	644073
buprenorphine, fentanyl, tramadol	rs1799971	OPRM1	AG	Toxicity	increased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs1799971:AG	644073
lenalidomide	rs1705814	CRBN	CC	Dosage, Toxicity	increased	Adverse_Event	Other:C0334634		L04AX04	rs1705814:CC	165412089
buprenorphine, fentanyl, tramadol	rs4680	COMT	AG	Toxicity	decreased	Adverse_Event	Other:Opioid-Related_Disorders		N02AB03|N02AX02|N07BC01	rs4680:AG	644073
fluorouracil, leucovorin, oxaliplatin	rs11615	ERCC1	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs11615:AA	135403648
fluorouracil, leucovorin, oxaliplatin	rs25487	XRCC1	CC	Toxicity	decreased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs25487:CC	135403648
rifampicin	rs2472677	NR1I2	T	Other, Metabolism/PK	decreased	LADME	Healthy		J04AB02	rs2472677:T	135542225
carbamazepine, lamotrigine, oxcarbazepine, phenytoin, topiramate	rs2304016	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AB02|N03AF01|N03AF02|N03AX09|N03AX11	rs2304016:A	1775
capecitabine, oxaliplatin	rs5275	PTGS2	AA	Efficacy	increased	Other	Disease:C0023055		L01BC06|L01XA03	rs5275:AA	9887054
hmg coa reductase inhibitors	rs708272	CETP	A	Efficacy	decreased	Adverse_Event	Disease:C1956346		C10AA	rs708272:A	445127
diuretics	rs4961	ADD1	GT	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03	rs4961:GT	No_match
diuretics	rs4961	ADD1	TT	Efficacy	decreased	Adverse_Event	Disease:C0020538		C03	rs4961:TT	No_match
warfarin	rs9923231	VKORC1	CT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	Indeterminado	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
ethanol	rs1076560	DRD2	A	Other	increased	Adverse_Event	Healthy		V03AB16	rs1076560:A	444899
clopidogrel	rs2046934	P2RY12	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2046934:AG	13748464
clopidogrel	rs2046934	P2RY12	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2046934:GG	13748464
methotrexate	rs717620	ABCC2	CT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:CT	11329481
methotrexate	rs717620	ABCC2	TT	Toxicity	increased	Adverse_Event	Other:C0023449		L04AX03	rs717620:TT	11329481
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:GT	2904
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:TT	2904
fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	AA	Toxicity	increased	Adverse_Event	Disease:C0024121		L01BC02|L01XA03	rs1801133:AA	135403648
bromperidol, nemonapride	rs1799732	DRD2	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs1799732:GG	156333
thiazides, plain	rs13306673	SLC12A3	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		A03B|C03A	rs13306673:CC	No_match
valproic acid	rs3789243	ABCB1	GG	Efficacy	decreased	Adverse_Event	Other:C0014544		N03AG01	rs3789243:GG	134459
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
azathioprine	rs1127354	ITPA	AC	Toxicity	increased	Adverse_Event	Disease:C0021390		L04AX01	rs1127354:AC	5778
valproic acid	rs3789243	ABCB1	GG	Efficacy	increased	Adverse_Event	Other:C0014544		N03AG01	rs3789243:GG	134459
atorvastatin, rosuvastatin	rs776746	CYP3A5	CC	Toxicity	increased	Adverse_Event	Disease:C0011849|Disease:C0020473|Disease:C0020538|Disease:C0028754		C10AA05|C10AA07	rs776746:CC	60823
methotrexate	rs4149056	SLCO1B1	CC	Efficacy	decreased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Efficacy	decreased	Adverse_Event	Other:C0023449		L04AX03	rs4149056:CT	11329481
thiazides, plain	rs4994	ADRB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		A03B|C03A	rs4994:AA	No_match
trastuzumab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs1801274:AA	166596981
irinotecan	rs3832043	UGT1A9	T/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:T/del	74990
irinotecan	rs3832043	UGT1A9	del/del	Toxicity	increased	Adverse_Event	Other:C0026640		L01CE02	rs3832043:del/del	74990
asparaginase	rs199695765	CPA2	T	Toxicity	increased	Adverse_Event	Disease:C0023449		L01XX02	rs199695765:T	6267
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA	37542
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA	37542
dapsone	rs701829	HLA-DRB1	T	Toxicity	increased	Adverse_Event	Healthy		J04BA02	rs701829:T	2955
tacrolimus	rs1057868	POR	CT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT	131769926
warfarin	rs1042580	THBD	CC	Toxicity	decreased	Adverse_Event	Healthy		B01AA03	rs1042580:CC	54688261
warfarin	rs1042580	THBD	CT	Toxicity	decreased	Adverse_Event	Healthy		B01AA03	rs1042580:CT	54688261
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3, IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT	37542
methylphenidate	rs3815583	CES1	AC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs3815583:AC	154100
methylphenidate	rs3815583	CES1	CC	Toxicity	increased	Adverse_Event	Disease:C1263846		N06BA04	rs3815583:CC	154100
ace inhibitors, plain	rs8012552	BDKRB2	C	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C09A	rs8012552:C	No_match
corticosteroids	rs724710	BCL2L11	CC	Toxicity	increased	Adverse_Event	Disease:C0023449		S02BA	rs724710:CC	No_match
ace inhibitors, plain	rs2016848	MME	A	Toxicity	increased	Adverse_Event	Disease:C0020538		A03B|C09A	rs2016848:A	No_match
irinotecan	rs2233678	PIN1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01CE02	rs2233678:CC	74990
irinotecan	rs2233678	PIN1	CG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01CE02	rs2233678:CG	74990
peginterferon alfa-2a, ribavirin	rs4273729	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4273729:GG	37542
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C03AA03	rs4961:GT	2904
acenocoumarol	rs9934438	VKORC1	AA	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AA	54742534
acenocoumarol	rs9934438	VKORC1	AG	Toxicity	increased	Adverse_Event	Healthy		B01AA07	rs9934438:AG	54742534
aspirin	rs4291	ACE	AT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4291:AT	72204814
aspirin	rs4291	ACE	TT	Toxicity	increased	Adverse_Event	Disease:C0004096		No_ATC	rs4291:TT	72204814
mycophenolate mofetil(mycophenolic acid)	rs11572103	CYP2C8	A	Toxicity	increased	Adverse_Event	Healthy		L04AA06	rs11572103:A	5281078
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:GT	2904
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4961:TT	2904
mycophenolate mofetil(mycophenolic acid)	rs11572076	CYP2C8	T	Toxicity	increased	Adverse_Event	Healthy		L04AA06	rs11572076:T	5281078
ace inhibitors, plain	rs11209716	PTGER3	C	Toxicity	decreased	Adverse_Event	Disease:C0020538		A03B|C09A	rs11209716:C	No_match
mycophenolate mofetil(mycophenolic acid)	rs1056663	HUS1	T	Toxicity	decreased	Adverse_Event	Healthy		L04AA06	rs1056663:T	5281078
dapsone	rs17211071	HLA-DRB1	A	Toxicity	increased	Adverse_Event	Healthy		J04BA02	rs17211071:A	2955
tacrolimus	rs4253728	PPARA	AA	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs4253728:AA	131769926
tacrolimus	rs4253728	PPARA	AG	Toxicity	increased	Adverse_Event	Disease:Kidney_Transplantation		L04AD02	rs4253728:AG	131769926
mycophenolate mofetil(mycophenolic acid)	rs2037483	HUS1	A	Toxicity	decreased	Adverse_Event	Healthy		L04AA06	rs2037483:A	5281078
none	rs4961	ADD1	GT	Other	increased	Adverse_Event	Healthy		A03DA02	rs4961:GT	5282367
none	rs4961	ADD1	TT	Other	increased	Adverse_Event	Healthy		A03DA02	rs4961:TT	5282367
fluorouracil	rs2032582	ABCB1	C	Toxicity	decreased	Adverse_Event	Other:C0023055		L01BC02	rs2032582:C	5790
fluorouracil	rs2306283	SLCO1B1	A	Toxicity	increased	Adverse_Event	Other:C0023055		L01BC02	rs2306283:A	5790
none	rs2781666	ARG1	TT	Other	increased	Adverse_Event	Healthy		A03DA02	rs2781666:TT	5282367
tacrolimus	rs2740574	CYP3A4	TT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2740574:TT	131769926
epirubicin	rs246221	ABCC1	CT	Toxicity	increased	Adverse_Event	Other:C1458155		L01DB03	rs246221:CT	65348
levodopa	rs4680	COMT	AA	Toxicity	increased	Adverse_Event	Other:C0030567		N04BA02	rs4680:AA	9307
methotrexate	rs1051266	SLC19A1	TT	Toxicity	increased	Adverse_Event	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1051266:TT	11329481
daunorubicin, doxorubicin	rs8187710	ABCC2	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs8187710:A	31703
folfox	DPYD c.1129-5923C>G, c.1236G>A (HapB3)	DPYD	c.1129-5923C>G, c.1236G>A (HapB3)	Efficacy	decreased	Adverse_Event	Other:C0022665		No_ATC	c.1129-5923C>G, c.1236G>A (HapB3)	135403647
daunorubicin, doxorubicin	rs1799945	HFE	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs1799945:G	31703
daunorubicin, doxorubicin	rs12468485	GPR35	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs12468485:T	31703
daunorubicin, doxorubicin	rs17863783	UGT1A6	T	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs17863783:T	31703
daunorubicin, doxorubicin	rs2180314	GSTA2	G	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs2180314:G	31703
daunorubicin, doxorubicin	rs79338777	ETFB	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs79338777:A	31703
daunorubicin, doxorubicin	rs17583889	HNMT	A	Toxicity	increased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs17583889:A	31703
daunorubicin, doxorubicin	rs7627754	ABCC5	AA	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs7627754:AA	31703
daunorubicin, doxorubicin	rs7627754	ABCC5	AT	Toxicity	decreased	Adverse_Event	Other:C0027651		L01DB01|L01DB02	rs7627754:AT	31703
cefazolin, cefdinir, ceftriaxone, cefuroxime, cephalexin	HLA-A*02:01	HLA-A	*02:01	Toxicity	increased	Adverse_Event	Healthy		J01DB04|J01DD04|J01DD15|S01AA27	*02:01	27447
tacrolimus	rs3745274	CYP2B6	GT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs3745274:GT	131769926
corticosteroids	rs73175102	WNT7B	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs73175102:A	No_match
corticosteroids	rs115587273	POGK	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs115587273:A	No_match
corticosteroids	rs78233573	FAM240C	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs78233573:A	No_match
corticosteroids	rs376867011	ZNF37A	A	Toxicity	increased	Adverse_Event	Other:C0023418|Other:C0024299		S02BA	rs376867011:A	No_match
codeine, hydrocodone, tramadol	intermediate metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Adverse_Event	Other:C0030193	intermediate metabolizer and poor metabolizer	N02AX02|R05DA03|R05DA04	__UNKNOWN__	5284569
valproic acid	rs758109	ACOT1	T	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs758109:T	134459
tacrolimus	rs2306283	SLCO1B1	AA	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2306283:AA	131769926
tacrolimus	rs2306283	SLCO1B1	AG	Toxicity	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2306283:AG	131769926
azathioprine	rs73430958	MOCOS	GT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs73430958:GT	5778
valproic acid	rs59288687	GABPA	CC	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs59288687:CC	134459
valproic acid	rs10517	NQO1	GG	Toxicity	decreased	Adverse_Event	Other:C0014544		N03AG01	rs10517:GG	134459
valproic acid	rs881740	PPARA	G	Toxicity	increased	Adverse_Event	Other:C0014544		N03AG01	rs881740:G	134459
methotrexate	rs7311358	SLCO1B3	AA	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs7311358:AA	11329481
methotrexate	rs4149117	SLCO1B3	GG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs4149117:GG	11329481
methotrexate	rs2306283	SLCO1B1	AA	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:AA	11329481
methotrexate	rs2306283	SLCO1B1	AG	Toxicity	increased	Adverse_Event	Other:C0003873		L04AX03	rs2306283:AG	11329481
apixaban	rs7412	APOE	C	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF02	rs7412:C	91667715
apixaban	rs429358	APOE	C	Toxicity	increased	Adverse_Event	Other:C0004238		B01AF02	rs429358:C	91667715
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs8099917	IFNL3	GG	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0039338		No_ATC	rs8099917:GG	No_match
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12980275	IFNL3	GG	Toxicity	increased	Adverse_Event	Other:C0024121		No_ATC	rs12980275:GG	No_match
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs12979860	IFNL3	TT	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0039338		No_ATC	rs12979860:TT	No_match
tacrolimus	rs9282564	ABCB1	TT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs9282564:TT	131769926
tacrolimus	rs2273697	ABCC2	GG	Efficacy	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs2273697:GG	131769926
tacrolimus	rs4149056	SLCO1B1	TT	Efficacy	decreased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs4149056:TT	131769926
tacrolimus	rs4244285	CYP2C19	AA	Toxicity	increased	Adverse_Event	Other:Kidney_Transplantation		L04AD02	rs4244285:AA	131769926
azathioprine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs116855232:CT	5778
azathioprine	rs1735053	RRM1	AG	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs1735053:AG	5778
azathioprine	rs1735053	RRM1	GG	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs1735053:GG	5778
azathioprine	rs9465102	TPMT	GT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs9465102:GT	5778
azathioprine	rs9465102	TPMT	TT	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	rs9465102:TT	5778
cisplatin	rs920829	TRPA1	TT	Toxicity	decreased	Adverse_Event	"""Other:C0007097|Squamous_Cell""|""Other:C0007097|""Other:C0001418"		L01XA01	rs920829:TT	441203
folfox, xelox	rs1801265	DPYD	AG	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1801265:AG	9887054
folfox, xelox	rs1801265	DPYD	GG	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1801265:GG	9887054
fluoxetine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy, Toxicity	increased	Adverse_Event	Healthy	poor metabolizer and ultrarapid metabolizer	N06AB03	__UNKNOWN__	1548968
cyclosporine	rs693955	SLC29A1	AA	Efficacy	decreased	Adverse_Event	Other:Hematopoietic_stem_cell_transplantation|Other:C0023418		L04AD01	rs693955:AA	86666680
afatinib, erlotinib, gefitinib	rs2494750	AKT1	CC	Efficacy	increased	Adverse_Event	Other:C0007131		L01EB01|L01EB02|L01EB03	rs2494750:CC	176870
sulfamethoxazole / trimethoprim	HLA-B*44:03	HLA-B	*44:03	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*44:03	5578
sulfamethoxazole / trimethoprim	HLA-B*38:01	HLA-B	*38:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*38:01	5578
sulfamethoxazole / trimethoprim	HLA-C*04:01	HLA-C	*04:01	Toxicity	increased	Adverse_Event	Healthy		J01EE01	*04:01	5578
folfox, xelox	rs1695	GSTP1	GG	Toxicity	decreased	Adverse_Event	Other:C0023055		No_ATC	rs1695:GG	9887054
folfox, xelox	rs11280056	TYMS	TTA/TTA	Toxicity	decreased	Adverse_Event	Other:C0023055		No_ATC	rs11280056:TTA/TTA	9887054
folfox, xelox	rs11280056	TYMS	TTA/TTAAAGTTA	Toxicity	decreased	Adverse_Event	Other:C0023055		No_ATC	rs11280056:TTA/TTAAAGTTA	9887054
folfox, xelox	rs45445694	TYMS	(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs45445694:(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3/(GGCCTGCCTCCGTCCCGCCGCGCCACTT)3	9887054
folfox, xelox	rs1695	GSTP1	GG	Toxicity	increased	Adverse_Event	Other:C0023055		No_ATC	rs1695:GG	9887054
azathioprine	HLA-DQA1*02:01	HLA-DQA1	*02:01	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*02:01	5778
azathioprine	HLA-DRB1*07:01	HLA-DRB1	*07:01	Toxicity	increased	Adverse_Event	Other:C0021390		L04AX01	*07:01	5778
hmg coa reductase inhibitors	rs2231142	ABCG2	T	Toxicity	increased	Adverse_Event	Healthy		C10AA	rs2231142:T	445127
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*1/*4	4543
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*2/*4	4543
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*5	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*2/*5	4543
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*4/*41	4543
amitriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Toxicity	increased	Adverse_Event	Disease:C0011581		N06AA09	*4/*10	4543
omeprazole	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC01	*2/*2	9579578
omeprazole	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC01	*2/*3	9579578
omeprazole	CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	A02BC01	*3/*3	9579578
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3A	5778
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3B	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3B	5778
azathioprine, mercaptopurine	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3C	Toxicity	increased	Adverse_Event	Other:C0021390		L01BB02|L04AX01	*3C	5778
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*4	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*3/*4	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*3/*4	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*3/*5	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*3/*5	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4xN	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*4xN	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*6	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*6	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*5/*41	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*5/*41	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*29	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*29	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*17	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*5/*10	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*5/*10	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*3/*41	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*3/*41	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*9	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*9	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*41	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*41	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*10	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*4/*10	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*5/*17	Toxicity	increased	Adverse_Event	Healthy	intermediate metabolizer and poor metabolizer	N05AX08	*5/*17	849421
codeine, morphine, oxycodone	rs1799971	OPRM1	AA	Toxicity	increased	Adverse_Event	Other:C0027651|Other:C0030193		N02AA01|N02AA05|R05DA04	rs1799971:AA	5284371
folfiri, folfirinox, irinotecan	rs2231142	ABCG2	GT	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs2231142:GT	60838
folfiri, folfirinox, irinotecan	rs2231142	ABCG2	TT	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs2231142:TT	60838
folfiri, folfirinox, irinotecan	rs3785161	CES1P1	AC	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs3785161:AC	60838
folfiri, folfirinox, irinotecan	rs3785161	CES1P1	CC	Toxicity	increased	Adverse_Event	Other:C0024121|Other:C0022665|Other:C0030297		L01CE02	rs3785161:CC	60838
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*28/*28	91668186
sacituzumab govitecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Efficacy	increased	Adverse_Event	Healthy		No_ATC	*28/*28	91668186
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Adverse_Event	Other:C0027051	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Adverse_Event	Other:C0027051	poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Adverse_Event	Other:C0027051	poor metabolizer	B01AC04	*3/*3	13748464
none	rs4820268	TMPRSS6	AG	Other	decreased	Adverse_Event	Other:C0002895|Other:C0274435		A03DA02	rs4820268:AG	5282367
none	rs747302	DRD4	C	Other	increased	Adverse_Event	Healthy		A03DA02	rs747302:C	5282367
dipeptidyl peptidase 4 (dpp-4) inhibitors	HLA-DQB1*03:01	HLA-DQB1	*03:01	Toxicity	increased	Adverse_Event	Healthy		No_ATC	*03:01	No_match
rosuvastatin	rs2231142	ABCG2	GT	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Efficacy, Toxicity	increased	Adverse_Event	Healthy		C10AA07	rs2231142:TT	5282455
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*2	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*1/*2	135413534
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*3	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*1/*3	135413534
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*5	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*1/*5	135413534
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*3/*3	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*3/*3	135413534
valganciclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*3/*5	Toxicity	increased	Adverse_Event	Other:Lung_transplantation		J05AB14	*3/*5	135413534
cefaclor	rs765144578	TPSAB1	T	Toxicity	increased	Adverse_Event	Healthy		J01DC04	rs765144578:T	8663
sitagliptin	rs2909451	DPP4	TT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs2909451:TT	11591741
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
sitagliptin	rs2285676	KCNJ11	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01	rs2285676:GG	11591741
sitagliptin	rs163184	KCNQ1	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs163184:GG	11591741
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*18	64139
sitagliptin	rs4664443	DPP4	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs4664443:GG	11591741
sitagliptin	rs1799853	CYP2C9	TT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs1799853:TT	11591741
sitagliptin	rs3765467	GLP1R	AG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01	rs3765467:AG	11591741
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del	16220172
fluoxetine	intermediate metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0011581	intermediate metabolizer	N06AB03	__UNKNOWN__	1548968
paroxetine	ultrarapid metabolizer	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0011581	ultrarapid metabolizer	N06AB05	__UNKNOWN__	667572
sitagliptin	rs6923761	GLP1R	AA	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01	rs6923761:AA	11591741
exenatide, liraglutide	rs3765467	GLP1R	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01|A10BJ02	rs3765467:GG	45588096
citalopram, fluoxetine, paroxetine, sertraline	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0011581	poor metabolizer	N06AB03|N06AB04|N06AB05|N06AB06	__UNKNOWN__	667572
albiglutide, dulaglutide, glp-1 receptor agonists	rs6923761	GLP1R	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs6923761:A	122173812
exenatide	rs7903146	TCF7L2	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01	rs7903146:CT	45588096
exenatide	rs7903146	TCF7L2	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01	rs7903146:TT	45588096
lansoprazole	CYP2C19*1	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Other:history_of_gastric_bypass_surgery		A02BC03	*1/*1	11985
albiglutide, dulaglutide, glp-1 receptor agonists	rs140226575	ARRB1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs140226575:A	122173812
propafenone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C0018824		C01BC03	*10/*10	184819
propafenone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Efficacy_Response	Disease:C0018824		C01BC03	*10/*10	184819
albiglutide, dulaglutide, glp-1 receptor agonists	rs78979036	ARRB1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs78979036:A	122173812
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	*1/*2xN	10090
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	*2/*2xN	10090
lurbinectedin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		No_ATC	*1/*1	57327016
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*3	131769926
albiglutide, dulaglutide, glp-1 receptor agonists	rs78052828	ARRB1	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs78052828:T	122173812
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Disease:Severe_Cutaneous_Adverse_Reactions		N03AB02	*3	1775
albiglutide, dulaglutide, glp-1 receptor agonists	rs58428187	ARRB1	C	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ04|A10BJ05	rs58428187:C	122173812
raloxifene 6-glucuronide, raloxifene-4-glucuronide	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0029456		G03XC01	*28/*28	10100752
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs8099917:TT	37542
dextromethorphan	CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*41	6603912
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*4	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*5	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*9	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*10	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*10	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*5/*10	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*10/*10	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17	CYP2D6	*10/*17	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*10/*17	63013
aripiprazole	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N05AX12	__UNKNOWN__	10114519
lurbinectedin	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:C0027651		No_ATC	*1/*1	57327016
lurbinectedin	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		No_ATC	*1/*1	57327016
leflunomide	rs705379	PON1	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs705379:GG	54684141
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*4	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*6	63013
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Dosage	decreased	Dosage	Disease:C0023055		L01CE02	*1/*28	74990
irinotecan	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Dosage	decreased	Dosage	Disease:C0023055		L01CE02	*28/*28	74990
dabigatran	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Healthy		B01AE07	*1/*1	169501783
levomethadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC05	*6/*6	22267
antiepileptics	rs2298771	SCN1A	C	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2298771:C	No_match
antiepileptics	rs10167228	SCN1A	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs10167228:T	No_match
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*5	CYP2C9	*1/*5	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*5	54688261
warfarin	CYP2C9*1, CYP2C9*11	CYP2C9	*1/*11	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*11	54688261
methadone	low activity	__INTRONIC__	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	N07BC02		10090
telmisartan	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Metabolism/PK	decreased	LADME	Healthy		C09CA07	*2	67184
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*1/*28	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28	60838
carvedilol	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Metabolism/PK	increased	LADME	Other:C0002962		C07AG02	*28	6322
lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Healthy		R07AX30	rs113993960:del/del	16678941
olanzapine	rs36120609	GSTM3	TCCTC/TCCTC	Metabolism/PK	decreased	LADME	Healthy		N05AH03	rs36120609:TCCTC/TCCTC	74603552
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
olanzapine	rs36120609	GSTM3	TCCTC/TCCTC	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs36120609:TCCTC/TCCTC	74603552
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*17/*17	6603912
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*29/*29	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*29/*29	6603912
liraglutide	rs1049353	CNR1	CT	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs1049353:CT	16134956
liraglutide	rs1049353	CNR1	TT	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0028754"		A10BJ02	rs1049353:TT	16134956
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	decreased	LADME	Healthy		M04AA01	*58:01	168354693
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08		5324346
clonidine	rs11269124	ADRA2C	GGGGAGCTTTCCCAGAGACCC/del	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs11269124:GGGGAGCTTTCCCAGAGACCC/del	20255880
clonidine	rs11269124	ADRA2C	del/del	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs11269124:del/del	20255880
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10	6603912
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*1/*10	6603912
dextromethorphan	CYP2D6*1, CYP2D6*10, CYP2D6*14	CYP2D6	*14	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*14	6603912
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs4149056:CC	25221209
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs4149056:CT	25221209
dextromethorphan	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA09	__UNKNOWN__	6603912
simvastatin acid	rs2306283	SLCO1B1	AG	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs2306283:AG	25221209
simvastatin acid	rs2306283	SLCO1B1	GG	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0242339		C10AA01	rs2306283:GG	25221209
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*3/*4	6603912
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4/*4	6603912
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4/*5	6603912
aspirin	rs1371097	P2RY1	T	Efficacy	decreased	Efficacy_Response	Other:C0018839		No_ATC	rs1371097:T	72204814
aspirin	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:C0018839		No_ATC	rs1045642:GG	72204814
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28	Metabolism/PK	increased	LADME	Other:C0024121		L01CE02	*28	60838
dextromethorphan	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA09	__UNKNOWN__	6603912
ribavirin, sofosbuvir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP01|J05AP08	rs11322783:TT/TT	37542
rifampicin	rs4149032	SLCO1B1	TT	Metabolism/PK	increased	LADME	Other:C0041296		J04AB02	rs4149032:TT	135542225
modafinil	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Other:Methamphetamine_dependence		N06BA07	rs4680:GG	6460146
isoniazid	rs1495741	__INTRONIC__	AA	Metabolism/PK	increased	LADME	Other:C0041296		J04AC01	rs1495741:AA	135483892
valsartan	rs699	AGT	GG	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA03	rs699:GG	9911647
meloxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*1/*3	12438
naltrexone	rs1799971	OPRM1	G	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB04	rs1799971:G	5360515
ivacaftor	rs113993960	CFTR	del	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs113993960:del	72722243
ivacaftor	rs113993960	CFTR	del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs113993960:del	72722243
elexacaftor	deficiency	CFTR	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0156318	deficiency	No_ATC		134587348
atorvastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA05	*15	656846
remifentanil	rs1800544	ADRA2A	CG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1800544:CG	60815
remifentanil	rs1800544	ADRA2A	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1800544:GG	60815
warfarin	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Dosage	increased	Dosage	Other:C0040038		B01AA03	*1/*28	54688261
warfarin	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Dosage	increased	Dosage	Other:C0040038		B01AA03	*28/*28	54688261
remifentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1799971:AG	60815
remifentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH06	rs1799971:GG	60815
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	*1/*3	131769926
posaconazole, tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		J02AC04|L04AD02	rs1045642:GG	468595
tacrolimus	CYP3A5*1, CYP3A5*6	CYP3A5	*6	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3	131769926
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*2	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*3	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*3/*3	156613579
tacrolimus	CYP3A5*1, CYP3A5*7	CYP3A5	*7	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*1/*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*2/*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB06	*3/*3	18642483
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*1/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*17	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*2/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0011581	intermediate metabolizer and poor metabolizer	N06AB10	*3/*3	162180
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Organ_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Organ_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0009324		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0009324		L04AD02	*1/*3	131769926
coumarin	CYP2A6*1, CYP2A6*4, CYP2A6*10	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*4/*4	182049
coumarin	CYP2A6*1, CYP2A6*4, CYP2A6*10	CYP2A6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*4/*10	182049
nicotine	CYP2A6*1, CYP2A6*2	CYP2A6	*1/*2	Dosage	decreased	Dosage	Disease:C0039338		N07BA01	*1/*2	936
nicotine	CYP2A6*1, CYP2A6*2	CYP2A6	*2/*2	Dosage	decreased	Dosage	Disease:C0039338		N07BA01	*2/*2	936
moxifloxacin	UGT1A1*1, UGT1A1*28, UGT1A1*36, UGT1A1*37	UGT1A1	*1/*36	Metabolism/PK	decreased	LADME	Disease:C0041296		S01AE07	*1/*36	9890250
dextromethorphan	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	poor metabolizer	R05DA09	__UNKNOWN__	6603912
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*46/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46/*46	936
buprenorphine	rs149319538	SLC39A10	C	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs149319538:C	11274356
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*1/*3	54688261
simvastatin, warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03|C10AA01	*3	54454
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4/*4	6603912
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*6/*6	6603912
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*3/*4	6603912
dextromethorphan	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*7	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*3/*3	6603912
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C0004238		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
dextromethorphan	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*4	6603912
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*1	Metabolism/PK	decreased	LADME	Disease:C1458155	normal metabolizer	L02BG04	*1/*1	10466550
dextromethorphan	CYP2D6*1, CYP2D6*2	CYP2D6	*1/*2	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*1/*2	6603912
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Other:Heart_valve_replacement|Other:C0004238|Other:C0018839|Other:C0034065|Other:C0042487		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Other:Heart_valve_replacement|Other:C0004238|Other:C0018839|Other:C0034065|Other:C0042487		B01AA03	*3	54688261
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Other:Heart_valve_replacement|Other:C0004238|Other:C0018839|Other:C0034065|Other:C0042487		B01AA03	rs9923231:T	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
rivaroxaban	rs4148738	ABCB1	CC	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4148738:CC	10700
rivaroxaban	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs1128503:AA	10700
diazepam	poor metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05BA01	__UNKNOWN__	3016
methotrexate	rs2853542	TYMS	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2853542:GG	11329481
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A	1268107
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*2	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3A	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3C	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*9	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*9	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*21	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*21	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*33	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*33	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34	TPMT	*1/*34	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*34	2723601
methotrexate	rs4673993	ATIC	TT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:TT	11329481
fluoxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Efficacy:C0011581		N06AB03	rs6295:GG	1548968
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*4/*4	849421
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*4/*5	849421
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*3	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*4/*3	849421
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*5	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*5/*5	849421
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*6/*6	Efficacy	increased	Adverse_Event	Other:C0036341|Other:C0036337|Other:C0005586|Other:C0011581	poor metabolizer	N05AX08	*6/*6	849421
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*60	UGT1A1	*6/*60	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*6/*60	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*60	UGT1A1	*6/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*6/*28	60838
dihydropyridine derivatives	rs10898815	NUMA1	AA	Other	increased	Adverse_Event	Healthy		C08CA	rs10898815:AA	No_match
dihydropyridine derivatives	rs10898815	NUMA1	AG	Other	increased	Adverse_Event	Healthy		C08CA	rs10898815:AG	No_match
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs2108622:CC	54688261
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1	11985
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	*1/*3	131769926
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*17	9741
sulfonamides, urea derivatives	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Other:C0011849	poor metabolizer	S01AB	*2/*2	1176
sulfonamides, urea derivatives	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Other:C0011849	poor metabolizer	S01AB	*2/*3	1176
sulfonamides, urea derivatives	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Other:C0011849	poor metabolizer	S01AB	*3/*3	1176
corticosteroids	rs10482634	NR3C1	GG	Efficacy	increased	Efficacy_Response	Other:C0027726		S02BA	rs10482634:GG	No_match
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*10, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Heart_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Heart_transplantation		L04AD02	*1/*3	131769926
valproic acid	rs6759892	UGT1A6	TT	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs6759892:TT	134459
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*46/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46/*46	936
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
methylphenidate	rs2251214	SYT1	AA	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs2251214:AA	154100
methylphenidate	rs2251214	SYT1	AG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs2251214:AG	154100
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	J02AC03	*1/*17	9741
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2	9741
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
chop, rituximab	rs8133052	CBR3	AA	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8133052:AA	No_match
chop, rituximab	rs8133052	CBR3	AG	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8133052:AG	No_match
chop, rituximab	rs8187710	ABCC2	AA	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8187710:AA	No_match
chop, rituximab	rs8187710	ABCC2	AG	Efficacy	decreased	Efficacy_Response	Other:C0024299		L01FA01	rs8187710:AG	No_match
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*1/*11	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*11	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*2/*11	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2/*11	54688261
n-desmethyltamoxifen	rs11914200	SEPTIN3	AG	Metabolism/PK	decreased	LADME	Healthy		L02BA01	rs11914200:AG	10474509
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0027651|Disease:C0030193		N02AB03	*3/*3	13653606
citalopram	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*1/*10	162180
citalopram	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AB04	*10/*10	162180
n-desmethyltamoxifen	rs133290	SREBF2	AC	Metabolism/PK	decreased	LADME	Healthy		L02BA01	rs133290:AC	10474509
hydroxyphenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*1/*11	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*11	17732
hydroxyphenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*11	CYP2C9	*2/*11	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*2/*11	17732
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*2	54688261
n-desmethyltamoxifen	rs5751251	TCF20	GG	Metabolism/PK	increased	LADME	Healthy		L02BA01	rs5751251:GG	10474509
n-desmethyltamoxifen	rs2267439	SREBF2	TT	Metabolism/PK	increased	LADME	Healthy		L02BA01	rs2267439:TT	10474509
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M02AA07	*1/*3	54697648
piroxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M02AA07	*3/*3	54697648
n-desmethyltamoxifen	rs9607850	SREBF2	TT	Metabolism/PK	increased	LADME	Healthy		L02BA01	rs9607850:TT	10474509
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage, Metabolism/PK	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
n-desmethyltamoxifen	rs8140869	CENPM, SMIM45	AG	Metabolism/PK	decreased	LADME	Healthy		L02BA01	rs8140869:AG	10474509
ribavirin, sofosbuvir	rs11322783	IFNL4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP08	rs11322783:GG	37542
varenicline	high activity	CYP2A6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0039338	high activity	N07BA03	__UNKNOWN__	6918678
etoposide	rs446112	__INTRONIC__	AA	Other	increased	Efficacy_Response	Healthy		L01CB01	rs446112:AA	46173784
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs2231142:TT	5282455
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08		5324346
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*1/*3	12438
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*2/*2	12438
opioids	poor and ultrarapid metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C0030193	poor metabolizer and ultrarapid metabolizer	N02A	__UNKNOWN__	No_match
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	J02AC03	*1/*17	9741
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB05		667572
ivacaftor, lumacaftor	rs113993960	CFTR	del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del	16220172
paroxetine	SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Healthy		N06AB05		667572
afatinib	rs28929495	EGFR	GG	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01EB03	rs28929495:GG	10184653
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del	16220172
3-aminoisobutyrate	rs3918290	DPYD	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs3918290:TT	439434
hydralazine	rapid acetylator	NAT2	__UNKNOWN__	Dosage, Efficacy	increased	Dosage	Other:C0020538	rapid acetylator	C02DB02	__UNKNOWN__	81764
mexiletine	CYP2D6*41	CYP2D6	*41	Efficacy	decreased	Efficacy_Response	Other:C0221260|Other:Nondystrophic_myotonia		C01BB02	*41	185376
3-aminoisobutyrate	rs143493067	UPB1	AA	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs143493067:AA	439434
3-aminoisobutyrate	rs114286107	AGXT2	TT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs114286107:TT	439434
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*3	12438
meloxicam	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*2	12438
meloxicam	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	PD, Metabolism/PK	decreased	LADME	Healthy		M01AC06	*1/*13	12438
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0030193|Postoperative		N02AB03	*3/*3	13653606
uracil	rs3918290	DPYD	TT	Metabolism/PK	increased	LADME	Healthy		H03BA	rs3918290:TT	1174
2-aminoheptanoate, 2-aminooctanoic acid, 2-hydroxylaurate	rs41272317	ACAD11	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs41272317:AA	69522
cysteine-s-sulfate, l-ornithine	rs140130028	NPC2	TT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs140130028:TT	6262
5,6-dihydrothymine	rs143493067	UPB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs143493067:AA	93556
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
10-monohydroxy oxcarbazepine	rs2273697	ABCC2	G	Metabolism/PK	increased	LADME	Other:C0014544		N03AF02	rs2273697:G	71750797
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*5/*10	6603912
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*1/*10	6603912
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		J05AG03	*6	64139
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10	6603912
rivaroxaban	rs776746	CYP3A5	TT	Toxicity	decreased	LADME	Other:C1861172		B01AF01	rs776746:TT	10700
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AC	54688261
praziquantel	CYP1A2*1, CYP1A2*30	CYP1A2	*1/*30	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*30	1917817
praziquantel	CYP1A2*1, CYP1A2*30	CYP1A2	*30/*30	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*30/*30	1917817
praziquantel	CYP2C9*1, CYP2C9*9	CYP2C9	*1/*9	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*9	1917817
praziquantel	CYP2C9*1, CYP2C9*9	CYP2C9	*9/*9	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*9/*9	1917817
aripiprazole	rs1065852	CYP2D6	AA	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1065852:AA	10114519
aripiprazole	rs1065852	CYP2D6	AG	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1065852:AG	10114519
aripiprazole	rs1080989	CYP2D6	CT	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1080989:CT	10114519
aripiprazole	rs1080989	CYP2D6	TT	Efficacy	increased	Efficacy_Response	Other:C0038354		N05AX12	rs1080989:TT	10114519
quinapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Healthy		C09AA06	rs1799752:del/del	54891
aripiprazole	rs1080989	CYP2D6	CT	Efficacy	decreased	LADME	Other:C0038354		N05AX12	rs1080989:CT	10114519
aripiprazole	rs1080989	CYP2D6	TT	Efficacy	decreased	LADME	Other:C0038354		N05AX12	rs1080989:TT	10114519
cyclophosphamide	rs2740574	CYP3A4	CC	Efficacy	decreased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	rs2740574:CC	9554282
cyclophosphamide	rs2740574	CYP3A4	CT	Efficacy	decreased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	rs2740574:CT	9554282
cyclophosphamide	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Efficacy	decreased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	*3	9554282
esomeprazole, pantoprazole	CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Healthy		A02BC02|A02BC05	*17/*17	4679
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage, Efficacy, Toxicity	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage, Efficacy, Toxicity	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3C	2265
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2	9741
meloxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC06	*3/*3	12438
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs2011425	UGT1A4	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs2011425:TT	131769926
tacrolimus	rs35599367	CYP3A4	GG	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:GG	131769926
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		J05AG03	*6/*6	64139
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs4149056:CC	5282455
rosuvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0011849|Other:C0020443		C10AA07	rs4149056:CT	5282455
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	Dosage	Disease:Liver_transplantation		L04AD02	*3/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*3/*3	131769926
warfarin	CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
alogliptin	rs738409	PNPLA3	CG	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0860195|""Other:C2732728"		A10BH04	rs738409:CG	11450633
alogliptin	rs738409	PNPLA3	GG	Efficacy	increased	Efficacy_Response	"""Other:C0011849""|""Other:C0860195|""Other:C2732728"		A10BH04	rs738409:GG	11450633
amlodipine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:C0020538		C08CA01	*1/*22	72734364
amlodipine	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:C0020538		C08CA01	*22/*22	72734364
ivacaftor, lumacaftor	rs113993960	CFTR	CTT/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:CTT/del	16220172
sertraline	rs167770	DRD3	AG	Efficacy	increased	Efficacy_Response	Other:C0028768		N06AB06	rs167770:AG	18642483
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*3	11985
sertraline	rs11721264	DRD3	AG	Efficacy	increased	Efficacy_Response	Other:C0028768		N06AB06	rs11721264:AG	18642483
iloperidone, iloperidone metabolite p88	rs1065852	CYP2D6	AA	Metabolism/PK	increased	LADME	Other:C0036341		No_ATC	rs1065852:AA	71360
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3	2244
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del	16220172
efavirenz	CYP2B6*1, CYP2B6*4	CYP2B6	*1/*4	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*4	64139
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del	16220172
valproic acid	rs3751664	CACNA1H	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs3751664:T	134459
fluvoxamine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08		154032615
penicillin g	rs1861494	IFNG	CC	Efficacy	decreased	Efficacy_Response	Other:C0039128		No_ATC	rs1861494:CC	656811
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2	2244
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2	13748464
penicillin g	rs2430561	IFNG	TT	Efficacy	decreased	Efficacy_Response	Other:C0039128		No_ATC	rs2430561:TT	656811
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del	16220172
imipramine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*1xN	Dosage	increased	Dosage	Disease:C0011581	ultrarapid metabolizer	N06AA02	*1/*1xN	65327
imipramine	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Dosage	increased	Dosage	Disease:C0011581	ultrarapid metabolizer	N06AA02	*1/*2xN	65327
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*6	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*7	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*7	NAT2	*7/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*7/*7	135483892
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C0020443		C10AA01	*1/*22	14373154
fluvoxamine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08		154032615
fluvoxamine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08		154032615
rivaroxaban	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		B01AF01	rs2231142:GT	10700
rivaroxaban	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		B01AF01	rs2231142:TT	10700
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage, Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*3/*3	131769926
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*10/*10	6093336
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*1/*10	6093336
ivacaftor, lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX30	rs113993960:del/del	16220172
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*3	54688261
avatrombopag	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*1/*3	9918581
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*3	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*5	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*1	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
avatrombopag	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1128503:AA	9918581
avatrombopag	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1128503:AG	9918581
venetoclax	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0023418|Myeloid|Acute		L01XX52	rs776746:CC	49846579
clozapine	rs28379954	NFIB	CT	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs28379954:CT	131769989
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N06BA09	*10/*10	6093336
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Healthy		N06BA09	*1/*10	6093336
pitavastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA08	*15	5282451
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
tacrolimus	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs2740574:TT	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	*1/*3	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	*1/*1	9579578
methylphenidate	rs998424	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs998424:GG	154100
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		J02AC03	*2/*3	9741
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0027697		L04AD02	*3/*3	131769926
lithium	rs7405404	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs7405404:T	11125
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*4/*4	1615
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*3/*5	1615
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AG03	rs28399499:C	64139
fentanyl	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Dosage	increased	Dosage	"""Other:C0017185|""Other:C0030193|Postoperative"""		N02AB03	*10/*10	13653606
varenicline	rs7164594	HYKK	CT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs7164594:CT	6918678
varenicline	rs7164594	HYKK	TT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs7164594:TT	6918678
sirolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	*3/*3	5284616
4-hydroxytamoxifen(tamoxifen)	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10/*10	5352135
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:del/del	44146831
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		V04CX05	*4/*4	1615
3,4-methylenedioxymethamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy		V04CX05	*3/*5	1615
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*1	Metabolism/PK	increased	LADME	Disease:C0023449	high activity	L01BB02	*1/*1	1268107
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AG03	rs3745274:T	64139
enalapril, losartan	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0010068		C09AA02|C09CA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5388962
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1	131769926
benazepril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07	rs1799752:del/del	5362124
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*3	11985
bupropion	rs8109525	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	rs8109525:GG	446
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*1	11985
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5	NUDT15	*1/*1	Dosage	increased	Dosage	Disease:C0023449	high activity	L01BB02	*1/*1	1268107
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	*3/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0027726		L04AD02	*3/*3	131769926
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*10	131769920
atomoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*10/*10	6093336
mesalazine, thioguanine	NAT1*3, NAT1*4, NAT1*10	NAT1	*10	Metabolism/PK	decreased	LADME	Disease:C0009324|Disease:C0010346|Disease:C0021390		A07EC02|L01BB03	*10	2723601
pioglitazone	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		A10BG03	*1/*3	60560
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Disease:C0009324		L04AD02	rs776746:CC	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Organ_Transplantation		L04AD02	*1/*3	131769926
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*4/*5	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*4/*6	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*3/*4	849421
risperidone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	*4/*4	849421
exemestane	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG06	*1/*22	13472
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3	Dosage	increased	Dosage	Healthy		B01AA03	*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	*3/*3	131769926
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*4	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*5	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*4	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*5	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*10	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14	CYP2D6	*14	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*14	849421
metoprolol	CYP2D6*4	CYP2D6	*4	Dosage	decreased	Dosage	Disease:C0085605		C07AB02	*4	6322
cetuximab	rs144854329	VEGFA	del/del	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs144854329:del/del	No_match
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*1/*28	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28	60838
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
ibuprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3	53464135
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*1	3883
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*1	3883
ibuprofen	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*2	53464135
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:C0003873|Disease:C0009324		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:C0003873|Disease:C0009324		L04AD02	*1/*3	131769926
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Disease:C0009324		L04AD02	rs776746:CC	131769926
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*1/*28	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Other:C0027651		L01CE02	*28/*28	60838
lornoxicam	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*13	54691489
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1	11985
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*7	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*4/*7	10285971
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*4/*9	10285971
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*4/*10	10285971
pilocarpine	CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7/*9	Metabolism/PK	decreased	LADME	Healthy		S01EB01	*7/*9	10285971
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*3	9579578
lornoxicam	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*13	54691489
lornoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*3	54691489
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
lornoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*3	54691489
atenolol	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Healthy		C07AB03	rs1801253:C	14211540
warfarin	CYP2C9*1, CYP2C9*6	CYP2C9	*1/*6	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*6	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX16	*3/*4	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AX16	*4/*4	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AX16	*4/*5	9795857
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	*3	54688261
propofol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Healthy		N01AX10	*1/*1	3014064
propofol	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N01AX10	*1/*2	3014064
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0271093		B01AA03	*1/*3	54688261
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03	*1/*2	3883
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03	*1/*3	3883
noroxycodone, oxycodone	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AA05	__UNKNOWN__	5489120
citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	decreased	Dosage	Disease:C0235876		N06AB03|N06AB04|N06AB05|N06AB06|N06AB08|N06AB10	*4/*4	5324346
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
disulfiram	rs28363170	SLC6A3	GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT/GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs28363170:GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT/GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT	101405
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	increased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	*2	54688261
benazepril, perindopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA04|C09AA07	rs1799752:del/del	5362124
risperidone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0033975	poor metabolizer	N05AX08	*4/*4	849421
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
thioguanine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Metabolism/PK	increased	LADME	Disease:C0010346		L01BB03	*1/*3A	137250051
thioguanine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Metabolism/PK	increased	LADME	Disease:C0010346		L01BB03	*1/*3C	137250051
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:C0009324		L04AD02	rs776746:CC	131769926
proguanil	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BB01	*2/*2	9570076
proguanil	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BB01	*2/*3	9570076
proguanil	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BB01	*3/*3	9570076
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A	1268107
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3C	1268107
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*3A/*3A	1268107
artemether	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		P01BE02	*6/*6	6450800
fluoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB03	__UNKNOWN__	1548968
fluoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB03	__UNKNOWN__	1548968
n-desmethylclozapine(clozapine)	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Metabolism/PK	increased	LADME	Disease:C0036337|Disease:C0036341		N05AH02	*17	135398737
clozapine	CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Disease:C0036337|Disease:C0036341		N05AH02	*17/*17	131769989
efavirenz	rs36118214	CYP2B6	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs36118214:GG	64139
cyclophosphamide	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*6	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*30	CYP2B6	*1/*30	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*1/*30	9554282
cyclophosphamide	CYP2B6*1, CYP2B6*29	CYP2B6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*1/*29	9554282
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03	*1/*1	3883
rosiglitazone	CYP2C8*3	CYP2C8	*3	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BG02	*3	9846723
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*1/*2	9554282
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0024299		L01AA01	*2/*2	9554282
quinapril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	54891
quinapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06	rs1799752:del/del	54891
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	*1/*2	9554282
cyclophosphamide	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	*2/*2	9554282
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	*3	54742534
testosterone	UGT1A4*1a, UGT1A4*3a	UGT1A4	*3a	Efficacy, Metabolism/PK	increased	LADME	Healthy		G03BA03	*3a	12850019
cyclophosphamide	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0024299		L01AA01	*1/*3	9554282
cyclophosphamide	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0024299		L01AA01	*3/*3	9554282
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
acenocoumarol	CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	Indeterminado	Dosage	Healthy		B01AA07	*2	54742534
acenocoumarol	CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	Indeterminado	Dosage	Healthy		B01AA07	*3	54742534
lamotrigine	UGT1A4*1a, UGT1A4*2, UGT1A4*3a	UGT1A4	*2	Efficacy, Metabolism/PK	decreased	LADME	Healthy		N03AX09	*2	71236569
lamotrigine	UGT1A4*1a, UGT1A4*2, UGT1A4*3a	UGT1A4	*3a	Efficacy, Metabolism/PK	decreased	LADME	Healthy		N03AX09	*3a	71236569
curcumin, ivacaftor	rs77010898	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs77010898:AA	16220172
curcumin, ivacaftor	rs77010898	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs77010898:AG	16220172
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*1/*2	4543
3-hydroxycotinine	CYP2A6*1, CYP2A6*12	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*12	416
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3	131769926
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA09	*1/*2	4543
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0024117		C09AA01	rs1799752:del/del	44146831
tacrolimus	CYP3A5*1	CYP3A5	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Dosage, Metabolism/PK	increased	LADME	Disease:C0027651	poor metabolizer	J02AC03	*2/*2	9741
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*49	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*49	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*52	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*52	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*49/*52	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*49/*52	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*41	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*5/*5	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*5/*5	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*41/*41	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*21	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*21	6603912
dextromethorphan	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*18, CYP2D6*21, CYP2D6*41, CYP2D6*49, CYP2D6*52	CYP2D6	*10/*18	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*18	6603912
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*9	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*9	6322
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*29	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*29	6322
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*45	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*45	6322
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*46	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*46	6322
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*17	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*17	6322
metoprolol	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*45, CYP2D6*46	CYP2D6	*10	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*10	6322
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Other:C0010068		B01AC04	*2	13748464
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*1/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*1/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*17/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*17/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*17/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*2/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB10	*3/*3	162180
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Dosage, Metabolism/PK	decreased	LADME	Disease:C0027651	ultrarapid metabolizer	J02AC03	*17/*17	9741
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
methotrexate	rs371194629	HLA-G	del/del	Efficacy	increased	Efficacy_Response	Efficacy:C0003873		L04AX03	rs371194629:del/del	11329481
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*4	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*3	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*5	6322
metoprolol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0020538		C07AB02	*6	6322
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*28/*28	60838
esomeprazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Efficacy_Response	Other:C0151788		A02BC05	*17	9579578
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Dosage, Metabolism/PK	increased	LADME	Disease:C0027651	intermediate metabolizer	J02AC03	*1/*2	9741
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Dosage	decreased	Dosage	Disease:C0027651		L01CE02	*6/*6	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Dosage	decreased	Dosage	Disease:C0027651		L01CE02	*28/*28	74990
irinotecan	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*28	Dosage	decreased	Dosage	Disease:C0027651		L01CE02	*6/*28	74990
captopril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0024117		C09AA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	44146831
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3	91987769
ivacaftor, tezacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs113993960:del/del	72722243
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9923231:TT	54688261
tramadol	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		N02AX02	*1/*1xN	63013
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*1/*2	11751549
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*1/*3	11751549
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*2/*2	11751549
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA01	*2/*3	11751549
chiglitazar	rs1800234	PPARA	CC	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs1800234:CC	9938010
chiglitazar	rs1800234	PPARA	CT	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs1800234:CT	9938010
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
lamotrigine	UGT1A4*1a, UGT1A4*1b	UGT1A4	*1b	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX09	*1b	71236569
haloperidol	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*5	9828
haloperidol	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10	9828
haloperidol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*3	9828
haloperidol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*4	9828
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Other:C0036341		N05AF05	*1/*4	5311507
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Other:C0036341		N05AF05	*3/*4	5311507
azathioprine, mercaptopurine	low activity	TPMT	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	low activity	L01BB02|L04AX01	__UNKNOWN__	5778
risperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	__UNKNOWN__	849421
mercaptopurine	intermediate activity	TPMT	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0023449	intermediate activity	L01BB02	__UNKNOWN__	1268107
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T	13653606
sulfasalazine	slow acetylator	NAT2	__UNKNOWN__	Other	increased	Adverse_Event	Disease:C0003873	slow acetylator	A07EC01	__UNKNOWN__	5336
fentanyl	rs2242480	CYP3A4	T/T	Metabolism/PK	increased	LADME	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T	13653606
ethanol	rs1799971	OPRM1	G	Dosage	increased	Dosage	Healthy		V03AB16	rs1799971:G	444899
sufentanil	rs2242480	CYP3A4	T/T	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N01AH03	rs2242480:T/T	41693
sufentanil	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193		N01AH03	rs2242480:T/T	41693
sufentanil	rs2242480	CYP3A4	T/T	Metabolism/PK	decreased	LADME	Disease:C0030193		N01AH03	rs2242480:T/T	41693
tacrolimus	rs2242480	CYP3A4	C/C	Other, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/C	131769926
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs2242480:T/T	13653606
sufentanil	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N01AH03	rs2242480:T/T	41693
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T	13653606
beta blocking agents	rs4752292	GRK5	T	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs4752292:T	No_match
interferon beta-1a	HLA-B*15:01	HLA-B	*15:01	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AB07	*15:01	64139
rubella vaccines	HLA-B*35:03	HLA-B	*35:03	Efficacy	increased	Efficacy_Response	Healthy		J07BJ	*35:03	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	HLA-B*38:01	HLA-B	*38:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	*38:01	37542
highly active antiretroviral therapy (haart)	rs671531	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:HIV_infectious_disease		No_ATC	rs671531:GG	No_match
tacrolimus	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*18	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*18	131769926
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*18/*18	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*18/*18	86666680
ustekinumab	HLA-C*06:02	HLA-C	*06:02	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	*06:02	No_match
methotrexate	HLA-C*06:02	HLA-C	*06:02	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	*06:02	11329481
fentanyl	CYP3A4*1, CYP3A4*18	CYP3A4	*18/*18	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	*18/*18	13653606
rubella vaccines	HLA-C*15:02	HLA-C	*15:02	Efficacy	increased	Efficacy_Response	Healthy		J07BJ	*15:02	No_match
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*02:02	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*02:02	37542
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*04:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*04:01	37542
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*05:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*05:01	37542
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*06:02	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*06:02	37542
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*15:02	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*15:02	37542
peginterferon alfa-2b, ribavirin	HLA-C*01:02, HLA-C*02:02, HLA-C*03:02, HLA-C*04:01, HLA-C*05:01, HLA-C*06:02, HLA-C*07:01, HLA-C*08:01, HLA-C*12:02, HLA-C*14:02, HLA-C*15:02, HLA-C*16:01, HLA-C*17:01	HLA-C	*17:01	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	*17:01	37542
measles vaccines	HLA-DQA1*01:04	HLA-DQA1	*01:04	Efficacy	increased	Efficacy_Response	Healthy		J07BD	*01:04	No_match
measles vaccines	HLA-DRB1*01:01	HLA-DRB1	*01:01	Efficacy	Indeterminado	Efficacy_Response	Healthy		J07BD	*01:01	No_match
cyclosporine	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Healthy		L04AD01	*1/*1	86666680
interferon beta-1a	HLA-DRB1*04:01	HLA-DRB1	*04:01	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07	*04:01	64139
adalimumab, etanercept, infliximab	HLA-DRB1*04:01	HLA-DRB1	*04:01	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	*04:01	No_match
hepatitis vaccines	HLA-DRB1*07:01	HLA-DRB1	*07:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BC	*07:01	16131310
influenza vaccines	HLA-DRB1*07:01	HLA-DRB1	*07:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BB	*07:01	No_match
measles vaccines	HLA-DRB1*08:01	HLA-DRB1	*08:01	Efficacy	Indeterminado	Efficacy_Response	Healthy		J07BD	*08:01	No_match
influenza vaccines	HLA-DRB1*13:01	HLA-DRB1	*13:01	Efficacy	increased	Efficacy_Response	Healthy		J07BB	*13:01	No_match
montelukast	CYP2C8*1, CYP2C8*4	CYP2C8	*4	Metabolism/PK	increased	LADME	Healthy		R03DC03	*4	122021
montelukast	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		R03DC03	*3	122021
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP2C8*1, CYP2C8*3	CYP2C8	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
methotrexate	rs11545078	GGH	AA	Toxicity	increased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs11545078:AA	11329481
methotrexate	rs11545078	GGH	AG	Toxicity	increased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs11545078:AG	11329481
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Dosage	decreased	Dosage	Healthy		M02AA13	*1/*3	53464135
rosiglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A10BG02	*1/*3	9846723
ibuprofen	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3	53464135
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*1/*6	10090
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*1/*18	10090
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*6/*6	10090
methadone	CYP2B6*1, CYP2B6*5, CYP2B6*6, CYP2B6*7, CYP2B6*18	CYP2B6	*6/*18	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	*6/*18	10090
disulfiram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele) / HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Other:C0278080	low activity	N07BB01		101405
disulfiram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele) / L allele-rs25531C	Efficacy	increased	Efficacy_Response	Other:C0278080	low activity	N07BB01		101405
disulfiram	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531C / L allele-rs25531C	Efficacy	increased	Efficacy_Response	Other:C0278080	low activity	N07BB01		101405
sertraline	CYP2B6*1, CYP2B6*4	CYP2B6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*1/*4	18642483
sertraline	CYP2B6*1, CYP2B6*4	CYP2B6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*4/*4	18642483
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6	Metabolism/PK	increased	LADME	Healthy		N06AB06	*6	18642483
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*9	Metabolism/PK	increased	LADME	Healthy		N06AB06	*9	18642483
sertraline	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*1/*17	18642483
sertraline	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB06	*17/*17	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		N06AB06	*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		N06AB06	*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*4	Metabolism/PK	increased	LADME	Healthy		N06AB06	*4	18642483
atorvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy		C10AA05	*1/*3	656846
atorvastatin	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy		C10AA05	*3/*3	656846
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*1/*5	Metabolism/PK	increased	LADME	Healthy		C10AA05	*1/*5	656846
atorvastatin	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5/*5	Metabolism/PK	increased	LADME	Healthy		C10AA05	*5/*5	656846
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*1/*15	Efficacy	decreased	Efficacy_Response	Other:C0020443		C10AA03	*1/*15	58746970
rifampin, warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*11	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Other:C0041296		B01AA03	*2	54678486
rifampin, warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*11	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Other:C0041296		B01AA03	*3	54678486
rifampin, warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*11	CYP2C9	*11	Efficacy	increased	Efficacy_Response	Other:C0041296		B01AA03	*11	54678486
pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Healthy		C10AA03	*15	58746970
pitavastatin, pravastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA03|C10AA08	*15/*15	5282452
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*2/*2	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*2/*2	135405018
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*2/*3	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*2/*3	135405018
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*3/*3	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*3/*3	135405018
acyclovir	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*5/*5	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	No_ATC	*5/*5	135405018
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1045642:GG	131769926
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
fluvastatin	SLCO1B1*1, SLCO1B1*14	SLCO1B1	*14	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA04	*14	131750727
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
methotrexate	SLCO1B1*1, SLCO1B1*31, SLCO1B1*37	SLCO1B1	*31	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*31	11329481
methotrexate	SLCO1B1*1, SLCO1B1*20, SLCO1B1*37	SLCO1B1	*20	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	*20	11329481
conjugated estrogens	rs4149056	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0025320		G03CA57	rs4149056:TT	223368
methotrexate	SLCO1B1*1, SLCO1B1*23, SLCO1B1*37	SLCO1B1	*23	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*23	11329481
acenocoumarol	rs1998591	CYP2C18	GG	Dosage	increased	Dosage	Healthy		B01AA07	rs1998591:GG	54742534
acenocoumarol	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA07	rs9934438:AA	54742534
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Other:C0018839		B01AC04	*2/*3	13748464
methotrexate	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*15	11329481
rosuvastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	decreased	LADME	Healthy		C10AA07	*15/*15	5282455
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*3/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	*2/*3	162180
atorvastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA05	*15/*15	656846
atorvastatin	SLCO1B1*1, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	*15	656846
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*15/*15	159594
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*1/*15	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*1/*15	159594
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*37	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*15/*37	159594
atrasentan	SLCO1B1*1, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37	SLCO1B1	*14/*37	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	*14/*37	159594
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*1/*17	162180
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*17/*17	162180
3,4-dehydrocilostazol	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0007785		B01AC23|V04CX05	*1/*1	10021885
3,4-dehydrocilostazol	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0007785		B01AC23|V04CX05	*1/*3	10021885
beta blocking agents	rs61767072	ADRA2C	del	Efficacy	increased	Efficacy_Response	Other:C0878544|Dilated		S01ED	rs61767072:del	No_match
hydroxybupropion(bupropion)	CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6	446
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*3	Metabolism/PK	increased	LADME	Healthy		N05AX12	*3	10114519
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		N05AX12	*4	10114519
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4xN	Metabolism/PK	increased	LADME	Healthy		N05AX12	*4xN	10114519
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		N05AX12	*5	10114519
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*6	Metabolism/PK	increased	LADME	Healthy		N05AX12	*6	10114519
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Metabolism/PK	increased	LADME	Healthy		N05AX12	*10	10114519
aripiprazole	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Metabolism/PK	increased	LADME	Healthy		N05AX12	*41	10114519
atomoxetine	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1263846	intermediate metabolizer and poor metabolizer	N06BA09	__UNKNOWN__	6093336
docetaxel, thalidomide	rs1402467	SULT1C4	G	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs1402467:G	148124
atomoxetine	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Other:C1263846	intermediate metabolizer and poor metabolizer	N06BA09	__UNKNOWN__	6093336
atomoxetine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	LADME	Other:C1263846		N06BA09	*2	6093336
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*17	Metabolism/PK	increased	LADME	Healthy		No_ATC	*17	131769920
amitriptyline, clomipramine	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Other	increased	Adverse_Event	Other:C0005586		N06AA04|N06AA09	*17/*17	2160
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*2	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*3	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*5	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*5	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6	NUDT15	*1/*6	Dosage	decreased	Dosage	Other:C0023449	intermediate metabolizer	L01BB02	*1/*6	1268107
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1	131769926
brexpiprazole	CYP2D6*1, CYP2D6*2	CYP2D6	*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*2	11978813
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*9	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*9	11978813
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*10	11978813
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*14	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*14	11978813
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*17	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*17	11978813
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*29	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*29	11978813
brexpiprazole	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*41	11978813
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*1/*5	9816106
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*1/*10	9816106
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*5	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*2/*5	9816106
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*2/*10	9816106
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*5/*10	9816106
n-desmethyltramadol(tramadol)	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:Head_and_Neck_Neoplasms		N02AX02	*10/*10	9816106
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
venlafaxine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX16		9795857
venlafaxine	SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Efficacy	increased	Efficacy_Response	Other:C0003469		N06AX16		9795857
venlafaxine	SLC6A4 L allele-rs25531T	SLC6A4	L allele-rs25531T/L allele-rs25531T	Efficacy	decreased	Efficacy_Response	Other:C0235876		N06AX16		9795857
methotrexate	rs717620	ABCC2	CT	Toxicity	decreased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs717620:CT	11329481
methotrexate	rs717620	ABCC2	TT	Toxicity	decreased	Adverse_Event	Side_Effect:C0003873		L04AX03	rs717620:TT	11329481
ketorolac	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		S01BC05	*2	3082630
ketorolac	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		S01BC05	*3	3082630
tramadol	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02AX02	*4	63013
fluorouracil, leucovorin, oxaliplatin	rs3212948	ERCC1	C	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs3212948:C	135403648
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Other:C0030319		N06AB06		18642483
endoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	decreased	LADME	Other:C1458155		No_ATC	*22/*22	131769920
midazolam	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		N05CD08	*1/*1	5384200
midazolam	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0027651		N05CD08	*1/*3	5384200
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*29	Metabolism/PK	decreased	LADME	Other:C1458155	poor metabolizer	No_ATC	*17/*29	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Other:C1458155	poor metabolizer	No_ATC	*17/*17	131769920
liraglutide	rs10305420	GLP1R	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ02	rs10305420:TT	16134956
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
oxycodone	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AA05	__UNKNOWN__	5462350
oxycodone	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AA05	__UNKNOWN__	5462350
oxycodone	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	decreased	LADME	Healthy		N02AA05	*22	5462350
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*3	131769926
gliclazide	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	A10BB09	__UNKNOWN__	169502072
fluvastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		C10AA04	*1/*3	131750727
bevacizumab, cyclophosphamide	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01FG01	rs4073:AA	2907
bevacizumab, cyclophosphamide	rs4073	CXCL8	AT	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01AA01|L01FG01	rs4073:AT	2907
nicotine	CYP2A6*1, CYP2A6*4	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*4	936
n-desmethylclozapine(clozapine)	low activity	CYP3A4	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0036341	low activity	N05AH02	__UNKNOWN__	135398737
dihydropyridine derivatives	rs776746	CYP3A5	TT	Other	increased	Adverse_Event	Healthy		C08CA	rs776746:TT	No_match
n-desmethylclozapine(clozapine)	low activity	CYP1A2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0036341	low activity	N05AH02	__UNKNOWN__	135398737
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35	CYP2A6	*1/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*35	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35	CYP2A6	*9/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*35	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35	CYP2A6	*17/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*17/*35	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*2	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*4	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*12	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*9/*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*12	936
disulfiram	deficiency	ALDH2	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0085762	deficiency	N07BB01		101405
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*4	89594
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*7	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*7	89594
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*9	89594
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*10	89594
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*4	89594
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*7/*7	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*7/*7	89594
coumarin, nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9	89594
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*1/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1/*46	936
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*46/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46/*46	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*2	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*4	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*17	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*20	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*20	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*23	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*23	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*24	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*24	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*25	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*25	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*26	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*26	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*27	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*27	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*28	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*28	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*1/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*35	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*17/*17	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*20/*20	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*20/*20	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*35/*35	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*35/*35	936
rosuvastatin	SLCO1B1*1, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	decreased	LADME	Healthy		C10AA07	*15/*15	5282455
fluvastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		C10AA04	*1/*3	131750727
pitavastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA08	*15/*15	5282451
pitavastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*37	Metabolism/PK	increased	LADME	Healthy		C10AA08	*15/*37	5282451
warfarin	rs11150606	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs11150606:C	54688261
pitavastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		C10AA08	*1/*3	5282451
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*1	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*46	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*9	Metabolism/PK	increased	LADME	Healthy		N07BA01	*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*14	Metabolism/PK	increased	LADME	Healthy		N07BA01	*14	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*14, CYP2A6*38, CYP2A6*46	CYP2A6	*38	Metabolism/PK	increased	LADME	Healthy		N07BA01	*38	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*1	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*12	936
nicotine	CYP2A6*1, CYP2A6*9, CYP2A6*12, CYP2A6*38, CYP2A6*46	CYP2A6	*38	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*38	936
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
oxaliplatin	rs1801131	MTHFR	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1801131:GG	9887054
oxaliplatin	rs1801131	MTHFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01XA03	rs1801131:GT	9887054
alprazolam	low activity	CYP3A4	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0085762|Other:C0003469	low activity	N05BA12	__UNKNOWN__	2118
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs2242480:C/C	131769926
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs2242480:C/C	131769926
tacrolimus	rs2242480	CYP3A4	C/T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/T	131769926
tacrolimus	rs2242480	CYP3A4	T/T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:T/T	131769926
tacrolimus	rs2242480	CYP3A4	C/C	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:C/C	131769926
fentanyl	rs2242480	CYP3A4	T/T	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T/T	13653606
endoxifen	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	intermediate metabolizer	No_ATC	__UNKNOWN__	131769920
tacrolimus	intermediate metabolizer and normal metabolizer	CYP3A5	__UNKNOWN__	Dosage	increased	Dosage	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	__UNKNOWN__	131769926
diclofenac	CYP2C9*1, CYP2C9*3, CYP2C9*8	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		S01BC03	*1/*3	112230
diclofenac	CYP2C9*1, CYP2C9*3, CYP2C9*8	CYP2C9	*1/*8	Metabolism/PK	decreased	LADME	Healthy		S01BC03	*1/*8	112230
clozapine	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0036341		N05AH02	rs2231142:GT	131769989
clozapine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0036341		N05AH02	rs2231142:TT	131769989
dolutegravir	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	*28/*28	118753073
dolutegravir	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6/*6	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	*6/*6	118753073
aspirin, clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_interventions_and_drug-eluting_stents		B01AC04	rs4244285:AA	2244
aspirin, clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_interventions_and_drug-eluting_stents		B01AC04	rs4244285:AG	2244
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*6	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*6	22267
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*7	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*7	22267
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*9	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*9	22267
levomethadone	CYP2B6*1, CYP2B6*6, CYP2B6*7, CYP2B6*9, CYP2B6*18	CYP2B6	*18	Metabolism/PK	decreased	LADME	Other:C0036439		N07BC05	*18	22267
mercaptopurine, thioguanine	TPMT*1, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3C	2723601
mercaptopurine, thioguanine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L01BB03	*1/*3A	2723601
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*4	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*4	936
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*7	Other, Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*7	936
hydralazine	rapid acetylator	NAT2	__UNKNOWN__	Dosage, Efficacy	increased	Dosage	Other:C0020538	rapid acetylator	C02DB02	__UNKNOWN__	81764
warfarin	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*13	54688261
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	poor metabolizer	J02AC03	*2/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	poor metabolizer	J02AC03	*3/*3	9741
rosuvastatin	rs11045854	SLCO1B1	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs11045854:A	5282455
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
venlafaxine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	intermediate metabolizer	N06AX16	__UNKNOWN__	9795857
escitalopram	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	intermediate metabolizer	N06AB10	__UNKNOWN__	162180
somatropin recombinant	rs1800012	COL1A1	AA	Dosage	decreased	Dosage	Other:C0853662		H01AC01	rs1800012:AA	No_match
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*17	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*20/*23	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*20/*23	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*9/*9	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*4	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*2	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*17/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*17/*17	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*17/*35	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*17/*35	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*2/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*2/*9	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*9/*12	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*9/*12	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*9	10466550
letrozole	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BG04	*1/*12	10466550
nicotine	CYP2A6*1, CYP2A6*46	CYP2A6	*1/*46	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1/*46	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*2	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*4	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*12	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*12	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*17	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*20	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*20	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*23	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*23	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*24	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*24	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*25	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*25	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*26	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*26	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*27	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*27	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*28	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*28	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*1/*35	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*1/*35	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*9/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*17/*17	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*17/*17	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*20/*20	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*20/*20	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46	CYP2A6	*35/*35	Metabolism/PK	decreased	LADME	Healthy	low activity and intermediate activity	N07BA01	*35/*35	936
vitamin b-complex, incl. combinations	rs1801133	MTHFR	A	Efficacy	increased	Efficacy_Response	Other:C0011581		A11E|S02DA30	rs1801133:A	No_match
rosuvastatin	rs2306283	SLCO1B1	GG	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2306283:GG	5282455
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A	54688261
vitamin b-complex, incl. combinations	rs1801131	MTHFR	G	Efficacy	increased	Efficacy_Response	Other:C0011581		A11E|S02DA30	rs1801131:G	No_match
atomoxetine	rs12708954	SLC6A2	A	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA09	rs12708954:A	6093336
cyclosporine, tacrolimus	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Side_Effect:Kidney_Transplantation		L04AD01|L04AD02	rs2740574:C	445643
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CC	5282455
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
rizatriptan	rs6275	DRD2	AA	Efficacy	decreased	Efficacy_Response	Other:C0338480		N02CC04	rs6275:AA	77997
rizatriptan	rs6275	DRD2	AG	Efficacy	decreased	Efficacy_Response	Other:C0338480		N02CC04	rs6275:AG	77997
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
warfarin	rs61162043	VKORC1	G	Dosage	increased	Dosage	Healthy		B01AA03	rs61162043:G	54688261
sulfonamides, urea derivatives	rs1057910	CYP2C9	CC	Efficacy	increased	Efficacy_Response	Healthy		S01AB	rs1057910:CC	1176
nicotine	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Other:C0039338		N07BA01	rs1799971:AG	936
nicotine	rs1799971	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:C0039338		N07BA01	rs1799971:GG	936
risperidone	rs6280	DRD3	CC	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6280:CC	849421
risperidone	rs6280	DRD3	CT	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6280:CT	849421
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
rosuvastatin	rs16980091	FOXA3	T	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs16980091:T	5282455
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
rosuvastatin	rs34671512	SLCO1B1	C	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs34671512:C	5282455
sirolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*3	5284616
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
cysteamine	rs113993960	CFTR	CTT/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		No_ATC	rs113993960:CTT/del	25201178
cysteamine	rs113993960	CFTR	del/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		No_ATC	rs113993960:del/del	25201178
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB10	*2/*3	162180
dextropropoxyphene	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		N02AC04	*3/*3	25137868
felodipine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		C08CA02	*3/*3	3333
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0277631		L04AX01	*1/*3A	5778
azathioprine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0277631		L04AX01	*1/*3C	5778
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6	64139
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*3	13748464
codeine	CYP2D6*17	CYP2D6	*17	Metabolism/PK	decreased	LADME	Disease:C0002895		R05DA04	*17	5284371
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC04	*2/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC04	*3/*3	11985
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC02	*1/*2	11954257
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*17/*17	9741
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*3	11985
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*2/*2	11954257
pantoprazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Metabolism/PK	increased	LADME	Healthy		A02BC02	*17	11954257
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*1	11985
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1	131769926
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
aripiprazole	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*4	10114519
aripiprazole	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*5	10114519
aripiprazole	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*6	10114519
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC04	*1/*1	11985
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01|A02BC03	*1/*1	3883
lansoprazole, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01|A02BC03	*1/*17	3883
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*3	11985
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*17/*17	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Dosage	Indeterminado	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*2	9741
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC02	*1/*1	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy		A02BC02	*1/*17	11954257
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
anthracyclines and related substances, capecitabine, cyclophosphamide, fluorouracil, taxanes	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01BC06|L01CD|L01DB		2907
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*2/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*2/*3	11985
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tolperisone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*4	688590
tolperisone	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*5	Metabolism/PK	increased	LADME	Healthy		No_ATC	*5	688590
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC03	*1/*3	11985
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC03	*1/*1	11985
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*3/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6	446
mianserin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX03	*1/*10	4184
mianserin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX03	*5/*10	4184
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*3/*3	131769926
salvianolic acid b	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Other:C0010068		No_ATC	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	5281793
mephenytoin	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*1/*2	91480
mephenytoin	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N03AB02	*2/*2	91480
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
valproic acid	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8	UGT1A6	*1a	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AG01	*1a	134459
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0026896		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0026896		L04AD02	*3/*3	131769926
mephenytoin, omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|N03AB02	*1/*2	4060
valproic acid	UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8	UGT1A6	*1a	Dosage	decreased	Dosage	Disease:C0014544		N03AG01	*1a	134459
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8/*8	Dosage	decreased	Dosage	Healthy		B01AA03	*8/*8	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
cyclosporine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*1/*1	86666680
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
sirolimus, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	5284616
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*3	9741
selective serotonin reuptake inhibitors	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage	decreased	Dosage	Disease:C0235876		N06AB	*4/*4	5202
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
tacrolimus	CYP3A4*1, CYP3A4*18	CYP3A4	*18	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*18	131769926
tramadol	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Dosage, Efficacy	increased	Dosage	Other:C0030193|Postoperative		N02AX02	*10/*10	63013
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3	131769926
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*3	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*4	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*5	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*1/*6	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*3/*3	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*4	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*5	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*10	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*41	63013
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*41	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*5/*41	63013
endoxifen	normal metabolizer and ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C1458155	normal metabolizer and ultrarapid metabolizer	No_ATC	__UNKNOWN__	131769920
imipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA02	*2	65327
o-desmethyltramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0024031|Disease:C0022408	poor metabolizer	N02AX02	__UNKNOWN__	9816106
rasagiline	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs1045642:AA	3052775
rasagiline	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs1045642:AG	3052775
antidepressants	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A		No_match
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	__UNKNOWN__	135483892
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10		162180
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*1/*2	9741
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01|A02BC02|A02BC04	*1/*2	5029
corticosteroids	rs3842689	NR1I2	del/del	Efficacy	increased	Efficacy_Response	Healthy		S02BA	rs3842689:del/del	No_match
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:GG	37542
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
voriconazole	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	__UNKNOWN__	9741
mephenytoin, omeprazole	CYP2C19*1, CYP2C19*26	CYP2C19	*26	Metabolism/PK	decreased	LADME	Healthy		A02BC01|N03AB02	*26	4060
irbesartan	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	2901
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*3	3045275
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*4	3045275
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*5	3045275
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*6	3045275
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*1/*17	162180
escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB10	*17/*17	162180
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		N06AB10	*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		N06AB10	*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4	CYP2C19	*4	Metabolism/PK	increased	LADME	Healthy		N06AB10	*4	162180
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
sipoglitazar	UGT2B15*1, UGT2B15*2	UGT2B15	*2/*2	Efficacy, Metabolism/PK	increased	Efficacy_Response	Healthy		No_ATC	*2/*2	9825652
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05		667572
nortriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*2/*2	9918
nortriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*2/*3	9918
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*9	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB06	*6/*9	18642483
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB06	*1/*6	18642483
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB06	*6/*6	18642483
metformin	rs72552763	SLC22A1	del/del	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs72552763:del/del	155906370
venlafaxine	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N06AX16	*10/*10	9795857
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	*2	13748464
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22	131769926
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0079102		B01AA07	*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0079102		B01AA07	*3	54742534
tacrolimus	CYP3A5*1	CYP3A5	*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*3	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB06	*1/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB06	*1/*3	18642483
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*2	13748464
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4	131769920
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2/*2	13748464
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*6	131769920
morphine	rs72552763	SLC22A1	GAT/del	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs72552763:GAT/del	5284371
morphine	rs72552763	SLC22A1	del/del	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs72552763:del/del	5284371
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*17	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*3	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*6	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*3	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*2/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*6	131769920
imatinib	GSTT1 non-null, GSTT1 null	GSTT1	null/null	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01		6113
glucocorticoids	rs1047303	HSD3B1	AA	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA	rs1047303:AA	No_match
glucocorticoids	rs1047303	HSD3B1	AC	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA	rs1047303:AC	No_match
lansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*2	11985
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*1	3883
lansoprazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Healthy		A02BC03	*17/*17	11985
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*17/*17	9741
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3/*9	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*17	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*17	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*5/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*41	131769920
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*1/*22	14373154
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*22/*22	14373154
morphine	rs72552763	SLC22A1	del/del	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs72552763:del/del	5284371
methotrexate	SLCO1B1*1, SLCO1B1*5, SLCO1B1*37	SLCO1B1	*5	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	*5	11329481
nortriptyline	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*10/*10	9918
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	*2/*2	13748464
fluvoxamine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:C0040435		N06AB05|N06AB08		5324346
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2	13748464
sildenafil	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C0085605		G04BE03	*1/*22	135499879
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A	1268107
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*28/*28	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*1/*28	60838
efavirenz	CYP2B6*6	CYP2B6	*6	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	*6	64139
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2	5790
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02	rs45445694:(CCGCGCCACTTCGCCTGCCTCCGTCCCG)2/3	5790
bilirubin	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*1/*6	46931084
bilirubin	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*6/*6	46931084
methadone	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*2	10090
methadone	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*3	10090
bilirubin	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*1/*28	46931084
bilirubin	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*28/*28	46931084
methadone	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		N07BC02	*3/*3	10090
methadone	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*2	10090
methadone	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*3	10090
losartan	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*3	11751549
methotrexate	SLCO1B1*1, SLCO1B1*14, SLCO1B1*37	SLCO1B1	*14	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	*14	11329481
warfarin	CYP2C9*1	CYP2C9	*1/*1	Dosage, Metabolism/PK	increased	Dosage	Healthy		B01AA03	*1/*1	54688261
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6	UGT1A1	*6/*6	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*6/*6	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6	UGT1A1	*1/*6	Metabolism/PK	decreased	LADME	Disease:C0027651		L01CE02	*1/*6	60838
rosuvastatin	rs1805343	RXRA	A	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs1805343:A	5282455
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*1/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	J02AC03	*2/*3	9741
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*3/*9	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*3/*9	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*17	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*4/*17	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*41	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*4/*41	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41	CYP2D6	*4/*10	Dosage	decreased	Dosage	Disease:C0011581		N06AX16	*4/*10	9795857
paclitaxel	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Disease:C1458155		L01CD01	*3	36314
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	Indeterminado	LADME	Healthy		N05BA09	*1/*1	2789
bupropion	CYP2B6*4	CYP2B6	*4	Other, Metabolism/PK	increased	LADME	Healthy		N06AX12	*4	446
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
glatiramer acetate	rs333	CCR5	del	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	rs333:del	3081884
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*13, CYP2C9*16, CYP2C9*60	CYP2C9	*1/*13	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*13	54688261
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*13, CYP2C9*16, CYP2C9*60	CYP2C9	*1/*16	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*16	54688261
warfarin	CYP2C9*1, CYP2C9*3, CYP2C9*13, CYP2C9*16, CYP2C9*60	CYP2C9	*1/*60	Dosage	decreased	Dosage	Other:C0004238		B01AA03	*1/*60	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB06	*2/*3	18642483
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	Indeterminado	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*3	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*3	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*8	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*8	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9	CYP2C19	*9	Metabolism/PK	decreased	LADME	Disease:C0004096	poor metabolizer	A02BC03	*9	11985
glipizide	rs7903146	TCF7L2	T	Efficacy	increased	Efficacy_Response	Healthy		A10BB07	rs7903146:T	70143
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0007282		B01AC04	*2	13748464
clopidogrel	rs12456693	SLC14A2	T	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs12456693:T	13748464
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
cisplatin, fluorouracil	TPMT*3C	TPMT	*3C	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		L01BC02|L01XA01	*3C	5460033
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
cavosonstat	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		No_ATC	rs113993960:del/del	No_match
bupropion	CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6	446
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*2/*2	13748464
risperidone	CYP2D6*5, CYP2D6*10	CYP2D6	*10	Metabolism/PK	increased	LADME	Disease:C0036341		N05AX08	*10	849421
risperidone	CYP2D6*5, CYP2D6*10	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0036341		N05AX08	*5	849421
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		J02AC03	*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*3	9741
zuclopenthixol	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AF05	*4	5311507
nevirapine	rs3842689	NR1I2	GAGAAG/del	Dosage, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3842689:GAGAAG/del	15979285
nevirapine	rs3842689	NR1I2	del/del	Dosage, Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3842689:del/del	15979285
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*4	135496227
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*5	135496227
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*3/*4	135496227
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*6	135496227
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*3/*5	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*3/*5	135496227
gefitinib	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*41	CYP2D6	*4/*4xN	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	L01EB01	*4/*4xN	135496227
tramadol	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		N02AX02	*10/*10	63013
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
voriconazole	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs1045642:AA	9741
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del	16220172
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*1	9741
midazolam	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		N05CD08	*1/*22	5384200
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*6	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	*6	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6, UGT1A1*28	UGT1A1	*28	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	*28	60838
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
telmisartan	UGT1A3*1, UGT1A3*3	UGT1A3	*3	Metabolism/PK	decreased	LADME	Healthy		C09CA07	*3	67184
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Dosage	decreased	Dosage	Disease:C0277631		L04AD02	*1/*22	131769926
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del	16220172
haloperidol	CYP2D6*1, CYP2D6*5	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*5	9828
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*3	131769926
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*8	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*1/*8	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C1956346		B01AC04	*2/*3	13748464
measles vaccines	HLA-B*51:01	HLA-B	*51:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*51:01	No_match
bucindolol	rs61767072	ADRA2C	GGGGCGGGGCCG/GGGGCGGGGCCG	Efficacy	increased	Efficacy_Response	Disease:C0085605		No_ATC	rs61767072:GGGGCGGGGCCG/GGGGCGGGGCCG	51045
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
risperidone	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C0033975	intermediate metabolizer and poor metabolizer	N05AX08	__UNKNOWN__	849421
measles vaccines	HLA-B*07:02	HLA-B	*07:02	Efficacy	increased	Efficacy_Response	Healthy		J07BD	*07:02	No_match
measles vaccines	HLA-B*13:01	HLA-B	*13:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*13:01	No_match
measles vaccines	HLA-B*08:01	HLA-B	*08:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*08:01	No_match
rosuvastatin	rs7579275	ABCB11	G	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs7579275:G	5282455
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
influenza vaccines	HLA-DQB1*03:03	HLA-DQB1	*03:03	Efficacy	decreased	Efficacy_Response	Healthy		J07BB	*03:03	No_match
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*3	9579578
omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC04	*1/*1	5029
measles vaccines	HLA-DQA1*02:01	HLA-DQA1	*02:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*02:01	No_match
measles vaccines	HLA-DRB1*03:01	HLA-DRB1	*03:01	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	*03:01	No_match
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A4*1, CYP3A4*20	CYP3A4	*1/*20	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*20	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*22	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Healthy		L04AD02	*22/*22	131769926
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
fluorouracil	poor metabolizer	DPYD	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C0023055|Disease:C0017185|Disease:C0022665	poor metabolizer	L01BC02	__UNKNOWN__	5790
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6	64139
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*1	3883
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*2	3883
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*3	3883
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:heart_transplantation		L04AD02	*1/*3	131769926
cisplatin, fluorouracil	TPMT*3B	TPMT	*3B	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		L01BC02|L01XA01	*3B	5460033
esomeprazole, lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04|A02BC05	*1/*1	3883
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*2	13748464
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:heart_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:heart_transplantation		L04AD02	*1/*3	131769926
rosuvastatin	rs2287622	ABCB11	G	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2287622:G	5282455
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*1/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*1/*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*3/*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2/*3	91987769
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0009324		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
amitriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA09	*4/*5	4543
amitriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA09	*4/*4	4543
sirolimus, temsirolimus	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Disease:C0877645		L01EG01	rs1128503:GG	6918289
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*3	9579578
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6	10090
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3	54742534
granisetron	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A04AA02	*3/*3	5284566
codeine	CYP2D6*1, CYP2D6*40	CYP2D6	*40	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*40	5284371
codeine	CYP2D6*1, CYP2D6*17	CYP2D6	*17	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*17	5284371
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Other	increased	Adverse_Event	Disease:C0003873		L04AD02	*1/*1	131769926
codeine	CYP2D6*1, CYP2D6*6	CYP2D6	*6	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*6	5284371
codeine	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*4	5284371
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*1/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*1/*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*17	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*3/*17	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*2	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*2/*3	2244
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839		B01AC04	*3/*3	2244
codeine	CYP2D6*1, CYP2D6*5	CYP2D6	*5	Efficacy	decreased	Efficacy_Response	Disease:C0002895		R05DA04	*5	5284371
granisetron	CYP1A1*1, CYP1A1*2A	CYP1A1	*2A	Metabolism/PK	increased	LADME	Healthy		A04AA02	*2A	5284566
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0003873		L04AD02	*3/*3	131769926
clomipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA04	*2/*2	68539
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
hmg coa reductase inhibitors	UGT1A1*28	UGT1A1	*28	Toxicity	decreased	Adverse_Event	Disease:C0020473		C10AA	*28	445127
rocuronium	rs7967354	SLCO1A2	CC	Dosage	decreased	Dosage	Healthy		M03AC09	rs7967354:CC	441290
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA04	*1/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2/*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA04	*1/*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA04	*2/*3	91987769
rosuvastatin	rs8187692	ABCC2	A	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs8187692:A	5282455
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*3	9918
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*4	9918
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*5	9918
nortriptyline	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA10	*6	9918
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0004936		N06AA09	*2/*2	4543
capecitabine, fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	60953
capecitabine, fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/CCGCGC(CACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/CCGCGC(CACTTGGCCTGCCTCCGTCCCG)3	60953
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA09	*2	4543
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*1	3883
fentanyl	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		N02AB03	*1/*22	13653606
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
carvedilol	CYP2D6*3, CYP2D6*4, CYP2D6*10	CYP2D6	*3/*10	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*3/*10	6322
carvedilol	CYP2D6*3, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*4	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*4/*4	6322
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*2	3883
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*1/*3	3883
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3	54742534
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*3	11985
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*2/*2	3883
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*2/*3	3883
lansoprazole, omeprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	*3/*3	3883
peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11322783:TT/TT	37542
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*2/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*2/*3	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC03	*3/*3	11985
voriconazole	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Healthy		J02AC03	*22	9741
haloperidol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N05AD01	*4/*4	9828
rosuvastatin	rs56903885	SLC10A1	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs56903885:T	5282455
vitamin k1	CYP4F2*1, CYP4F2*3	CYP4F2	*1/*3	Metabolism/PK	increased	LADME	Healthy		B02BA	*1/*3	5282367
vitamin k1	CYP4F2*1, CYP4F2*3	CYP4F2	*3/*3	Metabolism/PK	increased	LADME	Healthy		B02BA	*3/*3	5282367
tropisetron	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A04AA03	*10/*10	656665
tropisetron	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A04AA03	*5/*10	656665
bumetanide, furosemide, torasemide	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs1799752:del/del	41781
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*2/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*3/*3	9741
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0009324		L04AD02	*3/*3	131769926
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*3	9741
tropisetron	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		A04AA03	*1/*10	656665
amitriptyline	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0004936		N06AA09	*2	4543
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA02	*2/*2	65327
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA02	*2/*3	65327
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*2	54742534
morphine	low activity	SLC22A1	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	N02AA01		5284371
varenicline	normal metabolizer	CYP2A6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0039338	normal metabolizer	N07BA03	__UNKNOWN__	6918678
azathioprine	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Metabolism/PK	increased	Dosage	Disease:C0021390		L04AX01		5778
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*3	54742534
raloxifene	UGT1A8*1a, UGT1A8*2, UGT1A8*3	UGT1A8	*1a/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	G03XC01	*1a/*3	10100752
phenazepam	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy	decreased	Efficacy_Response	Other:C0085762|Other:C0003469		No_ATC	*17	40113
warfarin	CYP2C9*1, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6	54688261
warfarin	CYP2C9*1, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11	54688261
rosuvastatin	rs12721616	NR1I2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs12721616:T	5282455
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
dimethyl fumarate	rs1695	GSTP1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AX07	rs1695:GG	92042830
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*3/*3	66824
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AX16	*1/*3	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AX16	*1/*4	9795857
venlafaxine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AX16	*1/*5	9795857
rosuvastatin	rs11045874	SLCO1B1	C	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs11045874:C	5282455
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0009324		L04AD02	*3/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*3/*3	66824
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*3	66824
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10		162180
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Other	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3A	1268107
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Other	increased	Adverse_Event	Disease:C0023449		L01BB02	*1/*3C	1268107
mercaptopurine	TPMT*1, TPMT*3A, TPMT*3C	TPMT	*3A/*3A	Other	increased	Adverse_Event	Disease:C0023449		L01BB02	*3A/*3A	1268107
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*8	Dosage	decreased	Dosage	Healthy		B01AA03	*8	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*8, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11	54688261
o-desmethyltramadol	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0024031|Disease:C0022408	ultrarapid metabolizer	N02AX02	__UNKNOWN__	9816106
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*4/*41	6135
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*6	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*5/*6	6135
clopidogrel	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	Indeterminado	LADME	Healthy	intermediate metabolizer	B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3	13748464
tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2	2733525
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
acenocoumarol	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3	54742534
doxepin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*4	59023617
doxepin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*3/*5	59023617
doxepin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*4/*5	59023617
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*9	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*4	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*41	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*2/*4	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*5	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*10	Metabolism/PK	increased	LADME	Healthy		No_ATC	*2/*10	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*41	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*3	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*2/*4	45266826
mephedrone	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		No_ATC	*1/*4	45266826
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*9	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*9	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*10	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*10	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*41	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*41	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*2xN/*41	Metabolism/PK	increased	LADME	Healthy		N06AA12	*2xN/*41	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*1	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*1	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*2xN/*1	Metabolism/PK	increased	LADME	Healthy		N06AA12	*2xN/*1	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*1xN/*35	Metabolism/PK	increased	LADME	Healthy		N06AA12	*1xN/*35	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*2xN/*35	Metabolism/PK	increased	LADME	Healthy		N06AA12	*2xN/*35	59023617
doxepin	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41	CYP2D6	*35xN/*1	Metabolism/PK	increased	LADME	Healthy		N06AA12	*35xN/*1	59023617
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Other	increased	Efficacy_Response	Disease:C1956346		B01AC04	*2	13748464
capecitabine, fluorouracil	rs11479	TYMP	AA	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs11479:AA	60953
capecitabine, fluorouracil	rs11479	TYMP	AG	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs11479:AG	60953
ustekinumab	HLA-C*06:02	HLA-C	*06:02	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	*06:02	No_match
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT	37542
phenytoin	CYP2C19*2, CYP2C19*3	CYP2C19	*2	Dosage	Indeterminado	Dosage	Disease:C0014544		N03AB02	*2	1775
phenytoin	CYP2C19*2, CYP2C19*3	CYP2C19	*3	Dosage	Indeterminado	Dosage	Disease:C0014544		N03AB02	*3	1775
clozapine	SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T	SLC6A4	HTTLPR short form (S allele)/L allele-rs25531C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02		131769989
phenytoin	CYP2C9*3	CYP2C9	*3	Dosage	Indeterminado	Dosage	Disease:C0014544		N03AB02	*3	1775
antipsychotics, haloperidol, olanzapine, risperidone	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A|N05AD01|N05AH03|N05AX08		5073
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2	13748464
folic acid, hydroxychloroquine, methotrexate, sulfasalazine	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01|B03BB01|L04AX03|P01BA02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	135398658
ticagrelor	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		B01AC24	*1/*22	78358176
fluvastatin	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA04	rs1799752:del/del	131750727
ondansetron	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Healthy		A04AA01	*1/*1xN	4595
"""interferon alfa-2a, recombinant"", ""ribavirin"""	HLA-B*44:02	HLA-B	*44:02	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04	*44:02	37542
ondansetron, tropisetron	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Efficacy	decreased	Efficacy_Response	Disease:C0027651		A04AA01|A04AA03	*1/*1xN	656665
cyclosporine, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD01|L04AD02	*1	445643
pravastatin	rs1799752	ACE	del/del	Efficacy	Indeterminado	Efficacy_Response	Other:non-hypercholesterolaemic_patients_scheduled_for_angioplasty		C10AA03	rs1799752:del/del	58746970
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*3	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*4	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*4	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6	NUDT15	*1/*6	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*6	1268107
efavirenz	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*1/*18	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*18	64139
efavirenz	CYP2B6*1, CYP2B6*9	CYP2B6	*1/*9	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*9	64139
fluoxetine, sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB06		1548970
capecitabine, fluorouracil	rs3918290	DPYD	CT	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs3918290:CT	60953
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*3/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2/*17	13748464
rosuvastatin	rs12305884	SLCO1B1	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs12305884:A	5282455
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10	10090750
levomethadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	*6/*6	22267
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
metoprolol	rs61767072	ADRA2C	del	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02	rs61767072:del	6322
endoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:C1458155		No_ATC	*1/*22	131769920
endoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Disease:C1458155		No_ATC	*22/*22	131769920
imatinib	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs2231142:GT	6113
imatinib	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs2231142:TT	6113
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01	*2/*2	9579578
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*22	131769926
capecitabine, fluorouracil	rs67376798	DPYD	AT	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs67376798:AT	60953
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22	131769926
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1	9579578
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*3	11985
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2	13748464
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*6	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*6/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7/*7	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*7/*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*6	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*3/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3/*7	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*3/*7	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6/*7	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	poor metabolizer	L04AD02	*6/*7	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*22	131769926
vincristine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0023449		L01CA02	*1/*3	24848381
endoxifen	CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*9/*4	Metabolism/PK	increased	LADME	Disease:C1458155		No_ATC	*9/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*6	131769920
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*9/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*41	131769920
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3	91987769
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*9	131769920
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*41	131769920
mercaptopurine	TPMT*1, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A	1268107
capecitabine, fluorouracil	rs75017182	DPYD	CG	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs75017182:CG	60953
sirolimus, temsirolimus	rs6785049	NR1I2	GG	Metabolism/PK	increased	LADME	Disease:C0877645		L01EG01	rs6785049:GG	6918289
fluvastatin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Metabolism/PK	increased	LADME	Healthy		C10AA04	*3	131750727
nortriptyline	CYP2D6*1, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*4/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*1/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2xN, CYP2D6*4, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N06AA10	*1/*5	9918
rosuvastatin	rs11045873	SLCO1B1	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs11045873:A	5282455
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*3	131769926
tacrolimus	rs4646458	__INTRONIC__	G	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs4646458:G	131769926
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*2	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*2/*2	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*10	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*2/*10	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*3	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*1/*3	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*1/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*2/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*5/*10	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*4/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*3/*4	Dosage	decreased	Dosage	Disease:C0011581		N06AA10	*3/*4	9918
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1	9579578
rocuronium	rs11045995	IAPP, SLCO1A2	CC	Dosage	decreased	Dosage	Healthy		M03AC09	rs11045995:CC	441290
measles vaccines	HLA-B*44:02	HLA-B	*44:02	Efficacy	Indeterminado	Efficacy_Response	Healthy		J07BD	*44:02	No_match
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*3	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5	131769920
endoxifen	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*6	131769920
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Laparoscopic_sleeve_gastrectomy		L04AD02	*1/*3	131769926
metoprolol	rs5030655	CYP2D6	del/del	Efficacy	increased	Efficacy_Response	Healthy		C07AB02	rs5030655:del/del	6322
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*1	33613
allopurinol	HLA-B*58:01	HLA-B	*58:01	Toxicity	Indeterminado	Efficacy_Response	Healthy		M04AA01	*58:01	168354693
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*2	33613
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*3	33613
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3	NUDT15	*2/*3	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*2/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*2	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*3	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5	NUDT15	*1/*5	Toxicity	decreased	Dosage	Disease:C0023449		L01BB02	*1/*5	1268107
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
hmg coa reductase inhibitors	rs352046	CXCL5	CC	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA	rs352046:CC	445127
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AB05	*10/*10	667572
amoxicillin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|J01CA04	*1/*1	33613
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28, UGT1A1*36	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE03	*28/*28	25134325
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C0004238		B01AA03	*1/*3	54688261
celecoxib	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*3	66824
celecoxib	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*13	66824
celecoxib	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*3/*3	66824
dextromethorphan, dextrorphan	rs5758651	TCF20	C	Metabolism/PK	increased	LADME	Healthy		R05DA09	rs5758651:C	5360697
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*9, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11	54688261
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2	13748464
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Healthy		L04AD01	*1/*1	86666680
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11322783:TT/TT	37542
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	Indeterminado	Dosage	Healthy		B01AA03	*1/*3	54688261
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*6, CYP2D6*8	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*4	131769920
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*6, CYP2D6*8	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*6	131769920
endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*6, CYP2D6*8	CYP2D6	*8	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*8	131769920
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs11322783:TT/TT	37542
metformin	rs2954625	CSMD1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2954625:CT	155906370
metformin	rs2954625	CSMD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2954625:TT	155906370
atazanavir / ritonavir	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Toxicity	increased	Adverse_Event	Other:HIV_infectious_disease		J05AE03	*28/*28	25134325
estrone	SLCO1B1*1, SLCO1B1*5	SLCO1B1	*5/*5	Efficacy	increased	LADME	Other:C1458155		G03CA07	*5/*5	127676
voriconazole	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs1045642:AA	9741
mercaptopurine	rs72846714	NT5C2	AA	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs72846714:AA	1268107
mercaptopurine	rs72846714	NT5C2	AG	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs72846714:AG	1268107
bupropion	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		N06AX12	*2	446
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*1/*6	446
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6/*6	446
haloperidol	CYP2D6*1, CYP2D6*2	CYP2D6	*2/*2	Metabolism/PK	increased	LADME	Disease:C0036341		N05AD01	*2/*2	9828
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	*3/*3	86666680
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	UGT1A1*60	UGT1A1	*60	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*60	9887054
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*1/*8	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*1/*8	54688261
warfarin	CYP2C9*1, CYP2C9*8	CYP2C9	*8/*8	Metabolism/PK	decreased	LADME	Healthy		B01AA03	*8/*8	54688261
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*4/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*3	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*10/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*17/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*17/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*41/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*29	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2xN/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2xN/*4	131769920
sertraline	rs11188059	CYP2C18	GG	Metabolism/PK	decreased	LADME	Healthy		N06AB06	rs11188059:GG	18642483
simvastatin	CYP2D6*1, CYP2D6*14	CYP2D6	*14	Metabolism/PK	increased	LADME	Healthy		C10AA01	*14	14373154
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*4	9887054
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*7	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*7	9887054
irinotecan, oxaliplatin, tegafur / gimeracil / oteracil	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*9	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC03|L01CE02|L01XA03	*9	9887054
donepezil	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0002395	poor metabolizer	N06DA02	*4/*4	3152
donepezil	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Disease:C0002395	poor metabolizer	N06DA02	*4/*5	3152
nicotine	high activity	CYP2A6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0039338	high activity	N07BA01	__UNKNOWN__	936
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*2	2265
azathioprine, mercaptopurine, purine analogues	TPMT*1, TPMT*2, TPMT*3A	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0021390		L01BB|L01BB02|L04AX01	*1/*3A	2265
fentanyl	CYP2D6*1, CYP2D6*29	CYP2D6	*29	Metabolism/PK	decreased	LADME	Other:C0006434		N02AB03	*29	13653606
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*10x2	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10	6603912
dextromethorphan	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*10x2	CYP2D6	*10/*10x2	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10x2	6603912
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*3	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*4	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*6	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*9/*5	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*41	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*1/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*2/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*35/*10	131769920
levonorgestrel	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		G03AD01	rs3745274:GT	5991
levonorgestrel	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		G03AD01	rs3745274:TT	5991
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
adalimumab	rs9828223	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB04	rs9828223:T	107706
dextromethorphan, dextrorphan	rs61740999	IP6K2	AG	Metabolism/PK	increased	LADME	Healthy		R05DA09	rs61740999:AG	5360697
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Other:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5790
debrisoquine	CYP2D6*1, CYP2D6*29	CYP2D6	*29/*29	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*29/*29	2966
debrisoquine	CYP2D6*1, CYP2D6*17, CYP2D6*29	CYP2D6	*17/*29	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*17/*29	2966
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10		162180
progesterone	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		G03DA04	*1/*2	92786
progesterone	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Healthy		G03DA04	*2/*17	92786
debrisoquine, metoprolol	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*17/*17	2966
donepezil	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1/*1xN	Metabolism/PK	increased	LADME	Disease:C0002395	ultrarapid metabolizer	N06DA02	*1/*1xN	3152
donepezil	CYP2D6*1, CYP2D6*1xN	CYP2D6	*1xN/*1xN	Metabolism/PK	increased	LADME	Disease:C0002395	ultrarapid metabolizer	N06DA02	*1xN/*1xN	3152
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*1/*6	2907
cyclophosphamide, fludarabine	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01|L01BB05	*6/*6	2907
levonorgestrel	rs4803419	CYP2B6	CT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		G03AD01	rs4803419:CT	5991
atorvastatin	rs12979860	IFNL3, IFNL4	CC	Efficacy	decreased	LADME	Healthy		C10AA05	rs12979860:CC	656846
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	increased	Dosage	Healthy	poor metabolizer	B01AC04	*2	13748464
cilostazol	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Metabolism/PK	increased	LADME	Healthy		B01AC23	*2	10022985
cilostazol	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Metabolism/PK	increased	LADME	Healthy		B01AC23	*3	10022985
codeine, debrisoquine, dextromethorphan, metoprolol	CYP2D6*1, CYP2D6*5, CYP2D6*17	CYP2D6	*5/*17	Metabolism/PK	decreased	LADME	Healthy		C07AB02|R05DA04|R05DA09	*5/*17	2966
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Metabolism/PK	decreased	LADME	Healthy		B01AC04	*3	13748464
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX02	*1/*28	67424139
sorafenib	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX02	*28/*28	67424139
metoprolol	CYP2D6*1, CYP2D6*2, CYP2D6*29	CYP2D6	*29/*29	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*29/*29	6322
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03		1548968
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*1/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*1/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*2/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*2/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	Dosage	Disease:C0014544		N05BA09	*3/*3	2789
dextromethorphan	CYP2D6*1, CYP2D6*17	CYP2D6	*17	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*17	6603912
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*3/*3	2789
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0017168		A02BC01	*2	9579578
atenolol, enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0178298		C07AB03|C09AA02	rs1799752:del/del	5388962
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3C	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3C	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*2	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	TPMT*1, TPMT*2, TPMT*3A, TPMT*3C	TPMT	*1/*3A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	*1/*3A	1268107
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*2/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*3/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N05BA09	*3/*3	2789
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
lopinavir	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AR10	*22/*22	169501901
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*1/*1	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*2/*3	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*3/*3	2789
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4/*9	936
nicotine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*9/*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9/*9	936
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	*1/*1	9741
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
efavirenz	rs3842	ABCB1	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:C	64139
clobazam	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N05BA09	*1/*2	2789
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Healthy		C09AA01	rs1799752:del/del	44146831
citalopram, fluoxetine	rs2227631	SERPINE1	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04	rs2227631:G	1548970
phenytoin	rs71486745	CYP2C9	GT/del	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs71486745:GT/del	1775
phenytoin	rs71486745	CYP2C9	del/del	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs71486745:del/del	1775
atenolol, hydrochlorothiazide, metoprolol	rs201279313	SLC25A31	TTA/del	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03|C07AB02|C07AB03	rs201279313:TTA/del	3639
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*17	9741
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
captopril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	44146831
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	5790
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*7	131769926
tamoxifen	CYP2C19*1, CYP2C19*17	CYP2C19	*17	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1458155		L02BA01	*17	2733525
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA03	*1/*1	54688261
tamoxifen	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:C1458155		L02BA01	*2	2733525
captopril	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0085605		C09AA01	rs1799752:del/del	44146831
mercaptopurine	rs58700372	CNNM2	CC	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs58700372:CC	1268107
mercaptopurine	rs58700372	CNNM2	CT	Metabolism/PK	decreased	LADME	Other:C0023449		L01BB02	rs58700372:CT	1268107
oxycodone	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	Dosage	Disease:C0027651		N02AA05	*3/*3	5462350
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0035435		J02AC03	*1/*1	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0035435		J02AC03	*1/*17	9741
montelukast	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Metabolism/PK	decreased	LADME	Healthy		R03DC03	*2	122021
phenytoin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		N03AB02	*1/*2	1775
fluorouracil	rs11280056	TYMS	TTAAAGTTA/del	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02	rs11280056:TTAAAGTTA/del	5790
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*4/*41	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*1/*4	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*10/*10	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*10/*41	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*2/*4	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*41/*41	Efficacy	decreased	Efficacy_Response	Disease:C0024530		P01BA03	*41/*41	6135
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*1/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Metabolism/PK	increased	LADME	Healthy		N03AB02	*2/*2	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*2/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*3/*3	1775
sertraline	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB06	rs1799752:del/del	18642483
rosuvastatin	rs17216177	ABCC2	C	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs17216177:C	5282455
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		N03AB02	*1/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		N03AB02	*2/*2	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		N03AB02	*2/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		N03AB02	*3/*3	1775
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BA03	*4/*41	6135
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*6	Metabolism/PK	decreased	LADME	Disease:C0024530		P01BA03	*5/*6	6135
cilostazol	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	B01AC23	*1/*3	10022985
endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*10/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		No_ATC	*5/*10	131769920
rasagiline	rs12208357	SLC22A1	CT	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs12208357:CT	3052775
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*2	4679
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*3	4679
tacrolimus	CYP3A7*1A, CYP3A7*1C	CYP3A7	*1A/*1A	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1A/*1A	131769926
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*2	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*2	854019
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*4	854019
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*9	854019
cotinine, nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12	CYP2A6	*12	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*12	854019
ketamine	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:C0027651|Disease:C0030193		N01AX03	*6	182137
debrisoquine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*10/*10	2966
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*2	4679
esomeprazole, pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC02|A02BC05	*2/*3	4679
rosuvastatin	rs7899457	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs7899457:T	5282455
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*2	3883
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*3	3883
esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02|A02BC03|A02BC04|A02BC05	*1/*1	3883
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
rosuvastatin	rs8187706	ABCC2	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs8187706:A	5282455
flurbiprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Healthy		S01BC04	*1/*1	23684814
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
pitavastatin	rs717620	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA08	rs717620:T	5282451
ethanol	rs28363170	SLC6A3	del	Other	increased	Efficacy_Response	Healthy		V03AB16	rs28363170:del	444899
ethanol	rs1800497	DRD2	A	Dosage	increased	Dosage	Healthy		V03AB16	rs1800497:A	444899
vardenafil	rs776746	CYP3A5	TT	Other, Metabolism/PK	increased	LADME	Healthy		G04BE09	rs776746:TT	135414253
sipoglitazar	UGT2B15*1, UGT2B15*2	UGT2B15	*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*2	9825652
ethanol	rs28363170	SLC6A3	del	Toxicity	increased	LADME	Healthy		V03AB16	rs28363170:del	444899
ethanol	rs1799971	OPRM1	G	Dosage	increased	Dosage	Healthy		V03AB16	rs1799971:G	444899
imatinib	rs683369	SLC22A1	CC	Metabolism/PK	decreased	LADME	Other:C0238198		L01EA01	rs683369:CC	6113
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*3	11985
acetaminophen	UGT1A6*1a, UGT1A6*2a	UGT1A6	*2a	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		N02BE01	*2a	1983
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C0004238|Disease:C0004239|Disease:C0042487		B01AA07	*3	54742534
acetaminophen	UGT1A6*1a, UGT1A6*2a	UGT1A6	*2a/*2a	Metabolism/PK	increased	LADME	Healthy		N02BE01	*2a/*2a	1983
acetaminophen	UGT1A6*1a, UGT1A6*2a	UGT1A6	*1a/*2a	Metabolism/PK	increased	LADME	Healthy		N02BE01	*1a/*2a	1983
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
acetaminophen	UGT2B15*1, UGT2B15*2	UGT2B15	*2	Metabolism/PK	decreased	LADME	Healthy		N02BE01	*2	1983
haloperidol	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10	9828
methadone	rs3802281	OPRK1	TT	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs3802281:TT	10090
debrisoquine	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*1/*17	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*17	2966
debrisoquine	CYP2D6*1, CYP2D6*2, CYP2D6*17	CYP2D6	*17/*17	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*17/*17	2966
azathioprine	rs1142345	TPMT	CT	Dosage	decreased	Dosage	Other:C0009324|Other:C0010346		L04AX01	rs1142345:CT	5778
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tolterodine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*3	Metabolism/PK	decreased	LADME	Healthy		G04BD07	*3	443878
tolterodine	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		G04BD07	*4	443878
citalopram, mianserin, mirtazapine, nortriptyline, paroxetine, venlafaxine	CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*1xN	Efficacy	decreased	Efficacy_Response	Disease:C0040435		N06AA10|N06AB04|N06AB05|N06AX03|N06AX11|N06AX16	*1xN	4205
citalopram, mianserin, mirtazapine, nortriptyline, paroxetine, venlafaxine	CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*2xN	Efficacy	decreased	Efficacy_Response	Disease:C0040435		N06AA10|N06AB04|N06AB05|N06AX03|N06AX11|N06AX16	*2xN	4205
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0004364		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0004364		L04AD02	*1/*3	131769926
hydroxyurea	rs7166737	SIN3A	GG	Efficacy	decreased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7166737:GG	10220327
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0079487		A02BC04	*2/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0079487		A02BC04	*2/*3	11985
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03		1548968
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799964	TNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0038012|Ankylosing		No_ATC	rs1799964:TT	No_match
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	*1/*3	54688261
propafenone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		C01BC03	*10/*10	184819
venlafaxine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__	9795857
tacrolimus	CYP3A5*1, CYP3A5*6	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*6	CYP3A5	*1/*6	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*6	131769926
capecitabine, raltitrexed	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BA03|L01BC06	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	135400182
tacrolimus	CYP3A5*1, CYP3A5*7	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*7	CYP3A5	*1/*7	Metabolism/PK	increased	LADME	Healthy		L04AD02	*1/*7	131769926
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA03	*1/*1	54688261
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*3	13748464
venlafaxine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	poor metabolizer	N06AX16	__UNKNOWN__	9795857
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	G/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:G/TT	37542
peginterferon alfa-2a, ribavirin	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11322783:TT/TT	37542
venlafaxine	normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	normal metabolizer	N06AX16	__UNKNOWN__	9795857
rasagiline	rs34059508	SLC22A1	AG	Metabolism/PK	increased	LADME	Healthy		N04BD02	rs34059508:AG	3052775
escitalopram	normal metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Elderly_Adult	normal metabolizer	N06AB10	__UNKNOWN__	162180
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Toxicity	increased	LADME	Disease:C0014544		N03AB02	*1/*3	1775
lovastatin acid	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	*5/*15	Metabolism/PK	increased	LADME	Healthy		C10AA02	*5/*15	40474546
lovastatin acid	SLCO1B1*1, SLCO1B1*5, SLCO1B1*15	SLCO1B1	*15/*15	Metabolism/PK	increased	LADME	Healthy		C10AA02	*15/*15	40474546
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*1/*3	1775
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	increased	LADME	Healthy		N03AB02	*2/*3	1775
flurbiprofen	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		S01BC04	*1/*3	23684814
ambrisentan	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*17	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		C02KX02	*2	6918493
ambrisentan	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*17	CYP2C19	*3	Metabolism/PK	decreased	LADME	Healthy		C02KX02	*3	6918493
ambrisentan	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*17	CYP2C19	*4	Metabolism/PK	decreased	LADME	Healthy		C02KX02	*4	6918493
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		J05AG03	*6/*6	64139
cyclophosphamide	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:C0024299|B-Cell		L01AA01	*6	9554282
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Other:C0033575		N06AB06		18642483
rasagiline	rs2273697	ABCC2	AA	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs2273697:AA	3052775
bupropion	rs2770296	HTR2A	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs2770296:CC	446
capecitabine, fluorouracil	rs371194629	HLA-G	ATTTGTTCATGCCT/ATTTGTTCATGCCT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs371194629:ATTTGTTCATGCCT/ATTTGTTCATGCCT	60953
capecitabine, fluorouracil	rs371194629	HLA-G	ATTTGTTCATGCCT/del	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs371194629:ATTTGTTCATGCCT/del	60953
voriconazole	poor metabolizer	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	poor metabolizer	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*3	9741
pravastatin	rs20455	KIF6	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs20455:AG	58746970
pravastatin	rs20455	KIF6	GG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs20455:GG	58746970
fluvoxamine	SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08		154032615
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		J02AC03	*2/*2	9741
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
donepezil	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0002395	poor metabolizer	N06DA02	__UNKNOWN__	3152
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*10/*10	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*4	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*5	849421
risperidone	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*6	849421
fluoxetine	rs2032582	ABCB1	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs2032582:A	1548968
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		L02BA01	*4/*4	10090750
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	decreased	LADME	Healthy		L02BA01	*4/*5	10090750
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		R05DA09	*10/*10	6603912
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Healthy		R05DA09	*1/*10	6603912
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	*1/*6	446
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12	*6/*6	446
rabeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC04	*2/*2	11985
dipyrone	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*2	121882
fluoxetine, sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB06		1548970
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*1/*4	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*4/*4	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*7	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*4/*7	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9	CYP2A6	*4/*9	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC03	*4/*9	5386
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB10		162180
azathioprine	GSTM1 non-null, GSTM1 null	GSTM1	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0009324|Other:C0010346		L04AX01		5778
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*4/*10	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*5/*10	849421
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*6	Dosage	decreased	Dosage	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*6	6395
nilotinib	UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28	UGT1A1	*6/*28	Dosage	decreased	Dosage	Disease:C0023473|BCR-ABL1_positive		L01EA03	*6/*28	6395
cotinine, nicotine	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Healthy		N07BA01	*1/*6	854019
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*1/*5	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5	CYP2C9	*2/*5	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*5	54688261
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	*6	10090
bupropion	rs2873804	DBH	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs2873804:CC	446
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0003873|Disease:C0024141		L04AD02	*3/*3	131769926
fluorouracil, leucovorin, oxaliplatin	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus|Disease:C0026640		L01BC02|L01XA03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	135403648
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
paclitaxel, platinum compounds	GSTM1 non-null, GSTM1 null	GSTM1	non-null	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01CD01|L01XA		23939
bleomycin, dacarbazine, doxorubicin, vinblastine	GSTM1 non-null, GSTM1 null	GSTM1	non-null/non-null	Efficacy	increased	Efficacy_Response	Disease:C0019829		L01AX04|L01CA01|L01DB01|L01DC01		135398738
citalopram	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AB04	*2	162180
enalapril, lisinopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Other:C0020538		C09AA02|C09AA03	rs1799752:del/del	5388962
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
trimipramine	CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*3/*3	3045275
bupropion	rs363225	SLC18A2	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs363225:CC	446
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*3	3045275
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*4	3045275
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*5	3045275
trimipramine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*6	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*6	3045275
methadone	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N07BC02	*1/*4	10090
methadone	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*4/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*4/*6	10090
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*1/*3	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*3	9579578
raltegravir	UGT1A9*3a	UGT1A9	*3a	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AJ01	*3a	90478108
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC01	*2/*3	9579578
fluvoxamine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB08	__UNKNOWN__	154032615
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N07BC02	*1/*6	10090
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N07BC02	*6/*6	10090
fluvoxamine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB08	__UNKNOWN__	154032615
sertraline	rs2860840	CYP2C18	TT	Metabolism/PK	decreased	LADME	Healthy		N06AB06	rs2860840:TT	18642483
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	*3	54742534
aripiprazole	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0036337|Disease:C0036341	poor metabolizer	N05AX12	__UNKNOWN__	10114519
4-hydroxytamoxifen(tamoxifen)	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*22	5352135
tamoxifen	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*22	2733525
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1	9579578
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Other:C0022665		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	5790
fluorouracil	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Other:C0022665		L01BC02	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	5790
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*1	9741
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	CC	Efficacy	increased	Efficacy_Response	Disease:C0038012|Ankylosing		No_ATC	rs1799724:CC	No_match
hydroxyamitriptyline(amitriptyline)	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06AA09	*10/*10	2160
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*2	4543
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*3	4543
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy		N06AA09	*3/*3	4543
acetylcysteine	poor metabolizer	EPHX1	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0024117	poor metabolizer	V03AB23		12114682
bupropion	rs363226	SLC18A2	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs363226:GG	446
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
methotrexate	rs45445694	C18orf56, TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2	11329481
olanzapine	rs1799735	GSTM3	CCT/CCT	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs1799735:CCT/CCT	74603552
levodopa, methylphenidate	rs3836790	SLC6A3	ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BA02|N06BA04	rs3836790:ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA	6047
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4xN	Metabolism/PK	decreased	LADME	Disease:C1263846		N06BA09	*4/*4xN	6093336
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1263846		N06BA09	*4/*4	6093336
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*3/*3	54688261
levodopa	rs3836790	SLC6A3	ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BA02	rs3836790:ACATACACACTCAGACACACATACCATGCA/ACATACACACTCAGACACACATACCATGCA	9307
fluorouracil	deficiency	DPYD	__UNKNOWN__	Metabolism/PK	Indeterminado	LADME	Disease:Head_and_Neck_Neoplasms	deficiency	L01BC02	__UNKNOWN__	5790
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4xN	Metabolism/PK	increased	LADME	Disease:C1263846		N06BA09	*4/*4xN	6093336
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C1263846		N06BA09	*4/*4	6093336
bupropion	rs17614642	FKBP5	TT	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06AX12	rs17614642:TT	446
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*3	118753185
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*6	118753185
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*7	118753185
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage, Efficacy	decreased	Dosage	Disease:C0271093		B01AA03	*1/*2	54688261
interferon beta-1a	rs1799752	ACE	del/del	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AB07	rs1799752:del/del	64139
ethanol	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1799971:AG	444899
rabeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*1	11985
omeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC01	*2/*2	9579578
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
warfarin	rs2260863	EPHX1	CG	Dosage	increased	Dosage	Healthy		B01AA03	rs2260863:CG	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	*3/*3	131769926
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*2/*2	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*2/*3	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*3/*3	11954257
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*1	9579578
captopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:del/del	44146831
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0014868|Disease:C0017168		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0014868|Disease:C0017168		A02BC01	*1/*3	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*1	9579578
losartan	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09CA01	rs1799752:del/del	11751549
tacrolimus	rs35599367	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:GG	131769926
thalidomide	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Dosage	increased	Dosage	Disease:C0014743|Disease:Leprosy		L04AX02	*2	5743568
carvedilol	CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0002962		C07AG02	*10	6322
efavirenz	CYP2B6*1	CYP2B6	*1/*1	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*1	64139
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Other:C0004238|Other:C0034065|Other:C0042487		B01AA03	*3	54688261
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*17/*17	9741
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*6	131769926
nicotine	low activity	CYP2A6	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C0039338	low activity	N07BA01	__UNKNOWN__	936
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*2	9741
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*17/*17	9741
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
imatinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:CC	6113
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*3	11985
paclitaxel	SLCO1B1*5, SLCO1B1*15	SLCO1B1	*5	Metabolism/PK	increased	LADME	Disease:C1458155		L01CD01	*5	36314
paclitaxel	SLCO1B1*5, SLCO1B1*15	SLCO1B1	*15	Metabolism/PK	increased	LADME	Disease:C1458155		L01CD01	*15	36314
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*2/*3	65327
imipramine	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AA02	*2/*2	65327
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC04	*1/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC04	*1/*3	11985
lamotrigine	rs7668258	UGT2B7	CC	Dosage, Metabolism/PK	increased	LADME	Healthy		N03AX09	rs7668258:CC	71236569
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC04	*1/*1	11985
buprenorphine	UGT2B7	UGT2B7	*2	Efficacy	decreased	Efficacy_Response	Disease:C0030193		N07BC01		11274356
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Dosage	increased	Dosage	Disease:C0026946		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Dosage	increased	Dosage	Disease:C0026946		J02AC03	*17/*17	9741
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	*2/*2	9741
imatinib	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AG	6113
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*17/*17	9741
tolbutamide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A10BB03	*1/*3	159651
tolbutamide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A10BB03	*2/*3	159651
tolbutamide	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Metabolism/PK	decreased	LADME	Healthy		A10BB03	*3/*3	159651
bupropion	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6/*6	446
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N06AX12	*1/*4	446
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*6	CYP2B6	*4/*6	Metabolism/PK	increased	LADME	Healthy		N06AX12	*4/*6	446
endoxifen	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	Indeterminado	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	__UNKNOWN__	131769920
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Healthy		R03DC01	*1/*3	10393637
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	increased	LADME	Healthy		R03DC01	*1/*13	10393637
dexlansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC06	*1/*2	71749086
dexlansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC06	*1/*3	71749086
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		R03DC01	*1/*3	10393637
zafirlukast	CYP2C9*1, CYP2C9*3, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		R03DC01	*1/*13	10393637
nelfinavir	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		J05AE04	*1/*2	475066
hydroxybupropion(bupropion)	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Healthy		N06AX12	*6/*6	446
nelfinavir	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0030297		J05AE04	*1/*2	475066
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*1/*6	446
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*1/*18	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*1/*18	446
ivacaftor, tezacaftor	rs113993960	CFTR	del/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs113993960:del/del	72722243
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT/TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs11322783:TT/TT	37542
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*6/*6	446
bupropion	CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22	CYP2B6	*6/*18	Metabolism/PK	decreased	LADME	Disease:C0039338		N06AX12	*6/*18	446
ivacaftor, tezacaftor	rs113993960	CFTR	CTT/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs113993960:CTT/del	72722243
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Dosage	increased	Dosage	Disease:C0004238		B01AA03	*1/*2	54688261
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Dosage	increased	Dosage	Disease:C0004238		B01AA03	*1/*3	54688261
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Dosage	increased	Dosage	Disease:C0004238		B01AA03	*1/*1	54688261
atomoxetine	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		N06BA09	*10/*10	6093336
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*6	131769926
atomoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Disease:C1263846	poor metabolizer	N06BA09	__UNKNOWN__	6093336
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*1	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*2	11985
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC03	*1/*3	11985
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*1	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*3	9579578
gemcitabine	rs60369023	CDA	A	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC05	rs60369023:A	597
apixaban, dabigatran, edoxaban, rivaroxaban	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs1045642:GG	216210
atazanavir	rs2472677	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AE08	rs2472677:TT	118753185
imatinib	rs2032582	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:A	6113
antidepressants	rs1360780	FKBP5	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:CC	No_match
imatinib	rs1128503	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs1128503:A	6113
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
antidepressants	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs5443:CC	No_match
antidepressants	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs5443:CT	No_match
imatinib	rs1045642	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:A	6113
antidepressants	rs3800373	FKBP5	AC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:AC	No_match
antidepressants	rs3800373	FKBP5	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:CC	No_match
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
methadone	rs963549	OPRK1	CC	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs963549:CC	10090
antipsychotics	rs1128503	ABCB1	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs1128503:AA	No_match
imatinib	rs2231142	ABCG2	T	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2231142:T	6113
efavirenz	rs3745274	CYP2B6	GT	Efficacy	decreased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Efficacy	decreased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
tacrolimus	rs4823613	PPARA	G	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs4823613:G	131769926
infliximab	rs3794271	SLCO1C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB02	rs3794271:G	No_match
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
tacrolimus	rs1057868	POR	T	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs1057868:T	131769926
dalcetrapib	rs1967309	ADCY9	AA	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1967309:AA	6918540
antidepressants	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6265:CT	No_match
beta blocking agents, flecainide	rs1801253	ADRB1	G	Efficacy	decreased	Efficacy_Response	Disease:C0039231		C01BC04|S01ED	rs1801253:G	3356
methotrexate	rs717620	ABCC2	T	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs717620:T	11329481
rituximab	rs396991	FCGR3A	AA	Efficacy	increased	Efficacy_Response	Other:C0030353		L01FA01	rs396991:AA	No_match
efavirenz	CYP2B6*1, CYP2B6*18	CYP2B6	*18	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*18	64139
drugs used in alcohol dependence	rs13273672	GATA4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085762		N07BB	rs13273672:CC	No_match
chorionic gonadotropin	rs6166	FSHR	CC	Dosage	increased	Dosage	Healthy		G03GA01	rs6166:CC	No_match
bepridil	CYP2D6*10	CYP2D6	*10	Metabolism/PK	increased	LADME	Disease:C0018824		No_ATC	*10	2351
tacrolimus	rs35599367	CYP3A4	GG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs35599367:GG	131769926
nicardipine, nimodipine	rs2739260	CACNA1B	AG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739260:AG	4497
nicardipine, nimodipine	rs2739260	CACNA1B	GG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739260:GG	4497
citalopram, escitalopram	rs10975641	GLDC	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB04|N06AB10	rs10975641:G	162180
cortisone acetate	CYP3A7*1A, CYP3A7*1C	CYP3A7	*1C	Dosage	decreased	Dosage	Disease:C0011351|Congenital		S01BA03	*1C	5745
daunorubicin	G6PD A- 202A_376G	G6PD	A-202A_376G	Metabolism/PK	decreased	LADME	Healthy		L01DB02		11570269
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC03	*4/*4	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*4/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC03	*4/*7	5386
tegafur	CYP2A6*1, CYP2A6*4, CYP2A6*7	CYP2A6	*7/*7	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC03	*7/*7	5386
efavirenz	CYP2A6*2	CYP2A6	*2	Other, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	*2	64139
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Efficacy	decreased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage, Efficacy	decreased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	*3/*3	54688261
metformin	rs11868513	HNF1B	AA	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs11868513:AA	155906370
metformin	rs11868513	HNF1B	AG	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs11868513:AG	155906370
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
ibuprofen	CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3	53464135
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
warfarin	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
atorvastatin	rs2242480	CYP3A4	C/C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA05	rs2242480:C/C	656846
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*1	11985
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
glatiramer acetate	HLA-DRB1*15:01	HLA-DRB1	*15:01	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	*15:01	3081884
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3	Dosage, Metabolism/PK	decreased	LADME	Disease:C0007222		B01AA03	*3	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	Dosage	Disease:C0007222		B01AA03	*3	54688261
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*1	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*2/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Efficacy	increased	Efficacy_Response	Disease:C0002962		B01AC04	*3/*17	13748464
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
caffeine	NAT2*4	NAT2	*4	Metabolism/PK	increased	LADME	Healthy		N06BC01	*4	936
atorvastatin	rs2242480	CYP3A4	C/C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA05	rs2242480:C/C	656846
diazepam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Other, Metabolism/PK	decreased	LADME	Healthy		N05BA01	*2	3016
diazepam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Other, Metabolism/PK	decreased	LADME	Healthy		N05BA01	*3	3016
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""interferons"", ""peginterferon alfa-2a"", ""peginterferon alfa-2b"", ""ribavirin"""	rs1946518	IL18	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB|L03AB04|L03AB05|L03AB10|L03AB11	rs1946518:T	71306834
fluoxetine, paroxetine	rs57098334	SLC6A4	(CCCACCCGA)12/(CCCACCCGA)12	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB03|N06AB05	rs57098334:(CCCACCCGA)12/(CCCACCCGA)12	667572
ibuprofen	CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3	53464135
venlafaxine	CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0011581		N06AX16	*4/*4	9795857
tacrolimus	rs1057868	POR	CC	Metabolism/PK	decreased	LADME	Healthy		L04AD02	rs1057868:CC	131769926
acenocoumarol	CYP2C9*2	CYP2C9	*2	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*2	54742534
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	poor metabolizer	TPMT	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0021390	poor metabolizer	No_ATC	__UNKNOWN__	3440921
valproic acid	CYP2A6*1, CYP2A6*4	CYP2A6	*4	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AG01	*4	134459
tegafur	CYP2A6*1, CYP2A6*4	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy		L01BC03	*4	5386
nicotine	CYP2A6*1, CYP2A6*7	CYP2A6	*1/*7	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*1/*7	936
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage	decreased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*2/*2	54688261
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	*3	13748464
warfarin	CYP4F2*1, CYP4F2*3	CYP4F2	*3/*3	Dosage	increased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	*2/*3	54688261
paclitaxel	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD01	*1/*3	36314
paclitaxel	CYP2C8*1, CYP2C8*3	CYP2C8	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD01	*3/*3	36314
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*4	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*1/*4	936
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*9	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*1/*9	936
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*4	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*4/*4	936
caffeine	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*9	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	*4/*9	936
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0040038		B01AA03	*1/*3	54688261
tocilizumab	rs4845625	IL6R	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4845625:CT	No_match
tocilizumab	rs4845625	IL6R	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4845625:TT	No_match
acenocoumarol	CYP2C9*3	CYP2C9	*3	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	*3	54742534
rosuvastatin	rs17216198	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs17216198:T	5282455
atorvastatin	rs2242480	CYP3A4	T/T	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA05	rs2242480:T/T	656846
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	rs4244285:AG	13748464
fluvastatin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Metabolism/PK	increased	LADME	Healthy		C10AA04	*2	131750727
mirtazapine	CYP2B6*6	CYP2B6	*6/*6	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AX11	*6/*6	6451144
sulfapyridine	NAT2*7	NAT2	*7/*7	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*7/*7	5336
methotrexate	rs1051266	SLC19A1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1051266:CT	11329481
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage, Metabolism/PK	decreased	LADME	Disease:C0007222		B01AA03	*2	54688261
warfarin	CYP2C9*2	CYP2C9	*2	Metabolism/PK	decreased	Dosage	Disease:C0007222		B01AA03	*2	54688261
isoniazid	NAT2*4	NAT2	*4	Metabolism/PK	increased	LADME	Healthy		J04AC01	*4	135483892
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""interferons"", ""peginterferon alfa-2a"", ""peginterferon alfa-2b"", ""ribavirin"""	rs187238	IL18	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB|L03AB04|L03AB05|L03AB10|L03AB11	rs187238:C	71306834
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Metabolism/PK	decreased	LADME	Other:human_liver_microsomes		J05AG03	*6	64139
acenocoumarol	CYP2C9*1	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA07	*1/*1	54742534
isoniazid	NAT2*4	NAT2	*4/*4	Metabolism/PK	increased	LADME	Disease:C0041296		J04AC01	*4/*4	135483892
isoniazid	NAT2*4	NAT2	*4/*4	Metabolism/PK	increased	LADME	Disease:C0041296		J04AC01	*4/*4	135483892
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
ibuprofen	CYP2C8*3	CYP2C8	*3	Metabolism/PK	decreased	LADME	Healthy		M02AA13	*3	53464135
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
acenocoumarol	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3	54742534
acenocoumarol	CYP2C9*1	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA07	*1/*1	54742534
acenocoumarol	CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2	54742534
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
warfarin	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0178298		C09CA01	*1/*3	11751549
losartan	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*3	11751549
tropisetron	CYP2D6*3	CYP2D6	*3/*3	Efficacy	decreased	LADME	Disease:C0027651		A04AA03	*3/*3	656665
metoprolol	CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*10	6322
losartan	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0178298		C09CA01	*1/*2	11751549
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*3	91987769
clopidogrel	CYP2C19*2	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Disease:C0151744		B01AC04	*2	13748464
olmesartan	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15	Metabolism/PK	decreased	LADME	Healthy		C09CA08	*15	158781
tacrolimus	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*2/*2	131769926
metoprolol	CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		C07AB02	*10	6322
rosuvastatin	SLCO1B1*15, SLCO1B1*37	SLCO1B1	*15/*15	Metabolism/PK	decreased	LADME	Healthy		C10AA07	*15/*15	5282455
simvastatin	CYP3A4*1, CYP3A4*4	CYP3A4	*1/*4	Efficacy	increased	Efficacy_Response	Disease:C0020473		C10AA01	*1/*4	14373154
losartan	CYP2C9*1, CYP2C9*13	CYP2C9	*1/*13	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*13	11751549
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Healthy		B01AA04	*3	91987769
ondansetron	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*1xN	Efficacy	decreased	Efficacy_Response	Healthy		A04AA01	*1xN	4595
ondansetron	CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN	CYP2D6	*2xN	Efficacy	decreased	Efficacy_Response	Healthy		A04AA01	*2xN	4595
nateglinide	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		A10BX03	*1/*3	5311309
phenprocoumon	CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA04	*2	91987769
phenprocoumon	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA04	*3	91987769
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*10	849421
haloperidol	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10	9828
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC03	*1/*1	11985
carvedilol	CYP2D6*1, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	*1/*4	6322
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
rosuvastatin	rs3740066	ABCC2	T	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs3740066:T	5282455
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC02	*1/*1	11954257
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1	11985
carvedilol	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*4/*5	6322
carvedilol	CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Dosage	increased	Dosage	Disease:C0085605		C07AG02	*4/*6	6322
clopidogrel	CYP2C19*1	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*1	13748464
omeprazole, pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02	*1/*2	4679
carvedilol	CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	*10/*10	6322
carvedilol	CYP2D6*1, CYP2D6*5	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	*1/*5	6322
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Healthy		A02BC04	*2/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Healthy		A02BC04	*3/*3	11985
carvedilol	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		C07AG02	*10/*10	6322
zuclopenthixol	CYP2D6*1, CYP2D6*3	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AF05	*3	5311507
risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	*4/*4	849421
fluoxetine	rs3892097	CYP2D6	CC	Efficacy	increased	Efficacy_Response	Efficacy:C0085762|Efficacy:C0011581		N06AB03	rs3892097:CC	1548968
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Dosage, Efficacy	decreased	Dosage	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	*4/*4	9417
sufentanil	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	*1/*3	41693
sufentanil	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	*3/*3	41693
metformin	rs6719578	__INTRONIC__	CG	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs6719578:CG	155906370
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Efficacy, Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*10	849421
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
mephenytoin, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy		A02BC01|N03AB02	*2/*3	4060
haloperidol	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AD01	*10	9828
risperidone	CYP2D6*1, CYP2D6*4	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AX08	*4	849421
methotrexate	rs4673993	ATIC	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:CC	11329481
lornoxicam	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AC05	*1/*3	54691489
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC01	*1/*1	9579578
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC03	*1/*1	11985
rabeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1	11985
esomeprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC05	*1/*1	9579578
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N02AX02	*4/*4	63013
clopidogrel	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0007222		B01AC04	*3/*3	13748464
lansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*1/*2	11985
dexlansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC06	*2/*2	71749086
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
lovastatin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		C10AA02	*10	40474546
lovastatin	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		C10AA02	*5	40474546
benzbromarone	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M04AB03	*1/*3	2333
labetalol	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		C07AG01	*2/*2	137553867
celecoxib	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Metabolism/PK	increased	LADME	Healthy		M01AH01	*1/*2	66824
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0079487		A02BC01	*1/*1	9579578
bupropion	CYP2B6*1, CYP2B6*22	CYP2B6	*1/*22	Metabolism/PK	increased	LADME	Healthy		N06AX12	*1/*22	446
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*1	9741
lansoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC03	*2/*2	11985
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
fluoxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03		1548968
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Dosage	decreased	Dosage	Disease:C0156318|Disease:Lung_transplantation		J02AC03	*1/*2	9741
paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0030319		N06AB05		667572
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
fluoxetine, paroxetine	SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB05		667572
hydralazine	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0020538	slow acetylator	C02DB02	__UNKNOWN__	81764
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	*17/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*1/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy, Toxicity	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	*2/*3	13748464
pioglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*1	Metabolism/PK	decreased	LADME	Healthy		A10BG03	*1/*1	60560
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	HLA-A*01:01	HLA-A	*01:01	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	*01:01	37542
citalopram, fluoxetine, paroxetine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05		667572
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
efavirenz	rs70950385	CYP2B6	CA/CA	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs70950385:CA/CA	64139
aspirin, clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	*2/*2	2244
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3	54742534
mephenytoin	rs28399504	CYP2C19	G	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs28399504:G	91480
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA07	*2/*2	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3	54742534
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10/*10	10090750
tamoxifen, endoxifen	CYP2D6*1, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*5/*5	10090750
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA07	*3/*3	54742534
lamivudine, nevirapine, stavudine	HLA-B*40:01	HLA-B	*40:01	Efficacy	Indeterminado	Efficacy_Response	Disease:HIV_infectious_disease		J05AF04|J05AF05|J05AG01	*40:01	15979285
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	*2/*2	9741
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*1/*60	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*1/*60	6918638
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*60/*60	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	*60/*60	6918638
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*1/*60	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	*1/*60	6918638
belinostat	UGT1A1*1, UGT1A1*60	UGT1A1	*60/*60	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	*60/*60	6918638
doxepin	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy		N06AA12	*2/*2	59023617
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*2	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*2	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*10	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*1/*3	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*1/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*5/*10	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*3/*4	9918
boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs11322783	IFNL4	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10|L03AB11	rs11322783:TT	37542
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*5	Dosage	decreased	Dosage	Healthy		B01AA03	*5	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*6	Dosage	decreased	Dosage	Healthy		B01AA03	*6	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11	CYP2C9	*11	Dosage	decreased	Dosage	Healthy		B01AA03	*11	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*2	4543
amitriptyline	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy		N06AA09	*2/*3	4543
voriconazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		J02AC03	*1/*1	9741
deferasirox	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	decreased	LADME	Disease:C0002871		V03AC03	*1/*28	214348
deferasirox	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	decreased	LADME	Disease:C0002871		V03AC03	*28/*28	214348
clopidogrel, prasugrel, ticagrelor	rs4244285	CYP2C19	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04|B01AC22|B01AC24	rs4244285:A	9871419
clopidogrel	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0027051|Disease:C0018839		B01AC04	*2/*2	13748464
efavirenz	CYP2B6*1, CYP2B6*11	CYP2B6	*11	Metabolism/PK	decreased	LADME	Healthy		J05AG03	*11	64139
valproic acid	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Disease:C0005586|Disease:C0033975		N03AG01	*1/*2	134459
valproic acid	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Disease:C0005586|Disease:C0033975		N03AG01	*1/*3	134459
warfarin	rs41301394	POR	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs41301394:CT	54688261
warfarin	rs41301394	POR	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs41301394:TT	54688261
carboplatin, paclitaxel	rs1695	GSTP1	G	Toxicity	decreased	Efficacy_Response	Other:C0919267		L01CD01|L01XA02	rs1695:G	10339178
voriconazole	ultrarapid metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0026946	ultrarapid metabolizer	J02AC03	__UNKNOWN__	9741
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*6	64139
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
acenocoumarol	CYP2C9*1, CYP2C9*2	CYP2C9	*2	Dosage	decreased	Dosage	Disease:C0004238		B01AA07	*2	54742534
tacrolimus	CYP3A4*1, CYP3A4*18	CYP3A4	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
cisplatin	rs3807348	MIR335	AA	Efficacy	increased	Efficacy_Response	Other:C0025500		L01XA01	rs3807348:AA	441203
cisplatin	rs3807348	MIR335	AG	Efficacy	increased	Efficacy_Response	Other:C0025500		L01XA01	rs3807348:AG	441203
celecoxib	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		M01AH01	*1/*3	66824
cyclophosphamide, doxorubicin	rs6151031	ALDH1A1	CTGGTGAGGAGAGAACC/del	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs6151031:CTGGTGAGGAGAGAACC/del	2907
buprenorphine, methadone	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)/HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01|N07BC02		4095
warfarin	low activity	VKORC1	__UNKNOWN__	Dosage	decreased	Dosage	Healthy	low activity	B01AA03		54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	*2/*17	13748464
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*2/*17	9741
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*3/*3	131769926
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*3	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*3	118753185
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*6	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*6	118753185
atazanavir	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*7	Metabolism/PK	decreased	LADME	Healthy		J05AE08	*7	118753185
clozapine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	LADME	Disease:C0036337|Disease:C0036341		N05AH02	*1/*3	131769989
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Other:heart_transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	decreased	LADME	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	decreased	LADME	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3	131769926
sirolimus, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	5284616
sirolimus, tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	5284616
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
nimodipine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	LADME	Healthy		C08CA06	*3/*3	4497
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:C0009324		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:C0009324		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
carbamazepine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	*3/*3	114709
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:C0027651|Disease:C0030193		N02AB03	*3/*3	13653606
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3	131769926
fentanyl	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0030193|Postoperative		N02AB03	*3/*3	13653606
midazolam	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0027651		N05CD08	*1/*3	5384200
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD01	*3	86666680
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Hematopoietic_stem_cell_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1	131769926
fentanyl	CYP2D6*1, CYP2D6*9	CYP2D6	*9	Metabolism/PK	decreased	LADME	Other:C0006434		N02AB03	*9	13653606
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	*1/*3	131769926
simvastatin	rs3917643	F3	CT	Efficacy	increased	Efficacy_Response	Disease:C0151744		C10AA01	rs3917643:CT	14373154
ivacaftor / lumacaftor	rs113993960	CFTR	del/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX30	rs113993960:del/del	16220172
acetylcholine, nitroprusside	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	Efficacy	increased	Efficacy_Response	Healthy		C02DD01|S01EB09	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC	187
fluvastatin	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA04	rs1799752:del/del	131750727
ivacaftor	rs113993960	CFTR	CTT/del	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs113993960:CTT/del	72722243
enalapril	rs1799752	ACE	ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	Efficacy	increased	Efficacy_Response	Disease:C0003850		C09AA02	rs1799752:ATACAGTCACTTTTTTTTTTTTTTTGAGACGGAGTCTCGCTCTGTCGCCC/del	5950
enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0003850		C09AA02	rs1799752:del/del	5950
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	9887054
imatinib	rs776746	CYP3A5	C	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs776746:C	6113
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*22	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*22/*22	131769926
metoclopramide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Healthy		A03FA01	*1/*10	21761
metoclopramide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		A03FA01	*10/*10	21761
metoclopramide	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy		A03FA01	*5/*10	21761
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*22	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*22/*22	131769926
fentanyl, meperidine, midazolam	poor metabolizer	CYP3A5	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Other:C0235195	poor metabolizer	N02AB03|N05CD08	__UNKNOWN__	3345
fentanyl, meperidine, midazolam	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Other:C0235195	intermediate metabolizer and poor metabolizer	N02AB03|N05CD08	__UNKNOWN__	3345
fentanyl, meperidine, midazolam	poor metabolizer	UGT1A1	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Other:C0235195	poor metabolizer	N02AB03|N05CD08	__UNKNOWN__	3345
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG	131769926
4-hydroxytamoxifen(tamoxifen)	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	*1/*17	5352135
4-hydroxytamoxifen(tamoxifen)	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	*17/*17	5352135
tamsulosin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer	G04CA02	*1/*4	5362376
tamsulosin	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer	G04CA02	*4/*10	5362376
imatinib	rs2242480	CYP3A4	C	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2242480:C	6113
fulvestrant	poor metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1458155|Other:C2939419	intermediate metabolizer and poor metabolizer	L02BA03	__UNKNOWN__	104741
anastrozole	intermediate metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155|Other:C2939419	intermediate metabolizer and poor metabolizer	L02BG03	__UNKNOWN__	713
anastrozole	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Other:C1458155|Other:C2939419	intermediate metabolizer	L02BG03	*1/*22	713
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*2/*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3/*3	54688261
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*1/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*2/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0023418	intermediate metabolizer and poor metabolizer	J02AC03	*3/*3	9741
abatacept	HLA-DRB1*04:05	HLA-DRB1	*04:05	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:05	No_match
esomeprazole	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	A02BC05	__UNKNOWN__	9579578
esomeprazole	rapid metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	rapid metabolizer	A02BC05	__UNKNOWN__	9579578
etanercept	rs3794271	SLCO1C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs3794271:G	No_match
apatinib	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:C0027651		L01EH01	*1/*1	45139106
apatinib	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0027651		L01EH01	*1/*3	45139106
escitalopram	rapid metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer and rapid metabolizer	N06AB10	__UNKNOWN__	162180
escitalopram	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N06AB10	__UNKNOWN__	162180
sertraline	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N06AB06	__UNKNOWN__	18642483
duloxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AX21	__UNKNOWN__	44344115
amoxicillin, clarithromycin, omeprazole	rs7975232	VDR	A	Efficacy	increased	Efficacy_Response	Other:C0079487		A02BC01|J01CA04|J01FA09	rs7975232:A	33613
amoxicillin, clarithromycin, omeprazole	rs2228570	VDR	A	Efficacy	increased	Efficacy_Response	Other:C0079487		A02BC01|J01CA04|J01FA09	rs2228570:A	33613
metoprolol	rs1065852	CYP2D6	A	Metabolism/PK	increased	LADME	Healthy		C07AB02	rs1065852:A	6322
bupropion, naltrexone	rs1800497	ANKK1, DRD2	AA	Efficacy	increased	Efficacy_Response	Other:C0028754		N06AX12|N07BB04	rs1800497:AA	5360515
bupropion, naltrexone	rs1800497	ANKK1, DRD2	AG	Efficacy	increased	Efficacy_Response	Other:C0028754		N06AX12|N07BB04	rs1800497:AG	5360515
alpha-hydroxymetoprolol	rs1065852	CYP2D6	A	Metabolism/PK	decreased	LADME	Healthy		C07AB02	rs1065852:A	114962
tolperisone	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*10/*10	688590
tolperisone	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	688590
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Other:Heart_transplantation		L04AD02	*3/*3	131769926
dapoxetine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	G04BX14	*10/*10	8530
risperidone	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1510586	intermediate metabolizer	N05AX08	__UNKNOWN__	849421
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*1	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
dapoxetine	CYP2D6*1, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	G04BX14	*10/*41	8530
docetaxel, thalidomide	rs6922548	PPARD	G	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs6922548:G	148124
sn-38(irinotecan)	UGT1A1*1, UGT1A1*6	UGT1A1	*6	Metabolism/PK	increased	LADME	Other:C0022665		L01CE02	*6	60838
o-desmethyltramadol	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0030193|Postoperative	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__	9816106
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*22	131769926
naldemedine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:C0027651|Other:C0030193|Other:C0009806		No_ATC	*3/*3	56837137
methadone	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy		N07BC02	*6/*6	10090
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*41, CYP2D6*65	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:C0036341	intermediate metabolizer	N05AX08	*10/*10	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*41, CYP2D6*65	CYP2D6	*10/*65	Metabolism/PK	increased	LADME	Other:C0036341	intermediate metabolizer	N05AX08	*10/*65	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*41, CYP2D6*65	CYP2D6	*10/*41	Metabolism/PK	increased	LADME	Other:C0036341	intermediate metabolizer	N05AX08	*10/*41	849421
docetaxel, thalidomide	rs7769719	PPARD	G	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs7769719:G	148124
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
warfarin	rs2288344	NEDD4	G	Dosage	increased	Dosage	Healthy		B01AA03	rs2288344:G	54688261
quetiapine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Other:C0005586		N05AH04	*3/*3	118753024
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
warfarin	rs17126068	DDHD1	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs17126068:G	54688261
tacrolimus	intermediate metabolizer	CYP3A5	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Lung_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	__UNKNOWN__	131769926
primaquine 5,6-orthoquinone	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	P01BA03	__UNKNOWN__	4908
cisplatin, irinotecan	rs4148323	UGT1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs4148323:AA	5460033
primaquine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	P01BA03	__UNKNOWN__	6135
desvenlafaxine, venlafaxine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0011581	poor metabolizer	N06AX16|N06AX23	__UNKNOWN__	125017
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
acenocoumarol	rs9923231	VKORC1	T	Efficacy	increased	Efficacy_Response	Healthy		B01AA07	rs9923231:T	54742534
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)2/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	11329481
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*22	131769926
salbutamol	rs7903366	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs7903366:T	2083
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*2	1917817
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*3	1917817
paliperidone, risperidone	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		N05AX08|N05AX13	rs1045642:GG	9802545
losartan	rs1057910	CYP2C9	C	Metabolism/PK	decreased	LADME	PK:C0024198		C09CA01	rs1057910:C	11751549
sulfapyridine	NAT2*5	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*5	5336
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	decreased	Efficacy_Response	Disease:C0018839	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839	poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0018839	poor metabolizer	B01AC04	*3/*3	13748464
risperidone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0005586|Disease:C0235876|Disease:C0033975|Disease:C0036502	poor metabolizer	N05AX08	__UNKNOWN__	849421
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*16/*16	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*16/*6	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*6	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*7	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*7/*7	135483892
salbutamol	rs7081864	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs7081864:A	2083
sulfinpyrazone	rs72551330	UGT1A9	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs72551330:T	5342
sulfamethoxazole	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*4	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation	rapid acetylator	J01EC01	*4/*4	114821
icotinib	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*2	22024915
icotinib	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Healthy		No_ATC	*1/*3	22024915
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1051792	MICA	AA	Efficacy	decreased	Efficacy_Response	Other:C0038012		No_ATC	rs1051792:AA	No_match
warfarin	rs9923231	VKORC1	GG	Dosage	increased	Dosage	Other:C0004238|Other:C0034065|Other:C0042487		B01AA03	rs9923231:GG	54688261
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*9	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N02AX02	*1/*4	63013
tramadol	CYP2D6*1, CYP2D6*4, CYP2D6*9	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N02AX02	*1/*9	63013
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__	65327
sulfapyridine	NAT2*4, NAT2*5	NAT2	*5	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5	5336
3,4-methylenedioxymethamphetamine	ultrarapid metabolizer genotype	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	V04CX05	__UNKNOWN__	1615
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*1/*2xN	10090
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*2/*2xN	10090
lithium	rs6438552	GSK3B	GG	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs6438552:GG	11125
tacrolimus	rs1045642	ABCB1	AA	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	rs1045642:AA	131769926
lithium	rs2071427	NR1D1, THRA	TT	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs2071427:TT	11125
tacrolimus	poor metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation	poor metabolizer	L04AD02	__UNKNOWN__	131769926
morphine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AA01	__UNKNOWN__	5284371
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
sulfapyridine	NAT2*5	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*5	5336
aripiprazole	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	poor metabolizer	N05AX12	__UNKNOWN__	10114519
atomoxetine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06BA09	__UNKNOWN__	6093336
sulfapyridine	NAT2*4, NAT2*6	NAT2	*6	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*6	5336
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Metabolism/PK	decreased	LADME	Other:Heart_transplantation	normal metabolizer and intermediate metabolizer	L04AD02	*1/*7	131769926
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*5	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*6J	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6J	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*5/*7G	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7G	135483892
isoniazid	NAT2*1, NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G, NAT2*39	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*7	135483892
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1045642:GG	131769926
infliximab	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	*05	No_match
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AA	131769926
sulfapyridine	NAT2*6	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*6/*6	5336
enzyme inhibitors	rs700518	CYP19A1	CC	Other	Indeterminado	Efficacy_Response	Disease:C1458155		No_ATC	rs700518:CC	No_match
tacrolimus	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1128503:AA	131769926
corticosteroids	rs28364072	FCER2	G	Dosage	increased	Dosage	Disease:C0004096		S02BA	rs28364072:G	No_match
tacrolimus	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:AA	131769926
hydrochlorothiazide, olmesartan	rs34059508	SLC22A1	AG	Metabolism/PK	increased	LADME	Healthy		C03AA03|C09CA08	rs34059508:AG	158781
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1045642:AG	131769926
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1045642:GG	131769926
hydralazine	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*16	Metabolism/PK	increased	LADME	Other:C0020538|Other:C0032961	rapid acetylator	C02DB02	*4/*16	81764
hydralazine	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*6	Metabolism/PK	increased	LADME	Other:C0020538|Other:C0032961	rapid acetylator	C02DB02	*4/*6	81764
hydralazine	NAT2*4, NAT2*6, NAT2*7, NAT2*16	NAT2	*4/*7	Metabolism/PK	increased	LADME	Other:C0020538|Other:C0032961	rapid acetylator	C02DB02	*4/*7	81764
haloperidol	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	poor metabolizer	N05AD01	__UNKNOWN__	9828
escitalopram	rs12154537	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB10	rs12154537:G	162180
morphine	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs1128503:AG	5284371
morphine	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs1128503:GG	5284371
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*16	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*16/*16	5336
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*5	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*16/*5	5336
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*16/*6	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*16/*6	5336
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*6	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*6/*6	5336
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*6/*7	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*6/*7	5336
sulfapyridine	NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*16	NAT2	*7/*7	Metabolism/PK	increased	LADME	Healthy	slow acetylator	J01EB04	*7/*7	5336
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16, NAT2*19	NAT2	*4/*4	Dosage, Metabolism/PK	increased	Dosage	Disease:C0041296	rapid acetylator	J04AC01	*4/*4	135483892
docetaxel	rs11045585	SLCO1B3	G	Other, Metabolism/PK	decreased	LADME	Disease:C0023055		L01CD02	rs11045585:G	154272
sulfapyridine	NAT2*5, NAT2*7	NAT2	*5/*7	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*7	5336
docetaxel	rs7311358	SLCO1B3	A	Other, Metabolism/PK	decreased	LADME	Disease:C0023055		L01CD02	rs7311358:A	154272
docetaxel	rs4149118	SLCO1B3	G	Other, Metabolism/PK	decreased	LADME	Disease:C0023055		L01CD02	rs4149118:G	154272
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*5	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*5	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*6	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*6J	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*6J	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*5/*7G	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*5/*7G	135483892
isoniazid	NAT2*4, NAT2*5, NAT2*6, NAT2*6J, NAT2*7, NAT2*7G	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Disease:C0041296	slow acetylator	J04AC01	*6/*7	135483892
sulfapyridine	NAT2*4, NAT2*7	NAT2	*7	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*7	5336
warfarin	rs9934438	VKORC1	A	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:Heart_transplantation	poor metabolizer	L04AD02	*1/*22	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:Heart_transplantation	poor metabolizer	L04AD02	*22/*22	131769926
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC01	*1/*3	9579578
midazolam	rs1544410	VDR	C	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs1544410:C	5384200
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1154831	KLRC4	GG	Efficacy	increased	Efficacy_Response	Other:C0038012		No_ATC	rs1154831:GG	No_match
diazepam	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05BA01	__UNKNOWN__	3016
escitalopram	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0235876|Other:C0003469	intermediate metabolizer	N06AB10	__UNKNOWN__	162180
methadone	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0028043	ultrarapid metabolizer	N07BC02	__UNKNOWN__	10090
fluoxetine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0011581|Efficacy:C0028768	ultrarapid metabolizer	N06AB03	__UNKNOWN__	1548968
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*14	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*14	81764
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*16	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*16	81764
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*6	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*6	81764
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*7	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*16/*7	81764
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*14	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*6/*14	81764
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*6	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*6/*6	81764
hydralazine	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7/*6	Efficacy	increased	Efficacy_Response	Other:C0544618	slow acetylator	C02DB02	*7/*6	81764
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*14	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*14	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*16	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*16	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*6	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*6	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*7	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*7	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*14	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*14	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*6	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*6	135483892
isoniazid	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*7	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*7	135483892
sulfapyridine	NAT2*5, NAT2*6	NAT2	*5/*6	Metabolism/PK	decreased	LADME	Healthy		J01EB04	*5/*6	5336
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*14	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*14	71602
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*16	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*16	71602
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*6	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*6	71602
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*16/*7	71602
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*14	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*14	71602
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*6	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*6	71602
acetylisoniazid(isoniazid)	NAT2*4, NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6/*7	Metabolism/PK	decreased	LADME	Other:C0041296	slow acetylator	J04AC01	*6/*7	71602
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*16	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*16	121882
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*6	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*6	121882
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*7	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*7	121882
dipyrone	NAT2*6, NAT2*7, NAT2*14, NAT2*16	NAT2	*14	Metabolism/PK	decreased	LADME	Healthy	slow acetylator	No_ATC	*14	121882
bupropion	CYP2B6*6	CYP2B6	*6	Metabolism/PK	increased	LADME	Other:C0011581		N06AX12	*6	446
codeine	CYP2D6*1, CYP2D6*1xN, CYP2D6*41	CYP2D6	*1xN/*41	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1xN/*41	5284371
warfarin	rs7294	VKORC1	T	Dosage, Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs7294:T	54688261
paramethoxymethamphetamine	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0036502	normal metabolizer	No_ATC	__UNKNOWN__	No_match
maraviroc	intermediate metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease	intermediate metabolizer	J05AX09	__UNKNOWN__	3002977
clopidogrel	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	B01AC04	__UNKNOWN__	13748464
codeine	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1/*2xN	5284371
endoxifen	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
codeine	CYP2D6*2, CYP2D6*2xN, CYP2D6*41	CYP2D6	*2xN/*41	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*2xN/*41	5284371
codeine	CYP2D6*1, CYP2D6*1xN, CYP2D6*10	CYP2D6	*1xN/*10	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1xN/*10	5284371
endoxifen	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*3	9741
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*1/*2	162180
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*1/*3	162180
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*2/*17	162180
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*17	Metabolism/PK	increased	LADME	Healthy		N06AB04|N06AB10	*3/*17	162180
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AG03	rs3745274:TT	64139
nortriptyline	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	ultrarapid metabolizer	N06AA10	__UNKNOWN__	9918
haloperidol, olanzapine, perphenazine, quetiapine, risperidone	rs1799978	DRD2	C	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AB03|N05AD01|N05AH03|N05AH04|N05AX08	rs1799978:C	5073
maraviroc	poor metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AX09	__UNKNOWN__	3002977
citalopram, escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	decreased	LADME	Healthy	ultrarapid metabolizer	N06AB04|N06AB10	*17/*17	162180
nortriptyline	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	intermediate metabolizer	N06AA10	__UNKNOWN__	9918
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation	poor metabolizer	L04AD02	*1/*22	131769926
hydrocodone	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA03	__UNKNOWN__	5284371
imipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__	65327
atomoxetine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06BA09	__UNKNOWN__	6093336
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__	65327
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AA02	__UNKNOWN__	65327
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA02	__UNKNOWN__	65327
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
risperidone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	poor metabolizer	N05AX08	__UNKNOWN__	849421
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*2	Efficacy, Metabolism/PK	decreased	LADME	Disease:C1956346	poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*8	Efficacy, Metabolism/PK	decreased	LADME	Disease:C1956346	poor metabolizer	B01AC04	*1/*8	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*2	Efficacy, Metabolism/PK	decreased	LADME	Disease:C1956346	poor metabolizer	B01AC04	*2/*2	13748464
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	R05DA09	*10/*10	6603912
tamoxifen	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	Dosage	Disease:C1458155	intermediate metabolizer	L02BA01	__UNKNOWN__	2733525
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*1/*5	184819
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*2/*36	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*2/*36	184819
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*5/*10	184819
propafenone	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36	CYP2D6	*5/*5	Metabolism/PK	increased	LADME	Other:C0039231	poor metabolizer	C01BC03	*5/*5	184819
imipramine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Dosage	decreased	Dosage	Disease:C0011581	poor metabolizer	N06AA02	*4/*4	65327
imipramine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Dosage	decreased	Dosage	Disease:C0011581	poor metabolizer	N06AA02	*4/*5	65327
citalopram, escitalopram	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy		N06AB04|N06AB10	*1/*17	162180
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*2	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1956346	poor metabolizer	B01AC04	*1/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*1/*8	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1956346	poor metabolizer	B01AC04	*1/*8	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*8, CYP2C19*17	CYP2C19	*2/*2	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C1956346	poor metabolizer	B01AC04	*2/*2	13748464
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*4/*10	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*4/*10	36604
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*5/*10	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*5/*10	36604
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*5/*14	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*5/*14	36604
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*10/*10	36604
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*10/*18	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*10/*18	36604
methamphetamine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*18, CYP2D6*36	CYP2D6	*10/*36	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	No_ATC	*10/*36	36604
tolterodine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	G04BD07	__UNKNOWN__	443878
risperidone	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0033975|Other:C0036341	intermediate metabolizer and poor metabolizer	N05AX08	__UNKNOWN__	849421
tamoxifen, endoxifen	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	L02BA01	*2	10090750
tamoxifen, endoxifen	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*3	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	L02BA01	*3	10090750
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*5/*10	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*4/*10	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*10/*10	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	*10/*41	849421
venlafaxine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__	9795857
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*1/*2xN	Dosage	increased	Dosage	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*1/*2xN	10090
methadone	CYP2D6*1, CYP2D6*2, CYP2D6*2xN	CYP2D6	*2/*2xN	Dosage	increased	Dosage	Other:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC02	*2/*2xN	10090
desipramine, imipramine	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AA01|N06AA02	*4/*4	65327
desipramine, imipramine	CYP2D6*4, CYP2D6*5	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Disease:C0011581	poor metabolizer	N06AA01|N06AA02	*4/*5	65327
trans 4-hydroxypraziquantel	rs890293	CYP2J2	AA	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	rs890293:AA	No_match
trans 4-hydroxypraziquantel	rs890293	CYP2J2	AC	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	rs890293:AC	No_match
venlafaxine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__	9795857
perphenazine	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AB03	__UNKNOWN__	82341
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*1/*2	131769926
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*1/*3	131769926
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*2/*2	131769926
tacrolimus	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Dosage, Metabolism/PK	decreased	Dosage	Other:Heart_transplantation	intermediate metabolizer and poor metabolizer	L04AD02	*2/*3	131769926
vortioxetine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Toxicity	increased	Adverse_Event	Healthy	poor metabolizer	N06AX26	*4/*4	7929
fentanyl	poor metabolizers	__INTRONIC__	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0030193	poor metabolizer	N02AB03		13653606
escitalopram	ultrarapid metabolizer phenotype	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0011581	ultrarapid metabolizer	N06AB10	__UNKNOWN__	162180
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*1/*1	Metabolism/PK	increased	Dosage	Healthy	normal metabolizer	B01AA03	*1/*1	54688261
nortriptyline	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	poor metabolizer	N06AA10	__UNKNOWN__	9918
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*1/*5	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*5/*10	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*10	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*14	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*14	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*41	667572
escitalopram	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	poor metabolizer	N06AB10	__UNKNOWN__	162180
ethanol	rs2075572	OPRM1	G	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs2075572:G	444899
proton pump inhibitors	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0079487	intermediate metabolizer and poor metabolizer	A02BC	__UNKNOWN__	5460653
tramadol	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AX02	__UNKNOWN__	63013
metoprolol	poor metabolizers	CYP2D6	__UNKNOWN__	Dosage	decreased	Dosage	Healthy	poor metabolizer	C07AB02	__UNKNOWN__	6322
ethanol	rs548646	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs548646:T	444899
gliclazide	rs2237892	KCNQ1	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB09	rs2237892:T	169502072
nicotine	rs1799732	DRD2	G/del	Efficacy	increased	Efficacy_Response	Disease:C0039338		N07BA01	rs1799732:G/del	936
nicotine	rs1799732	DRD2	del/del	Efficacy	increased	Efficacy_Response	Disease:C0039338		N07BA01	rs1799732:del/del	936
paroxetine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB05	__UNKNOWN__	667572
desipramine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__	65327
linagliptin	rs7903146	TCF7L2	CC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH05	rs7903146:CC	91971625
linagliptin	rs7903146	TCF7L2	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH05	rs7903146:CT	91971625
citalopram, escitalopram	poor metabolizer phenotype	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C0011581	poor metabolizer	N06AB04|N06AB10	__UNKNOWN__	162180
ethanol	rs681243	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs681243:T	444899
dextromethorphan	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	R05DA09	__UNKNOWN__	6603912
tramadol	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AX02	__UNKNOWN__	63013
hydroxybupropion(bupropion)	poor metabolizer and intermediate metabolizer genotypes	CYP2B6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N06AX12	__UNKNOWN__	446
tramadol	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	N02AX02	__UNKNOWN__	63013
amoxicillin, clarithromycin, esomeprazole	normal metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Disease:C0017152	normal metabolizer	A02BC05|J01CA04|J01FA09	__UNKNOWN__	33613
dabigatran	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	B01AE07	__UNKNOWN__	169501783
escitalopram	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AB10	__UNKNOWN__	162180
venlafaxine	poor metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0011581	poor metabolizer	N06AX16	__UNKNOWN__	9795857
bupropion	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs4680:AG	446
bupropion	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AX12	rs4680:GG	446
aripiprazole	intermediate metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX12	__UNKNOWN__	10114519
codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, tramadol	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193	intermediate metabolizer and poor metabolizer	N02AA01|N02AA03|N02AA05|N02AB03|N02AX02|N07BC02|R05DA03|R05DA04	__UNKNOWN__	4095
venlafaxine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0011581	poor metabolizer	N06AX16	__UNKNOWN__	9795857
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*1/*5	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*5/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*5/*10	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*10	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*14	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*14	667572
paroxetine	CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*14, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N06AB05	*10/*41	667572
ethanol	rs1461773	OPRM1	A	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1461773:A	444899
3,4-methylenedioxymethamphetamine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*4/*4	1615
3,4-methylenedioxymethamphetamine	CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*41	CYP2D6	*3/*5	Efficacy	increased	Efficacy_Response	Healthy		V04CX05	*3/*5	1615
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
ethanol	rs3778148	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs3778148:T	444899
amoxicillin, clarithromycin, lansoprazole	normal metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0079487	normal metabolizer	A02BC03|J01CA04|J01FA09	__UNKNOWN__	33613
amoxicillin, clarithromycin, omeprazole	normal metabolizer genotype	CYP2C19	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Efficacy:C0079487	normal metabolizer	A02BC01|J01CA04|J01FA09	__UNKNOWN__	33613
midazolam	rs4516035	VDR	T	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs4516035:T	5384200
codeine	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6	CYP2D6	*1xN/*1	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	R05DA04	*1xN/*1	5284371
oxycodone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N02AA05	__UNKNOWN__	5462350
oxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	5359390
oxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	5359390
noroxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	5497189
amitriptyline	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C1328447	poor metabolizer	N06AA09	__UNKNOWN__	4543
noroxymorphone	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	5497189
tramadol	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C1328447	poor metabolizer	N02AX02	__UNKNOWN__	63013
tamsulosin	intermediate metabolizer and normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and intermediate metabolizer	G04CA02	__UNKNOWN__	5362376
noroxycodone	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	ultrarapid metabolizer	No_ATC	__UNKNOWN__	5489120
morphine	rs4680	COMT	A	Efficacy	increased	Efficacy_Response	Disease:C0024031		N02AA01	rs4680:A	5284371
voriconazole	poor metabolizers	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	J02AC03	__UNKNOWN__	9741
tamsulosin	intermediate metabolizer and normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and intermediate metabolizer	G04CA02	__UNKNOWN__	5362376
antidepressants	rs3800373	FKBP5	AC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:AC	No_match
antidepressants	rs3800373	FKBP5	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:CC	No_match
tamsulosin	intermediate metabolizer and normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and intermediate metabolizer	G04CA02	__UNKNOWN__	5362376
venlafaxine	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AX16	__UNKNOWN__	9795857
voriconazole	poor metabolizers and intermediate metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	J02AC03	__UNKNOWN__	9741
opioids	rs4680	COMT	GG	Dosage	increased	Dosage	Disease:C0030193|Postoperative		N02A	rs4680:GG	No_match
atenolol, metoprolol	rs1042714	ADRB2	CC	Efficacy	increased	Efficacy_Response	Other:C0039231		C07AB02|C07AB03	rs1042714:CC	4171
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*3	3045275
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*5	3045275
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*4/*4	3045275
tamsulosin	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Healthy	poor metabolizer	G04CA02	__UNKNOWN__	5362376
gliclazide	rs2237895	KCNQ1	C	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB09	rs2237895:C	169502072
warfarin	normal metabolizers	CYP2C9	__UNKNOWN__	Dosage	increased	Dosage	Healthy	normal metabolizer	B01AA03	__UNKNOWN__	54688261
solanidine	poor metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0235876	poor metabolizer	No_ATC	__UNKNOWN__	65727
flecainide	normal metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	Indeterminado	LADME	Disease:C0039231|Supraventricular	normal metabolizer	C01BC04	__UNKNOWN__	134295
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*3	3045275
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*3/*5	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*3/*5	3045275
trimipramine	CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA06	*4/*4	3045275
voriconazole	poor metabolizers	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	poor metabolizers	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*3	9741
voriconazole	poor metabolizers	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*3/*3	9741
pridopidine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	9795739
morphine	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AA01	__UNKNOWN__	5284371
tramadol	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AX02	__UNKNOWN__	63013
rabeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC04	__UNKNOWN__	11985
bupropion	CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2	Metabolism/PK	decreased	LADME	Disease:C0032961	intermediate metabolizer and poor metabolizer	N06AX12	*2	446
bupropion	CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3	Metabolism/PK	decreased	LADME	Disease:C0032961	intermediate metabolizer and poor metabolizer	N06AX12	*3	446
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*1/*1xN	Metabolism/PK	decreased	LADME	Other:C0028043		N07BC02|N07BC05	*1/*1xN	22267
methadone	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs1799971:AA	10090
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	N07BA01	*1/*2	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	N07BA01	*1/*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	N07BA01	*1/*17	936
metronidazole	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*2	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	P01AB01	*1/*2	12760
metronidazole	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*9	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	P01AB01	*1/*9	12760
metronidazole	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17	CYP2A6	*1/*17	Metabolism/PK	decreased	LADME	Healthy	reduced metabolizers	P01AB01	*1/*17	12760
arsenic compounds	rs4920037	CBS	AA	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4920037:AA	5359596
arsenic compounds	rs4920037	CBS	AG	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4920037:AG	5359596
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02|N07BC05	*3/*4	22267
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02|N07BC05	*4/*4	22267
dextromethadone, levomethadone	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02|N07BC05	*4/*6	22267
morphine	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative	ultrarapid metabolizer	N02AA01	__UNKNOWN__	5284371
codeine	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	R05DA04	__UNKNOWN__	5284371
clomipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA04	__UNKNOWN__	68539
o-desmethyltramadol	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0027651|Other:C0030193	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__	9816106
levomethadone	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders	ultrarapid metabolizer	N07BC05	__UNKNOWN__	22267
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9934438:GG	54688261
voriconazole	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Healthy	intermediate metabolizer and poor metabolizer	J02AC03	__UNKNOWN__	9741
tramadol	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*9	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AX02	*4/*4	63013
methotrexate	rs3761548	FOXP3	G	Other	decreased	Efficacy_Response	Disease:C0235763		L04AX03	rs3761548:G	11329481
atenolol, metoprolol	rs1042713	ADRB2	AA	Efficacy	increased	Efficacy_Response	Other:C0039231		C07AB02|C07AB03	rs1042713:AA	4171
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Disease:C0026946	poor metabolizer	J02AC03	*2/*3	9741
n-desmethyltramadol(tramadol)	poor metabolizers and intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0027651|Other:C0030193	intermediate metabolizer and poor metabolizer	N02AX02	__UNKNOWN__	9816106
tamoxifen, endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	L02BA01	__UNKNOWN__	10090750
gemcitabine	rs11598702	NT5C2	TT	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs11598702:TT	597
gemcitabine	rs1048977	CDA	TT	Metabolism/PK	decreased	LADME	Healthy		L01BC05	rs1048977:TT	597
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__	9579578
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*1	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*1/*1	5359390
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*1/*9	5359390
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*2/*9	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*2/*9	5359390
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*1/*2	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*1/*2	5359390
oxymorphone	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*17, CYP2D6*41	CYP2D6	*2/*2	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	No_ATC	*2/*2	5359390
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7202877	CTRB1, CTRB2	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs7202877:GG	No_match
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7202877	CTRB1, CTRB2	GT	Efficacy	decreased	Efficacy_Response	Other:C0011849		No_ATC	rs7202877:GT	No_match
lansoprazole, omeprazole	poor metabolizer and intermediate metabolizer genotypes	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0079487	intermediate metabolizer and poor metabolizer	A02BC01|A02BC03	__UNKNOWN__	3883
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB06	*6/*6	18642483
sertraline	CYP2B6*1, CYP2B6*6, CYP2B6*9	CYP2B6	*6/*9	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB06	*6/*9	18642483
olanzapine	poor metabolizers	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AH03	__UNKNOWN__	74603552
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*3	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*3	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*4	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*4	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*5	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*5	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*6	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*6	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*9	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*9	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*10	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*10	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*17	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*17	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*29	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*29	131769920
endoxifen	poor metabolizers and intermediate metabolizers	CYP2D6	*41	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	*41	131769920
arsenic compounds	rs234709	CBS	CT	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs234709:CT	5359596
arsenic compounds	rs234709	CBS	TT	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs234709:TT	5359596
3-hydroxycotinine, 3-hydroxycotinine glucuronide	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*10	CYP2A6	*1	Metabolism/PK	increased	LADME	Other:C0039338	normal metabolizer and intermediate metabolizer	No_ATC	*1	10219774
3-hydroxycotinine, 3-hydroxycotinine glucuronide	CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*10	CYP2A6	*2	Metabolism/PK	increased	LADME	Other:C0039338	normal metabolizer and intermediate metabolizer	No_ATC	*2	10219774
risperidone	ultrarapid metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0033975	ultrarapid metabolizer	N05AX08	__UNKNOWN__	849421
risperidone	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N05AX08	__UNKNOWN__	849421
selective beta-2-adrenoreceptor agonists	rs2239179	VDR	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC	rs2239179:C	No_match
selective beta-2-adrenoreceptor agonists	rs1540339	VDR	C	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC	rs1540339:C	No_match
endoxifen	poor metabolizers	CYP2C9	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	131769920
clopidogrel	rs12248560	CYP2C19	CT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:CT	13748464
clopidogrel	rs12248560	CYP2C19	TT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:TT	13748464
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0035435|Disease:C0699744	intermediate metabolizer	J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0035435|Disease:C0699744	intermediate metabolizer	J02AC03	*1/*3	9741
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
carisoprodol	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	M03BA02	*1/*2	2576
lansoprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC03	__UNKNOWN__	11985
imipramine	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C0011581	poor metabolizer	N06AA02	__UNKNOWN__	65327
gemigliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin	rs3765467	GLP1R	AA	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH03|A10BH05	rs3765467:AA	11243969
gemigliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin	rs3765467	GLP1R	AG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH03|A10BH05	rs3765467:AG	11243969
methadone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs1045642:AA	10090
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*1/*3	13653606
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*6	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*1/*6	13653606
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*3	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*3/*3	13653606
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*3/*6	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*3/*6	13653606
fentanyl	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*6/*6	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N02AB03	*6/*6	13653606
gliclazide	intermediate metabolizers	CYP2C9	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	A10BB09	__UNKNOWN__	169502072
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
norquetiapine	poor metabolizer and intermediate metabolizer genotypes	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	No_ATC	__UNKNOWN__	11369918
voriconazole	intermediate metabolizers	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*2	9741
voriconazole	intermediate metabolizers	CYP2C19	*1/*3	Metabolism/PK	decreased	LADME	Disease:C0026946	intermediate metabolizer	J02AC03	*1/*3	9741
tropisetron	CYP2D6*1, CYP2D6*2xN	CYP2D6	*1/*2xN	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	A04AA03	*1/*2xN	656665
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB04|N06AB10	*2/*2	162180
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB04|N06AB10	*3/*3	162180
citalopram, escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB04|N06AB10	*2/*3	162180
indomethacin	rs2153628	CYP2C9	G	Efficacy	increased	Efficacy_Response	Healthy		S01BC01	rs2153628:G	4292
gemcitabine	rs2072671	CDA	AA	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC05	rs2072671:AA	597
tacrolimus	poor metabolizer genotype	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:Liver_transplantation	poor metabolizer	L04AD02	__UNKNOWN__	131769926
venlafaxine	rs25531	SLC6A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs25531:TT	9795857
endoxifen	poor metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	poor metabolizer	No_ATC	__UNKNOWN__	131769920
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__	9579578
nimodipine	rs2239128	CACNA1C	CC	Efficacy	increased	Efficacy_Response	Healthy		C08CA06	rs2239128:CC	4497
endoxifen	intermediate metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:C1458155	intermediate metabolizer	No_ATC	__UNKNOWN__	131769920
nimodipine	rs2239050	CACNA1C	CG	Efficacy	increased	Efficacy_Response	Healthy		C08CA06	rs2239050:CG	4497
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__	9579578
tramadol	ultrarapid metabolizer genotype	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	N02AX02	__UNKNOWN__	63013
omeprazole	poor metabolizers	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC01	__UNKNOWN__	9579578
tramadol	poor metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N02AX02	__UNKNOWN__	63013
maraviroc	poor metabolizers	CYP3A5	__UNKNOWN__	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	poor metabolizer	J05AX09	__UNKNOWN__	3002977
venlafaxine	rs3810651	GABRQ	AA	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs3810651:AA	9795857
venlafaxine	rs3810651	GABRQ	AT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs3810651:AT	9795857
metoprolol	normal metabolizers	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0032961	normal metabolizer	C07AB02	__UNKNOWN__	6322
cytarabine, idarubicin	rs80143932	DCK	G	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs80143932:G	6253
fentanyl, hydromorphone, opioids, oxycodone, tramadol	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Dosage	increased	Dosage	Other:C0549433	ultrarapid metabolizer	N02A|N02AA03|N02AA05|N02AB03|N02AX02	__UNKNOWN__	33741
2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin	UGT1A3*1, UGT1A3*2	UGT1A3	*2	Metabolism/PK	decreased	LADME	Healthy		C10AA05	*2	60823
clozapine, n-desmethylclozapine	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02		135398737
ibogaine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders	poor metabolizer	No_ATC	__UNKNOWN__	197060
atorvastatin, atorvastatin lactone	CYP3A4*1, CYP3A4*2, CYP3A4*22	CYP3A4	*2	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	C10AA05	*2	6483036
atorvastatin, atorvastatin lactone	CYP3A4*1, CYP3A4*2, CYP3A4*22	CYP3A4	*22	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	C10AA05	*22	6483036
atomoxetine	CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:C1263846	intermediate metabolizer	N06BA09	*10/*10	6093336
atomoxetine	CYP2D6*10	CYP2D6	*10/*10	Efficacy	increased	Efficacy_Response	Other:C1263846	intermediate metabolizer	N06BA09	*10/*10	6093336
amphetamine, lisdexamfetamine	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C1263846	poor metabolizer	N06BA12	__UNKNOWN__	11597698
selective serotonin reuptake inhibitors, venlafaxine	rs502434	GRIA3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB|N06AX16	rs502434:CC	5202
nicotine	CYP2A6*1, CYP2A6*41	CYP2A6	*41	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*41	936
nicotine	CYP2A6*1, CYP2A6*39	CYP2A6	*39	Metabolism/PK	decreased	LADME	Healthy		N07BA01	*39	936
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	__UNKNOWN__	135483892
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
tumor necrosis factor alpha (tnf-alpha) inhibitors	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	decreased	Efficacy_Response	Other:C0021390|Other:C0021368		No_ATC	*05	No_match
clopidogrel	rs4244285	CYP2C19	AA	Dosage, Efficacy	Indeterminado	Dosage	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Dosage, Efficacy	Indeterminado	Dosage	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AG	13748464
metoprolol	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*95, CYP2D6*97	CYP2D6	*10/*87	Metabolism/PK	increased	LADME	Healthy		C07AB02	*10/*87	6322
metoprolol	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*95, CYP2D6*97	CYP2D6	*10/*95	Metabolism/PK	increased	LADME	Healthy		C07AB02	*10/*95	6322
metoprolol	CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*95, CYP2D6*97	CYP2D6	*97/*97	Metabolism/PK	increased	LADME	Healthy		C07AB02	*97/*97	6322
voriconazole	poor metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	__UNKNOWN__	9741
1-hydroxymidazolam, midazolam	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy		N05CD08	*1/*22	107917
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Healthy	ultrarapid metabolizer	J02AC03	*1/*17	9741
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG	13748464
selective serotonin reuptake inhibitors, venlafaxine	rs3761554	GRIA3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB|N06AX16	rs3761554:TT	5202
warfarin	rs339097	CALU	G	Dosage	increased	Dosage	Healthy		B01AA03	rs339097:G	54688261
isoniazid	intermediate acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0041296	intermediate acetylator and rapid acetylator	J04AC01	__UNKNOWN__	135483892
dihydroartemisinin	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*6/*6	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		P01BE01	*6/*6	6917864
dihydroartemisinin	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*18/*18	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		P01BE01	*18/*18	6917864
dihydroartemisinin	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*1/*6	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		P01BE01	*1/*6	6917864
desbutyl lumefantrine	CYP3A5*1, CYP3A5*3, CYP3A5*6	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:C0024530|Falciparum		No_ATC	*1/*3	9934522
sertraline	CYP2D6*1, CYP2D6*2	CYP2D6	*2	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373		N06AB06	*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373	intermediate metabolizer and poor metabolizer	N06AB06	*1/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373	intermediate metabolizer and poor metabolizer	N06AB06	*2/*2	18642483
sertraline	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*2/*17	Metabolism/PK	decreased	LADME	Other:C0036502|Other:C0011581|Other:C0003469|Other:C1704373	intermediate metabolizer and poor metabolizer	N06AB06	*2/*17	18642483
tacrolimus	rs3740066	ABCC2	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs3740066:TT	131769926
levonorgestrel	poor metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease	poor metabolizer	G03AD01	__UNKNOWN__	5991
selective serotonin reuptake inhibitors, venlafaxine	rs3761555	GRIA3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB|N06AX16	rs3761555:TT	5202
warfarin	rs310279	NKX2-6	AG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs310279:AG	54688261
warfarin	rs310279	NKX2-6	GG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs310279:GG	54688261
cytarabine, idarubicin	rs2306744	DCK	T	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L01DB06	rs2306744:T	6253
venlafaxine	rs7997012	HTR2A	AG	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs7997012:AG	9795857
venlafaxine	rs7997012	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs7997012:GG	9795857
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:therapeutic_drug_monitoring_analyses	poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:therapeutic_drug_monitoring_analyses	poor metabolizer	J02AC03	*2/*3	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:therapeutic_drug_monitoring_analyses	poor metabolizer	J02AC03	*3/*3	9741
antiepileptics	rs16935279	__INTRONIC__	CC	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0033975		N03A	rs16935279:CC	No_match
antiepileptics	rs16935279	__INTRONIC__	CT	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0033975		N03A	rs16935279:CT	No_match
follitropin beta, urofollitropin	rs6166	FSHR	CC	Dosage	increased	Dosage	Healthy		G03GA04|G03GA06	rs6166:CC	73759969
follitropin beta, urofollitropin	rs6166	FSHR	CT	Dosage	increased	Dosage	Healthy		G03GA04|G03GA06	rs6166:CT	73759969
paroxetine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0011581	ultrarapid metabolizer	N06AB05	__UNKNOWN__	667572
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Healthy		B01AA03	*1/*17	54688261
warfarin	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Healthy		B01AA03	*17/*17	54688261
atorvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*8, CYP2C19*11	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Other:C0007222	poor metabolizer	C10AA05	*2	656846
atorvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*8, CYP2C19*11	CYP2C19	*4	Efficacy	decreased	Efficacy_Response	Other:C0007222	poor metabolizer	C10AA05	*4	656846
atorvastatin	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*8, CYP2C19*11	CYP2C19	*8	Efficacy	decreased	Efficacy_Response	Other:C0007222	poor metabolizer	C10AA05	*8	656846
cisplatin, irinotecan	rs9597	UBE2I	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CE02|L01XA01	rs9597:CG	5460033
warfarin	rs4386623	FRAS1	AA	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs4386623:AA	54688261
warfarin	rs4386623	FRAS1	AG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs4386623:AG	54688261
lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0017168		A02BC03	*1/*1	11985
warfarin	rs1890109	FAM201A	AG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1890109:AG	54688261
warfarin	rs1890109	FAM201A	GG	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1890109:GG	54688261
methotrexate	rs45445694	TYMS	(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs45445694:(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3/(CCGCGCCACTTGGCCTGCCTCCGTCCCG)3	11329481
valproic acid	rs3812718	SCN1A	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs3812718:T	134459
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC02	*1/*1	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC02	*1/*2	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Disease:C0041582		A02BC02	*1/*3	11954257
risperidone	CYP2D6*1, CYP2D6*10	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*10	849421
capecitabine	rs1801159	DPYD	CC	Efficacy	increased	Efficacy_Response	Disease:C2931822		L01BC06	rs1801159:CC	11809635
capecitabine	rs1801159	DPYD	CT	Efficacy	increased	Efficacy_Response	Disease:C2931822		L01BC06	rs1801159:CT	11809635
nicotine	rs6277	DRD2	A	Efficacy	increased	Efficacy_Response	Healthy		N07BA01	rs6277:A	936
captopril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs1799752:del/del	44146831
apixaban, dabigatran, edoxaban, rivaroxaban	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0040038		B01AE07|B01AF01|B01AF02|B01AF03	rs776746:CC	216210
bupropion	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR short form (S allele)	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12		446
bupropion	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12		446
losartan	CYP2C9*1, CYP2C9*5, CYP2C9*6	CYP2C9	*1/*5	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*1/*5	11751549
losartan	CYP2C9*1, CYP2C9*5, CYP2C9*6	CYP2C9	*5/*6	Metabolism/PK	decreased	LADME	Healthy		C09CA01	*5/*6	11751549
ethanol	rs648007	OPRM1	A	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs648007:A	444899
famotidine, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC01	*1/*1	5702160
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*3	11985
esomeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC05	*1/*1	9579578
midazolam	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		N05CD08	*1/*22	5384200
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1	11985
ethanol	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs1799971:GG	444899
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	increased	LADME	Disease:C0024530		P01BA03	*4/*41	6135
primaquine	CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41	CYP2D6	*5/*6	Metabolism/PK	increased	LADME	Disease:C0024530		P01BA03	*5/*6	6135
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
nicotine	rs2337980	CHRNA7	CC	Efficacy	increased	Efficacy_Response	Healthy		N07BA01	rs2337980:CC	936
bupropion	rs1799732	DRD2	GG	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12	rs1799732:GG	446
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT	54688261
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT	54688261
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*1/*22	14373154
simvastatin	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	Indeterminado	LADME	Healthy		C10AA01	*22/*22	14373154
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*1	9579578
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*2	9579578
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BC01	*1/*3	9579578
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	decreased	LADME	Disease:C0026946		J02AC03	*1/*17	9741
quetiapine	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:C0033975		N05AH04	*1/*22	118753024
quetiapine	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:C0033975		N05AH04	*22/*22	118753024
warfarin	rs1131873	EPHX1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs1131873:A	54688261
trimipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*2	3045275
famotidine, omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC01	*1/*1	5702160
metformin	rs8192675	SLC2A2	C	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs8192675:C	155906370
warfarin	rs28371686	CYP2C9	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371686:G	54688261
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:C0026272		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:C0026272		L04AD02	rs776746:TT	131769926
warfarin	rs28371685	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371685:T	54688261
duloxetine	rs3892097	CYP2D6	CC	Efficacy	increased	Efficacy_Response	Other:C0085762|Other:C0011581		N06AX21	rs3892097:CC	44344115
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01CE02	*1/*28	60838
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*28/*28	Metabolism/PK	increased	LADME	Disease:C0027651		L01CE02	*28/*28	60838
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*3	11985
warfarin	rs9332131	CYP2C9	del	Dosage	decreased	Dosage	Healthy		B01AA03	rs9332131:del	54688261
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		L04AD02	*3/*3	131769926
hydroxyurea	rs4671393	BCL11A	A	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs4671393:A	10220327
warfarin	rs7900194	CYP2C9	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs7900194:A	54688261
rosiglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*3	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BG02	*3	9846723
phenytoin	CYP2C9*1, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	*1/*3	1775
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*1/*2	11954257
beta blocking agents	rs36217263	KL	A/del	Efficacy	decreased	Efficacy_Response	Other:C0020538		S01ED	rs36217263:A/del	No_match
beta blocking agents	rs36217263	KL	del/del	Efficacy	decreased	Efficacy_Response	Other:C0020538		S01ED	rs36217263:del/del	No_match
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*6/*6	64139
efavirenz	CYP2B6*1, CYP2B6*6	CYP2B6	*1/*6	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	*1/*6	64139
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	*2/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Disease:C0026946	intermediate metabolizer and poor metabolizer	J02AC03	*1/*3	9741
gemcitabine	rs12806698	RRM1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs12806698:AC	597
fluoxetine, sertraline	rs57098334	SLC6A4	(CCCACCCGA)12/(CCCACCCGA)12	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB06	rs57098334:(CCCACCCGA)12/(CCCACCCGA)12	1548970
bupropion	rs8075924	ACE	TT	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06AX12	rs8075924:TT	446
lorazepam, valproic acid	rs7438284	UGT2B7	A	Efficacy	increased	Efficacy_Response	Healthy		N03AG01|N05BA06	rs7438284:A	3121
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Healthy		A02BC04	*1/*1	11985
lorazepam, valproic acid	rs7439366	UGT2B7	T	Efficacy	increased	Efficacy_Response	Healthy		N03AG01|N05BA06	rs7439366:T	3121
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
sertraline	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR long form (L allele)/HTTLPR long form (L allele)	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB06		18642483
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
sunitinib	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Healthy		L01EX01	*1/*22	11221549
sunitinib	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	decreased	LADME	Healthy		L01EX01	*22/*22	11221549
hydroxychloroquine	rs3735451	CYP3A4	CC	Metabolism/PK	decreased	LADME	Other:C0003873|Other:C0024141		P01BA02	rs3735451:CC	71826
fluorouracil	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC02	rs25487:CC	5790
mirtazapine	CYP2B6*6	CYP2B6	*6/*6	Metabolism/PK	increased	LADME	Disease:C0235876		N06AX11	*6/*6	6451144
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*1/*2	2789
clobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0014544		N05BA09	*1/*3	2789
gemcitabine	rs11030918	RRM1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs11030918:CT	597
rosuvastatin	rs3212207	HNF4A	C	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs3212207:C	5282455
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1045642:AG	131769926
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1045642:GG	131769926
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA07	*1/*3	54742534
acenocoumarol	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*2/*3	Metabolism/PK	decreased	LADME	Healthy		B01AA07	*2/*3	54742534
risperidone	intermediate metabolizer phenotype	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	N05AX08	__UNKNOWN__	849421
rosuvastatin	rs8187710	ABCC2	A	Metabolism/PK	decreased	LADME	Healthy		C10AA07	rs8187710:A	5282455
clopidogrel	rs4244285	CYP2C19	AA	Dosage, Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Dosage, Efficacy	decreased	Efficacy_Response	Other:percutaneous_coronary_intervention		B01AC04	rs4244285:AG	13748464
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BC04	*1/*1	11985
cyclosporine	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Healthy		L04AD01	*1/*3	86666680
cyclosporine	rs35599367	CYP3A4	A	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD01	rs35599367:A	86666680
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*1/*1	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*1/*1	1548968
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*10/*10	1548968
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*1/*4	1548968
fluoxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Other:C0003469|Other:C0235876|Other:C0011581	normal metabolizer	N06AB03	*1/*10	1548968
codeine	CYP2D6*1, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C0022661		R05DA04	*4/*4	5284371
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Metabolism/PK	increased	LADME	Other:patients_with_decreased_concentrations_of_voriconazole	ultrarapid metabolizer	J02AC03	*1/*17	9741
voriconazole	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Metabolism/PK	increased	LADME	Other:patients_with_decreased_concentrations_of_voriconazole	ultrarapid metabolizer	J02AC03	*17/*17	9741
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation	normal metabolizer and intermediate metabolizer	L04AD02	rs776746:TT	131769926
docetaxel, thalidomide	rs3734254	PPARD	T	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs3734254:T	148124
atenolol, metoprolol	rs17117817	OR10P1	G	PD	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs17117817:G	4171
aripiprazole	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*5	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*5	10114519
aripiprazole	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*10	10114519
aripiprazole	CYP2D6*1, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*41	10114519
trimipramine	CYP2C19*1, CYP2C19*2	CYP2C19	*2	Metabolism/PK	decreased	LADME	Healthy		N06AA06	*2	3045275
pioglitazone	CYP2C8*1, CYP2C8*3	CYP2C8	*1/*1	Metabolism/PK	increased	LADME	Healthy		A10BG03	*1/*1	60560
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Metabolism/PK	increased	LADME	Healthy		N05AX12	*3/*3	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N05AX12	*4/*4	10114519
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*2	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*3	Dosage	decreased	Dosage	Healthy		B01AA03	*1/*3	54688261
carboplatin, gemcitabine	rs12806698	RRM1	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA02	rs12806698:AC	10339178
famotidine, lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC03	*1/*2	5702160
famotidine, lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC03	*1/*3	5702160
famotidine, lansoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Efficacy	decreased	Efficacy_Response	Healthy		A02BA03|A02BC03	*1/*1	5702160
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:01	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:01	No_match
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:04	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:04	No_match
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:05	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:05	No_match
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*04:10	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*04:10	No_match
abatacept	HLA-DRB1*04:01, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:10, HLA-DRB1*10:01	HLA-DRB1	*10:01	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AA24	*10:01	No_match
methadone	rs17180299	__INTRONIC__	AG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs17180299:AG	10090
methadone	rs17180299	__INTRONIC__	GG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs17180299:GG	10090
warfarin	rs339097	CALU	G	Dosage	increased	Dosage	Healthy		B01AA03	rs339097:G	54688261
noscapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*9	CYP2C9	*1/*1	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	R05DA07	*1/*1	275196
noscapine	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*9	CYP2C9	*1/*9	Metabolism/PK	increased	LADME	Healthy	normal metabolizer	R05DA07	*1/*9	275196
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
atenolol, metoprolol	rs2364349	SNX9	A	PD	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs2364349:A	4171
tacrolimus	rs11265572	__INTRONIC__	GT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs11265572:GT	131769926
tacrolimus	rs11265572	__INTRONIC__	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs11265572:TT	131769926
warfarin	rs10871454	STX4	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs10871454:T	54688261
sirolimus, temsirolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:C0877645		L01EG01	rs776746:CT	6918289
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		J02AC03	*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		J02AC03	*3	9741
enalapril	rs1799752	ACE	del/del	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA02	rs1799752:del/del	5950
uracil	DPYD c.295_298delTCAT (*7), DPYD Reference	DPYD	c.295_298delTCAT (*7)	Metabolism/PK	increased	LADME	Healthy		H03BA	c.295_298delTCAT (*7)	1174
uracil	DPYD c.2846A>T, DPYD Reference	DPYD	c.2846A>T	Metabolism/PK	increased	LADME	Healthy		H03BA	c.2846A>T	1174
uracil	DPYD c.1679T>G (*13), DPYD Reference	DPYD	c.1679T>G (*13)	Metabolism/PK	increased	LADME	Healthy		H03BA	c.1679T>G (*13)	1174
uracil	DPYD c.1905+1G>A (*2A), DPYD Reference	DPYD	c.1905	Metabolism/PK	increased	LADME	Healthy		H03BA	c.1905	1174
uracil	DPYD c.1905+1G>A (*2A), DPYD Reference	DPYD	1G>A (*2A)	Metabolism/PK	increased	LADME	Healthy		H03BA	1G>A (*2A)	1174
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*29	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*41	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*41	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*41	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*4	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*5	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*4	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*3	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*4	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*6	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*5	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*9	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*9	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*10	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*2/*10	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*35/*10	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*35/*10	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*4/*4	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*41/*4	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*3	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*41/*3	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*10/*4	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*10/*4	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*9/*41	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*17/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*17/*41	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*41/*41	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*41/*41	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*9/*5	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*9/*5	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41	CYP2D6	*1/*29	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	*1/*29	10474509
atorvastatin	CYP3A5*3	CYP3A5	*3/*3	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	*3/*3	656846
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*10/*10	10474509
n-desmethyltamoxifen	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	*1/*10	10474509
escitalopram	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N06AB10	__UNKNOWN__	162180
escitalopram	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N06AB10	__UNKNOWN__	162180
efavirenz	rs3842	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3842:CC	64139
efavirenz	poor metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J05AG03	__UNKNOWN__	64139
bcr-abl tyrosine kinase inhibitors	HLA-A*03:01	HLA-A	*03:01	Efficacy	decreased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA	*03:01	No_match
bcr-abl tyrosine kinase inhibitors	HLA-A*23:17	HLA-A	*23:17	Efficacy	decreased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA	*23:17	No_match
bcr-abl tyrosine kinase inhibitors	HLA-B*57:03	HLA-B	*57:03	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA	*57:03	No_match
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*7	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*7	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*2	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*2	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*9	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*9	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*10	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*10	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*35	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*35	849421
risperidone	CYP2D6*1, CYP2D6*2, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*41	CYP2D6	*41	Metabolism/PK	decreased	LADME	Healthy		N05AX08	*41	849421
antidepressants	poor metabolizer	CYP2C19	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0011581	poor metabolizer	N06A	__UNKNOWN__	No_match
methadone	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*6	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	poor metabolizer	N07BC02	*6	10090
methadone	CYP2B6*1, CYP2B6*6, CYP2B6*18	CYP2B6	*18	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders	poor metabolizer	N07BC02	*18	10090
lamotrigine	UGT1A4*3b	UGT1A4	*3b	Efficacy	decreased	Efficacy_Response	Healthy		N03AX09	*3b	71236569
docetaxel, thalidomide	rs2016520	PPARD	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs2016520:C	148124
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	*1/*3	131769926
infliximab	HLA-DQA1*05	HLA-DQA1	*05	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02	*05	No_match
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*2	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*4, CYP2C19*17	CYP2C19	*4	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	*4	13748464
docetaxel, thalidomide	rs1871450	CHST3	A	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs1871450:A	148124
propofol	CYP2B6*1, CYP2B6*6	CYP2B6	*6	Toxicity	decreased	Efficacy_Response	Other:C1140716		N01AX10	*6	3014064
tildrakizumab	rs10556657	PDE4D	CT/CT	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AC17	rs10556657:CT/CT	No_match
buprenorphine, dihydrocodeine, fentanyl, hydromorphone, methadone, morphine, oxycodone, piritramide, tilidine, tramadol	rs1045642	ABCB1	A	Dosage	decreased	Dosage	Disease:C0030193		N02AA01|N02AA03|N02AA05|N02AA08|N02AB03|N02AX01|N02AX02|N07BC01|N07BC02	rs1045642:A	4095
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	increased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	*3/*3	131769926
tacrolimus	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	*1/*22	131769926
sirolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation	deficiency	No_ATC	*3/*3	5284616
docetaxel, thalidomide	rs1883322	PPARD	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs1883322:C	148124
phenytoin	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N03AB02	__UNKNOWN__	1775
valproic acid	intermediate metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	N03AG01	__UNKNOWN__	134459
carbamazepine	poor metabolizer	CYP3A5	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N03AF01	__UNKNOWN__	114709
valproic acid	intermediate metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N03AG01	__UNKNOWN__	134459
valproic acid	UGT1A6*1a, UGT1A6*2a	UGT1A6	*2a	Metabolism/PK	decreased	LADME	Healthy		N03AG01	*2a	134459
phenytoin	intermediate metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	N03AB02	__UNKNOWN__	1775
sn-38(irinotecan)	UGT1A1*1, UGT1A1*28	UGT1A1	*1/*28	Metabolism/PK	increased	LADME	Other:C0023055|Other:C2939419		L01CE02	*1/*28	60838
docetaxel, thalidomide	rs12418	CHST3	A	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs12418:A	148124
folfiri, irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*60	UGT1A1	*28	Dosage	decreased	Dosage	Other:C0023055		L01CE02	*28	60838
folfiri, irinotecan	UGT1A1*1, UGT1A1*28, UGT1A1*60	UGT1A1	*60	Dosage	decreased	Dosage	Other:C0023055		L01CE02	*60	60838
omeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Other:C0030920|Other:C0017168|Other:C0014868		A02BC01	*1/*1	9579578
mercaptopurine	TPMT*1, TPMT*8	TPMT	*1/*8	Metabolism/PK	decreased	LADME	Healthy		L01BB02	*1/*8	1268107
warfarin	CYP2C9*1	CYP2C9	*1/*1	Dosage	increased	Dosage	Healthy		B01AA03	*1/*1	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*2	Dosage	decreased	Dosage	Healthy		B01AA03	*2	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*3	Dosage	decreased	Dosage	Healthy		B01AA03	*3	54688261
warfarin	CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8	CYP2C9	*8	Dosage	decreased	Dosage	Healthy		B01AA03	*8	54688261
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*3	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*4	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*5	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*5	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*6	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*6	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*9	Metabolism/PK	increased	LADME	Healthy		N05AX12	*1/*9	10114519
pantoprazole	CYP2C19*1, CYP2C19*2	CYP2C19	*1/*2	Metabolism/PK	decreased	LADME	Healthy		A02BC02	*1/*2	11954257
opioids	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0699744|Other:C0030193		N02A	rs1799971:GG	No_match
duloxetine	rs963468	DRD3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs963468:GG	44344115
metformin	rs11212617	C11orf65	C	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs11212617:C	155906370
cyclosporine	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		L04AD01	rs776746:CC	86666680
efavirenz, nevirapine	rs2307424	NR1I3	AA	Efficacy	increased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs2307424:AA	64139
efavirenz, nevirapine	rs2307424	NR1I3	AG	Efficacy	increased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs2307424:AG	64139
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*1	Metabolism/PK	increased	LADME	Other:C0745761|Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	J02AC03	*1/*1	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:C0745761|Other:Hematopoietic_stem_cell_transplantation	normal metabolizer and intermediate metabolizer	J02AC03	*1/*2	9741
aripiprazole	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AX12	*1/*22	10114519
aripiprazole	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AX12	*22/*22	10114519
aripiprazole, dehydroaripiprazole	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	N05AX12	__UNKNOWN__	10114519
pimozide	CYP3A4*1, CYP3A4*22	CYP3A4	*22	Metabolism/PK	decreased	LADME	Disease:C0033975		N05AG02	*22	16362
docetaxel, thalidomide	rs4148943	CHST3	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148943:C	148124
docetaxel, thalidomide	rs4148945	CHST3	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148945:C	148124
glyburide	rs4148776	ABCB11	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs4148776:G	29981563
imatinib	rs7311358	SLCO1B3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs7311358:AA	6113
imatinib	rs7311358	SLCO1B3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs7311358:AG	6113
imatinib	rs4149117	SLCO1B3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs4149117:GG	6113
imatinib	rs4149117	SLCO1B3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs4149117:GT	6113
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*2	1917817
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*2/*2	1917817
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*1/*3	1917817
praziquantel	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:Schistosomiasis		P02BA01	*3/*3	1917817
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*3	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*3	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*4	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*4	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*5	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*5	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*6	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*6	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9	CYP2D6	*1/*9	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*1/*9	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*3/*3	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*3/*3	10114519
aripiprazole	CYP2D6*1, CYP2D6*1x2, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	decreased	LADME	Healthy		N05AX12	*4/*4	10114519
fesoterodine	ultrarapid metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	ultrarapid metabolizer	G04BD11	__UNKNOWN__	6918558
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	intermediate metabolizer	J02AC03	*1/*2	9741
voriconazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Metabolism/PK	increased	LADME	"""Other:C0023449|""Other:C0024299|""Other:C0023418|Myeloid|Acute"""	intermediate metabolizer	J02AC03	*1/*3	9741
glyburide	rs1054097	CHST13	C	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1054097:C	29981563
lacosamide	normal metabolizer	CYP2C19	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0014544	normal metabolizer	N03AX18	__UNKNOWN__	156613579
fesoterodine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer and poor metabolizer	G04BD11	__UNKNOWN__	6918558
rosiglitazone	rs10509681	CYP2C8	C	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BG02	rs10509681:C	9846723
lacosamide	rs717620	ABCC2	T	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX18	rs717620:T	156613579
fesoterodine	intermediate metabolizer	CYP3A4	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer	G04BD11	__UNKNOWN__	6918558
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*3	Metabolism/PK	increased	LADME	Healthy		N05AF05	*1/*3	5311507
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Healthy		N05AF05	*1/*4	5311507
zuclopenthixol	CYP2D6*1, CYP2D6*3, CYP2D6*4	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N05AF05	*4/*4	5311507
phenytoin	CYP2C9*1, CYP2C9*2, CYP2C9*3	CYP2C9	*1/*1	Metabolism/PK	decreased	LADME	Other:C0549433	normal metabolizer	N03AB02	*1/*1	1775
clozapine	normal metabolizer	CYP2D6	__UNKNOWN__	Dosage	increased	Dosage	Other:C0036341|Other:C0033975	normal metabolizer	N05AH02	__UNKNOWN__	131769989
efavirenz	intermediate metabolizer	CYP2B6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease	intermediate metabolizer and poor metabolizer	J05AG03	__UNKNOWN__	64139
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3A	Metabolism/PK	increased	LADME	Other:C0021390	intermediate metabolizer and poor metabolizer	No_ATC	*3A	3440921
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3B	Metabolism/PK	increased	LADME	Other:C0021390	intermediate metabolizer and poor metabolizer	No_ATC	*3B	3440921
thioguanosine diphosphate, thioguanosine monophosphate, thioguanosine triphosphate	TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C	TPMT	*3C	Metabolism/PK	increased	LADME	Other:C0021390	intermediate metabolizer and poor metabolizer	No_ATC	*3C	3440921
metoprolol	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	C07AB02	__UNKNOWN__	6322
clozapine	rs2535629	ITIH3	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2535629:AA	131769989
atomoxetine	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Disease:C1263846	poor metabolizer	N06BA09	__UNKNOWN__	6093336
cotinine	low activity	CYP2A6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0039338	low activity	No_ATC	__UNKNOWN__	108114
cotinine	low activity	CYP2A6	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	No_ATC	__UNKNOWN__	108114
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*2	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*2	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*4	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*4	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*9	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*9	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*17	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*17	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*20	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*20	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*23	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*23	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*25	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*25	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*26	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*26	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*27	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*27	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*28	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*28	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*35	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*35	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*12	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*12	936
nicotine	CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35	CYP2A6	*24	Metabolism/PK	decreased	LADME	Healthy	low activity	N07BA01	*24	936
escitalopram	SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)	SLC6A4	HTTLPR short form (S allele)	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06AB10		162180
endoxifen	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	intermediate metabolizer and poor metabolizer	No_ATC	__UNKNOWN__	131769920
caffeine	rs10920573	ADORA1	CC	Efficacy	decreased	Efficacy_Response	Other:Apnea_of_prematurity		N06BC01	rs10920573:CC	936
norquetiapine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		No_ATC	*3/*3	11369918
quetiapine	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Metabolism/PK	increased	LADME	Healthy		N05AH04	*3/*3	118753024
amlodipine	rs312481	CACNA1D	GG	Efficacy	increased	Efficacy_Response	Other:C0020538		C08CA01	rs312481:GG	72734364
peginterferon alfa-2a	rs17289471	ZHX2	C	Efficacy	increased	Efficacy_Response	Other:C0019372		L03AB11	rs17289471:C	No_match
berberine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	No_ATC	__UNKNOWN__	34458
clopidogrel	rs12248560	CYP2C19	T	Efficacy, Other	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs12248560:T	13748464
ranibizumab	rs833069	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs833069:CC	No_match
ranibizumab	rs833069	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs833069:CT	No_match
tacrolimus	rs4646449	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs4646449:CC	131769926
ondansetron	poor metabolizer	CYP2D6	__UNKNOWN__	Dosage	increased	Dosage	Other:C0549433	poor metabolizer	A04AA01	__UNKNOWN__	4595
imatinib	rs150929	ABCA3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs150929:GG	6113
imatinib	rs150929	ABCA3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs150929:GT	6113
metformin	rs2301759	CBARP, STK11	TT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs2301759:TT	155906370
metformin	rs3127602	SLC22A3	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs3127602:T	155906370
metformin	rs11749180	PRKAA1	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs11749180:A	155906370
metformin	rs10234709	SLC29A4	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs10234709:A	155906370
metformin	rs4725434	PRKAG2	T	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs4725434:T	155906370
metformin	rs2120274	SLC47A1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs2120274:A	155906370
metformin	rs2301759	STK11	C	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs2301759:C	155906370
metformin	rs4621031	SLC47A2	C	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs4621031:C	155906370
alectinib	CYP3A4*1, CYP3A4*22	CYP3A4	*1/*22	Metabolism/PK	increased	LADME	Other:C0007131		L01ED03	*1/*22	49806720
alectinib	CYP3A4*1, CYP3A4*22	CYP3A4	*22/*22	Metabolism/PK	increased	LADME	Other:C0007131		L01ED03	*22/*22	49806720
metformin	rs7903146	TCF7L2	T	Efficacy	increased	Efficacy_Response	Healthy		A10BA02	rs7903146:T	155906370
methadone	rs3802279	OPRK1	CC	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs3802279:CC	10090
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*2	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*2/*3	156613579
lacosamide	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:C0014544	poor metabolizer	N03AX18	*3/*3	156613579
n-desmethyltramadol, o-desmethyltramadol	rs41267797	SLC22A1	AG	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs41267797:AG	9816106
n,n-didesmethyltramadol	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41, CYP2D6*45	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	A02A|N02AX02	*4/*6	9816106
n,n-didesmethyltramadol	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*41, CYP2D6*45	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	A02A|N02AX02	*4/*5	9816106
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Disease:C0239987		L04AD02	*1/*3	131769926
tocilizumab	rs35717427	IL6R	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs35717427:AG	No_match
tocilizumab	rs35717427	IL6R	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs35717427:GG	No_match
n-desmethyltramadol, o-desmethyltramadol	rs17216317	ABCC2	CT	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs17216317:CT	9816106
tocilizumab	rs6690230	IL6R	CG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs6690230:CG	No_match
tocilizumab	rs6690230	IL6R	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs6690230:GG	No_match
tocilizumab	rs11265621	IL6R	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs11265621:AA	No_match
tocilizumab	rs11265621	IL6R	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs11265621:AG	No_match
tocilizumab	rs10108210	__INTRONIC__	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs10108210:AA	No_match
tocilizumab	rs1560011	CLEC2D	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs1560011:GG	No_match
tocilizumab	rs703505	KCNMB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs703505:AA	No_match
tocilizumab	rs703505	KCNMB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs703505:AG	No_match
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:Elderly_Adult|Other:C0011581	poor metabolizer	N06AB10	*2/*2	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	increased	LADME	Other:Elderly_Adult|Other:C0011581	poor metabolizer	N06AB10	*2/*3	162180
escitalopram	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	increased	LADME	Other:Elderly_Adult|Other:C0011581	poor metabolizer	N06AB10	*3/*3	162180
morphine	rs17809012	CCL11	AA	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs17809012:AA	5284371
morphine	rs4778889	IL16	TT	Efficacy	increased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs4778889:TT	5284371
n-desmethyltramadol, o-desmethyltramadol	rs35235578	SLC22A1	CT	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs35235578:CT	9816106
valproic acid	rs7169	SLC16A1	GG	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs7169:GG	134459
n-desmethyltramadol, o-desmethyltramadol	rs9457841	SLC22A1	C	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs9457841:C	9816106
n-desmethyltramadol, o-desmethyltramadol	rs34134157	SLC22A1	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs34134157:CC	9816106
tenofovir	rs3742106	ABCC4	AC	Toxicity	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs3742106:AC	9574768
tenofovir	rs3742106	ABCC4	CC	Toxicity	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs3742106:CC	9574768
antidepressants	rs1360780	FKBP5	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:CT	No_match
antidepressants	rs1360780	FKBP5	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:TT	No_match
acetaminophen sulfate	CYP2E1*1, CYP2E1*5B	CYP2E1	*1/*5B	Metabolism/PK	increased	LADME	Other:C0013274|Other:C0022876		N02BE01	*1/*5B	1983
fentanyl	rs58572178	ABCC1	(A)14	Metabolism/PK	increased	LADME	Other:C0030193|Other:C0022876		N02AB03	rs58572178:(A)14	13653606
voriconazole	CYP2C19*2, CYP2C19*17	CYP2C19	*2	Dosage	Indeterminado	Dosage	Other:Hematopoietic_stem_cell_transplantation		J02AC03	*2	9741
voriconazole	CYP2C19*2, CYP2C19*17	CYP2C19	*17	Dosage	Indeterminado	Dosage	Other:Hematopoietic_stem_cell_transplantation		J02AC03	*17	9741
rosuvastatin	poor metabolizer	ABCG2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer and reduced metabolizers	C10AA07		5282455
rosuvastatin	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	slow acetylator and intermediate acetylator	C10AA07	__UNKNOWN__	5282455
rosuvastatin	intermediate metabolizer	TPMT	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	intermediate metabolizer	C10AA07	__UNKNOWN__	5282455
doxorubicin	rs20572	CBR1	T	Metabolism/PK	increased	LADME	Other:C1458155		L01DB01	rs20572:T	83958
sunitinib	rs34231037	KDR	AG	Efficacy	increased	Efficacy_Response	Healthy		L01EX01	rs34231037:AG	11221549
antidepressants	rs3800373	FKBP5	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs3800373:CC	No_match
gliclazide, glimepiride, glipizide, glyburide	rs163184	KCNQ1	GT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB07|A10BB09|A10BB12	rs163184:GT	3475
gliclazide, glimepiride, glipizide, glyburide	rs163184	KCNQ1	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BB07|A10BB09|A10BB12	rs163184:TT	3475
isoniazid	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0041296	slow acetylator	J04AC01	__UNKNOWN__	135483892
ramipril	low activity	SLCO1B1	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	low activity	C09AA05	__UNKNOWN__	5464096
ramipril	poor metabolizer	ABCG2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	poor metabolizer and low activity	C09AA05		5464096
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
duloxetine	rs324026	DRD3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs324026:CC	44344115
duloxetine	rs324026	DRD3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs324026:CT	44344115
cytarabine, daunorubicin	rs2299014	RAD50	AA	Efficacy	increased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs2299014:AA	6253
cytarabine, daunorubicin	rs2299014	RAD50	AC	Efficacy	increased	Efficacy_Response	Other:C0023418|Myeloid|Acute		L01BC01|L01DB02	rs2299014:AC	6253
tenofovir	rs1751034	ABCC4	TT	Toxicity	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs1751034:TT	9574768
duloxetine	rs324023	DRD3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs324023:CT	44344115
efavirenz, nevirapine	rs1523127	NR1I2	AA	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs1523127:AA	64139
efavirenz, nevirapine	rs1523127	NR1I2	AC	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs1523127:AC	64139
ezetimibe	deficiency	ABCG8	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0342881	deficiency	C10AX09		169502242
ezetimibe	deficiency	ABCG5	__UNKNOWN__	Efficacy	increased	Efficacy_Response	Other:C0342881	deficiency	C10AX09		169502242
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*1/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*1/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*1/*3	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*2/*2	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*2/*3	11985
rabeprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Disease:C0079487	intermediate metabolizer and poor metabolizer	A02BC04	*3/*3	11985
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC02	*2/*2	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC02	*2/*3	11954257
pantoprazole	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	A02BC02	*3/*3	11954257
duloxetine	rs167770	DRD3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003469		N06AX21	rs167770:AG	44344115
risperidone	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Disease:C0005586|Disease:C0036337|Disease:C0036341	poor metabolizer	N05AX08	__UNKNOWN__	849421
tamsulosin	CYP2D6*10, CYP2D6*41	CYP2D6	*10	Efficacy	increased	Efficacy_Response	Other:C1704272		G04CA02	*10	5362376
tamsulosin	CYP2D6*10, CYP2D6*41	CYP2D6	*41	Efficacy	increased	Efficacy_Response	Other:C1704272		G04CA02	*41	5362376
hydroxyurea	rs7482144	HBG2	AA	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7482144:AA	10220327
hydroxyurea	rs7482144	HBG2	AG	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7482144:AG	10220327
hydroxyurea	rs7482144	HBG2	AA	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs7482144:AA	10220327
hydroxyurea	rs766432	BCL11A	C	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs766432:C	10220327
fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1801133:A	135403648
vortioxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Healthy		N06AX26	*4/*4	7929
vortioxetine	CYP2D6*1, CYP2D6*4, CYP2D6*10	CYP2D6	*4/*10	Metabolism/PK	increased	LADME	Healthy		N06AX26	*4/*10	7929
antiepileptics	rs121917953	SCN1A	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs121917953:AA	No_match
antiepileptics	rs121917953	SCN1A	AT	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs121917953:AT	No_match
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Healthy		R05DA09	*10/*10	6603912
methotrexate	rs1800956	ENG	G	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1800956:G	11329481
methotrexate	rs16954698	PKD1L2	A	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs16954698:A	11329481
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*1/*2	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*1/*2	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*1/*3	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*1/*3	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*1/*4	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*1/*4	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*2/*4	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*2/*4	1268107
mercaptopurine	NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4	NUDT15	*3/*3	Dosage	decreased	Dosage	Other:C0023449		L01BB02	*3/*3	1268107
pregabalin	slow acetylator	NAT2	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	slow acetylator	N02BF02	__UNKNOWN__	5486971
antidepressants	rs1360780	FKBP5	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1360780:TT	No_match
pitavastatin	poor metabolizer	CYP2C9	__UNKNOWN__	Metabolism/PK	increased	LADME	Healthy	intermediate metabolizer and poor metabolizer	C10AA08	__UNKNOWN__	5282451
efavirenz, nevirapine	rs3003596	NR1I3	AG	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs3003596:AG	64139
efavirenz, nevirapine	rs3003596	NR1I3	GG	Efficacy	decreased	Efficacy_Response	Efficacy:HIV_infectious_disease		J05AG01|J05AG03	rs3003596:GG	64139
antidepressants	rs4713916	FKBP5	AA	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs4713916:AA	No_match
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Other:C1458155		No_ATC	*10/*10	131769920
endoxifen	CYP2D6*1, CYP2D6*2, CYP2D6*10	CYP2D6	*2/*10	Metabolism/PK	decreased	LADME	Other:C1458155		No_ATC	*2/*10	131769920
endoxifen	normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C1458155	normal metabolizer	No_ATC	__UNKNOWN__	131769920
clozapine	rs202102799	CYP2D6	C	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs202102799:C	131769989
clozapine	rs28371726	CYP2D6	G	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs28371726:G	131769989
clozapine, n-desmethylclozapine	CYP2C19*1, CYP2C19*2	CYP2C19	*2/*2	Metabolism/PK	increased	LADME	Other:C0036341|Other:C0033975	poor metabolizer	N05AH02	*2/*2	135398737
clozapine	rs762502	DRD4	C	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs762502:C	131769989
nifedipine	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:C0032961		C08CA05	rs776746:CT	4485
nifedipine	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:C0032961		C08CA05	rs776746:TT	4485
clozapine	rs2133251840	DRD4	del	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs2133251840:del	131769989
clozapine, n-desmethylclozapine	ultrarapid metabolizer	CYP1A2	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975	ultrarapid metabolizer	N05AH02	__UNKNOWN__	135398737
exenatide	rs1416406	SORCS1	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ01	rs1416406:GG	45588096
linagliptin, sitagliptin, vildagliptin	rs2285676	KCNJ11	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH05	rs2285676:GG	4369359
linagliptin, saxagliptin, sitagliptin, vildagliptin	rs57803087	PRKD1	G	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02|A10BH03|A10BH05	rs57803087:G	11243969
midazolam	rs2461817	NR1I2	CC	Metabolism/PK	increased	LADME	Other:respiratory_failure_requiring_assisted_ventilation		N05CD08	rs2461817:CC	5384200
methadone, r-eddp, s-eddp	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0277589	intermediate metabolizer	N07BC02	__UNKNOWN__	4095
dextromethorphan	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Healthy		R05DA09	*10/*10	6603912
fluorouracil, leucovorin, oxaliplatin	rs1801131	MTHFR	G	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1801131:G	135403648
azathioprine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:CT	5778
azathioprine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0009324|Disease:C0010346|Disease:C0241910		L04AX01	rs116855232:TT	5778
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AA	54688261
warfarin	rs7412	APOE	CC	Dosage	increased	Dosage	Other:C0004238|Other:C0034065|Other:C0042487		B01AA03	rs7412:CC	54688261
metformin	rs2282143	SLC22A1	CC	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs2282143:CC	155906370
metformin	rs316019	SLC22A2	CC	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs316019:CC	155906370
methacholine	rs1042713	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		No_ATC	rs1042713:AA	6114
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT	54742534
temsirolimus	rs3814055	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:C0877645		L01EG01	rs3814055:TT	6918289
temsirolimus	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Disease:C0877645		L01EG01	rs2032582:CC	6918289
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs4646457	__INTRONIC__	C	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs4646457:C	131769926
tacrolimus	rs15524	CYP3A5	G	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs15524:G	131769926
tacrolimus	rs12333983	CYP3A4	A	Dosage	Indeterminado	Dosage	Disease:Kidney_Transplantation		L04AD02	rs12333983:A	131769926
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C2939420		B01AA07	rs9923231:TT	54742534
atenolol, metoprolol	rs294610	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs294610:A	4171
atenolol, metoprolol	rs45545233	SLC4A1	CC	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs45545233:CC	4171
atenolol, metoprolol	rs45545233	SLC4A1	CT	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB02|C07AB03	rs45545233:CT	4171
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3794271:G	No_match
capecitabine, fluorouracil	rs56038477	DPYD	CT	Dosage	Indeterminado	Dosage	Disease:C0023055		L01BC02|L01BC06	rs56038477:CT	60953
dichloroacetic acid	rs7975	GSTZ1, POMT2	G	Other, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs7975:G	10808
dichloroacetic acid	rs1046428	GSTZ1, POMT2	C	Other, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1046428:C	10808
dichloroacetic acid	rs7972	GSTZ1, POMT2	G	Other, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs7972:G	10808
sunitinib	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs2032582:AA	11221549
fluorouracil	rs17376848	DPYD	AG	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs17376848:AG	5790
fluorouracil	rs17376848	DPYD	GG	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs17376848:GG	5790
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
hydrochlorothiazide	rs11065987	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs11065987:AA	2904
hydrochlorothiazide	rs11065987	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs11065987:AG	2904
methadone	rs1128503	ABCB1	AA	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs1128503:AA	10090
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
caffeine	rs12720461	CYP1A2	CT	Metabolism/PK	decreased	LADME	Healthy		N06BC01	rs12720461:CT	936
ethanol	rs553202	OPRM1	T	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs553202:T	444899
ethanol	rs524731	OPRM1	A	Efficacy	increased	Efficacy_Response	Healthy		V03AB16	rs524731:A	444899
nicotine	rs3852209	HINT1	CT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs3852209:CT	936
nicotine	rs3852209	HINT1	TT	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs3852209:TT	936
opioids	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0030193|Postoperative		N02A	rs1799971:AG	No_match
phenprocoumon	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:CT	91987769
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT	91987769
fluoxetine	rs3892097	CYP2D6	CT	Efficacy	increased	LADME	Efficacy:C0085762|Efficacy:C0011581		N06AB03	rs3892097:CT	1548968
levodopa	rs1611115	DBH	CT	Efficacy	increased	Efficacy_Response	Disease:C0278080		N04BA02	rs1611115:CT	9307
levodopa	rs1611115	DBH	TT	Efficacy	increased	Efficacy_Response	Disease:C0278080		N04BA02	rs1611115:TT	9307
quetiapine	rs2069514	CYP1A2	AA	Metabolism/PK	increased	LADME	Healthy		N05AH04	rs2069514:AA	118753024
venlafaxine	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs4680:GG	9795857
axitinib	rs35305980	OR2B11	A	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs35305980:A	6450551
sulfonamides, urea derivatives	rs5219	KCNJ11	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs5219:CT	1176
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:AG	13748464
sulfonamides, urea derivatives	rs757110	ABCC8	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs757110:AA	1176
sulfonamides, urea derivatives	rs757110	ABCC8	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		S01AB	rs757110:CC	1176
tipiracil hydrochloride, trifluridine	rs9394992	SLC29A1	CT	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs9394992:CT	6323266
tipiracil hydrochloride, trifluridine	rs9394992	SLC29A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs9394992:TT	6323266
axitinib	rs3832043	UGT1A10, UGT1A8, UGT1A9	del	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs3832043:del	6450551
axitinib	rs17868323	UGT1A7	G	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs17868323:G	6450551
risperidone	rs3813928	HTR2C	A	Efficacy	decreased	Efficacy_Response	Disease:C0004352		N05AX08	rs3813928:A	849421
methotrexate	rs1532268	MTRR	CT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1532268:CT	11329481
methotrexate	rs1532268	MTRR	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1532268:TT	11329481
risperidone	rs6311	HTR2A	CT	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6311:CT	849421
risperidone	rs6311	HTR2A	TT	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs6311:TT	849421
axitinib	rs1045642	ABCB1	A	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs1045642:A	6450551
butorphanol	rs6269	COMT	GG	Efficacy	decreased	Efficacy_Response	Healthy		N02AF01	rs6269:GG	5464090
axitinib	rs2231142	ABCG2	T	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs2231142:T	6450551
axitinib	rs2032582	ABCB1	T	Metabolism/PK	Indeterminado	LADME	Disease:C0007134		L01EK01	rs2032582:T	6450551
voriconazole	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4244285:AA	9741
voriconazole	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4244285:AG	9741
erlotinib	rs121434568	EGFR	GT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:GT	176870
erlotinib	rs121434568	EGFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:TT	176870
methotrexate	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1045642:AA	11329481
cytarabine	rs3734703	SLC29A1	A	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01	rs3734703:A	6918130
butorphanol	rs4633	COMT	CC	Efficacy	decreased	Efficacy_Response	Healthy		N02AF01	rs4633:CC	5464090
sunitinib	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0007134|Disease:C2939419		L01EX01	rs1045642:AA	11221549
sunitinib	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0007134|Disease:C2939419		L01EX01	rs1045642:AG	11221549
methotrexate	rs1051266	SLC19A1	CC	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1051266:CC	11329481
methotrexate	rs1051266	SLC19A1	TT	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1051266:TT	11329481
sn-38(irinotecan)	rs3832043	UGT1A9	TT	Dosage	increased	LADME	Disease:C0007131		L01CE02	rs3832043:TT	60838
efavirenz	rs2279345	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CC	64139
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT	64139
risperidone	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs1128503:AA	849421
risperidone	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0004352		N05AX08	rs1128503:AG	849421
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT	64139
glucocorticoids	rs1876828	CRHR1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA	rs1876828:T	No_match
antidepressants	rs11580409	ERICH3	C	Efficacy	increased	Efficacy_Response	Healthy		N06A	rs11580409:C	No_match
sn-38(irinotecan)	rs4149056	SLCO1B1	CC	Dosage	increased	Dosage	Disease:C0007131		L01CE02	rs4149056:CC	60838
sn-38(irinotecan)	rs4149056	SLCO1B1	CT	Dosage	increased	Dosage	Disease:C0007131		L01CE02	rs4149056:CT	60838
salmeterol	rs1042713	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03AC12	rs1042713:AA	5152
levomethadone	rs2740574	CYP3A4	CT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	rs2740574:CT	22267
voriconazole	rs4986893	CYP2C19	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4986893:AA	9741
voriconazole	rs4986893	CYP2C19	AG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs4986893:AG	9741
methylphenidate	rs2284411	GRIN2B	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs2284411:CC	154100
fentanyl	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Other:C0006434		N02AB03	rs2740574:C	13653606
salbutamol, selective beta-2-adrenoreceptor agonists	rs7793837	CRHR2	T	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC|R03CC02	rs7793837:T	2083
atorvastatin, rosuvastatin, simvastatin	rs2230806	ABCA1	T	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01|C10AA05|C10AA07	rs2230806:T	60823
salbutamol, selective beta-2-adrenoreceptor agonists	rs7793837	CRHR2	T	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC|R03CC02	rs7793837:T	2083
atorvastatin, rosuvastatin, simvastatin	rs3892097	CYP2D6	T	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01|C10AA05|C10AA07	rs3892097:T	60823
nicardipine, nimodipine	rs2739258	CACNA1B	AG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739258:AG	4497
nicardipine, nimodipine	rs2739258	CACNA1B	GG	Efficacy	increased	Efficacy_Response	Other:C0005586		C08CA04|C08CA06	rs2739258:GG	4497
methotrexate	rs1801131	MTHFR	TT	Efficacy	decreased	Efficacy_Response	Other:C0024299|Other:C0023449		L04AX03	rs1801131:TT	11329481
imatinib	rs776746	CYP3A5	C	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:C	6113
imatinib	rs683369	SLC22A1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CG	6113
imatinib	rs683369	SLC22A1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:GG	6113
simvastatin	rs662799	APOA5	AA	Efficacy	increased	Efficacy_Response	Disease:C0242339		C10AA01	rs662799:AA	14373154
irbesartan	rs1367117	APOB	AG	Efficacy, Metabolism/PK	Indeterminado	Efficacy_Response	Disease:C0020538		C09CA04	rs1367117:AG	2901
irbesartan	rs1367117	APOB	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09CA04	rs1367117:GG	2901
atorvastatin	rs662799	APOA5	AA	Efficacy	increased	Efficacy_Response	Disease:C0242339		C10AA05	rs662799:AA	656846
efavirenz	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:C	64139
methotrexate	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs1801133:AA	11329481
benazepril	rs2229437	PRCP	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs2229437:GG	5362124
benazepril	rs2229437	PRCP	GT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs2229437:GT	5362124
efavirenz	rs28365062	UGT2B7	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28365062:GG	64139
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C	64139
clopidogrel	rs4244285	CYP2C19	A	Efficacy, Other	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:A	13748464
efavirenz, lamivudine, tenofovir	rs2279343	CYP2B6	AG	Efficacy	increased	Efficacy_Response	Other:HIV_infectious_disease		J05AF05|J05AF07|J05AG03	rs2279343:AG	64139
efavirenz, lamivudine, tenofovir	rs2279343	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:HIV_infectious_disease		J05AF05|J05AF07|J05AG03	rs2279343:GG	64139
methotrexate	rs1801131	MTHFR	GG	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs1801131:GG	11329481
clopidogrel	rs1045642	ABCB1	G	Efficacy, Other	Indeterminado	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:G	13748464
midazolam	rs11568820	VDR	CT	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs11568820:CT	5384200
midazolam	rs11568820	VDR	TT	Metabolism/PK	increased	LADME	Healthy		N05CD08	rs11568820:TT	5384200
methyldopa	rs3742879	ARG2	G	Efficacy	increased	Efficacy_Response	Other:C0032961|Other:C0032914		C02AB	rs3742879:G	9307
fluorouracil	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02	rs1801133:AA	5790
fluorouracil	rs1801133	MTHFR	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02	rs1801133:AG	5790
repaglinide	rs10509681	CYP2C8	C	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BX02	rs10509681:C	22132924
repaglinide	rs11572080	CYP2C8	T	Dosage, Metabolism/PK	increased	LADME	Healthy		A10BX02	rs11572080:T	22132924
aripiprazole	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Other:C0011581		N05AX12	rs1128503:AA	10114519
omeprazole	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		A02BC01	rs12248560:TT	9579578
mephenytoin	rs12248560	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs12248560:TT	91480
omeprazole	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		A02BC01	rs11188072:TT	9579578
mephenytoin	rs11188072	CYP2C19	TT	Dosage, Metabolism/PK	increased	LADME	Other:C0024198		N03AB02	rs11188072:TT	91480
methadone	rs3211371	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs3211371:TT	10090
mercaptopurine, methotrexate	rs4149056	SLCO1B1	CC	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L04AX03	rs4149056:CC	126941
mercaptopurine, methotrexate	rs4149056	SLCO1B1	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02|L04AX03	rs4149056:CT	126941
gemcitabine	rs1044457	CMPK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs1044457:CC	597
dexmedetomidine	rs1800035	ADRA2A	CG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs1800035:CG	6918081
dexmedetomidine	rs1800035	ADRA2A	GG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs1800035:GG	6918081
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3024498	IL10	CC	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3024498:CC	5311101
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3024498	IL10	CT	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3024498:CT	5311101
dexmedetomidine	rs775887911	ADRA2A	CT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs775887911:CT	6918081
dexmedetomidine	rs775887911	ADRA2A	TT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs775887911:TT	6918081
dexmedetomidine	rs201376588	ADRA2A	CT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs201376588:CT	6918081
dexmedetomidine	rs201376588	ADRA2A	TT	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N05CM18	rs201376588:TT	6918081
gemcitabine	rs35687416	CMPK1	GG	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs35687416:GG	597
gemcitabine	rs12507552	DCTD	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs12507552:CC	597
beta blocking agents	rs139945292	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C0020538		S01ED	rs139945292:T	No_match
rosuvastatin	rs662799	APOA5	AA	Efficacy	increased	Efficacy_Response	Disease:C0242339		C10AA07	rs662799:AA	5282455
gemcitabine	rs274713	TENT4A	GG	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs274713:GG	597
methotrexate	rs1544105	FPGS	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1544105:CT	11329481
methotrexate	rs1544105	FPGS	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1544105:TT	11329481
gemcitabine	rs992160	CDC5L	CT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs992160:CT	597
gemcitabine	rs992160	CDC5L	TT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs992160:TT	597
methotrexate	rs2853539	TYMS	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2853539:AA	11329481
atorvastatin, rosuvastatin, simvastatin	rs662799	APOA5	AA	Other	Indeterminado	Efficacy_Response	Disease:C0242339		C10AA01|C10AA05|C10AA07	rs662799:AA	60823
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3819024	IL17A	AG	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3819024:AG	5311101
budesonide, fluticasone / salmeterol, formoterol, omalizumab	rs3819024	IL17A	GG	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03AC12|R03AC13|R03BA02|R03BA05|R03DX05	rs3819024:GG	5311101
gemcitabine	rs10916852	SH2D5	GT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs10916852:GT	597
gemcitabine	rs10916852	SH2D5	TT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs10916852:TT	597
rosuvastatin	rs708272	CETP	A	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs708272:A	5282455
atorvastatin	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C1956346		C10AA05	rs1045642:AA	656846
atorvastatin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Other:C1956346		C10AA05	rs2306283:AA	656846
repaglinide	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		A10BX02	rs4149056:CT	22132924
phenprocoumon	rs9923231	VKORC1	TT	Dosage, Toxicity	decreased	Dosage	Healthy		B01AA04	rs9923231:TT	91987769
azathioprine	rs1142345	TPMT	CT	Metabolism/PK	decreased	LADME	Disease:C0021390		L04AX01	rs1142345:CT	5778
azathioprine	rs1127354	ITPA	AC	Metabolism/PK	increased	LADME	Disease:C0021390		L04AX01	rs1127354:AC	5778
repaglinide	rs4149056	SLCO1B1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		A10BX02	rs4149056:TT	22132924
buprenorphine	rs2740574	CYP3A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0022116|Disease:C0030193		N07BC01	rs2740574:TT	11274356
perindopril	rs5186	AGTR1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA04	rs5186:AA	441313
nitrendipine	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA08	rs5186:AA	7449
hydromorphone	rs1799971	OPRM1	AG	PD	increased	Efficacy_Response	Healthy		N02AA03	rs1799971:AG	5462347
hydromorphone	rs1799971	OPRM1	GG	PD	increased	Efficacy_Response	Healthy		N02AA03	rs1799971:GG	5462347
lamotrigine	rs2071197	HNF4A	AA	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AX09	rs2071197:AA	71236569
lamotrigine	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:GT	71236569
lamotrigine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:TT	71236569
lamotrigine	rs3114020	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs3114020:CC	71236569
lamotrigine	rs3114020	ABCG2	CT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs3114020:CT	71236569
cyclosporine	rs3828743	TSPYL1	AG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD01	rs3828743:AG	86666680
cyclosporine	rs3828743	TSPYL1	GG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD01	rs3828743:GG	86666680
gemcitabine	rs7543016	CMPK1	CC	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs7543016:CC	597
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
gemcitabine	rs944050	ESR2	TT	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs944050:TT	597
risperidone	rs1799978	DRD2	TT	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs1799978:TT	849421
irinotecan	rs2273697	ABCC2	AA	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs2273697:AA	74990
irinotecan	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs2273697:AG	74990
risperidone	rs1799978	DRD2	T	Other	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs1799978:T	849421
antiepileptics	rs717620	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:CT	No_match
antiepileptics	rs717620	ABCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:TT	No_match
glucose	rs4149056	SLCO1B1	TT	Metabolism/PK	Indeterminado	LADME	Healthy		V06DC01	rs4149056:TT	86583511
warfarin	rs12777823	__INTRONIC__	A	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs12777823:A	54688261
methotrexate	rs2306283	SLCO1B1	AA	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs2306283:AA	11329481
methotrexate	rs2306283	SLCO1B1	AG	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs2306283:AG	11329481
ivacaftor	rs75527207	CFTR	AA	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AA	72722243
ivacaftor	rs75527207	CFTR	AG	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AG	72722243
methotrexate	rs4149056	SLCO1B1	CC	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:CT	11329481
conjugated estrogens	rs4149056	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0025320		G03CA57	rs4149056:CT	223368
cisplatin	rs3212986	ERCC1	A	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01XA01	rs3212986:A	441203
antipsychotics	rs1045642	ABCB1	GG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs1045642:GG	No_match
antipsychotics	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs2032582:AA	No_match
diazepam	rs4244285	CYP2C19	AA	Efficacy	increased	Efficacy_Response	Other:C0085762		N05BA01	rs4244285:AA	3016
diazepam	rs4244285	CYP2C19	AG	Efficacy	increased	Efficacy_Response	Other:C0085762		N05BA01	rs4244285:AG	3016
alprazolam	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:C0085762|Other:C0003469		N05BA12	rs35599367:AG	2118
diazepam	rs12248560	CYP2C19	CT	Efficacy	decreased	Efficacy_Response	Other:C0085762		N05BA01	rs12248560:CT	3016
diazepam	rs12248560	CYP2C19	TT	Efficacy	decreased	Efficacy_Response	Other:C0085762		N05BA01	rs12248560:TT	3016
clozapine	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs1057868:CT	131769989
clozapine	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs1057868:TT	131769989
salbutamol	rs8191725	IGF2R	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs8191725:AG	2083
salbutamol	rs77441273	SLC24A4	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs77441273:AG	2083
alprazolam	rs35599367	CYP3A4	AG	Efficacy	decreased	Efficacy_Response	Other:C0085762|Other:C0003469		N05BA12	rs35599367:AG	2118
lansoprazole, omeprazole, rabeprazole	rs16944	IL1B	AG	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	rs16944:AG	3883
lansoprazole, omeprazole, rabeprazole	rs16944	IL1B	AA	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC03|A02BC04	rs16944:AA	3883
warfarin	rs2359612	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AA	54688261
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
platinum compounds	rs11615	ERCC1	AG	Efficacy	increased	Efficacy_Response	Other:C0919267|Other:Neoplasm_of_esophagus|Other:C0027651		L01XA	rs11615:AG	23939
platinum compounds	rs11615	ERCC1	GG	Efficacy	increased	Efficacy_Response	Other:C0919267|Other:Neoplasm_of_esophagus|Other:C0027651		L01XA	rs11615:GG	23939
ulinastatin	rs243865	MMP2	T	Efficacy	decreased	Efficacy_Response	Other:C0030305		No_ATC	rs243865:T	105102
antipsychotics	rs1128503	ABCB1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1128503:G	No_match
ulinastatin	rs3918242	MMP9	T	Efficacy	increased	Efficacy_Response	Other:C0030305		No_ATC	rs3918242:T	105102
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AA	131769926
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG	131769926
tacrolimus	rs2276707	NR1I2	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2276707:CT	131769926
tacrolimus	rs2276707	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2276707:TT	131769926
antipsychotics	rs1045642	ABCB1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1045642:G	No_match
irinotecan	rs10934498	NR1I2	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0024121		L01CE02	rs10934498:AA	74990
tacrolimus	rs1800896	IL10	CC	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	rs1800896:CC	131769926
olanzapine	rs324026	DRD3	C	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs324026:C	74603552
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs6811453	ADH1A	A	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs6811453:A	657237
measles vaccines	rs3775291	TLR3	CT	Efficacy	decreased	Efficacy_Response	Healthy		J07BD	rs3775291:CT	No_match
cytarabine, fludarabine, gemtuzumab ozogamicin, idarubicin	rs1826909	ADH1A	T	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BB05|L01BC01|L01DB06	rs1826909:T	657237
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
tamoxifen	rs717620	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs717620:CT	2733525
salbutamol	rs77149876	__INTRONIC__	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs77149876:CT	2083
etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02	rs1800629:A	No_match
carbamazepine	rs3812718	SCN1A	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT	114709
salbutamol	rs77977790	PAPPA2	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs77977790:CT	2083
norbuprenorphine	rs569356	OPRD1	GG	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		No_ATC	rs569356:GG	114976
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
salmeterol	rs1042713	ADRB2	G	Efficacy	increased	Efficacy_Response	Other:C0004096		R03AC12	rs1042713:G	5152
salbutamol	rs116551936	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs116551936:AG	2083
salbutamol	rs115501901	NCOA3	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs115501901:CT	2083
salbutamol	rs74973995	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs74973995:AG	2083
salbutamol	rs73294475	CRHR2	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs73294475:CT	2083
phenprocoumon	rs2740574	CYP3A4	C	Dosage	decreased	Dosage	Healthy		B01AA04	rs2740574:C	91987769
salbutamol	rs144315541	ADCY9	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs144315541:AG	2083
perphenazine	rs17570753	MCPH1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs17570753:A	82341
perphenazine	rs2116971	CDH13	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs2116971:G	82341
perphenazine	rs9952628	SKOR2	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs9952628:G	82341
metformin	rs12943590	SLC47A2	AA	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs12943590:AA	155906370
quetiapine	rs35793	KCNMA1	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH04	rs35793:G	118753024
perphenazine	rs11100483	MAML3	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs11100483:A	82341
valproic acid	rs7668258	UGT2B7	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:CC	134459
valproic acid	rs7668258	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:CT	134459
methacholine	rs11702779	RUNX1	AA	Other	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs11702779:AA	6114
risperidone	rs874295	LRP1B	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs874295:G	849421
bevacizumab	rs11200638	HTRA1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs11200638:AA	No_match
risperidone	rs9713	PSMD14	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs9713:A	849421
risperidone	rs1869295	AGAP1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs1869295:C	849421
bevacizumab	rs10490924	ARMS2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs10490924:TT	No_match
valproic acid	rs3816877	APEH	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs3816877:CC	134459
risperidone	rs1315115	NPAS3	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs1315115:G	849421
risperidone	rs3738883	TMEFF2	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AX08	rs3738883:G	849421
metformin	rs4810083	PCK1	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs4810083:CT	155906370
metformin	rs4810083	PCK1	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs4810083:TT	155906370
ziprasidone	rs4925300	CDH4	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs4925300:A	656685
ziprasidone	rs1546519	LYN	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs1546519:G	656685
bevacizumab	rs800292	CFH	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs800292:GG	No_match
warfarin	rs1799853	CYP2C9	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:CT	54688261
ziprasidone	rs9585618	NALCN	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs9585618:C	656685
ziprasidone	rs17194378	CNTN4	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AE04	rs17194378:A	656685
opioids	rs4680	COMT	GG	Dosage	increased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs4680:GG	No_match
imatinib	rs4148978	SLCO1A2	CT	Toxicity, Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs4148978:CT	6113
imatinib	rs4148978	SLCO1A2	TT	Toxicity, Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs4148978:TT	6113
imatinib	rs4149117	SLCO1B3	GG	Toxicity, Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs4149117:GG	6113
hydrochlorothiazide	rs4961	ADD1	GT	Efficacy	increased	Efficacy_Response	Healthy		C03AA03	rs4961:GT	2904
hydrochlorothiazide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Healthy		C03AA03	rs4961:TT	2904
warfarin	rs2290228	CALU	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2290228:AA	54688261
olanzapine	rs12610827	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs12610827:T	74603552
remifentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0549433		N01AH06	rs1799971:AG	60815
remifentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0549433		N01AH06	rs1799971:GG	60815
fenofibrate	rs676210	APOB	AA	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs676210:AA	11350701
methacholine	rs11702779	RUNX1	AG	Other	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs11702779:AG	6114
methacholine	rs11702779	RUNX1	GG	Other	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs11702779:GG	6114
citalopram, fluoxetine	rs1799889	SERPINE1	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04	rs1799889:G	1548970
methotrexate	rs1805087	MTR	G	Metabolism/PK	increased	LADME	Other:C0024299|Other:C0023449		L04AX03	rs1805087:G	11329481
citalopram, fluoxetine, mirtazapine, paroxetine, selective serotonin reuptake inhibitors, venlafaxine	rs4713916	FKBP5	A	Efficacy	increased	Efficacy_Response	Disease:C0040435		N06AB|N06AB03|N06AB04|N06AB05|N06AX11|N06AX16	rs4713916:A	5202
olanzapine	rs17070785	CSMD1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs17070785:A	74603552
olanzapine	rs2247408	PLAGL1	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs2247408:C	74603552
sirolimus	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		No_ATC	rs15524:AA	5284616
olanzapine	rs3819811	PLAGL1	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs3819811:A	74603552
sirolimus	rs4646453	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		No_ATC	rs4646453:CC	5284616
acetaminophen	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02BE01	rs1799971:AG	1983
acetaminophen	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02BE01	rs1799971:GG	1983
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
olanzapine	rs221253	PTPRN2	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH03	rs221253:C	74603552
imatinib	rs628031	SLC22A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs628031:AA	6113
imatinib	rs628031	SLC22A1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs628031:AG	6113
warfarin	rs1800566	NQO1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AA	54688261
warfarin	rs1800566	NQO1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AG	54688261
perphenazine	rs2278773	PRKCE	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs2278773:C	82341
perphenazine	rs11774231	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AB03	rs11774231:C	82341
clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	13748464
hydrochlorothiazide	rs2269879	DOT1L	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs2269879:CT	2904
hydrochlorothiazide	rs2269879	DOT1L	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs2269879:TT	2904
paroxetine	rs11042725	ADM	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs11042725:CC	667572
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
tildrakizumab	rs9373839	ATG5	CT	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AC17	rs9373839:CT	No_match
tildrakizumab	rs708567	IL17RC	CC	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AC17	rs708567:CC	No_match
citalopram	rs7124442	BDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs7124442:TT	162180
aripiprazole	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N05AX12	rs2032582:AA	10114519
clozapine	rs2740204	OXT	T	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2740204:T	131769989
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
diazepam	rs35599367	CYP3A4	GG	Efficacy	increased	Efficacy_Response	Other:C0085762		N05BA01	rs35599367:GG	3016
methotrexate	rs1801133	MTHFR	G	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AX03	rs1801133:G	11329481
methotrexate	rs408626	DHFR	C	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AX03	rs408626:C	11329481
repaglinide	rs10494366	NOS1AP	T	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs10494366:T	22132924
citalopram	rs7103411	BDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs7103411:TT	162180
highly active antiretroviral therapy (haart)	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		No_ATC	rs1045642:AA	No_match
highly active antiretroviral therapy (haart)	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		No_ATC	rs1045642:AG	No_match
citalopram	rs6265	BDNF	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs6265:CC	162180
lamivudine, lopinavir, ritonavir, zidovudine	rs212091	ABCC1	CC	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AE03|J05AF01|J05AF05|J05AR10	rs212091:CC	60825
lamivudine, lopinavir, ritonavir, zidovudine	rs212091	ABCC1	CT	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AE03|J05AF01|J05AF05|J05AR10	rs212091:CT	60825
fluoxetine	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs6265:CT	1548968
tildrakizumab	rs610604	TNFAIP3	GG	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AC17	rs610604:GG	No_match
clopidogrel	rs4986893	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4986893:A	13748464
antidepressants	rs11580409	ERICH3	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs11580409:CC	No_match
clopidogrel	rs12248560	CYP2C19	CT	Efficacy	increased	Efficacy_Response	Disease:C1956346		B01AC04	rs12248560:CT	13748464
aripiprazole	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N05AX12	rs1045642:AA	10114519
ivacaftor	rs77932196	CFTR	A	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs77932196:A	72722243
paroxetine	rs6280	DRD3	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs6280:CC	667572
paroxetine	rs6280	DRD3	CT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs6280:CT	667572
entacapone	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BX02	rs4680:GG	21864625
clozapine	rs1065852	CYP2D6	AA	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs1065852:AA	131769989
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
telmisartan	rs60140950	SLCO1B3	C	Metabolism/PK	increased	LADME	Healthy		C09CA07	rs60140950:C	67184
clozapine	rs16947	CYP2D6	GG	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs16947:GG	131769989
atorvastatin, simvastatin	rs11887534	ABCG8	CC	Efficacy	decreased	Efficacy_Response	Other:C0242339		C10AA01|C10AA05	rs11887534:CC	60823
atorvastatin, simvastatin	rs11887534	ABCG8	CG	Efficacy	decreased	Efficacy_Response	Other:C0242339		C10AA01|C10AA05	rs11887534:CG	60823
ivacaftor	rs121909011	CFTR	C	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs121909011:C	72722243
imatinib	rs2290573	ULK3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2290573:GG	6113
clozapine	rs265976	DRD1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs265976:GT	131769989
ivacaftor	rs75527207	CFTR	AA	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AA	72722243
ivacaftor	rs75527207	CFTR	AG	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AG	72722243
interferons	rs4796793	STAT3	GG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L03AB	rs4796793:GG	No_match
tamoxifen	rs12422149	SLCO2B1	AA	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs12422149:AA	2733525
tamoxifen	rs12422149	SLCO2B1	AG	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs12422149:AG	2733525
warfarin	rs2359612	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AA	54688261
warfarin	rs2359612	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AG	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
warfarin	rs8050894	VKORC1	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:CG	54688261
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG	54688261
risperidone	rs3787430	HRH3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs3787430:TT	849421
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA	54688261
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG	54688261
warfarin	rs2884737	VKORC1	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:AC	54688261
warfarin	rs2884737	VKORC1	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:CC	54688261
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT	54688261
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT	54688261
risperidone	rs3787429	HRH3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs3787429:TT	849421
aripiprazole	rs4305746	TAAR6	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs4305746:AA	10114519
aripiprazole	rs4305746	TAAR6	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs4305746:AG	10114519
peginterferon alfa-2a	rs1800795	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		L03AB11	rs1800795:G	No_match
sulfasalazine	rs2231142	ABCG2	TT	Metabolism/PK	decreased	LADME	Healthy		A07EC01	rs2231142:TT	5336
peginterferon alfa-2a	rs1800796	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		L03AB11	rs1800796:G	No_match
peginterferon alfa-2a	rs1800797	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		L03AB11	rs1800797:G	No_match
rosuvastatin	rs2199936	ABCG2	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs2199936:AA	5282455
rosuvastatin	rs2199936	ABCG2	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs2199936:AG	5282455
iloperidone	rs1800169	CNTF, ZFP91-CNTF	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs1800169:GG	18467218
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
disulfiram	rs678849	OPRD1	CC	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs678849:CC	101405
erythropoietin	rs1561876	STIM1	AG	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs1561876:AG	35370
erythropoietin	rs1561876	STIM1	GG	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs1561876:GG	35370
latanoprost	rs3753380	PTGFR	CC	Efficacy	increased	Efficacy_Response	Healthy		S01EE01	rs3753380:CC	118984471
ranibizumab	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs699947:AC	No_match
ranibizumab	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs699947:CC	No_match
furosemide	rs17268282	ABCC4	T	Efficacy	increased	Efficacy_Response	Disease:C0085605		C03CA01	rs17268282:T	76523
metformin	rs622342	SLC22A1	CC	Efficacy	Indeterminado	Efficacy_Response	Other:genetic_variation_at_rs2289669		A10BA02	rs622342:CC	155906370
morphine	rs737866	COMT	T	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs737866:T	5284371
morphine	rs2075507	COMT	G	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs2075507:G	5284371
antiepileptics	rs2606345	CYP1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N03A	rs2606345:AA	No_match
morphine	rs5746849	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs5746849:A	5284371
morphine	rs7287550	COMT, TXNRD2	C	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs7287550:C	5284371
morphine	rs6269	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs6269:A	5284371
carbamazepine	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2740574:TT	114709
morphine	rs740603	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs740603:A	5284371
morphine	rs4793665	ABCC3	T	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs4793665:T	5284371
tacrolimus	rs1057868	POR	T	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1057868:T	131769926
n-desmethyltramadol, o-desmethyltramadol	rs35742686	CYP2D6	DELT/T	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs35742686:DELT/T	9816106
n-desmethyltramadol, tramadol	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs35599367:AG	9816106
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Other:C1956346		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4986893	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Other:C1956346		B01AC04	rs4986893:AG	13748464
clopidogrel	rs717620	ABCC2	CC	Efficacy	decreased	Efficacy_Response	Other:C1956346		B01AC04	rs717620:CC	13748464
atazanavir	rs73208473	SORCS2	A	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AE08	rs73208473:A	118753185
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs9304742	ZNF816	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs9304742:CC	No_match
carbamazepine	rs28365063	UGT2B7	AA	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs28365063:AA	114709
carbamazepine	rs3814055	NR1I2	T	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs3814055:T	114709
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2916205	PGLYRP4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2916205:CC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2916205	PGLYRP4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2916205:CT	No_match
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801133:AG	11329481
sulfonamides, urea derivatives	rs1799853	CYP2C9	TT	Efficacy	increased	Efficacy_Response	Healthy		S01AB	rs1799853:TT	1176
sumatriptan	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Disease:C0009088		N02CC01	rs5443:CT	68647
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2546890	IL12B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2546890:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2546890	IL12B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs2546890:GG	No_match
desethyl hydroxychloroquine	rs1135840	CYP2D6	G	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01	rs1135840:G	71826
cannabinoids	rs8065080	TRPV1	CC	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs8065080:CC	2543
cannabinoids	rs7438135	UGT2B7	AA	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs7438135:AA	2543
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11126740	CTNNA2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11126740:AA	No_match
imatinib	rs2231142	ABCG2	GT	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01EA01	rs2231142:GT	6113
desethyl hydroxychloroquine	rs1065852	CYP2D6	AA	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01	rs1065852:AA	71826
repaglinide	rs5219	KCNJ11	T	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs5219:T	22132924
tramadol	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N02AX02	rs1799971:AG	63013
tramadol	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N02AX02	rs1799971:GG	63013
repaglinide	rs290487	TCF7L2	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs290487:TT	22132924
morphine	rs4680	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs4680:A	5284371
carbamazepine	rs1051740	EPHX1	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs1051740:TT	114709
morphine	rs4818	COMT	C	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs4818:C	5284371
erythropoietin	rs12320939	ORAI1	GG	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs12320939:GG	35370
erythropoietin	rs12320939	ORAI1	GT	Efficacy	increased	Efficacy_Response	Other:C0178298|Other:C0002871		B03XA01	rs12320939:GT	35370
carbamazepine	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1128503:AA	114709
carbamazepine	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1128503:AG	114709
morphine	rs2239393	COMT	A	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs2239393:A	5284371
mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:CT	1268107
morphine	rs165728	ARVCF, COMT	T	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs165728:T	5284371
carbamazepine	rs4148740	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4148740:AG	114709
carbamazepine	rs4148739	ABCB1	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs4148739:TT	114709
morphine	rs174699	ARVCF, COMT	T	Dosage, Efficacy	decreased	Dosage	Disease:C0027651		N02AA01	rs174699:T	5284371
antipsychotics	rs1799732	DRD2	del	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1799732:del	No_match
hmg coa reductase inhibitors	rs1532624	CETP	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA	rs1532624:AA	445127
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6908425	CDKAL1	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs6908425:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6908425	CDKAL1	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs6908425:TT	No_match
carbamazepine	rs2273697	ABCC2	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2273697:AA	114709
carbamazepine	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2273697:AG	114709
hmg coa reductase inhibitors	rs533556	SIK3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA	rs533556:AA	445127
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12191877	HLA-C	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs12191877:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12191877	HLA-C	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs12191877:TT	No_match
ritodrine	rs7624046	KCNMB2	TT	Efficacy	decreased	Efficacy_Response	Healthy		G02CA01	rs7624046:TT	33572
carbamazepine	rs4148386	ABCC2	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4148386:AA	114709
carbamazepine	rs4148386	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4148386:AG	114709
warfarin	rs61742245	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AA	54688261
warfarin	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AC	54688261
carbamazepine	rs3740066	ABCC2	CT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs3740066:CT	114709
carbamazepine	rs3740066	ABCC2	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs3740066:TT	114709
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs96844	MAP3K1	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs96844:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs96844	MAP3K1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs96844:GG	No_match
ritodrine	rs9839376	KCNMB2	CC	Efficacy	decreased	Efficacy_Response	Healthy		G02CA01	rs9839376:CC	33572
warfarin	rs11676382	GGCX	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:G	54688261
carbamazepine	rs7643645	NR1I2	G	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs7643645:G	114709
morphine	rs2952768	METTL21A	CC	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs2952768:CC	5284371
carbamazepine	rs4688040	NR1I2	T	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs4688040:T	114709
cannabinoids	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs1045642:AG	2543
cannabinoids	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:C0030193		N02BG10	rs1045642:GG	2543
morphine	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs1799971:AG	5284371
morphine	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs1799971:GG	5284371
carbamazepine	rs2461817	NR1I2	C	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2461817:C	114709
metoprolol	rs1801252	ADRB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB02	rs1801252:AA	6322
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	rs2884737	VKORC1	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:CC	54688261
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
citalopram, fluoxetine, paroxetine, sertraline	rs495794	SRP19	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05|N06AB06	rs495794:G	667572
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
citalopram, fluoxetine, paroxetine, sertraline	rs153560	REEP5	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05|N06AB06	rs153560:G	667572
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG	54688261
citalopram, fluoxetine, paroxetine, sertraline	rs153549	REEP5	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04|N06AB05|N06AB06	rs153549:A	667572
atazanavir	rs1045642	ABCB1	AA	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs1045642:AA	118753185
atazanavir	rs1045642	ABCB1	AG	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs1045642:AG	118753185
atazanavir	rs4149056	SLCO1B1	TT	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs4149056:TT	118753185
fluorouracil	rs3918290	DPYD	CT	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs3918290:CT	5790
atazanavir	rs2472677	NR1I2	TT	Dosage	Indeterminado	Dosage	Disease:HIV_infectious_disease		J05AE08	rs2472677:TT	118753185
warfarin	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Other:warfarin_maintenance_treatment		B01AA03	rs61742245:AC	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT	54742534
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs2227310	CASP7	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs2227310:CG	23939
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs2227310	CASP7	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs2227310:GG	23939
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs4353229	CASP7	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs4353229:CC	23939
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs4353229	CASP7	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs4353229:CT	23939
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs12415607	CASP7	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs12415607:AA	23939
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs12415607	CASP7	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs12415607:AC	23939
docetaxel, gemcitabine, paclitaxel, platinum compounds, vinorelbine	rs7921977	CASP7	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01CA04|L01CD01|L01CD02|L01XA	rs7921977:CT	23939
olanzapine	rs11240594	SLC26A9	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs11240594:A	74603552
solanidine	rs28379954	NFIB	CC	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs28379954:CC	65727
solanidine	rs28379954	NFIB	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs28379954:CT	65727
ziprasidone	rs286913	EHF	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AE04	rs286913:A	656685
clozapine	rs2975226	SLC6A3	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2975226:A	131769989
olanzapine	rs11677416	IL1A	C	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs11677416:C	74603552
cyclosporine	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs1057868:TT	86666680
carbamazepine	rs1051740	EPHX1	C	Dosage, Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1051740:C	114709
fesoterodine	rs10929302	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	AA	Metabolism/PK	increased	LADME	Healthy		G04BD11	rs10929302:AA	6918558
pioglitazone	rs17584499	PTPRD	CC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BG03	rs17584499:CC	60560
acenocoumarol, warfarin	rs9923231	VKORC1	CC	Efficacy	increased	Dosage	Healthy		B01AA03|B01AA07	rs9923231:CC	54676537
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Efficacy	increased	Dosage	Healthy		B01AA03|B01AA07	rs9923231:CT	54676537
ethanol	rs1799971	OPRM1	G	Toxicity	increased	Efficacy_Response	Other:C0085762		V03AB16	rs1799971:G	444899
acamprosate	rs2058878	GRIN2B	A	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB03	rs2058878:A	1646
olanzapine	rs6688363	ATP1A2	T	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AH03	rs6688363:T	74603552
risperidone	rs8050896	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs8050896:T	849421
risperidone	rs2980976	TNFRSF11A	A	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AX08	rs2980976:A	849421
risperidone	rs2636697	PPA2	G	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AX08	rs2636697:G	849421
methotrexate	rs1232027	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0235889|Psoriatic		L04AX03	rs1232027:A	11329481
fentanyl, hydromorphone, opioids, oxycodone, tramadol	rs1799971	OPRM1	AA	Dosage	increased	Dosage	Other:C0549433		N02A|N02AA03|N02AA05|N02AB03|N02AX02	rs1799971:AA	33741
risperidone	rs2636719	PPA2	A	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AX08	rs2636719:A	849421
repaglinide	rs4402960	IGF2BP2	GT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs4402960:GT	22132924
repaglinide	rs4402960	IGF2BP2	TT	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs4402960:TT	22132924
rasagiline	rs4680	COMT	AA	Metabolism/PK	decreased	LADME	Healthy		N04BD02	rs4680:AA	3052775
repaglinide	rs1470579	IGF2BP2	AC	Dosage, Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1470579:AC	22132924
repaglinide	rs1470579	IGF2BP2	CC	Dosage, Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BX02	rs1470579:CC	22132924
disulfiram	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0278080		N07BB01	rs1801133:AA	101405
disulfiram	rs1801133	MTHFR	AG	Efficacy	increased	Efficacy_Response	Disease:C0278080		N07BB01	rs1801133:AG	101405
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	AG	Efficacy	increased	Efficacy_Response	"""Disease:C0235889|Psoriatic""|""Disease:C0010346|""Disease:C0235763|""Disease:C0038012|Ankylosing"""		No_ATC	rs1801274:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	"""Disease:C0235889|Psoriatic""|""Disease:C0010346|""Disease:C0235763|""Disease:C0038012|Ankylosing"""		No_ATC	rs1801274:GG	No_match
isoniazid	rs4646244	NAT2	AT	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0041296		J04AC01	rs4646244:AT	135483892
platinum compounds	rs11615	ERCC1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs11615:AA	23939
isoniazid	rs1799930	NAT2	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0041296		J04AC01	rs1799930:AA	135483892
hydrochlorothiazide	rs61747221	BEST3	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs61747221:AA	2904
hydrochlorothiazide	rs61747221	BEST3	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs61747221:AG	2904
deferiprone	rs2070959	UGT1A6	AA	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs2070959:AA	8369
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	"""Disease:C0235889|Psoriatic""|""Disease:C0010346|""Disease:C0235763|""Disease:C0038012|Ankylosing"""		No_ATC	rs396991:C	No_match
nifedipine	rs1048101	ADRA1A	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA05	rs1048101:AA	4485
nifedipine	rs1048101	ADRA1A	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA05	rs1048101:AG	4485
deferiprone	rs2070959	UGT1A6	AA	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs2070959:AA	8369
deferiprone	rs6759892	UGT1A6	GG	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC02	rs6759892:GG	8369
pioglitazone	rs1801282	PPARG	CG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BG03	rs1801282:CG	60560
paclitaxel, platinum compounds	rs4353229	CASP7	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs4353229:CC	23939
paclitaxel, platinum compounds	rs4353229	CASP7	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs4353229:CT	23939
opioids	rs1800629	TNF	GG	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1800629:GG	No_match
carbamazepine	rs3812718	SCN1A	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:CT	114709
paclitaxel, platinum compounds	rs2227310	CASP7	CG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs2227310:CG	23939
paclitaxel, platinum compounds	rs2227310	CASP7	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs2227310:GG	23939
risperidone	rs813676	TJP1	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs813676:T	849421
opioids	rs1800797	IL6	A	Dosage	decreased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1800797:A	No_match
warfarin	rs9934438	VKORC1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0027051		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage, Efficacy	decreased	Dosage	Disease:C0027051		B01AA03	rs9934438:AG	54688261
methylphenidate	rs734644	ADGRL3	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs734644:CC	154100
methylphenidate	rs734644	ADGRL3	CT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs734644:CT	154100
paclitaxel, platinum compounds	rs1127687	CASP7	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs1127687:AA	23939
paclitaxel, platinum compounds	rs1127687	CASP7	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs1127687:AG	23939
fluticasone propionate, montelukast	rs967676	CA10	CC	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs967676:CC	5311101
fluticasone propionate, montelukast	rs967676	CA10	CT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs967676:CT	5311101
carbamazepine	rs1051740	EPHX1	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1051740:CT	114709
carbamazepine	rs1051740	EPHX1	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1051740:CC	114709
gemcitabine, platinum compounds	rs1127687	CASP7	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA	rs1127687:AA	23939
gemcitabine, platinum compounds	rs1127687	CASP7	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA	rs1127687:AG	23939
fluticasone propionate, montelukast	rs1786929	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs1786929:AA	5311101
fluticasone propionate, montelukast	rs1786929	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05|R03DC03	rs1786929:AG	5311101
tacrolimus	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs2032582:AA	131769926
carbamazepine	rs3812718	SCN1A	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT	114709
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT	5282455
methylphenidate	rs1355368	ADGRL3	AG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1355368:AG	154100
methylphenidate	rs1355368	ADGRL3	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1355368:GG	154100
methylphenidate	rs6813183	ADGRL3	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs6813183:CC	154100
methylphenidate	rs6813183	ADGRL3	CG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs6813183:CG	154100
risperidone	rs7395555	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs7395555:C	849421
ranibizumab	rs1061170	CFH	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		S01LA04	rs1061170:TT	No_match
olanzapine	rs10170310	SPOPL	C	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AH03	rs10170310:C	74603552
quetiapine	rs17382202	PDE4D	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH04	rs17382202:T	118753024
acenocoumarol	rs9923231	VKORC1	T	Dosage	Indeterminado	Dosage	Healthy		B01AA07	rs9923231:T	54742534
quetiapine	rs17742120	PDE4D	G	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH04	rs17742120:G	118753024
quetiapine	rs2164660	PDE4D	A	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH04	rs2164660:A	118753024
acenocoumarol	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	rs9923231:CC	54742534
perindopril	rs5182	AGTR1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs5182:CC	441313
perindopril	rs5182	AGTR1	CT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs5182:CT	441313
risperidone	rs711355	TJP1	T	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs711355:T	849421
risperidone	rs785423	TJP1	A	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs785423:A	849421
tenofovir alafenamide	rs3842	ABCB1	CT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AF13	rs3842:CT	9574768
clozapine	rs25531	SLC6A4	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0036341		N05AH02	rs25531:T	131769989
raloxifene	rs1042597	UGT1A8	CC	Efficacy	increased	Efficacy_Response	Disease:C0025320|Disease:C0036341		G03XC01	rs1042597:CC	10100752
esomeprazole	rs1059513	STAT6	CC	Efficacy	increased	Efficacy_Response	Other:C0151788		A02BC05	rs1059513:CC	9579578
esomeprazole	rs1059513	STAT6	CT	Efficacy	increased	Efficacy_Response	Other:C0151788		A02BC05	rs1059513:CT	9579578
risperidone	rs5758550	WBP2NL	A	Metabolism/PK	decreased	LADME	Healthy		N05AX08	rs5758550:A	849421
paclitaxel, platinum compounds	rs12415607	CASP7	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs12415607:AA	23939
paclitaxel, platinum compounds	rs12415607	CASP7	AC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01CD01|L01XA	rs12415607:AC	23939
adalimumab	rs1126535	CD40LG	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1126535:T	107706
raloxifene	rs11543791	ESR1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0025320|Disease:C0036341		G03XC01	rs11543791:CC	10100752
perindopril	rs275651	AGTR1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs275651:AA	441313
perindopril	rs275651	AGTR1	AT	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs275651:AT	441313
lithium	rs7959663	MYO1H	C	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs7959663:C	11125
infliximab	rs1801274	FCGR2A	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB02	rs1801274:G	No_match
lithium	rs59724122	EPHX2	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs59724122:T	11125
losartan, losartan e-3174	rs17080138	FBXW12	CT	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs17080138:CT	108185
lithium	rs61123830	GRAMD1B	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs61123830:A	11125
warfarin	rs7294	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:T	54688261
lithium	rs66486766	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs66486766:A	11125
lithium	rs324899	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs324899:A	11125
lithium	rs1611259	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs1611259:T	11125
lithium	rs6942227	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs6942227:A	11125
nevirapine	rs28371706	CYP2D6	AA	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs28371706:AA	15979285
nevirapine	rs28371706	CYP2D6	AG	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs28371706:AG	15979285
nevirapine	rs3745274	CYP2B6	GT	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:GT	15979285
nevirapine	rs3745274	CYP2B6	TT	Dosage, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
catecholamines	rs1801253	ADRB1	CC	Dosage	decreased	Dosage	Disease:C1956346		No_ATC	rs1801253:CC	No_match
acenocoumarol	rs429358	APOE	CC	Dosage	increased	Dosage	Disease:C0004238|Disease:C1861172		B01AA07	rs429358:CC	54742534
losartan, losartan e-3174	rs79707182	ZNF703	CT	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs79707182:CT	108185
perindopril	rs12050217	BDKRB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs12050217:AA	441313
perindopril	rs12050217	BDKRB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C09AA04	rs12050217:AG	441313
losartan, losartan e-3174	rs11754288	SLC17A4	A	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs11754288:A	108185
warfarin	rs17708472	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs17708472:A	54688261
drugs used in nicotine dependence	rs680244	CHRNA5	C	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs680244:C	89594
adalimumab, etanercept, infliximab	rs3787186	NFATC2	CC	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs3787186:CC	No_match
adalimumab, etanercept, infliximab	rs3787186	NFATC2	CT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs3787186:CT	No_match
drugs used in nicotine dependence	rs16969968	CHRNA3, CHRNA5	G	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs16969968:G	89594
drugs used in nicotine dependence	rs680244	CHRNA5	T	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs680244:T	89594
allopurinol	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Other:C0018099		M04AA01	rs2231142:T	168354693
lithium	rs79403677	FAM177A1	T	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs79403677:T	11125
clopidogrel	rs2487032	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs2487032:A	13748464
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C07AB02	rs1801253:CC	6322
warfarin	rs9923231	VKORC1	A	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	rs9923231:A	54688261
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11591741	CHUK	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs11591741:G	No_match
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
lithium	rs1521470	ADCY1	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs1521470:A	11125
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC	54688261
repaglinide	rs2237892	KCNQ1	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237892:CT	22132924
repaglinide	rs2237892	KCNQ1	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237892:TT	22132924
lithium	rs7588746	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs7588746:A	11125
lithium	rs6728642	FAM178B	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs6728642:A	11125
beta blocking agents	rs2230345	GRK5	AT	Efficacy	increased	Efficacy_Response	Other:C0085605		S01ED	rs2230345:AT	No_match
beta blocking agents	rs2230345	GRK5	TT	Efficacy	increased	Efficacy_Response	Other:C0085605		S01ED	rs2230345:TT	No_match
zileuton	rs12436663	PRORP	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		No_ATC	rs12436663:AA	71752997
losartan, losartan e-3174	rs10509680	CYP2C9	GT	Metabolism/PK	increased	LADME	Healthy		C09CA01	rs10509680:GT	108185
lithium	rs62200793	ZNF804A	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs62200793:T	11125
lithium	rs1611255	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs1611255:A	11125
lithium	rs209474	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs209474:A	11125
repaglinide	rs2237895	KCNQ1	AC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237895:AC	22132924
repaglinide	rs2237895	KCNQ1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs2237895:CC	22132924
lithium	rs3919583	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs3919583:A	11125
platinum compounds	rs1799782	XRCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AA	23939
platinum compounds	rs1799782	XRCC1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AG	23939
glatiramer acetate	rs1800469	TGFB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	rs1800469:A	3081884
antiepileptics	rs3740066	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs3740066:CT	No_match
antiepileptics	rs3740066	ABCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs3740066:TT	No_match
n-desmethyltamoxifen	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs2231142:GT	10474509
n-desmethyltamoxifen	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C1458155		L02BA01	rs2231142:TT	10474509
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
glucocorticoids	rs37973	GLCCI1	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA	rs37973:G	No_match
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
antiepileptics	rs717620	ABCC2	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:CT	No_match
antiepileptics	rs717620	ABCC2	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs717620:TT	No_match
amlodipine	rs2246709	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2246709:AG	72734364
amlodipine	rs2246709	CYP3A4	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2246709:GG	72734364
teneligliptin	rs2266780	FMO3	AG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266780:AG	11949652
teneligliptin	rs2266780	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266780:GG	11949652
drugs used in nicotine dependence	rs16969968	CHRNA3, CHRNA5	A	Other	increased	Efficacy_Response	Disease:C0039338		N07BA	rs16969968:A	89594
quetiapine	rs4818	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH04	rs4818:C	118753024
hydrochlorothiazide	rs3758785	GPR83	GG	Efficacy	decreased	Efficacy_Response	Efficacy:C0085580		C03AA03	rs3758785:GG	2904
quetiapine	rs5993883	COMT	T	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH04	rs5993883:T	118753024
teneligliptin	rs909530	FMO3	CT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs909530:CT	11949652
teneligliptin	rs909530	FMO3	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs909530:TT	11949652
quetiapine	rs6269	COMT	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH04	rs6269:A	118753024
candesartan	rs3758785	GPR83	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09CA06	rs3758785:GG	146026636
tacrolimus	rs1800795	IL6	GG	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	rs1800795:GG	131769926
teneligliptin	rs2266782	FMO3	AG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266782:AG	11949652
teneligliptin	rs2266782	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266782:GG	11949652
paclitaxel	rs2032582	ABCB1	CT	Metabolism/PK	increased	LADME	Disease:C0919267		L01CD01	rs2032582:CT	36314
hydrochlorothiazide	rs7553527	HSD3B1	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs7553527:CC	2904
hydrochlorothiazide	rs7553527	HSD3B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs7553527:CT	2904
hydrochlorothiazide	rs177852	TTC6	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs177852:CC	2904
hydrochlorothiazide	rs177852	TTC6	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs177852:CT	2904
teneligliptin	rs2242480	CYP3A4	CT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2242480:CT	11949652
teneligliptin	rs2242480	CYP3A4	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2242480:TT	11949652
glatiramer acetate	rs1012335	IFNAR1	G	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AX13	rs1012335:G	3081884
5-hydroxyomeprazole, omeprazole	rs12777823	__INTRONIC__	A	Metabolism/PK	increased	LADME	Healthy		A02BC01	rs12777823:A	119560
atorvastatin	rs2740574	CYP3A4	CC	Efficacy	decreased	Efficacy_Response	Other:C0007222|Other:C0020473		C10AA05	rs2740574:CC	656846
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
6-hydroxy s-warfarin	rs368245720	__INTRONIC__	A	Metabolism/PK	increased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs368245720:A	54688261
atorvastatin	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Other:C0007222|Other:C0020473		C10AA05	rs776746:CC	656846
citalopram, escitalopram, fluoxetine, sertraline	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB04|N06AB06|N06AB10	rs6265:CC	146570
6-hydroxy s-warfarin	rs10433340	PARP14	A	Metabolism/PK	increased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs10433340:A	54688261
metoprolol	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB02	rs1801253:C	6322
salbutamol	rs1042713	ADRB2	AA	PD	decreased	Efficacy_Response	Healthy		R03CC02	rs1042713:AA	2083
efavirenz	rs3003596	NR1I3	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3003596:GG	64139
imatinib	rs12505410	ABCG2	G	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:G	6113
imatinib	rs12505410	ABCG2	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:GG	6113
imatinib	rs12505410	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:GT	6113
tamoxifen	rs4646	CYP19A1	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs4646:AA	2733525
tamoxifen	rs4646	CYP19A1	AC	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01	rs4646:AC	2733525
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
6-hydroxy r-warfarin, 6-hydroxy s-warfarin	rs558364281	GRID2	G	Metabolism/PK	increased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs558364281:G	54688261
imatinib	rs13120400	ABCG2	CC	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs13120400:CC	6113
imatinib	rs13120400	ABCG2	CT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs13120400:CT	6113
methotrexate	rs10841753	SLCO1B1	CT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs10841753:CT	11329481
methotrexate	rs10841753	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs10841753:TT	11329481
imatinib	rs2725252	ABCG2	AC	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:AC	6113
imatinib	rs2725252	ABCG2	CC	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:CC	6113
lacidipine, nifedipine, nitrendipine	rs2238032	CACNA1C	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA05|C08CA08|C08CA09	rs2238032:TT	4507
lumefantrine	rs2740574	CYP3A4	C	Metabolism/PK	increased	LADME	Disease:C0024530|Other:C0032961		P01BF01	rs2740574:C	6450800
quetiapine	rs10042486	HTR1A	TT	Metabolism/PK	increased	LADME	Other:C0036341		N05AH04	rs10042486:TT	118753024
amitriptyline, clomipramine, duloxetine, imipramine, milnacipran, venlafaxine	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AA02|N06AA04|N06AA09|N06AX16|N06AX17|N06AX21	rs6265:CT	60835
amitriptyline, clomipramine, duloxetine, imipramine, milnacipran, venlafaxine	rs6265	BDNF	TT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AA02|N06AA04|N06AA09|N06AX16|N06AX17|N06AX21	rs6265:TT	60835
chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone, trifluoperazine	rs1415744	EPM2A	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AA01|N05AB06|N05AD01|N05AH02|N05AH03|N05AH04|N05AX08	rs1415744:C	5566
amlodipine, felodipine	rs2239050	CACNA1C	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01|C08CA02	rs2239050:GG	3333
warfarin	rs41291550	CYP2C18	A	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs41291550:A	54688261
atorvastatin	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0020473		C10AA05	rs2740574:TT	656846
citalopram, fluoxetine	rs334558	GSK3B	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03|N06AB04	rs334558:GG	1548970
ethanol	rs17376019	SRPRB	CT	Metabolism/PK	decreased	LADME	Healthy		V03AB16	rs17376019:CT	444899
warfarin	rs9332241	CYP2C9	T	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs9332241:T	54688261
ethanol	rs671	ALDH2	AG	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs671:AG	444899
lumefantrine	rs10264272	CYP3A5	T	Metabolism/PK	increased	LADME	Disease:C0024530|Other:C0032961		P01BF01	rs10264272:T	6450800
atorvastatin	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0007222|Other:C0020473		C10AA05	rs776746:CC	656846
ethanol	rs4643	PGM1	CC	Metabolism/PK	decreased	LADME	Healthy		V03AB16	rs4643:CC	444899
warfarin	rs7856096	FPGS	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs7856096:G	54688261
acetaldehyde	rs1229976	ADH1A	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1229976:CT	10342
warfarin	rs7856096	FPGS	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs7856096:G	54688261
lumefantrine	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Disease:C0024530|Other:C0032961		P01BF01	rs776746:C	6450800
acetaldehyde	rs671	ALDH2	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs671:AG	10342
infliximab	rs396991	FCGR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs396991:A	No_match
cetuximab	rs396991	FCGR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs396991:A	No_match
acetaldehyde	rs4643	PGM1	CC	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4643:CC	10342
verapamil	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		C08DA01	rs1045642:GG	65808
acetaldehyde	rs1229984	ADH1B	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1229984:CT	10342
naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:AG	5360515
naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:GG	5360515
amlodipine, felodipine	rs2239128	CACNA1C	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01|C08CA02	rs2239128:C	3333
fluorouracil	rs3918290	DPYD	CT	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023055		L01BC02	rs3918290:CT	5790
sunitinib	rs776746	CYP3A5	T	Dosage	decreased	Dosage	Disease:C0007134		L01EX01	rs776746:T	11221549
n-desmethylclozapine(clozapine)	rs61750900	UGT2B10	GT	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs61750900:GT	135398737
lumefantrine	rs2740574	CYP3A4	T	Efficacy	decreased	Efficacy_Response	Disease:C0024530|Disease:C0032961		P01BF01	rs2740574:T	6450800
clopidogrel	rs2254638	N6AMT1	G	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs2254638:G	13748464
valproic acid	rs6759892	UGT1A6	TT	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs6759892:TT	134459
fentanyl	rs7858836	ASTN2	CT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs7858836:CT	13653606
fentanyl	rs7858836	ASTN2	TT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs7858836:TT	13653606
benazepril, imidapril	rs1799998	CYP11B2	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07|C09AA16	rs1799998:AA	5362124
benazepril, imidapril	rs1799998	CYP11B2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07|C09AA16	rs1799998:AG	5362124
fentanyl	rs958804	ASTN2	CC	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs958804:CC	13653606
fentanyl	rs958804	ASTN2	CT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs958804:CT	13653606
valproic acid	rs1105879	UGT1A6	AA	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1105879:AA	134459
valproic acid	rs2070959	UGT1A6	AA	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs2070959:AA	134459
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AA	131769926
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AG	131769926
verapamil	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Healthy		C08DA01	rs2032582:CC	65808
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CT	37542
etidronic acid	rs1800012	COL1A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0005944		M05BA01	rs1800012:AA	3305
etidronic acid	rs1800012	COL1A1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0005944		M05BA01	rs1800012:AC	3305
voriconazole	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs13120400:CC	9741
morphine, nortriptyline	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:C0030193		N02AA01|N06AA10	rs1045642:GG	4543
risperidone	rs6295	HTR1A	CG	Metabolism/PK	increased	LADME	Other:C0036341		N05AX08	rs6295:CG	849421
risperidone	rs6295	HTR1A	GG	Metabolism/PK	increased	LADME	Other:C0036341		N05AX08	rs6295:GG	849421
duloxetine	rs4858478	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs4858478:G	44344115
fluorouracil	rs67376798	DPYD	AT	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023055		L01BC02	rs67376798:AT	5790
valproic acid	rs6759892	UGT1A6	GG	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs6759892:GG	134459
duloxetine	rs13093500	ZNF385D	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs13093500:T	44344115
escitalopram, fluoxetine, paroxetine, sertraline	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB05|N06AB06|N06AB10	rs6265:CC	667572
folic acid, hydroxychloroquine, methotrexate, sulfasalazine	rs1051266	SLC19A1	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01|B03BB01|L04AX03|P01BA02	rs1051266:T	135398658
duloxetine	rs4334661	ZNF385D	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs4334661:T	44344115
folic acid, hydroxychloroquine, methotrexate, sulfasalazine	rs1805087	MTR	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01|B03BB01|L04AX03|P01BA02	rs1805087:A	135398658
duloxetine	rs7625956	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7625956:G	44344115
tacrolimus	rs4646453	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs4646453:CC	131769926
tamoxifen	rs1042028	SULT1A1	TT	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L02BA01	rs1042028:TT	2733525
duloxetine	rs7616119	ZNF385D	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7616119:G	44344115
terbutaline	rs1800888	ADRB2	CT	Efficacy	decreased	Efficacy_Response	Healthy		R03CC03	rs1800888:CT	5403
duloxetine	rs2933304	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs2933304:T	44344115
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Disease:C0040038		B01AA03	rs9923231:CT	54688261
methotrexate	rs1051266	SLC19A1	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:T	11329481
duloxetine	rs4971678	NRXN1	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs4971678:T	44344115
duloxetine	rs12630569	ZNF385D	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12630569:G	44344115
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Disease:C0040038		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Disease:C0040038		B01AA03	rs2108622:TT	54688261
bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin, oxaliplatin	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02|L01FG01|L01XA03	rs699947:CC	135403648
erythropoietin	rs1800562	HFE	A	Dosage, Metabolism/PK	decreased	Dosage	Other:hemodialysis_treatment		B03XA01	rs1800562:A	35370
duloxetine	rs6700741	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs6700741:C	44344115
enalapril	rs1042714	ADRB2	CG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09AA02	rs1042714:CG	5950
enalapril	rs1042714	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09AA02	rs1042714:GG	5950
atenolol, enalapril	rs1042714	ADRB2	CG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C07AB03|C09AA02	rs1042714:CG	5388962
atenolol, enalapril	rs1042714	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C07AB03|C09AA02	rs1042714:GG	5388962
bevacizumab, capecitabine, fluorouracil, irinotecan, leucovorin, oxaliplatin	rs3025039	VEGFA	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02|L01FG01|L01XA03	rs3025039:TT	135403648
erythropoietin	rs1799945	HFE	G	Dosage, Metabolism/PK	decreased	Dosage	Other:hemodialysis_treatment		B03XA01	rs1799945:G	35370
duloxetine	rs6479008	TEX10	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs6479008:C	44344115
tacrolimus	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs15524:AA	131769926
duloxetine	rs7035619	TEX10	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7035619:A	44344115
duloxetine	rs10989064	TEX10	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs10989064:T	44344115
digoxin	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:GG	15478
duloxetine	rs12595802	ATP10A	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12595802:G	44344115
duloxetine	rs7472	TEX10	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7472:G	44344115
duloxetine	rs56229625	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs56229625:G	44344115
digoxin	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:CC	15478
duloxetine	rs61692318	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61692318:G	44344115
duloxetine	rs62319299	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs62319299:A	44344115
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
duloxetine	rs10124893	TEX10	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs10124893:G	44344115
duloxetine	rs10123866	INVS	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs10123866:G	44344115
abemaciclib, palbociclib, ribociclib	rs1045642	ABCB1	A	Dosage, Toxicity	decreased	Dosage	Other:C1458155		L01EF01|L01EF02|L01EF03	rs1045642:A	5330286
amlodipine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		C08CA01	rs776746:CC	72734364
duloxetine	rs10007051	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10007051:C	44344115
ivacaftor	rs75527207	CFTR	A	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02	rs75527207:A	72722243
duloxetine	rs9879065	ZNF385D	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9879065:C	44344115
duloxetine	rs55881666	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs55881666:C	44344115
infliximab	rs2097432	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02	rs2097432:CC	No_match
infliximab	rs2097432	__INTRONIC__	CT	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02	rs2097432:CT	No_match
valproic acid	rs4918758	CYP2C9	CC	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4918758:CC	134459
valproic acid	rs4918758	CYP2C9	CT	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4918758:CT	134459
duloxetine	rs11933890	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs11933890:A	44344115
valproic acid	rs4244285	CYP2C19	AA	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4244285:AA	134459
valproic acid	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs4244285:AG	134459
duloxetine	rs9310658	ZNF385D	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9310658:C	44344115
duloxetine	rs7653345	ZNF385D	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs7653345:A	44344115
valproic acid	rs1731017	ABAT	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1731017:GG	134459
duloxetine	rs9310657	ZNF385D	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9310657:T	44344115
duloxetine	rs9824595	ZNF385D	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9824595:G	44344115
duloxetine	rs9873889	ZNF385D	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9873889:C	44344115
duloxetine	rs9819548	ZNF385D	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs9819548:G	44344115
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
capecitabine	rs532545	CDA	CC	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01BC06	rs532545:CC	11809635
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
hydralazine / isosorbide dinitrate	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Other:C0085605		C05AE02	rs1799983:GG	6883
warfarin	rs56165452	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs56165452:C	54688261
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AA	131769926
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GG	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GT	37542
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
adalimumab	rs1130864	CRP	AG	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs1130864:AG	107706
adalimumab	rs1130864	CRP	GG	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs1130864:GG	107706
olanzapine	rs472660	CYP3A43	AA	Dosage, Efficacy, Toxicity, Metabolism/PK	increased	LADME	Disease:C0036341		N05AH03	rs472660:AA	74603552
glatiramer acetate	rs2371108	EOMES	T	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AX13	rs2371108:T	3081884
carvedilol	rs4148323	UGT1A1	A	Metabolism/PK	decreased	LADME	Disease:C0002962		C07AG02	rs4148323:A	6322
etoposide	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0023449		L01CB01	rs1045642:GG	46173784
adalimumab	rs9373839	ATG5	CC	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs9373839:CC	107706
adalimumab	rs9373839	ATG5	CT	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs9373839:CT	107706
duloxetine	rs56355515	MIEF2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs56355515:G	44344115
duloxetine	rs12603700	MIEF2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12603700:G	44344115
adalimumab	rs510432	ATG5	CT	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs510432:CT	107706
adalimumab	rs510432	ATG5	TT	Efficacy	increased	Efficacy_Response	Disease:C0021390		L04AB04	rs510432:TT	107706
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	Dosage	Disease:C0277631		L04AD02	rs1045642:GG	131769926
duloxetine	rs3889402	MIEF2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs3889402:G	44344115
azathioprine	rs55754655	AOX1	G	Efficacy	decreased	Efficacy_Response	Disease:C0021390		L04AX01	rs55754655:G	5778
azathioprine	rs55754655	AOX1	AG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs55754655:AG	5778
azathioprine	rs55754655	AOX1	GG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs55754655:GG	5778
hydralazine / isosorbide dinitrate	rs1799998	CYP11B2	AA	Efficacy	increased	Efficacy_Response	Other:C0085605		C05AE02	rs1799998:AA	6883
duloxetine	rs58042962	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs58042962:G	44344115
tacrolimus	rs2740574	CYP3A4	C	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:C	131769926
duloxetine	rs10771997	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10771997:T	44344115
fenofibrate	rs320	LPL	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020557		C10AB05	rs320:GG	11350701
duloxetine	rs3124955	FCN2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs3124955:T	44344115
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
fenofibrate	rs2727786	APOA1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0020557		C10AB05	rs2727786:CG	11350701
duloxetine	rs3128624	FCN2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs3128624:A	44344115
duloxetine	rs7306991	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs7306991:A	44344115
glatiramer acetate	rs6498169	CLEC16A	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AX13	rs6498169:A	3081884
tacrolimus	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:C	131769926
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1045642:AA	15478
duloxetine	rs10771999	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10771999:C	44344115
duloxetine	rs10771998	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs10771998:A	44344115
duloxetine	rs12657120	SKIC3	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12657120:G	44344115
ethosuximide	rs61734410	CACNA1H	T	Efficacy	decreased	Efficacy_Response	Efficacy:C0014544		N03AD01	rs61734410:T	101661944
duloxetine	rs4639250	SKIC3	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs4639250:G	44344115
duloxetine	rs4437856	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs4437856:A	44344115
ethosuximide	rs3747178	CACNA1I	T	Efficacy	decreased	Efficacy_Response	Efficacy:C0014544		N03AD01	rs3747178:T	101661944
duloxetine	rs9369266	TREML4	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs9369266:A	44344115
azathioprine	rs594445	MOCOS	AA	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs594445:AA	5778
azathioprine	rs594445	MOCOS	AC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AX01	rs594445:AC	5778
duloxetine	rs13204353	TREML4	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs13204353:G	44344115
lamotrigine	rs2032582	ABCB1	A	Efficacy	decreased	Efficacy_Response	Efficacy:C0014544		N03AX09	rs2032582:A	71236569
cyclosporine	rs12885713	CALM1	T	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AD01	rs12885713:T	86666680
irbesartan	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09CA04	rs699:GG	2901
duloxetine	rs2419128	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs2419128:C	44344115
methotrexate	rs1051266	SLC19A1	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:T	11329481
duloxetine	rs12502866	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs12502866:G	44344115
methotrexate	rs3758149	GGH	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3758149:AA	11329481
methotrexate	rs3758149	GGH	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3758149:AG	11329481
duloxetine	rs12094644	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs12094644:T	44344115
capecitabine	rs2072671	CDA	AA	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01BC06	rs2072671:AA	11809635
capecitabine	rs2072671	CDA	AC	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01BC06	rs2072671:AC	11809635
lamotrigine	rs2753326	CACNA1H	A	Efficacy	increased	Efficacy_Response	Efficacy:C0014544		N03AX09	rs2753326:A	71236569
rivaroxaban	rs4728709	ABCB1	GG	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4728709:GG	10700
atenolol	rs1800545	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C07AB03	rs1800545:GG	14211540
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
cyclosporine	rs2874116	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AD01	rs2874116:G	86666680
irbesartan	rs1801701	APOB	CC	Efficacy	increased	Efficacy_Response	Disease:C0020564|Left_Ventricular		C09CA04	rs1801701:CC	2901
rivaroxaban	rs4148738	ABCB1	CC	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4148738:CC	10700
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C	64139
mephenytoin	rs183701923	CYP2C19	T	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs183701923:T	91480
mephenytoin	rs140278421	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs140278421:A	91480
efavirenz	rs4803419	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs4803419:T	64139
chlorpromazine	rs1799732	DRD2	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AA01	rs1799732:GG	62875
methotrexate	rs17602729	AMPD1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs17602729:AA	11329481
methotrexate	rs17602729	AMPD1	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs17602729:AG	11329481
benazepril	rs7079	AGT	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs7079:TT	5362124
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
omeprazole	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	rs1045642:AA	9579578
omeprazole	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:C0017168		A02BC01	rs1045642:AG	9579578
opioids	rs1799971	OPRM1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02A	rs1799971:AA	No_match
nelfinavir	rs4244285	CYP2C19	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AE04	rs4244285:AA	475066
tolbutamide	rs771237265	CYP2C9	C	Metabolism/PK	decreased	LADME	Healthy		A10BB03	rs771237265:C	159651
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:TT	11329481
tolbutamide	rs762081829	CYP2C9	T	Metabolism/PK	decreased	LADME	Healthy		A10BB03	rs762081829:T	159651
metformin	rs628031	SLC22A1	A	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs628031:A	155906370
mephenytoin	rs145119820	CYP2C19	A	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs145119820:A	91480
tolbutamide	rs761895497	CYP2C9	C	Metabolism/PK	decreased	LADME	Healthy		A10BB03	rs761895497:C	159651
warfarin	rs510317	F7	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs510317:AA	54688261
warfarin	rs510317	F7	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs510317:AG	54688261
fluoxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs6295:GG	1548968
mephenytoin	rs61311738	CYP2C19	T	Metabolism/PK	decreased	LADME	Healthy		N03AB02	rs61311738:T	91480
sulfonamides, urea derivatives	rs7903146	TCF7L2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		S01AB	rs7903146:TT	1176
benazepril	rs4762	AGT	G	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs4762:G	5362124
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1045642:AA	15478
benazepril	rs699	AGT	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs699:A	5362124
fluorouracil, oxaliplatin	rs1695	GSTP1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:AG	9887054
fluorouracil, oxaliplatin	rs1695	GSTP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs1695:GG	9887054
acenocoumarol	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:CT	54742534
acenocoumarol	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:TT	54742534
benazepril	rs7079	AGT	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs7079:T	5362124
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
fenofibrate	rs3135506	APOA5	CG	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:CG	11350701
fenofibrate	rs3135506	APOA5	GG	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:GG	11350701
pravastatin, simvastatin	rs11716445	RHOA	A	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01|C10AA03	rs11716445:A	54454
efavirenz	rs35303484	CYP2B6	AG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs35303484:AG	64139
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
citalopram	rs585719	__INTRONIC__	CT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB04	rs585719:CT	162180
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG	54688261
warfarin	rs11676382	GGCX	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:GG	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
warfarin	rs12777823	__INTRONIC__	A	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs12777823:A	54688261
warfarin	rs7900194	CYP2C9	A	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs7900194:A	54688261
isoniazid	rs6413432	CYP2E1	A	Metabolism/PK	increased	LADME	Other:C0041296		J04AC01	rs6413432:A	135483892
efavirenz	rs4803419	CYP2B6	TT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs4803419:TT	64139
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
warfarin	rs2645400	GATA4	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2645400:TT	54688261
warfarin	rs28371685	CYP2C9	T	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs28371685:T	54688261
warfarin	rs4841588	GATA4	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs4841588:TT	54688261
mycophenolic acid acyl glucuronide	rs7662029	UGT2B7	GG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		D08AE03	rs7662029:GG	70678773
buprenorphine	rs7439366	UGT2B7	CC	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs7439366:CC	11274356
methotrexate	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs4149056:CC	11329481
mycophenolic acid acyl glucuronide	rs7439366	UGT2B7	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		D08AE03	rs7439366:CC	70678773
methotrexate	rs2838958	SLC19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs2838958:AA	11329481
warfarin	rs1057910	CYP2C9	AC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
warfarin	rs1057910	CYP2C9	CC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1057910:CC	54688261
sildenafil	rs1570360	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0242350		G04BE03	rs1570360:AA	135499879
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC	54688261
sildenafil	rs699947	VEGFA	AA	Efficacy	decreased	Efficacy_Response	Disease:C0242350		G04BE03	rs699947:AA	135499879
sildenafil	rs699947	VEGFA	AC	Efficacy	decreased	Efficacy_Response	Disease:C0242350		G04BE03	rs699947:AC	135499879
warfarin	rs2108622	CYP4F2	CT	Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
captopril	rs2106809	ACE2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA01	rs2106809:GG	44146831
cyclophosphamide, doxorubicin, paclitaxel, trastuzumab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01CD01|L01DB01	rs1801274:AA	2907
trastuzumab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C1458155		No_ATC	rs396991:CC	166596981
buprenorphine	rs7662029	UGT2B7	GG	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs7662029:GG	11274356
eculizumab	rs2274567	CR1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024790		No_ATC	rs2274567:AG	No_match
eculizumab	rs2274567	CR1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024790		No_ATC	rs2274567:GG	No_match
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
mycophenolic acid	rs4148323	UGT1A1	AG	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AA06	rs4148323:AG	5281078
mirabegron	rs12708954	SLC6A2	CC	Metabolism/PK	increased	LADME	Healthy		G04BD12	rs12708954:CC	91810674
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT	91987769
clozapine	rs686	DRD1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs686:G	131769989
mycophenolic acid acyl glucuronide	rs7438135	UGT2B7	AA	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		D08AE03	rs7438135:AA	70678773
fluvastatin	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		C10AA04	rs1057910:CC	131750727
mirabegron	rs1051266	SLC19A1	TT	Metabolism/PK	decreased	LADME	Healthy		G04BD12	rs1051266:TT	91810674
clozapine	rs6280	DRD3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs6280:TT	131769989
mercaptopurine	rs12199316	TPMT	G	Dosage	increased	Dosage	Other:C0023449		L01BB02	rs12199316:G	1268107
ticagrelor	rs56324128	CYP3A4	CC	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs56324128:CC	78358176
candesartan	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0085605		C09CA06	rs5186:AA	146026636
irbesartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C09CA04	rs5186:AC	2901
warfarin	rs2256871	CYP2C9	G	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs2256871:G	54688261
docetaxel, paclitaxel	rs776746	CYP3A5	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD01|L01CD02	rs776746:CC	36314
capecitabine, fluorouracil, tegafur / gimeracil / oteracil	rs1801159	DPYD	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01BC03|L01BC06	rs1801159:CC	60953
capecitabine, fluorouracil, tegafur / gimeracil / oteracil	rs1801159	DPYD	CT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01BC03|L01BC06	rs1801159:CT	60953
candesartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C09CA06	rs5186:AC	146026636
ticagrelor	rs113681054	SLCO1B1	C	Metabolism/PK	increased	LADME	Disease:C0027051		B01AC24	rs113681054:C	78358176
ticagrelor	rs4149056	SLCO1B1	T	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs4149056:T	78358176
gemcitabine, paclitaxel	rs760370	SLC29A1	A	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01BC05|L01CD01	rs760370:A	36314
citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB04|N06AB05|N06AB06|N06AB08|N06AB10	rs6265:CC	5324346
warfarin	rs11188082	CYP2C19	T	Metabolism/PK	decreased	LADME	Other:C0004238|Other:C1861172|Other:C0026265		B01AA03	rs11188082:T	54688261
methylphenidate	rs71647871	CES1	CT	Dosage, Metabolism/PK	decreased	Dosage	Disease:C1263846		N06BA04	rs71647871:CT	154100
ticagrelor	rs61361928	UGT2B7	TT	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs61361928:TT	78358176
quetiapine	rs6295	HTR1A	GG	Metabolism/PK	increased	LADME	Other:C0036341		N05AH04	rs6295:GG	118753024
ticagrelor	rs62471956	CYP3A43	G	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC24	rs62471956:G	78358176
acenocoumarol, warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs9923231:CT	54676537
acenocoumarol, warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs9923231:TT	54676537
simvastatin	rs1137101	LEPR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01	rs1137101:GG	14373154
lamotrigine	rs2231142	ABCG2	T	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:T	71236569
acetaminophen	rs1042028	SULT1A1	CC	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs1042028:CC	1983
opioids	rs2069762	IL2	AA	Dosage	increased	Dosage	Other:C0030193|Other:C0027651		N02A	rs2069762:AA	No_match
opioids	rs6265	BDNF	CC	Dosage	increased	Dosage	Other:C0030193|Other:C0027651		N02A	rs6265:CC	No_match
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs2108622:CT	54676537
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs2108622:TT	54676537
voriconazole	rs4646437	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:C0026946		J02AC03	rs4646437:AG	9741
opioids	rs1800795	IL6	CC	Dosage	increased	Dosage	Other:C0030193|Other:C0027651		N02A	rs1800795:CC	No_match
atenolol, irbesartan	rs4762	AGT	AG	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C07AB03|C09CA04	rs4762:AG	2249
tenofovir	rs1059751	ABCC4	AA	Metabolism/PK	decreased	LADME	Other:C0019163|Chronic		J05AF07	rs1059751:AA	9574768
tenofovir	rs1059751	ABCC4	AG	Metabolism/PK	decreased	LADME	Other:C0019163|Chronic		J05AF07	rs1059751:AG	9574768
caffeine	rs2472297	CYP1A1	T	Metabolism/PK	increased	LADME	Healthy		N06BC01	rs2472297:T	936
docetaxel	rs1570360	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02	rs1570360:GG	154272
opioids	rs1143634	IL1B	AA	Efficacy	decreased	Efficacy_Response	Other:C0030193|Other:C0027651		N02A	rs1143634:AA	No_match
opioids	rs1143634	IL1B	AG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Other:C0027651		N02A	rs1143634:AG	No_match
fenofibrate	rs4238001	SCARB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs4238001:CT	11350701
fenofibrate	rs4238001	SCARB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs4238001:TT	11350701
tenofovir	rs4149170	SLC22A6	TT	Metabolism/PK	increased	LADME	Other:C0019163|Chronic		J05AF07	rs4149170:TT	9574768
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
opioids	rs678849	OPRD1	CC	Efficacy	decreased	Efficacy_Response	Other:C0030193|Other:C0027651		N02A	rs678849:CC	No_match
acenocoumarol, warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs1057910:AC	54676537
acenocoumarol, warfarin	rs1057910	CYP2C9	CC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03|B01AA07	rs1057910:CC	54676537
irbesartan	rs699	AGT	AG	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C09CA04	rs699:AG	2901
irbesartan	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Other:C0020564|Left_Ventricular		C09CA04	rs699:GG	2901
peginterferon alfa-2a, peginterferon alfa-2b	rs56061981	CXCL10	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10|L03AB11	rs56061981:CT	No_match
peginterferon alfa-2a, peginterferon alfa-2b	rs56061981	CXCL10	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10|L03AB11	rs56061981:TT	No_match
atorvastatin	rs2032582	ABCB1	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:T	656846
atorvastatin	rs2032582	ABCB1	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:T	656846
ataluren	rs113993959	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs113993959:T	11219835
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
ataluren	rs75039782	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs75039782:T	11219835
ataluren	rs77010898	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs77010898:A	11219835
platinum compounds	rs1052555	ERCC2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AA	23939
platinum compounds	rs1052555	ERCC2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1052555:AG	23939
fenofibrate	rs3135506	APOA5	CC	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:CC	11350701
fenofibrate	rs3135506	APOA5	CG	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs3135506:CG	11350701
insulin recombinant, zinc acetate	rs13266634	SLC30A8	CT	Efficacy	increased	Efficacy_Response	Healthy		A16AX05	rs13266634:CT	70678557
insulin recombinant, zinc acetate	rs13266634	SLC30A8	TT	Efficacy	increased	Efficacy_Response	Healthy		A16AX05	rs13266634:TT	70678557
methylphenidate	rs5326	DRD1	CT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs5326:CT	154100
methylphenidate	rs5326	DRD1	TT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs5326:TT	154100
metformin	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy		A10BA02	rs12208357:T	155906370
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
fentanyl	rs1045642	ABCB1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1045642:GG	13653606
folic acid, methotrexate	rs2372536	ATIC	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		B03BB01|L04AX03	rs2372536:CC	135398658
corticosteroids, selective beta-2-adrenoreceptor agonists	rs2853209	ADAM33	AA	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC|S02BA	rs2853209:AA	No_match
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
lithium	rs17026688	GADL1	T	Efficacy	increased	Efficacy_Response	Other:C0005586		N05AN01	rs17026688:T	11125
tacrolimus	rs1057868	POR	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs1057868:CC	131769926
folic acid, methotrexate	rs1127354	ITPA	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		B03BB01|L04AX03	rs1127354:CC	135398658
methotrexate	rs4673993	ATIC	C	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:C	11329481
warfarin	rs9923231	VKORC1	TT	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	rs12714145	GGCX	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs12714145:C	54688261
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
methotrexate	rs244076	ADA	C	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs244076:C	11329481
methotrexate	rs5751876	ADORA2A	T	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs5751876:T	11329481
folic acid, methotrexate	rs17602729	AMPD1	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		B03BB01|L04AX03	rs17602729:A	135398658
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
rituximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs396991:CC	No_match
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
fluorouracil	rs2293347	EGFR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02	rs2293347:CC	5790
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
antidepressants	rs12082710	TGFBR3	TT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06A	rs12082710:TT	No_match
warfarin	rs7294	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:C	54688261
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs1051266:TT	11329481
allopurinol	rs2231142	ABCG2	T	Dosage	increased	Dosage	Disease:C0018099		M04AA01	rs2231142:T	168354693
warfarin	rs2884737	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:C	54688261
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A	54688261
rifampicin	rs1803155	AADAC	GG	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs1803155:GG	135542225
abiraterone	rs1077858	SLCO2B1	AA	Metabolism/PK	increased	LADME	Healthy		L02BX03	rs1077858:AA	91826892
abiraterone	rs1077858	SLCO2B1	AG	Metabolism/PK	increased	LADME	Healthy		L02BX03	rs1077858:AG	91826892
cetuximab, panitumumab	rs9996584	AREG	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs9996584:AA	No_match
cetuximab, panitumumab	rs1353295	AREG	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1353295:GG	No_match
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	increased	LADME	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1801133:AG	11329481
rifampicin	rs3842	ABCB1	CC	Metabolism/PK	increased	LADME	Other:C0041296		J04AB02	rs3842:CC	135542225
methotrexate	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	"""Disease:C0006413|""Disease:C0024299|T-Cell""|""Disease:C0023449"		L04AX03	rs1045642:AA	11329481
fentanyl	rs1718125	P2RX7	CT	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N02AB03	rs1718125:CT	13653606
fentanyl	rs1718125	P2RX7	TT	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N02AB03	rs1718125:TT	13653606
methylphenidate	rs4867798	DRD1	CC	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4867798:CC	154100
methylphenidate	rs4867798	DRD1	CT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4867798:CT	154100
methylphenidate	rs6280	DRD3	TT	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs6280:TT	154100
methylphenidate	rs11246226	DRD4	AA	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs11246226:AA	154100
platinum compounds	rs25487	XRCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CT	23939
platinum compounds	rs25487	XRCC1	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:TT	23939
methylphenidate	rs1800544	ADRA2A	CC	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs1800544:CC	154100
methylphenidate	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4680:AA	154100
methylphenidate	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Disease:C1510586		N06BA04	rs4680:AG	154100
estrone sulfate	rs10841753	SLCO1B1	C	Efficacy	decreased	LADME	Other:C1458155		G03CA07	rs10841753:C	3001028
dobutamine	rs62205366	GNAS	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs62205366:CC	208850
dobutamine	rs62205366	GNAS	CT	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs62205366:CT	208850
warfarin	rs12714145	GGCX	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs12714145:TT	54688261
nevirapine	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:GT	15979285
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
cetuximab, panitumumab	rs13104811	AREG	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs13104811:GG	No_match
cetuximab, panitumumab	rs11942466	AREG	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023055		No_ATC	rs11942466:AA	No_match
antidepressants	rs28364032	CRHR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs28364032:AA	No_match
antidepressants	rs28364032	CRHR1	AG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs28364032:AG	No_match
topiramate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AX11	rs4148324:GG	2723872
topiramate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GT	Metabolism/PK	increased	LADME	Other:C0014544		N03AX11	rs4148324:GT	2723872
cyclosporine	rs1057868	POR	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs1057868:T	86666680
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs760370	SLC29A1	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs760370:GG	37542
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1801133:AG	11329481
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
tipiracil hydrochloride, trifluridine	rs760370	SLC29A1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs760370:AG	6323266
tipiracil hydrochloride, trifluridine	rs760370	SLC29A1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		S01AD02	rs760370:GG	6323266
ethanol	rs2018417	ADH1B	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs2018417:A	444899
ethanol	rs17033	ADH1B	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs17033:C	444899
ethanol	rs1229985	ADH1B	G	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1229985:G	444899
phenprocoumon	rs4253728	PPARA	A	Dosage	increased	Dosage	Healthy		B01AA04	rs4253728:A	91987769
ethanol	rs931635	ADH1A	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs931635:A	444899
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
ethanol	rs283416	ADH1C	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs283416:A	444899
rosiglitazone	rs1801282	PPARG	CG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs1801282:CG	9846723
ethanol	rs283411	ADH1C	A	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs283411:A	444899
ethanol	rs1662060	ADH1C	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1662060:C	444899
tacrolimus	rs237025	SUMO4	AA	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs237025:AA	131769926
acenocoumarol	rs17878544	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs17878544:TT	54742534
hmg coa reductase inhibitors	rs10455872	LPA	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs10455872:G	445127
acenocoumarol	rs7200749	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA07	rs7200749:AA	54742534
acenocoumarol	rs7200749	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA07	rs7200749:AG	54742534
hmg coa reductase inhibitors	rs2231142	ABCG2	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs2231142:G	445127
acenocoumarol	rs61742245	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA07	rs61742245:AA	54742534
acenocoumarol	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Healthy		B01AA07	rs61742245:AC	54742534
warfarin	rs7200749	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs7200749:A	54688261
acenocoumarol	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA07	rs9923231:CC	54742534
warfarin	rs7294	VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:T	54688261
citalopram	rs520210	NEDD4L	A	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB04	rs520210:A	162180
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT	656846
hmg coa reductase inhibitors	rs2075650	TOMM40	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs2075650:G	445127
acenocoumarol	rs55894764	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA07	rs55894764:CT	54742534
acenocoumarol	rs55894764	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs55894764:TT	54742534
valproic acid	rs28898617	UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	G	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs28898617:G	134459
ivacaftor	rs78655421	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AA	72722243
ivacaftor	rs78655421	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AG	72722243
methylphenidate	rs17685420	PEBP4	T	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs17685420:T	154100
aripiprazole	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		N05AX12	rs1128503:AA	10114519
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9923231:T	54688261
verapamil	rs2230433	ITGAL	C	Efficacy	increased	Efficacy_Response	Other:C0022078		C08DA01	rs2230433:C	65808
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	rs4149056:CT	656846
pazopanib	rs34231037	KDR	AG	Efficacy	increased	Efficacy_Response	Disease:C0007134		L01EX03	rs34231037:AG	10113978
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
ethanol	rs1154461	ADH7	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1154461:C	444899
hepatitis vaccines	rs1805015	IL4R	C	Efficacy	increased	Efficacy_Response	Healthy		J07BC	rs1805015:C	16131310
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
ethanol	rs1229967	ADH1A	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1229967:C	444899
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
ethanol	rs2276332	ADH1A	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs2276332:C	444899
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT	37542
benazepril, imidapril	rs5051	AGT	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07|C09AA16	rs5051:CC	5362124
ethanol	rs1229976	ADH1A	C	Toxicity, Metabolism/PK	Indeterminado	LADME	Healthy		V03AB16	rs1229976:C	444899
ursodeoxycholic acid	rs661899	MGAT5	TT	Efficacy	decreased	Efficacy_Response	Other:C0008311		A05AA02	rs661899:TT	222528
clopidogrel thiol metabolite h4	rs4244285	CYP2C19	A	Metabolism/PK	Indeterminado	LADME	Healthy		B01AC04	rs4244285:A	60606
hepatitis vaccines	rs1295686	IL13	T	Efficacy	decreased	Efficacy_Response	Healthy		J07BC	rs1295686:T	16131310
phenprocoumon	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA04	rs9934438:AA	91987769
phenprocoumon	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA04	rs9934438:AG	91987769
phenprocoumon	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA04	rs7294:CT	91987769
phenprocoumon	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA04	rs7294:TT	91987769
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0003873		L04AD02	rs1045642:AA	131769926
peginterferon alfa-2b, ribavirin	rs10877012	CYP27B1	GT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10877012:GT	37542
peginterferon alfa-2b, ribavirin	rs10877012	CYP27B1	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10877012:TT	37542
dabigatran	rs8192935	CES1	AA	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs8192935:AA	169501783
dabigatran	rs8192935	CES1	AG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs8192935:AG	169501783
irinotecan	rs11574077	VDR	TT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs11574077:TT	74990
methylphenidate	rs1868790	ADGRL3	AA	Efficacy	decreased	Efficacy_Response	Disease:C1263846		N06BA04	rs1868790:AA	154100
methylphenidate	rs3746544	SNAP25	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs3746544:GG	154100
methylphenidate	rs3746544	SNAP25	GT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs3746544:GT	154100
methylphenidate	rs2550948	SLC6A3	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs2550948:CC	154100
methylphenidate	rs2550948	SLC6A3	CT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs2550948:CT	154100
phenprocoumon	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:CT	91987769
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT	91987769
atorvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:C	656846
interferons, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB	rs12979860:CC	37542
morphine	rs34059508	SLC22A1	AA	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34059508:AA	5284371
morphine	rs34059508	SLC22A1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34059508:AG	5284371
methylphenidate	rs1800544	ADRA2A	G	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:G	154100
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT	131769926
platinum	rs25487	XRCC1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs25487:CT	441203
platinum	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs25487:TT	441203
selective serotonin reuptake inhibitors	rs10514475	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB	rs10514475:A	5202
selective serotonin reuptake inhibitors	rs6108160	PLCB1	A	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB	rs6108160:A	5202
warfarin	rs1800139	LRP1	TT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1800139:TT	54688261
warfarin	rs2108622	CYP4F2	T	Dosage, Efficacy	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
warfarin	rs1800154	LRP1	CC	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1800154:CC	54688261
nicotine	rs56113850	CYP2A6	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs56113850:T	936
warfarin	rs9923231	VKORC1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:TT	54688261
interferons, ribavirin	rs8099917	IFNL3	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB	rs8099917:GG	37542
phenprocoumon	rs2359612	VKORC1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AA04	rs2359612:AA	91987769
phenprocoumon	rs2359612	VKORC1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AA04	rs2359612:AG	91987769
warfarin	rs2108622	CYP4F2	T	Dosage, Efficacy	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
platinum compounds	rs1799782	XRCC1	G	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs1799782:G	23939
morphine	rs12208357	SLC22A1	TT	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs12208357:TT	5284371
fluorouracil	rs17109924	LGR5	CC	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BC02	rs17109924:CC	5790
fluorouracil	rs17109924	LGR5	CT	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01BC02	rs17109924:CT	5790
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT	5282455
morphine	rs34059508	SLC22A1	AA	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs34059508:AA	5284371
acetaminophen	rs1902023	UGT2B15	A	Metabolism/PK	decreased	LADME	Healthy		N02BE01	rs1902023:A	1983
morphine	rs34130495	SLC22A1	AA	Metabolism/PK	decreased	LADME	Other:adenotonsillectomy		N02AA01	rs34130495:AA	5284371
acetaminophen	rs1902023	UGT2B15	AA	Metabolism/PK	increased	LADME	Healthy		N02BE01	rs1902023:AA	1983
atorvastatin, pravastatin	rs9462535	KIF6	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9462535:AA	60823
atorvastatin, pravastatin	rs9462535	KIF6	AC	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9462535:AC	60823
capecitabine, fluorouracil	rs1801133	MTHFR	AA	Dosage	decreased	Dosage	Other:C0027651		L01BC02|L01BC06	rs1801133:AA	60953
capecitabine, fluorouracil	rs1801133	MTHFR	AG	Dosage	decreased	Dosage	Other:C0027651		L01BC02|L01BC06	rs1801133:AG	60953
pitavastatin, pitavastatin lactone	rs4363657	SLCO1B1	A	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4363657:A	9801294
rosuvastatin	rs1481012	ABCG2	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs1481012:AG	5282455
rosuvastatin	rs1481012	ABCG2	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs1481012:GG	5282455
somatropin recombinant	rs2069502	CDK4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0041408		H01AC01	rs2069502:CC	No_match
atorvastatin, pravastatin	rs9471077	KIF6	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9471077:AG	60823
atorvastatin, pravastatin	rs9471077	KIF6	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs9471077:GG	60823
metformin	rs7541245	FMO5	A	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs7541245:A	155906370
methotrexate	rs1801133	MTHFR	AA	Toxicity	decreased	Efficacy_Response	Disease:C0023449		L04AX03	rs1801133:AA	11329481
rosuvastatin	rs17111584	USP24	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs17111584:CC	5282455
rosuvastatin	rs17111584	USP24	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs17111584:CT	5282455
pitavastatin, pitavastatin lactone	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4149056:C	9801294
methylphenidate	rs5569	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:GG	154100
interferon beta-1a	rs4774388	RORA	TT	Efficacy	increased	Efficacy_Response	Other:C0026769		L03AB07	rs4774388:TT	64139
methylphenidate	rs28386840	SLC6A2	AT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:AT	154100
methylphenidate	rs28386840	SLC6A2	TT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:TT	154100
remimazolam	rs71647871	CES1	CT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs71647871:CT	23658607
remimazolam	rs71647871	CES1	TT	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs71647871:TT	23658607
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
nicotine	rs113288603	__INTRONIC__	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs113288603:T	936
rosuvastatin	rs71352238	APOE	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs71352238:CC	5282455
rosuvastatin	rs71352238	APOE	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs71352238:CT	5282455
methylphenidate	rs1800544	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:GG	154100
nicotine	rs12461964	__INTRONIC__	A	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs12461964:A	936
rosuvastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs7412:CT	5282455
rosuvastatin	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs7412:TT	5282455
methylphenidate	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:CG	154100
methylphenidate	rs1800544	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:GG	154100
idarubicin	rs1883112	NCF4	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs1883112:AA	124720
simvastatin	rs717620	ABCC2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs717620:CT	14373154
simvastatin	rs717620	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs717620:TT	14373154
idarubicin	rs13058338	RAC2	AT	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01DB06	rs13058338:AT	124720
peginterferon alfa-2a, peginterferon alfa-2b	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0027022		L03AB10|L03AB11	rs12979860:CC	No_match
rosuvastatin	rs10455872	LPA	AG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs10455872:AG	5282455
rosuvastatin	rs10455872	LPA	GG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs10455872:GG	5282455
atorvastatin	rs887829	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	T	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs887829:T	656846
methylphenidate	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs6265:CC	154100
efavirenz	rs3745274	CYP2B6	GG	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:GG	64139
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
ivacaftor	rs78655421	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AA	72722243
ivacaftor	rs78655421	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:AG	72722243
atorvastatin	rs45446698	CYP3A7	G	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs45446698:G	656846
ataluren	rs77010898	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs77010898:A	11219835
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs4149056:C	58746970
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs762551:AA	131769989
efavirenz	rs2279343	CYP2B6	G	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs2279343:G	64139
efavirenz	rs2279345	CYP2B6	T	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AG03	rs2279345:T	64139
atorvastatin, pravastatin	rs20455	KIF6	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs20455:AG	60823
atorvastatin, pravastatin	rs20455	KIF6	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03|C10AA05	rs20455:GG	60823
ataluren	rs113993959	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs113993959:T	11219835
methylphenidate	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs4680:GG	154100
efavirenz	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs1045642:AG	64139
somatropin recombinant	rs2270777	CDK4	TT	Efficacy	increased	Efficacy_Response	Disease:C0853662		H01AC01	rs2270777:TT	No_match
methylphenidate	rs1800544	ADRA2A	G	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:G	154100
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
ataluren	rs75039782	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs75039782:T	11219835
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT	54742534
metformin	rs254271	PRPF31	C	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs254271:C	155906370
gabapentin	rs4240803	SLC7A5	AG	Dosage	increased	Dosage	Other:C0522067		No_ATC	rs4240803:AG	260003
ataluren	rs77010898	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs77010898:A	11219835
metformin	rs57081354	NBEA	C	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs57081354:C	155906370
sumatriptan	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs12208357:T	68647
metformin	rs628031	SLC22A1	AA	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs628031:AA	155906370
metformin	rs628031	SLC22A1	AG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs628031:AG	155906370
fenoterol	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs34130495:A	3343
fenoterol	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs12208357:T	3343
fenoterol	rs55918055	SLC22A1	C	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs55918055:C	3343
sumatriptan	rs34059508	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs34059508:A	68647
cyclophosphamide	rs3745274	CYP2B6	GT	Efficacy	increased	Efficacy_Response	Other:C0027697		L01AA01	rs3745274:GT	9554282
cyclophosphamide	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Other:C0027697		L01AA01	rs3745274:TT	9554282
sumatriptan	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs34130495:A	68647
drugs used in diabetes	rs1801278	IRS1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10	rs1801278:CT	No_match
drugs used in diabetes	rs1801278	IRS1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10	rs1801278:TT	No_match
sumatriptan	rs55918055	SLC22A1	C	Metabolism/PK	increased	LADME	Healthy	low activity	N02CC01	rs55918055:C	68647
fluorouracil, leucovorin, oxaliplatin	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs25487:CC	135403648
methotrexate	rs1801394	MTRR	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:A	11329481
fluorouracil, leucovorin, oxaliplatin	rs11615	ERCC1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01XA03	rs11615:GG	135403648
fenoterol	rs34059508	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		R03CC04	rs34059508:A	3343
hydrochlorothiazide	rs4149601	NEDD4L	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4149601:A	2904
metformin	rs622342	SLC22A1	AC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs622342:AC	155906370
metformin	rs622342	SLC22A1	CC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs622342:CC	155906370
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
peginterferon alfa-2a, peginterferon alfa-2b	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0027022		L03AB10|L03AB11	rs12980275:AA	No_match
emtricitabine	rs2273897	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Other:C0032961		J05AF09	rs2273897:TT	60877
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
cycloguanil	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs12208357:T	169502230
ataluren	rs113993959	CFTR	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		M09AX03	rs113993959:T	11219835
cycloguanil	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs34130495:A	169502230
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
gabapentin, pregabalin	rs4240803	SLC7A5	AG	Efficacy	decreased	Efficacy_Response	Other:C0522067		N02BF02	rs4240803:AG	5486971
methotrexate	rs1051266	SLC19A1	CT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:CT	11329481
methotrexate	rs1051266	SLC19A1	TT	Toxicity	decreased	Adverse_Event	Disease:C0003873		L04AX03	rs1051266:TT	11329481
morphine	rs4680	COMT	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs4680:AA	5284371
metformin	rs2162145	CPA6	T	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2162145:T	155906370
salbutamol	rs881152	DUSP1	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC02	rs881152:G	2083
ivacaftor	rs75527207	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AA	72722243
ivacaftor	rs75527207	CFTR	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:AG	72722243
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs2242480:CC	131769926
warfarin	rs61742245	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AA	54688261
warfarin	rs61742245	VKORC1	AC	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:AC	54688261
tramadol	rs34059508	SLC22A1	A	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs34059508:A	63013
tacrolimus	rs4149117	SLCO1B3	GG	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs4149117:GG	131769926
tacrolimus	rs4149117	SLCO1B3	GT	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs4149117:GT	131769926
escitalopram	rs1126757	IL11	CT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB10	rs1126757:CT	162180
escitalopram	rs1126757	IL11	TT	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AB10	rs1126757:TT	162180
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
clopidogrel	rs2307240	CES1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2307240:CT	13748464
clopidogrel	rs2307240	CES1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027051		B01AC04	rs2307240:TT	13748464
tacrolimus	rs1499821	SLC2A2	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs1499821:CC	131769926
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
abiraterone	rs10493112	YBX1	AC	Efficacy	increased	Efficacy_Response	Other:C0033578		L02BX03	rs10493112:AC	91826892
abiraterone	rs10493112	YBX1	CC	Efficacy	increased	Efficacy_Response	Other:C0033578		L02BX03	rs10493112:CC	91826892
tacrolimus	rs1955915	NFATC4	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs1955915:CC	131769926
tacrolimus	rs1955915	NFATC4	CT	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs1955915:CT	131769926
grazoprevir	rs4149056	SLCO1B1	C	PD	increased	LADME	Other:C0019372		J05AP54	rs4149056:C	44603531
bisoprolol	rs1080985	CYP2D6	CC	Metabolism/PK	decreased	LADME	Other:C0007222		C07AB07	rs1080985:CC	91810599
grazoprevir	rs11045819	SLCO1B1	A	PD	increased	LADME	Other:C0019372		J05AP54	rs11045819:A	44603531
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
warfarin	rs9923231	VKORC1	C	Metabolism/PK	increased	Dosage	Healthy		B01AA03	rs9923231:C	54688261
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA	54688261
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG	54688261
methadone	rs7127507	BDNF, BDNF-AS	C	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs7127507:C	10090
o-desmethyltramadol	rs12208357	SLC22A1	T	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs12208357:T	9816106
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
enalapril	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs2070744:CC	5950
enalapril	rs2070744	NOS3	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs2070744:CT	5950
methadone	rs11030118	BDNF, BDNF-AS	G	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs11030118:G	10090
warfarin	rs2359612	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:AG	54688261
warfarin	rs2359612	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:GG	54688261
warfarin	rs7089580	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs7089580:T	54688261
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
methadone	rs1967554	BDNF, BDNF-AS	C	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs1967554:C	10090
warfarin	rs8050894	VKORC1	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:CG	54688261
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG	54688261
bisoprolol	rs1080985	CYP2D6	G	Metabolism/PK	increased	LADME	Other:C0027051		C07AB07	rs1080985:G	91810599
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT	54688261
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT	54688261
methadone	rs2030324	BDNF	G	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs2030324:G	10090
bisoprolol	rs3892097	CYP2D6	CT	Metabolism/PK	increased	LADME	Other:C0027051		C07AB07	rs3892097:CT	91810599
bisoprolol	rs3892097	CYP2D6	TT	Metabolism/PK	increased	LADME	Other:C0027051		C07AB07	rs3892097:TT	91810599
busulfan	rs3957357	GSTA1	AA	Metabolism/PK	increased	LADME	Disease:C0277631		L01AB01	rs3957357:AA	4684
o-desmethyltramadol	rs34130495	SLC22A1	A	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs34130495:A	9816106
o-desmethyltramadol	rs34059508	SLC22A1	A	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs34059508:A	9816106
enalapril	rs1799722	BDKRB2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA02	rs1799722:TT	5950
methadone	rs988748	BDNF	C	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs988748:C	10090
o-desmethyltramadol	rs55918055	SLC22A1	C	Metabolism/PK	increased	LADME	Disease:C0030193		N02AX02	rs55918055:C	9816106
warfarin	rs61742245	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:A	54688261
tramadol	rs55918055	SLC22A1	C	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs55918055:C	63013
celecoxib	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		M01AH01	rs1057910:CC	66824
methadone	rs11030119	BDNF	G	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs11030119:G	10090
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	rs776746:CC	131769926
tramadol	rs12208357	SLC22A1	T	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs12208357:T	63013
fentanyl	rs2242480	CYP3A4	T	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2242480:T	13653606
celecoxib	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		M01AH01	rs1057910:CC	66824
bisoprolol	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:C0027051		C07AB07	rs776746:TT	91810599
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
tramadol	rs34130495	SLC22A1	A	Dosage	decreased	Dosage	Disease:C0030193		N02AX02	rs34130495:A	63013
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4149570	TNFRSF1A	AA	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs4149570:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs5030728	TLR4	AA	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs5030728:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs5030728	TLR4	AG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs5030728:AG	No_match
metformin	rs8065082	SLC47A1	CT	Efficacy	increased	Efficacy_Response	Other:C0016751		A10BA02	rs8065082:CT	155906370
metformin	rs8065082	SLC47A1	TT	Efficacy	increased	Efficacy_Response	Other:C0016751		A10BA02	rs8065082:TT	155906370
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4696480	TLR2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs4696480:TT	No_match
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2430561	IFNG	AA	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs2430561:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2430561	IFNG	AT	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs2430561:AT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	TT	Efficacy	decreased	Efficacy_Response	Disease:C0010346|Disease:C0021390		No_ATC	rs352139:TT	No_match
warfarin	rs4072879	VKORC1L1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs4072879:AA	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3804099	TLR2	CC	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs3804099:CC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3804099	TLR2	CT	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs3804099:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1816702	TLR2	CT	Efficacy	increased	Efficacy_Response	Disease:C0010346		No_ATC	rs1816702:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1816702	TLR2	TT	Efficacy	increased	Efficacy_Response	Disease:C0010346		No_ATC	rs1816702:TT	No_match
tacrolimus	rs35599367	CYP3A4	A	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs35599367:A	131769926
sufentanil	rs1799971	OPRM1	G	Dosage	decreased	Dosage	Disease:C0030193		N01AH03	rs1799971:G	41693
opioids	rs2249015	ENPP2	AA	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs2249015:AA	No_match
donepezil, galantamine, rivastigmine	rs429358	APOE	CC	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs429358:CC	3152
donepezil, galantamine, rivastigmine	rs429358	APOE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs429358:CT	3152
rosiglitazone	rs6467136	PAX4	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AA	9846723
rosiglitazone	rs6467136	PAX4	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AG	9846723
rosiglitazone	rs6467136	PAX4	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AA	9846723
rosiglitazone	rs6467136	PAX4	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs6467136:AG	9846723
atorvastatin	rs429358	APOE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs429358:CT	656846
opioids	rs1045642	ABCB1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02A	rs1045642:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10499563	IL6	CC	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs10499563:CC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10499563	IL6	CT	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs10499563:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2275913	IL17A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs2275913:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2275913	IL17A	AG	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs2275913:AG	No_match
latanoprost	rs11568658	ABCC4	AC	Efficacy	decreased	Efficacy_Response	Disease:Open-angle_glaucoma		S01EE01	rs11568658:AC	118984471
adalimumab, etanercept, infliximab, ustekinumab	rs1061622	TNFRSF1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04|L04AC05	rs1061622:GG	No_match
adalimumab, etanercept, infliximab, ustekinumab	rs1061622	TNFRSF1B	GT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04|L04AC05	rs1061622:GT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1554973	CNPY4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0021390		No_ATC	rs1554973:CC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1554973	CNPY4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0021390		No_ATC	rs1554973:CT	No_match
botulinum toxin type a	rs3781719	CALCA	G	Efficacy	decreased	Efficacy_Response	Other:C0022078		M03AX01	rs3781719:G	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2569190	CD14	AA	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs2569190:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2569190	CD14	AG	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs2569190:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs11938228:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AC	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs11938228:AC	No_match
botulinum toxin type a	rs222749	TRPV1	A	Efficacy	decreased	Efficacy_Response	Other:C0022078		M03AX01	rs222749:A	No_match
opioids	rs7832704	ENPP2	AA	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs7832704:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4848306	IL1B	AA	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs4848306:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4848306	IL1B	AG	Efficacy	increased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs4848306:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4251961	IL1RN	CC	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs4251961:CC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4251961	IL1RN	CT	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs4251961:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6927172	TNFAIP3	CG	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs6927172:CG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6927172	TNFAIP3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0009324|Disease:C0021390		No_ATC	rs6927172:GG	No_match
hmg coa reductase inhibitors	rs429358	APOE	CC	Efficacy	increased	Efficacy_Response	Other:C0002395		C10AA	rs429358:CC	445127
losartan	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA01	rs1045642:AA	11751549
losartan	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA01	rs1045642:AG	11751549
pemetrexed	rs61734430	FOLR3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs61734430:CT	135565228
pemetrexed	rs61734430	FOLR3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131|Disease:C0025500		L01BA04	rs61734430:TT	135565228
peginterferon alfa-2a, ribavirin	rs4803217	IFNL3	AC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4803217:AC	37542
peginterferon alfa-2a, ribavirin	rs4803217	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4803217:CC	37542
metoprolol	rs1801058	GRK4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs1801058:CT	6322
highly active antiretroviral therapy (haart)	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		No_ATC	rs12979860:CC	No_match
fluoxetine	rs7997012	HTR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03	rs7997012:GG	1548968
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0021368		No_ATC	rs1800629:GG	No_match
direct acting antivirals, elbasvir / grazoprevir, ledipasvir / sofosbuvir	rs8099917	IFNL3, IFNL4	GG	Efficacy	decreased	Efficacy_Response	Other:C0019372		J05A|J05AP08|J05AP51|J05AP54	rs8099917:GG	67505836
direct acting antivirals, elbasvir / grazoprevir, ledipasvir / sofosbuvir	rs8099917	IFNL3, IFNL4	GT	Efficacy	decreased	Efficacy_Response	Other:C0019372		J05A|J05AP08|J05AP51|J05AP54	rs8099917:GT	67505836
metoprolol	rs2960306	GRK4	GT	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs2960306:GT	6322
metoprolol	rs2960306	GRK4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs2960306:TT	6322
tacrolimus	rs3740066	ABCC2	CT	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3740066:CT	131769926
tacrolimus	rs3740066	ABCC2	TT	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3740066:TT	131769926
tacrolimus	rs3740066	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3740066:CT	131769926
tacrolimus	rs3740066	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3740066:TT	131769926
methotrexate	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:CT	11329481
methotrexate	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:C0024299		L04AX03	rs717620:TT	11329481
tacrolimus	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs717620:CT	131769926
tacrolimus	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs717620:TT	131769926
metoprolol	rs1024323	GRK4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0848548		C07AB02	rs1024323:CC	6322
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	CC	Efficacy	increased	Efficacy_Response	Disease:C0021368		No_ATC	rs1799724:CC	No_match
methadone	rs3762556	GAD1	G	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3762556:G	10090
infliximab	rs1143634	IL1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		L04AB02	rs1143634:GG	No_match
methadone	rs769404	GAD1	TT	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs769404:TT	10090
rocuronium	rs3834939	SLCO1A2	T/del	Metabolism/PK	decreased	LADME	Healthy		M03AC09	rs3834939:T/del	441290
rocuronium	rs3834939	SLCO1A2	TT	Metabolism/PK	decreased	LADME	Healthy		M03AC09	rs3834939:TT	441290
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs762551:AA	131769989
clozapine	rs762551	CYP1A2	AC	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs762551:AC	131769989
aripiprazole	rs1058164	CYP2D6	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1058164:GG	10114519
aripiprazole	rs28371699	CYP2D6	AA	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs28371699:AA	10114519
ticagrelor	rs2074900	CYP4F2	AA	Metabolism/PK	decreased	LADME	Healthy		B01AC24	rs2074900:AA	78358176
acenocoumarol	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA07	rs9934438:GG	54742534
capecitabine	rs67376798	DPYD	AT	Dosage	decreased	Dosage	Disease:C0023055		L01BC06	rs67376798:AT	11809635
clozapine	rs2011404	UGT1A4	C	Metabolism/PK	increased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs2011404:C	131769989
capecitabine	rs3918290	DPYD	CT	Dosage	decreased	Dosage	Disease:C0023055		L01BC06	rs3918290:CT	11809635
uric acid	rs1002976	VEGFC	C	Metabolism/PK	increased	LADME	Disease:C0020538		M04AA	rs1002976:C	1175
letermovir	rs4149032	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Healthy		J05AX18	rs4149032:TT	45138674
clozapine	rs34946978	UGT1A1	T	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs34946978:T	131769989
metformin	rs3792269	CAPN10	G	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs3792269:G	155906370
letermovir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4149056:CC	45138674
letermovir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4149056:CT	45138674
letermovir	rs4148323	UGT1A1	AA	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4148323:AA	45138674
letermovir	rs4148323	UGT1A1	AG	Metabolism/PK	increased	LADME	Healthy		J05AX18	rs4148323:AG	45138674
interferon beta-1a, interferon beta-1b	rs760316	FHIT	C	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs760316:C	No_match
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
glyburide	rs7512785	FMO2	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs7512785:T	29981563
methotrexate	rs1801394	MTRR	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:AG	11329481
methotrexate	rs1801394	MTRR	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:GG	11329481
propranolol	rs1042713	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		C07AA05	rs1042713:GG	135862
methotrexate	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1128503:AA	11329481
methotrexate	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1045642:AA	11329481
clozapine	rs10248420	ABCB1	G	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs10248420:G	131769989
methotrexate	rs3763980	SLC16A7	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3763980:A	11329481
peginterferon alfa-2a, peginterferon alfa-2b	rs12979860	IFNL3, IFNL4	C	Efficacy	increased	Efficacy_Response	Disease:C0019163|Chronic		L03AB10|L03AB11	rs12979860:C	No_match
methotrexate	rs12231740	SLC16A7	T	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs12231740:T	11329481
methotrexate	rs4948496	ARID5B	CC	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs4948496:CC	11329481
clozapine	rs4148323	UGT1A1	A	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0033975		N05AH02	rs4148323:A	131769989
fenofibrate	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs7412:CT	11350701
fenofibrate	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs7412:TT	11350701
methotrexate	rs4149056	SLCO1B1	TT	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:TT	11329481
peginterferon alfa-2a, peginterferon alfa-2b	rs8099917	IFNL3, IFNL4	T	Efficacy	increased	Efficacy_Response	Disease:C0019163|Chronic		L03AB10|L03AB11	rs8099917:T	No_match
methadone	rs3762555	GAD1	G	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3762555:G	10090
methotrexate	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801133:AA	11329481
methadone	rs3749034	GAD1	G	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3749034:G	10090
clozapine	rs7787082	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0033975		N05AH02	rs7787082:A	131769989
iguratimod	rs1495741	NAT2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1495741:AG	No_match
iguratimod	rs1495741	NAT2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1495741:GG	No_match
interferon beta-1a, interferon beta-1b	rs4278350	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs4278350:T	No_match
aripiprazole	rs28371702	CYP2D6	CC	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs28371702:CC	10114519
sitagliptin, vildagliptin	rs163184	KCNQ1	GG	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02	rs163184:GG	4369359
sitagliptin, vildagliptin	rs163184	KCNQ1	GT	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02	rs163184:GT	4369359
iguratimod	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2231142:GT	No_match
iguratimod	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2231142:TT	No_match
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__	65327
interferon beta-1a, interferon beta-1b	rs2291858	GAPVD1	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs2291858:G	No_match
methadone	rs204047	OPRD1	GG	Dosage	increased	Dosage	Healthy		N07BC02	rs204047:GG	10090
methadone	rs797397	OPRD1	AA	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs797397:AA	10090
methadone	rs204047	OPRD1	GG	Metabolism/PK	increased	LADME	Healthy		N07BC02	rs204047:GG	10090
antipsychotics	rs1344706	ZNF804A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1344706:AA	No_match
platinum compounds	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CC	23939
platinum compounds	rs25487	XRCC1	CT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CT	23939
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
interferon beta-1a, interferon beta-1b	rs10819043	GAPVD1	T	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs10819043:T	No_match
interferon beta-1a, interferon beta-1b	rs3133084	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs3133084:A	No_match
capecitabine, docetaxel	rs1048943	CYP1A1	AG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01BC06|L01CD02	rs1048943:AG	148124
capecitabine, docetaxel	rs1048943	CYP1A1	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01BC06|L01CD02	rs1048943:GG	148124
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT	131769926
glyburide	rs7793861	CYP51A1	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs7793861:G	29981563
interferon beta-1a, interferon beta-1b	rs1448673	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs1448673:G	No_match
glyburide	rs7515157	FMO2	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs7515157:T	29981563
anastrozole	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG03	rs2032582:AA	713
amisulpride, antipsychotics, olanzapine, quetiapine, risperidone	rs10042486	HTR1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A|N05AH03|N05AH04|N05AL05|N05AX08	rs10042486:TT	2159
uric acid	rs950569	BRINP3	T	Metabolism/PK	increased	LADME	Disease:C0020538		M04AA	rs950569:T	1175
glyburide	rs4148269	UGT2B15	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs4148269:G	29981563
interferon beta-1a, interferon beta-1b	rs10760397	GAPVD1	C	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs10760397:C	No_match
uric acid	rs2477134	PADI4	G	Metabolism/PK	increased	LADME	Disease:C0020538		M04AA	rs2477134:G	1175
interferon beta-1a, interferon beta-1b	rs10494227	ZNF697	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs10494227:A	No_match
doxorubicin	rs1533682	ABCC5	TT	Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs1533682:TT	83958
platinum compounds	rs861539	XRCC3	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs861539:AA	23939
platinum compounds	rs861539	XRCC3	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs861539:AG	23939
glyburide	rs1803545	MAPK1	A	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs1803545:A	29981563
glyburide	rs3749442	ABCC5	A	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3749442:A	29981563
aripiprazole	rs1135840	CYP2D6	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1135840:GG	10114519
glyburide	rs2303070	SPINK5	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs2303070:T	29981563
glyburide	rs5224	BDKRB2	A	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs5224:A	29981563
glyburide	rs3729910	MAPK1	G	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3729910:G	29981563
iguratimod	rs2032582	ABCB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2032582:CT	No_match
iguratimod	rs2032582	ABCB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2032582:TT	No_match
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
ethanol	rs11940694	KLB	A	Toxicity	decreased	Dosage	Healthy		V03AB16	rs11940694:A	444899
platinum compounds	rs1799782	XRCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AA	23939
platinum compounds	rs1799782	XRCC1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1799782:AG	23939
glyburide	rs2077647	ESR1	T	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs2077647:T	29981563
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	G	Efficacy	increased	Efficacy_Response	Other:C0003873|Other:C0004364|Other:C0235763		No_ATC	rs1800629:G	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
antidepressants	rs6265	BDNF	C	Efficacy	increased	Efficacy_Response	Healthy		N06A	rs6265:C	No_match
flunisolide	rs2305089	TBXT	TT	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA03	rs2305089:TT	82153
granisetron, palonosetron	rs3212986	ERCC1	AC	Efficacy	increased	Efficacy_Response	Side_Effect:C0027497|Side_Effect:C0042963		A04AA02|A04AA05	rs3212986:AC	6337614
granisetron, palonosetron	rs3212986	ERCC1	CC	Efficacy	increased	Efficacy_Response	Side_Effect:C0027497|Side_Effect:C0042963		A04AA02|A04AA05	rs3212986:CC	6337614
tacrolimus	rs1800795	IL6	GG	Efficacy	decreased	Efficacy_Response	Other:Kidney_Transplantation		L04AD02	rs1800795:GG	131769926
valproic acid	rs3892097	CYP2D6	CT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AG01	rs3892097:CT	134459
valproic acid	rs3892097	CYP2D6	TT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AG01	rs3892097:TT	134459
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1061622	TNFRSF1B	T	Efficacy	increased	Efficacy_Response	Other:C0235763		No_ATC	rs1061622:T	No_match
tacrolimus	rs1800795	IL6	GG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1800795:GG	131769926
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	C	Efficacy	increased	Efficacy_Response	Other:C0235763		No_ATC	rs1799724:C	No_match
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:GG	131769926
rasagiline	rs1076560	DRD2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BD02	rs1076560:CC	3052775
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:CC	131769926
rasagiline	rs2283265	DRD2	CC	Efficacy	increased	Efficacy_Response	Disease:C0030567		N04BD02	rs2283265:CC	3052775
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4646437:GG	131769926
tacrolimus	rs4553808	CTLA4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4553808:AG	131769926
tacrolimus	rs4553808	CTLA4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4553808:GG	131769926
antidepressants	rs10501087	BDNF-AS	T	Efficacy	increased	Efficacy_Response	Healthy		N06A	rs10501087:T	No_match
tacrolimus	rs181781	IL3	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs181781:AA	131769926
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__	65327
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
lamotrigine	rs6755571	UGT1A4	CC	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX09	rs6755571:CC	71236569
warfarin	rs4917639	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs4917639:C	54688261
telaprevir	rs2585428	CYP24A1	C	Metabolism/PK	decreased	LADME	Disease:C0019372		J05AP02	rs2585428:C	3010818
tacrolimus	rs4553808	CTLA4	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4553808:AA	131769926
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:CC	131769926
varenicline	rs1044396	CHRNA4	GG	Efficacy	decreased	Efficacy_Response	Disease:C0039338		N07BA03	rs1044396:GG	6918678
escitalopram	rs4646425	CYP1A2	T	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs4646425:T	162180
escitalopram	rs2069526	CYP1A2	G	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs2069526:G	162180
escitalopram	rs4646427	CYP1A2	C	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs4646427:C	162180
platinum compounds	rs430397	HSPA5	TT	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs430397:TT	23939
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	A	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs1801274:A	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	Other:C0038012		No_ATC	rs396991:C	No_match
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG	64139
morphine	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AA01	rs1045642:AA	5284371
clopidogrel	rs6785930	P2RY12	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6785930:AA	13748464
clopidogrel	rs6785930	P2RY12	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6785930:AG	13748464
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6809699:AA	13748464
clopidogrel	rs6809699	P2RY12	AC	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs6809699:AC	13748464
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG	64139
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs361525	TNF	G	Efficacy	increased	Efficacy_Response	Other:C0235763		No_ATC	rs361525:G	No_match
fluticasone propionate	rs2872507	ORMDL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs2872507:AA	5311101
fluticasone propionate	rs2872507	ORMDL3	AG	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs2872507:AG	5311101
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
rituximab	rs396991	FCGR3A	AC	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01	rs396991:AC	No_match
rituximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01	rs396991:CC	No_match
abatacept, rituximab, tocilizumab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01|L04AA24|L04AC07	rs1801274:AG	No_match
abatacept, rituximab, tocilizumab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L01FA01|L04AA24|L04AC07	rs1801274:GG	No_match
valproic acid	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1057910:AC	134459
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
warfarin	rs339097	CALU	G	Dosage	increased	Dosage	Healthy		B01AA03	rs339097:G	54688261
atazanavir / ritonavir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CC	25134325
atazanavir / ritonavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CT	25134325
deferasirox	rs13120400	ABCG2	CT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:CT	214348
deferasirox	rs13120400	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:TT	214348
atazanavir / ritonavir	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs776746:CC	25134325
warfarin	rs10509680	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs10509680:T	54688261
adalimumab, certolizumab pegol, etanercept, golimumab, infliximab	rs7975232	VDR	AA	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AB06	rs7975232:AA	No_match
adalimumab, certolizumab pegol, etanercept, golimumab, infliximab	rs7975232	VDR	AC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AB06	rs7975232:AC	No_match
angiotensin ii	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Healthy		C09CA	rs5186:AA	45266664
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__	65327
antiepileptics	rs41423247	NR3C1	GG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03A	rs41423247:GG	No_match
deferasirox	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2273697:AG	214348
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
fluvastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs7412:CT	131750727
metformin	rs2289669	SLC47A1	A	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:A	155906370
talinolol	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AA	68770
lamotrigine	rs7439366	UGT2B7	TT	Metabolism/PK	increased	LADME	Other:C0014544		N03AX09	rs7439366:TT	71236569
tacrolimus	rs2740574	CYP3A4	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:CC	131769926
tacrolimus	rs2740574	CYP3A4	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
ritodrine	rs598961	PDE4B	AA	Efficacy	decreased	Efficacy_Response	Other:C0022876		G02CA01	rs598961:AA	33572
tacrolimus	rs4986910	CYP3A4	G	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs4986910:G	131769926
acenocoumarol, warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03|B01AA07	rs2108622:CT	54676537
acenocoumarol, warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03|B01AA07	rs2108622:TT	54676537
lamotrigine	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Other:C0014544		N03AX09	rs1902023:AA	71236569
desipramine	poor metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	poor metabolizer	N06AA01	__UNKNOWN__	65327
platinum compounds	rs1800975	XPA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs1800975:CC	23939
aripiprazole, dehydroaripiprazole	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs2032582:CC	10114519
aripiprazole, dehydroaripiprazole	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1045642:GG	10114519
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
aripiprazole, dehydroaripiprazole	rs1128503	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		N05AX12	rs1128503:GG	10114519
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
tacrolimus	rs1800871	IL10	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs1800871:AA	131769926
antihypertensives, hydralazine, methyldopa, nifedipine	rs3918242	MMP9	CT	Efficacy	decreased	Efficacy_Response	Disease:C0340274		C02|C02AB|C02DB02|C08CA05	rs3918242:CT	4485
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Other:C2939420|Other:C0004238|Other:C0026265|Other:C1956346		B01AA03	rs2108622:T	54688261
daclatasvir	rs11568820	VDR	TT	Metabolism/PK	decreased	LADME	Disease:C0019372		J05AP07	rs11568820:TT	25154714
morphine	rs4680	COMT	AG	Efficacy	increased	Dosage	Healthy		N02AA01	rs4680:AG	5284371
morphine	rs4680	COMT	GG	Efficacy	increased	Dosage	Healthy		N02AA01	rs4680:GG	5284371
methyldopa	rs3918242	MMP9	CT	Efficacy	decreased	Efficacy_Response	Disease:C0340274		C02AB	rs3918242:CT	9307
methyldopa	rs3918242	MMP9	TT	Efficacy	decreased	Efficacy_Response	Disease:C0340274		C02AB	rs3918242:TT	9307
daclatasvir	rs2248359	CYP24A1	CT	Metabolism/PK	increased	LADME	Disease:C0019372		J05AP07	rs2248359:CT	25154714
daclatasvir	rs2248359	CYP24A1	TT	Metabolism/PK	increased	LADME	Disease:C0019372		J05AP07	rs2248359:TT	25154714
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG	131769926
tacrolimus	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:GG	131769926
carbamazepine, oxcarbazepine	rs3812718	SCN1A	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AF01|N03AF02	rs3812718:TT	71750797
metoprolol	rs1801252	ADRB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB02	rs1801252:AA	6322
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB02	rs1801253:CC	6322
calcium channel blockers	rs10898815	NUMA1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs10898815:GG	5460341
carbamazepine, oxcarbazepine	rs3812718	SCN1A	TT	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AF01|N03AF02	rs3812718:TT	71750797
calcium channel blockers	rs2429427	TANC2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2429427:GG	5460341
sibutramine	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Other:C0028754		A08AA10	rs5443:CC	5210
carbamazepine, oxcarbazepine	rs2273697	ABCC2	AG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0014544		N03AF01|N03AF02	rs2273697:AG	71750797
busulfan	rs3957356	GSTA1	T	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L01AB01	rs3957356:T	4684
s-eddp	rs8192709	CYP2B6	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs8192709:CT	28292
busulfan	rs3957357	GSTA1	A	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L01AB01	rs3957357:A	4684
simvastatin	rs12052787	UGT1A9	T	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs12052787:T	14373154
tacrolimus	rs776746	CYP3A5	CT	Efficacy, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
simvastatin	rs2003569	UGT1A9	A	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2003569:A	14373154
platinum compounds	rs1799801	ERCC4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs1799801:TT	23939
platinum compounds	rs11615	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11615:AA	23939
platinum compounds	rs11615	ERCC1	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs11615:AG	23939
amitriptyline, clomipramine, doxepin, imipramine, maprotiline, nortriptyline, opipramol	rs3892097	CYP2D6	TT	Dosage, Efficacy	decreased	Dosage	Disease:C0235876		N06AA02|N06AA04|N06AA09|N06AA10|N06AA12|N06AA21	rs3892097:TT	9417
platinum compounds	rs3738948	ERCC3	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3738948:AG	23939
platinum compounds	rs3738948	ERCC3	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3738948:GG	23939
tegafur	rs8192720	CYP2A6	AA	Metabolism/PK	increased	LADME	Healthy		L01BC03	rs8192720:AA	5386
tegafur	rs8192720	CYP2A6	AG	Metabolism/PK	increased	LADME	Healthy		L01BC03	rs8192720:AG	5386
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	Dosage	Healthy		C01AA05	rs1045642:AA	15478
digoxin	rs1045642	ABCB1	AG	Metabolism/PK	decreased	Dosage	Healthy		C01AA05	rs1045642:AG	15478
antipsychotics, chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05A|N05AA01|N05AD01|N05AH02|N05AH03|N05AH04|N05AX08	rs1801133:AG	2726
oxycodone	rs7439366	UGT2B7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0027651|Disease:C0030193		N02AA05	rs7439366:TT	5462350
terbutaline	rs1042714	ADRB2	GG	Metabolism/PK	increased	Efficacy_Response	Healthy		R03CC03	rs1042714:GG	5403
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
bupropion	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:C0011581		N06AX12	rs3745274:T	446
risperidone	rs4483927	HRH4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs4483927:TT	849421
atenolol	rs2960306	GRK4	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C07AB03	rs2960306:T	14211540
atenolol	rs1024323	GRK4	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C07AB03	rs1024323:T	14211540
calcium channel blockers	rs588076	PICALM	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs588076:GG	5460341
deleobuvir, faldaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		No_ATC	rs12979860:CC	42601552
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
propofol	rs11503014	GABRA2	CC	Other	decreased	Efficacy_Response	Healthy		N01AX10	rs11503014:CC	3014064
warfarin	rs3212198	HNF4A	T	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs3212198:T	54688261
codeine, tramadol	rs1056836	CYP1B1	C	Efficacy	decreased	Efficacy_Response	Other:C0030193		N02AX02|R05DA04	rs1056836:C	33741
erlotinib, gefitinib	rs121434568	EGFR	G	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01EB01|L01EB02	rs121434568:G	176870
warfarin	rs2501873	NR1I3	TT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2501873:TT	54688261
verapamil	rs3733694	PCDHB8	G	Efficacy	decreased	Efficacy_Response	Other:C0022078		C08DA01	rs3733694:G	65808
rivaroxaban	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1057868:TT	10700
verapamil	rs17844444	PCDHB6	A	Efficacy	decreased	Efficacy_Response	Other:C0022078		C08DA01	rs17844444:A	65808
capecitabine, cetuximab, oxaliplatin	rs61764370	KRAS	AC	Efficacy	increased	Efficacy_Response	Disease:C0022665		L01BC06|L01XA03	rs61764370:AC	9887054
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CT	25221209
atorvastatin	rs5186	AGTR1	AC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs5186:AC	656846
atorvastatin	rs1799722	BDKRB2	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1799722:CT	656846
losartan	rs5186	AGTR1	AA	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		C09CA01	rs5186:AA	11751549
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
heroin	rs9479757	OPRM1	AG	Dosage	increased	Dosage	Disease:C0028043		No_ATC	rs9479757:AG	9844225
5-hydroxyindole-3-acetic acid, serotonin	rs1799836	MAOB	T	Metabolism/PK	increased	LADME	Other:C0011581		A03AE	rs1799836:T	5202
antidepressants	rs1954787	GRIK4	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1954787:CC	No_match
rivaroxaban	rs4148738	ABCB1	CT	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs4148738:CT	10700
5-hydroxyindole-3-acetic acid, serotonin	rs1799836	MAOB	TT	Metabolism/PK	increased	LADME	Other:C0011581		A03AE	rs1799836:TT	5202
apixaban	rs1057868	POR	T	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF02	rs1057868:T	91667715
oxcarbazepine	rs2741049	UGT1A9	CC	Efficacy	increased	Efficacy_Response	Disease:Seizures		N03AF02	rs2741049:CC	46782646
codeine, tramadol	rs1056837	CYP1B1	A	Efficacy	decreased	Efficacy_Response	Other:C0030193		N02AX02|R05DA04	rs1056837:A	33741
candesartan	rs1799998	CYP11B2	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA06	rs1799998:GG	146026636
3-hydroxycotinine	rs4105144	__INTRONIC__	CC	Metabolism/PK	increased	LADME	Other:C0039338		No_ATC	rs4105144:CC	416
3-hydroxycotinine	rs4105144	__INTRONIC__	CT	Metabolism/PK	increased	LADME	Other:C0039338		No_ATC	rs4105144:CT	416
hydrocodone, oxycodone	rs35742686	CYP2D6	DELT	Efficacy	increased	Efficacy_Response	Other:C0030193		N02AA05|R05DA03	rs35742686:DELT	5284569
3-hydroxycotinine	rs3733829	EGLN2	AA	Metabolism/PK	decreased	LADME	Other:C0039338		No_ATC	rs3733829:AA	416
3-hydroxycotinine	rs3733829	EGLN2	AG	Metabolism/PK	decreased	LADME	Other:C0039338		No_ATC	rs3733829:AG	416
hydrocodone, oxycodone	rs76026520	MACROD2	G	Efficacy	increased	Efficacy_Response	Other:C0030193		N02AA05|R05DA03	rs76026520:G	5284569
clonidine	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Healthy		S01EA04	rs5443:CT	20255880
clonidine	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Healthy		S01EA04	rs5443:TT	20255880
benazepril	rs1801133	MTHFR	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA07	rs1801133:AA	5362124
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
deferasirox	rs2606345	CYP1A1	AC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:AC	214348
deferasirox	rs2606345	CYP1A1	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:CC	214348
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
pitrakinra	rs1029489	IL4R	GG	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs1029489:GG	No_match
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
radiotherapy	rs11130424	CACNA2D3	AG	Efficacy	increased	Efficacy_Response	Other:C0023055		No_ATC	rs11130424:AG	No_match
radiotherapy	rs11130424	CACNA2D3	GG	Efficacy	increased	Efficacy_Response	Other:C0023055		No_ATC	rs11130424:GG	No_match
hydroxyurea	rs9483947	MAP3K5	CC	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs9483947:CC	10220327
antihypertensives	rs13144136	CLNK	G	Efficacy	increased	Efficacy_Response	Disease:C0020538		C02	rs13144136:G	No_match
hydroxyurea	rs9376230	MAP3K5	CC	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		No_ATC	rs9376230:CC	10220327
imatinib	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1128503:GG	6113
imatinib	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA	6113
atorvastatin	rs717620	ABCC2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs717620:CT	656846
atorvastatin	rs717620	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs717620:TT	656846
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
lenalidomide, thalidomide	rs308395	FGF2	CG	Efficacy	decreased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02|L04AX04	rs308395:CG	216326
lenalidomide, thalidomide	rs308395	FGF2	GG	Efficacy	decreased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02|L04AX04	rs308395:GG	216326
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
methotrexate	rs717620	ABCC2	CT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs717620:CT	11329481
methotrexate	rs717620	ABCC2	TT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs717620:TT	11329481
antidepressants	rs979605	MAOA	AA	Metabolism/PK	decreased	Efficacy_Response	Other:C0011581		N06A	rs979605:AA	No_match
methotrexate	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1045642:GG	11329481
antidepressants	rs1954787	GRIK4	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs1954787:C	No_match
ethanol	rs671	ALDH2	AG	Other	increased	LADME	Healthy		V03AB16	rs671:AG	444899
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
hydrochlorothiazide	rs292449	NEDD4L	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs292449:CC	2904
hydrochlorothiazide	rs292449	NEDD4L	CG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs292449:CG	2904
pitrakinra	rs8832	IL4R	GG	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs8832:GG	No_match
tacrolimus	rs776746	CYP3A5	T	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:T	131769926
pitrakinra	rs3024530	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs3024530:AA	No_match
pitrakinra	rs1110470	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs1110470:AA	No_match
pitrakinra	rs2239347	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs2239347:AA	No_match
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
benazepril	rs1805087	MTR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09AA07	rs1805087:AG	5362124
benazepril	rs1805087	MTR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09AA07	rs1805087:GG	5362124
pitrakinra	rs1805010	IL4R	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		No_ATC	rs1805010:AA	No_match
voriconazole	rs717620	ABCC2	CT	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs717620:CT	9741
voriconazole	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs717620:TT	9741
acenocoumarol, phenprocoumon	rs9934438	VKORC1	GG	Dosage, Toxicity	increased	Dosage	Healthy		B01AA04|B01AA07	rs9934438:GG	54680692
sulindac	rs2266782	FMO3	AA	Metabolism/PK	increased	LADME	Healthy		M01AB02	rs2266782:AA	5472495
mycophenolate mofetil(mycophenolic acid)	rs7311358	SLCO1B3	A	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs7311358:A	5281078
sulindac	rs2266780	FMO3	GG	Metabolism/PK	increased	LADME	Healthy		M01AB02	rs2266780:GG	5472495
morphine	rs4793665	ABCC3	CC	Metabolism/PK	increased	LADME	Healthy		N02AA01	rs4793665:CC	5284371
peginterferon alfa-2a, ribavirin	rs8105790	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8105790:C	37542
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT	656846
peginterferon alfa-2a, ribavirin	rs8103142	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8103142:C	37542
memantine	rs1523130	NR1I2	CT	Metabolism/PK	decreased	LADME	Disease:C0497327		N06DX01	rs1523130:CT	3382167
memantine	rs1523130	NR1I2	TT	Metabolism/PK	decreased	LADME	Disease:C0497327		N06DX01	rs1523130:TT	3382167
benazepril	rs1042713	ADRB2	AG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07	rs1042713:AG	5362124
benazepril	rs1042713	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C09AA07	rs1042713:GG	5362124
peginterferon alfa-2a, ribavirin	rs11881222	IFNL3	G	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs11881222:G	37542
peginterferon alfa-2a, ribavirin	rs7248668	IFNL3	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs7248668:A	37542
amisulpride	rs7968606	ANKS1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AL05	rs7968606:CC	169501917
peginterferon alfa-2a, ribavirin	rs28416813	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs28416813:C	37542
peginterferon alfa-2a, ribavirin	rs4803219	IFNL3	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs4803219:C	37542
morphine	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Disease:C0027651		N02AA01	rs1799971:AG	5284371
escitalopram	rs2069521	__INTRONIC__	A	Metabolism/PK	increased	LADME	Disease:C0011581		N06AB10	rs2069521:A	162180
imatinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:CC	6113
rosuvastatin	rs4238001	SCARB1	CC	Efficacy	increased	Efficacy_Response	Other:C0151744		C10AA07	rs4238001:CC	5282455
imatinib	rs1045642	ABCB1	AA	Metabolism/PK	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA	6113
imatinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs776746:CC	6113
lacosamide	rs2273697	ABCC2	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AX18	rs2273697:GG	156613579
imatinib	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA	6113
simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA01	rs4149056:CT	14373154
olanzapine	rs11960832	SV2C	TT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH03	rs11960832:TT	74603552
corticosteroids	rs2240017	TBX21	CG	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs2240017:CG	No_match
methotrexate	rs2238476	ABCC1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs2238476:GG	11329481
antidepressants	rs6314	HTR2A	AG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6314:AG	No_match
antidepressants	rs6314	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6314:GG	No_match
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs1065852	CYP2D6	A	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs1065852:A	1775
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs9332120	CYP2C9	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs9332120:C	1775
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C	131769926
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs3892097	CYP2D6	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs3892097:C	1775
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs2740574	CYP3A4	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs2740574:C	1775
carbamazepine, lamotrigine, phenytoin, primidone, valproic acid	rs2687116	CYP3A4	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA03|N03AB02|N03AF01|N03AG01|N03AX09	rs2687116:C	1775
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
duloxetine	rs61908411	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908411:C	44344115
duloxetine	rs61908409	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908409:C	44344115
duloxetine	rs61908410	ANO2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908410:T	44344115
duloxetine	rs78615940	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs78615940:A	44344115
duloxetine	rs78482393	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs78482393:G	44344115
duloxetine	rs61908405	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908405:C	44344115
duloxetine	rs61908406	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908406:G	44344115
selective beta-2-adrenoreceptor agonists	rs2781659	ARG1	A	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03CC	rs2781659:A	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AA	13748464
clopidogrel	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs4244285:AG	13748464
duloxetine	rs61908404	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908404:C	44344115
duloxetine	rs61908408	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908408:A	44344115
duloxetine	rs61908407	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908407:A	44344115
duloxetine	rs17786412	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17786412:G	44344115
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
duloxetine	rs17786400	ANO2	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17786400:A	44344115
methadone	rs9282564	ABCB1	C	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs9282564:C	10090
duloxetine	rs61908403	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908403:G	44344115
duloxetine	rs61908402	ANO2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs61908402:T	44344115
dobutamine	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs1801253:CC	208850
duloxetine	rs17724452	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17724452:C	44344115
glatiramer acetate	rs2114358	PVT1	A	Efficacy	increased	Efficacy_Response	Disease:C0026769		L03AX13	rs2114358:A	3081884
duloxetine	rs7316769	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs7316769:G	44344115
duloxetine	rs17724494	ANO2	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17724494:C	44344115
warfarin	rs56165452	CYP2C9	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs56165452:CT	54688261
methadone	rs1045642	ABCB1	A	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1045642:A	10090
duloxetine	rs17786394	ANO2	T	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17786394:T	44344115
duloxetine	rs17724464	ANO2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AX21	rs17724464:G	44344115
methadone	rs7439366	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs7439366:CT	10090
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
pemetrexed, platinum compounds	rs9344	CCND1	A	Efficacy	increased	Efficacy_Response	Other:C0024121		L01BA04|L01XA	rs9344:A	23939
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A	54688261
metoprolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AB02	rs1801253:CC	6322
warfarin	rs7294	VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:T	54688261
liraglutide	rs10305420	GLP1R	CT	Efficacy	decreased	Efficacy_Response	Disease:C0028754|Disease:Polycystic_Ovary_Syndrome		A10BJ02	rs10305420:CT	16134956
liraglutide	rs10305420	GLP1R	TT	Efficacy	decreased	Efficacy_Response	Disease:C0028754|Disease:Polycystic_Ovary_Syndrome		A10BJ02	rs10305420:TT	16134956
lamotrigine	rs2753325	CACNA1H	A	Efficacy	increased	Efficacy_Response	Efficacy:C0014544		N03AX09	rs2753325:A	71236569
azathioprine	low activity	TPMT	__UNKNOWN__	Metabolism/PK	decreased	Dosage	Healthy	low activity	L04AX01	__UNKNOWN__	5778
fluorouracil	rs3918290	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs3918290:CT	5790
fluorouracil	rs2297595	DPYD	CC	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs2297595:CC	5790
fluorouracil	rs2297595	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs2297595:CT	5790
aspirin	rs6065	GP1BA	CT	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs6065:CT	72204814
aspirin	rs6065	GP1BA	TT	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs6065:TT	72204814
fluorouracil	rs1801160	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs1801160:CT	5790
fluorouracil	rs1801160	DPYD	TT	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs1801160:TT	5790
fluorouracil	rs1801265	DPYD	GG	Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC02	rs1801265:GG	5790
lacosamide	rs717620	ABCC2	CC	Metabolism/PK	increased	LADME	Other:C0014544		N03AX18	rs717620:CC	156613579
anastrozole	rs11648166	__INTRONIC__	G	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG03	rs11648166:G	713
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
lacosamide	rs2273697	ABCC2	A	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AX18	rs2273697:A	156613579
lacosamide	rs717620	ABCC2	T	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AX18	rs717620:T	156613579
anastrozole	rs28845026	__INTRONIC__	T	Metabolism/PK	increased	LADME	Disease:C1458155		L02BG03	rs28845026:T	713
trazodone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N06AX05	rs1045642:AA	62935
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AC	54688261
warfarin	rs1057910	CYP2C9	CC	Dosage	decreased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:CC	54688261
cyclophosphamide	rs4802101	CYP2B6	C	Metabolism/PK	decreased	LADME	Disease:C0409974		L01AA01	rs4802101:C	9554282
dobutamine	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs1801253:CC	208850
simvastatin acid	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:C	25221209
methotrexate	rs10994982	ARID5B	A	Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs10994982:A	11329481
oxycodone	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02AA05	rs1799971:AG	5462350
oxycodone	rs1799971	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02AA05	rs1799971:GG	5462350
cyclophosphamide	rs4244285	CYP2C19	A	Metabolism/PK	decreased	LADME	Disease:C0409974		L01AA01	rs4244285:A	9554282
imatinib	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs1045642:AG	6113
imatinib	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Other:C0238198		L01EA01	rs1045642:GG	6113
fenofibrate	rs4253778	PPARA	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		C10AB05	rs4253778:GG	11350701
methotrexate	rs11231809	SLC22A11	AT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs11231809:AT	11329481
methotrexate	rs11231809	SLC22A11	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs11231809:TT	11329481
methotrexate	rs246240	ABCC1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs246240:AG	11329481
methotrexate	rs246240	ABCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs246240:GG	11329481
hmg coa reductase inhibitors	rs3846662	HMGCR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0342881		C10AA	rs3846662:AA	445127
methotrexate	rs3784864	ABCC1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3784864:AG	11329481
methotrexate	rs3784864	ABCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs3784864:GG	11329481
cyclophosphamide	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027697		L01AA01	rs4244285:AG	9554282
cyclophosphamide	rs4244285	CYP2C19	GG	Efficacy	decreased	Efficacy_Response	Disease:C0027697		L01AA01	rs4244285:GG	9554282
4-hydroxycyclophosphamide	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:C0027697		L01AA01	rs776746:CC	99735
4-hydroxycyclophosphamide	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:C0027697		L01AA01	rs776746:CT	99735
cyclophosphamide	rs7254579	CYP2B6	C	Metabolism/PK	Indeterminado	LADME	Disease:C0409974		L01AA01	rs7254579:C	9554282
hmg coa reductase inhibitors	rs445925	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs445925:A	445127
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
hmg coa reductase inhibitors	rs10455872	LPA	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs10455872:G	445127
fenofibrate	rs1800795	IL6	CC	Efficacy	increased	Efficacy_Response	Other:patients_with_a_high_risk_of_cardiovascular_disease		C10AB05	rs1800795:CC	11350701
fenofibrate	rs1800795	IL6	CG	Efficacy	increased	Efficacy_Response	Other:patients_with_a_high_risk_of_cardiovascular_disease		C10AB05	rs1800795:CG	11350701
ranibizumab	rs2070296	NRP1	T	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs2070296:T	No_match
atorvastatin	rs708272	CETP	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		C10AA05	rs708272:GG	656846
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs3828913	MICB	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs3828913:CC	37542
methotrexate	rs13120400	ABCG2	CC	Efficacy	increased	Efficacy_Response	Side_Effect:C0235763		L04AX03	rs13120400:CC	11329481
nicotine	rs77905	DBH	GG	Dosage	decreased	Dosage	Disease:C0039338		N07BA01	rs77905:GG	936
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9923231:CC	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs9923231:CT	54688261
nicotine	rs1137070	MAOA	TT	Dosage	increased	Dosage	Disease:C0039338		N07BA01	rs1137070:TT	936
omeprazole, pantoprazole	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0079487		A02BC01|A02BC02	rs1045642:AA	4679
deferasirox	rs7975232	VDR	AA	Metabolism/PK	Indeterminado	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs7975232:AA	214348
fluvoxamine, milnacipran, paroxetine	rs1364043	HTR1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs1364043:TT	5324346
deferasirox	rs2228570	VDR	G	Metabolism/PK	Indeterminado	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2228570:G	214348
antipsychotics	rs6465084	GRM3	AA	Toxicity	increased	Efficacy_Response	Disease:C0036341		N05A	rs6465084:AA	No_match
metformin	rs2289669	SLC47A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:AA	155906370
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC	54688261
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
metformin	rs2289669	SLC47A1	AA	Metabolism/PK	decreased	LADME	Disease:C0011849		A10BA02	rs2289669:AA	155906370
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
efavirenz	rs2307424	NR1I3	G	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2307424:G	64139
efavirenz	rs2307424	NR1I3	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2307424:AG	64139
antihypertensives	rs12817819	ATP2B1	CT	Efficacy	increased	Efficacy_Response	Disease:C1956346|Disease:C0020538		C02	rs12817819:CT	No_match
antihypertensives	rs12817819	ATP2B1	TT	Efficacy	increased	Efficacy_Response	Disease:C1956346|Disease:C0020538		C02	rs12817819:TT	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
warfarin	rs1051741	EPHX1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1051741:CT	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8103142	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8103142:TT	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:AA	37542
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs11881222:AA	37542
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
isoniazid	rs1799930	NAT2	AA	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01	rs1799930:AA	135483892
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
mercaptopurine	rs73189762	NUDT15	T	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs73189762:T	1268107
warfarin	rs7294	PRSS53, VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:CT	54688261
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
isoniazid	rs2472677	NR1I2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01	rs2472677:TT	135483892
amlodipine, felodipine	rs2238032	CACNA1C	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01|C08CA02	rs2238032:TT	3333
isoniazid	rs4149032	SLCO1B1	CC	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J04AC01	rs4149032:CC	135483892
calcium channel blockers	rs2239128	CACNA1C	C	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2239128:C	5460341
morphine	rs1799971	OPRM1	AG	Efficacy	increased	Dosage	Healthy		N02AA01	rs1799971:AG	5284371
morphine	rs1799971	OPRM1	GG	Efficacy	increased	Dosage	Healthy		N02AA01	rs1799971:GG	5284371
gefitinib	rs121434568	EGFR	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007131		L01EB01	rs121434568:G	135496227
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
erlotinib	rs121434568	EGFR	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0007131		L01EB02	rs121434568:G	176870
hmg coa reductase inhibitors	rs2900478	SLCO1B1	A	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs2900478:A	445127
calcium channel blockers	rs2239050	CACNA1C	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2239050:GG	5460341
hmg coa reductase inhibitors	rs646776	CELSR2	C	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs646776:C	445127
valproic acid	rs12233719	UGT2B7	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs12233719:GG	134459
efavirenz	rs28399454	CYP2A6	T	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399454:T	64139
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
calcium channel blockers	rs2238032	CACNA1C	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08	rs2238032:TT	5460341
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs9923231:TT	54688261
phenprocoumon, warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03|B01AA04	rs9923231:TT	54680692
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG	64139
atazanavir	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	rs1045642:GG	118753185
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
warfarin	rs7900194	CYP2C9	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs7900194:A	54688261
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG	64139
valproic acid	rs7668258	UGT2B7	CT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:CT	134459
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	rs28371686	CYP2C9	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371686:G	54688261
warfarin	rs429358	APOC1, APOE	T	Dosage	decreased	Dosage	Other:haplotype_epsilon2		B01AA03	rs429358:T	54688261
valproic acid	rs7668258	UGT2B7	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AG01	rs7668258:TT	134459
warfarin	rs7412	APOC1, APOE	T	Dosage	decreased	Dosage	Other:haplotype_epsilon2		B01AA03	rs7412:T	54688261
infliximab	rs2097432	__INTRONIC__	CC	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	rs2097432:CC	No_match
infliximab	rs2097432	__INTRONIC__	CT	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	rs2097432:CT	No_match
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
photodynamic therapy	rs1061170	CFH	TT	Efficacy	decreased	Efficacy_Response	Disease:C0024437		No_ATC	rs1061170:TT	No_match
valproic acid	rs7439366	UGT2B7	TT	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AG01	rs7439366:TT	134459
risperidone	rs2231142	ABCG2	GT	Metabolism/PK	decreased	LADME	Healthy		N05AX08	rs2231142:GT	849421
risperidone	rs2231142	ABCG2	TT	Metabolism/PK	decreased	LADME	Healthy		N05AX08	rs2231142:TT	849421
fluoxetine	rs9361233	HTR1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361233:CC	1548968
fluoxetine	rs9361233	HTR1B	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361233:TT	1548968
efavirenz	rs8192709	CYP2B6	CC	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs8192709:CC	64139
infliximab	rs73277969	__INTRONIC__	T	Efficacy	increased	Adverse_Event	Efficacy:C0010346		L04AB02	rs73277969:T	No_match
ivacaftor	rs121908757	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121908757:C	72722243
ivacaftor	rs121909005	CFTR	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121909005:G	72722243
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	2244
ivacaftor	rs121908755	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121908755:A	72722243
aspirin, prasugrel	rs2768759	PEAR1	AC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs2768759:AC	2244
aspirin, prasugrel	rs2768759	PEAR1	CC	Efficacy	decreased	Efficacy_Response	Healthy		B01AC22	rs2768759:CC	2244
cyclosporine	rs2032582	ABCB1	AC	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD01	rs2032582:AC	86666680
cyclosporine	rs2032582	ABCB1	CC	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD01	rs2032582:CC	86666680
aspirin, clopidogrel, prasugrel	rs12041331	PEAR1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04|B01AC22	rs12041331:AA	2244
aspirin, clopidogrel, prasugrel	rs12041331	PEAR1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04|B01AC22	rs12041331:AG	2244
cyclosporine	rs4646437	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs4646437:AG	86666680
cyclosporine	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs4646437:GG	86666680
hydralazine / isosorbide dinitrate	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Disease:C0085605		C05AE02	rs5443:TT	6883
ivacaftor	rs397508453	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs397508453:C	72722243
tacrolimus	rs776746	CYP3A5	CC	Dosage	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CC	131769926
ivacaftor	rs121909013	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121909013:A	72722243
lovastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4149056:CC	40474546
lovastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4149056:CT	40474546
simvastatin	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		C10AA01	rs776746:CC	14373154
ivacaftor	rs121909041	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121909041:C	72722243
tacrolimus	rs2242480	CYP3A4	T	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2242480:T	131769926
simvastatin	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		C10AA01	rs776746:CC	14373154
aspirin, clopidogrel	rs4244285	CYP2C19	A	Efficacy	decreased	Efficacy_Response	Disease:C1956346		B01AC04	rs4244285:A	2244
ivacaftor	rs74503330	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs74503330:A	72722243
lovastatin	rs4823613	PPARA	AG	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4823613:AG	40474546
lovastatin	rs4823613	PPARA	GG	Metabolism/PK	increased	LADME	Healthy		C10AA02	rs4823613:GG	40474546
nevirapine	rs762551	CYP1A2	CC	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG01	rs762551:CC	15979285
fentanyl	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02AB03	rs1799971:AG	13653606
fentanyl	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02AB03	rs1799971:GG	13653606
anastrozole, letrozole, tamoxifen	rs4646	CYP19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1458155|Disease:C0025320		L02BA01|L02BG03|L02BG04	rs4646:AA	3902
ivacaftor	rs267606723	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs267606723:A	72722243
serotonin	rs696692	ERICH3	T	Other	decreased	LADME	Disease:C0011581		A03AE	rs696692:T	10027372
ivacaftor	rs80282562	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs80282562:A	72722243
tacrolimus	rs1045642	ABCB1	AG	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:AG	131769926
tacrolimus	rs1045642	ABCB1	GG	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1045642:GG	131769926
cyclosporine	rs4646437	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs4646437:AG	86666680
cyclosporine	rs4646437	CYP3A4	GG	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs4646437:GG	86666680
anastrozole, letrozole, tamoxifen	rs4646	CYP19A1	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L02BA01|L02BG03|L02BG04	rs4646:AA	3902
platinum compounds	rs1799793	ERCC2	CT	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1799793:CT	23939
platinum compounds	rs1799793	ERCC2	TT	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1799793:TT	23939
serotonin	rs11947402	TSPAN5	G	Other	decreased	LADME	Disease:C0011581		A03AE	rs11947402:G	10027372
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3761847	TRAF1	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3761847:G	No_match
thalidomide	rs4533622	CTNNB1	AA	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L04AX02	rs4533622:AA	5743568
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Disease:C0004238|Disease:C0878544|Disease:Heart_valve_replacement|Disease:C0085096|Disease:C0034065|Disease:C0042487		B01AA03	rs9934438:AG	54688261
fentanyl	rs1799971	OPRM1	AG	Dosage	decreased	Dosage	Disease:C0030193		N02AB03	rs1799971:AG	13653606
fentanyl	rs1799971	OPRM1	GG	Dosage	decreased	Dosage	Disease:C0030193		N02AB03	rs1799971:GG	13653606
ivacaftor	rs193922525	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs193922525:A	72722243
cyclophosphamide, dexamethasone, thalidomide	rs4135385	CTNNB1	AA	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01AA01|L04AX02|S02BA06	rs4135385:AA	2907
opioids	rs2275913	IL17A	A	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02A	rs2275913:A	No_match
platinum compounds	rs1048943	CYP1A1	CC	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1048943:CC	23939
platinum compounds	rs1048943	CYP1A1	CT	Efficacy	increased	Efficacy_Response	Other:C0007131		L01XA	rs1048943:CT	23939
warfarin	rs2108622	CYP4F2	C	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs2108622:C	54688261
tacrolimus	rs2032582	ABCB1	AC	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:AC	131769926
tacrolimus	rs2032582	ABCB1	CC	Dosage	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:CC	131769926
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs9923231:T	54688261
antidepressants, citalopram, escitalopram	rs11580409	ERICH3	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A|N06AB04|N06AB10	rs11580409:C	146570
ethanol	rs1799971	OPRM1	AG	Other	decreased	Dosage	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Other	decreased	Dosage	Healthy		V03AB16	rs1799971:GG	444899
cyclosporine	rs2032582	ABCB1	AC	Dosage	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2032582:AC	86666680
cyclosporine	rs2032582	ABCB1	CC	Dosage	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2032582:CC	86666680
tacrolimus	rs10211	CYP3A7	TT	Metabolism/PK	increased	LADME	Other:null		L04AD02	rs10211:TT	131769926
warfarin	rs9923231	VKORC1	C	Dosage, Efficacy	increased	Dosage	Healthy		B01AA03	rs9923231:C	54688261
warfarin	rs9923231	VKORC1	T	Dosage, Efficacy	increased	Efficacy_Response	Healthy		B01AA03	rs9923231:T	54688261
acetaminophen, tramadol	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Disease:C0522067		N02AX02|N02BE01	rs1799971:AA	1983
rituximab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs1801274:AA	No_match
methadone	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs3745274:T	10090
cotinine	rs2942857	UGT2B10	CC	Metabolism/PK	decreased	LADME	Disease:C0039338		No_ATC	rs2942857:CC	108114
fentanyl	rs6961071	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs6961071:GG	13653606
rituximab	rs396991	FCGR3A	AC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs396991:AC	No_match
rituximab	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs396991:CC	No_match
warfarin	rs2359612	VKORC1	G	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:G	54688261
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	AG	Efficacy	increased	Efficacy_Response	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:AG	2907
cyclophosphamide, doxorubicin, fec100, fluorouracil	rs13959	ALDH1A1	GG	Efficacy	increased	Efficacy_Response	Other:C1458155		L01AA01|L01BC02|L01DB01	rs13959:GG	2907
tacrolimus	rs1057868	POR	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CC	131769926
methadone	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs2032582:CC	10090
tocilizumab	rs396991	FCGR3A	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs396991:AA	No_match
carvedilol	rs1042714	ADRB2	GG	Efficacy	increased	Efficacy_Response	Disease:C0085605		C07AG02	rs1042714:GG	6322
fentanyl	rs13093031	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs13093031:GG	13653606
atorvastatin, lovastatin, simvastatin	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Disease:C0003850		C10AA01|C10AA02|C10AA05	rs776746:CC	60823
cotinine	rs2942857	UGT2B10	CC	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs2942857:CC	108114
clopidogrel	rs1045642	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0027051		B01AC04	rs1045642:A	13748464
cisplatin	rs11615	ERCC1	A	Efficacy	decreased	Efficacy_Response	Other:C0919267		L01XA01	rs11615:A	441203
warfarin	rs2884737	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs2884737:C	54688261
warfarin	rs7294	PRSS53, VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT	54688261
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:G	54688261
phenobarbital	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AA02	rs1045642:GG	71371485
tacrolimus	rs1800822	FMO3	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1800822:CC	131769926
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
fenofibrate	rs1417938	CRP	TT	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs1417938:TT	11350701
pravastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA03	rs4149056:CC	58746970
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0242339		C10AA03	rs4149056:CT	58746970
metformin	rs2076828	SLC22A3	G	Efficacy	decreased	Efficacy_Response	Healthy		A10BA02	rs2076828:G	155906370
fluoxetine	rs9361235	HTR1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361235:CC	1548968
fluoxetine	rs9361235	HTR1B	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB03	rs9361235:TT	1548968
n-desmethylclozapine(clozapine)	rs61750900	UGT2B10	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs61750900:T	135398737
warfarin	rs10517	NQO1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs10517:GG	54688261
fenofibrate	rs3091244	CRP	AG	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:AG	11350701
fenofibrate	rs3091244	CRP	GG	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:GG	11350701
pravastatin	rs35068180	MMP3	A/del	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA03	rs35068180:A/del	58746970
pravastatin	rs35068180	MMP3	AA	Efficacy	increased	Efficacy_Response	Disease:C1956346		C10AA03	rs35068180:AA	58746970
n-desmethylclozapine(clozapine)	rs2011425	UGT1A4	G	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs2011425:G	135398737
fenofibrate	rs3091244	CRP	GG	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:GG	11350701
fenofibrate	rs3091244	CRP	GT	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AB05	rs3091244:GT	11350701
fentanyl	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027651|Disease:C0030193		N02AB03	rs1128503:AA	13653606
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs2108622:T	54688261
clozapine	rs1126545	CYP2C18	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs1126545:T	131769989
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
simvastatin	rs4149056	SLCO1B1	C	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:C	14373154
desloratadine, mizolastine	rs2298805	FCER1A	AA	Efficacy	increased	Efficacy_Response	Disease:C0042109		R06AX25|R06AX27	rs2298805:AA	65906
atorvastatin	rs17161788	CYP3A5	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs17161788:TT	656846
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:G	37542
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs3917412	SELE	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01BC02|L01BC06|L01XA03	rs3917412:CC	135403648
atorvastatin	rs776746	CYP3A5	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs776746:CC	656846
opioids	rs2952768	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Other:C0030193|Postoperative		N02A	rs2952768:CC	No_match
hmg coa reductase inhibitors	rs11591147	PCSK9	T	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA	rs11591147:T	445127
imatinib	rs28371759	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs28371759:AG	6113
digoxin	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Disease:C0085605		C01AA05	rs2032582:CC	15478
capecitabine, fluorouracil, leucovorin, oxaliplatin	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01BC02|L01BC06|L01XA03	rs1801133:AA	135403648
platinum	rs17655	ERCC5	GG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs17655:GG	441203
elexacaftor / tezacaftor / ivacaftor, ivacaftor / tezacaftor	rs75389940	CFTR	AG	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02|R07AX31	rs75389940:AG	134587348
elexacaftor / tezacaftor / ivacaftor, ivacaftor / tezacaftor	rs75389940	CFTR	GG	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02|R07AX31	rs75389940:GG	134587348
carvedilol	rs12233719	UGT2B7	T	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	rs12233719:T	6322
bupropion, nicotine, varenicline	rs2036527	CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs2036527:AA	5310966
bupropion, nicotine, varenicline	rs2036527	CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs2036527:AG	5310966
bupropion, nicotine, varenicline	rs16969968	CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs16969968:AA	5310966
bupropion, nicotine, varenicline	rs16969968	CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N06AX12|N07BA01|N07BA03	rs16969968:AG	5310966
carvedilol	rs28365063	UGT2B7	G	Metabolism/PK	decreased	LADME	Disease:C0271093		C07AG02	rs28365063:G	6322
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs909530	FMO3	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs909530:CC	131769926
digoxin	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C0085605		C01AA05	rs2032582:AA	15478
digoxin	rs2032582	ABCB1	AT	Metabolism/PK	decreased	LADME	Disease:C0085605		C01AA05	rs2032582:AT	15478
tacrolimus	rs3814055	NR1I2	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs3814055:CT	131769926
tacrolimus	rs3814055	NR1I2	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs3814055:TT	131769926
lumacaftor	rs121909047	CFTR	AA	Efficacy	Indeterminado	Efficacy_Response	Healthy		R07AX30	rs121909047:AA	16678941
methadone	rs8094439	CDH2	AA	Efficacy	increased	Efficacy_Response	Healthy		N07BC02	rs8094439:AA	10090
pertussis vaccines	rs4986790	TLR4	AA	Efficacy	increased	Efficacy_Response	Healthy		J07AJ	rs4986790:AA	No_match
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT	131769926
methadone	rs17446819	CDH2	CC	Efficacy	increased	Efficacy_Response	Healthy		N07BC02	rs17446819:CC	10090
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
sorafenib	rs2231137	ABCG2	CT	Metabolism/PK	Indeterminado	LADME	Disease:C2239176		L01EX02	rs2231137:CT	67424139
nicotine	rs376817657	CYP2A6	CT	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs376817657:CT	936
nicotine	rs376817657	CYP2A6	TT	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs376817657:TT	936
sorafenib	rs2231142	ABCG2	GT	Metabolism/PK	Indeterminado	LADME	Disease:C2239176		L01EX02	rs2231142:GT	67424139
imatinib	rs683369	SLC22A1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC	6113
imatinib	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:GG	6113
simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CT	14373154
fentanyl	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1799971:GG	13653606
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
bilirubin	rs887829	UGT1A1	TT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs887829:TT	46931084
warfarin	rs1799853	CYP2C9	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1799853:CT	54688261
methotrexate	rs3758149	GGH	AA	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs3758149:AA	11329481
methotrexate	rs3758149	GGH	AG	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs3758149:AG	11329481
mercaptopurine	rs186364861	NUDT15	A	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs186364861:A	1268107
imiquimod	rs179008	TLR7	A	Efficacy	increased	Efficacy_Response	Disease:C0007117		D06BB10	rs179008:A	57469
mercaptopurine	rs116855232	NUDT15	T	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:T	1268107
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
methotrexate	rs11545077	GGH	CC	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545077:CC	11329481
methotrexate	rs11545077	GGH	CT	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545077:CT	11329481
warfarin	rs9923231	VKORC1	T	Dosage, Other	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
clonidine	rs5443	GNB3	CT	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs5443:CT	20255880
clonidine	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Disease:Liver_Cirrhosis		S01EA04	rs5443:TT	20255880
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
clozapine	rs61750900	UGT2B10	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs61750900:T	131769989
opioids	rs1277441	TAOK3	AG	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1277441:AG	No_match
opioids	rs1277441	TAOK3	GG	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs1277441:GG	No_match
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
opioids	rs795484	TAOK3	TT	Dosage	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02A	rs795484:TT	No_match
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
fentanyl	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1799971:GG	13653606
opioids	rs795484	TAOK3	CT	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs795484:CT	No_match
opioids	rs795484	TAOK3	TT	Dosage	increased	Dosage	Other:C0027651|Other:C0030193		N02A	rs795484:TT	No_match
fentanyl	rs1128503	ABCB1	AA	Dosage	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1128503:AA	13653606
tenofovir	rs3742106	ABCC4	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs3742106:AC	9574768
tenofovir	rs3742106	ABCC4	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs3742106:CC	9574768
vitamin b12 and folic acid	rs1801133	MTHFR	A	Efficacy	decreased	Efficacy_Response	Other:C0267988|Other:C0018839		B03B	rs1801133:A	135398658
methotrexate	rs1801133	MTHFR	AA	Toxicity, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Toxicity, Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1801133:AG	11329481
captopril	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs5186:AC	44146831
captopril	rs5186	AGTR1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		C09AA01	rs5186:CC	44146831
anthracyclines and related substances	rs1695	GSTP1	A	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01DB	rs1695:A	No_match
simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CC	14373154
simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA01	rs4149056:CT	14373154
daunorubicin	rs25678	CBR1	CC	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		L01DB02	rs25678:CC	11570269
silibinin	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:GG	1548994
ivacaftor	rs78655421	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs78655421:A	72722243
mercaptopurine	rs1142345	TPMT	CC	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs1142345:CC	1268107
citalopram	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Other:C0085762|Other:C0011581		N06AB04	rs4244285:AG	162180
bilirubin	rs1910167	SLCO1B1, SLCO1B3, SLCO1B7	C	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1910167:C	46931084
citalopram	rs4244285	CYP2C19	AG	Metabolism/PK	increased	LADME	Other:C0085762|Other:C0011581		N06AB04	rs4244285:AG	162180
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
atenolol	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs5443:CC	14211540
etanercept	rs2233945	PSORS1C1	C	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs2233945:C	No_match
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT	131769926
mercaptopurine	rs2274407	ABCC4	AA	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs2274407:AA	1268107
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT	64139
disulfiram	rs4290270	TPH2	AA	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs4290270:AA	101405
disulfiram	rs4290270	TPH2	AT	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs4290270:AT	101405
atenolol	rs11064426	GNB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs11064426:AA	14211540
enalapril	rs5522	NR3C2	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs5522:TT	5950
atenolol	rs2301339	GNB3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs2301339:GG	14211540
atenolol	rs5443	GNB3	CC	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs5443:CC	14211540
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:TT	1268107
atenolol	rs11064426	GNB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs11064426:AA	14211540
acenocoumarol	rs4086116	CYP2C9	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs4086116:T	54742534
atenolol	rs11064426	GNB3	AA	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs11064426:AA	14211540
etanercept	rs7574865	STAT4	T	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs7574865:T	No_match
atenolol	rs2301339	GNB3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs2301339:GG	14211540
methotrexate	rs11545076	GGH	AC	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545076:AC	11329481
methotrexate	rs11545076	GGH	CC	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs11545076:CC	11329481
digoxin	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		C01AA05	rs1128503:AG	15478
allopurinol	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Disease:C0018099		M04AA01	rs2231142:T	168354693
pravastatin	rs4149015	SLCO1B1	AG	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Healthy		C10AA03	rs4149015:AG	58746970
digoxin	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:GG	15478
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
digoxin	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:CC	15478
ivacaftor, tezacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02|R07AX31	rs75527207:A	72722243
atorvastatin, hmg coa reductase inhibitors, pravastatin, simvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Other:C0020473		C10AA|C10AA01|C10AA03|C10AA05	rs4149056:CC	60823
atorvastatin, hmg coa reductase inhibitors, pravastatin, simvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Other:C0020473		C10AA|C10AA01|C10AA03|C10AA05	rs4149056:CT	60823
fenofibrate	rs2230806	ABCA1	CT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs2230806:CT	11350701
sertraline	rs6313	HTR2A	AA	Dosage	increased	Dosage	Other:C0235876|Other:C0003469		N06AB06	rs6313:AA	18642483
sertraline	rs6313	HTR2A	AG	Dosage	increased	Dosage	Other:C0235876|Other:C0003469		N06AB06	rs6313:AG	18642483
fenofibrate	rs2230808	ABCA1	CC	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs2230808:CC	11350701
platinum compounds	rs79419059	NUP107	C	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01XA	rs79419059:C	23939
fenofibrate	rs2230806	ABCA1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs2230806:TT	11350701
venlafaxine	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs4680:AA	9795857
venlafaxine	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Disease:C0003469		N06AX16	rs4680:AG	9795857
warfarin	rs1800566	NQO1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs1800566:AA	54688261
ketoprofen	rs1799853	CYP2C9	CC	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		M02AA10	rs1799853:CC	667550
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
etanercept	rs1800629	TNF	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:AG	No_match
etanercept	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:GG	No_match
antidepressants	rs1516338	CHL1	TT	Efficacy	increased	Efficacy_Response	Disease:C0005586|Disease:C0011581|Disease:C0011581		N06A	rs1516338:TT	No_match
adalimumab	rs1267067	TANK	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1267067:CC	107706
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
tacrolimus	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs15524:AA	131769926
adalimumab	rs25648	VEGFA	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs25648:T	107706
carvedilol	rs1801253	ADRB1	GG	Dosage	increased	Dosage	Disease:C0085605		C07AG02	rs1801253:GG	6322
tacrolimus	rs4646450	CYP3A5	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs4646450:GG	131769926
infliximab	rs361525	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs361525:GG	No_match
methotrexate	rs11045879	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs11045879:CC	11329481
methotrexate	rs11045879	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs11045879:CT	11329481
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
tacrolimus	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs4646437:GG	131769926
hydrochlorothiazide	rs10995	VASP	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs10995:AG	2904
hydrochlorothiazide	rs10995	VASP	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs10995:GG	2904
adalimumab	rs2230926	TNFAIP3	T	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs2230926:T	107706
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
methotrexate	rs2838958	SLC19A1	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2838958:AA	11329481
methotrexate	rs2838958	SLC19A1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2838958:AG	11329481
simvastatin, simvastatin acid	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Disease:C0020443		C10AA01	rs4149056:C	25221209
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
ivacaftor	rs121908757	CFTR	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs121908757:C	72722243
methotrexate	rs3788200	SLC19A1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3788200:AG	11329481
methotrexate	rs3788200	SLC19A1	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3788200:GG	11329481
lithium	rs2314339	NR1D1, THRA	T	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs2314339:T	11125
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Disease:C1861172		B01AA03	rs1057910:C	54688261
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
atenolol	rs2301339	GNB3	GG	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03	rs2301339:GG	14211540
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs13181	ERCC2	GG	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs13181:GG	9887054
acenocoumarol	rs429358	APOE	C	Dosage	decreased	Dosage	Disease:C1861172		B01AA07	rs429358:C	54742534
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
warfarin	rs8050894	VKORC1	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:CG	54688261
warfarin	rs8050894	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:GG	54688261
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC	54688261
warfarin	rs2359612	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AA	54688261
warfarin	rs2359612	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:AG	54688261
atazanavir	rs73208473	SORCS2	A	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AE08	rs73208473:A	118753185
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT	5282455
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs11615	ERCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs11615:GG	9887054
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
bevacizumab, capecitabine, cisplatin, docetaxel, epirubicin, oxaliplatin, trastuzumab	rs1801133	MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD02|L01DB03|L01FG01|L01XA01|L01XA03	rs1801133:AA	9887054
methadone	rs806368	CNR1	CT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs806368:CT	10090
methadone	rs806368	CNR1	TT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs806368:TT	10090
methadone	rs1386493	TPH2	GG	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs1386493:GG	10090
bumetanide, furosemide, torasemide	rs5065	NPPA-AS1	GG	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5065:GG	41781
morphine	rs7439366	UGT2B7	CT	Metabolism/PK	decreased	LADME	Other:C0027651|Other:C0030193		N02AA01	rs7439366:CT	5284371
morphine	rs7439366	UGT2B7	TT	Metabolism/PK	decreased	LADME	Other:C0027651|Other:C0030193		N02AA01	rs7439366:TT	5284371
atorvastatin, simvastatin	rs20455	KIF6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01|C10AA05	rs20455:GG	60823
efavirenz	rs35303484	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs35303484:GG	64139
methadone	rs16974799	CYP2B6	CT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs16974799:CT	10090
methadone	rs2229205	OPRL1	CT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs2229205:CT	10090
rosuvastatin	rs20455	KIF6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA07	rs20455:GG	5282455
adrenergics, inhalants	rs34548976	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03A	rs34548976:T	No_match
topiramate	rs2832407	GRIK1	AA	Metabolism/PK	increased	LADME	Disease:C0221016		N03AX11	rs2832407:AA	2723872
topiramate	rs2832407	GRIK1	AC	Metabolism/PK	increased	LADME	Disease:C0221016		N03AX11	rs2832407:AC	2723872
bumetanide, furosemide, torasemide	rs4961	ADD1	TT	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs4961:TT	41781
cisplatin, gemcitabine	rs2072671	CDA	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs2072671:AA	5460033
topiramate	rs2832407	GRIK1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0221016		N03AX11	rs2832407:AA	2723872
topiramate	rs2832407	GRIK1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0221016		N03AX11	rs2832407:AC	2723872
atorvastatin	rs20455	KIF6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA05	rs20455:GG	656846
cisplatin, gemcitabine	rs11615	ERCC1	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs11615:AA	5460033
bumetanide, furosemide, torasemide	rs1529927	SLC12A3	CC	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs1529927:CC	41781
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
fluvastatin	rs1922242	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA04	rs1922242:AA	131750727
gliclazide	rs2237897	KCNQ1	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs2237897:CT	169502072
gliclazide	rs2237897	KCNQ1	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs2237897:TT	169502072
warfarin	rs1060467	CYP4F11	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs1060467:G	54688261
carboplatin, taxanes	rs9369421	VEGFA	CC	Efficacy	increased	Efficacy_Response	Healthy		L01CD|L01XA02	rs9369421:CC	10339178
carboplatin, taxanes	rs9369421	VEGFA	CT	Efficacy	increased	Efficacy_Response	Healthy		L01CD|L01XA02	rs9369421:CT	10339178
debrisoquine	rs1080985	CYP2D6	C	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1080985:C	2966
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs35599367:AA	131769926
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs35599367:AG	131769926
efavirenz	rs28399433	CYP2A6	AC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399433:AC	64139
fluvastatin	rs4783961	CETP	GG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA04	rs4783961:GG	131750727
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs9282564	ABCB1	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs9282564:CC	131769926
tacrolimus	rs9282564	ABCB1	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs9282564:CT	131769926
methotrexate	rs1801394	MTRR	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801394:AG	11329481
methotrexate	rs1801394	MTRR	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801394:GG	11329481
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
tenofovir	rs12979860	IFNL3, IFNL4	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AF07	rs12979860:C	9574768
glucocorticoids	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		R03BA	rs1128503:GG	No_match
metformin	rs622342	SLC22A1	A	Efficacy	increased	Efficacy_Response	Efficacy:C0011849		A10BA02	rs622342:A	155906370
glucocorticoids	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		R03BA	rs1045642:GG	No_match
hydroxyurea	rs1427407	BCL11A	T	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs1427407:T	10220327
hydroxyurea	rs766432	BCL11A	C	Efficacy	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs766432:C	10220327
warfarin	rs2860905	CYP2C9	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2860905:A	54688261
fentanyl	rs7439366	UGT2B7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs7439366:TT	13653606
warfarin	rs1057910	CYP2C9	AC	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
warfarin	rs1057910	CYP2C9	CC	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	rs1057910:CC	54688261
tiotropium	rs1042713	ADRB2	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		A07DA02	rs1042713:AA	12723754
lumefantrine	rs8187710	ABCC2	AA	Metabolism/PK	increased	LADME	Other:C0024530		P01BF01	rs8187710:AA	6450800
elexacaftor / tezacaftor / ivacaftor	rs80034486	CFTR	G	Efficacy	increased	Efficacy_Response	Other:C0156318		R07AX02	rs80034486:G	134587348
atorvastatin	rs7412	APOE	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs7412:CT	656846
methadone	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1045642:AG	10090
bumetanide, furosemide, torasemide	rs5065	NPPA-AS1	GG	Efficacy	increased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5065:GG	41781
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
clopidogrel	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		B01AC04	rs1045642:GG	13748464
bumetanide, furosemide, torasemide	rs5443	GNB3	TT	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5443:TT	41781
morphine	rs7439366	UGT2B7	CT	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs7439366:CT	5284371
morphine	rs7439366	UGT2B7	TT	Efficacy	decreased	Efficacy_Response	Other:C0027651|Other:C0030193		N02AA01	rs7439366:TT	5284371
bumetanide, furosemide, torasemide	rs5063	NPPA-AS1	TT	Efficacy	decreased	Efficacy_Response	Healthy		C03CA01|C03CA02|C03CA04	rs5063:TT	41781
valproic acid	rs2070959	UGT1A6	AG	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs2070959:AG	134459
valproic acid	rs2070959	UGT1A6	GG	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs2070959:GG	134459
valproic acid	rs1105879	UGT1A6	AC	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs1105879:AC	134459
valproic acid	rs1105879	UGT1A6	CC	Metabolism/PK	decreased	LADME	Other:C0014544		N03AG01	rs1105879:CC	134459
clozapine	rs6314	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH02	rs6314:AA	131769989
clozapine	rs6314	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH02	rs6314:AG	131769989
fluvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:TT	131750727
pravastatin	rs4341	ACE	CG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs4341:CG	58746970
pravastatin	rs4341	ACE	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs4341:GG	58746970
pravastatin	rs328	LPL	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs328:GG	58746970
lovastatin	rs708272	CETP	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs708272:AG	40474546
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
fentanyl	rs10028494	UGT2B7	CC	Efficacy	decreased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs10028494:CC	13653606
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Disease:C0023449		L04AX03	rs1801133:AA	11329481
nicotine	rs1051730	CHRNA3	A	Metabolism/PK	increased	Dosage	Healthy		N07BA01	rs1051730:A	936
fluvastatin	rs1800588	LIPC	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs1800588:CC	131750727
fluvastatin	rs1800588	LIPC	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs1800588:CT	131750727
clozapine	rs2472297	CYP1A1	T	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs2472297:T	131769989
methylphenidate	rs114119971	CES1	CG	Dosage	decreased	Dosage	Other:C1263846		N06BA04	rs114119971:CG	154100
simvastatin	rs1800588	LIPC	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs1800588:CT	14373154
cisplatin, fluorouracil, oxaliplatin	rs25648	VEGFA	CT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA01|L01XA03	rs25648:CT	9887054
cisplatin, fluorouracil, oxaliplatin	rs25648	VEGFA	TT	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA01|L01XA03	rs25648:TT	9887054
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs2108622:T	54688261
atorvastatin	rs2032582	ABCB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs2032582:CC	656846
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
atorvastatin	rs4149036	SLCO1B1	AC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs4149036:AC	656846
atorvastatin	rs4149036	SLCO1B1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs4149036:CC	656846
atorvastatin	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs776746:CC	656846
atorvastatin	rs776746	CYP3A5	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA05	rs776746:CT	656846
pertussis vaccines	rs2770150	TLR4	GG	Efficacy	decreased	Efficacy_Response	Healthy		J07AJ	rs2770150:GG	No_match
cisplatin, fluorouracil, mitoxantrone	rs6025211	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01DB07|L01XA01	rs6025211:CC	5460033
cisplatin, fluorouracil, mitoxantrone	rs6025211	__INTRONIC__	TT	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01DB07|L01XA01	rs6025211:TT	5460033
tacrolimus	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027726		L04AD02	rs2032582:AA	131769926
tacrolimus	rs2032582	ABCB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0027726		L04AD02	rs2032582:TT	131769926
lovastatin	rs2291073	SLCO1B1	GT	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs2291073:GT	40474546
lovastatin	rs2291073	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs2291073:TT	40474546
tacrolimus	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0027726		L04AD02	rs1128503:AA	131769926
catecholamines, metformin	rs8187725	SLC22A3	T	Other, Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs8187725:T	4091
lovastatin	rs688	LDLR	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs688:TT	40474546
amlodipine	rs2239050	CACNA1C	GG	Efficacy	increased	Efficacy_Response	Other:C0020538		C08CA01	rs2239050:GG	72734364
fluvastatin	rs4986910	CYP3A4	AG	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4986910:AG	131750727
naltrexone	rs698	ADH1C	C	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB04	rs698:C	5360515
naltrexone	rs2066702	ADH1B	A	Efficacy	decreased	Efficacy_Response	Other:C0085762		N07BB04	rs2066702:A	5360515
lovastatin	rs5925	LDLR	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA02	rs5925:CC	40474546
cisplatin, fluorouracil, mitoxantrone	rs9679162	GALNT14	TT	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01DB07|L01XA01	rs9679162:TT	5460033
naltrexone	rs671	ALDH2	G	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB04	rs671:G	5360515
varenicline	rs8109525	CYP2B6	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs8109525:AG	6918678
varenicline	rs8109525	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs8109525:GG	6918678
tacrolimus	rs1128503	ABCB1	AG	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1128503:AG	131769926
warfarin	rs7089580	CYP2C9	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7089580:T	54688261
clopidogrel	rs2046934	P2RY12	AA	Efficacy	increased	Efficacy_Response	Disease:C0010068		B01AC04	rs2046934:AA	13748464
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:null		L04AD02	rs776746:CC	131769926
tacrolimus	rs1045642	ABCB1	AA	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1045642:AA	131769926
warfarin	rs3814637	CYP2C19	C	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs3814637:C	54688261
tacrolimus	rs2032582	ABCB1	AA	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2032582:AA	131769926
warfarin	rs4917639	CYP2C9	A	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs4917639:A	54688261
warfarin	rs2359612	VKORC1	A	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs2359612:A	54688261
tacrolimus	rs2257401	CYP3A7	CG	Metabolism/PK	decreased	LADME	Other:null		L04AD02	rs2257401:CG	131769926
tacrolimus	rs2257401	CYP3A7	GG	Metabolism/PK	decreased	LADME	Other:null		L04AD02	rs2257401:GG	131769926
clopidogrel	rs3732759	P2RY12	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010068		B01AC04	rs3732759:GG	13748464
antibiotics, esomeprazole	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0079487		A02BC05|S01AA	rs1045642:AA	9568614
carfilzomib, dexamethasone, lenalidomide	rs833061	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs833061:CT	216326
carfilzomib, dexamethasone, lenalidomide	rs833061	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs833061:TT	216326
dolutegravir	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AJ03	rs2231142:TT	118753073
quetiapine	rs6280	DRD3	TT	Metabolism/PK	increased	LADME	Healthy		N05AH04	rs6280:TT	118753024
clopidogrel	rs1128503	ABCB1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs1128503:AA	13748464
clopidogrel	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs1128503:AG	13748464
cisplatin, fluorouracil	rs9679162	GALNT14	GG	Efficacy	increased	Efficacy_Response	Other:C0023885		L01BC02|L01XA01	rs9679162:GG	5460033
carfilzomib, dexamethasone, lenalidomide	rs2305948	KDR	CT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs2305948:CT	216326
carfilzomib, dexamethasone, lenalidomide	rs2305948	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs2305948:TT	216326
carfilzomib, dexamethasone, lenalidomide	rs1870377	KDR	AT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs1870377:AT	216326
carfilzomib, dexamethasone, lenalidomide	rs1870377	KDR	TT	Efficacy	increased	Efficacy_Response	Disease:Multiple_Myeloma		L01XG02|L04AX04|S02BA06	rs1870377:TT	216326
morphine	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0023885|Other:C0030193		N02AA01	rs1799971:AG	5284371
morphine	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0023885|Other:C0030193		N02AA01	rs1799971:GG	5284371
sorafenib	rs9679162	GALNT14	GG	Efficacy	increased	Efficacy_Response	Other:C0019372|Other:C0023885		L01EX02	rs9679162:GG	67424139
mycophenolic acid	rs2273697	ABCC2	A	Metabolism/PK	decreased	LADME	Healthy		L04AA06	rs2273697:A	5281078
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Other:Liver_transplantation		L04AD02	rs776746:CC	131769926
mycophenolic acid	rs717620	ABCC2	T	Metabolism/PK	Indeterminado	LADME	Other:Kidney_Transplantation		L04AA06	rs717620:T	5281078
fentanyl	rs7583431	ATF2	A	Efficacy	increased	Efficacy_Response	Disease:C0030193|Postoperative		N02AB03	rs7583431:A	13653606
mycophenolic acid	rs717620	ABCC2	T	Metabolism/PK	Indeterminado	LADME	Other:Kidney_Transplantation		L04AA06	rs717620:T	5281078
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
tacrolimus	rs3814055	NR1I2	CT	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3814055:CT	131769926
tacrolimus	rs3814055	NR1I2	TT	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs3814055:TT	131769926
aflibercept, ranibizumab	rs2110166	ANO2	TT	Efficacy	increased	Efficacy_Response	Other:C0024437		S01LA04|S01LA05	rs2110166:TT	No_match
tacrolimus	rs3814055	NR1I2	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3814055:CT	131769926
tacrolimus	rs3814055	NR1I2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs3814055:TT	131769926
venlafaxine	rs2242446	SLC6A2	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX16	rs2242446:CC	9795857
mycophenolic acid	rs2273697	ABCC2	A	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AA06	rs2273697:A	5281078
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	C	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10|L03AB11	rs12979860:C	37542
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs1799724:TT	No_match
donepezil, galantamine, rivastigmine	rs6494223	CHRNA7	T	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs6494223:T	3152
adalimumab	rs1801274	FCGR2A	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1801274:A	107706
fluorouracil	rs2612091	ENOSF1	CC	Efficacy	increased	Efficacy_Response	Other:C0026640		L01BC02	rs2612091:CC	5790
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CT	25221209
dobutamine	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Healthy		C01CA07	rs1801253:CC	208850
daclatasvir, sofosbuvir	rs7728773	HINT1	CT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP07|J05AP08	rs7728773:CT	25154714
daclatasvir, sofosbuvir	rs7728773	HINT1	TT	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP07|J05AP08	rs7728773:TT	25154714
mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:TT	1268107
adalimumab, etanercept, infliximab	rs1800795	IL6	G	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800795:G	No_match
lithium	rs78015114	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs78015114:T	11125
buprenorphine	rs678849	OPRD1	CC	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs678849:CC	11274356
carbamazepine, phenobarbital, phenytoin, valproic acid	rs17183814	SCN2A	A	Efficacy	Indeterminado	Efficacy_Response	Healthy		N03AA02|N03AB02|N03AF01|N03AG01	rs17183814:A	1775
quetiapine	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		N05AH04	rs776746:CC	118753024
lithium	rs79663003	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs79663003:T	11125
apremilast	rs1203844	CYP3A4, TMEM130	C	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs1203844:C	67116
apremilast	rs35599367	CYP3A4	A	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs35599367:A	67116
atorvastatin	rs9370867	MYLIP	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs9370867:AA	656846
lithium	rs75222709	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs75222709:T	11125
lithium	rs74795342	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs74795342:G	11125
apremilast	rs295943	PDE4D	T	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs295943:T	67116
methylphenidate	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:CG	154100
methylphenidate	rs1800544	ADRA2A	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs1800544:GG	154100
simvastatin	rs12487736	SCAP	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs12487736:TT	14373154
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	rs1057910:C	54688261
caffeine	rs2069514	CYP1A2	AA	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	rs2069514:AA	936
caffeine	rs2069514	CYP1A2	AG	Other, Metabolism/PK	decreased	LADME	Healthy		N06BC01	rs2069514:AG	936
apremilast	rs1063192	CDKN2B, CDKN2B-AS1	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs1063192:G	67116
pravastatin	rs1800588	LIPC	CT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA03	rs1800588:CT	58746970
pravastatin	rs1800588	LIPC	TT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA03	rs1800588:TT	58746970
warfarin	rs1799853	CYP2C9	T	Dosage	decreased	Dosage	Other:total_knee_or_hip_arthroplasty		B01AA03	rs1799853:T	54688261
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
losartan	rs5186	AGTR1	AC	Efficacy	increased	Efficacy_Response	Healthy		C09CA01	rs5186:AC	11751549
losartan	rs5186	AGTR1	CC	Efficacy	increased	Efficacy_Response	Healthy		C09CA01	rs5186:CC	11751549
dextromethadone	rs2307424	NR1I3	GG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		N07BC02	rs2307424:GG	No_match
olanzapine	rs6314	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs6314:GG	74603552
simvastatin	rs1128503	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs1128503:GG	14373154
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Toxicity	increased	Adverse_Event	Disease:C0021390		L01BB02|L04AX01	rs116855232:CT	5778
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
dextromethadone	rs3003596	NR1I3	GG	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		N07BC02	rs3003596:GG	No_match
bevacizumab	rs1061170	CFH	CT	Dosage	increased	Dosage	Disease:C0024437		L01FG01	rs1061170:CT	No_match
methadone	rs678849	OPRD1	CC	Efficacy	increased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs678849:CC	10090
azathioprine, mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0021390		L01BB02|L04AX01	rs116855232:CT	5778
bevacizumab	rs10490924	ARMS2	GT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01	rs10490924:GT	No_match
bevacizumab	rs10490924	ARMS2	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01	rs10490924:TT	No_match
pravastatin	rs4149056	SLCO1B1	C	Metabolism/PK	decreased	LADME	Healthy		C10AA03	rs4149056:C	58746970
simvastatin	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020443		C10AA01	rs2032582:CC	14373154
warfarin	rs1800566	NQO1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AA	54688261
warfarin	rs1800566	NQO1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs1800566:AG	54688261
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT	656846
atorvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:CT	656846
deferasirox	rs2273697	ABCC2	AG	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2273697:AG	214348
budesonide	rs2392165	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA02	rs2392165:AG	5281004
budesonide	rs2392165	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Other:C0004096		R03BA02	rs2392165:GG	5281004
thioridazine	rs1080985	CYP2D6	CC	Metabolism/PK	decreased	LADME	Healthy		N05AC02	rs1080985:CC	5452
thioridazine	rs1080985	CYP2D6	CG	Metabolism/PK	decreased	LADME	Healthy		N05AC02	rs1080985:CG	5452
pravastatin	rs2306283	SLCO1B1	G	Metabolism/PK	decreased	LADME	Healthy		C10AA03	rs2306283:G	58746970
deferasirox	rs2470890	CYP1A2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2470890:CC	214348
deferasirox	rs2470890	CYP1A2	CT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2470890:CT	214348
mercaptopurine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:CT	1268107
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:TT	1268107
deferasirox	rs762551	CYP1A2	AC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs762551:AC	214348
deferasirox	rs762551	CYP1A2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs762551:CC	214348
atorvastatin	rs2273697	ABCC2	AG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs2273697:AG	656846
olanzapine	rs1076560	DRD2	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs1076560:AA	74603552
olanzapine	rs1076560	DRD2	AC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs1076560:AC	74603552
deferasirox	rs2606345	CYP1A1	AC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:AC	214348
deferasirox	rs2606345	CYP1A1	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2606345:CC	214348
deferasirox	rs887829	UGT1A1	TT	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs887829:TT	214348
pravastatin	rs2296651	SLC10A1	A	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs2296651:A	58746970
adalimumab, etanercept, infliximab	rs1801274	FCGR2A	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04	rs1801274:GG	No_match
capecitabine	rs1801133	MTHFR	GG	Metabolism/PK	increased	LADME	Disease:C0027651		L01BC06	rs1801133:GG	11809635
daclatasvir, sofosbuvir	rs12979860	IFNL3	CC	Efficacy	increased	Efficacy_Response	Other:C0019372		J05AP07|J05AP08	rs12979860:CC	25154714
buprenorphine	rs6973474	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs6973474:T	11274356
buprenorphine	rs13169373	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs13169373:T	11274356
haloperidol	rs3892097	CYP2D6	CC	Efficacy	decreased	Efficacy_Response	Disease:C0033936|Disease:C0085762|Disease:C0221016		N05AD01	rs3892097:CC	9828
nevirapine	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Healthy		J05AG01	rs28399499:C	15979285
imatinib	rs628031	SLC22A1	GG	Metabolism/PK	decreased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs628031:GG	6113
nicotine	rs16969968	CHRNA5	A	Dosage	increased	Dosage	Disease:C0039338		N07BA01	rs16969968:A	936
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
buprenorphine	rs62368105	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs62368105:G	11274356
buprenorphine	rs11782370	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs11782370:T	11274356
adalimumab, etanercept, infliximab	rs396991	FCGR3A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01|L04AB02|L04AB04	rs396991:AA	No_match
buprenorphine	rs7205113	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs7205113:T	11274356
etanercept	rs1800896	IL10	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800896:CC	No_match
buprenorphine	rs756770	ADAMTSL2	A	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs756770:A	11274356
dextromethadone	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		N07BC02	rs2032582:AA	No_match
etanercept	rs1800471	TGFB1	CG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800471:CG	No_match
atorvastatin	rs2306283	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:AG	656846
atorvastatin	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:GG	656846
efavirenz, non-nucleoside reverse transcriptase inhibitors	rs3745274	CYP2B6	T	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease		J05AG|J05AG03	rs3745274:T	64139
efavirenz	rs2279345	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CC	64139
efavirenz	rs2279345	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:CT	64139
efavirenz	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT	64139
methotrexate	rs4149056	SLCO1B1	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs4149056:TT	11329481
xk469	rs10931910	AOX1	G	Metabolism/PK	decreased	LADME	Disease:C0027651		No_ATC	rs10931910:G	No_match
simvastatin	rs662	PON1	CC	Efficacy	increased	Efficacy_Response	Disease:C0010068		C10AA01	rs662:CC	14373154
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT	64139
mercaptopurine	rs116855232	NUDT15	T	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs116855232:T	1268107
etanercept	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:GG	No_match
mercaptopurine	rs1142345	TPMT	CT	Dosage	decreased	Dosage	Disease:C0023449		L01BB02	rs1142345:CT	1268107
nevirapine	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Healthy		J05AG01	rs3745274:T	15979285
bucindolol	rs1801253	ADRB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0085605		No_ATC	rs1801253:CC	51045
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
tacrolimus	rs4986907	CYP3A4	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs4986907:CT	131769926
nevirapine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
phenprocoumon	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA04	rs9923231:CC	91987769
warfarin	rs2189784	CYP4F2	AG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2189784:AG	54688261
warfarin	rs2189784	CYP4F2	GG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2189784:GG	54688261
phenprocoumon	rs1051740	EPHX1	CC	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA04	rs1051740:CC	91987769
aspirin, diclofenac, ibuprofen, indomethacin, ketorolac, naproxen	rs1800629	TNF	A	Efficacy	decreased	Efficacy_Response	Other:C0338480		M02AA12|M02AA13|S01BC01|S01BC03|S01BC05	rs1800629:A	2244
phenprocoumon	rs1799808	PROC	CC	Dosage, Metabolism/PK	increased	Dosage	Healthy		B01AA04	rs1799808:CC	91987769
infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs1800629:GG	No_match
imatinib	rs1050152	SLC22A4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0238198		L01EA01	rs1050152:TT	6113
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9923231:TT	54688261
atorvastatin	rs1800629	TNF	AA	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1800629:AA	656846
atorvastatin	rs1800629	TNF	AG	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs1800629:AG	656846
imatinib	rs2631367	SLC22A5	CG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631367:CG	6113
imatinib	rs2631367	SLC22A5	GG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631367:GG	6113
imatinib	rs2631372	SLC22A5	CG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631372:CG	6113
imatinib	rs2631372	SLC22A5	GG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs2631372:GG	6113
metformin	rs784888	SP1	G	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs784888:G	155906370
etanercept	rs1799724	TNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1799724:CT	No_match
etanercept	rs1799724	TNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1799724:TT	No_match
warfarin	rs2260863	EPHX1	CG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2260863:CG	54688261
warfarin	rs7412	APOE	CC	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs7412:CC	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
cyclophosphamide	rs2279343	CYP2B6	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	rs2279343:AG	9554282
cyclophosphamide	rs2279343	CYP2B6	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024299		L01AA01	rs2279343:GG	9554282
warfarin	rs28371759	CYP3A4	AA	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs28371759:AA	54688261
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs1045642:AA	13748464
warfarin	rs2069514	CYP1A2	GG	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2069514:GG	54688261
imatinib	rs9561765	ABCC4	AG	Efficacy	increased	Efficacy_Response	Disease:C0238198		L01EA01	rs9561765:AG	6113
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC	54688261
atorvastatin	rs6280	DRD3	TT	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs6280:TT	656846
warfarin	rs1143671	SLC15A2	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1143671:TT	54688261
atorvastatin	rs1801133	MTHFR	AA	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs1801133:AA	656846
atorvastatin	rs1801133	MTHFR	AG	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs1801133:AG	656846
warfarin	rs2260863	EPHX1	CC	Dosage	decreased	Dosage	Other:C0004238		B01AA03	rs2260863:CC	54688261
ritonavir	rs1523130	NR1I2	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs1523130:CC	71749331
ritonavir	rs1523130	NR1I2	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs1523130:CT	71749331
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
l-tryptophan	rs316019	SLC22A2	CC	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs316019:CC	172407874
warfarin	rs9923231	VKORC1	AA	Dosage	increased	Dosage	Other:C0004238		B01AA03	rs9923231:AA	54688261
phenprocoumon	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA04	rs9934438:A	91987769
ritonavir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CC	71749331
ritonavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE03	rs4149056:CT	71749331
ritonavir	rs2032582	ABCB1	AC	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs2032582:AC	71749331
ritonavir	rs2032582	ABCB1	CC	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs2032582:CC	71749331
erenumab	rs13386048	RAMP1	A	Efficacy	decreased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs13386048:A	No_match
adalimumab, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		L04AB02|L04AB04	rs1800629:GG	No_match
erlotinib	rs2472304	CYP1A2	AA	Metabolism/PK	increased	LADME	Healthy		L01EB02	rs2472304:AA	176870
erlotinib	rs2472304	CYP1A2	AG	Metabolism/PK	increased	LADME	Healthy		L01EB02	rs2472304:AG	176870
sirolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1057868:CT	5284616
sirolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1057868:TT	5284616
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:C0004238		B01AA03	rs1057910:AC	54688261
olanzapine	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs6265:CC	74603552
ritonavir	rs6785049	NR1I2	AA	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs6785049:AA	71749331
ritonavir	rs6785049	NR1I2	AG	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AE03	rs6785049:AG	71749331
erenumab	rs6431564	RAMP1	G	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs6431564:G	No_match
infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs1800629:GG	No_match
losartan	rs1529909	SLC22A12	CC	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs1529909:CC	11751549
losartan	rs1529909	SLC22A12	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs1529909:CT	11751549
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
erenumab	rs12465864	RAMP1	G	Efficacy	decreased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs12465864:G	No_match
adalimumab, etanercept, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:GG	No_match
losartan	rs3825016	SLC22A12	CT	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs3825016:CT	11751549
losartan	rs3825016	SLC22A12	TT	Efficacy	decreased	Efficacy_Response	Disease:C0020538|Disease:C0740394		C09CA01	rs3825016:TT	11751549
ethanol	rs1799971	OPRM1	AG	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Metabolism/PK	increased	LADME	Healthy		V03AB16	rs1799971:GG	444899
adalimumab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB04	rs1800629:GG	107706
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
sirolimus	rs1800896	IL10	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1800896:CC	5284616
cyclosporine	rs9282564	ABCB1	CT	Toxicity, Metabolism/PK	increased	LADME	Other:Heart_transplantation		L04AD01	rs9282564:CT	86666680
cladribine, cytarabine	rs1042919	RRM1	AT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1042919:AT	6253
cladribine, cytarabine	rs1265138	RRM2B	AA	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1265138:AA	6253
fluorouracil	rs1801265	DPYD	AA	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BC02	rs1801265:AA	5790
cladribine, cytarabine	rs2898950	RRM1	AC	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs2898950:AC	6253
cladribine, cytarabine	rs2898950	RRM1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs2898950:CC	6253
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs12979860:CC	71306834
bupropion	rs2279343	CYP2B6	AA	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12	rs2279343:AA	446
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs8099917:TT	71306834
cladribine, cytarabine	rs1561876	RRM1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1561876:GG	6253
cotinine	rs57064725	PSMA4	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs57064725:A	108114
methotrexate	rs16853826	ATIC	GG	Toxicity	increased	Adverse_Event	Disease:C0003873		L04AX03	rs16853826:GG	11329481
methotrexate	rs35592	ABCC1	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs35592:TT	11329481
cotinine	rs16969968	CHRNA5	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs16969968:A	108114
infliximab	rs20575	TNFRSF10A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB02	rs20575:CC	No_match
cladribine, cytarabine	rs1130609	RRM2	GT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1130609:GT	6253
cladribine, cytarabine	rs1130609	RRM2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs1130609:TT	6253
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs9939609	FTO	AA	Efficacy	decreased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB04|L03AB05	rs9939609:AA	71306834
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs9939609	FTO	AT	Efficacy	decreased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB04|L03AB05	rs9939609:AT	71306834
cotinine	rs77107237	__INTRONIC__	G	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs77107237:G	108114
clozapine	rs742105	DTNBP1	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs742105:CT	131769989
clozapine	rs742105	DTNBP1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs742105:TT	131769989
cladribine, cytarabine	rs5030743	RRM2	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs5030743:CG	6253
cladribine, cytarabine	rs5030743	RRM2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Myeloid|Acute		L01BC01|L04AA40	rs5030743:GG	6253
cotinine	rs10851907	CHRNB4	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs10851907:A	108114
sirolimus	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1045642:AA	5284616
sirolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		No_ATC	rs1045642:AG	5284616
warfarin	rs7311358	SLCO1B3	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs7311358:AA	54688261
warfarin	rs1143672	SLC15A2	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs1143672:AA	54688261
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs12979860:CC	71306834
warfarin	rs4149117	SLCO1B3	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4149117:GG	54688261
etanercept	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01	rs1800629:GG	No_match
cotinine	rs7170068	CHRNA3	A	Metabolism/PK	increased	LADME	Disease:C0039338		No_ATC	rs7170068:A	108114
sunitinib	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1045642:AA	11221549
warfarin	rs2108622	CYP4F2	CC	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA03	rs2108622:CC	54688261
"""interferon alfa-2a, recombinant"", ""interferon alfa-2b, recombinant"", ""ribavirin"""	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB04|L03AB05	rs8099917:TT	71306834
flupenthixol	rs230504	NFKB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs230504:CT	53627486
flupenthixol	rs230504	NFKB1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs230504:TT	53627486
montelukast	rs12422149	SLCO2B1	AG	Efficacy, Metabolism/PK	decreased	Efficacy_Response	Disease:C0004096		R03DC03	rs12422149:AG	122021
deferasirox	rs927650	CYP24A1	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs927650:CT	214348
deferasirox	rs927650	CYP24A1	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs927650:TT	214348
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
deferasirox	rs2585428	CYP24A1	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2585428:CT	214348
deferasirox	rs2585428	CYP24A1	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2585428:TT	214348
flupenthixol	rs3774959	NFKB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs3774959:AG	53627486
antidepressants	rs10879346	TPH2	C	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs10879346:C	No_match
methotrexate polyglutamate	rs4731448	IMPDH1	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs4731448:GG	126941
carboplatin, cisplatin	rs3740556	EIF3A	AA	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs3740556:AA	10339178
carboplatin, cisplatin	rs3740556	EIF3A	AG	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs3740556:AG	10339178
methotrexate polyglutamate	rs924607	CEP72	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs924607:TT	126941
tacrolimus	rs1800896	IL10	TT	Dosage	decreased	Dosage	Disease:Liver_transplantation		L04AD02	rs1800896:TT	131769926
mirtazapine, venlafaxine	rs1487278	TPH2	C	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AX11|N06AX16	rs1487278:C	4205
tacrolimus	rs1045642	ABCB1	GG	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs1045642:GG	131769926
bilirubin	rs4124874	UGT1A1	GG	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs4124874:GG	46931084
bilirubin	rs4124874	UGT1A1	GT	Metabolism/PK	increased	LADME	Disease:C0027651		No_ATC	rs4124874:GT	46931084
carboplatin, cisplatin	rs3740556	EIF3A	AA	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA01|L01XA02	rs3740556:AA	10339178
carboplatin, cisplatin	rs3740556	EIF3A	AG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA01|L01XA02	rs3740556:AG	10339178
deferasirox	rs2248359	CYP24A1	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2248359:CT	214348
deferasirox	rs2248359	CYP24A1	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs2248359:TT	214348
flupenthixol	rs230493	NFKB1	AT	Efficacy	increased	Efficacy_Response	Disease:C0036341		No_ATC	rs230493:AT	53627486
methotrexate polyglutamate	rs7311358	SLCO1B3	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs7311358:AA	126941
methotrexate polyglutamate	rs7311358	SLCO1B3	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs7311358:AG	126941
nicotine	rs2266780	FMO3	AA	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs2266780:AA	936
pazopanib	rs699947	VEGFA	A	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs699947:A	10113978
methotrexate polyglutamate	rs3749598	FSTL5	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3749598:AA	126941
methotrexate polyglutamate	rs3749598	FSTL5	AC	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs3749598:AC	126941
methotrexate polyglutamate	rs2241880	ATG16L1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2241880:AG	126941
methotrexate polyglutamate	rs2241880	ATG16L1	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2241880:GG	126941
fluorouracil	rs3918290	DPYD	CC	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01BC02	rs3918290:CC	5790
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
theophylline	rs2069514	CYP1A2	AA	Other, Metabolism/PK	decreased	LADME	Disease:C0004096		R03DA04	rs2069514:AA	5489638
theophylline	rs2069514	CYP1A2	AG	Other, Metabolism/PK	decreased	LADME	Disease:C0004096		R03DA04	rs2069514:AG	5489638
infliximab	rs20575	TNFRSF10A	CC	Efficacy	increased	Efficacy_Response	Disease:C0235889|Psoriatic		L04AB02	rs20575:CC	No_match
adalimumab, etanercept, infliximab	rs767455	TNFRSF1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0235889|Psoriatic		L04AB01|L04AB02|L04AB04	rs767455:TT	No_match
pazopanib	rs2010963	VEGFA	G	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs2010963:G	10113978
adalimumab, etanercept, infliximab	rs20575	TNFRSF10A	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs20575:CC	No_match
adalimumab, etanercept, infliximab	rs767455	TNFRSF1A	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs767455:TT	No_match
pazopanib	rs833061	VEGFA	T	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs833061:T	10113978
etanercept	rs2431697	PTTG1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2431697:CC	No_match
etanercept	rs2431697	PTTG1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2431697:CT	No_match
cisplatin, gemcitabine	rs4492666	CMPK1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs4492666:CC	5460033
bupropion, nicotine, varenicline	rs503464	CHRNA5	A	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12|N07BA01|N07BA03	rs503464:A	5310966
voriconazole	rs6785049	NR1I2	GG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs6785049:GG	9741
etanercept	rs13437088	HLA-B	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs13437088:TT	No_match
etanercept	rs96844	MAP3K1	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs96844:AG	No_match
etanercept	rs96844	MAP3K1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs96844:GG	No_match
clozapine	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs4680:GG	131769989
clozapine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs6295:GG	131769989
etanercept	rs928655	GBP6	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs928655:AG	No_match
etanercept	rs928655	GBP6	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs928655:GG	No_match
celiprolol	rs1045642	ABCB1	G	Metabolism/PK	decreased	LADME	Healthy		C07AB08	rs1045642:G	42373
atorvastatin	rs4149056	SLCO1B1	TT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs4149056:TT	656846
celiprolol	rs11568563	SLCO1A2	G	Metabolism/PK	decreased	LADME	Healthy		C07AB08	rs11568563:G	42373
etanercept	rs2546890	IL12B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2546890:AG	No_match
etanercept	rs2546890	IL12B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs2546890:GG	No_match
temozolomide	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:C0017638		L01AX03	rs1128503:AA	5394
temozolomide	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0017638		L01AX03	rs1128503:AG	5394
ivacaftor	rs7512462	SLC26A9	CC	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs7512462:CC	72722243
ivacaftor	rs7512462	SLC26A9	CT	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs7512462:CT	72722243
gemcitabine	rs66878317	DCK	AG	Metabolism/PK	increased	LADME	Healthy		L01BC05	rs66878317:AG	597
gemcitabine	rs66878317	DCK	GG	Metabolism/PK	increased	LADME	Healthy		L01BC05	rs66878317:GG	597
voriconazole	rs3814057	NR1I2	CC	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs3814057:CC	9741
nicotine	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0039338		N07BA01	rs4680:GG	936
milnacipran	rs1800544	ADRA2A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs1800544:CC	65833
milnacipran	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs1800544:CG	65833
platinum compounds	rs4244809	IGF2, IGF2-AS, INS-IGF2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs4244809:GG	23939
voriconazole	rs2266780	FMO3	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs2266780:AA	9741
hmg coa reductase inhibitors	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs2306283:GG	445127
fluvoxamine	rs1449683	FGF2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	rs1449683:CC	154032615
fluvoxamine	rs1449683	FGF2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	rs1449683:CT	154032615
voriconazole	rs10954732	POR	GG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs10954732:GG	9741
platinum compounds	rs3842761	INS-IGF2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0919267		L01XA	rs3842761:GG	23939
milnacipran	rs6295	HTR1A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs6295:CC	65833
milnacipran	rs6295	HTR1A	CG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX17	rs6295:CG	65833
valproic acid	rs17183814	SCN2A	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs17183814:AA	134459
valproic acid	rs17183814	SCN2A	AG	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs17183814:AG	134459
valproic acid	rs2298771	SCN1A	TT	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs2298771:TT	134459
voriconazole	rs2461817	NR1I2	AA	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs2461817:AA	9741
voriconazole	rs3732359	NR1I2	GG	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs3732359:GG	9741
methotrexate	rs3740066	ABCC2	TT	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs3740066:TT	11329481
cisplatin, gemcitabine	rs720106	RRM1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs720106:TT	5460033
voriconazole	rs7643645	NR1I2	AA	Metabolism/PK	increased	LADME	Healthy		J02AC03	rs7643645:AA	9741
simvastatin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2306283:AA	14373154
cisplatin, gemcitabine	rs232043	RRM1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs232043:AA	5460033
cisplatin, gemcitabine	rs11211524	CMPK1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs11211524:CC	5460033
simvastatin	rs2306283	SLCO1B1	GG	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs2306283:GG	14373154
cisplatin, gemcitabine	rs2284449	RRM1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05|L01XA01	rs2284449:TT	5460033
acenocoumarol	rs11676382	GGCX	G	Dosage	decreased	Dosage	Healthy		B01AA07	rs11676382:G	54742534
acenocoumarol	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:T	54742534
acenocoumarol	rs7294	VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA07	rs7294:T	54742534
methotrexate	rs6785049	NR1I2	G	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs6785049:G	11329481
rituximab	rs1800470	TGFB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs1800470:AG	No_match
rituximab	rs1800471	TGFB1	CG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L01FA01	rs1800471:CG	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12980275:A	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:T	37542
simvastatin	rs35599367	CYP3A4	A	Efficacy	increased	Efficacy_Response	Other:C0020443		C10AA01	rs35599367:A	14373154
pioglitazone	rs2241766	ADIPOQ	GT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG03	rs2241766:GT	60560
morphine	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:GG	5284371
morphine	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:GG	5284371
acenocoumarol	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:T	54742534
rosuvastatin	rs776746	CYP3A5	C	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA07	rs776746:C	5282455
methotrexate	rs3732361	GSK3B	A	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs3732361:A	11329481
naloxone	rs1799971	OPRM1	AG	Other	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:AG	11274356
naloxone	rs1799971	OPRM1	GG	Other	increased	Efficacy_Response	Healthy		V03AB15	rs1799971:GG	11274356
tipifarnib	rs1128503	ABCB1	AA	Other, Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs1128503:AA	159324
etanercept	rs9304742	ZNF816	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB01	rs9304742:CC	No_match
rosuvastatin	rs2231142	ABCG2	T	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA07	rs2231142:T	5282455
naltrexone	rs1799971	OPRM1	G	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:G	5360515
antipsychotics	rs13250975	NRG1	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs13250975:G	No_match
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Disease:C0271093		B01AA03	rs9934438:AA	54688261
methotrexate	rs4149009	SLCO1A2	CC	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs4149009:CC	11329481
methotrexate	rs4149009	SLCO1A2	CT	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs4149009:CT	11329481
antipsychotics	rs2513265	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2513265:A	No_match
antipsychotics	rs1544938	ADCY2	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1544938:C	No_match
antipsychotics	rs17716295	NRG1	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs17716295:A	No_match
nicotine	rs16969968	CHRNA5	GG	Other	decreased	Dosage	Disease:C0039338		N07BA01	rs16969968:GG	936
methadone	rs55944529	DAO	TT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs55944529:TT	10090
antipsychotics	rs4795893	CCL2	G	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs4795893:G	No_match
antipsychotics	rs4586	CCL2	T	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs4586:T	No_match
methadone	rs55944529	DAO	TT	Metabolism/PK	increased	LADME	Other:C0028043		N07BC02	rs55944529:TT	10090
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
escitalopram, fluoxetine, fluvoxamine, sertraline	rs3803189	HTR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB06|N06AB08|N06AB10	rs3803189:GG	5324346
escitalopram, fluoxetine, fluvoxamine, sertraline	rs3803189	HTR2A	GT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB03|N06AB06|N06AB08|N06AB10	rs3803189:GT	5324346
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease|Other:C0024530		J05AG03	rs3745274:T	64139
ivacaftor	rs121908755	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121908755:A	72722243
methadone	rs5326	DRD1	TT	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs5326:TT	10090
ivacaftor	rs121908757	CFTR	C	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121908757:C	72722243
ivacaftor	rs80282562	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs80282562:A	72722243
rifampicin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs4149056:CT	135542225
methylphenidate	rs1065852	CYP2D6	GG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs1065852:GG	154100
hmg coa reductase inhibitors	rs11045819	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs11045819:CC	445127
methylphenidate	rs1135840	CYP2D6	CG	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA04	rs1135840:CG	154100
ivacaftor	rs121909041	CFTR	C	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121909041:C	72722243
pravastatin	rs2306283	SLCO1B1	GG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs2306283:GG	58746970
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1057910:AA	54688261
ivacaftor	rs193922525	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs193922525:A	72722243
warfarin	rs7196161	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs7196161:AA	54688261
warfarin	rs7196161	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs7196161:AG	54688261
ivacaftor	rs267606723	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs267606723:A	72722243
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
ivacaftor	rs74503330	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs74503330:A	72722243
ivacaftor	rs121909005	CFTR	G	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121909005:G	72722243
ivacaftor	rs121909013	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs121909013:A	72722243
sunitinib	rs6923761	GLP1R	A	Metabolism/PK	decreased	LADME	Other:C0007134|Other:C0238198		L01EX01	rs6923761:A	11221549
doxorubicin	rs1128503	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs1128503:AA	83958
atomoxetine	rs1135840	CYP2D6	CC	Efficacy	increased	Efficacy_Response	Other:C1263846		N06BA09	rs1135840:CC	6093336
beta blocking agents	rs3740563	GRK5	A	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs3740563:A	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069705	IFNG	G	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2069705:G	No_match
montelukast	rs6475448	MLLT3	AA	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03DC03	rs6475448:AA	122021
beta blocking agents	rs10787959	GRK5	A	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs10787959:A	No_match
bupropion	rs1908557	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AX12	rs1908557:C	446
beta blocking agents	rs11198893	GRK5	A	Efficacy	decreased	Efficacy_Response	Other:C1956346		S01ED	rs11198893:A	No_match
rifampicin	rs4646536	CYP27B1	AG	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs4646536:AG	135542225
rifampicin	rs4646536	CYP27B1	GG	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs4646536:GG	135542225
corticosteroids	rs138335	ST13	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		S02BA	rs138335:G	No_match
rifampicin	rs1544410	VDR	TT	Metabolism/PK	increased	LADME	Disease:C0041296		J04AB02	rs1544410:TT	135542225
docetaxel	rs2740574	CYP3A4	C	Metabolism/PK	increased	LADME	Disease:C0027651		L01CD02	rs2740574:C	154272
methadone	rs3745274	CYP2B6	GG	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs3745274:GG	10090
methadone	rs3745274	CYP2B6	GT	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs3745274:GT	10090
docetaxel	rs776746	CYP3A5	T	Metabolism/PK	increased	LADME	Disease:C0027651		L01CD02	rs776746:T	154272
hmg coa reductase inhibitors	rs4149056	SLCO1B1	C	Efficacy	decreased	Efficacy_Response	Disease:C0007222		C10AA	rs4149056:C	445127
ramipril	rs2053044	ADRB2	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs2053044:AA	5464096
ramipril	rs2053044	ADRB2	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs2053044:AG	5464096
opioids	rs4680	COMT	GG	Dosage	increased	Dosage	"""Other:C1458155|""Other:C0030193|Postoperative"""		N02A	rs4680:GG	No_match
methadone	rs2239622	NGF	AA	Dosage	decreased	Dosage	Disease:Opioid-Related_Disorders		N07BC02	rs2239622:AA	10090
nicotine	rs35694136	CYP1A2	T/del	Efficacy	increased	LADME	Other:C0877645		N07BA01	rs35694136:T/del	936
nicotine	rs35694136	CYP1A2	del/del	Efficacy	increased	LADME	Other:C0877645		N07BA01	rs35694136:del/del	936
methadone	rs2279343	CYP2B6	AA	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs2279343:AA	10090
methadone	rs2279343	CYP2B6	AG	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs2279343:AG	10090
gemcitabine	rs3750117	NT5C3A	AA	Other, Metabolism/PK	increased	LADME	Disease:C0027651		L01BC05	rs3750117:AA	597
gemcitabine	rs11598702	NT5C2	TT	Other, Metabolism/PK	decreased	LADME	Disease:C0027651		L01BC05	rs11598702:TT	597
fentanyl, remifentanil	rs199670311	PGAP6	T	Efficacy	increased	Dosage	Disease:C0030193		N01AH06|N02AB03	rs199670311:T	60815
olanzapine	rs2011425	UGT1A4	GT	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AH03	rs2011425:GT	74603552
antidepressants	rs2230739	ADCY9	CC	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs2230739:CC	No_match
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Other:C0018839		B01AE07	rs2244613:GG	169501783
dabigatran	rs2244613	CES1	GT	Metabolism/PK	decreased	LADME	Other:C0018839		B01AE07	rs2244613:GT	169501783
antipsychotics	rs165854	PI4KA	AG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs165854:AG	No_match
antipsychotics	rs165854	PI4KA	GG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs165854:GG	No_match
antipsychotics	rs1468412	GRM3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1468412:AA	No_match
antipsychotics	rs1468412	GRM3	AT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1468412:AT	No_match
budesonide, corticosteroids, fluticasone / salmeterol, fluticasone propionate	rs3752120	ZNF432	TT	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03AC12|R03BA02|R03BA05|S02BA	rs3752120:TT	5311101
azathioprine	rs1127354	ITPA	AA	Efficacy	increased	Efficacy_Response	Disease:C0024141		L04AX01	rs1127354:AA	5778
azathioprine	rs1127354	ITPA	AC	Efficacy	increased	Efficacy_Response	Disease:C0024141		L04AX01	rs1127354:AC	5778
carboplatin, docetaxel, trastuzumab	rs1136201	ERBB2	G	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs1136201:G	10339178
antipsychotics	rs1529461	SLC1A3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1529461:AA	No_match
antipsychotics	rs1529461	SLC1A3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs1529461:AG	No_match
antipsychotics	rs2299214	GRM3	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2299214:CC	No_match
carboplatin, docetaxel, trastuzumab	rs2284922	RNF8	A	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs2284922:A	10339178
antipsychotics	rs6465084	GRM3	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6465084:AG	No_match
antipsychotics	rs6465084	GRM3	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6465084:GG	No_match
carboplatin, docetaxel, trastuzumab	rs2070096	BARD1	A	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs2070096:A	10339178
gemcitabine	rs1048977	CDA	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01BC05	rs1048977:CC	597
carboplatin, docetaxel, trastuzumab	rs2229046	ERBB3	C	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs2229046:C	10339178
corticosteroids	rs138337	ST13	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		S02BA	rs138337:G	No_match
carboplatin, docetaxel, trastuzumab	rs773123	ERBB3	A	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD02|L01XA02	rs773123:A	10339178
antipsychotics	rs10211524	SLC1A4	AA	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05A	rs10211524:AA	No_match
risperidone	rs2299214	GRM3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2299214:CC	849421
risperidone	rs2299214	GRM3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2299214:CT	849421
pravastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs4149056:CC	58746970
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA03	rs4149056:CT	58746970
sufentanil	rs4680	COMT	AA	Dosage, Efficacy	decreased	Dosage	Healthy		N01AH03	rs4680:AA	41693
fluindione	rs9923231	VKORC1	TT	Metabolism/PK	Indeterminado	Dosage	Healthy		No_ATC	rs9923231:TT	68942
apremilast	rs1045895	LEPR, LEPROT	AA	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs1045895:AA	67116
apremilast	rs1045895	LEPR, LEPROT	AG	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs1045895:AG	67116
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
opioids	rs1045642	ABCB1	AA	Dosage, Efficacy	decreased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs1045642:AA	No_match
carboplatin, cisplatin	rs2494752	AKT1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA01|L01XA02	rs2494752:AG	10339178
quinapril	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Disease:C1956346		C09AA06	rs699:GG	54891
opioids	rs6517442	KCNJ6	CC	Dosage	increased	Dosage	Other:C0024031		N02A	rs6517442:CC	No_match
olanzapine	rs35694136	CYP1A2	T/del	Metabolism/PK	increased	LADME	Disease:C0036341		N05AH03	rs35694136:T/del	74603552
opioids	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0027651|Disease:C0030193		N02A	rs1799971:GG	No_match
olanzapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Disease:C0036341		N05AH03	rs762551:AA	74603552
fentanyl	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs1799971:GG	13653606
rosuvastatin	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:GT	5282455
rosuvastatin	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs2231142:TT	5282455
phenprocoumon	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA04	rs2108622:TT	91987769
capecitabine, fluorouracil, tegafur	rs183205964	TYMS	C	Toxicity	increased	Adverse_Event	Disease:C0027651		L01BC02|L01BC03|L01BC06	rs183205964:C	60953
ketoprofen	rs1057910	CYP2C9	AC	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		M02AA10	rs1057910:AC	667550
atorvastatin	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C1956346		C10AA05	rs1045642:GG	656846
imatinib	rs683369	SLC22A1	CC	Metabolism/PK	increased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC	6113
caffeine	rs762551	CYP1A2	AA	Other, Metabolism/PK	increased	LADME	Healthy		N06BC01	rs762551:AA	936
imatinib	rs683369	SLC22A1	CC	Metabolism/PK	decreased	LADME	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs683369:CC	6113
etanercept	rs1061622	TNFRSF1B	GT	Efficacy	decreased	Efficacy_Response	Disease:C0038012|Ankylosing		L04AB01	rs1061622:GT	No_match
fentanyl, remifentanil	rs4839603	SLC9A9	GG	Efficacy	decreased	Dosage	Disease:C0030193		N01AH06|N02AB03	rs4839603:GG	60815
efavirenz	rs3745274	CYP2B6	T	Efficacy	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
apremilast	rs12745871	PDE4B	T	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs12745871:T	67116
atorvastatin	rs5888	SCARB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs5888:AA	656846
apremilast	rs322144	TSPAN16	C	Efficacy	decreased	Efficacy_Response	Other:C0235763		L04AA32	rs322144:C	67116
pravastatin	rs11666735	FCAR	AA	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs11666735:AA	58746970
pravastatin	rs11666735	FCAR	AG	Efficacy	increased	Efficacy_Response	Disease:C0027051		C10AA03	rs11666735:AG	58746970
cyclophosphamide, epirubicin	rs1695	GSTP1	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB03	rs1695:AA	2907
cyclophosphamide, epirubicin	rs1695	GSTP1	AG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB03	rs1695:AG	2907
fenofibrate	rs964184	APOA1	G	Efficacy	increased	Efficacy_Response	Disease:C0020557		C10AB05	rs964184:G	11350701
antiepileptics	rs10188577	SCN1A	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs10188577:CT	No_match
apremilast	rs12979813	DOCK6	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs12979813:G	67116
daptomycin	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J01XX09	rs1045642:AA	21585658
naltrexone	rs1611115	DBH	CT	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1611115:CT	5360515
naltrexone	rs1611115	DBH	TT	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1611115:TT	5360515
gemcitabine	rs11854484	SLC28A2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05	rs11854484:CC	597
antineoplastic agents	rs2231142	ABCG2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01	rs2231142:GG	No_match
gemcitabine	rs1060896	SLC28A2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01BC05	rs1060896:CC	597
apremilast	rs2305795	EIF3G, P2RY11, PPAN-P2RY11	G	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs2305795:G	67116
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs767455	TNFRSF1A	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs767455:TT	No_match
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
methotrexate	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs4149056:CC	11329481
methotrexate	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs4149056:CT	11329481
drugs for treatment of tuberculosis	rs1139130	METTL3	GG	Efficacy	increased	Efficacy_Response	Other:C0041296		J04A	rs1139130:GG	No_match
methotrexate	rs11045879	SLCO1B1	CC	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs11045879:CC	11329481
methotrexate	rs11045879	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs11045879:CT	11329481
sufentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs1799971:AG	41693
apremilast	rs76966440	ILF3	T	Efficacy	increased	Efficacy_Response	Other:C0235763		L04AA32	rs76966440:T	67116
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
cyclophosphamide, epirubicin, fluorouracil	rs1695	GSTP1	A	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs1695:A	2907
sulfasalazine	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01	rs2231142:GT	5336
sulfasalazine	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		A07EC01	rs2231142:TT	5336
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:T	37542
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
tacrolimus	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0009324		L04AD02	rs1128503:AG	131769926
tacrolimus	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0009324		L04AD02	rs1128503:GG	131769926
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CC	5282455
rosuvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA07	rs4149056:CT	5282455
peginterferon alfa-2b	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10	rs8099917:TT	71306834
warfarin	rs9934438	PRSS53, VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	PRSS53, VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	T	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:T	37542
peginterferon alfa-2b, ribavirin	rs2228570	VDR	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2228570:A	37542
nortriptyline	rs1799983	NOS3	TT	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N06AA10	rs1799983:TT	9918
allopurinol	rs1934341	GREM2	T	Efficacy	increased	Efficacy_Response	Healthy		M04AA01	rs1934341:T	168354693
cotinine	rs13253389	NAT1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs13253389:AG	108114
cotinine	rs13253389	NAT1	GG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs13253389:GG	108114
allopurinol	rs77567654	GREM2	G	Efficacy	increased	Efficacy_Response	Healthy		M04AA01	rs77567654:G	168354693
tacrolimus	rs2032582	ABCB1	CC	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2032582:CC	131769926
allopurinol	rs45499402	ABCG2	C	Efficacy	decreased	Efficacy_Response	Healthy		M04AA01	rs45499402:C	168354693
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
allopurinol	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Healthy		M04AA01	rs2231142:T	168354693
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
exenatide	rs10305420	GLP1R	T	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BJ01	rs10305420:T	45588096
topiramate	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N03AX11	rs1045642:AA	2723872
lamotrigine	rs7668258	UGT2B7	TT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AX09	rs7668258:TT	71236569
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT	54688261
benazepril	rs4762	AGT	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs4762:GG	5362124
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
imatinib	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1128503:GG	6113
lamotrigine	rs28365063	UGT2B7	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs28365063:GG	71236569
3,4-methylenedioxymethamphetamine	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		V04CX05	rs3745274:TT	1615
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
methotrexate	rs7317112	ABCC4	GG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs7317112:GG	11329481
benazepril	rs2640543	AGTR1	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs2640543:GG	5362124
alendronate	rs10161126	MVK	GG	Efficacy	increased	Efficacy_Response	Disease:C0006079		No_ATC	rs10161126:GG	2088
peginterferon alfa-2b, ribavirin	rs1127354	ITPA	A	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1127354:A	37542
sarilumab	rs11265618	IL6R	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC14	rs11265618:CC	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs14158	LDLR	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10|L03AB11	rs14158:GG	37542
benazepril	rs2106089	SPTA1	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs2106089:G	5362124
imatinib	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:GG	6113
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
sarilumab	rs4329505	IL6R	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC14	rs4329505:TT	No_match
losartan	rs1934969	CYP2C9	AT	Metabolism/PK	decreased	LADME	Healthy		C09CA01	rs1934969:AT	11751549
losartan	rs1934969	CYP2C9	TT	Metabolism/PK	decreased	LADME	Healthy		C09CA01	rs1934969:TT	11751549
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
imatinib	rs2032582	ABCB1	C	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:C	6113
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
buprenorphine	rs678849	OPRD1	CC	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs678849:CC	11274356
phenprocoumon	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:CT	91987769
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT	91987769
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1052248	NCR3	AT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs1052248:AT	No_match
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1052248	NCR3	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs1052248:TT	No_match
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
salbutamol	rs3809324	COL2A1	GT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3809324:GT	2083
salbutamol	rs3809324	COL2A1	TT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3809324:TT	2083
antipsychotics	rs2238087	CACNA1C	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2238087:CC	No_match
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs4791040	PRKCA	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs4791040:T	3639
antipsychotics	rs2229949	CACNA1B	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs2229949:CC	No_match
acenocoumarol	rs10871454	STX4	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs10871454:T	54742534
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA	54688261
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG	54688261
corticosteroids	rs37973	GLCCI1	GG	Efficacy	decreased	Efficacy_Response	Other:C0035455		S02BA	rs37973:GG	No_match
deferasirox	rs7041	GC	AA	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs7041:AA	214348
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
acenocoumarol	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA07	rs9934438:AA	54742534
acenocoumarol	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA07	rs9934438:AG	54742534
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GG	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:GT	37542
aspirin, clopidogrel	rs2108622	CYP4F2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs2108622:CC	2244
aspirin, clopidogrel	rs2108622	CYP4F2	CT	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs2108622:CT	2244
acenocoumarol	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:T	54742534
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9934438:AG	54688261
methylphenidate	rs71647871	CES1	T	Metabolism/PK	decreased	LADME	Healthy		N06BA04	rs71647871:T	154100
warfarin	rs7294	VKORC1	CT	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs7294:CT	54688261
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Disease:C0007222		B01AA03	rs7294:TT	54688261
interferon beta-1a, interferon beta-1b	rs12044852	CD58	CC	Efficacy	decreased	Efficacy_Response	Disease:C0026769		L03AB07|L03AB08	rs12044852:CC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs610604	TNFAIP3	GG	Efficacy	increased	Efficacy_Response	"""Other:C0235889|Psoriatic""|""Other:C0235763"		No_ATC	rs610604:GG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs610604	TNFAIP3	GT	Efficacy	increased	Efficacy_Response	"""Other:C0235889|Psoriatic""|""Other:C0235763"		No_ATC	rs610604:GT	No_match
morphine	rs1799971	OPRM1	AG	Efficacy	decreased	Efficacy_Response	Healthy		N02AA01	rs1799971:AG	5284371
morphine	rs1799971	OPRM1	GG	Efficacy	decreased	Efficacy_Response	Healthy		N02AA01	rs1799971:GG	5284371
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs9923231:TT	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs6920220	TNFAIP3	AA	Efficacy	decreased	Efficacy_Response	"""Other:C0235889|Psoriatic""|""Other:C0235763"		No_ATC	rs6920220:AA	No_match
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs2108622:CC	54688261
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Dosage	Disease:C0007222		B01AA03	rs2108622:CT	54688261
antipsychotics	rs12245847	CACNB2	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs12245847:TT	No_match
tacrolimus	rs2257401	CYP3A7	C	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs2257401:C	131769926
deferasirox	rs887829	UGT1A1	CC	Efficacy	decreased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs887829:CC	214348
antipsychotics	rs1859204	CACNG3	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1859204:TT	No_match
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs776746:C	131769926
deferasirox	rs1983023	UGT1A3	TT	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs1983023:TT	214348
deferasirox	rs10877012	CYP27B1	GG	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs10877012:GG	214348
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
tacrolimus	rs4646437	CYP3A4	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs4646437:A	131769926
adalimumab	rs10210302	ATG16L1	CT	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs10210302:CT	107706
adalimumab	rs10210302	ATG16L1	TT	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs10210302:TT	107706
antipsychotics	rs982003	CACNB2	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs982003:CC	No_match
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
tacrolimus	rs2242480	CYP3A4	T	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs2242480:T	131769926
deferasirox	rs731236	VDR	GG	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs731236:GG	214348
deferasirox	rs1544410	VDR	TT	Efficacy	increased	Efficacy_Response	Other:Beta-thalassemia_and_related_diseases		V03AC03	rs1544410:TT	214348
tacrolimus	rs41303343	CYP3A5	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs41303343:A	131769926
capecitabine, fluorouracil, irinotecan, leucovorin	rs1051266	SLC19A1	CC	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02	rs1051266:CC	135403648
capecitabine, fluorouracil, irinotecan, leucovorin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02	rs2306283:AA	135403648
capecitabine, fluorouracil, irinotecan, leucovorin	rs2306283	SLCO1B1	AG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06|L01CE02	rs2306283:AG	135403648
tacrolimus	rs4646450	CYP3A5	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs4646450:A	131769926
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CC	25221209
simvastatin acid	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CT	25221209
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs2776546	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs2776546:A	3639
warfarin	rs28371686	CYP2C9	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs28371686:CG	54688261
antipsychotics	rs10741058	CACNB2	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10741058:TT	No_match
atazanavir	rs887829	UGT1A1	TT	Toxicity	increased	Adverse_Event	Disease:HIV_infectious_disease		J05AE08	rs887829:TT	118753185
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs238	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs238:A	3639
antipsychotics	rs4505744	CACNA2D3	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs4505744:AA	No_match
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs4815273	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs4815273:T	3639
antipsychotics	rs12060765	CACNA1E	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs12060765:TT	No_match
corticosteroids	rs7772821	TAAR6	GG	Efficacy	increased	Efficacy_Response	Disease:C0004096		S02BA	rs7772821:GG	No_match
salbutamol	rs3025039	VEGFA	CT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3025039:CT	2083
salbutamol	rs3025039	VEGFA	TT	PD	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs3025039:TT	2083
bevacizumab, ranibizumab	rs1061170	CFH	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs1061170:CC	No_match
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
morphine	rs795484	TAOK3	TT	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs795484:TT	5284371
prednisone	rs6196	NR3C1	G	Efficacy	decreased	Efficacy_Response	Disease:C0027726		H02AB07	rs6196:G	91438
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
sn-38(irinotecan)	rs4148323	UGT1A1	AA	Metabolism/PK	decreased	LADME	Disease:C0007131		L01CE02	rs4148323:AA	60838
docetaxel	rs4842198	__INTRONIC__	G	Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs4842198:G	154272
fluvoxamine	rs6311	HTR2A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB08	rs6311:CC	154032615
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs3794271:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs3794271:GG	No_match
acenocoumarol	rs9934438	VKORC1	AA	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA07	rs9934438:AA	54742534
acenocoumarol	rs9934438	VKORC1	AG	Dosage, Efficacy	decreased	Dosage	Healthy		B01AA07	rs9934438:AG	54742534
prednisone	rs258751	NR3C1	A	Efficacy	decreased	Efficacy_Response	Disease:C0027726		H02AB07	rs258751:A	91438
ledipasvir, sofosbuvir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP08|J05AP51	rs12979860:CC	67505836
sn-38(irinotecan)	rs3832043	UGT1A9	del/del	Metabolism/PK	decreased	LADME	Disease:C0007131		L01CE02	rs3832043:del/del	60838
phenytoin	rs28371686	CYP2C9	G	Other, Metabolism/PK	decreased	LADME	Other:C0024198		N03AB02	rs28371686:G	1775
imatinib	rs2231137	ABCG2	CT	Dosage	decreased	Dosage	Other:C0238198		L01EA01	rs2231137:CT	6113
imatinib	rs2231137	ABCG2	TT	Dosage	decreased	Dosage	Other:C0238198		L01EA01	rs2231137:TT	6113
prednisone	rs10052957	NR3C1	A	Efficacy	decreased	Efficacy_Response	Disease:C0027726		H02AB07	rs10052957:A	91438
imatinib	rs762551	CYP1A2	CC	Dosage	decreased	Dosage	Other:C0238198		L01EA01	rs762551:CC	6113
phenytoin	rs7900194	CYP2C9	A	Other, Metabolism/PK	decreased	LADME	Other:C0024198		N03AB02	rs7900194:A	1775
lurasidone	rs6295	HTR1A	CG	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AE05	rs6295:CG	2772144
lurasidone	rs6295	HTR1A	GG	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AE05	rs6295:GG	2772144
phenytoin	rs28371685	CYP2C9	T	Other, Metabolism/PK	increased	LADME	PK:C0024198		N03AB02	rs28371685:T	1775
phenytoin	rs9332131	CYP2C9	del	Other, Metabolism/PK	decreased	LADME	PK:C0024198		N03AB02	rs9332131:del	1775
docetaxel	rs3132291	RXRA	A	Metabolism/PK	increased	LADME	Disease:C0023055		L01CD02	rs3132291:A	154272
infliximab	rs1061622	TNFRSF1B	G	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB02	rs1061622:G	No_match
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
metformin	rs12208357	SLC22A1	TT	Metabolism/PK	decreased	LADME	Healthy		A10BA02	rs12208357:TT	155906370
codeine	rs1799971	OPRM1	AA	Dosage	decreased	Dosage	Healthy		R05DA04	rs1799971:AA	5284371
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
codeine	rs7439366	UGT2B7	TT	Dosage	decreased	Dosage	Healthy		R05DA04	rs7439366:TT	5284371
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
peginterferon alfa-2b	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		L03AB10	rs8099917:TT	71306834
antipsychotics	rs4237348	CACNB2	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs4237348:CC	No_match
tacrolimus	rs2740574	CYP3A4	T	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs2740574:T	131769926
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
antipsychotics	rs3768652	CACNB4	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs3768652:AA	No_match
antipsychotics	rs3768652	CACNB4	AC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs3768652:AC	No_match
tacrolimus	rs35599367	CYP3A4	A	Metabolism/PK	Indeterminado	LADME	Disease:Kidney_Transplantation|Disease:C0277631		L04AD02	rs35599367:A	131769926
antipsychotics	rs7427395	CACNA2D3	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs7427395:CC	No_match
antipsychotics	rs1277733	CACNB2	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs1277733:TT	No_match
sofosbuvir	rs4513095	CES1	A	Efficacy	decreased	Efficacy_Response	Other:C0019372		J05AP08	rs4513095:A	67683363
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
propofol	rs6746030	SCN9A	AA	Other	increased	Efficacy_Response	Healthy		N01AX10	rs6746030:AA	3014064
propofol	rs6746030	SCN9A	AG	Other	increased	Efficacy_Response	Healthy		N01AX10	rs6746030:AG	3014064
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:C0277631		L04AD02	rs776746:CC	131769926
salbutamol	rs7081864	PRKG1	A	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs7081864:A	2083
tacrolimus	rs776746	CYP3A5	C	Dosage	decreased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:C	131769926
tocilizumab	rs12083537	IL6R	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs12083537:AA	No_match
antipsychotics	rs11030104	BDNF	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs11030104:AG	No_match
antipsychotics	rs11030104	BDNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs11030104:GG	No_match
sunitinib	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0007134		L01EX01	rs1045642:GG	11221549
propofol	rs6313	HTR2A	AA	Dosage	decreased	Dosage	Healthy		N01AX10	rs6313:AA	3014064
antipsychotics	rs10501087	BDNF-AS	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10501087:CC	No_match
antipsychotics	rs10501087	BDNF-AS	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10501087:CT	No_match
propofol	rs2279020	GABRA1	GG	Other	increased	Efficacy_Response	Healthy		N01AX10	rs2279020:GG	3014064
sunitinib	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX01	rs1045642:GG	11221549
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
opioids	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02A	rs4680:AA	No_match
opioids	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Healthy		N02A	rs4680:AG	No_match
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
doxorubicin, methotrexate, prednisolone, vincristine	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023449		L01CA02|L01DB01|L04AX03|S02BA03	rs1045642:AA	5755
antipsychotics	rs6265	BDNF	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6265:CT	No_match
antipsychotics	rs6265	BDNF	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs6265:TT	No_match
opioids	rs4680	COMT	AG	Dosage	decreased	Dosage	Healthy		N02A	rs4680:AG	No_match
"""metformin"", ""sulfonamides, urea derivatives"""	rs5219	ABCC8, KCNJ11	CT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02|S01AB	rs5219:CT	4091
"""metformin"", ""sulfonamides, urea derivatives"""	rs5219	ABCC8, KCNJ11	TT	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02|S01AB	rs5219:TT	4091
paliperidone, risperidone	rs28379954	NFIB	CT	Metabolism/PK	increased	LADME	Healthy		N05AX08|N05AX13	rs28379954:CT	9802545
remifentanil, sevoflurane	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Other:tonsillectomy		N01AB08|N01AH06	rs1128503:GG	5206
morphine	rs1277441	TAOK3	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1277441:GG	5284371
doxorubicin, methotrexate, prednisolone, vincristine	rs2229109	ABCB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0023449		L01CA02|L01DB01|L04AX03|S02BA03	rs2229109:CT	5755
hydroxyurea	rs2236599	KLF4	C	Efficacy	increased	Efficacy_Response	Other:C0002895|Other:Beta-thalassemia_and_related_diseases		No_ATC	rs2236599:C	10220327
oxycodone	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA05	rs1799971:GG	5462350
tacrolimus	rs2242480	CYP3A4	CT	Metabolism/PK	increased	LADME	Other:Heart_transplantation		L04AD02	rs2242480:CT	131769926
tacrolimus	rs2242480	CYP3A4	TT	Metabolism/PK	increased	LADME	Other:Heart_transplantation		L04AD02	rs2242480:TT	131769926
methotrexate	rs11045821	SLCO1B1	A	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs11045821:A	11329481
methylphenidate	rs28386840	SLC6A2	AT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:AT	154100
methylphenidate	rs28386840	SLC6A2	TT	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs28386840:TT	154100
bilirubin	rs11563250	UGT1A	AG	Metabolism/PK	decreased	LADME	Disease:C0023055		No_ATC	rs11563250:AG	46931084
bilirubin	rs11563250	UGT1A	GG	Metabolism/PK	decreased	LADME	Disease:C0023055		No_ATC	rs11563250:GG	46931084
deferasirox	rs1983023	UGT1A3	CT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs1983023:CT	214348
deferasirox	rs1983023	UGT1A3	TT	Metabolism/PK	decreased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs1983023:TT	214348
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs13393173	CERS6	A	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs13393173:A	No_match
morphine	rs12208357	SLC22A1	CT	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs12208357:CT	5284371
morphine	rs12208357	SLC22A1	TT	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs12208357:TT	5284371
midazolam	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:C0027651		N05CD08	rs35599367:AG	5384200
morphine	rs55918055	SLC22A1	CC	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs55918055:CC	5284371
morphine	rs55918055	SLC22A1	CT	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs55918055:CT	5284371
bupropion, drugs used in nicotine dependence	rs4803381	CYP2A6	T	Efficacy	increased	Efficacy_Response	Disease:C0039338		N06AX12|N07BA	rs4803381:T	89594
metformin	rs391300	SRR	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs391300:CC	155906370
metformin	rs391300	SRR	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs391300:CT	155906370
methylphenidate	rs5569	SLC6A2	AG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:AG	154100
methylphenidate	rs5569	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:GG	154100
erythromycin	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:C0027651		S01AA17	rs35599367:AG	9831800
nicotine	rs4803381	CYP2A6	T	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs4803381:T	936
clozapine	rs7787082	ABCB1	G	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs7787082:G	131769989
caffeine	rs762551	CYP1A2	AA	Metabolism/PK	increased	LADME	Healthy		N06BC01	rs762551:AA	936
caffeine	rs762551	CYP1A2	AC	Metabolism/PK	increased	LADME	Healthy		N06BC01	rs762551:AC	936
atenolol	rs12346562	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs12346562:AA	14211540
atenolol	rs12346562	__INTRONIC__	AC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs12346562:AC	14211540
hydrochlorothiazide	rs12346562	__INTRONIC__	AA	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs12346562:AA	2904
hydrochlorothiazide	rs12346562	__INTRONIC__	AC	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03	rs12346562:AC	2904
atenolol	rs1104514	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs1104514:AA	14211540
atenolol	rs1104514	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs1104514:AG	14211540
morphine	rs34130495	SLC22A1	AA	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34130495:AA	5284371
morphine	rs34130495	SLC22A1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs34130495:AG	5284371
atenolol	rs10739150	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs10739150:GG	14211540
atenolol	rs10739150	__INTRONIC__	GT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs10739150:GT	14211540
clozapine	rs10248420	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs10248420:A	131769989
deferasirox	rs3806596	UGT1A3	CC	Efficacy, Metabolism/PK	increased	Efficacy_Response	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs3806596:CC	214348
trandolapril, verapamil	rs4742610	PTPRD	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C08DA01|C09AA10	rs4742610:T	2520
deferasirox	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:CC	214348
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
"""metformin"", ""sulfonamides, urea derivatives"""	rs2289669	SLC47A1	A	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02|S01AB	rs2289669:A	4091
sunitinib	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX01	rs2231142:GT	11221549
sunitinib	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0027651		L01EX01	rs2231142:TT	11221549
warfarin	rs11168292	VDR	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs11168292:GG	54688261
tamoxifen, endoxifen	rs1136703	SULT1A2	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	rs1136703:AA	10090750
ara-ctp	rs17343066	SLC28A3	AA	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs17343066:AA	6176
warfarin	rs4760658	VDR	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs4760658:GG	54688261
warfarin	rs11168293	VDR	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs11168293:TT	54688261
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs885814	ALPL	T	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs885814:T	No_match
methotrexate	rs4149056	SLCO1B1	C	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149056:C	11329481
methotrexate	rs2306283	SLCO1B1	A	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs2306283:A	11329481
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1350948	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs1350948:A	No_match
tamoxifen, endoxifen	rs1059491	SULT1A2	TT	Metabolism/PK	decreased	LADME	Disease:C1458155		L02BA01	rs1059491:TT	10090750
methotrexate	rs4149081	SLCO1B1	A	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs4149081:A	11329481
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs17301249	EYA4	C	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs17301249:C	No_match
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
adalimumab, certolizumab pegol, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12081765	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04|L04AB05	rs12081765:G	No_match
methotrexate	rs11045879	SLCO1B1	C	Efficacy, Toxicity, Metabolism/PK	decreased	LADME	Disease:C0023449		L04AX03	rs11045879:C	11329481
phenylephrine	rs1042713	ADRB2	AA	Dosage	increased	Dosage	Healthy		S01GA05	rs1042713:AA	165411843
warfarin	rs2108622	CYP4F2	CT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs2108622:TT	54688261
anastrozole	rs6990851	CSMD1	G	Efficacy	increased	Efficacy_Response	Other:C1458155		L02BG03	rs6990851:G	713
n-desmethyltramadol, o-desmethyltramadol	rs2273697	ABCC2	AA	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs2273697:AA	9816106
peginterferon alfa-2b, ribavirin	rs6806020	__INTRONIC__	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs6806020:C	37542
nicotine	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs28399433:C	936
atorvastatin	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:AA	656846
atorvastatin	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2032582:AC	656846
warfarin	rs7294	VKORC1	CT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs7294:CT	54688261
warfarin	rs7294	VKORC1	TT	Dosage, Efficacy	increased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs7294:TT	54688261
peginterferon alfa-2b, ribavirin	rs1931704	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1931704:A	37542
acamprosate	rs6801605	CHDH, IL17RB	A	Efficacy	increased	Efficacy_Response	Other:C0085762		N07BB03	rs6801605:A	1646
warfarin	rs9923231	VKORC1	TT	Dosage, Efficacy	decreased	Dosage	Other:mechanical_heart_valve_replacement		B01AA03	rs9923231:TT	54688261
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG	37542
cyclophosphamide	rs3745274	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Other:C0023418|Lymphocytic|Chronic|B-Cell		L01AA01	rs3745274:GG	9554282
fentanyl	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		N02AB03	rs1128503:AG	13653606
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
coumarin	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs28399433:C	182049
peginterferon alfa-2b, ribavirin	rs3093390	IL21R	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs3093390:C	37542
bevacizumab, irinotecan	rs1570360	VEGFA	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01CE02|L01FG01	rs1570360:GG	60838
peginterferon alfa-2b, ribavirin	rs7512595	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7512595:A	37542
peginterferon alfa-2b, ribavirin	rs1792774	CARD16	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1792774:C	37542
warfarin	rs3814637	CYP2C19	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs3814637:CC	54688261
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs1057910:AA	54688261
warfarin	rs1057910	CYP2C9	AC	Dosage	increased	Dosage	Healthy		B01AA03	rs1057910:AC	54688261
n-desmethyltramadol(tramadol)	rs3740066	ABCC2	TT	Metabolism/PK	increased	LADME	Other:C0277589		N02AX02	rs3740066:TT	9816106
peginterferon alfa-2b, ribavirin	rs7750468	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7750468:G	37542
warfarin	rs699664	GGCX	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs699664:CT	54688261
warfarin	rs699664	GGCX	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs699664:TT	54688261
atorvastatin	rs2306283	SLCO1B1	AA	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs2306283:AA	656846
fentanyl	rs11079921	ABCC3	C	Metabolism/PK	increased	LADME	Other:C0030193|Other:C0022876		N02AB03	rs11079921:C	13653606
peginterferon alfa-2b, ribavirin	rs1503391	CARD16	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1503391:A	37542
peginterferon alfa-2b, ribavirin	rs557905	CASP1	T	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs557905:T	37542
peginterferon alfa-2b, ribavirin	rs2066911	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs2066911:A	37542
hmg coa reductase inhibitors	rs13064411	CFAP44	G	Efficacy	decreased	Efficacy_Response	Healthy		C10AA	rs13064411:G	445127
atorvastatin	rs3808607	CYP7A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs3808607:TT	656846
peginterferon alfa-2b, ribavirin	rs568910	CASP1	A	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs568910:A	37542
nicotine	rs2072658	CHRNB2	AG	Other	increased	Efficacy_Response	Other:C0234925		N07BA01	rs2072658:AG	936
metformin	rs622342	SLC22A1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs622342:AC	155906370
metformin	rs622342	SLC22A1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs622342:CC	155906370
n-desmethyltramadol(tramadol)	rs8330	UGT1A8	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs8330:CC	9816106
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT	37542
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT	37542
nicotine	rs2229959	CHRNA4	C	Other	increased	Efficacy_Response	Other:C0234925		N07BA01	rs2229959:C	936
peginterferon alfa-2b, ribavirin	rs17461620	TUT7	C	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs17461620:C	37542
acetylcysteine	rs3750920	TOLLIP	TT	Efficacy	increased	Efficacy_Response	Disease:C0034069		V03AB23	rs3750920:TT	12114682
oxcarbazepine	rs1045642	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N03AF02	rs1045642:A	46782646
peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs12979860:CC	37542
oxcarbazepine	rs7439366	UGT2B7	C	Efficacy	decreased	Efficacy_Response	Disease:C0014544		N03AF02	rs7439366:C	46782646
ara-ctp	rs12404655	CDA	AG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12404655:AG	6176
ara-ctp	rs12404655	CDA	GG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12404655:GG	6176
peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10	rs8099917:TT	37542
ara-ctp	rs11030918	RRM1	CT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11030918:CT	6176
ara-ctp	rs11030918	RRM1	TT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11030918:TT	6176
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs762551:AA	131769989
clopidogrel	rs776746	CYP3A5	CC	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	rs776746:CC	13748464
clopidogrel	rs776746	CYP3A5	CT	Efficacy	increased	Efficacy_Response	Disease:C0018839		B01AC04	rs776746:CT	13748464
peginterferon alfa-2a, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs8099917:TT	37542
ara-ctp	rs11577910	CTPS1	AG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11577910:AG	6176
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
ara-ctp	rs12067645	CTPS1	AA	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12067645:AA	6176
ara-ctp	rs12067645	CTPS1	AG	Metabolism/PK	increased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs12067645:AG	6176
ara-ctp	rs4364871	CTPS1	CT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4364871:CT	6176
ara-ctp	rs4364871	CTPS1	TT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4364871:TT	6176
n-desmethyltramadol(tramadol)	rs10929303	UGT1A8	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs10929303:CC	9816106
acenocoumarol	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:CT	54742534
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
n-desmethyltramadol, o-desmethyltramadol	rs34650714	UGT1A8	CC	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs34650714:CC	9816106
ara-ctp	rs11853372	SLC28A1	TT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs11853372:TT	6176
ara-ctp	rs4742	DCTD	GG	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4742:GG	6176
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
allopurinol	rs2231142	ABCG2	GT	Efficacy	decreased	Efficacy_Response	Disease:C0018099		M04AA01	rs2231142:GT	168354693
allopurinol	rs2231142	ABCG2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0018099		M04AA01	rs2231142:TT	168354693
oxcarbazepine	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF02	rs1045642:GG	46782646
amantadine, anticholinergics, levodopa, selegiline	rs622342	SLC22A1	C	Dosage, Efficacy	increased	Dosage	Disease:C0030567		N04BA02|N04BD01|S01FA	rs622342:C	5195
ara-ctp	rs4643786	DCK	CC	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4643786:CC	6176
ara-ctp	rs4643786	DCK	CT	Metabolism/PK	decreased	LADME	Disease:C0023418|Myeloid|Acute		No_ATC	rs4643786:CT	6176
peginterferon alfa-2a, ribavirin	rs12980275	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12980275:AA	37542
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
morphine-3-glucuronide, morphine-6-glucuronide	rs4793665	ABCC3	CC	Metabolism/PK	increased	LADME	Disease:C0036439|Disease:tonsillectomy		N02AA01	rs4793665:CC	5360621
tacrolimus	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs1128503:GG	131769926
morphine-3-glucuronide	rs4148412	ABCC3	TT	Metabolism/PK	increased	LADME	Disease:tonsillectomy		N02AA01	rs4148412:TT	5288826
glucose	rs8450	CRTC2	AA	Toxicity	increased	LADME	Disease:C0277631		V06DC01	rs8450:AA	86583511
glucose	rs8450	CRTC2	AG	Toxicity	increased	LADME	Disease:C0277631		V06DC01	rs8450:AG	86583511
acenocoumarol	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:CT	54742534
acenocoumarol	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:TT	54742534
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235889|Psoriatic		No_ATC	rs3794271:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3794271	SLCO1C1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235889|Psoriatic		No_ATC	rs3794271:GG	No_match
tacrolimus	rs1128503	ABCB1	GG	Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs1128503:GG	131769926
sertraline	rs5441	GNB3	GG	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB06	rs5441:GG	18642483
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
fentanyl	rs2242480	CYP3A4	TT	Efficacy	increased	Efficacy_Response	Other:C0030193|Postoperative		N02AB03	rs2242480:TT	13653606
sufentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1799971:AG	41693
sufentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1799971:GG	41693
sufentanil	rs1323040	OPRM1	AG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1323040:AG	41693
sufentanil	rs1323040	OPRM1	GG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1323040:GG	41693
sufentanil	rs1128503	ABCB1	AA	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1128503:AA	41693
sufentanil	rs1128503	ABCB1	AG	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs1128503:AG	41693
cyclosporine	rs1045642	ABCB1	A	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AD01	rs1045642:A	86666680
sufentanil	rs2032582	ABCB1	AA	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs2032582:AA	41693
sufentanil	rs2032582	ABCB1	AC	Dosage	increased	Dosage	"""Other:C0024121|""Other:C0030193|Postoperative"""		N01AH03	rs2032582:AC	41693
morphine	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AA01	rs1799971:GG	5284371
hdl cholesterol	rs8450	CRTC2	AA	Toxicity	decreased	LADME	Disease:C0277631		No_ATC	rs8450:AA	5997
o-desmethyltramadol	rs34130495	SLC22A1	GG	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs34130495:GG	9816106
mycophenolic acid	rs717620	ABCC2	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs717620:TT	5281078
methylphenidate	rs4680	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs4680:GG	154100
n-desmethyltramadol, o-desmethyltramadol	rs1867351	SLC22A1	TT	Metabolism/PK	decreased	LADME	Other:C0277589		N02AX02	rs1867351:TT	9816106
phenytoin	rs12782374	CYP2C9	AA	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs12782374:AA	1775
phenytoin	rs12782374	CYP2C9	AG	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AB02	rs12782374:AG	1775
warfarin	rs1057910	CYP2C9	C	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
fentanyl	rs8077268	ABCC3	T	Metabolism/PK	increased	LADME	Other:C0030193|Other:C0022876		N02AB03	rs8077268:T	13653606
methylphenidate	rs4680	COMT	G	Efficacy	increased	LADME	Disease:C1263846		N06BA04	rs4680:G	154100
warfarin	rs1799853	CYP2C9	T	Dosage, Metabolism/PK	decreased	Dosage	Healthy		B01AA03	rs1799853:T	54688261
platinum compounds	rs25487	XRCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs25487:CC	23939
warfarin	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:T	54688261
cyclosporine	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs1045642:GG	86666680
nicotine	rs35694136	CYP1A2	T/del	Efficacy	decreased	LADME	Healthy		N07BA01	rs35694136:T/del	936
nicotine	rs35694136	CYP1A2	del/del	Efficacy	decreased	LADME	Healthy		N07BA01	rs35694136:del/del	936
sirolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	LADME	Disease:C0277631		No_ATC	rs776746:CC	5284616
platinum compounds	rs3212986	ERCC1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs3212986:CC	23939
mycophenolic acid	rs7662029	UGT2B7	G	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AA06	rs7662029:G	5281078
methylphenidate	rs2070762	TH	GG	Efficacy	decreased	Efficacy_Response	Disease:C1263846		N06BA04	rs2070762:GG	154100
atorvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs4149056:CC	656846
atorvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA05	rs4149056:CT	656846
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
tacrolimus	rs5744247	IL18	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs5744247:CC	131769926
tacrolimus	rs5744247	IL18	CG	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs5744247:CG	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
sirolimus	rs2740574	CYP3A4	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs2740574:CC	5284616
sirolimus	rs2740574	CYP3A4	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs2740574:CT	5284616
sirolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs776746:CT	5284616
sirolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		No_ATC	rs776746:TT	5284616
cetuximab	rs1801274	FCGR2A	AA	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1801274:AA	No_match
carbamazepine	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2242480:CC	114709
risperidone	rs518147	HTR2C	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs518147:CC	849421
carbamazepine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs776746:CC	114709
sitagliptin, vildagliptin	rs6923761	GLP1R	AA	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BH01|A10BH02	rs6923761:AA	4369359
desethylchloroquine, hydroxychloroquine	rs7910936	CYP2C8	C	Metabolism/PK	increased	LADME	Other:C0024141		P01BA01|P01BA02	rs7910936:C	38989112
carbamazepine	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1045642:GG	114709
carbamazepine	rs3738046	EPHX1	CG	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AF01	rs3738046:CG	114709
rosuvastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0020443		C10AA07	rs4149056:CC	5282455
rosuvastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0020443		C10AA07	rs4149056:CT	5282455
phenytoin	rs1799853	CYP2C9	CT	Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	rs1799853:CT	1775
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CC	25221209
phenytoin	rs4244285	CYP2C19	AG	Other, Metabolism/PK	decreased	LADME	Disease:C0014544		N03AB02	rs4244285:AG	1775
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB11	rs12979860:CC	37542
clozapine	rs6318	HTR2C	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs6318:C	131769989
carbamazepine	rs2234922	EPHX1	AG	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AF01	rs2234922:AG	114709
carbamazepine	rs2234922	EPHX1	GG	Metabolism/PK	Indeterminado	LADME	Disease:C0014544		N03AF01	rs2234922:GG	114709
carbamazepine	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs776746:CT	114709
carbamazepine	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs776746:TT	114709
sulfonamides, urea derivatives	rs12255372	TCF7L2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011849		S01AB	rs12255372:TT	1176
simvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Other:C0020443		C10AA01	rs4149056:TT	14373154
carboplatin, cisplatin, fluorouracil	rs25487	XRCC1	T	Efficacy	decreased	Efficacy_Response	Disease:C0007869		L01BC02|L01XA01|L01XA02	rs25487:T	10339178
tramadol	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs2032582:AA	63013
tramadol	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs1045642:AA	63013
carboplatin, cisplatin, fluorouracil	rs12659	SLC19A1	A	Efficacy	decreased	Efficacy_Response	Disease:C0007869		L01BC02|L01XA01|L01XA02	rs12659:A	10339178
tramadol	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs1128503:AA	63013
tocilizumab	rs12083537	IL6R	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AC07	rs12083537:AA	No_match
caffeine	rs16851030	ADORA1	CC	Efficacy	increased	Efficacy_Response	Other:Apnea_of_prematurity		N06BC01	rs16851030:CC	936
tocilizumab	rs4329505	IL6R	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AC07	rs4329505:CC	No_match
tocilizumab	rs4329505	IL6R	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AC07	rs4329505:CT	No_match
risperidone	rs1023574	HTR2C	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs1023574:CC	849421
risperidone	rs9698290	HTR2C	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs9698290:TT	849421
"""diuretics"", ""hydrochlorothiazide"", ""thiazides, plain"""	rs16960228	PRKCA	A	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|C03AA03	rs16960228:A	3639
antidepressants	rs672170	RGS17	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs672170:A	No_match
warfarin	rs7089580	CYP2C9	AT	Dosage	increased	Dosage	Healthy		B01AA03	rs7089580:AT	54688261
warfarin	rs7089580	CYP2C9	AT	Dosage	increased	LADME	Healthy		B01AA03	rs7089580:AT	54688261
voriconazole	rs4149117	SLCO1B3	GT	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs4149117:GT	9741
voriconazole	rs4149117	SLCO1B3	TT	Metabolism/PK	decreased	LADME	Healthy		J02AC03	rs4149117:TT	9741
oxaliplatin	rs1042522	TP53	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs1042522:CG	9887054
oxaliplatin	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01XA03	rs1042522:GG	9887054
antidepressants	rs9315310	NBEA	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs9315310:T	No_match
antidepressants	rs4737771	CRH	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs4737771:C	No_match
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
antidepressants	rs49411	FHIT	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs49411:C	No_match
antidepressants	rs2532560	PARP11	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs2532560:G	No_match
antidepressants	rs2831440	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs2831440:T	No_match
sildenafil	rs5443	GNB3	TT	Efficacy	increased	Efficacy_Response	Disease:C0242350		G04BE03	rs5443:TT	135499879
antidepressants	rs766127	MTRF1L	G	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs766127:G	No_match
atorvastatin	rs1057868	POR	CT	Efficacy	decreased	Efficacy_Response	Disease:C0342881		C10AA05	rs1057868:CT	656846
atorvastatin	rs1057868	POR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0342881		C10AA05	rs1057868:TT	656846
tacrolimus	rs846908	HSD11B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs846908:AA	131769926
sarilumab	rs4845625	IL6R	CC	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC14	rs4845625:CC	No_match
salvianolic acid b	rs1799983	NOS3	GG	Efficacy	increased	Efficacy_Response	Disease:C0010068		No_ATC	rs1799983:GG	5281793
bupropion	rs165599	COMT	AA	Efficacy	increased	Efficacy_Response	Other:smokers		N06AX12	rs165599:AA	446
bupropion	rs165599	COMT	AG	Efficacy	increased	Efficacy_Response	Other:smokers		N06AX12	rs165599:AG	446
bupropion	rs737865	COMT	AA	Efficacy	decreased	Efficacy_Response	Other:smokers		N06AX12	rs737865:AA	446
salbutamol	rs2267715	CRHR2	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs2267715:G	2083
desethylchloroquine, hydroxychloroquine	rs10882521	CYP2C8	T	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01|P01BA02	rs10882521:T	38989112
salmeterol	rs1042713	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03AC12	rs1042713:AA	5152
warfarin	rs4889606	STX1B	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs4889606:AG	54688261
warfarin	rs4889606	STX1B	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs4889606:GG	54688261
adalimumab	rs2071303	HFE	CC	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs2071303:CC	107706
adalimumab	rs2071303	HFE	CT	Efficacy	increased	Efficacy_Response	Disease:C0010346		L04AB04	rs2071303:CT	107706
rosiglitazone	rs10192566	LPIN1	G	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs10192566:G	9846723
tacrolimus	rs4844880	HSD11B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs4844880:AA	131769926
desethylchloroquine, hydroxychloroquine	rs1065852	CYP2D6	AA	Metabolism/PK	decreased	LADME	Other:C0024141		P01BA01|P01BA02	rs1065852:AA	38989112
tacrolimus	rs846910	HSD11B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs846910:AA	131769926
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
acenocoumarol	rs3735814	GATA4	AG	Dosage	decreased	Dosage	Healthy		B01AA07	rs3735814:AG	54742534
acenocoumarol	rs3735814	GATA4	GG	Dosage	decreased	Dosage	Healthy		B01AA07	rs3735814:GG	54742534
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|S01ED	rs4149601:AG	No_match
"""beta blocking agents, selective"", ""diuretics"""	rs4149601	NEDD4L	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03|S01ED	rs4149601:GG	No_match
antidepressants	rs10997242	CTNNA3	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs10997242:C	No_match
aldosterone antagonists, amiloride	rs4149601	NEDD4L	G	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03DA|C03DB01	rs4149601:G	16231
antidepressants	rs7997012	HTR2A	AG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs7997012:AG	No_match
antidepressants	rs7997012	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs7997012:GG	No_match
salbutamol	rs255100	CRHR2	A	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs255100:A	2083
antidepressants	rs6313	HTR2A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs6313:GG	No_match
antidepressants	rs2112460	CACNA1A	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs2112460:A	No_match
salbutamol	rs2284220	CRHR2	G	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC02	rs2284220:G	2083
warfarin	rs17650	ORM1	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs17650:AG	54688261
warfarin	rs17650	ORM1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs17650:GG	54688261
antidepressants	rs521093	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs521093:T	No_match
morphine	rs7439366	UGT2B7	CC	Dosage	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs7439366:CC	5284371
warfarin	rs7294	VKORC1	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:C	54688261
antidepressants	rs16873129	RAPGEF5	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs16873129:C	No_match
valproic acid	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AG01	rs1128503:AA	134459
antidepressants	rs2299267	PON2	G	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06A	rs2299267:G	No_match
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C	131769926
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C	131769926
cisplatin	rs7937567	GALNT18	GG	Efficacy	increased	Efficacy_Response	Disease:C0877645		L01XA01	rs7937567:GG	441203
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG	64139
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG	64139
rituximab	rs3759467	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C0042384		L01FA01	rs3759467:CC	No_match
antipsychotics, aripiprazole, clozapine, haloperidol, olanzapine, quetiapine, risperidone	rs680055	CYP3A43	CG	Efficacy	increased	Efficacy_Response	Disease:C0036337|Disease:C0036341		N05A|N05AD01|N05AH02|N05AH03|N05AH04|N05AX08|N05AX12	rs680055:CG	60795
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
corticosteroids	rs1741981	HDAC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0004096		S02BA	rs1741981:CC	No_match
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
vincristine	rs8192552	MTNR1B	AG	Metabolism/PK	increased	LADME	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs8192552:AG	24848381
morphine	rs3804100	TLR2	CC	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs3804100:CC	5284371
morphine	rs3804100	TLR2	CT	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs3804100:CT	5284371
tacrolimus	rs776746	CYP3A5	CT	Other, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
docetaxel, thalidomide	rs4148947	CHST3	T	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148947:T	148124
morphine	rs1143634	IL1B	A	Dosage, Efficacy	decreased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1143634:A	5284371
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
cisplatin	rs10964552	MLLT3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0877645		L01XA01	rs10964552:AA	441203
cisplatin	rs10964552	MLLT3	AC	Efficacy	decreased	Efficacy_Response	Disease:C0877645		L01XA01	rs10964552:AC	441203
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	T	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:T	131769926
morphine	rs1143634	IL1B	A	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1143634:A	5284371
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
docetaxel, thalidomide	rs4148950	CHST3	A	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs4148950:A	148124
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
atorvastatin	rs1800591	MTTP	TT	Efficacy	increased	Efficacy_Response	Disease:C0342882		C10AA05	rs1800591:TT	656846
nitroglycerin	rs671	ALDH2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0018798		No_ATC	rs671:AA	4510
nitroglycerin	rs671	ALDH2	AG	Efficacy	decreased	Efficacy_Response	Disease:C0018798		No_ATC	rs671:AG	4510
tocilizumab	rs4910008	GALNT18	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs4910008:CC	No_match
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
cisplatin	rs244898	RARS1	TT	Efficacy	increased	Efficacy_Response	Disease:C0877645		L01XA01	rs244898:TT	441203
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
risperidone	rs2235048	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2235048:AG	849421
risperidone	rs2235048	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2235048:GG	849421
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Other:heart_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
nitroglycerin	rs671	ALDH2	AA	Metabolism/PK	increased	LADME	Disease:C0018798|Disease:C0020542		No_ATC	rs671:AA	4510
nitroglycerin	rs671	ALDH2	AG	Metabolism/PK	increased	LADME	Disease:C0018798|Disease:C0020542		No_ATC	rs671:AG	4510
digoxin	rs2032582	ABCB1	AT	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:AT	15478
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tocilizumab	rs11052877	CD69	A	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs11052877:A	No_match
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
phenazepam	rs12248560	CYP2C19	CC	Efficacy	increased	Efficacy_Response	Disease:C0221016		No_ATC	rs12248560:CC	40113
phenazepam	rs12248560	CYP2C19	CT	Efficacy	increased	Efficacy_Response	Disease:C0221016		No_ATC	rs12248560:CT	40113
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
vincristine	rs6519270	SNU13	G	Metabolism/PK	increased	LADME	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs6519270:G	24848381
atenolol	rs7184292	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB03	rs7184292:A	14211540
atenolol	rs7606603	XIRP2	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB03	rs7606603:C	14211540
cyclosporine	rs10211	CYP3A7	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs10211:TT	86666680
cyclosporine	rs2257401	CYP3A7	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs2257401:CC	86666680
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs12343867	JAK2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs12343867:CC	No_match
nilotinib	rs1695	GSTP1	A	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA03	rs1695:A	6395
hydrochlorothiazide	rs16872401	__INTRONIC__	C	Efficacy	increased	Efficacy_Response	Other:C0020538		C03AA03	rs16872401:C	2904
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3212217	IL12B	GG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs3212217:GG	No_match
cyclosporine	rs4646437	CYP3A4	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs4646437:GG	86666680
carvedilol	rs1801252	ADRB1	G	Efficacy	increased	Efficacy_Response	Healthy		C07AG02	rs1801252:G	6322
paroxetine	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB05	rs2032582:CC	667572
paroxetine	rs2032582	ABCB1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB05	rs2032582:CT	667572
nilotinib	rs1048943	CYP1A1	CT	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA03	rs1048943:CT	6395
nilotinib	rs1048943	CYP1A1	TT	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA03	rs1048943:TT	6395
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10754558	NLRP3	CG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs10754558:CG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs10754558	NLRP3	GG	Efficacy	increased	Efficacy_Response	Disease:C0021390		No_ATC	rs10754558:GG	No_match
atenolol	rs7184292	__INTRONIC__	GG	Dosage	decreased	Dosage	Other:C0020538		C07AB03	rs7184292:GG	14211540
atorvastatin	rs2306283	SLCO1B1	GG	Efficacy	decreased	Efficacy_Response	Other:C0020473		C10AA05	rs2306283:GG	656846
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1946518	IL18	GT	Efficacy	increased	Efficacy_Response	Disease:C0009324		No_ATC	rs1946518:GT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1946518	IL18	TT	Efficacy	increased	Efficacy_Response	Disease:C0009324		No_ATC	rs1946518:TT	No_match
carvedilol	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Healthy		C07AG02	rs1801253:C	6322
risperidone	rs3803300	AKT1	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs3803300:CT	849421
risperidone	rs2494732	AKT1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2494732:TT	849421
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:TT	64139
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2234711	IFNGR1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs2234711:AG	No_match
imatinib	rs3745274	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GG	6113
imatinib	rs3745274	CYP2B6	TT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:TT	6113
warfarin	rs4986893	CYP2C19	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs4986893:AA	54688261
warfarin	rs4986893	CYP2C19	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4986893:AG	54688261
cyclosporine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD01	rs776746:CC	86666680
warfarin	rs3814637	CYP2C19	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs3814637:CT	54688261
warfarin	rs3814637	CYP2C19	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs3814637:TT	54688261
cannabidiol	rs12539	AOC1	CT	Efficacy	increased	Efficacy_Response	Other:C0014544		No_ATC	rs12539:CT	644019
cannabidiol	rs12539	AOC1	TT	Efficacy	increased	Efficacy_Response	Other:C0014544		No_ATC	rs12539:TT	644019
efavirenz	rs3211371	CYP2B6	CT	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs3211371:CT	64139
efavirenz	rs3211371	CYP2B6	TT	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs3211371:TT	64139
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs17250932	TBX21	CC	Efficacy	decreased	Efficacy_Response	Disease:C0009324		No_ATC	rs17250932:CC	No_match
vincristine	rs4548	RAB7A	CT	Metabolism/PK	increased	LADME	Other:C0023449|Other:C0019829|Other:Rhabdomyosarcoma|Other:C0017636|Other:C0017638		L01CA02	rs4548:CT	24848381
docetaxel, thalidomide	rs730720	CHST3	C	Efficacy	increased	Efficacy_Response	Disease:C0033578		L01CD02|L04AX02	rs730720:C	148124
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs8126756	IFNGR2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs8126756:CC	No_match
cannabidiol	rs1339067	SLC15A1	TT	Efficacy	decreased	Efficacy_Response	Other:C0014544		No_ATC	rs1339067:TT	644019
warfarin	rs12772169	__INTRONIC__	T	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs12772169:T	54688261
rosiglitazone	rs4149056	SLCO1B1	C	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BG02	rs4149056:C	9846723
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3212217	IL12B	CG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs3212217:CG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3212217	IL12B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs3212217:GG	No_match
corticosteroids for systemic use	rs1741981	HDAC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0004096		H02	rs1741981:CC	No_match
risperidone	rs165599	COMT	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs165599:G	849421
risperidone	rs724226	GRM3	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs724226:G	849421
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs5744174	TLR5	AG	Efficacy	decreased	Efficacy_Response	Disease:C0010346		No_ATC	rs5744174:AG	No_match
morphine	rs6517442	KCNJ6	CC	Efficacy	increased	Efficacy_Response	Disease:C0030193		N02AA01	rs6517442:CC	5284371
methotrexate	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs2231142:GT	11329481
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT	131769926
morphine, remifentanil	rs6517442	KCNJ6	TT	Efficacy	decreased	Efficacy_Response	Disease:C0030193		N01AH06|N02AA01	rs6517442:TT	5288826
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
low density lipoprotein	rs3888190	SH2B1	CC	Other	increased	LADME	Disease:C0005586|Disease:C0011581|Disease:C0033975|Disease:C0036337		No_ATC	rs3888190:CC	No_match
tacrolimus	rs776746	CYP3A5	T	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:T	131769926
enalapril	rs699947	VEGFA	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs699947:AA	5950
enalapril	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA02	rs699947:AC	5950
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs8099917:TT	37542
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
lithium	rs2284018	CACNG2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N05AN01	rs2284018:TT	11125
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
efavirenz	rs1045642	ABCB1	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs1045642:GG	64139
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3745274:TT	64139
anastrozole	rs1437153	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BG03	rs1437153:T	713
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
docetaxel	rs2250242	ORM2	AA	Metabolism/PK	increased	LADME	Disease:C0033578		L01CD02	rs2250242:AA	154272
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
etanercept, infliximab	rs2043211	CARD8	TT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02	rs2043211:TT	No_match
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
methotrexate	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1045642:AA	11329481
methotrexate	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0023449		L04AX03	rs1045642:AG	11329481
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs12979860:CC	37542
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2234711	IFNGR1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0021390		No_ATC	rs2234711:AG	No_match
etanercept, infliximab	rs4612666	NLRP3	TT	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02	rs4612666:TT	No_match
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
anastrozole	rs2449598	DLG2	T	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BG03	rs2449598:T	713
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:C0027726		L04AD02	rs776746:CC	131769926
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG	64139
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs2242480	CYP3A4	CC	Metabolism/PK	increased	LADME	Other:C0027726		L04AD02	rs2242480:CC	131769926
digoxin	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs2032582:AA	15478
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1801133:AA	11329481
peginterferon alfa-2b	rs3077	HLA-DPA1	GG	Efficacy	increased	Efficacy_Response	Disease:C0019163|Chronic		L03AB10	rs3077:GG	71306834
rivastigmine	rs1803274	BCHE	CC	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA03	rs1803274:CC	6918078
digoxin	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:AG	15478
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC	54688261
methotrexate	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1045642:AG	11329481
adalimumab, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	A	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:A	No_match
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
cannabidiol	rs3749442	ABCC5	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		No_ATC	rs3749442:AA	644019
cannabidiol	rs3749442	ABCC5	AG	Efficacy	decreased	Efficacy_Response	Other:C0014544		No_ATC	rs3749442:AG	644019
peginterferon alfa-2b, ribavirin	rs4803217	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs4803217:CC	37542
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
efavirenz	rs3181842	CYP2B6	CC	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3181842:CC	64139
efavirenz	rs3181842	CYP2B6	CT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs3181842:CT	64139
efavirenz	rs707265	CYP2B6	AA	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs707265:AA	64139
efavirenz	rs707265	CYP2B6	AG	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs707265:AG	64139
efavirenz	rs7246465	CYP2B6	CT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs7246465:CT	64139
efavirenz	rs7246465	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		J05AG03	rs7246465:TT	64139
sufentanil	rs696	NFKBIA	TT	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs696:TT	41693
efavirenz	rs1042389	CYP2B6	TT	Metabolism/PK	decreased	LADME	Healthy		J05AG03	rs1042389:TT	64139
peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs11881222:AA	37542
glucose	rs1000940	RABEP1	AG	Other	decreased	LADME	Disease:C0005586|Disease:C0011581|Disease:C0033975|Disease:C0036337		V06DC01	rs1000940:AG	86583511
glucose	rs1000940	RABEP1	GG	Other	decreased	LADME	Disease:C0005586|Disease:C0011581|Disease:C0033975|Disease:C0036337		V06DC01	rs1000940:GG	86583511
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
paroxetine	rs6265	BDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs6265:TT	667572
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
remifentanil	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C0030193		N01AH06	rs4680:AA	60815
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
morphine	rs4680	COMT	GG	Efficacy	decreased	Efficacy_Response	Disease:C0030193		N02AA01	rs4680:GG	5284371
morphine, remifentanil	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Disease:C0030193		N01AH06|N02AA01	rs4680:AA	5288826
morphine, remifentanil	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Disease:C0030193		N01AH06|N02AA01	rs4680:AG	5288826
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
antipsychotics	rs2032582	ABCB1	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0036341		N05A	rs2032582:CC	No_match
adalimumab, infliximab	rs3804099	TLR2	T	Efficacy	decreased	Efficacy_Response	Other:C0010346		L04AB02|L04AB04	rs3804099:T	No_match
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs12979860:CC	71306834
morphine	rs4680	COMT	G	Dosage, Efficacy	increased	Dosage	"""Other:C1956346|""Efficacy:C0030193|Postoperative"""		N02AA01	rs4680:G	5284371
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs8099917:TT	71306834
peginterferon alfa-2b, ribavirin	rs8103142	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs8103142:TT	37542
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:HSCT		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:HSCT		L04AD02	rs776746:TT	131769926
peginterferon alfa-2b, ribavirin	rs28416813	IFNL3	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs28416813:CC	37542
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:C1561643		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:C1561643		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
imatinib	rs2231142	ABCG2	GT	Efficacy	increased	Efficacy_Response	Other:C0023473|BCR-ABL1_positive		L01EA01	rs2231142:GT	6113
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
peginterferon alfa-2b, ribavirin	rs8113007	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs8113007:AA	37542
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372|Disease:HIV_infectious_disease		J05AP01|L03AB10	rs12979860:CC	37542
clozapine	rs2075748	CHRM1	CC	Dosage	decreased	Dosage	Other:C0036341		N05AH02	rs2075748:CC	131769989
cyclophosphamide, epirubicin, fluorouracil	rs1056836	CYP1B1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01BC02|L01DB03	rs1056836:CC	2907
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs28416813	IFNL3	G	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs28416813:G	37542
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs8099917:TT	71306834
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
interferon alfa-n1, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB06|L03AB10	rs12979860:CC	71306834
erenumab, fremanezumab, galcanezumab	rs12615320	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01|N02CD02|N02CD03	rs12615320:G	No_match
rosuvastatin	rs4149056	SLCO1B1	CC	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs4149056:CC	5282455
rosuvastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs4149056:CT	5282455
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
hydroxyurea	rs10901080	ASS1	T	Efficacy	increased	Efficacy_Response	Disease:C0002895|Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs10901080:T	10220327
anastrozole	rs6981827	CSMD1	T	Efficacy	decreased	Efficacy_Response	Other:C1458155		L02BG03	rs6981827:T	713
hydroxyurea	rs10793902	ASS1	T	Efficacy	increased	Efficacy_Response	Disease:C0002895|Disease:Beta-thalassemia_and_related_diseases		No_ATC	rs10793902:T	10220327
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG	37542
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT	37542
doxorubicin	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs2032582:AA	83958
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG	37542
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT	37542
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8103142	IFNL3	T	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8103142:T	37542
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
epirubicin	rs1800566	NQO1	AA	Efficacy, Toxicity	decreased	Efficacy_Response	Other:C0235653		L01DB03	rs1800566:AA	65348
docetaxel, epirubicin	rs1563828	MDM4	AA	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02|L01DB03	rs1563828:AA	148124
gemcitabine	rs2072671	CDA	C	Metabolism/PK	decreased	LADME	Disease:C0007131		L01BC05	rs2072671:C	597
hydrochlorothiazide	rs75982813	NEDD4L	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs75982813:AG	2904
hydrochlorothiazide	rs75982813	NEDD4L	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs75982813:GG	2904
gliclazide	rs5219	KCNJ11	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BB09	rs5219:TT	169502072
warfarin	rs12777823	__INTRONIC__	AA	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AA	54688261
warfarin	rs12777823	__INTRONIC__	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs12777823:AG	54688261
doxorubicin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs1045642:AA	83958
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
aripiprazole	rs6277	DRD2	GG	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX12	rs6277:GG	10114519
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
digoxin	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		C01AA05	rs1045642:AA	15478
capecitabine, radiotherapy	rs11942466	AREG	AA	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11942466:AA	60953
capecitabine, radiotherapy	rs11942466	AREG	AC	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11942466:AC	60953
levomethadone	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	rs3745274:GT	22267
levomethadone	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC05	rs3745274:TT	22267
dextromethadone	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs3745274:GT	No_match
dextromethadone	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs3745274:TT	No_match
capecitabine, radiotherapy	rs11615	ERCC1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11615:AG	60953
capecitabine, radiotherapy	rs11615	ERCC1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0022665		L01BC06	rs11615:GG	60953
capecitabine, oxaliplatin	rs2010963	VEGFA	CG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC06|L01XA03	rs2010963:CG	9887054
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
acetaminophen	rs1902023	UGT2B15	AA	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs1902023:AA	1983
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
aripiprazole	rs1800497	ANKK1	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs1800497:AA	10114519
aripiprazole	rs1800497	ANKK1	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX12	rs1800497:AG	10114519
morphine	rs4633	COMT	C	Dosage, Efficacy	increased	Dosage	"""Other:C1956346|""Efficacy:C0030193|Postoperative"""		N02AA01	rs4633:C	5284371
acetaminophen	rs224534	TRPV1	AA	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs224534:AA	1983
acetaminophen	rs224534	TRPV1	AG	Efficacy	increased	Efficacy_Response	Healthy		N02BE01	rs224534:AG	1983
clozapine	rs1150226	HTR3A	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs1150226:G	131769989
risperidone	rs2069062	GRM7	CC	Efficacy	increased	Efficacy_Response	Healthy		N05AX08	rs2069062:CC	849421
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AG	13748464
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
clozapine	rs2276302	HTR3A	A	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2276302:A	131769989
glucose	rs4680	COMT	AA	Toxicity	increased	LADME	Healthy		V06DC01	rs4680:AA	86583511
glucose	rs4680	COMT	AG	Toxicity	increased	LADME	Healthy		V06DC01	rs4680:AG	86583511
clozapine	rs1062613	HTR3A	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs1062613:C	131769989
clopidogrel	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Disease:C0027051		B01AC04	rs1045642:AG	13748464
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
adalimumab, etanercept, infliximab	rs10919563	PTPRC	G	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs10919563:G	No_match
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	Adverse_Event	Disease:C0178298		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	Adverse_Event	Disease:C0178298		L04AD02	rs776746:TT	131769926
risperidone	rs1875705	GRID2	GG	Efficacy	increased	Efficacy_Response	Healthy		N05AX08	rs1875705:GG	849421
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT	131769926
clopidogrel	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0027051		B01AC04	rs1045642:AG	13748464
paclitaxel	rs2032582	ABCB1	CC	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01CD01	rs2032582:CC	36314
tacrolimus	rs2276707	NR1I2	CC	Metabolism/PK	increased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	rs2276707:CC	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
capecitabine, oxaliplatin	rs699947	VEGFA	AC	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC06|L01XA03	rs699947:AC	9887054
warfarin	rs17886199	PRSS53, VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs17886199:A	54688261
4-hydroxyatorvastatin, 4-hydroxyatorvastatin lactone	rs12422149	SLCO2B1	AG	Metabolism/PK	increased	LADME	Other:C0010068		C10AA05	rs12422149:AG	10650434
paclitaxel	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01CD01	rs2032582:AA	36314
paclitaxel	rs2032582	ABCB1	AT	Efficacy	increased	Efficacy_Response	Disease:C0919267		L01CD01	rs2032582:AT	36314
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11881222:AG	37542
peginterferon alfa-2b, ribavirin	rs11881222	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs11881222:GG	37542
tacrolimus	rs776746	CYP3A5	CT	Other, Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Other, Metabolism/PK	increased	LADME	Healthy		L04AD02	rs776746:TT	131769926
2-hydroxyatorvastatin lactone, 4-hydroxyatorvastatin lactone, atorvastatin lactone	rs887829	UGT1A1	CC	Metabolism/PK	decreased	LADME	Other:C0010068		C10AA05	rs887829:CC	6483036
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1056515	RGS5	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1056515:TT	135403648
sn-38(irinotecan)	rs4148323	UGT1A1	AA	Dosage	decreased	LADME	Disease:C0027651		L01CE02	rs4148323:AA	60838
peginterferon alfa-2b, ribavirin	rs8105790	IFNL3	CC	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8105790:CC	37542
peginterferon alfa-2b, ribavirin	rs8105790	IFNL3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8105790:CT	37542
peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12980275:AG	37542
peginterferon alfa-2b, ribavirin	rs12980275	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12980275:GG	37542
valproic acid	rs10068980	GABRA1	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs10068980:AA	134459
valproic acid	rs10068980	GABRA1	AG	Efficacy	increased	Efficacy_Response	Other:C0014544		N03AG01	rs10068980:AG	134459
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CT	37542
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:TT	37542
clozapine	rs1942499	CHRM1	GG	Dosage	decreased	Dosage	Other:C0036341		N05AH02	rs1942499:GG	131769989
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GG	37542
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT	37542
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
rosuvastatin	rs12487736	SCAP	C	Efficacy	increased	Efficacy_Response	Disease:C0524620		C10AA07	rs12487736:C	5282455
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		L04AD02	rs776746:CC	131769926
peginterferon alfa-2b, ribavirin	rs4803219	IFNL3	CT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs4803219:CT	37542
bevacizumab, fluorouracil, irinotecan, leucovorin	rs329007	RALBP1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs329007:GG	135403648
ivacaftor	rs75527207	CFTR	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0156318		R07AX02	rs75527207:A	72722243
rocuronium	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Healthy		M03AC09	rs1128503:AA	441290
mycophenolic acid	rs6714486	UGT1A9	AA	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AA06	rs6714486:AA	5281078
mycophenolic acid	rs6714486	UGT1A9	AT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AA06	rs6714486:AT	5281078
acenocoumarol	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:T	54742534
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
rocuronium	rs2306283	SLCO1B1	AA	Efficacy	decreased	Efficacy_Response	Healthy		M03AC09	rs2306283:AA	441290
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	G	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:G	37542
perampanel	rs776746	CYP3A5, ZSCAN25	C	Metabolism/PK	increased	LADME	Other:C0014544		N03AX22	rs776746:C	66827
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
morphine	rs7438135	UGT2B7	AA	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs7438135:AA	5284371
morphine	rs7438135	UGT2B7	AG	Metabolism/PK	decreased	LADME	Healthy		N02AA01	rs7438135:AG	5284371
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	GT	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:GT	37542
peginterferon alfa-2b, ribavirin	rs7248668	IFNL3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7248668:AA	37542
peginterferon alfa-2b, ribavirin	rs7248668	IFNL3	AG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs7248668:AG	37542
peginterferon alfa-2b, ribavirin	rs10853728	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10853728:GG	37542
pravastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0020443		C10AA03	rs4149056:CC	58746970
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0020443		C10AA03	rs4149056:CT	58746970
peginterferon alfa-2b, ribavirin	rs10853728	__INTRONIC__	CG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10853728:CG	37542
peginterferon alfa-2b, ribavirin	rs10853728	__INTRONIC__	GG	Efficacy	decreased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs10853728:GG	37542
acenocoumarol	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA07	rs2108622:TT	54742534
imatinib	rs2725252	ABCG2	C	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:C	6113
phenprocoumon	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Other:maintenance_dosage_by_1.5_mg/week		B01AA04	rs2108622:T	91987769
atenolol, irbesartan	rs5370	EDN1	GT	Efficacy	increased	Efficacy_Response	Disease:C0085580		C07AB03|C09CA04	rs5370:GT	2249
paroxetine	rs6311	HTR2A	CC	Efficacy	increased	Efficacy_Response	Other:C0028768		N06AB05	rs6311:CC	667572
phenprocoumon	rs4086116	CYP2C9	T	Dosage	decreased	Dosage	Other:maintenance_dosage_by_2.2_mg/week		B01AA04	rs4086116:T	91987769
atorvastatin, pravastatin, simvastatin	rs7412	APOE	C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA03|C10AA05	rs7412:C	60823
imatinib	rs2725252	ABCG2	C	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2725252:C	6113
atazanavir	rs2472677	NR1I2	CT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease	deficiency	J05AE08	rs2472677:CT	118753185
pravastatin	rs4149015	SLCO1B1	AG	Metabolism/PK	increased	LADME	Disease:C0342882		C10AA03	rs4149015:AG	58746970
apixaban	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0004238		B01AF02	rs776746:CC	91667715
apixaban	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:C0004238		B01AF02	rs776746:CT	91667715
imatinib	rs12505410	ABCG2	G	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs12505410:G	6113
niacin	rs2454727	HCAR2	CT	Efficacy	decreased	Efficacy_Response	Healthy		No_ATC	rs2454727:CT	16098
niacin	rs2454727	HCAR2	TT	Efficacy	decreased	Efficacy_Response	Healthy		No_ATC	rs2454727:TT	16098
atorvastatin, pravastatin, simvastatin	rs12003906	ABCA1	C	Efficacy	decreased	Efficacy_Response	Disease:C0020473		C10AA01|C10AA03|C10AA05	rs12003906:C	60823
ceftriaxone	rs13120400	ABCG2	TT	Metabolism/PK	Indeterminado	LADME	Disease:C0007682		J01DD04	rs13120400:TT	44120005
ribavirin	rs1127354	ITPA	CC	Dosage	decreased	Dosage	Healthy		J05AP01	rs1127354:CC	451448
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
pravastatin	rs4149015	SLCO1B1	AG	Metabolism/PK	increased	Efficacy_Response	Disease:C0342882		C10AA03	rs4149015:AG	58746970
creatine	rs616147	MOBP	AA	Efficacy	increased	Efficacy_Response	Other:C1388177		No_ATC	rs616147:AA	9548602
creatine	rs616147	MOBP	AG	Efficacy	increased	Efficacy_Response	Other:C1388177		No_ATC	rs616147:AG	9548602
pemetrexed	rs1047840	EXO1	AA	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01BA04	rs1047840:AA	135565228
pemetrexed	rs1047840	EXO1	AG	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01BA04	rs1047840:AG	135565228
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Disease:C0277631		C10AA03	rs4149056:CT	58746970
phenprocoumon	rs10871454	STX4	T	Dosage	decreased	Dosage	Other:maintenance_dosage_by_4.8_mg/week		B01AA04	rs10871454:T	91987769
pravastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Disease:C0277631		C10AA03	rs4149056:CT	58746970
propofol	rs3745274	CYP2B6	GT	Dosage	decreased	Dosage	Healthy		N01AX10	rs3745274:GT	3014064
propofol	rs3745274	CYP2B6	TT	Dosage	decreased	Dosage	Healthy		N01AX10	rs3745274:TT	3014064
adalimumab, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs352139:CT	No_match
adalimumab, etanercept, infliximab, tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AB01|L04AB02|L04AB04	rs352139:TT	No_match
valproic acid	rs4244285	CYP2C19	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0026986		N03AG01	rs4244285:AA	134459
valproic acid	rs4244285	CYP2C19	AG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0026986		N03AG01	rs4244285:AG	134459
apixaban	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0004238		B01AF02	rs2231142:TT	91667715
peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs12979860:CC	37542
3,4-methylenedioxymethamphetamine	rs2242446	SLC6A2	TT	Other	decreased	Efficacy_Response	Healthy		V04CX05	rs2242446:TT	1615
atenolol	rs699	AGT	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs699:AG	14211540
atenolol	rs699	AGT	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs699:GG	14211540
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs1057910:AC	2901
3,4-methylenedioxymethamphetamine	rs1861647	SLC6A2	GG	Other	increased	Efficacy_Response	Healthy		V04CX05	rs1861647:GG	1615
3,4-methylenedioxymethamphetamine	rs36029	SLC6A2	AA	Other	increased	Efficacy_Response	Healthy		V04CX05	rs36029:AA	1615
atenolol	rs5051	AGT	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs5051:CT	14211540
atenolol	rs5051	AGT	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB03	rs5051:TT	14211540
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs1057910:AC	2901
irbesartan	rs72558187	CYP2C9	CT	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs72558187:CT	2901
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Healthy		C09CA04	rs1057910:AC	2901
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs1264457	HLA-E	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs1264457:AA	126941
repaglinide	rs13266634	SLC30A8	CT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs13266634:CT	22132924
repaglinide	rs13266634	SLC30A8	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BX02	rs13266634:TT	22132924
disulfiram	rs1048101	ADRA1A	AA	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs1048101:AA	101405
disulfiram	rs1048101	ADRA1A	AG	Efficacy	increased	Efficacy_Response	Other:C0278080		N07BB01	rs1048101:AG	101405
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs1059150	ATP5F1E	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs1059150:GG	126941
sirolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AG	5284616
mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs116855232:TT	1268107
felodipine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Healthy		C08CA02	rs2231142:TT	3333
dexmedetomidine	rs28399433	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		N05CM18	rs28399433:C	6918081
irbesartan	rs1799853	CYP2C9	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09CA04	rs1799853:CT	2901
fentanyl	rs145837941	CALCA	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AB03	rs145837941:GG	13653606
nitric oxide	rs1319501	NAMPT	TT	Efficacy	increased	LADME	Other:C0032914		R07AX01	rs1319501:TT	23932
tocilizumab	rs4910008	GALNT18	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4910008:CC	No_match
tocilizumab	rs4910008	GALNT18	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AC07	rs4910008:CT	No_match
buprenorphine	rs529520	OPRD1	AA	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs529520:AA	11274356
nicotine	rs12459249	__INTRONIC__	C	Metabolism/PK	decreased	LADME	Healthy		N07BA01	rs12459249:C	936
warfarin	rs2592551	GGCX	AA	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs2592551:AA	54688261
warfarin	rs2592551	GGCX	AG	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs2592551:AG	54688261
arsenic compounds	rs11191439	AS3MT	C	Toxicity, Metabolism/PK	increased	LADME	Healthy		No_ATC	rs11191439:C	5359596
selective serotonin reuptake inhibitors	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB	rs7905446:TT	5202
escitalopram	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB10	rs7905446:TT	162180
atomoxetine, desvenlafaxine, duloxetine, selective serotonin reuptake inhibitors, venlafaxine	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AB|N06AX16|N06AX21|N06AX23|N06BA09	rs7905446:TT	5202
irbesartan	rs72558187	CYP2C9	CT	Metabolism/PK	decreased	LADME	Healthy		C09CA04	rs72558187:CT	2901
tocilizumab	rs2069840	IL6	CC	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AC07	rs2069840:CC	No_match
antidepressants	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06A	rs7905446:TT	No_match
irbesartan	rs72558187	CYP2C9	CT	Metabolism/PK	increased	LADME	Healthy		C09CA04	rs72558187:CT	2901
benazepril	rs1801131	MTHFR	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs1801131:G	5362124
fluoxetine, paroxetine	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N06AB03|N06AB05	rs7905446:TT	667572
benazepril	rs1801133	MTHFR	G	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C09AA07	rs1801133:G	5362124
tramadol	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Healthy		N02AX02	rs3745274:TT	63013
irbesartan	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Disease:C0085580		C09CA04	rs1057910:AC	2901
paroxetine	rs7905446	HTR7	TT	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N06AB05	rs7905446:TT	667572
fentanyl	rs145837941	CALCA	AG	Dosage	increased	Dosage	"""Other:C0030193|Postoperative""|""Other:C0699744"		N02AB03	rs145837941:AG	13653606
fentanyl	rs145837941	CALCA	GG	Dosage	increased	Dosage	"""Other:C0030193|Postoperative""|""Other:C0699744"		N02AB03	rs145837941:GG	13653606
pemetrexed	rs1653586	CAMKK2	GT	Efficacy	decreased	Efficacy_Response	Other:C0024121		L01BA04	rs1653586:GT	135565228
abiraterone	rs523349	SRD5A2	CC	Efficacy	increased	Efficacy_Response	Other:C0033578		L02BX03	rs523349:CC	91826892
buprenorphine	rs581111	OPRD1	AA	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs581111:AA	11274356
buprenorphine	rs581111	OPRD1	AG	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC01	rs581111:AG	11274356
carboplatin, lonafarnib, paclitaxel	rs11623866	FNTB	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0919267		L01CD01|L01XA02	rs11623866:GG	10339178
methotrexate	rs12505410	ABCG2	GG	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs12505410:GG	11329481
escitalopram	rs41271330	BMP5	A	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB10	rs41271330:A	162180
enalapril	rs71647871	CES1	CT	Metabolism/PK	decreased	LADME	Healthy		C09AA02	rs71647871:CT	5950
methotrexate	rs13137622	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs13137622:GT	11329481
methotrexate	rs13137622	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs13137622:TT	11329481
methotrexate	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:C0029463		L04AX03	rs13120400:CC	11329481
amlodipine	rs2740574	CYP3A4	CT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2740574:CT	72734364
amlodipine	rs2740574	CYP3A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C08CA01	rs2740574:TT	72734364
tacrolimus	rs1946518	IL18	GG	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1946518:GG	131769926
tacrolimus	rs1946518	IL18	GT	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1946518:GT	131769926
tacrolimus	rs1800896	IL10	TT	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1800896:TT	131769926
rivastigmine	rs1803274	BCHE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03	rs1803274:CT	6918078
rivastigmine	rs1803274	BCHE	TT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03	rs1803274:TT	6918078
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
efavirenz	rs35303484	CYP2B6	G	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs35303484:G	64139
valproic acid	rs1057910	CYP2C9	C	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs1057910:C	134459
azathioprine	rs116855232	NUDT15	TT	Toxicity	decreased	Dosage	Disease:C0023530		L04AX01	rs116855232:TT	5778
celecoxib	rs689466	PTGS2	CC	Efficacy	increased	Efficacy_Response	Healthy		M01AH01	rs689466:CC	66824
clozapine	rs28379954	NFIB	CT	Metabolism/PK	decreased	LADME	Other:C0036341		N05AH02	rs28379954:CT	131769989
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs776746:CC	131769926
metformin	rs594709	SLC22A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs594709:AA	155906370
metformin	rs594709	SLC22A1	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs594709:AG	155906370
irinotecan	rs2401863	TDP1	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01CE02	rs2401863:GG	74990
losartan	rs1934969	CYP2C9	AA	Metabolism/PK	decreased	LADME	Healthy		C09CA01	rs1934969:AA	11751549
metformin	rs2289669	SLC47A1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:GG	155906370
tacrolimus	rs5744247	IL18	CC	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs5744247:CC	131769926
tacrolimus	rs5744247	IL18	CG	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs5744247:CG	131769926
dexmedetomidine	rs16947	CYP2D6	GG	Dosage	increased	Dosage	Other:C0549433		N05CM18	rs16947:GG	6918081
carbamazepine	rs762551	CYP1A2	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs762551:AA	114709
rivaroxaban	rs2242480	CYP3A4	T	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs2242480:T	10700
cyclosporine, tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD01|L04AD02	rs776746:CC	445643
methotrexate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs4148324:GG	11329481
methotrexate	rs4148324	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GT	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs4148324:GT	11329481
efavirenz	rs3842	ABCB1	C	Metabolism/PK	Indeterminado	LADME	Disease:HIV_infectious_disease		J05AG03	rs3842:C	64139
cyclosporine, tacrolimus	rs776746	CYP3A5	CC	Dosage, Metabolism/PK	decreased	Dosage	Other:Liver_transplantation		L04AD01|L04AD02	rs776746:CC	445643
dexmedetomidine	rs5758550	WBP2NL	AG	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs5758550:AG	6918081
dexmedetomidine	rs5758550	WBP2NL	GG	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs5758550:GG	6918081
memantine, rivastigmine	rs1803274	BCHE	CT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03|N06DX01	rs1803274:CT	77991
memantine, rivastigmine	rs1803274	BCHE	TT	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA03|N06DX01	rs1803274:TT	77991
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC	54688261
warfarin	rs699664	GGCX	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs699664:CC	54688261
methotrexate	rs1801131	MTHFR	GT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:GT	11329481
clopidogrel	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs1045642:AA	13748464
tacrolimus	rs1057868	POR	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT	131769926
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG	54688261
rivastigmine	rs1803274	BCHE	CT	Efficacy	increased	Efficacy_Response	Disease:Lewy_Body_Disease		N06DA03	rs1803274:CT	6918078
fentanyl	rs145837941	CALCA	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02AB03	rs145837941:GG	13653606
apixaban	rs2231142	ABCG2	G	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF02	rs2231142:G	91667715
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1061622	TNFRSF1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1061622:GG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3397	TNFRSF1B	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3397:CC	No_match
amlodipine	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		C08CA01	rs1045642:GG	72734364
latanoprost	rs3766355	PTGFR	CC	Efficacy	increased	Efficacy_Response	Disease:C0020302|Disease:C0028840		S01EE01	rs3766355:CC	118984471
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1061631	TNFRSF1B	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs1061631:AA	No_match
methotrexate	rs1801133	MTHFR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801133:AG	11329481
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs3397	TNFRSF1B	C	Efficacy	decreased	Efficacy_Response	Disease:C0003873		No_ATC	rs3397:C	No_match
amlodipine	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Healthy		C08CA01	rs2032582:CC	72734364
methadone	rs11265549	NECTIN4	AA	Metabolism/PK	decreased	LADME	Other:Opioid-Related_Disorders		N07BC02	rs11265549:AA	10090
opioid anesthetics, other general anesthetics, volatile anesthetics	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Healthy		N01|N01AH|N01AX	rs1799971:GG	No_match
opioid anesthetics, other general anesthetics, volatile anesthetics	rs2231142	ABCG2	TT	Efficacy	increased	Efficacy_Response	Healthy		N01|N01AH|N01AX	rs2231142:TT	No_match
methadone	rs11265549	NECTIN4	AA	Dosage	decreased	Dosage	Other:Opioid-Related_Disorders		N07BC02	rs11265549:AA	10090
dexmedetomidine	rs16934182	KCNMA1	AA	Dosage	decreased	Dosage	Other:C0549433		N05CM18	rs16934182:AA	6918081
dexmedetomidine	rs16934182	KCNMA1	AG	Dosage	decreased	Dosage	Other:C0549433		N05CM18	rs16934182:AG	6918081
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs2244613:GG	169501783
dabigatran	rs2244613	CES1	GT	Metabolism/PK	decreased	LADME	Other:C0004238		B01AE07	rs2244613:GT	169501783
atorvastatin	rs11887534	ABCG8	CC	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs11887534:CC	656846
atorvastatin	rs11887534	ABCG8	CG	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs11887534:CG	656846
dexmedetomidine	rs1800544	ADRA2A	GG	Dosage	decreased	Dosage	Other:C0549433		N05CM18	rs1800544:GG	6918081
tamoxifen-n-glucuronide	rs2011425	UGT1A4	GG	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	rs2011425:GG	5460873
tamoxifen-n-glucuronide	rs2011425	UGT1A4	GT	Metabolism/PK	increased	LADME	Disease:C1458155		L02BA01	rs2011425:GT	5460873
imatinib	rs3745274	CYP2B6	GG	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GG	6113
imatinib	rs3745274	CYP2B6	GT	Efficacy	increased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs3745274:GT	6113
methotrexate	rs4673993	ATIC	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:CC	11329481
benazepril	rs7079	AGT	GG	Efficacy	Indeterminado	Efficacy_Response	Disease:C0020538		C09AA07	rs7079:GG	5362124
warfarin	rs9332098	CYP2C9	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9332098:GG	54688261
cannabidiol	rs6729738	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Other:C0014544		No_ATC	rs6729738:CC	644019
methotrexate	rs1801133	MTHFR	AG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs1801133:AG	11329481
methotrexate	rs1801133	MTHFR	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs1801133:GG	11329481
dexmedetomidine	rs1042713	ADRB2	AA	Efficacy	increased	Efficacy_Response	Other:C0549433		N05CM18	rs1042713:AA	6918081
warfarin	rs9332092	CYP2C9	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs9332092:TT	54688261
hydrochlorothiazide	rs3784921	TXNDC11	G	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs3784921:G	2904
warfarin	rs1057910	CYP2C9	CC	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs1057910:CC	54688261
paroxetine	rs762551	CYP1A2	A	Metabolism/PK	increased	Dosage	Disease:C0011581		N06AB05	rs762551:A	667572
warfarin	rs1799853	CYP2C9	TT	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs1799853:TT	54688261
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
dexmedetomidine	rs16934182	KCNMA1	AA	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs16934182:AA	6918081
dexmedetomidine	rs16934182	KCNMA1	AG	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs16934182:AG	6918081
topotecan	rs4148157	ABCG2	AA	Metabolism/PK	increased	LADME	Disease:C0006118		L01CE01	rs4148157:AA	60699
topotecan	rs4148157	ABCG2	AG	Metabolism/PK	increased	LADME	Disease:C0006118		L01CE01	rs4148157:AG	60699
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC	64139
efavirenz	rs28399499	CYP2B6	CT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CT	64139
rivaroxaban	rs2246709	CYP3A4	G	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs2246709:G	10700
duloxetine	rs117986340	KMT2E	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs117986340:GG	44344115
rivastigmine	rs2571598	ACHE	TT	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA03	rs2571598:TT	6918078
morphine	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:AG	5284371
morphine	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AA01	rs1799971:GG	5284371
duloxetine	rs2303377	NCAM1	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs2303377:TT	44344115
rivaroxaban	rs776746	CYP3A5	T	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs776746:T	10700
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:TT	131769926
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
duloxetine	rs4261893	ZNF385D	TT	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AX21	rs4261893:TT	44344115
efavirenz	rs2279343	CYP2B6	AG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:AG	64139
efavirenz	rs2279343	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:GG	64139
rivaroxaban	rs3735451	CYP3A4	C	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs3735451:C	10700
warfarin	rs2359612	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:GG	54688261
warfarin	rs7294	VKORC1	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:TT	54688261
dexmedetomidine	rs141294036	__INTRONIC__	CC	Toxicity	increased	Efficacy_Response	Other:C0549433		N05CM18	rs141294036:CC	6918081
amphetamine	rs3784943	CDH13	AG	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3784943:AG	11597698
amphetamine	rs3784943	CDH13	GG	Efficacy	increased	Efficacy_Response	Healthy		No_ATC	rs3784943:GG	11597698
everolimus	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Disease:C1458155		L01EG02	rs35599367:AG	6442177
pravastatin	rs4149056	SLCO1B1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0242231		C10AA03	rs4149056:CT	58746970
dexmedetomidine	rs11739136	KCNMB1	CC	Efficacy	increased	Efficacy_Response	Other:C0549433		N05CM18	rs11739136:CC	6918081
dexmedetomidine	rs11739136	KCNMB1	CT	Efficacy	increased	Efficacy_Response	Other:C0549433		N05CM18	rs11739136:CT	6918081
morphine	rs7668282	UGT2B7	CC	Metabolism/PK	decreased	LADME	Disease:C0002895		N02AA01	rs7668282:CC	5284371
morphine	rs7668282	UGT2B7	CT	Metabolism/PK	decreased	LADME	Disease:C0002895		N02AA01	rs7668282:CT	5284371
efavirenz	rs3745274	CYP2A7P1, CYP2B6	T	Metabolism/PK	increased	LADME	Other:C0032961		J05AG03	rs3745274:T	64139
dabigatran	rs8192935	CES1	GG	Metabolism/PK	increased	LADME	Other:C0004238		B01AE07	rs8192935:GG	169501783
ethanol	rs1799971	OPRM1	AG	Dosage	decreased	Dosage	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Dosage	decreased	Dosage	Healthy		V03AB16	rs1799971:GG	444899
methotrexate	rs1801133	CLCN6, MTHFR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801131	C1orf167, CLCN6, MTHFR	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:TT	11329481
methotrexate	rs1805087	MTR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1805087:AA	11329481
ranibizumab	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs4073:AA	No_match
ethanol	rs10485057	OPRM1	AA	Dosage	increased	Dosage	Healthy		V03AB16	rs10485057:AA	444899
warfarin	rs9934438	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs9934438:A	54688261
opioids	rs4680	COMT	AA	Dosage	decreased	Dosage	Other:C0030193|Other:C0027651		N02A	rs4680:AA	No_match
opioids	rs4680	COMT	AG	Dosage	decreased	Dosage	Other:C0030193|Other:C0027651		N02A	rs4680:AG	No_match
methotrexate	rs9904341	BIRC5	CG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs9904341:CG	11329481
acenocoumarol	rs9934438	VKORC1	GG	Efficacy	decreased	Efficacy_Response	Healthy		B01AA07	rs9934438:GG	54742534
salbutamol	rs17834628	__INTRONIC__	A	Efficacy	increased	Efficacy_Response	Healthy		R03CC02	rs17834628:A	2083
nicotine	rs1051730	CHRNA3	A	Dosage	decreased	Dosage	Other:C0039338		N07BA01	rs1051730:A	936
abiraterone, prednisolone	rs3828743	TSPYL1	A	Efficacy	decreased	Efficacy_Response	Disease:C0033578		L02BX03|S02BA03	rs3828743:A	132971
platinum	rs6878291	RICTOR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0007131		L01XA	rs6878291:GG	441203
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
clozapine	rs2514218	DRD2	T	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2514218:T	131769989
methotrexate	rs1801394	FASTKD3, MTRR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:AA	11329481
methotrexate	rs1801394	FASTKD3, MTRR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801394:AG	11329481
ranibizumab	rs2071559	KDR	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs2071559:AA	No_match
ranibizumab	rs2071559	KDR	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024437		S01LA04	rs2071559:AG	No_match
ethanol	rs1799971	OPRM1	AG	Other	increased	Efficacy_Response	Other:C0085762		V03AB16	rs1799971:AG	444899
busulfan	rs3957356	GSTA1	CT	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L01AB01	rs3957356:CT	4684
methotrexate	rs12995526	ATIC	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs12995526:CT	11329481
methotrexate	rs12995526	ATIC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs12995526:TT	11329481
clozapine	rs1062613	HTR3A	T	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs1062613:T	131769989
methotrexate	rs7563206	ATIC	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs7563206:CT	11329481
methotrexate	rs7563206	ATIC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs7563206:TT	11329481
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs2108622:CC	54688261
methotrexate	rs2372536	ATIC	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:CC	11329481
methotrexate	rs2372536	ATIC	CG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:CG	11329481
methotrexate	rs4673993	ATIC	CT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:CT	11329481
methotrexate	rs4673993	ATIC	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs4673993:TT	11329481
candesartan	rs1275988	KCNK3	C	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA06	rs1275988:C	146026636
risperidone	rs1523130	NR1I2	CC	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0235876|Disease:C0036502		N05AX08	rs1523130:CC	849421
sufentanil	rs1045642	ABCB1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs1045642:GG	41693
adalimumab	rs763780	IL17F	TT	Efficacy	increased	Efficacy_Response	Healthy		L04AB04	rs763780:TT	107706
immunoglobulins	rs113420705	CASP3, PRIMPOL	CT	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs113420705:CT	No_match
immunoglobulins	rs113420705	CASP3, PRIMPOL	TT	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs113420705:TT	No_match
sufentanil	rs4680	COMT	AA	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs4680:AA	41693
warfarin	rs7294	VKORC1	CC	Dosage	decreased	LADME	Other:Heart_valve_replacement		B01AA03	rs7294:CC	54688261
immunoglobulins	rs28493229	COQ8B, ITPKC	CC	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs28493229:CC	No_match
immunoglobulins	rs28493229	COQ8B, ITPKC	CG	Efficacy	decreased	Efficacy_Response	Disease:C0236036		J06B	rs28493229:CG	No_match
ustekinumab	rs763780	IL17F	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs763780:TT	No_match
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Other:Heart_valve_replacement		B01AA03	rs1057910:AA	54688261
infliximab	rs763780	IL17F	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02	rs763780:CT	No_match
hydrochlorothiazide	rs1378942	CSK	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs1378942:C	2904
salbutamol	rs35661809	__INTRONIC__	G	Efficacy	increased	Efficacy_Response	Healthy		R03CC02	rs35661809:G	2083
antipsychotics	rs6280	DRD3	CT	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs6280:CT	No_match
antipsychotics	rs6280	DRD3	TT	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs6280:TT	No_match
hydrochlorothiazide	rs12579720	PDE3A	C	Efficacy	increased	Efficacy_Response	Other:C0020538		C03AA03	rs12579720:C	2904
candesartan	rs6722745	SULT1C3	T	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA06	rs6722745:T	146026636
atenolol	rs4387287	STN1	A	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB03	rs4387287:A	14211540
metformin	rs10783050	__INTRONIC__	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs10783050:TT	155906370
metformin	rs1143623	IL1B	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs1143623:GG	155906370
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
warfarin	rs9923231	VKORC1	TT	Metabolism/PK	decreased	LADME	Healthy		B01AA03	rs9923231:TT	54688261
cisplatin, paclitaxel	rs1042522	TP53	CG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:CG	5460033
cisplatin, paclitaxel	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD01|L01XA01	rs1042522:GG	5460033
rifapentine	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AA	135403821
rifapentine	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs1045642:AG	135403821
bevacizumab, pegaptanib, ranibizumab	rs2010963	VEGFA	CC	Efficacy	decreased	Efficacy_Response	Disease:Choroidal_Neovascularization		L01FG01|S01LA03|S01LA04	rs2010963:CC	No_match
epirubicin, fluorouracil, oxaliplatin	rs1800566	NQO1	AA	Efficacy	decreased	Efficacy_Response	Disease:C2939419|Disease:C0026640		L01BC02|L01DB03|L01XA03	rs1800566:AA	9887054
epirubicin, fluorouracil, oxaliplatin	rs1800566	NQO1	AG	Efficacy	decreased	Efficacy_Response	Disease:C2939419|Disease:C0026640		L01BC02|L01DB03|L01XA03	rs1800566:AG	9887054
warfarin	rs9923231	VKORC1	CT	Efficacy	increased	Dosage	Other:C0242698		B01AA03	rs9923231:CT	54688261
epirubicin, fluorouracil, oxaliplatin	rs662	PON1	CC	Efficacy	increased	Efficacy_Response	Disease:C2939419|Disease:C0026640		L01BC02|L01DB03|L01XA03	rs662:CC	9887054
risperidone	rs2276707	NR1I2	CC	Metabolism/PK	decreased	LADME	Disease:C0005586|Disease:C0235876|Disease:C0036502		N05AX08	rs2276707:CC	849421
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs28399499:C	64139
warfarin	rs9923231	VKORC1	CT	Efficacy	decreased	Efficacy_Response	Other:C0242698		B01AA03	rs9923231:CT	54688261
rituximab	rs396991	FCGR3A	C	Efficacy	increased	Efficacy_Response	Other:C0004364		L01FA01	rs396991:C	No_match
nicotine	rs16969968	CHRNA3, CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs16969968:AA	936
nicotine	rs16969968	CHRNA3, CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs16969968:AG	936
clozapine	rs2276302	HTR3A	G	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH02	rs2276302:G	131769989
imatinib	rs2032582	ABCB1	AT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:AT	6113
imatinib	rs2032582	ABCB1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2032582:TT	6113
imatinib	rs2231142	ABCG2	T	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs2231142:T	6113
telmisartan	rs5443	GNB3	TT	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09CA07	rs5443:TT	67184
efavirenz	rs8192719	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs8192719:T	64139
lithium, valproic acid	rs2769605	__INTRONIC__	CC	Efficacy	decreased	Efficacy_Response	Disease:C0005586		N03AG01|N05AN01	rs2769605:CC	3028194
cisplatin, fluorouracil	rs7121	GNAS	CC	Efficacy	increased	Efficacy_Response	Disease:Neoplasm_of_esophagus		L01BC02|L01XA01	rs7121:CC	5460033
atenolol, metoprolol	rs1367094	ZMAT4	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB02|C07AB03	rs1367094:T	4171
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:T	64139
atenolol, hydrochlorothiazide, metoprolol	rs11313667	LRRC15	del	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03|C07AB02|C07AB03	rs11313667:del	3639
ondansetron	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		A04AA01	rs776746:CC	4595
lithium, olanzapine	rs1800497	DRD2	GG	Efficacy	increased	Efficacy_Response	Other:C0005586		N05AH03|N05AN01	rs1800497:GG	3028194
hmg coa reductase inhibitors	rs247616	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs247616:T	445127
boceprevir, peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|J05AP03|L03AB10|L03AB11	rs12979860:CC	37542
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs7301582	KLRC1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs7301582:CC	126941
hydrochlorothiazide	rs10224002	PRKAG2	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C03AA03	rs10224002:A	2904
agomelatine, melatonin receptor agonists, selective serotonin reuptake inhibitors, venlafaxine	rs1045642	ABCB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N05CH|N06AB|N06AX16|N06AX22	rs1045642:GG	5202
adalimumab, certolizumab pegol, etanercept, glucocorticoids, infliximab, methotrexate	rs2302489	KLRD1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04|L04AB05|L04AX03|R03BA	rs2302489:TT	126941
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
hydrochlorothiazide	rs932764	PLCE1	A	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs932764:A	2904
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, simeprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP05|L03AB10|L03AB11	rs8099917:TT	37542
metoprolol	rs1446468	__INTRONIC__	T	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB02	rs1446468:T	6322
atenolol	rs9306160	RRP1B	T	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AB03	rs9306160:T	14211540
atenolol	rs8068318	TBX2	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C07AB03	rs8068318:C	14211540
amisulpride	rs1079597	DRD2	C	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AL05	rs1079597:C	169501917
ustekinumab	rs2145623	NFKBIA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs2145623:CC	No_match
hydrochlorothiazide	rs10995311	ADO	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs10995311:C	2904
platinum compounds	rs2269577	XBP1	CC	Efficacy	increased	Efficacy_Response	Disease:C0007131		L01XA	rs2269577:CC	23939
candesartan	rs740406	DOT1L, PLEKHJ1	A	Efficacy	decreased	Efficacy_Response	Other:C0020538		C09CA06	rs740406:A	146026636
ustekinumab	rs2787094	ADAM33	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs2787094:CC	No_match
hydrochlorothiazide	rs757081	NUCB2	C	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs757081:C	2904
ustekinumab	rs1975974	__INTRONIC__	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs1975974:AG	No_match
ustekinumab	rs1975974	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs1975974:GG	No_match
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs8099917:TT	37542
exenatide	rs163184	KCNQ1	G	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BJ01	rs163184:G	45588096
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease|Disease:C0041296		J05AG03	rs3745274:TT	64139
ustekinumab	rs191190	AGBL4	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs191190:CC	No_match
ustekinumab	rs191190	AGBL4	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs191190:CT	No_match
nortriptyline	rs17060812	SLC39A14	C	Efficacy	increased	Efficacy_Response	Disease:C0235876		N06AA10	rs17060812:C	9918
acenocoumarol	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA07	rs9923231:CC	54742534
ustekinumab	rs11591741	CHUK	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs11591741:CC	No_match
ustekinumab	rs11591741	CHUK	CG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs11591741:CG	No_match
ustekinumab	rs6311	HTR2A	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs6311:CT	No_match
ustekinumab	rs6311	HTR2A	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs6311:TT	No_match
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
hydrochlorothiazide	rs12521868	C5orf56	G	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03AA03	rs12521868:G	2904
pitavastatin	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4149056:CC	5282451
pitavastatin	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Healthy		C10AA08	rs4149056:CT	5282451
candesartan	rs3184504	SH2B3	T	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA06	rs3184504:T	146026636
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
carbamazepine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs776746:CC	114709
2-hydroxyatorvastatin, 2-hydroxyatorvastatin lactone, 4-hydroxyatorvastatin, 4-hydroxyatorvastatin lactone, atorvastatin, atorvastatin lactone	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA05	rs4149056:C	6483036
carbamazepine	rs15524	CYP3A5	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs15524:AA	114709
paroxetine	rs4680	COMT	A	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05	rs4680:A	667572
capecitabine, paclitaxel	rs1042522	TP53	GG	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC06|L01CD01	rs1042522:GG	60953
sufentanil	rs2242480	CYP3A4	CC	Dosage	increased	Dosage	Other:C0030193|Postoperative		N01AH03	rs2242480:CC	41693
triglycerides	rs749292	CYP19A1	A	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs749292:A	56842239
hdl cholesterol	rs1062033	CYP19A1	G	Other	increased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs1062033:G	5997
efavirenz	rs28399499	CYP2B6	C	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:C	64139
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Disease:C0026265		B01AA03	rs1057910:AA	54688261
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Other:heart_valve_replacement		B01AA03	rs9934438:AA	54688261
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
nortriptyline	rs2273623	PPM1A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235876		N06AA10	rs2273623:AA	9918
amiloride, spironolactone	rs1126742	CYP4A11	GG	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03DA01|C03DB01	rs1126742:GG	5833
azathioprine, mercaptopurine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0021390		L01BB02|L04AX01	rs116855232:TT	5778
deferasirox	rs3806596	UGT1A3	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs3806596:CC	214348
lopinavir	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs776746:C	169501901
propofol	rs2279343	CYP2B6	AA	Metabolism/PK	decreased	LADME	Healthy		N01AX10	rs2279343:AA	3014064
propofol	rs2279343	CYP2B6	AG	Metabolism/PK	decreased	LADME	Healthy		N01AX10	rs2279343:AG	3014064
spironolactone	rs3890011	CYP4A11	CC	Efficacy	decreased	Efficacy_Response	Other:C0020538		C03DA01	rs3890011:CC	169502192
opioids	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:GG	No_match
atazanavir	rs2472677	NR1I2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AE08	rs2472677:TT	118753185
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT	131769926
rifampicin	rs1803155	AADAC	AA	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs1803155:AA	135542225
apatinib, apatinib metabolite m1-1	rs1934968	CYP2C9	GG	Metabolism/PK	increased	LADME	Other:C0027651		L01EH01	rs1934968:GG	No_match
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs11075995	FTO	AT	Efficacy	increased	Efficacy_Response	Other:C0027651		No_ATC	rs11075995:AT	No_match
pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors	rs11075995	FTO	TT	Efficacy	increased	Efficacy_Response	Other:C0027651		No_ATC	rs11075995:TT	No_match
amprenavir	rs4149056	SLCO1B1	C	Metabolism/PK	decreased	LADME	Other:HIV_infectious_disease		J05AE05	rs4149056:C	131535
acamprosate	rs77583603	__INTRONIC__	G	Efficacy	decreased	Efficacy_Response	Other:C0085762		N07BB03	rs77583603:G	1646
everolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L01EG02	rs776746:CC	6442177
everolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L01EG02	rs776746:CT	6442177
naltrexone	rs12749274	__INTRONIC__	A	Efficacy	decreased	Efficacy_Response	Other:C0085762		N07BB04	rs12749274:A	5360515
deferasirox	rs13120400	ABCG2	CC	Metabolism/PK	increased	LADME	Disease:Beta-thalassemia_and_related_diseases		V03AC03	rs13120400:CC	214348
fluvastatin	rs4149056	SLCO1B1	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:CC	131750727
fluvastatin	rs4149056	SLCO1B1	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:CT	131750727
ritonavir	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE03	rs1128503:AA	71749331
ritonavir	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE03	rs2032582:AA	71749331
fluvastatin	rs429358	APOE	CC	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs429358:CC	131750727
ritonavir	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE03	rs1045642:AA	71749331
doxorubicin	rs20572	CBR1	CC	Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs20572:CC	83958
dehydroaripiprazole	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341		N05AX12	rs762551:AA	10114519
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Other:C0036341|Other:C0039338		N05AH02	rs762551:AA	131769989
ethanol	rs1799971	OPRM1	AA	Dosage	increased	Dosage	Healthy		V03AB16	rs1799971:AA	444899
prednisolone	rs3824662	GATA3	AA	Efficacy	decreased	Efficacy_Response	Other:C0023449		S02BA03	rs3824662:AA	54605501
tacrolimus	rs7483	GSTM3	TT	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs7483:TT	131769926
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1051792	MICA	AG	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs1051792:AG	No_match
adalimumab	rs1799724	TNF	CC	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB04	rs1799724:CC	107706
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1051792	MICA	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		No_ATC	rs1051792:GG	No_match
fluoxetine	rs130058	HTR1B	AA	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AB03	rs130058:AA	1548968
fluoxetine	rs130058	HTR1B	TT	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AB03	rs130058:TT	1548968
adalimumab	rs1800629	TNF	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB04	rs1800629:GG	107706
clozapine	rs762551	CYP1A2	AA	Efficacy	decreased	Efficacy_Response	Other:C0036341		N05AH02	rs762551:AA	131769989
fluvastatin	rs7412	APOE	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs7412:TT	131750727
adalimumab	rs361525	TNF	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AB04	rs361525:GG	107706
morphine	rs1042173	SLC6A4	CC	Dosage	decreased	Dosage	Other:C0024121|Other:C0030193		N02AA01	rs1042173:CC	5284371
fluoxetine	rs4570625	TPH2	TT	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06AB03	rs4570625:TT	1548968
methotrexate	rs17004921	ADORA2A-AS1	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs17004921:CT	11329481
methotrexate	rs17004921	ADORA2A-AS1	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs17004921:TT	11329481
antiepileptics	rs2032582	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2032582:AA	No_match
antiepileptics	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs1045642:AA	No_match
atenolol, hydrochlorothiazide	rs261316	ALDH1A2	T	Efficacy	decreased	Efficacy_Response	Disease:C0020538		C03AA03|C07AB03	rs261316:T	3639
cisplatin	rs462779	REV3L	AG	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs462779:AG	441203
cisplatin	rs462779	REV3L	GG	Efficacy	decreased	Efficacy_Response	Disease:C0029463		L01XA01	rs462779:GG	441203
cisplatin	rs3087403	REV1	CT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs3087403:CT	441203
cisplatin	rs3087403	REV1	TT	Efficacy	increased	Efficacy_Response	Disease:C0029463		L01XA01	rs3087403:TT	441203
antiepileptics	rs2298771	SCN1A	CC	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2298771:CC	No_match
antiepileptics	rs2298771	SCN1A	CT	Efficacy	increased	Efficacy_Response	Other:C0014544		N03A	rs2298771:CT	No_match
azithromycin	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		S01AA26	rs2032582:AA	168720537
azithromycin	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Healthy		S01AA26	rs1045642:AA	168720537
lopinavir	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:C	169501901
fentanyl	rs9384179	OPRM1	AA	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs9384179:AA	13653606
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
fluvastatin	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs1057910:AC	131750727
fentanyl	rs2835859	KCNJ6	TT	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs2835859:TT	13653606
abiraterone	rs1047303	HSD3B1	AC	Metabolism/PK	increased	LADME	Other:C0033578		L02BX03	rs1047303:AC	91826892
fentanyl	rs2952768	__INTRONIC__	CC	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs2952768:CC	13653606
fentanyl	rs11959113	__INTRONIC__	AA	Dosage, Efficacy	increased	Dosage	Side_Effect:C0030193|Postoperative		N02AB03	rs11959113:AA	13653606
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Heart_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Heart_transplantation		L04AD02	rs776746:TT	131769926
cyclophosphamide	rs3957356	GSTA1	CT	Efficacy, Toxicity, Metabolism/PK	decreased	Efficacy_Response	Disease:C0027697		L01AA01	rs3957356:CT	9554282
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
bilirubin	rs4880	SOD2	GG	Toxicity	increased	LADME	Other:C0023449		No_ATC	rs4880:GG	46931084
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Heart_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
ethanol	rs1799971	OPRM1	AG	Other	increased	LADME	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Other	increased	LADME	Healthy		V03AB16	rs1799971:GG	444899
methylphenidate	rs5569	SLC6A2	GG	Efficacy	increased	Efficacy_Response	Disease:C1263846		N06BA04	rs5569:GG	154100
tacrolimus	rs1057868	POR	CT	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Metabolism/PK	increased	LADME	Disease:Heart_transplantation		L04AD02	rs1057868:TT	131769926
montelukast	rs7604115	UGT1A3	T	Metabolism/PK	decreased	LADME	Healthy		R03DC03	rs7604115:T	122021
montelukast	rs704212	ABCC9	T	Metabolism/PK	decreased	LADME	Healthy		R03DC03	rs704212:T	122021
ivacaftor	rs77010898	CFTR	AA	Efficacy	increased	Efficacy_Response	Disease:C0156318		R07AX02	rs77010898:AA	72722243
docetaxel, doxorubicin	rs1937840	AKR1C3	GG	Efficacy	increased	Efficacy_Response	Disease:C1458155		L01CD02|L01DB01	rs1937840:GG	148124
cyclophosphamide, doxorubicin	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs4244285:AA	2907
cyclophosphamide, doxorubicin	rs4244285	CYP2C19	AG	Efficacy	decreased	Efficacy_Response	Disease:C1458155		L01AA01|L01DB01	rs4244285:AG	2907
antidepressants	rs1954787	GRIK4	TT	Efficacy	decreased	Efficacy_Response	Other:C0011581		N06A	rs1954787:TT	No_match
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Other:Hematopoietic_stem_cell_transplantation		L04AD02	rs776746:TT	131769926
antidepressants	rs1954787	GRIK4	C	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs1954787:C	No_match
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Other:C0580417		B01AA03	rs1057910:AC	54688261
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
warfarin	rs7294	VKORC1	T	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs7294:T	54688261
warfarin	rs1057910	CYP2C9	A	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs1057910:A	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG	54688261
buprenorphine	rs2075572	OPRM1	CC	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs2075572:CC	11274356
buprenorphine	rs2075572	OPRM1	CG	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC01	rs2075572:CG	11274356
selective serotonin (5ht1) agonists	rs2651899	PRDM16	C	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		No_ATC	rs2651899:C	5202
afatinib	rs6785049	NR1I2	AA	Metabolism/PK	decreased	LADME	Other:C0007131		L01EB03	rs6785049:AA	10184653
afatinib	rs6785049	NR1I2	AG	Metabolism/PK	decreased	LADME	Other:C0007131		L01EB03	rs6785049:AG	10184653
warfarin	rs4917639	CYP2C9	C	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4917639:C	54688261
lopinavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:CT	169501901
naltrexone	rs1799971	OPRM1	AG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:AG	5360515
naltrexone	rs1799971	OPRM1	GG	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB04	rs1799971:GG	5360515
atazanavir	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1128503:AG	118753185
atazanavir	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1128503:GG	118753185
antidepressants	rs1128503	ABCB1	A	Efficacy	increased	Efficacy_Response	Other:C0011581		N06A	rs1128503:A	No_match
methadone	rs933271	COMT	CC	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs933271:CC	10090
methadone	rs933271	COMT	CT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC02	rs933271:CT	10090
valproic acid	rs2070959	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	AG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs2070959:AG	134459
atazanavir	rs2032582	ABCB1	AC	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs2032582:AC	118753185
atazanavir	rs2032582	ABCB1	CC	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs2032582:CC	118753185
atazanavir	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1045642:AG	118753185
atazanavir	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Healthy		J05AE08	rs1045642:GG	118753185
methotrexate	rs1801131	MTHFR	GT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:GT	11329481
methotrexate	rs1801131	MTHFR	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:TT	11329481
valproic acid	rs1019385	GRIN2B	AC	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AG01	rs1019385:AC	134459
valproic acid	rs1019385	GRIN2B	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0014544		N03AG01	rs1019385:CC	134459
methotrexate	rs1051266	SLC19A1	CT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:CT	11329481
methotrexate	rs1051266	SLC19A1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs1051266:TT	11329481
carbamazepine, clobazam, ethosuximide, lamotrigine, levetiracetam, oxcarbazepine, valproic acid	rs2298771	SCN1A	C	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AD01|N03AF01|N03AF02|N03AG01|N03AX09|N03AX14|N05BA09	rs2298771:C	3878
lopinavir	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:C	169501901
valproic acid	rs1105879	UGT1A6	AC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs1105879:AC	134459
fluvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA04	rs4149056:TT	131750727
everolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:C1458155|Other:C0005967|Other:Neuroendocrine_Tumors		L01EG02	rs776746:CT	6442177
warfarin	rs2108622	CYP4F2	C	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2108622:C	54688261
amisulpride	rs8636	SNAP25	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AL05	rs8636:CT	169501917
clopidogrel	rs2487032	ABCA1	A	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs2487032:A	13748464
clopidogrel	rs2254638	N6AMT1	G	Metabolism/PK	decreased	LADME	Healthy		B01AC04	rs2254638:G	13748464
tenofovir	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs2231142:GT	9574768
tenofovir	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AF07	rs2231142:TT	9574768
sirolimus	rs2032582	ABCB1	A	Metabolism/PK	increased	LADME	Disease:Hematopoietic_stem_cell_transplantation		No_ATC	rs2032582:A	5284616
antipsychotics	rs12467557	NRXN1	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs12467557:AA	No_match
antipsychotics	rs10490162	NRXN1	TT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05A	rs10490162:TT	No_match
clopidogrel	rs4986893	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4986893:AA	13748464
dabigatran	rs8192935	CES1	GG	Metabolism/PK	increased	LADME	Disease:C0004238		B01AE07	rs8192935:GG	169501783
atazanavir	rs2032582	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE08	rs2032582:AA	118753185
adalimumab, certolizumab pegol, golimumab, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Other:C0023370		L04AB02|L04AB04|L04AB05|L04AB06	rs1800629:GG	No_match
clopidogrel	rs4244285	CYP2C19	AA	Efficacy	decreased	Efficacy_Response	Healthy		B01AC04	rs4244285:AA	13748464
tacrolimus	rs776746	CYP3A5	CC	Other, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
atazanavir	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE08	rs1045642:AA	118753185
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
bevacizumab	rs1061170	CFH	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs1061170:CC	No_match
valproic acid	rs2070959	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs2070959:GG	134459
cisplatin, fluorouracil	rs3918290	DPYD	CT	Efficacy	decreased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		L01BC02|L01XA01	rs3918290:CT	5460033
cisplatin, docetaxel, irinotecan	rs861539	XRCC3	AA	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01CD02|L01CE02|L01XA01	rs861539:AA	5460033
valproic acid	rs6759892	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GG	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs6759892:GG	134459
valproic acid	rs6759892	UGT1A10, UGT1A6, UGT1A7, UGT1A8, UGT1A9	GT	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs6759892:GT	134459
peginterferon alfa-2a, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB11	rs12979860:CC	37542
valproic acid	rs1105879	UGT1A6	CC	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AG01	rs1105879:CC	134459
10-monohydroxy oxcarbazepine	rs2396185	INSR	C	Metabolism/PK	decreased	LADME	Other:C0014544		N03AF02	rs2396185:C	71750797
atazanavir	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		J05AE08	rs1128503:AA	118753185
risperidone	rs6295	HTR1A	GG	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs6295:GG	849421
fentanyl	rs3845446	CACNA1E	CC	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs3845446:CC	13653606
fentanyl	rs3845446	CACNA1E	CT	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs3845446:CT	13653606
fentanyl	rs2076222	LAMB3	G	Dosage, Efficacy	increased	Dosage	Disease:C0030193|Postoperative		N02AB03	rs2076222:G	13653606
cetuximab	rs833061	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs833061:TT	No_match
cetuximab	rs1570360	VEGFA	GG	Efficacy	increased	Efficacy_Response	Disease:C0023055		No_ATC	rs1570360:GG	No_match
cisplatin, fluorouracil, mitoxantrone	rs1734791	MECP2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs1734791:A	5460033
cisplatin, fluorouracil, mitoxantrone	rs1734787	MECP2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs1734787:A	5460033
cisplatin, fluorouracil, mitoxantrone	rs17435	MECP2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs17435:A	5460033
voriconazole	rs2242480	CYP3A4	CT	Metabolism/PK	increased	LADME	Healthy	poor metabolizer	J02AC03	rs2242480:CT	9741
cisplatin, fluorouracil, mitoxantrone	rs5906072	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs5906072:T	5460033
prochlorperazine	rs1800497	ANKK1, DRD2	AA	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1800497:AA	3084059
prochlorperazine	rs1800497	ANKK1, DRD2	AG	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1800497:AG	3084059
prochlorperazine	rs1079597	DRD2	CT	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1079597:CT	3084059
prochlorperazine	rs1079597	DRD2	TT	Efficacy	decreased	Efficacy_Response	Other:C0027497		No_ATC	rs1079597:TT	3084059
metformin	rs11212617	ATM	AC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs11212617:AC	155906370
morphine	rs1051660	OPRK1	A	Dosage, Efficacy	decreased	Dosage	Disease:C0030193		N02AA01	rs1051660:A	5284371
cisplatin, fluorouracil, mitoxantrone	rs12613732	GALNT14	G	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs12613732:G	5460033
cisplatin, fluorouracil, mitoxantrone	rs5009910	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs5009910:C	5460033
atorvastatin	rs17671591	HMGCR	CT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs17671591:CT	656846
atorvastatin	rs17671591	HMGCR	TT	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA05	rs17671591:TT	656846
escitalopram	rs1800532	TPH1	GT	Efficacy	decreased	Efficacy_Response	Other:C0235876		N06AB10	rs1800532:GT	162180
escitalopram	rs1800532	TPH1	TT	Efficacy	decreased	Efficacy_Response	Other:C0235876		N06AB10	rs1800532:TT	162180
cisplatin, fluorouracil, mitoxantrone	rs6752303	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs6752303:C	5460033
tenofovir alafenamide	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Healthy		J05AF13	rs35599367:AG	9574768
cisplatin, fluorouracil, mitoxantrone	rs10209881	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs10209881:C	5460033
dabigatran	rs2244613	CES1	GG	Metabolism/PK	decreased	LADME	Disease:C0004238		B01AE07	rs2244613:GG	169501783
clopidogrel	rs4244285	CYP2C19	A	Metabolism/PK	increased	Dosage	Healthy	poor metabolizer	B01AC04	rs4244285:A	13748464
cisplatin, fluorouracil, mitoxantrone	rs12999804	GALNT14	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs12999804:A	5460033
tacrolimus	rs2740574	CYP3A4	TT	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs2740574:TT	131769926
apatinib, apatinib metabolite m1-1	rs34532201	CYP2C9	TT	Metabolism/PK	increased	LADME	Other:C0027651		L01EH01	rs34532201:TT	No_match
cisplatin, fluorouracil, mitoxantrone	rs5934731	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs5934731:C	5460033
cisplatin, fluorouracil, mitoxantrone	rs715171	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs715171:C	5460033
cisplatin, fluorouracil, mitoxantrone	rs4932551	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs4932551:C	5460033
cisplatin, fluorouracil, mitoxantrone	rs7170769	__INTRONIC__	T	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs7170769:T	5460033
cisplatin, fluorouracil, mitoxantrone	rs6458232	__INTRONIC__	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs6458232:C	5460033
cisplatin, fluorouracil, mitoxantrone	rs7608731	GALNT14	C	Efficacy	Indeterminado	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs7608731:C	5460033
allopurinol, febuxostat	rs3731722	AOX1	G	Dosage	Indeterminado	Dosage	Disease:C0018099		M04AA01|M04AA03	rs3731722:G	134018
pazopanib	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Other:C0027651		L01EX03	rs35599367:AG	10113978
rituximab	rs6822844	IL2	GG	Efficacy	increased	Efficacy_Response	Disease:C0004364		L01FA01	rs6822844:GG	No_match
rituximab	rs6822844	IL2	GG	Efficacy	increased	Efficacy_Response	Disease:C0024141		L01FA01	rs6822844:GG	No_match
allopurinol, febuxostat	rs11678615	AOX1	T	Dosage	Indeterminado	Dosage	Disease:C0018099		M04AA01|M04AA03	rs11678615:T	134018
methotrexate	rs1801131	MTHFR	GG	Efficacy	decreased	Efficacy_Response	Disease:C0003873		L04AX03	rs1801131:GG	11329481
diazepam	rs1128503	ABCB1	AA	Metabolism/PK	increased	LADME	Healthy		N05BA01	rs1128503:AA	3016
allopurinol, febuxostat	rs34650714	UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9	T	Dosage	decreased	Dosage	Disease:C0018099		M04AA01|M04AA03	rs34650714:T	134018
allopurinol, febuxostat	rs1884725	XDH	G	Dosage	decreased	Dosage	Disease:C0018099		M04AA01|M04AA03	rs1884725:G	134018
allopurinol, febuxostat	rs75995567	AOX1	T	Dosage	increased	Dosage	Disease:C0018099		M04AA01|M04AA03	rs75995567:T	134018
metformin	rs622342	SLC22A1	AC	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs622342:AC	155906370
propofol, remifentanil	rs1128503	ABCB1	GG	Efficacy	increased	Efficacy_Response	Healthy		N01AH06|N01AX10	rs1128503:GG	60815
methotrexate	rs4148416	ABCC3	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs4148416:TT	11329481
tacrolimus	rs2740574	CYP3A4	TT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:TT	131769926
methotrexate	rs17004785	SLC19A1	CG	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs17004785:CG	11329481
donepezil	rs1803274	BCHE	T	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02	rs1803274:T	3152
cisplatin, doxorubicin, methotrexate	rs2236225	MTHFD1	AA	Efficacy	increased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs2236225:AA	5460033
cisplatin, doxorubicin, methotrexate	rs2236225	MTHFD1	AG	Efficacy	increased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs2236225:AG	5460033
cisplatin, fluorouracil, mitoxantrone	rs9679162	GALNT14	TT	Efficacy	increased	Efficacy_Response	Disease:C2239176		L01BC02|L01DB07|L01XA01	rs9679162:TT	5460033
paroxetine	rs2973049	GDNF	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2973049:CT	667572
paroxetine	rs2973049	GDNF	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2973049:TT	667572
paroxetine	rs2216711	GDNF	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2216711:AA	667572
paroxetine	rs2216711	GDNF	AG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs2216711:AG	667572
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4819554	IL17RA	AA	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs4819554:AA	No_match
atomoxetine	rs3785143	SLC6A2	T	Efficacy	decreased	Efficacy_Response	Disease:C1263846		N06BA09	rs3785143:T	6093336
paroxetine	rs6265	BDNF	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs6265:CC	667572
paroxetine	rs6265	BDNF	CT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB05	rs6265:CT	667572
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	AC	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs396991:AC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs396991	FCGR3A	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs396991:CC	No_match
rosuvastatin	rs5882	CETP	G	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs5882:G	5282455
fluoxetine	rs1135840	CYP2D6	C	Metabolism/PK	increased	LADME	Healthy		N06AB03	rs1135840:C	1548968
disulfiram	rs1611115	DBH	CC	Efficacy	increased	Efficacy_Response	Disease:C0085762		N07BB01	rs1611115:CC	101405
risperidone	rs9606186	COMT	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs9606186:GG	849421
rivaroxaban	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs1045642:AA	10700
rivaroxaban	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:C0004238		B01AF01	rs1045642:AG	10700
tacrolimus	rs10052999	C6	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs10052999:CC	131769926
tacrolimus	rs10052999	C6	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs10052999:TT	131769926
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG	54688261
tacrolimus	rs9200	C6	CC	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs9200:CC	131769926
tacrolimus	rs9200	C6	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs9200:CT	131769926
cisplatin, doxorubicin, methotrexate	rs717620	ABCC2	CT	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs717620:CT	5460033
cisplatin, doxorubicin, methotrexate	rs717620	ABCC2	TT	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs717620:TT	5460033
risperidone	rs2661319	RGS4	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2661319:C	849421
lamotrigine	rs628031	SLC22A1	AA	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs628031:AA	71236569
lamotrigine	rs628031	SLC22A1	AG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs628031:AG	71236569
risperidone	rs1800497	ANKK1	A	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs1800497:A	849421
tacrolimus	rs2740574	CYP3A4	CT	Metabolism/PK	increased	Dosage	Other:C0277631		L04AD02	rs2740574:CT	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CC	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	AG	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:AG	5460033
cisplatin, doxorubicin, methotrexate	rs1695	GSTP1	GG	Efficacy	decreased	Efficacy_Response	Other:C0029463		L01DB01|L01XA01|L04AX03	rs1695:GG	5460033
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	decreased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:TT	131769926
phenytoin	rs1057910	CYP2C9	C	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AB02	rs1057910:C	1775
carbamazepine	rs3812718	SCN1A	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT	114709
phenytoin	rs3812718	SCN1A	T	Dosage	increased	Dosage	Disease:C0014544		N03AB02	rs3812718:T	1775
acenocoumarol	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:TT	54742534
tacrolimus	rs2032582	ABCB1	T	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2032582:T	131769926
alpha-hydroxymetoprolol	rs28371738	CYP2D6	A	Metabolism/PK	increased	LADME	Healthy		C07AB02	rs28371738:A	114962
rivaroxaban	rs1128503	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1128503:AG	10700
rivaroxaban	rs1128503	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1128503:GG	10700
fluvoxamine, milnacipran, paroxetine	rs6295	HTR1A	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs6295:GG	5324346
lansoprazole	rs1045642	ABCB1	G	Other, Metabolism/PK	increased	LADME	Healthy		A02BC03	rs1045642:G	11985
fluvoxamine, milnacipran, paroxetine	rs10042486	HTR1A	CC	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB05|N06AB08|N06AX17	rs10042486:CC	5324346
lamotrigine	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2231142:TT	71236569
rivaroxaban	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1045642:AG	10700
rivaroxaban	rs1045642	ABCB1	GG	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs1045642:GG	10700
rivaroxaban	rs4148738	ABCB1	T	Metabolism/PK	decreased	LADME	Other:C0004238		B01AF01	rs4148738:T	10700
phenytoin	rs1934969	CYP2C9	AT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1934969:AT	1775
phenytoin	rs1934969	CYP2C9	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AB02	rs1934969:TT	1775
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs9923231:TT	54688261
hmg coa reductase inhibitors	rs4420638	APOC1	G	Efficacy	decreased	Efficacy_Response	Disease:C0007222|Disease:C0020443		C10AA	rs4420638:G	445127
warfarin	rs1057910	CYP2C9	AC	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs1057910:AC	54688261
warfarin	rs1057910	CYP2C9	CC	Dosage	decreased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs1057910:CC	54688261
photodynamic therapy	rs5985	F13A1	AA	Efficacy	decreased	Efficacy_Response	Disease:Choroidal_Neovascularization		No_ATC	rs5985:AA	No_match
photodynamic therapy	rs5985	F13A1	AC	Efficacy	decreased	Efficacy_Response	Disease:Choroidal_Neovascularization		No_ATC	rs5985:AC	No_match
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Disease:C0004238|Disease:Heart_valve_replacement|Disease:C0020542|Disease:C0034065|Disease:C0042487		B01AA03	rs2108622:TT	54688261
citalopram	rs1800532	TPH1	GT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs1800532:GT	162180
citalopram	rs1800532	TPH1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs1800532:TT	162180
hmg coa reductase inhibitors	rs2072183	NPC1L1	G	Efficacy	decreased	Efficacy_Response	Disease:C0007222|Disease:C0020443		C10AA	rs2072183:G	445127
hmg coa reductase inhibitors	rs629301	SORT1	T	Efficacy	decreased	Efficacy_Response	Disease:C0007222|Disease:C0020443		C10AA	rs629301:T	445127
mycophenolic acid	rs3832043	UGT1A9	del	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs3832043:del	5281078
bisoprolol	rs2514036	ACY3	T	Efficacy	increased	Efficacy_Response	Disease:C0020538		C07AB07	rs2514036:T	91810599
mycophenolic acid	rs2306283	SLCO1B1	AA	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs2306283:AA	5281078
mycophenolic acid	rs2306283	SLCO1B1	AG	Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AA06	rs2306283:AG	5281078
imatinib	rs724710	BCL2L11	T	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs724710:T	6113
fluorouracil	rs3918290	DPYD	CT	Metabolism/PK	decreased	LADME	Disease:C0023055		L01BC02	rs3918290:CT	5790
itopride	rs2266782	FMO3	AA	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266782:AA	3792
metoprolol	rs56234624	SEPTIN3	G	Metabolism/PK	increased	LADME	Healthy		C07AB02	rs56234624:G	6322
itopride	rs2266780	FMO3	GG	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs2266780:GG	3792
alemtuzumab, chlorambucil, cyclophosphamide, fludarabine, prednisone, rituximab, vincristine	rs1801157	CXCL12	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		H02AB07|L01AA01|L01AA02|L01BB05|L01CA02|L01FA01	rs1801157:CT	2907
alemtuzumab, chlorambucil, cyclophosphamide, fludarabine, prednisone, rituximab, vincristine	rs1801157	CXCL12	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023418|Lymphocytic|Chronic|B-Cell		H02AB07|L01AA01|L01AA02|L01BB05|L01CA02|L01FA01	rs1801157:TT	2907
mycophenolic acid	rs3740066	ABCC2	CT	Metabolism/PK	decreased	LADME	Disease:Lung_transplantation		L04AA06	rs3740066:CT	5281078
gemcitabine	rs9937	RRM1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs9937:AA	597
tacrolimus	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1045642:AA	131769926
tacrolimus	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Lung_transplantation		L04AD02	rs1045642:AG	131769926
bevacizumab	rs4073	CXCL8	AA	Efficacy	decreased	Efficacy_Response	Disease:C0024437		L01FG01	rs4073:AA	No_match
gemcitabine	rs183484	RRM1	AC	Efficacy, Toxicity	decreased	Efficacy_Response	Disease:C0030297		L01BC05	rs183484:AC	597
hydrochlorothiazide	rs4149601	NEDD4L	AG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4149601:AG	2904
hydrochlorothiazide	rs4149601	NEDD4L	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C03AA03	rs4149601:GG	2904
sn-38(irinotecan)	rs4148323	UGT1A1	AA	Dosage	increased	LADME	Other:C0007131		L01CE02	rs4148323:AA	60838
cotinine	rs12471326	UGT1A9	CT	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs12471326:CT	108114
nicotine	rs145014075	CYP2A6	GT	Metabolism/PK	increased	LADME	Healthy		N07BA01	rs145014075:GT	936
bevacizumab, ranibizumab	rs3025000	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:CT	No_match
bevacizumab, ranibizumab	rs3025000	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:TT	No_match
cyclosporine	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		L04AD01	rs776746:CC	86666680
cyclosporine	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Healthy		L04AD01	rs776746:CT	86666680
granisetron	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Side_Effect:C0027497|Side_Effect:C0042963		A04AA02	rs1045642:AA	5284566
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Other:C0085605		B01AA03	rs9923231:CC	54688261
warfarin	rs9923231	VKORC1	CT	Dosage	increased	Dosage	Other:C0085605		B01AA03	rs9923231:CT	54688261
carbamazepine	rs3812718	SCN1A	CC	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs3812718:CC	114709
carbamazepine	rs3812718	SCN1A	CT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs3812718:CT	114709
bevacizumab, ranibizumab	rs3025000	VEGFA	CT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:CT	No_match
bevacizumab, ranibizumab	rs3025000	VEGFA	TT	Efficacy	increased	Efficacy_Response	Disease:C0024437		L01FG01|S01LA04	rs3025000:TT	No_match
carbamazepine	rs3812718	SCN1A	TT	Dosage	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT	114709
etanercept	rs6427528	CD84	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB01	rs6427528:AG	No_match
lopinavir	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:CC	169501901
lopinavir	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AR10	rs4149056:CT	169501901
carbamazepine	rs2298771	SCN1A	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs2298771:TT	114709
methadone	rs10485058	OPRM1	AA	Efficacy	increased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs10485058:AA	10090
carbamazepine	rs2290732	GABRA1	AA	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs2290732:AA	114709
carbamazepine	rs2290732	GABRA1	AG	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AF01	rs2290732:AG	114709
warfarin	rs9923231	VKORC1	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
ustekinumab	rs3213094	IL12B	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs3213094:CT	No_match
gemcitabine	rs2072671	CDA	AA	Efficacy	increased	Efficacy_Response	Disease:C0030297		L01BC05	rs2072671:AA	597
tocilizumab	rs11265618	IL6R	CC	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs11265618:CC	No_match
tocilizumab	rs12083537	IL6R	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AC07	rs12083537:AA	No_match
efavirenz	rs2032582	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2032582:AA	64139
alfentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Disease:C0030193		N01AH02	rs1799971:AG	51263
alfentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Disease:C0030193		N01AH02	rs1799971:GG	51263
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
efavirenz	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs1045642:AA	64139
cetuximab	rs396991	FCGR3A	AA	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs396991:AA	No_match
cetuximab	rs1801274	FCGR2A	GG	Efficacy	increased	Efficacy_Response	Disease:Head_and_Neck_Neoplasms		No_ATC	rs1801274:GG	No_match
efavirenz	rs1884613	HNF4A	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs1884613:CC	64139
methadone	rs2760118	ALDH5A1	CT	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs2760118:CT	10090
methadone	rs2760118	ALDH5A1	TT	Efficacy	decreased	Efficacy_Response	Disease:Opioid-Related_Disorders		N07BC02	rs2760118:TT	10090
atazanavir	rs887829	UGT1A1	TT	Toxicity	increased	Adverse_Event	Healthy		J05AE08	rs887829:TT	118753185
platinum compounds	rs25487	XRCC1	CT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C0026640		L01XA	rs25487:CT	23939
platinum compounds	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C0026640		L01XA	rs25487:TT	23939
olanzapine	rs1880676	CHAT	A	Dosage, Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AH03	rs1880676:A	74603552
pravastatin	rs113646094	ABCC2	CG	Metabolism/PK	increased	LADME	Healthy		C10AA03	rs113646094:CG	58746970
ramipril	rs4359	ACE	CC	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4359:CC	5464096
ramipril	rs4359	ACE	TT	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4359:TT	5464096
ramipril	rs4344	ACE	AA	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4344:AA	5464096
ramipril	rs4344	ACE	GG	Efficacy	increased	Efficacy_Response	Disease:C0020538		C09AA05	rs4344:GG	5464096
warfarin	rs2108622	CYP4F2	T	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs2108622:T	54688261
tacrolimus	rs776746	CYP3A5	CT	Efficacy	decreased	LADME	Other:C0017658|Membranous		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Efficacy	decreased	LADME	Other:C0017658|Membranous		L04AD02	rs776746:TT	131769926
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs8099917:TT	37542
oxycodone	rs581111	OPRD1	AA	Efficacy	decreased	Efficacy_Response	Healthy		N02AA05	rs581111:AA	5462350
oxycodone	rs581111	OPRD1	AG	Efficacy	decreased	Efficacy_Response	Healthy		N02AA05	rs581111:AG	5462350
peginterferon alfa-2b, ribavirin	rs1049174	KLRK1	GG	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs1049174:GG	37542
citalopram	rs2270007	CRHR2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs2270007:CC	162180
citalopram	rs2270007	CRHR2	CG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB04	rs2270007:CG	162180
rifampicin	rs3732357	NR1I2	AA	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs3732357:AA	135542225
rifampicin	rs3732357	NR1I2	AG	Metabolism/PK	decreased	LADME	Other:C0041296		J04AB02	rs3732357:AG	135542225
methotrexate	rs1051266	SLC19A1	CT	Metabolism/PK	decreased	LADME	Other:C0029463		L04AX03	rs1051266:CT	11329481
methotrexate	rs1051266	SLC19A1	TT	Metabolism/PK	decreased	LADME	Other:C0029463		L04AX03	rs1051266:TT	11329481
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin, telaprevir	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|J05AP02|L03AB10|L03AB11	rs12979860:CC	37542
oxycodone	rs6848893	__INTRONIC__	CT	Efficacy	decreased	Efficacy_Response	Healthy		N02AA05	rs6848893:CT	5462350
platinum compounds	rs9535826	ATP7B	G	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs9535826:G	23939
antidepressants	rs6313	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AA	No_match
antidepressants	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0005586|Other:C0235876|Other:C0011581		N06A	rs6313:AG	No_match
platinum compounds	rs9535828	ATP7B	A	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs9535828:A	23939
risperidone	rs4795893	CCL2	AA	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4795893:AA	849421
risperidone	rs4795893	CCL2	AG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4795893:AG	849421
risperidone	rs4586	CCL2	CC	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4586:CC	849421
risperidone	rs4586	CCL2	CT	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs4586:CT	849421
ethanol	rs1799971	OPRM1	AG	Toxicity	decreased	LADME	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Toxicity	decreased	LADME	Healthy		V03AB16	rs1799971:GG	444899
methotrexate	rs1544105	FPGS	TT	Efficacy	increased	Efficacy_Response	Other:C0023449		L04AX03	rs1544105:TT	11329481
acenocoumarol	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA07	rs9923231:T	54742534
methotrexate	rs1544105	FPGS	TT	Metabolism/PK	increased	LADME	Other:C0023449		L04AX03	rs1544105:TT	11329481
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
atorvastatin, rosuvastatin, simvastatin	rs769705621	ABCA1	AAAA	Efficacy	decreased	Efficacy_Response	Other:C0342881		C10AA01|C10AA05|C10AA07	rs769705621:AAAA	60823
corticosteroids, selective beta-2-adrenoreceptor agonists	rs1042713	ADRB2	A	Efficacy	decreased	Efficacy_Response	Disease:C0004096		R03CC|S02BA	rs1042713:A	No_match
risperidone	rs2857657	CCL2	GG	Efficacy	increased	Efficacy_Response	Disease:C0036341		N05AX08	rs2857657:GG	849421
lamotrigine	rs2011425	UGT1A4	TT	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03AX09	rs2011425:TT	71236569
mercaptopurine	rs1127354	ITPA	A	Metabolism/PK	Indeterminado	LADME	Disease:C0023449		L01BB02	rs1127354:A	1268107
lamotrigine	rs2011425	UGT1A4	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AX09	rs2011425:TT	71236569
warfarin	rs1057910	CYP2C9	C	Dosage	decreased	Dosage	Healthy		B01AA03	rs1057910:C	54688261
olanzapine	rs34059508	SLC22A1	AG	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs34059508:AG	74603552
efavirenz	rs28399499	CYP2B6	CC	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs28399499:CC	64139
nicotine	rs4950	CHRNB3	G	Efficacy, Other	increased	Efficacy_Response	Other:smokers		N07BA01	rs4950:G	936
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
platinum compounds	rs1412125	HMGB1	CC	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs1412125:CC	23939
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs352139:CT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs352139	TLR9	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		No_ATC	rs352139:TT	No_match
nicotine	rs13280604	CHRNB3	G	Efficacy, Other	increased	Efficacy_Response	Other:smokers		N07BA01	rs13280604:G	936
warfarin	rs749671	VKORC1	G	Dosage	increased	Dosage	Healthy		B01AA03	rs749671:G	54688261
olanzapine	rs3842	ABCB1	T	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs3842:T	74603552
platinum compounds	rs2249825	HMGB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs2249825:GG	23939
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:T	64139
efavirenz	rs2279343	CYP2B6	G	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279343:G	64139
cisplatin, radiotherapy	rs25487	XRCC1	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023055|Disease:C0039338		L01XA01	rs25487:TT	5460033
losartan	rs4291	ACE	AT	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA01	rs4291:AT	11751549
losartan	rs4291	ACE	TT	Efficacy	increased	Efficacy_Response	Other:C0020538		C09CA01	rs4291:TT	11751549
vegf/vegfr (vascular endothelial growth factor) inhibitors	rs699947	VEGFA	AC	Efficacy	increased	Efficacy_Response	Other:C0024437		L01EK	rs699947:AC	No_match
vegf/vegfr (vascular endothelial growth factor) inhibitors	rs699947	VEGFA	CC	Efficacy	increased	Efficacy_Response	Other:C0024437		L01EK	rs699947:CC	No_match
oxycodone	rs4680	COMT	AA	Efficacy	increased	Efficacy_Response	Healthy		N02AA05	rs4680:AA	5462350
oxycodone	rs4680	COMT	AG	Efficacy	increased	Efficacy_Response	Healthy		N02AA05	rs4680:AG	5462350
adalimumab, infliximab	rs2546890	IL12B	AA	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2546890:AA	No_match
adalimumab, infliximab	rs2546890	IL12B	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2546890:AG	No_match
tacrolimus	rs2740574	CYP3A4	T	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs2740574:T	131769926
adalimumab, infliximab	rs6661932	IVL	CT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs6661932:CT	No_match
adalimumab, infliximab	rs6661932	IVL	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs6661932:TT	No_match
opioids	rs4680	COMT	AA	Dosage	increased	Dosage	Other:C0030193		N02A	rs4680:AA	No_match
opioids	rs4680	COMT	AG	Dosage	increased	Dosage	Other:C0030193		N02A	rs4680:AG	No_match
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
ustekinumab	rs8177374	TIRAP	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs8177374:CT	No_match
ustekinumab	rs8177374	TIRAP	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs8177374:TT	No_match
nicotine	rs1799971	OPRM1	AG	Other	increased	LADME	Other:C0036341		N07BA01	rs1799971:AG	936
nicotine	rs1799971	OPRM1	GG	Other	increased	LADME	Other:C0036341		N07BA01	rs1799971:GG	936
ustekinumab	rs5744174	TLR5	AG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs5744174:AG	No_match
ustekinumab	rs5744174	TLR5	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs5744174:GG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11938228:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11938228	TLR2	AC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11938228:AC	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11465996	LY96	CG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11465996:CG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs11465996	LY96	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs11465996:GG	No_match
rivaroxaban	rs467387	BRD3	AA	PD	increased	Efficacy_Response	Healthy		B01AF01	rs467387:AA	10700
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4696480	TLR2	AT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs4696480:AT	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs4696480	TLR2	TT	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs4696480:TT	No_match
tacrolimus	rs776746	CYP3A5	C	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C	131769926
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143623	IL1B	CG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143623:CG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143623	IL1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143623:GG	No_match
warfarin	rs1045642	ABCB1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs1045642:A	54688261
warfarin	rs429358	APOE	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs429358:CC	54688261
warfarin	rs429358	APOE	CT	Dosage	decreased	Dosage	Healthy		B01AA03	rs429358:CT	54688261
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143627	IL1B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143627:AG	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors, ustekinumab	rs1143627	IL1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs1143627:GG	No_match
repaglinide	rs2276706	NR1I2	GG	Metabolism/PK	decreased	LADME	Healthy		A10BX02	rs2276706:GG	22132924
cotinine	rs510769	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs510769:T	108114
risperidone	rs9606186	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs9606186:C	849421
repaglinide	rs3814058	NR1I2	CC	Metabolism/PK	decreased	LADME	Healthy		A10BX02	rs3814058:CC	22132924
atezolizumab, bevacizumab	rs16906115	IL7	AA	Efficacy	decreased	Efficacy_Response	Other:C2239176		L01FG01	rs16906115:AA	No_match
cotinine	rs12209447	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs12209447:T	108114
risperidone	rs2020917	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs2020917:C	849421
cotinine	rs3798676	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs3798676:T	108114
warfarin	rs2359612	VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A	54688261
fentanyl	rs1045642	ABCB1	AA	Dosage	decreased	Dosage	Healthy		N02AB03	rs1045642:AA	13653606
risperidone	rs933271	COMT	C	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AX08	rs933271:C	849421
cotinine	rs553202	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs553202:T	108114
cotinine	rs1074287	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs1074287:G	108114
methadone	rs529520	OPRD1	AA	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs529520:AA	10090
methadone	rs529520	OPRD1	AC	Dosage	increased	Dosage	Disease:C0028043		N07BC02	rs529520:AC	10090
peginterferon alfa-2a, peginterferon alfa-2b, ribavirin	rs12979860	IFNL3, IFNL4	CC	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10|L03AB11	rs12979860:CC	37542
cotinine	rs1799971	OPRM1	A	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs1799971:A	108114
cotinine	rs6912029	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs6912029:T	108114
prednisone	rs5333	EDNRA	CC	Efficacy	increased	Efficacy_Response	Disease:C0027726		H02AB07	rs5333:CC	91438
prednisone	rs5333	EDNRA	CT	Efficacy	increased	Efficacy_Response	Disease:C0027726		H02AB07	rs5333:CT	91438
repaglinide	rs3814058	NR1I2	CC	Metabolism/PK	increased	LADME	Healthy		A10BX02	rs3814058:CC	22132924
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs1927907	TLR4	CC	Metabolism/PK	increased	LADME	Disease:Liver_transplantation		L04AD02	rs1927907:CC	131769926
pazopanib	rs3814055	NR1I2	T	Efficacy	decreased	Efficacy_Response	Disease:C0007134		L01EX03	rs3814055:T	10113978
acenocoumarol	rs2108622	CYP4F2	T	Dosage	increased	Dosage	Disease:C0004238		B01AA07	rs2108622:T	54742534
adalimumab, infliximab	rs9304742	ZNF816	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs9304742:CC	No_match
adalimumab, infliximab	rs9304742	ZNF816	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs9304742:CT	No_match
acenocoumarol	rs1043550	CALU	G	Dosage	increased	Dosage	Disease:C0004238		B01AA07	rs1043550:G	54742534
efavirenz	rs3745274	CYP2B6	GT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GT	64139
efavirenz	rs3745274	CYP2B6	TT	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:TT	64139
tacrolimus	rs1946518	IL18	GG	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1946518:GG	131769926
tacrolimus	rs1946518	IL18	GT	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs1946518:GT	131769926
adalimumab, infliximab	rs2145623	NFKBIA	CC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2145623:CC	No_match
adalimumab, infliximab	rs2145623	NFKBIA	CG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs2145623:CG	No_match
adalimumab, infliximab	rs1061624	TNFRSF1B	AG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs1061624:AG	No_match
adalimumab, infliximab	rs1061624	TNFRSF1B	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs1061624:GG	No_match
repaglinide	rs2276706	NR1I2	GG	Metabolism/PK	increased	LADME	Healthy		A10BX02	rs2276706:GG	22132924
adalimumab, infliximab	rs645544	SLC9A8	GG	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AB02|L04AB04	rs645544:GG	No_match
fluorouracil, platinum compounds, radiotherapy	rs10040363	XRCC4	G	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA	rs10040363:G	23939
fluorouracil, platinum compounds, radiotherapy	rs2075685	XRCC4	T	Efficacy	decreased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA	rs2075685:T	23939
mycophenolic acid	rs4149056	SLCO1B1	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AA06	rs4149056:TT	5281078
hmg coa reductase inhibitors	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA	rs4149056:TT	445127
fluorouracil, platinum compounds, radiotherapy	rs2298881	ERCC1	A	Efficacy	increased	Efficacy_Response	Disease:C0026640		L01BC02|L01XA	rs2298881:A	23939
cotinine	rs563649	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs563649:T	108114
cotinine	rs2075572	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs2075572:G	108114
simvastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA01	rs4149056:TT	14373154
cotinine	rs7748401	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs7748401:G	108114
cotinine	rs495491	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs495491:G	108114
cotinine	rs10457090	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs10457090:G	108114
cotinine	rs3778152	OPRM1	G	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs3778152:G	108114
pravastatin	rs4149056	SLCO1B1	TT	Efficacy	increased	Efficacy_Response	Healthy		C10AA03	rs4149056:TT	58746970
cotinine	rs589046	OPRM1	T	Metabolism/PK	increased	LADME	Disease:C0028043		No_ATC	rs589046:T	108114
methotrexate	rs3814055	NR1I2	T	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs3814055:T	11329481
methotrexate	rs2306283	SLCO1B1	AA	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs2306283:AA	11329481
methotrexate	rs2306283	SLCO1B1	AG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs2306283:AG	11329481
methotrexate	rs4793665	ABCC3	C	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs4793665:C	11329481
methotrexate	rs7643038	NR1I2	G	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs7643038:G	11329481
methotrexate	rs9282564	ABCB1	C	Metabolism/PK	increased	LADME	Healthy		L04AX03	rs9282564:C	11329481
methotrexate	rs2231142	ABCG2	T	Metabolism/PK	decreased	LADME	Disease:C0029463		L04AX03	rs2231142:T	11329481
glucocorticoids	rs17446593	__INTRONIC__	AA	Efficacy	increased	Efficacy_Response	Other:C0040034		R03BA	rs17446593:AA	No_match
dabigatran glucuronide	rs1902023	UGT2B15	AA	Metabolism/PK	decreased	LADME	Healthy		B01AE07	rs1902023:AA	216210
sunitinib	rs776746	CYP3A5	CC	Metabolism/PK	decreased	LADME	Healthy		L01EX01	rs776746:CC	11221549
clozapine	rs10465180	NTRK2	CC	Efficacy	decreased	Efficacy_Response	Disease:C0036341		N05AH02	rs10465180:CC	131769989
warfarin	rs9332238	CYP2C9	G	Dosage	increased	Dosage	Healthy		B01AA03	rs9332238:G	54688261
clopidogrel	rs6809699	P2RY12	AA	Efficacy	increased	Efficacy_Response	Other:C0010068		B01AC04	rs6809699:AA	13748464
clopidogrel	rs6809699	P2RY12	AC	Efficacy	increased	Efficacy_Response	Other:C0010068		B01AC04	rs6809699:AC	13748464
efavirenz	rs3745274	CYP2B6	T	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AG03	rs3745274:T	64139
doxorubicin	rs20572	CBR1	CC	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs20572:CC	83958
selective serotonin reuptake inhibitors	rs1800544	ADRA2A	CG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06AB	rs1800544:CG	5202
erlotinib	rs1045642	ABCB1	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0007131		L01EB02	rs1045642:AA	176870
erlotinib	rs1128503	ABCB1	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0007131		L01EB02	rs1128503:AA	176870
methotrexate	rs28364006	ABCC1	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs28364006:GG	11329481
dolutegravir	rs2472677	NR1I2	TT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	rs2472677:TT	118753073
erlotinib	rs2032582	ABCB1	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:C0007131		L01EB02	rs2032582:AA	176870
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
losartan	rs5186	AGTR1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0085580		C09CA01	rs5186:CC	11751549
clopidogrel	rs2305948	KDR	T	Efficacy	decreased	Efficacy_Response	Disease:C0010068		B01AC04	rs2305948:T	13748464
lamotrigine	rs7668258	UGT2B7	CT	Dosage	increased	Dosage	Other:C0014544		N03AX09	rs7668258:CT	71236569
lamotrigine	rs7668258	UGT2B7	TT	Dosage	increased	Dosage	Other:C0014544		N03AX09	rs7668258:TT	71236569
mercaptopurine	rs73189762	NUDT15	T	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs73189762:T	1268107
metformin	rs143276236	ARFGEF3	AC	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs143276236:AC	155906370
trastuzumab	rs1136201	ERBB2	G	Toxicity	Indeterminado	Efficacy_Response	Healthy		No_ATC	rs1136201:G	166596981
doxorubicin	rs9024	CBR1	GG	Metabolism/PK	increased	LADME	Disease:C1458155		L01DB01	rs9024:GG	83958
metformin	rs7541245	PRKAB2	A	Efficacy	decreased	Efficacy_Response	Other:C0011849		A10BA02	rs7541245:A	155906370
azathioprine	rs116855232	NUDT15	CT	Dosage	decreased	Dosage	Disease:C0021390|Disease:C0023449		L04AX01	rs116855232:CT	5778
azathioprine	rs116855232	NUDT15	TT	Dosage	decreased	Dosage	Disease:C0021390|Disease:C0023449		L04AX01	rs116855232:TT	5778
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
tacrolimus	rs1057868	POR	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1057868:CT	131769926
tacrolimus	rs1057868	POR	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs1057868:TT	131769926
doxorubicin	rs9024	CBR1	GG	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs9024:GG	83958
doxorubicin	rs9024	CBR1	GG	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs9024:GG	83958
pramipexole	rs6280	DRD3	T	Efficacy	increased	Efficacy_Response	Healthy		N04BC05	rs6280:T	119569
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Healthy		B01AA03	rs2108622:TT	54688261
warfarin	rs7196161	VKORC1	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs7196161:GG	54688261
antidepressants, benzodiazepine derivatives, mirtazapine, selective serotonin reuptake inhibitors	rs948854	GAL	C	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N05CD|N06A|N06AB|N06AX11	rs948854:C	5202
tacrolimus	rs776746	CYP3A5	CC	Metabolism/PK	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CC	131769926
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG	54688261
sufentanil	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0032961		N01AH03	rs1799971:AG	41693
sufentanil	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0032961		N01AH03	rs1799971:GG	41693
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs9923231:CC	54688261
tacrolimus	rs41303343	CYP3A5	A	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs41303343:A	131769926
metformin	rs628031	SLC22A1	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BA02	rs628031:GG	155906370
tacrolimus	rs10264272	CYP3A5	T	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs10264272:T	131769926
warfarin	rs2884737	VKORC1	AA	Dosage	increased	Dosage	Healthy		B01AA03	rs2884737:AA	54688261
warfarin	rs61742245	VKORC1	A	Dosage	increased	Dosage	Healthy		B01AA03	rs61742245:A	54688261
tacrolimus	rs776746	CYP3A5	C	Dosage, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD02	rs776746:C	131769926
mycophenolic acid	rs717620	ABCC2	CC	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AA06	rs717620:CC	5281078
warfarin	rs2359612	PRSS53, VKORC1	A	Dosage	decreased	Dosage	Healthy		B01AA03	rs2359612:A	54688261
caffeine	rs762551	CYP1A2	AA	Other, Metabolism/PK	increased	LADME	Disease:C0039338		N06BC01	rs762551:AA	936
doxorubicin	rs20572	CBR1	CC	Metabolism/PK	decreased	LADME	Disease:C1458155		L01DB01	rs20572:CC	83958
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG	54688261
caffeine	rs762551	CYP1A2	AA	Other, Metabolism/PK	increased	LADME	Other:heavy_coffee_consumption		N06BC01	rs762551:AA	936
ticagrelor	rs4661012	PEAR1	GT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC24	rs4661012:GT	78358176
ticagrelor	rs4661012	PEAR1	TT	Efficacy	decreased	Efficacy_Response	Healthy		B01AC24	rs4661012:TT	78358176
methotrexate	rs2372536	ATIC	GG	Efficacy	decreased	Efficacy_Response	Other:C0003873		L04AX03	rs2372536:GG	11329481
tacrolimus	rs35599367	CYP3A4	AA	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AA	131769926
tacrolimus	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs35599367:AG	131769926
ticagrelor	rs12566888	PEAR1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	rs12566888:TT	78358176
tacrolimus	rs2740574	CYP3A4	C	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD02	rs2740574:C	131769926
tacrolimus	rs35599367	CYP3A4	A	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs35599367:A	131769926
ticagrelor	rs12041331	PEAR1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	rs12041331:AA	78358176
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT	131769926
ticagrelor	rs12041331	PEAR1	AA	Efficacy	increased	Efficacy_Response	Healthy		B01AC24	rs12041331:AA	78358176
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
tacrolimus	rs776746	CYP3A5	CT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Metabolism/PK	increased	LADME	Other:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
warfarin	rs7294	PRSS53, VKORC1	T	Dosage	increased	Dosage	Healthy		B01AA03	rs7294:T	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069885	IL9	AA	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069885:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069885	IL9	AG	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069885:AG	No_match
rituximab	rs396991	FCGR3A	AA	Efficacy	decreased	Efficacy_Response	Disease:C0030353		L01FA01	rs396991:AA	No_match
prednisolone	rs1883832	CD40	CC	Efficacy	decreased	Efficacy_Response	Other:C0040034		S02BA03	rs1883832:CC	54605501
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	LADME	Other:Liver_transplantation		L04AD02	rs776746:TT	131769926
metformin	rs2289669	SLC47A1	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs2289669:AA	155906370
erenumab	rs6710852	CALCRL	G	Efficacy	increased	Efficacy_Response	Other:C0338480|Other:C0338480		N02CD01	rs6710852:G	No_match
tacrolimus	rs2032582	ABCB1	AA	Dosage, Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs2032582:AA	131769926
tacrolimus	rs2032582	ABCB1	TT	Dosage, Metabolism/PK	decreased	LADME	Other:Liver_transplantation		L04AD02	rs2032582:TT	131769926
warfarin	rs7294	VKORC1	CC	Dosage	decreased	Dosage	Healthy		B01AA03	rs7294:CC	54688261
halothane	rs118192161	RYR1	T	Other	increased	Efficacy_Response	Healthy		N01AB01	rs118192161:T	445258
warfarin	rs8050894	VKORC1	CC	Dosage	increased	Dosage	Healthy		B01AA03	rs8050894:CC	54688261
warfarin	rs2359612	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs2359612:GG	54688261
2-hydroxyatorvastatin	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs35599367:AG	3364535
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069812	IL5	AA	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069812:AA	No_match
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs2069812	IL5	AG	Efficacy	increased	Efficacy_Response	Other:C0038012|Ankylosing		No_ATC	rs2069812:AG	No_match
beta blocking agents, selective	rs28404156	BST1	A	Efficacy	increased	Efficacy_Response	Other:C0020538		C07AA|S01ED	rs28404156:A	No_match
tamoxifen	rs4646	CYP19A1	AA	Efficacy	decreased	Efficacy_Response	Disease:C1458155|Disease:C0025320		L02BA01	rs4646:AA	2733525
bisphosphonates	rs2297480	FDPS	T	Efficacy	increased	Efficacy_Response	Disease:C0029456		M05BA	rs2297480:T	No_match
simvastatin	rs5882	CETP	A	Efficacy	increased	Efficacy_Response	Disease:C0020443		C10AA01	rs5882:A	14373154
selective serotonin reuptake inhibitors	rs405509	APOE	TT	Efficacy	increased	Efficacy_Response	Other:C0011581		N06AB	rs405509:TT	5202
methotrexate	rs17731538	ABCG2	GG	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AX03	rs17731538:GG	11329481
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1799724	TNF	C	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390|Disease:C0235763|Disease:C0038012		No_ATC	rs1799724:C	No_match
cyclosporine	rs12917707	UMOD	GT	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs12917707:GT	86666680
cyclosporine	rs12917707	UMOD	TT	Efficacy	increased	Efficacy_Response	Disease:Kidney_Transplantation		L04AD01	rs12917707:TT	86666680
modafinil	rs2032582	ABCB1	AC	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs2032582:AC	6460146
modafinil	rs2032582	ABCB1	CT	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs2032582:CT	6460146
modafinil	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs1045642:AG	6460146
warfarin	rs4645962	MYC	CT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645962:CT	54688261
warfarin	rs4645943	MYC	CT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645943:CT	54688261
warfarin	rs4645943	MYC	TT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645943:TT	54688261
carbamazepine	rs2234922	EPHX1	G	Dosage, Metabolism/PK	decreased	LADME	Disease:C0014544		N03AF01	rs2234922:G	114709
modafinil	rs1128503	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0027404		N06BA07	rs1128503:AG	6460146
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs361525	TNF	G	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390|Disease:C0235763|Disease:C0038012		No_ATC	rs361525:G	No_match
bisphosphonates	rs11264359	FDPS	A	Efficacy	increased	Efficacy_Response	Disease:C0029456		M05BA	rs11264359:A	No_match
warfarin	rs4645974	MYC	CC	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs4645974:CC	54688261
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800629	TNF	G	Efficacy	increased	Efficacy_Response	Disease:C0010346|Disease:C0021390|Disease:C0235763|Disease:C0038012		No_ATC	rs1800629:G	No_match
atorvastatin, simvastatin	rs717620	ABCC2	T	Efficacy	decreased	Dosage	Healthy		C10AA01|C10AA05	rs717620:T	60823
leflunomide	rs3213422	DHODH	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		No_ATC	rs3213422:CC	54684141
antipsychotics	rs1799732	DRD2	G	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs1799732:G	No_match
imatinib	rs1050152	SLC22A4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1050152:TT	6113
risperidone	rs6313	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs6313:AA	849421
risperidone	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs6313:AG	849421
antipsychotics	rs7997012	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0040435|Other:C0036341		N05A	rs7997012:AG	No_match
methadone	rs3745274	CYP2B6	TT	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0028043		N07BC02	rs3745274:TT	10090
methadone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC02	rs1045642:AA	10090
methadone	rs1045642	ABCB1	AG	Metabolism/PK	increased	LADME	Other:Opioid-Related_Disorders		N07BC02	rs1045642:AG	10090
olanzapine	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:AG	74603552
olanzapine	rs6313	HTR2A	GG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:GG	74603552
olanzapine	rs6313	HTR2A	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:AA	74603552
olanzapine	rs6313	HTR2A	AG	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AH03	rs6313:AG	74603552
carbamazepine	rs1051740	EPHX1	CC	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs1051740:CC	114709
efavirenz	rs3745274	CYP2B6	GG	Metabolism/PK	increased	LADME	Disease:HIV_infectious_disease		J05AG03	rs3745274:GG	64139
carbamazepine	rs2234922	EPHX1	GG	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs2234922:GG	114709
azathioprine, mercaptopurine	rs7270101	ITPA	AC	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390|Disease:C0023449		L01BB02|L04AX01	rs7270101:AC	5778
azathioprine, mercaptopurine	rs7270101	ITPA	CC	Toxicity, Metabolism/PK	increased	LADME	Disease:C0021390|Disease:C0023449		L01BB02|L04AX01	rs7270101:CC	5778
imatinib	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AA	6113
imatinib	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1045642:AG	6113
imatinib	rs1050152	SLC22A4	TT	Efficacy	decreased	Efficacy_Response	Disease:C0023473|BCR-ABL1_positive		L01EA01	rs1050152:TT	6113
tacrolimus	rs776746	CYP3A5	CT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage, Metabolism/PK	increased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs776746:TT	131769926
carbamazepine	rs1045642	ABCB1	AG	Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1045642:AG	114709
antiepileptics	rs1045642	ABCB1	AG	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs1045642:AG	No_match
raloxifene	rs737865	COMT	AG	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs737865:AG	10100752
paclitaxel	rs717620	ABCC2	CT	Toxicity	decreased	Dosage	Side_Effect:Peripheral_Nervous_System_Diseases		L01CD01	rs717620:CT	36314
raloxifene	rs737865	COMT	AA	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs737865:AA	10100752
buprenorphine	rs678849	OPRD1	CT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs678849:CT	11274356
buprenorphine	rs678849	OPRD1	TT	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BC01	rs678849:TT	11274356
methadone	rs2032582	ABCB1	AC	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs2032582:AC	10090
ethanol	rs1799971	OPRM1	AG	Other	increased	LADME	Healthy		V03AB16	rs1799971:AG	444899
ethanol	rs1799971	OPRM1	GG	Other	increased	LADME	Healthy		V03AB16	rs1799971:GG	444899
antiepileptics	rs1045642	ABCB1	AA	Efficacy	increased	Efficacy_Response	Disease:C0014544		N03A	rs1045642:AA	No_match
risperidone	rs7627954	TNIK	CC	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs7627954:CC	849421
raloxifene	rs4818	COMT	CG	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs4818:CG	10100752
methadone	rs35599367	CYP3A4	AG	Metabolism/PK	decreased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs35599367:AG	10090
sunitinib	rs2032582	ABCB1	AA	Dosage, Toxicity	increased	Dosage	Disease:C0007134		L01EX01	rs2032582:AA	11221549
sunitinib	rs2032582	ABCB1	AT	Dosage, Toxicity	increased	Dosage	Disease:C0007134		L01EX01	rs2032582:AT	11221549
tacrolimus	rs776746	CYP3A5	CT	Dosage	increased	Dosage	Other:C0024141		L04AD02	rs776746:CT	131769926
tacrolimus	rs776746	CYP3A5	TT	Dosage	increased	Dosage	Other:C0024141		L04AD02	rs776746:TT	131769926
adalimumab, etanercept, infliximab	rs1800629	TNF	AG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:AG	No_match
adalimumab, etanercept, infliximab	rs1800629	TNF	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AB01|L04AB02|L04AB04	rs1800629:GG	No_match
sunitinib	rs1128503	ABCB1	AA	Dosage, Toxicity	increased	Dosage	Disease:C0007134		L01EX01	rs1128503:AA	11221549
methadone	rs1045642	ABCB1	AA	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1045642:AA	10090
methadone	rs1128503	ABCB1	AG	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1128503:AG	10090
methadone	rs1057868	POR	CT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1057868:CT	10090
methadone	rs1057868	POR	TT	Metabolism/PK	increased	LADME	Disease:Opioid-Related_Disorders		N07BC02	rs1057868:TT	10090
methadone	rs2279343	CYP2B6	AA	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs2279343:AA	10090
dolutegravir	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:HIV_infectious_disease		J05AJ03	rs2231142:TT	118753073
methadone	rs3745274	CYP2B6	GG	Dosage	increased	Dosage	Other:C0028043		N07BC02	rs3745274:GG	10090
prednisolone	rs4986791	TLR4	T	Efficacy	decreased	Efficacy_Response	Other:C0040034		S02BA03	rs4986791:T	54605501
perampanel	rs4986908	CYP3A4	CG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AX22	rs4986908:CG	66827
telbivudine	rs3826160	TK2	CC	Metabolism/PK	increased	LADME	Other:C0019163|Chronic		J05AF11	rs3826160:CC	159269
telbivudine	rs3826160	TK2	CT	Metabolism/PK	increased	LADME	Other:C0019163|Chronic		J05AF11	rs3826160:CT	159269
warfarin	rs1877724	EPHX1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs1877724:TT	54688261
nevirapine	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
ethanol	rs3778150	OPRM1	CC	Dosage	increased	Dosage	Healthy		V03AB16	rs3778150:CC	444899
ethanol	rs3778150	OPRM1	CT	Dosage	increased	Dosage	Healthy		V03AB16	rs3778150:CT	444899
olanzapine	rs1695	GSTP1	AA	Metabolism/PK	increased	LADME	Healthy		N05AH03	rs1695:AA	74603552
cefotaxime	rs11568482	SLC22A8	AT	Metabolism/PK	decreased	LADME	Healthy		J01DD01	rs11568482:AT	76972700
ivacaftor	rs75527207	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs75527207:A	72722243
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
escitalopram	rs11188059	CYP2C18	G	Metabolism/PK	decreased	LADME	Healthy		N06AB10	rs11188059:G	162180
donepezil, galantamine, rivastigmine	rs6720975	PRKCE	T	Efficacy	increased	Efficacy_Response	Other:C0002395		N06DA02|N06DA03|N06DA04	rs6720975:T	3152
escitalopram	rs2860840	CYP2C18	T	Metabolism/PK	decreased	LADME	Healthy		N06AB10	rs2860840:T	162180
efavirenz	rs2279345	CYP2B6	TT	Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG03	rs2279345:TT	64139
perampanel	rs2242480	CYP3A4	CT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AX22	rs2242480:CT	66827
perampanel	rs2242480	CYP3A4	TT	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AX22	rs2242480:TT	66827
donepezil, galantamine, rivastigmine	rs17798800	__INTRONIC__	T	Efficacy	decreased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs17798800:T	3152
warfarin	rs9923231	VKORC1	T	Dosage	decreased	Dosage	Healthy		B01AA03	rs9923231:T	54688261
prednisolone	rs4986790	TLR4	G	Efficacy	decreased	Efficacy_Response	Other:C0040034		S02BA03	rs4986790:G	54605501
methadone	rs2032582	ABCB1	CC	Dosage	decreased	Dosage	Other:C0028043		N07BC02	rs2032582:CC	10090
methadone	rs1045642	ABCB1	AA	Dosage, Metabolism/PK	increased	Dosage	Disease:C0028043		N07BC02	rs1045642:AA	10090
sn-38(irinotecan)	rs12720066	ABCB1	AC	Metabolism/PK	decreased	LADME	Disease:C0023055		L01CE02	rs12720066:AC	60838
sn-38(irinotecan)	rs12720066	ABCB1	CC	Metabolism/PK	decreased	LADME	Disease:C0023055		L01CE02	rs12720066:CC	60838
antipsychotics	rs4627835	GABRB1	T	Dosage	increased	Dosage	Disease:C0036337|Disease:C0036341		N05A	rs4627835:T	No_match
antipsychotics	rs16860087	GABRB1	A	Dosage	increased	Dosage	Disease:C0036337|Disease:C0036341		N05A	rs16860087:A	No_match
warfarin	rs9923231	VKORC1	CC	Dosage	increased	Dosage	Other:a_stable_international_normalized_ratio_of_between_two_and_three		B01AA03	rs9923231:CC	54688261
sn-38(irinotecan)	rs35621	ABCC1	CT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs35621:CT	60838
sn-38(irinotecan)	rs35621	ABCC1	TT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs35621:TT	60838
carbamazepine	rs1045642	ABCB1	AA	Dosage	increased	Dosage	Other:C0014544		N03AF01	rs1045642:AA	114709
lithium	rs11869731	ASIC2	CC	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs11869731:CC	11125
sn-38(irinotecan)	rs6498588	ABCC1	AT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs6498588:AT	60838
sn-38(irinotecan)	rs6498588	ABCC1	TT	Metabolism/PK	increased	LADME	Disease:C0023055		L01CE02	rs6498588:TT	60838
capecitabine, fluorouracil	rs9380142	HLA-G	GG	Efficacy	decreased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs9380142:GG	60953
antidepressants	rs8136867	MAPK1	AG	Efficacy	increased	Efficacy_Response	Disease:C0004936		N06A	rs8136867:AG	No_match
warfarin	rs8050894	VKORC1	G	Dosage	decreased	Dosage	Healthy		B01AA03	rs8050894:G	54688261
capecitabine, fluorouracil	rs17179108	HLA-G	CT	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01BC06	rs17179108:CT	60953
warfarin	rs9923231	VKORC1	CC	Dosage, Efficacy	increased	Dosage	Disease:C0271093		B01AA03	rs9923231:CC	54688261
donepezil, galantamine, rivastigmine	rs3793790	CHAT	G	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs3793790:G	3152
fluvoxamine	rs4680	COMT	GG	Efficacy	decreased	Efficacy_Response	Disease:C0011581		N06AB08	rs4680:GG	154032615
2-hydroxyatorvastatin	rs4253728	PPARA	AA	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs4253728:AA	3364535
2-hydroxyatorvastatin	rs4253728	PPARA	AG	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs4253728:AG	3364535
lithium	rs16909440	OR52E2	TT	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs16909440:TT	11125
lithium	rs2499984	OR52J3	GG	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs2499984:GG	11125
antidepressants	rs889895	CREB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011581		N06A	rs889895:GG	No_match
lithium	rs16973410	__INTRONIC__	CC	Efficacy	increased	Efficacy_Response	Disease:C0005586		N05AN01	rs16973410:CC	11125
mercaptopurine	rs1142345	TPMT	C	Efficacy	Indeterminado	LADME	Disease:C0023418		L01BB02	rs1142345:C	1268107
ivacaftor	rs75527207	CFTR	A	Efficacy	increased	Efficacy_Response	Healthy		R07AX02	rs75527207:A	72722243
donepezil, galantamine, rivastigmine	rs2177370	CHAT	A	Efficacy	increased	Efficacy_Response	Disease:C0002395		N06DA02|N06DA03|N06DA04	rs2177370:A	3152
methotrexate	rs2372536	ATIC	GG	Efficacy	increased	Efficacy_Response	Disease:C0003873		L04AX03	rs2372536:GG	11329481
zidovudine	rs28365062	UGT2B7	G	Metabolism/PK	increased	LADME	Healthy		J05AF01	rs28365062:G	455742
rosuvastatin	rs2231142	ABCG2	CT	Efficacy	increased	Efficacy_Response	Healthy		C10AA07	rs2231142:CT	5282455
cholesterol	rs429358	APOE	TT	Toxicity	increased	LADME	Other:C0023449		V09XA01	rs429358:TT	99486
methadone	rs6275	DRD2	AA	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0028043		N07BC02	rs6275:AA	10090
metformin	rs12943590	SLC47A2	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs12943590:AA	155906370
metformin	rs12943590	SLC47A2	AG	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs12943590:AG	155906370
atenolol, carvedilol, diltiazem, metoprolol, verapamil	rs1801253	ADRB1	CG	Efficacy	increased	Efficacy_Response	Disease:C0004238		C07AB02|C07AB03|C07AG02|C08DA01|C08DB01	rs1801253:CG	2520
atenolol, carvedilol, diltiazem, metoprolol, verapamil	rs1801253	ADRB1	GG	Efficacy	increased	Efficacy_Response	Disease:C0004238		C07AB02|C07AB03|C07AG02|C08DA01|C08DB01	rs1801253:GG	2520
methadone	rs1799978	DRD2	CC	Dosage, Metabolism/PK	decreased	Dosage	Disease:C0028043		N07BC02	rs1799978:CC	10090
metformin	rs316019	SLC22A2	AA	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs316019:AA	155906370
metformin	rs316019	SLC22A2	AC	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs316019:AC	155906370
carbamazepine	rs1128503	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1128503:AA	114709
carbamazepine	rs1128503	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1128503:AG	114709
carbamazepine	rs2032582	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs2032582:AA	114709
carbamazepine	rs2032582	ABCB1	AC	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs2032582:AC	114709
erythromycin	rs717620	ABCC2	TT	Other, Metabolism/PK	increased	LADME	Healthy		S01AA17	rs717620:TT	9831800
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG	54688261
warfarin	rs11676382	GGCX	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:GG	54688261
carbamazepine	rs1045642	ABCB1	AA	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1045642:AA	114709
carbamazepine	rs1045642	ABCB1	AG	Efficacy	decreased	Efficacy_Response	Other:C0014544		N03AF01	rs1045642:AG	114709
abiraterone, dutasteride	rs1047303	HSD3B1	AC	Efficacy	decreased	Efficacy_Response	Other:C0033578		G04CB02|L02BX03	rs1047303:AC	132971
azathioprine	rs2413739	PACSIN2	CT	Efficacy	decreased	Efficacy_Response	Other:C0022104		L04AX01	rs2413739:CT	5778
azathioprine	rs2413739	PACSIN2	TT	Efficacy	decreased	Efficacy_Response	Other:C0022104		L04AX01	rs2413739:TT	5778
rosuvastatin	rs12422149	SLCO2B1	AA	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs12422149:AA	5282455
rosuvastatin	rs12422149	SLCO2B1	AG	Efficacy	decreased	Efficacy_Response	Healthy		C10AA07	rs12422149:AG	5282455
gefitinib	rs776746	CYP3A5	CC	Metabolism/PK	increased	LADME	Healthy		L01EB01	rs776746:CC	135496227
sildenafil	rs2070744	NOS3	CC	Efficacy	increased	Efficacy_Response	Disease:C0242350		G04BE03	rs2070744:CC	135499879
sildenafil	rs2070744	NOS3	CT	Efficacy	increased	Efficacy_Response	Disease:C0242350		G04BE03	rs2070744:CT	135499879
nevirapine	rs3745274	CYP2B6	TT	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:TT	15979285
abiraterone	rs523349	SRD5A2	CC	Metabolism/PK	increased	LADME	Other:C0033578		L02BX03	rs523349:CC	91826892
gefitinib	rs1057910	CYP2C9	AC	Metabolism/PK	increased	LADME	Healthy		L01EB01	rs1057910:AC	135496227
triglycerides	rs10046	CYP19A1	A	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs10046:A	56842239
triglycerides	rs3759811	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs3759811:C	56842239
hdl cholesterol	rs1008805	CYP19A1	G	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs1008805:G	5997
opioids	rs1799971	OPRM1	AG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Dosage	increased	Dosage	Other:C0030193|Postoperative		N02A	rs1799971:GG	No_match
triglycerides	rs2289105	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs2289105:C	56842239
methotrexate	rs1051296	SLC19A1	AC	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1051296:AC	11329481
methotrexate	rs1051296	SLC19A1	CC	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs1051296:CC	11329481
hdl cholesterol	rs10046	CYP19A1	G	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs10046:G	5997
fentanyl	rs2242480	CYP3A4	T	Dosage	decreased	Dosage	Other:C0030193|Postoperative		N02AB03	rs2242480:T	13653606
hdl cholesterol	rs2289105	CYP19A1	T	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs2289105:T	5997
leflunomide	rs2234693	ESR1	TT	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs2234693:TT	54684141
nevirapine	rs3745274	CYP2B6	GT	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:GT	15979285
leflunomide	rs9340799	ESR1	AA	Efficacy	increased	Efficacy_Response	Disease:C0003873		No_ATC	rs9340799:AA	54684141
2-hydroxyatorvastatin, 4-hydroxyatorvastatin, atorvastatin, atorvastatin lactone	rs1975991	LPP	A	Metabolism/PK	decreased	LADME	Healthy		C10AA05	rs1975991:A	6483036
ustekinumab	rs774359	C9orf72	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs774359:CC	No_match
ustekinumab	rs774359	C9orf72	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs774359:CT	No_match
methotrexate	rs3758149	GGH	GG	Metabolism/PK	decreased	LADME	Other:C0023449		L04AX03	rs3758149:GG	11329481
hdl cholesterol	rs4646	CYP19A1	A	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		No_ATC	rs4646:A	5997
ustekinumab	rs848	IL13	AA	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs848:AA	No_match
ustekinumab	rs848	IL13	AC	Efficacy	decreased	Efficacy_Response	Disease:C0235763		L04AC05	rs848:AC	No_match
triglycerides	rs700518	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs700518:C	56842239
ustekinumab	rs9304742	ZNF816	CC	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs9304742:CC	No_match
ustekinumab	rs9304742	ZNF816	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs9304742:CT	No_match
triglycerides	rs4775936	CYP19A1	C	Other	decreased	LADME	Disease:C1458155|Disease:C0025320		C10AX06	rs4775936:C	56842239
warfarin	rs11676382	GGCX	CG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:CG	54688261
warfarin	rs11676382	GGCX	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs11676382:GG	54688261
ustekinumab	rs7574865	STAT4	GT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs7574865:GT	No_match
ustekinumab	rs7574865	STAT4	TT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs7574865:TT	No_match
ustekinumab	rs1050152	SLC22A4	CT	Efficacy	increased	Efficacy_Response	Disease:C0235763		L04AC05	rs1050152:CT	No_match
nicotine	rs16969968	CHRNA5	GG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA01	rs16969968:GG	936
warfarin	rs72800847	STX1B	AA	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs72800847:AA	54688261
warfarin	rs72800847	STX1B	AG	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs72800847:AG	54688261
warfarin	rs3826041	CYP1A1	CC	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs3826041:CC	54688261
varenicline	rs16969968	CHRNA5	AA	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs16969968:AA	6918678
varenicline	rs16969968	CHRNA5	AG	Efficacy	increased	Efficacy_Response	Other:C0039338		N07BA03	rs16969968:AG	6918678
warfarin	rs2304429	DNMT3A	TT	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2304429:TT	54688261
warfarin	rs10517	NQO1	AA	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs10517:AA	54688261
raloxifene	rs2234693	ESR1	TT	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0036337		G03XC01	rs2234693:TT	10100752
acenocoumarol, phenprocoumon	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Healthy		B01AA04|B01AA07	rs9934438:AA	54680692
acenocoumarol, phenprocoumon	rs9934438	VKORC1	AG	Dosage	decreased	Dosage	Healthy		B01AA04|B01AA07	rs9934438:AG	54680692
fentanyl	rs966775	DRD1	AG	Efficacy	increased	LADME	Other:C0030193|Postoperative		N02AB03	rs966775:AG	13653606
fentanyl	rs966775	DRD1	GG	Efficacy	increased	LADME	Other:C0030193|Postoperative		N02AB03	rs966775:GG	13653606
fluticasone / salmeterol	rs8191992	CHRM2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03AK06	rs8191992:A	5311101
methotrexate	rs1801133	MTHFR	AA	Metabolism/PK	increased	LADME	Other:C0024299		L04AX03	rs1801133:AA	11329481
methotrexate	rs1801133	MTHFR	AG	Metabolism/PK	increased	LADME	Other:C0024299		L04AX03	rs1801133:AG	11329481
phenprocoumon	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Healthy		B01AA04	rs9923231:TT	91987769
warfarin	rs1057910	CYP2C9	AA	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs1057910:AA	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs9934438:GG	54688261
aripiprazole, risperidone	rs2514218	DRD2	CC	Efficacy	increased	Efficacy_Response	Other:C0033975|Other:C0036337|Other:C0036341		N05AX08|N05AX12	rs2514218:CC	60795
voriconazole	rs2231142	ABCG2	GT	Metabolism/PK	increased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs2231142:GT	9741
voriconazole	rs2231142	ABCG2	TT	Metabolism/PK	increased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs2231142:TT	9741
warfarin	rs4889606	STX1B	AG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4889606:AG	54688261
warfarin	rs4889606	STX1B	GG	Dosage	decreased	Dosage	Healthy		B01AA03	rs4889606:GG	54688261
warfarin	rs887829	UGT1A1	CC	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs887829:CC	54688261
warfarin	rs2108622	CYP4F2	CC	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2108622:CC	54688261
warfarin	rs2108622	CYP4F2	CT	Dosage	decreased	Dosage	Disease:Heart_valve_replacement		B01AA03	rs2108622:CT	54688261
azathioprine, mercaptopurine	rs1127354	ITPA	AA	Metabolism/PK	decreased	LADME	Disease:C0021390		L01BB02|L04AX01	rs1127354:AA	5778
azathioprine, mercaptopurine	rs1127354	ITPA	AC	Metabolism/PK	decreased	LADME	Disease:C0021390		L01BB02|L04AX01	rs1127354:AC	5778
warfarin	rs9923231	VKORC1	TT	Dosage	decreased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs9923231:TT	54688261
bevacizumab, fluorouracil, irinotecan, leucovorin	rs1979277	SHMT1	A	Efficacy	increased	Efficacy_Response	Disease:C0023055		L01BC02|L01CE02|L01FG01	rs1979277:A	135403648
tumor necrosis factor alpha (tnf-alpha) inhibitors	rs1800795	IL6	G	Efficacy	decreased	Efficacy_Response	Disease:C0235763		No_ATC	rs1800795:G	No_match
warfarin	rs1057910	CYP2C9	AC	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs1057910:AC	54688261
warfarin	rs1057910	CYP2C9	CC	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs1057910:CC	54688261
warfarin	rs2108622	CYP4F2	CT	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs2108622:CT	54688261
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs2108622:TT	54688261
platinum compounds	rs6983267	__INTRONIC__	GG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs6983267:GG	23939
platinum compounds	rs6983267	__INTRONIC__	GT	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs6983267:GT	23939
fluvastatin	rs77760615	CYP2C9	G	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs77760615:G	131750727
metformin	rs316009	SLC22A2	TT	Efficacy	increased	Efficacy_Response	Disease:C0011849		A10BA02	rs316009:TT	155906370
opioids	rs1799971	OPRM1	AG	Dosage, Efficacy	increased	Dosage	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:AG	No_match
opioids	rs1799971	OPRM1	GG	Dosage, Efficacy	increased	Dosage	"""Other:C0030193|""Other:C0030193|Postoperative"""		N02A	rs1799971:GG	No_match
fluvastatin	rs58310495	SLCO1B1	T	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs58310495:T	131750727
atorvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Other:C0020443		C10AA05	rs4149056:C	656846
cyclosporine	rs35599367	CYP3A4	AA	Toxicity, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs35599367:AA	86666680
cyclosporine	rs35599367	CYP3A4	AG	Toxicity, Metabolism/PK	decreased	LADME	Disease:Kidney_Transplantation		L04AD01	rs35599367:AG	86666680
fluvastatin	rs4149056	SLCO1B1	C	Metabolism/PK	increased	LADME	Healthy		C10AA04	rs4149056:C	131750727
platinum compounds	rs619586	MALAT1	AG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs619586:AG	23939
platinum compounds	rs619586	MALAT1	GG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs619586:GG	23939
platinum compounds	rs7958904	HOTAIR	CC	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs7958904:CC	23939
platinum compounds	rs7958904	HOTAIR	CG	Efficacy	decreased	Efficacy_Response	Disease:C0024121		L01XA	rs7958904:CG	23939
platinum compounds	rs2839698	H19	AA	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs2839698:AA	23939
platinum compounds	rs2839698	H19	AG	Efficacy	increased	Efficacy_Response	Disease:C0024121		L01XA	rs2839698:AG	23939
tacrolimus	rs35599367	CYP3A4	AG	Dosage	decreased	Dosage	Disease:Kidney_Transplantation		L04AD02	rs35599367:AG	131769926
carbamazepine	rs1051740	EPHX1	C	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs1051740:C	114709
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Healthy		B01AA03	rs9934438:GG	54688261
fluticasone / salmeterol	rs6962027	CHRM2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03AK06	rs6962027:A	5311101
nicotine	rs1799971	OPRM1	AG	Other	increased	LADME	Healthy		N07BA01	rs1799971:AG	936
nicotine	rs1799971	OPRM1	GG	Other	increased	LADME	Healthy		N07BA01	rs1799971:GG	936
beta blocking agents	rs1801253	ADRB1	C	Efficacy	increased	Efficacy_Response	Other:C0878544|Dilated		S01ED	rs1801253:C	No_match
simvastatin acid	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Healthy		C10AA01	rs4149056:CC	25221209
beta blocking agents	rs1042713	ADRB2	A	Efficacy	increased	Efficacy_Response	Other:C0878544|Dilated		S01ED	rs1042713:A	No_match
fluticasone / salmeterol	rs6962027	CHRM2	A	Efficacy	Indeterminado	Efficacy_Response	Disease:C0004096		R03AK06	rs6962027:A	5311101
carbamazepine	rs2234922	EPHX1	G	Dosage, Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs2234922:G	114709
fluticasone propionate	rs1876831	CRHR1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs1876831:T	5311101
risperidone	rs2088885	TNIK	AA	Efficacy	increased	Efficacy_Response	Other:C0036341		N05AX08	rs2088885:AA	849421
fluticasone propionate	rs1876828	CRHR1	T	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs1876828:T	5311101
metformin	rs2617102	CSMD1	AC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2617102:AC	155906370
metformin	rs2617102	CSMD1	CC	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BA02	rs2617102:CC	155906370
fluticasone propionate	rs1876829	CRHR1	C	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs1876829:C	5311101
fluticasone propionate	rs739645	CRHR1	G	Efficacy	increased	Efficacy_Response	Disease:C0004096		R03BA05	rs739645:G	5311101
warfarin	rs9923231	VKORC1	CT	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs9923231:CT	54688261
warfarin	rs9923231	VKORC1	TT	Dosage	Indeterminado	Dosage	Healthy		B01AA03	rs9923231:TT	54688261
nevirapine	rs3745274	CYP2B6	T	Toxicity, Metabolism/PK	decreased	LADME	Disease:HIV_infectious_disease		J05AG01	rs3745274:T	15979285
nicotine	rs1057868	POR	CT	Metabolism/PK	increased	LADME	PK:CYP2A6_normal|but_not_reduced|metabolizers		N07BA01	rs1057868:CT	936
nicotine	rs1057868	POR	TT	Metabolism/PK	increased	LADME	PK:CYP2A6_normal|but_not_reduced|metabolizers		N07BA01	rs1057868:TT	936
carbamazepine	rs3812718	SCN1A	TT	Metabolism/PK	increased	LADME	Disease:C0014544		N03AF01	rs3812718:TT	114709
warfarin	rs2108622	CYP4F2	TT	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs2108622:TT	54688261
voriconazole	rs2860840	CYP2C18	T	Metabolism/PK	decreased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs2860840:T	9741
voriconazole	rs11188059	CYP2C18	G	Metabolism/PK	decreased	LADME	Other:C0023418|Other:C0024299|Other:C0026986		J02AC03	rs11188059:G	9741
remifentanil	rs1045642	ABCB1	GG	Dosage	increased	Dosage	Healthy		N01AH06	rs1045642:GG	60815
warfarin	rs12714145	GGCX	CT	Dosage	decreased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs12714145:CT	54688261
warfarin	rs12714145	GGCX	TT	Dosage	decreased	Dosage	Other:C0004238|Other:Heart_valve_replacement|Other:C0034065		B01AA03	rs12714145:TT	54688261
warfarin	rs9934438	VKORC1	AG	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs9934438:AG	54688261
warfarin	rs9934438	VKORC1	GG	Dosage	increased	Dosage	Disease:C0004238		B01AA03	rs9934438:GG	54688261
remifentanil	rs1045642	ABCB1	GG	Efficacy	decreased	Efficacy_Response	Healthy		N01AH06	rs1045642:GG	60815
fluorouracil	rs1801159	DPYD	CC	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs1801159:CC	5790
fluorouracil	rs1801159	DPYD	CT	Metabolism/PK	increased	LADME	Disease:C0023055		L01BC02	rs1801159:CT	5790
warfarin	rs9934438	VKORC1	AA	Dosage	decreased	Dosage	Disease:C0004238		B01AA03	rs9934438:AA	54688261
peginterferon alfa-2b, ribavirin	rs8099917	IFNL3	TT	Efficacy	increased	Efficacy_Response	Disease:C0019372		J05AP01|L03AB10	rs8099917:TT	37542
clopidogrel	rs71647871	CES1	CT	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs71647871:CT	13748464
clopidogrel	rs71647871	CES1	TT	Metabolism/PK	increased	LADME	Healthy		B01AC04	rs71647871:TT	13748464
clopidogrel	rs71647871	CES1	CT	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs71647871:CT	13748464
clopidogrel	rs71647871	CES1	TT	Efficacy	increased	Efficacy_Response	Healthy		B01AC04	rs71647871:TT	13748464
carbamazepine	rs3812718	SCN1A	TT	Metabolism/PK	increased	Dosage	Disease:C0014544		N03AF01	rs3812718:TT	114709
naltrexone	rs1799971	OPRM1	AA	Efficacy	increased	Efficacy_Response	Other:Opioid-Related_Disorders		N07BB04	rs1799971:AA	5360515
aspirin	rs1371097	P2RY1	T	Efficacy	decreased	Efficacy_Response	Other:C0018839		No_ATC	rs1371097:T	72204814
gemcitabine	rs1044457	CMPK1	TT	Efficacy	decreased	Efficacy_Response	Other:C0007131		L01BC05	rs1044457:TT	597
mercaptopurine	rs55713253	NUDT15	CC	Dosage	increased	Dosage	Other:C0023449		L01BB02	rs55713253:CC	1268107
cyclophosphamide, doxorubicin, paclitaxel	rs145008610	ABCC2	AA	Efficacy	decreased	Efficacy_Response	Other:C1458155		L01AA01|L01CD01|L01DB01	rs145008610:AA	2907
deoxy-thioguanosine triphosphate, thioguanosine triphosphate	rs1142345	TPMT	CT	Metabolism/PK	increased	LADME	Other:C0021390		No_ATC	rs1142345:CT	3000543
azathioprine	rs2413739	PACSIN2	CC	Efficacy	increased	Efficacy_Response	Other:C0021390		L04AX01	rs2413739:CC	5778
azathioprine	rs2413739	PACSIN2	CT	Efficacy	increased	Efficacy_Response	Other:C0021390		L04AX01	rs2413739:CT	5778
clopidogrel	rs1045642	ABCB1	AA	Metabolism/PK	decreased	LADME	Other:C0007222		B01AC04	rs1045642:AA	13748464
clopidogrel	rs1045642	ABCB1	AG	Metabolism/PK	decreased	LADME	Other:C0007222		B01AC04	rs1045642:AG	13748464
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*3/*4	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*3/*4	5452
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*4	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*4/*4	5452
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*5	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*4/*5	5452
thioridazine	CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6	CYP2D6	*4/*6	Metabolism/PK	increased	LADME	Other:C0004936		N05AC02	*4/*6	5452
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*4/*4	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*4/*4	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*4/*5	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*4/*5	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*4/*9	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*4/*9	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*2/*4	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*2/*4	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*1/*4	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*1/*4	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*1/*5	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*1/*5	6135
primaquine	CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*17, CYP2D6*29, CYP2D6*34, CYP2D6*39, CYP2D6*41	CYP2D6	*9/*9	Efficacy	increased	LADME	Other:C0024530|Vivax	intermediate metabolizer and poor metabolizer	P01BA03	*9/*9	6135
cyclosporine	rs776746	CYP3A5	CT	Metabolism/PK	decreased	LADME	Other:Kidney_Transplantation		L04AD01	rs776746:CT	86666680
clozapine	rs762551	CYP1A2	AA	Metabolism/PK	decreased	LADME	Healthy		N05AH02	rs762551:AA	131769989
n-desmethylclozapine(clozapine)	rs2032582	ABCB1	CC	Metabolism/PK	increased	LADME	Healthy		N05AH02	rs2032582:CC	135398737
dulaglutide, liraglutide, semaglutide	rs6923761	GLP1R	GG	Efficacy	increased	Efficacy_Response	Other:C0011849		A10BJ02|A10BJ05|A10BJ06	rs6923761:GG	56843331
n-desmethylclozapine(clozapine)	rs4149056	SLCO1B1	CC	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs4149056:CC	135398737
n-desmethylclozapine(clozapine)	rs4149056	SLCO1B1	CT	Metabolism/PK	increased	LADME	Other:C0036341		N05AH02	rs4149056:CT	135398737
norclobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*2	Metabolism/PK	decreased	LADME	Other:C0014544	poor metabolizer	No_ATC	*2/*2	89657
norclobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*2/*3	Metabolism/PK	decreased	LADME	Other:C0014544	poor metabolizer	No_ATC	*2/*3	89657
norclobazam	CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17	CYP2C19	*3/*3	Metabolism/PK	decreased	LADME	Other:C0014544	poor metabolizer	No_ATC	*3/*3	89657
artemether, lumefantrine	rs3745274	CYP2B6	GT	Efficacy	decreased	Efficacy_Response	Other:C0024530		P01BE02|P01BF01	rs3745274:GT	6450800
4-ene valproic acid	rs2228502	CPT1A	GG	Metabolism/PK	increased	LADME	Other:C0014544		N03AG01	rs2228502:GG	131769943
methotrexate	rs4673991	ATIC	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673991:CC	11329481
methotrexate	rs4673991	ATIC	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673991:CT	11329481
methotrexate	rs4673993	ATIC	CT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:CT	11329481
methotrexate	rs4673993	ATIC	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs4673993:TT	11329481
methotrexate	rs2057638	ADA	GT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2057638:GT	11329481
methotrexate	rs2057638	ADA	TT	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2057638:TT	11329481
methotrexate	rs2372536	ATIC	CC	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2372536:CC	11329481
methotrexate	rs2372536	ATIC	CG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs2372536:CG	11329481
methotrexate	rs6017375	ADA	CG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs6017375:CG	11329481
methotrexate	rs6017375	ADA	GG	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs6017375:GG	11329481
methotrexate	rs371927	ADA	AA	Efficacy	increased	Efficacy_Response	Other:C0003873		L04AX03	rs371927:AA	11329481
codeine, hydrocodone, oxycodone, tramadol	poor metabolizer	CYP2D6	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0030193	poor metabolizer	N02AA05|N02AX02|R05DA03|R05DA04	__UNKNOWN__	5284569
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*2	Efficacy	increased	Efficacy_Response	Other:C0027051	poor metabolizer	B01AC04	*2/*2	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*2/*3	Efficacy	increased	Efficacy_Response	Other:C0027051	poor metabolizer	B01AC04	*2/*3	13748464
clopidogrel	CYP2C19*1, CYP2C19*2, CYP2C19*3	CYP2C19	*3/*3	Efficacy	increased	Efficacy_Response	Other:C0027051	poor metabolizer	B01AC04	*3/*3	13748464
zuclopenthixol	normal metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Healthy	normal metabolizer and ultrarapid metabolizer	N05AF05	__UNKNOWN__	5311507
sitagliptin	rs6923761	GLP1R	GG	Efficacy	increased	Efficacy_Response	Other:C0020538|Other:C0011849		A10BH01	rs6923761:GG	11591741
salbutamol	rs1042717	ADRB2	AA	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs1042717:AA	2083
salbutamol	rs1042714	ADRB2	GG	Efficacy	decreased	Efficacy_Response	Other:C0004096		R03CC02	rs1042714:GG	2083
zuclopenthixol	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0004936	intermediate metabolizer and poor metabolizer	N05AF05	__UNKNOWN__	5311507
perphenazine	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	increased	LADME	Other:C0004936	intermediate metabolizer and poor metabolizer	N05AB03	__UNKNOWN__	82341
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7754840	CDKAL1	CC	Efficacy	increased	Efficacy_Response	Disease:C0011849		No_ATC	rs7754840:CC	No_match
dipeptidyl peptidase 4 (dpp-4) inhibitors	rs7756992	CDKAL1	GG	Efficacy	increased	Efficacy_Response	Disease:C0011849		No_ATC	rs7756992:GG	No_match
sitagliptin, vildagliptin	rs6923761	GLP1R	AA	Efficacy	decreased	Efficacy_Response	Disease:C0011849		A10BH01|A10BH02	rs6923761:AA	4369359
hydroxyurea	rs7943316	CAT	AT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs7943316:AT	10220327
hydroxyurea	rs7943316	CAT	TT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs7943316:TT	10220327
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*1/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*1/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*4	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*4	9918
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*2/*5	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*2/*5	9918
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*41	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4/*41	9918
nortriptyline	CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*41	CYP2D6	*4/*10	Metabolism/PK	increased	LADME	Disease:C0011581		N06AA10	*4/*10	9918
antidepressants, antipsychotics	CYP2C19*17	CYP2C19	*17	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0004936|Other:C0029132|Other:C0031212		N05A|N06A	*17	No_match
antidepressants, antipsychotics	CYP2D6*3	CYP2D6	*3	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0004936|Other:C0029132|Other:C0031212		N05A|N06A	*3	No_match
antidepressants, antipsychotics	CYP1A2*30	CYP1A2	*30	Efficacy	increased	Efficacy_Response	Other:C0036341|Other:C0004936|Other:C0029132|Other:C0031212		N05A|N06A	*30	No_match
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*3	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*6	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*6	131769926
tacrolimus	CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7	CYP3A5	*1/*7	Dosage	increased	Dosage	Other:Liver_transplantation		L04AD02	*1/*7	131769926
tacrolimus	rs35599367	CYP3A4	AG	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	rs35599367:AG	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	*1/*3	131769926
tacrolimus	rs2740574	CYP3A4	CC	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	rs2740574:CC	131769926
tacrolimus	rs2740574	CYP3A4	CT	Dosage	increased	Dosage	Other:Kidney_Transplantation		L04AD02	rs2740574:CT	131769926
antidepressants	rs2292334	SLC22A3	AG	Dosage	increased	Dosage	Other:C0235876		N06A	rs2292334:AG	No_match
antidepressants	rs2292334	SLC22A3	GG	Dosage	increased	Dosage	Other:C0235876		N06A	rs2292334:GG	No_match
hydroxyurea	rs2298720	SLC14A1	AA	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs2298720:AA	10220327
hydroxyurea	rs2298720	SLC14A1	AG	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs2298720:AG	10220327
cisplatin, gemcitabine, pemetrexed	rs11549465	HIF1A	CT	Efficacy	decreased	Efficacy_Response	Other:C0025500		L01BA04|L01BC05|L01XA01	rs11549465:CT	5460033
"""1,7-dimethylxanthine"", ""caffeine"""	rs4410790	AHR	C	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs4410790:C	5429
silodosin	rs35599367	CYP3A4	AG	Metabolism/PK	increased	LADME	Other:C1704272		G04CA04	rs35599367:AG	5312125
silodosin	rs7439366	UGT2B7	CT	Metabolism/PK	increased	LADME	Healthy		G04CA04	rs7439366:CT	5312125
silodosin	rs7439366	UGT2B7	TT	Metabolism/PK	increased	LADME	Healthy		G04CA04	rs7439366:TT	5312125
endoxifen	intermediate metabolizer	CYP2D6	__UNKNOWN__	Metabolism/PK	decreased	LADME	Other:C1458155	intermediate metabolizer	No_ATC	__UNKNOWN__	131769920
mercaptopurine	rs60561071	GNAQ	T	Dosage	decreased	Dosage	Other:C0023449		L01BB02	rs60561071:T	1268107
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Dosage	decreased	Dosage	Other:Kidney_Transplantation		L04AD02	*3/*3	131769926
hydroxyurea	rs3892097	CYP2D6	CT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs3892097:CT	10220327
hydroxyurea	rs3892097	CYP2D6	TT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs3892097:TT	10220327
hydroxyurea	rs1001179	CAT	CT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs1001179:CT	10220327
hydroxyurea	rs1001179	CAT	TT	Efficacy	increased	Efficacy_Response	Other:C0002895		No_ATC	rs1001179:TT	10220327
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*3/*3	Efficacy	increased	Efficacy_Response	Other:C0027697		L04AD02	*3/*3	131769926
"""1,7-dimethylxanthine"", ""caffeine"""	rs2472297	CYP1A1	T	Metabolism/PK	increased	LADME	Healthy		No_ATC	rs2472297:T	5429
"""1,7-dimethylxanthine"", ""caffeine"""	rs56113850	CYP2A6	C	Metabolism/PK	decreased	LADME	Healthy		No_ATC	rs56113850:C	5429
empagliflozin	rs1860561	ATP2A2	GG	Efficacy	increased	Efficacy_Response	Other:C0085605		A10BK03	rs1860561:GG	169501985
hydroxychloroquine	CYP2D6*1, CYP2D6*10	CYP2D6	*1/*10	Metabolism/PK	increased	LADME	Other:C0024138		P01BA02	*1/*10	71826
hydroxychloroquine	CYP2D6*1, CYP2D6*10	CYP2D6	*10/*10	Metabolism/PK	increased	LADME	Other:C0024138		P01BA02	*10/*10	71826
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*9	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*1/*9	10466550
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*1/*4	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*1/*4	10466550
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*4	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*4/*4	10466550
letrozole	CYP2A6*1, CYP2A6*4, CYP2A6*9	CYP2A6	*4/*9	Efficacy	increased	Efficacy_Response	Other:C1458155	intermediate metabolizer and poor metabolizer	L02BG04	*4/*9	10466550
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*1	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*1	131769926
tacrolimus	CYP3A5*1, CYP3A5*3	CYP3A5	*1/*3	Metabolism/PK	increased	LADME	Other:Lung_transplantation		L04AD02	*1/*3	131769926
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*1	Efficacy	increased	Efficacy_Response	Other:C0018839|Other:C0007787		B01AC04	*1/*1	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*1/*17	Efficacy	increased	Efficacy_Response	Other:C0018839|Other:C0007787		B01AC04	*1/*17	13748464
clopidogrel	CYP2C19*1, CYP2C19*17	CYP2C19	*17/*17	Efficacy	increased	Efficacy_Response	Other:C0018839|Other:C0007787		B01AC04	*17/*17	13748464
clozapine, n-desmethylclozapine	rs2472297	CYP1A1	CT	Metabolism/PK	decreased	LADME	Healthy		N05AH02	rs2472297:CT	135398737
clozapine, n-desmethylclozapine	rs2472297	CYP1A1	TT	Metabolism/PK	decreased	LADME	Healthy		N05AH02	rs2472297:TT	135398737
mepolizumab	rs1042713	ADRB2	G	Efficacy	increased	Efficacy_Response	Other:C0004096		R03DX09	rs1042713:G	No_match
immunosuppressants	GSTT1 non-null, GSTT1 null	GSTT1	__UNKNOWN__	Efficacy	decreased	Efficacy_Response	Other:C0002874		L04A		No_match
corticosteroids, montelukast	rs11572080	CYP2C8	CC	Efficacy	increased	Efficacy_Response	Other:C0004096		R03DC03|S02BA	rs11572080:CC	5281040
loratadine	CYP2D6*1, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*41	Metabolism/PK	decreased	LADME	Other:C0004096|Other:C0035455	intermediate metabolizer	R06AX13	*10/*41	3957
loratadine	CYP2D6*1, CYP2D6*10, CYP2D6*41	CYP2D6	*10/*10	Metabolism/PK	decreased	LADME	Other:C0004096|Other:C0035455	intermediate metabolizer	R06AX13	*10/*10	3957
empagliflozin	rs6265	BDNF	CC	Efficacy	increased	Efficacy_Response	Other:C0085605		A10BK03	rs6265:CC	169501985
